data_1sr3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1sr3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.24 156.25 14.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.85 -167.26 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.948 0.795 . . . . 0.0 109.291 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.93 170.94 8.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 125.796 1.638 . . . . 0.0 109.361 168.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -64.63 -4.13 7.88 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.166 2.577 . . . . 0.0 115.581 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.05 -46.31 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 161.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.83 -20.27 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.499 -1.589 . . . . 0.0 113.331 -160.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.04 -13.47 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.575 -0.703 . . . . 0.0 111.462 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.27 -47.39 2.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.66 0.784 . . . . 0.0 109.446 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -90.08 -36.85 14.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.12 0.968 . . . . 0.0 111.07 -168.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.77 4.22 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.801 1.667 . . . . 0.0 111.014 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 CA--C 1.514 -0.408 0 O-C-N 120.0 -1.882 . . . . 0.0 111.43 178.001 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 24.3 mtp . . . . . 0 C--O 1.24 0.586 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.14 165.62 27.83 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.789 1.659 . . . . 0.0 111.493 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.3 136.05 36.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 127.099 2.16 . . . . 0.0 109.358 172.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.17 -14.36 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.073 164.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.93 4.18 71.34 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 116.06 -2.522 . . . . 0.0 114.901 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -117.82 168.41 10.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 123.15 3.475 . . . . 0.0 112.645 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 147.32 22.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 164.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.09 176.19 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 128.288 2.635 . . . . 0.0 110.06 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -131.26 142.47 50.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.91 2.084 . . . . 0.0 109.073 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.52 124.19 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -76.63 150.83 38.71 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 169.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 166.86 37.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.081 1.801 . . . . 0.0 110.285 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttm -95.38 125.32 39.92 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.124 1.37 . . . . 0.0 108.665 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.69 124.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 119.498 1.045 . . . . 0.0 108.494 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.9 mtt -60.06 139.51 90.96 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.381 0.992 . . . . 0.0 110.667 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.6 146.03 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.751 2.968 . . . . 0.0 109.562 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.39 -22.93 0.49 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.328 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -61.13 -38.65 87.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.812 1.806 . . . . 0.0 112.106 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.73 94.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.661 1.584 . . . . 0.0 109.301 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -84.2 144.08 29.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 158.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.832 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.235 0.335 0 N-CA-C 111.328 0.121 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -54.61 143.53 24.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 123.787 0.835 . . . . 0.0 108.817 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.24 155.63 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 125.155 1.382 . . . . 0.0 107.518 172.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.72 120.85 16.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 161.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -134.91 170.26 16.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.882 0.873 . . . . 0.0 110.71 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 m -117.83 145.8 44.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.92 139.47 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -135.11 175.6 9.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.557 1.543 . . . . 0.0 108.803 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 88' ' ' GLU . 30.4 t0 -149.42 -169.83 3.48 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 163.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 6.65 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -119.45 -68.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.873 1.669 . . . . 0.0 109.527 -171.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -168.1 12.76 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.219 1.39 . . . . 0.0 110.401 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.6 p -142.95 160.83 39.6 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.664 0.732 . . . . 0.0 112.684 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.44 154.3 32.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.294 2.238 . . . . 0.0 108.159 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.17 158.73 15.47 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.8 t -138.63 119.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.404 1.482 . . . . 0.0 108.072 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 m -88.06 128.52 35.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 154.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -125.05 161.95 25.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 160.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.58 112.05 5.55 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.07 -159.86 28.28 Favored Glycine 0 CA--C 1.507 -0.453 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.882 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -80.57 111.01 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.64 148.24 48.46 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.205 -1.362 . . . . 0.0 107.832 -169.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.96 131.93 49.25 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -17.31 63.34 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.201 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.49 -25.22 54.01 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.562 1.545 . . . . 0.0 113.796 168.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -51.91 121.87 7.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.385 1.448 . . . . 0.0 111.797 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -135.78 157.48 46.75 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.195 1.474 . . . . 0.0 112.256 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -71.62 95.96 1.51 Allowed 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 128.184 2.594 . . . . 0.0 107.622 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.65 33.81 4.02 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 113.326 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 164.03 17.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.125 1.963 . . . . 0.0 110.357 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.07 83.62 1.44 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.774 1.654 . . . . 0.0 109.401 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.6 -179.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.705 1.202 . . . . 0.0 109.014 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.1 t -126.89 135.75 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.314 2.246 . . . . 0.0 105.577 167.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.68 163.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -161.22 144.78 12.96 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.01 -133.06 3.88 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.97 153.31 51.86 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 120.056 1.928 . . . . 0.0 110.211 -159.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.98 131.48 41.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.65 -62.53 1.49 Allowed 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.119 0.568 . . . . 0.0 109.683 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 -72.34 0.17 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.87 -74.44 0.99 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.34 44.93 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 107.997 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -128.54 135.99 50.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.0 130.15 64.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 127.327 2.251 . . . . 0.0 109.148 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.27 90.43 4.95 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 156.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.8 150.2 7.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.925 0.869 . . . . 0.0 111.174 161.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -12.14 8.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.779 2.832 . . . . 0.0 111.514 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.05 -45.72 0.2 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.1 t 58.97 133.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.584 1.954 . . . . 0.0 111.456 -171.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.84 150.74 48.48 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 120.184 -1.572 . . . . 0.0 107.9 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.26 29.09 8.0 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.464 0.706 . . . . 0.0 111.798 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 124.865 1.266 . . . . 0.0 113.785 -174.599 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 122.906 1.336 . . . . 0.0 109.684 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.99 146.36 14.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -139.42 -176.49 4.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.055 0.942 . . . . 0.0 110.798 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -137.78 172.69 6.37 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 -9.78 17.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.766 2.311 . . . . 0.0 116.19 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.8 -40.87 3.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 121.001 1.728 . . . . 0.0 112.646 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.53 -15.51 56.51 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.316 1.558 . . . . 0.0 112.278 -158.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mt -82.4 -22.82 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.146 1.779 . . . . 0.0 110.896 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -56.87 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.864 1.211 . . . . 0.0 109.784 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -75.25 -64.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.328 1.851 . . . . 0.0 108.255 -171.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.36 151.92 6.37 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tttt . . . . . 0 C--O 1.224 -0.262 0 CA-C-N 117.223 0.511 . . . . 0.0 110.005 176.619 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.99 159.27 41.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.924 1.749 . . . . 0.0 111.52 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 155.33 28.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.15 2.18 . . . . 0.0 108.983 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.9 -8.44 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.824 1.25 . . . . 0.0 110.899 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.03 38.07 2.09 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 125.955 1.74 . . . . 0.0 109.654 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -121.87 164.79 16.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.663 0.744 . . . . 0.0 109.509 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.22 149.91 24.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.299 172.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.96 164.05 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.831 0.852 . . . . 0.0 111.774 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -122.23 99.84 6.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.736 2.414 . . . . 0.0 110.785 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -80.23 159.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.619 -1.301 . . . . 0.0 110.292 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 152.11 24.27 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.278 -0.889 . . . . 0.0 111.789 148.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.26 -178.52 45.18 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.998 1.761 . . . . 0.0 110.395 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.0 ttm -100.83 127.43 47.28 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 117.935 0.867 . . . . 0.0 111.579 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.73 125.88 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.2 mtt -57.04 151.1 36.25 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.484 0.584 . . . . 0.0 110.999 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.5 122.29 9.92 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.418 2.745 . . . . 0.0 108.077 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.7 4.85 48.61 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.872 -1.516 . . . . 0.0 115.538 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.9 p -64.68 -24.9 67.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.339 2.07 . . . . 0.0 110.962 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.68 105.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.588 1.555 . . . . 0.0 109.412 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -60.22 -65.34 0.7 Allowed 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 126.606 1.963 . . . . 0.0 108.901 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 131.31 3.844 . . . . 0.0 115.759 -172.169 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.234 0.064 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.86 142.98 39.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 109.489 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.45 144.05 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -121.81 151.3 40.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 165.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -146.4 178.09 8.53 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.786 0.834 . . . . 0.0 109.054 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -125.86 138.47 53.81 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.27 144.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.807 2.043 . . . . 0.0 106.694 176.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -140.45 171.05 14.68 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.091 1.357 . . . . 0.0 110.357 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.54 -164.6 2.04 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.961 1.304 . . . . 0.0 109.077 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.78 -4.37 6.49 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -112.84 -80.84 0.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -170.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.09 -156.11 6.88 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.575 1.083 . . . . 0.0 111.897 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.4 p -150.08 165.28 33.26 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 117.368 0.584 . . . . 0.0 111.688 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.49 138.31 44.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.041 1.736 . . . . 0.0 108.639 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 151.44 39.37 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.58 127.31 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.666 1.186 . . . . 0.0 109.772 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 p -97.47 135.53 39.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.015 1.326 . . . . 0.0 109.126 164.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -142.09 169.65 17.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.928 1.691 . . . . 0.0 108.679 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -150.56 105.87 3.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.06 -165.32 36.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.724 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -19.47 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.881 0.472 . . . . 0.0 112.187 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 mt 67.13 151.87 0.12 Allowed Pre-proline 0 CA--C 1.527 0.088 0 C-N-CA 129.237 3.015 . . . . 0.0 112.177 -165.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -62.93 139.51 74.24 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.536 1.491 . . . . 0.0 108.25 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.78 -13.04 60.99 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.027 0.918 . . . . 0.0 110.333 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.31 -25.41 51.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 119.662 -1.899 . . . . 0.0 112.411 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.17 128.23 34.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.204 1.802 . . . . 0.0 112.238 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.07 170.29 16.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.954 1.301 . . . . 0.0 110.021 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.08 80.07 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.71 1.204 . . . . 0.0 108.866 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 32.1 0.47 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.449 1.023 . . . . 0.0 112.068 -170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.31 166.79 21.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.931 1.366 . . . . 0.0 110.869 171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.31 121.37 5.44 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.488 1.994 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.69 170.23 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.179 1.392 . . . . 0.0 108.541 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.77 100.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.636 1.974 . . . . 0.0 107.898 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.67 159.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -155.15 137.97 15.33 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.02 -105.77 0.23 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -150.51 157.91 43.55 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.459 1.63 . . . . 0.0 108.941 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.6 tp -80.55 146.4 31.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.318 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -103.44 -64.09 1.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.825 0.739 . . . . 0.0 111.05 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 167.05 158.41 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 129.699 3.199 . . . . 0.0 106.692 -168.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.54 22.53 46.06 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.945 -0.919 . . . . 0.0 114.036 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.3 m120 73.52 29.32 1.6 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.386 1.875 . . . . 0.0 112.702 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -96.09 132.0 41.93 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.833 1.653 . . . . 0.0 109.018 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.7 mm -99.76 129.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 126.306 1.842 . . . . 0.0 109.599 172.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.03 114.41 17.95 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 157.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.42 160.33 29.85 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.009 1.385 . . . . 0.0 109.357 162.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 -26.29 5.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.503 -1.681 . . . . 0.0 110.496 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -139.61 -41.48 0.45 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t 59.28 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.183 1.793 . . . . 0.0 111.878 -173.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.72 157.97 45.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 120.648 -1.282 . . . . 0.0 108.052 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.58 37.35 4.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.954 1.302 . . . . 0.0 110.124 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.4 mmpm? . . . . . 0 C--N 1.341 0.207 0 C-N-CA 125.157 1.383 . . . . 0.0 112.512 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--O 1.237 0.432 0 CA-C-O 121.038 0.447 . . . . 0.0 111.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.451 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 40.4 t80 -171.19 158.29 5.42 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.591 3.156 . . . . 0.0 107.101 173.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.67 -178.9 6.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.629 1.972 . . . . 0.0 110.247 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 p -134.38 163.35 51.83 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 125.16 1.384 . . . . 0.0 111.682 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.07 71.63 5.59 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.602 3.534 . . . . 0.0 108.576 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.52 -66.78 0.15 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 105.44 -3.064 . . . . 0.0 105.44 -163.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.47 -33.5 71.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.131 1.465 . . . . 0.0 111.984 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.45 -11.71 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.354 1.061 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.65 -31.51 3.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.193 . . . . 0.0 111.646 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -98.09 -18.59 18.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.556 1.942 . . . . 0.0 112.218 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.7 147.69 16.99 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.869 1.223 . . . . 0.0 110.403 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 20.0 tptp . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 116.359 -1.781 . . . . 0.0 109.987 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.2 mtp . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.96 155.94 11.43 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.918 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.58 144.35 31.32 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.254 1.422 . . . . 0.0 111.523 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -63.35 -20.82 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 113.001 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.41 59.85 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.88 176.61 9.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.041 1.42 . . . . 0.0 112.328 157.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.36 149.96 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.454 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.39 163.88 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.157 1.383 . . . . 0.0 113.262 166.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -101.53 140.77 35.38 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 126.549 1.94 . . . . 0.0 109.164 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -126.73 139.89 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.098 1.359 . . . . 0.0 108.251 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.44 137.25 12.01 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 163.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.64 -163.28 12.2 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.971 1.748 . . . . 0.0 109.364 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 ttm -126.71 127.53 45.26 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 126.525 1.93 . . . . 0.0 109.525 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.466 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 21.9 t -65.54 130.07 30.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.0 mtt -65.06 124.48 86.88 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.78 103.8 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.775 2.983 . . . . 0.0 106.649 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.49 -5.39 8.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-O 118.246 -1.308 . . . . 0.0 112.632 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.6 p -88.81 -44.19 10.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.467 1.634 . . . . 0.0 111.949 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.89 104.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.508 1.123 . . . . 0.0 110.951 -167.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.46 -66.22 0.58 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.773 1.629 . . . . 0.0 109.954 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 126.8 2.04 . . . . 0.0 112.048 -153.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 119.945 -0.074 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.58 145.14 55.93 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.233 -0.917 . . . . 0.0 108.974 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 p -157.81 132.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -130.98 109.45 10.53 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.768 1.627 . . . . 0.0 108.455 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CE1' HG21 ' A' ' 93' ' ' VAL . 54.8 p90 -123.21 165.99 15.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.141 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 m -114.25 143.34 45.01 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 145.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.73 173.52 11.62 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.239 1.016 . . . . 0.0 109.591 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.14 -169.72 3.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.049 1.34 . . . . 0.0 107.47 164.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.84 -9.07 5.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.511 1.524 . . . . 0.0 114.015 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.12 -71.33 0.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.352 1.861 . . . . 0.0 107.002 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.07 -152.11 5.61 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.9 p -155.21 164.36 38.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.069 0.548 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.38 154.87 11.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.894 1.678 . . . . 0.0 109.547 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.64 164.27 16.91 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.014 0.912 . . . . 0.0 110.307 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 82' ' ' PHE . 1.3 m -132.7 156.46 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.103 1.361 . . . . 0.0 107.957 169.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.6 t -120.74 134.72 55.27 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 157.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -131.99 162.58 30.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.07 1.748 . . . . 0.0 107.403 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -141.13 103.61 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 168.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.53 163.88 26.25 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.2 tt -75.64 -22.1 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -164.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 mt 89.43 149.84 0.07 OUTLIER Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 131.377 3.871 . . . . 0.0 113.109 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -63.2 150.52 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 121.809 1.673 . . . . 0.0 109.576 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.29 -28.97 65.49 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.847 1.259 . . . . 0.0 109.74 163.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.16 -14.08 59.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 128.107 2.563 . . . . 0.0 114.098 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -85.63 127.66 34.54 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 122.947 2.612 . . . . 0.0 106.877 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -134.54 162.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.254 1.026 . . . . 0.0 111.148 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.11 108.7 6.15 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.111 1.765 . . . . 0.0 108.273 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.466 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 96.99 37.86 4.53 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.103 0.858 . . . . 0.0 111.737 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -139.7 170.65 15.51 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.392 1.096 . . . . 0.0 111.646 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.17 136.95 40.33 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.111 0.862 . . . . 0.0 111.294 172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.04 168.1 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.974 1.71 . . . . 0.0 107.15 170.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.46 107.65 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.52 157.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -150.28 139.09 20.83 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 128.014 2.526 . . . . 0.0 105.54 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.85 -118.21 0.81 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 104.343 -3.503 . . . . 0.0 104.343 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -141.17 156.97 45.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 119.717 1.759 . . . . 0.0 111.452 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.57 143.11 32.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -93.39 -72.34 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.295 1.038 . . . . 0.0 109.365 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.86 -86.07 0.17 Allowed 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.143 1.377 . . . . 0.0 109.134 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.87 -69.75 1.3 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -171.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -147.42 5.11 0.81 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -89.6 136.79 32.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 -167.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mm -107.96 127.23 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.742 1.217 . . . . 0.0 109.006 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.62 104.28 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 164.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.57 133.46 42.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.386 0.675 . . . . 0.0 109.301 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -21.82 15.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.574 1.55 . . . . 0.0 111.728 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -144.41 -38.31 0.29 Allowed 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.3 t 58.1 106.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.368 1.867 . . . . 0.0 113.015 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -120.6 156.89 30.68 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 0.0 108.259 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.75 32.25 6.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.284 1.402 . . . . 0.0 112.483 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.038 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.695 0.76 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -159.42 157.59 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.308 2.243 . . . . 0.0 106.492 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.433 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 91.8 m-85 -143.36 177.86 8.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.997 1.719 . . . . 0.0 109.547 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.505 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 45.1 p -132.7 171.41 9.19 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 110.63 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.58 0.01 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.834 2.356 . . . . 0.0 114.803 162.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.84 25.33 7.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.718 1.151 . . . . 0.0 111.734 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 39' ' ' THR . 43.5 mt-10 -132.39 -41.17 0.98 Allowed 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.876 1.338 . . . . 0.0 110.69 173.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.16 -23.5 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 118.326 0.512 . . . . 0.0 110.944 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -53.9 2.58 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.521 1.528 . . . . 0.0 107.603 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -88.38 14.8 8.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -166.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.62 124.7 3.25 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 29.9 tttm . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.908 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 83.4 mmm . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.03 148.27 62.94 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.284 1.323 . . . . 0.0 109.649 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.87 146.65 33.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -76.48 1.52 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.02 1.328 . . . . 0.0 112.018 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.63 38.39 1.37 Allowed Glycine 0 CA--C 1.51 -0.261 0 O-C-N 118.544 -2.597 . . . . 0.0 110.287 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.77 168.35 9.54 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 164.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -79.89 152.38 29.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 168.39 27.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.552 1.141 . . . . 0.0 111.229 165.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -114.4 136.45 52.98 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.954 2.102 . . . . 0.0 107.725 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.01 151.91 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.73 2.012 . . . . 0.0 107.777 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.32 149.69 17.9 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.4 179.17 48.9 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.388 0.995 . . . . 0.0 110.85 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.2 ttm -91.08 126.12 36.07 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.805 1.642 . . . . 0.0 109.968 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.84 130.04 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 O-C-N 120.445 -1.41 . . . . 0.0 108.198 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.1 mtt -62.9 139.19 97.33 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 118.54 0.609 . . . . 0.0 111.637 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.83 146.8 60.85 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.395 2.73 . . . . 0.0 108.941 163.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.22 20.97 75.52 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.414 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.5 m -120.22 -26.18 5.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.704 1.252 . . . . 0.0 112.15 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.05 93.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 119.318 0.963 . . . . 0.0 108.91 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -73.25 -66.11 0.72 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.124 1.77 . . . . 0.0 109.317 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 128.563 2.745 . . . . 0.0 110.868 -176.272 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 119.16 -0.448 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -60.25 139.15 57.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.281 1.039 . . . . 0.0 108.249 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 158.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.097 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 140.63 52.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 151.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 43.8 p90 -140.94 -179.11 5.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.999 0.919 . . . . 0.0 109.296 160.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.9 m -130.85 151.27 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.32 129.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -116.58 -177.51 3.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.093 1.757 . . . . 0.0 107.42 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -155.13 -141.65 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 155.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -18.74 65.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 121.266 1.848 . . . . 0.0 114.663 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.69 -69.69 0.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -151.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.63 -153.47 5.9 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.2 p -147.27 163.53 36.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.282 1.041 . . . . 0.0 112.008 170.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.92 138.56 38.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.54 1.936 . . . . 0.0 109.504 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.65 150.78 37.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 5.0 m -127.24 152.77 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 164.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.406 ' HG ' ' CE1' ' A' ' 120' ' ' HIS . 20.2 p -125.99 128.36 47.35 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 161.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -125.83 170.58 11.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.37 1.868 . . . . 0.0 108.011 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -158.76 107.5 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.5 14.98 0.02 OUTLIER Glycine 0 N--CA 1.473 1.145 0 C-N-CA 114.409 -3.758 . . . . 0.0 121.265 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 99' ' ' LEU 0.265 0.4 OUTLIER 58.01 143.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.957 2.103 . . . . 0.0 110.186 -152.222 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.404 ' H ' HD12 ' A' ' 98' ' ' ILE . 20.8 mt -92.08 162.67 29.87 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.525 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -58.32 147.87 82.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 166.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -66.15 -18.14 65.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.771 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.44 -31.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.858 -1.544 . . . . 0.0 112.493 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.9 137.9 58.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.572 1.078 . . . . 0.0 109.164 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -142.54 168.96 18.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.1 132.83 53.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 159.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.69 15.54 56.47 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.7 163.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -121.23 163.68 18.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.42 1.11 . . . . 0.0 111.545 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.91 124.08 10.15 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.84 162.39 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.99 134.31 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 t -107.79 160.51 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -158.64 151.07 21.74 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 166.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.07 -145.34 12.09 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 -165.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.97 157.88 35.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.734 1.267 . . . . 0.0 109.463 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.56 137.08 33.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.15 -65.91 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -163.9 154.84 15.87 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 133.956 4.902 . . . . 0.0 104.725 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -98.44 0.22 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.16 1.82 2.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.406 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 18.6 t-160 -70.78 124.64 24.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.956 1.253 . . . . 0.0 109.772 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.28 122.45 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.66 1.584 . . . . 0.0 110.531 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.92 81.67 5.18 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 165.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.63 133.5 30.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.041 1.336 . . . . 0.0 109.892 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 -25.25 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.611 1.564 . . . . 0.0 111.196 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.45 -37.39 0.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t 52.19 113.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 127.068 2.147 . . . . 0.0 115.523 176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.47 154.32 47.1 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.519 -1.363 . . . . 0.0 108.889 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -118.16 37.11 4.1 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.253 1.842 . . . . 0.0 111.894 -166.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 127.851 2.46 . . . . 0.0 112.304 -173.846 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.28 0.562 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -150.54 139.46 20.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.219 -166.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -140.68 -174.74 4.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.595 1.958 . . . . 0.0 107.7 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.467 ' H ' ' HG3' ' A' ' 42' ' ' GLU . 26.0 p -141.26 174.48 3.83 Favored Pre-proline 0 C--O 1.235 0.325 0 O-C-N 120.542 -1.349 . . . . 0.0 110.542 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -57.69 0.88 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -108.22 -41.94 1.46 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 121.789 2.086 . . . . 0.0 112.904 163.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 5.8 pt-20 -80.44 -2.61 46.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 119.607 1.704 . . . . 0.0 113.249 -162.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.55 -18.11 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.135 0.974 . . . . 0.0 110.38 166.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.61 -47.68 5.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.79 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -87.51 -26.37 23.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.364 1.466 . . . . 0.0 110.907 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.9 146.17 9.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.664 1.602 . . . . 0.0 110.301 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 44.8 tttm . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 117.971 -1.014 . . . . 0.0 112.228 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.645 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.2 134.48 45.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.667 2.245 . . . . 0.0 109.371 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.29 130.7 35.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.22 -11.1 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.418 0.627 . . . . 0.0 112.192 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.27 3.73 61.93 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 116.885 -2.064 . . . . 0.0 113.009 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -110.01 167.2 10.35 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.893 2.347 . . . . 0.0 112.766 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -85.29 137.54 32.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 108.669 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.99 173.37 16.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.217 1.007 . . . . 0.0 110.175 171.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -122.34 157.36 31.96 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 111.136 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -131.96 143.24 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.571 1.948 . . . . 0.0 107.326 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.19 127.51 5.91 Favored Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 168.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.51 -178.89 38.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.7 ttm -105.22 129.71 53.54 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.028 0.931 . . . . 0.0 110.277 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.99 129.01 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.289 0.95 . . . . 0.0 108.925 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' MET . . . . . 0.451 ' HG3' ' CD1' ' A' ' 85' ' ' TYR . 5.3 mtm -68.9 149.45 97.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.489 0.586 . . . . 0.0 110.967 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.31 137.97 24.18 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.355 2.703 . . . . 0.0 108.966 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.59 57.9 15.68 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -142.62 -30.58 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 164.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.303 2.2 p -75.16 95.54 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 120.833 -1.167 . . . . 0.0 111.855 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.05 28.56 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 131.469 3.908 . . . . 0.0 113.896 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 124.41 1.084 . . . . 0.0 110.84 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 111.402 0.149 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 137.27 57.15 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 109.387 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -161.15 127.2 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.0 p -105.47 159.94 15.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 53.3 p90 -153.82 -178.4 7.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.042 0.837 . . . . 0.0 110.059 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 m -129.92 142.4 50.66 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.7 136.78 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.451 ' CD1' ' HG3' ' A' ' 67' ' ' MET . 15.8 p90 -135.21 169.9 16.75 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.096 1.359 . . . . 0.0 109.559 -173.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.75 -166.76 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.339 1.855 . . . . 0.0 107.692 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -3.52 1.76 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.834 2.054 . . . . 0.0 114.972 -171.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -111.6 -62.28 1.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.819 1.248 . . . . 0.0 107.73 -173.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.26 -167.98 17.08 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.896 1.712 . . . . 0.0 112.005 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.9 p -137.51 164.04 29.69 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.92 0.888 . . . . 0.0 112.006 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.98 144.64 25.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.121 1.368 . . . . 0.0 109.501 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.97 152.52 30.98 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.209 1.004 . . . . 0.0 108.641 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 3.4 m -132.65 147.95 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.354 163.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -119.92 112.45 19.21 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.263 1.825 . . . . 0.0 108.557 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.88 166.51 11.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 108.32 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.13 97.89 1.96 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 168.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.65 -174.07 46.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.508 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.04 118.93 21.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.5 tp -97.14 135.3 21.99 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 109.113 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.45 156.9 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.154 1.903 . . . . 0.0 112.435 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.92 -40.8 75.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 123.098 1.428 . . . . 0.0 108.957 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.44 -27.02 68.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.766 1.626 . . . . 0.0 111.715 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -66.29 106.64 1.75 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 119.374 0.988 . . . . 0.0 108.867 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -133.16 158.84 41.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.21 1.004 . . . . 0.0 109.829 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.71 105.48 3.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.628 1.571 . . . . 0.0 107.462 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.05 26.19 7.57 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.384 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.21 163.87 17.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.663 1.731 . . . . 0.0 110.508 160.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.88 138.2 19.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.61 174.47 12.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.36 1.464 . . . . 0.0 107.237 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.15 137.43 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.04 156.82 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.249 1.42 . . . . 0.0 107.508 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.21 141.88 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 127.072 2.149 . . . . 0.0 106.645 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.33 -103.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 166.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -142.89 161.35 38.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.983 1.892 . . . . 0.0 109.418 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.16 144.3 31.75 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -101.82 -72.53 0.68 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.319 0.509 . . . . 0.0 109.979 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -163.69 -83.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.147 2.179 . . . . 0.0 108.158 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.56 73.34 2.07 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.175 1.369 . . . . 0.0 111.555 -162.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.2 m120 44.49 46.39 8.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.304 1.841 . . . . 0.0 110.542 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -122.16 129.39 52.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.543 1.137 . . . . 0.0 108.395 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.69 132.9 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.506 1.522 . . . . 0.0 109.487 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.17 114.37 18.06 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 159.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.009 170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 -35.83 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.76 2.874 . . . . 0.0 118.76 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.9 t 50.65 122.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.39 1.876 . . . . 0.0 115.337 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.79 156.02 49.59 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 119.893 -1.754 . . . . 0.0 108.308 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.83 30.06 7.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 112.268 -168.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 123.008 1.385 . . . . 0.0 112.178 -172.862 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.237 0.445 0 CA-C-O 122.275 1.036 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -161.84 150.69 15.6 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.418 1.887 . . . . 0.0 109.107 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.04 172.35 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.897 1.279 . . . . 0.0 111.549 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.4 p -135.59 158.72 73.71 Favored Pre-proline 0 C--O 1.243 0.762 0 C-N-CA 125.168 1.387 . . . . 0.0 111.591 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.76 78.58 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.975 3.784 . . . . 0.0 109.567 164.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.71 -63.16 0.22 Allowed Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 106.587 -2.605 . . . . 0.0 106.587 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.48 -21.47 66.34 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 122.149 -0.618 . . . . 0.0 110.39 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -77.45 -13.31 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.108 1.763 . . . . 0.0 110.683 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.11 -54.33 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.411 1.484 . . . . 0.0 107.499 -163.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -77.65 -78.87 0.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.962 2.505 . . . . 0.0 107.171 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.16 152.7 8.68 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.45 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptm . . . . . 0 N--CA 1.472 0.674 0 C-N-CA 125.291 1.436 . . . . 0.0 110.972 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.3 mtp . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.22 149.11 15.13 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.8 1.667 . . . . 0.0 109.285 168.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.01 148.65 31.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.19 -9.82 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.239 1.016 . . . . 0.0 111.149 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.44 61.59 0.43 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 168.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.64 174.41 14.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.799 1.3 . . . . 0.0 112.942 163.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -80.75 147.29 30.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.734 1.214 . . . . 0.0 108.88 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.1 165.23 24.89 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -97.46 144.58 27.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.002 2.921 . . . . 0.0 108.746 167.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.1 t -128.98 146.36 34.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.703 1.601 . . . . 0.0 108.167 167.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.41 139.07 10.63 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.33 -169.01 28.37 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 ttm -107.46 124.61 50.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.062 1.431 . . . . 0.0 109.682 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -55.24 130.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.4 ttm -63.0 124.52 84.06 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.89 134.44 46.61 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.831 2.354 . . . . 0.0 108.465 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.58 7.93 85.48 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.032 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.5 p -98.17 -32.73 11.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.755 1.777 . . . . 0.0 113.71 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -77.2 123.37 33.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 118.889 0.768 . . . . 0.0 110.166 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.41 127.2 41.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 152.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 161.147 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.685 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 144.78 46.53 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.745 1.611 . . . . 0.0 109.226 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.85 136.39 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 p -118.37 152.47 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -153.02 -178.57 7.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.842 0.746 . . . . 0.0 109.796 166.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m -124.04 154.61 39.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.27 134.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -121.98 178.33 4.94 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.38 -148.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.35 61.66 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.764 -1.21 . . . . 0.0 113.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.3 -64.17 1.3 Allowed 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.475 1.11 . . . . 0.0 109.085 -162.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.81 -157.44 7.58 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.7 p -145.22 162.54 36.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.286 0.543 . . . . 0.0 112.265 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.65 154.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.166 2.186 . . . . 0.0 108.826 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 155.56 16.91 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.03 1.332 . . . . 0.0 109.481 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.5 t -139.23 128.66 30.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 123.574 0.75 . . . . 0.0 109.082 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.447 ' HG ' ' CE1' ' A' ' 120' ' ' HIS . 47.5 m -110.85 117.23 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.066 1.347 . . . . 0.0 107.451 162.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -121.37 159.64 25.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.618 1.567 . . . . 0.0 107.071 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -146.68 90.12 1.9 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.51 -171.85 44.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.872 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.91 115.77 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.34 131.85 39.21 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.5 138.06 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.442 -1.407 . . . . 0.0 108.442 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.92 -20.81 65.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.06 0.933 . . . . 0.0 109.396 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.2 -21.71 63.94 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.304 1.442 . . . . 0.0 110.439 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -71.0 134.98 47.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.895 1.278 . . . . 0.0 109.252 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -138.35 -177.04 4.67 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.95 127.63 52.87 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.485 ' H ' ' CG1' ' A' ' 66' ' ' VAL . . . 80.71 31.67 35.64 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 118.077 -1.402 . . . . 0.0 110.992 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.479 ' H ' ' CG1' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -118.14 168.08 10.89 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.042 1.421 . . . . 0.0 110.368 170.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.01 133.44 18.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.04 165.78 29.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.269 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.81 117.21 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 166.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.06 159.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.189 0.995 . . . . 0.0 108.65 162.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -154.04 146.6 24.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.889 1.676 . . . . 0.0 107.195 162.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.03 -104.26 0.2 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 161.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.64 154.04 46.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 119.219 1.51 . . . . 0.0 109.623 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 144.52 39.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -104.3 -83.75 0.49 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.782 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 -82.15 0.11 Allowed 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.544 1.066 . . . . 0.0 111.13 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.53 73.4 2.22 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -169.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m120 51.96 56.41 7.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.836 1.254 . . . . 0.0 109.205 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.447 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 20.6 t-160 -135.3 123.7 23.32 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.2 130.76 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.127 1.371 . . . . 0.0 107.745 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.38 110.13 13.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 157.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.45 154.36 39.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 122.076 0.941 . . . . 0.0 109.822 168.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -17.96 7.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.425 1.89 . . . . 0.0 111.997 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -143.18 -43.27 0.29 Allowed 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.8 t 54.13 121.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 123.686 1.708 . . . . 0.0 113.638 -172.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 mt -130.58 155.37 46.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.796 1.238 . . . . 0.0 108.094 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.9 39.9 3.26 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.312 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 126.595 1.958 . . . . 0.0 113.356 -177.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 123.5 1.619 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -166.26 153.62 9.84 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.195 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.423 ' CE1' ' HD2' ' A' ' 47' ' ' LYS . 97.6 m-85 -144.91 -179.9 6.91 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.715 1.606 . . . . 0.0 108.73 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 12.1 p -139.38 177.09 2.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.64 -13.53 22.26 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 CA-C-N 120.661 1.272 . . . . 0.0 111.567 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.87 -45.59 5.66 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 165.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 39' ' ' THR . 45.4 mt-10 -63.83 -30.78 71.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.029 1.414 . . . . 0.0 111.177 -167.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.01 -21.43 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.43 1.013 . . . . 0.0 111.238 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.94 -44.98 4.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.562 1.074 . . . . 0.0 111.433 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -98.12 -9.94 25.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.5 1.92 . . . . 0.0 113.23 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.9 133.9 5.18 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 26.5 tttm . . . . . 0 N--CA 1.449 -0.517 0 O-C-N 121.299 -1.118 . . . . 0.0 109.161 160.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.1 mtp . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 172.15 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.261 1.486 . . . . 0.0 110.85 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -89.17 139.49 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.011 1.324 . . . . 0.0 107.684 163.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.9 0.59 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.824 1.249 . . . . 0.0 110.275 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.48 56.96 0.72 Allowed Glycine 0 N--CA 1.451 -0.305 0 O-C-N 120.196 -1.565 . . . . 0.0 111.847 164.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -141.36 -175.47 4.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.162 0.981 . . . . 0.0 111.314 166.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.88 141.03 36.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.117 0.967 . . . . 0.0 110.376 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -179.62 8.02 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.408 1.483 . . . . 0.0 111.082 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -122.65 151.53 41.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.071 2.148 . . . . 0.0 110.751 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -148.98 128.55 3.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 120.261 3.43 . . . . 0.0 120.261 169.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.85 141.51 18.66 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.405 1.002 . . . . 0.0 110.82 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.34 177.67 47.82 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 119.427 -0.652 . . . . 0.0 113.153 166.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 35.2 ttm -102.36 129.74 48.91 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.481 1.112 . . . . 0.0 110.152 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.9 132.14 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.358 1.063 . . . . 0.0 109.643 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtt -62.47 132.61 94.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.292 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.15 131.3 29.97 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.901 1.734 . . . . 0.0 108.714 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.17 72.73 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.702 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -86.14 -74.39 0.42 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 159.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.282 2.6 p -37.66 88.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 130.616 3.566 . . . . 0.0 114.816 -170.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -77.6 137.84 38.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 127.467 2.307 . . . . 0.0 105.553 163.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 149.16 18.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.276 1.83 . . . . 0.0 109.69 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.6 148.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 166.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 p -131.94 119.8 21.61 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.27 168.04 20.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.233 0.613 . . . . 0.0 109.603 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -122.99 147.31 46.78 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.91 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.09 174.34 10.61 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.298 1.039 . . . . 0.0 110.27 -170.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.11 -168.9 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.174 2.189 . . . . 0.0 106.266 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.03 -4.35 16.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.9 -66.77 0.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.45 -163.47 11.99 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.371 1.462 . . . . 0.0 110.681 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.9 p -150.94 158.71 44.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.013 0.906 . . . . 0.0 111.251 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.66 150.23 20.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 108.721 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 157.57 23.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.1 120.8 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 168.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 m -91.56 121.79 33.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 152.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.11 171.44 7.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 164.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -162.15 99.06 1.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.82 -144.71 9.11 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.214 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.82 91.8 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.47 130.03 87.36 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.901 -1.499 . . . . 0.0 107.868 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -54.84 138.31 76.92 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.031 1.82 . . . . 0.0 109.359 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -56.78 -31.84 65.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.672 0.749 . . . . 0.0 111.197 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.32 -22.32 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 114.63 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.98 131.79 44.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.927 1.24 . . . . 0.0 108.835 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -140.96 170.29 16.02 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.014 -1.054 . . . . 0.0 109.468 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -73.41 123.16 23.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.49 26.55 25.01 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 123.381 0.515 . . . . 0.0 113.269 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.47 171.69 10.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.555 1.142 . . . . 0.0 109.684 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.74 128.02 9.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.999 1.762 . . . . 0.0 109.054 -173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.35 175.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.05 139.57 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.622 1.969 . . . . 0.0 106.668 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.37 164.84 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -160.4 143.0 13.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.527 1.931 . . . . 0.0 107.627 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.59 -124.1 1.67 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 105.098 -3.201 . . . . 0.0 105.098 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -128.9 156.91 42.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 120.127 1.963 . . . . 0.0 109.192 -161.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.73 137.73 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.843 0.857 . . . . 0.0 109.482 171.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -84.0 0.42 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.995 0.816 . . . . 0.0 109.063 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.91 167.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.714 3.206 . . . . 0.0 106.299 -172.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.24 50.14 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.96 -0.911 . . . . 0.0 113.151 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 m120 62.66 58.19 1.66 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 0.0 111.087 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -131.32 127.49 37.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.5 mm -102.63 125.92 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 126.675 1.99 . . . . 0.0 109.037 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.52 83.97 5.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.47 148.2 9.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.112 0.958 . . . . 0.0 112.25 165.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -18.76 8.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 128.384 2.674 . . . . 0.0 110.912 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.33 -51.64 0.48 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.8 t 60.69 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.097 2.159 . . . . 0.0 112.394 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.97 146.49 47.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.746 -1.221 . . . . 0.0 107.897 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.41 34.66 3.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.854 0.862 . . . . 0.0 110.563 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 125.704 1.602 . . . . 0.0 114.708 174.603 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -174.53 135.39 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.11 2.164 . . . . 0.0 106.074 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.09 176.71 6.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.509 1.524 . . . . 0.0 109.202 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 61.5 p -136.24 173.85 5.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.645 1.578 . . . . 0.0 108.545 173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.74 -13.36 19.95 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.685 1.59 . . . . 0.0 112.205 -166.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.25 -45.75 7.33 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 162.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HB2' ' H ' ' A' ' 39' ' ' THR . 30.3 mt-10 -60.17 -29.17 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.334 2.067 . . . . 0.0 113.036 -168.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mt -73.34 -22.26 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.475 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -35.51 3.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.478 -169.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.86 -31.27 18.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.482 2.313 . . . . 0.0 110.518 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.64 149.46 7.47 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.251 1.405 . . . . 0.0 111.869 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 tttm . . . . . 0 CA--C 1.51 -0.572 0 O-C-N 122.013 -0.698 . . . . 0.0 110.826 -179.449 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 40.9 mtp . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 158.01 59.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 CA-C-N 121.432 1.547 . . . . 0.0 110.085 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.43 144.9 33.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 165.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.9 -7.25 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.625 0.77 . . . . 0.0 111.582 174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.55 43.18 1.72 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.748 1.166 . . . . 0.0 110.512 165.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.52 169.32 17.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.127 1.964 . . . . 0.0 113.047 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -87.92 140.58 29.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.041 2.537 . . . . 0.0 108.609 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.12 -174.59 5.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.495 0.718 . . . . 0.0 110.621 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.38 147.21 50.46 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.148 1.779 . . . . 0.0 107.485 169.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.28 130.48 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.177 1.791 . . . . 0.0 106.532 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.65 157.01 20.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 163.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.68 41.62 Favored Glycine 0 C--O 1.236 0.26 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.2 ttm -99.01 125.31 44.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.37 121.12 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 3.7 ttm -64.16 126.84 91.11 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.93 154.43 73.21 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.28 1.987 . . . . 0.0 108.368 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.76 44.55 80.57 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.778 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -133.12 -38.43 0.96 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.895 1.348 . . . . 0.0 113.225 169.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.269 1.6 p -64.57 92.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.567 1.076 . . . . 0.0 112.059 -172.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.07 86.46 6.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.892 2.477 . . . . 0.0 107.703 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.99 131.03 46.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 164.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.25 130.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.0 m -126.46 134.45 50.96 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.35 176.38 10.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.231 -1.543 . . . . 0.0 110.352 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 m -123.18 145.78 48.34 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.68 142.24 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -137.99 171.99 13.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.635 1.174 . . . . 0.0 109.516 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.09 -169.07 3.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.299 1.439 . . . . 0.0 107.383 168.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 9.99 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.582 1.553 . . . . 0.0 114.412 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.47 -67.11 0.78 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.003 1.321 . . . . 0.0 109.504 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.32 -175.47 13.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.1 p -143.51 158.08 43.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.297 1.039 . . . . 0.0 109.973 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.37 149.01 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.627 1.171 . . . . 0.0 109.707 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.13 148.0 26.35 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.99 1.316 . . . . 0.0 107.883 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.01 119.09 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.104 0.961 . . . . 0.0 108.779 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 t -91.94 129.65 37.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 159.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -124.23 163.78 20.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.653 1.181 . . . . 0.0 108.747 166.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -144.87 100.17 3.45 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.88 -179.4 43.58 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -71.36 -24.38 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 122.064 -0.668 . . . . 0.0 111.84 -159.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 tp 65.36 129.24 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.727 0 C-N-CA 128.803 2.841 . . . . 0.0 110.623 -166.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -66.03 169.04 14.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.255 3.303 . . . . 0.0 110.689 -168.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.49 -36.07 77.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.982 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -35.34 63.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.568 2.747 . . . . 0.0 113.025 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -63.76 131.88 49.23 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.466 1.03 . . . . 0.0 109.092 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -143.14 161.0 39.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.882 0.873 . . . . 0.0 111.313 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -64.06 117.39 7.01 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.86 4.95 16.17 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.958 -0.912 . . . . 0.0 114.938 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.7 167.04 20.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.925 1.363 . . . . 0.0 112.151 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.05 137.28 15.34 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 125.737 1.637 . . . . 0.0 109.977 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.82 168.61 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.95 108.91 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 127.652 2.381 . . . . 0.0 106.541 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.26 158.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 124.717 1.207 . . . . 0.0 108.986 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -156.67 147.15 21.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 129.439 3.096 . . . . 0.0 105.716 172.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.84 -112.39 0.52 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -147.63 159.34 43.88 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 119.734 1.767 . . . . 0.0 110.41 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.02 142.61 28.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.117 0.967 . . . . 0.0 108.589 172.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 -84.25 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.55 1.14 . . . . 0.0 108.185 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -166.92 154.53 9.32 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 128.94 2.896 . . . . 0.0 106.709 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.6 42.91 99.85 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.16 40.88 30.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 111.929 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -109.82 124.36 51.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -96.28 131.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.711 1.204 . . . . 0.0 108.649 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.88 114.21 17.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 154.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 149.22 39.94 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.874 0.845 . . . . 0.0 108.849 161.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -21.85 11.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.606 1.163 . . . . 0.0 111.173 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -146.17 -47.13 0.2 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.242 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.0 t 59.24 150.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.243 1.817 . . . . 0.0 109.371 -167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.0 mt -147.89 151.59 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 119.192 -2.193 . . . . 0.0 107.045 172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.14 33.88 3.76 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.681 1.128 . . . . 0.0 112.674 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.44 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -170.32 154.77 4.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.179 0.991 . . . . 0.0 109.908 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.27 -170.11 2.41 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.553 1.07 . . . . 0.0 110.302 170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -141.99 170.99 7.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 158.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -81.22 -1.43 11.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.511 1.474 . . . . 0.0 112.439 -159.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -7.58 41.28 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.673 1.606 . . . . 0.0 110.578 165.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.97 18.0 22.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.436 -1.626 . . . . 0.0 110.066 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.12 -23.15 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.658 ' H ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.35 -50.68 4.91 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 126.629 1.972 . . . . 0.0 111.036 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.95 -63.9 1.12 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.03 175.73 39.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 116.9 -1.524 . . . . 0.0 108.311 159.797 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 mtp . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.41 147.21 87.01 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.53 1.487 . . . . 0.0 109.633 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.36 147.48 32.39 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.54 -8.47 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.369 1.468 . . . . 0.0 111.232 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.1 40.72 1.82 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 125.217 1.389 . . . . 0.0 110.504 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -134.96 170.55 15.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.341 1.57 . . . . 0.0 111.837 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 151.81 22.27 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 170.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.88 176.75 12.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.291 1.036 . . . . 0.0 112.376 172.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.471 HH21 ' CD1' ' A' ' 127' ' ' LEU . 50.8 ttt180 -124.48 148.53 47.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.146 2.578 . . . . 0.0 107.049 172.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -147.56 167.27 5.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 119.975 1.261 . . . . 0.0 111.353 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -142.2 155.25 25.49 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 119.981 1.264 . . . . 0.0 111.677 169.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.84 -175.93 47.01 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.563 1.077 . . . . 0.0 113.28 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.5 ttm -103.21 123.78 47.37 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.484 1.514 . . . . 0.0 110.673 -170.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.9 t -71.7 129.58 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.885 -1.134 . . . . 0.0 109.848 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 49.5 mtt -63.75 152.22 87.0 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 118.62 0.645 . . . . 0.0 112.085 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.99 141.32 68.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.251 2.634 . . . . 0.0 110.745 170.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.75 3.85 1.27 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.369 1.461 . . . . 0.0 115.649 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.7 p -73.24 -26.21 61.03 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.743 1.771 . . . . 0.0 112.121 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.39 103.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.897 1.279 . . . . 0.0 109.909 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -86.78 30.32 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.669 2.787 . . . . 0.0 111.219 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? . . . . . 0 CA--C 1.511 -0.547 0 C-N-CA 123.458 0.703 . . . . 0.0 109.192 170.19 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -60.57 136.14 57.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.66 134.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 p -124.9 162.15 25.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 167.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 93' ' ' VAL . 27.6 p90 -152.13 179.32 8.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.741 1.155 . . . . 0.0 109.349 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -115.71 145.88 42.37 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 139.1 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.05 170.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.116 1.766 . . . . 0.0 109.636 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -161.3 -154.12 0.34 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.558 1.543 . . . . 0.0 106.879 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 -22.38 62.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.814 -1.179 . . . . 0.0 112.872 -164.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -76.12 0.53 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.88 -166.98 12.66 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.46 -0.775 . . . . 0.0 112.229 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.3 p -140.78 160.64 39.61 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 112.023 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.14 153.97 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.036 1.334 . . . . 0.0 109.646 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.15 150.56 37.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.51 165.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -118.0 160.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 156.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.9 m -129.62 127.44 40.63 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -127.41 168.62 14.6 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.633 1.573 . . . . 0.0 108.505 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.96 92.13 1.16 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.0 -176.38 45.09 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.418 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.02 113.35 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 tp -77.24 143.39 69.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -58.46 146.31 90.92 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.113 1.209 . . . . 0.0 109.065 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.45 -30.82 71.89 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.46 -36.97 85.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.705 2.002 . . . . 0.0 110.978 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -56.23 133.0 52.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.002 1.721 . . . . 0.0 109.039 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.83 167.13 21.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.319 0.963 . . . . 0.0 112.312 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -74.72 112.9 11.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.74 49.13 5.85 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 112.181 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -119.63 -170.29 1.92 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.386 -1.067 . . . . 0.0 109.542 145.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.87 140.68 14.95 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.66 178.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.764 1.625 . . . . 0.0 107.922 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.2 t -131.65 142.18 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.65 163.98 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.868 0.842 . . . . 0.0 109.55 162.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -157.48 144.27 18.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 106.609 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.93 -109.02 0.38 Allowed Glycine 0 CA--C 1.518 0.253 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -140.91 162.93 34.3 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 120.165 1.983 . . . . 0.0 109.541 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -89.24 140.26 29.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.566 0.746 . . . . 0.0 110.154 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 -77.95 0.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.82 166.47 3.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.287 3.835 . . . . 0.0 105.13 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.9 42.04 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 120.198 1.363 . . . . 0.0 113.653 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.71 4.96 5.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.841 2.057 . . . . 0.0 114.263 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -71.35 139.31 49.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.042 2.137 . . . . 0.0 109.691 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.29 133.89 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 126.765 2.026 . . . . 0.0 110.164 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.84 106.94 11.2 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 154.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.65 58.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.513 0.673 . . . . 0.0 110.22 153.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 -11.61 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.615 2.366 . . . . 0.0 110.974 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -147.82 -46.23 0.16 Allowed 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.8 t 57.17 141.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.876 1.67 . . . . 0.0 111.601 -165.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.471 ' CD1' HH21 ' A' ' 61' ' ' ARG . 53.9 mt -139.38 162.59 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.53 29.27 6.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.384 1.074 . . . . 0.0 112.226 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 115.137 173.611 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 122.836 1.303 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -173.13 136.77 0.66 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.768 2.427 . . . . 0.0 106.311 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 79.3 m-85 -131.6 -175.11 3.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.033 1.733 . . . . 0.0 109.545 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 72.5 p -142.1 169.07 11.8 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 112.78 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.77 71.54 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.569 2.846 . . . . 0.0 110.747 157.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.21 -56.17 0.19 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 127.899 2.666 . . . . 0.0 106.976 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 39' ' ' THR . 32.3 mt-10 -68.24 -9.36 46.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.1 mt -104.84 -22.35 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.118 1.367 . . . . 0.0 108.327 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.42 -48.38 5.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.731 2.412 . . . . 0.0 111.711 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.93 -64.51 1.07 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.684 1.994 . . . . 0.0 107.081 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.59 164.5 18.85 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.663 1.602 . . . . 0.0 109.226 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 1.2 tptt . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 126.673 1.989 . . . . 0.0 111.229 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.796 0.332 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.3 155.73 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.44 2.093 . . . . 0.0 109.747 150.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.88 143.97 30.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 159.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.57 -15.58 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.053 0.541 . . . . 0.0 111.369 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.04 37.38 3.74 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.384 -1.787 . . . . 0.0 111.741 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -137.1 174.06 11.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.654 2.227 . . . . 0.0 112.399 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -106.89 138.86 42.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.409 1.484 . . . . 0.0 110.226 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.06 167.5 30.26 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.797 1.239 . . . . 0.0 112.034 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -99.52 150.43 22.22 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.1 1.76 . . . . 0.0 109.779 165.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.73 154.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.841 2.056 . . . . 0.0 106.925 168.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.63 152.97 21.44 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 155.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.24 179.51 48.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttm -101.51 130.04 47.71 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.835 0.854 . . . . 0.0 109.545 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.7 t -69.04 125.28 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.782 1.173 . . . . 0.0 108.266 -176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.5 mtt -57.44 139.18 80.87 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 119.006 0.821 . . . . 0.0 110.25 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.89 124.69 10.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.302 2.668 . . . . 0.0 107.522 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.6 65.37 3.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.9 p -135.41 -35.01 0.83 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.45 0.625 . . . . 0.0 111.952 167.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.34 107.34 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -174.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -91.77 59.84 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 131.623 3.969 . . . . 0.0 108.697 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 1.7 ptt85 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 120.708 -1.245 . . . . 0.0 110.472 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -53.86 126.66 23.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.892 1.277 . . . . 0.0 107.938 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 1.5 p -132.28 146.72 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -134.47 123.61 24.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 48.1 p90 -131.51 173.51 11.03 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 120.899 1.681 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -127.78 141.55 51.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.28 139.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.962 1.705 . . . . 0.0 106.618 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -138.88 172.22 13.17 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.597 1.159 . . . . 0.0 111.321 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -157.0 -165.9 1.95 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.15 1.78 . . . . 0.0 109.405 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -12.67 60.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.201 1.4 . . . . 0.0 113.561 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.16 -67.09 0.87 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -172.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.52 -152.41 5.66 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -140.25 167.18 22.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.611 0.764 . . . . 0.0 110.31 167.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.83 142.76 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.8 152.55 22.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.063 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 2.7 m -138.47 137.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 110.992 171.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -100.28 136.87 39.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 164.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -142.05 164.31 30.53 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.458 1.503 . . . . 0.0 107.167 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.62 110.13 3.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.41 41.35 Favored Glycine 0 C--N 1.324 -0.115 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -22.48 6.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.924 0.862 . . . . 0.0 112.394 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 81.55 152.86 0.12 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.939 2.895 . . . . 0.0 108.852 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.87 141.8 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.633 1.555 . . . . 0.0 108.993 174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -31.26 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.55 1.14 . . . . 0.0 109.161 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.38 -40.98 98.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.35 1.86 . . . . 0.0 112.737 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -65.52 137.05 57.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.696 0.798 . . . . 0.0 110.91 -165.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -142.55 173.49 11.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.801 1.24 . . . . 0.0 109.206 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -58.55 135.58 57.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.759 152.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 6.11 69.35 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.704 0.669 . . . . 0.0 113.785 155.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -103.16 172.61 6.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 109.443 171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.52 129.07 9.72 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.76 172.5 15.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.62 126.71 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.73 159.26 4.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.05 134.38 10.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.52 -119.29 0.9 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -142.17 154.0 44.49 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 119.232 1.516 . . . . 0.0 110.46 -163.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 135.19 35.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -85.45 0.24 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -151.1 -88.6 0.06 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.408 1.883 . . . . 0.0 109.417 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.41 82.8 1.14 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -160.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.0 m120 29.69 67.1 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.188 2.595 . . . . 0.0 110.726 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -141.37 131.19 24.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.213 1.405 . . . . 0.0 107.667 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.2 mm -106.2 135.45 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.217 1.807 . . . . 0.0 109.263 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.89 105.42 10.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 156.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.84 148.87 50.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.96 -25.01 10.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 109.115 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -148.38 -16.14 0.33 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t 38.54 101.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.207 2.203 . . . . 0.0 114.468 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.17 145.9 30.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.15 30.98 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.24 -0.913 . . . . 0.0 111.694 -172.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.975 0.893 . . . . 0.0 110.949 -174.513 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 122.464 1.126 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -169.58 145.4 3.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.051 1.74 . . . . 0.0 107.534 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -142.3 -173.83 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.588 2.355 . . . . 0.0 108.573 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 20.6 p -135.32 171.2 9.34 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.059 0.943 . . . . 0.0 109.292 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 63.9 Cg_endo -73.8 71.31 4.12 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.925 2.417 . . . . 0.0 108.989 169.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.68 -66.73 0.1 Allowed Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 -167.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.52 -3.71 22.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.359 0.664 . . . . 0.0 112.442 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.55 -41.97 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.535 ' CD1' ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -85.9 -43.53 13.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.599 0.759 . . . . 0.0 109.688 -165.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -102.31 3.32 37.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.323 1.449 . . . . 0.0 112.883 -168.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.2 165.95 39.18 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 110.847 174.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 27.9 mtp . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.5 158.69 32.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.909 1.739 . . . . 0.0 109.917 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -79.12 157.75 27.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.261 9.5 p -93.65 0.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.332 0.587 . . . . 0.0 112.203 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.04 55.65 0.68 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.934 1.731 . . . . 0.0 110.13 162.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -144.86 168.81 19.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.188 1.494 . . . . 0.0 112.254 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.41 129.6 36.58 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.402 1.096 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 -177.08 4.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.277 172.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.71 142.7 51.25 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.402 2.281 . . . . 0.0 106.491 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.27 124.67 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.33 135.47 12.89 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.61 174.37 46.58 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.718 1.152 . . . . 0.0 110.606 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.2 ttm -95.76 126.2 40.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.514 1.526 . . . . 0.0 110.996 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.97 127.3 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 124.227 1.011 . . . . 0.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.9 mtt -59.92 127.5 85.61 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 122.501 0.321 . . . . 0.0 110.58 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.0 113.73 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.072 3.181 . . . . 0.0 110.364 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.88 47.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.336 1.922 . . . . 0.0 113.967 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.7 p -69.43 -19.68 63.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.469 1.134 . . . . 0.0 114.005 -165.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.71 83.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.954 1.302 . . . . 0.0 109.864 -167.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.77 -58.27 9.32 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.667 1.987 . . . . 0.0 111.472 -167.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.408 0 C-N-CA 129.612 3.165 . . . . 0.0 110.852 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -55.39 140.69 39.02 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 164.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 156.73 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 p -126.37 141.06 52.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 152.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.67 170.6 15.55 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 108.329 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -112.47 144.5 41.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.41 143.09 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 169.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.44 173.46 11.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.111 1.765 . . . . 0.0 107.88 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 88' ' ' GLU . 3.7 t0 -155.07 -162.54 1.38 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 13.65 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.51 1.924 . . . . 0.0 113.725 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -126.13 -76.53 0.58 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.876 1.271 . . . . 0.0 107.914 -172.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.52 -151.21 5.4 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.7 p -146.08 166.97 24.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.639 0.719 . . . . 0.0 112.519 172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.63 157.86 10.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 126.112 1.765 . . . . 0.0 109.045 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.0 151.06 19.81 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 126.006 1.722 . . . . 0.0 108.468 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.56 103.33 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.055 0.942 . . . . 0.0 111.33 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.4 m -78.44 120.68 23.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.228 1.011 . . . . 0.0 109.361 161.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -116.41 171.5 7.8 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.333 1.453 . . . . 0.0 107.843 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.84 101.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.61 169.73 26.43 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -73.74 -25.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 122.94 0.496 . . . . 0.0 110.67 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.5 mt 87.52 156.55 0.09 OUTLIER Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 131.401 3.88 . . . . 0.0 110.185 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -56.08 143.59 83.08 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 N-CA-C 107.058 -1.939 . . . . 0.0 107.058 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -62.21 -37.02 83.72 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.511 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mp -61.44 -20.16 62.79 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.12 1.768 . . . . 0.0 115.159 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.38 125.05 23.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.613 1.097 . . . . 0.0 109.524 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -126.95 160.27 31.54 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.19 0.995 . . . . 0.0 110.488 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -81.24 104.81 11.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.891 1.677 . . . . 0.0 107.434 168.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.5 13.78 5.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.062 0.839 . . . . 0.0 114.07 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -130.92 166.93 19.87 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.711 1.256 . . . . 0.0 112.131 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.72 139.94 29.55 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 170.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.47 109.04 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.19 158.18 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 125.08 1.352 . . . . 0.0 108.939 164.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -153.25 152.09 30.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.3 3.04 . . . . 0.0 106.16 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.97 -111.42 0.48 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.78 160.78 33.36 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 119.917 1.858 . . . . 0.0 109.153 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.72 142.61 44.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 159.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -99.65 -88.33 0.34 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.886 1.275 . . . . 0.0 108.031 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.35 157.33 4.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.667 2.787 . . . . 0.0 107.433 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.16 25.54 73.45 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.87 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m120 58.65 71.45 0.58 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.347 2.259 . . . . 0.0 110.114 -168.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -141.18 136.49 31.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.68 130.2 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 126.678 1.991 . . . . 0.0 108.497 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.84 111.5 15.05 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 157.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.44 37.33 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.23 1.812 . . . . 0.0 108.329 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -24.64 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.954 1.301 . . . . 0.0 111.399 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.38 -47.54 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 t 61.26 129.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 124.237 1.97 . . . . 0.0 111.328 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.4 mt -133.85 159.03 41.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.03 55.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.397 0.544 . . . . 0.0 110.097 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 176.188 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.401 0 CA-C-O 122.46 1.124 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -168.04 154.62 7.68 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.144 2.578 . . . . 0.0 106.018 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.42 ' CE2' ' CD ' ' A' ' 47' ' ' LYS . 74.5 m-85 -141.54 173.66 11.29 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.066 2.146 . . . . 0.0 109.051 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 p -134.88 164.05 46.81 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 123.959 0.904 . . . . 0.0 109.606 168.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.88 72.94 2.52 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.677 2.918 . . . . 0.0 109.804 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.13 -62.55 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 105.182 -3.167 . . . . 0.0 105.182 -168.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -47.85 -48.66 30.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.331 1.065 . . . . 0.0 109.956 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.19 -15.37 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 127.149 2.18 . . . . 0.0 112.17 -172.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.48 -32.8 3.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.096 1.359 . . . . 0.0 110.883 -166.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.77 -60.67 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.653 2.381 . . . . 0.0 108.242 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.43 135.97 2.11 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.493 1.521 . . . . 0.0 110.547 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' CD ' ' CE2' ' A' ' 38' ' ' TYR . 5.3 tptp . . . . . 0 N--CA 1.471 0.604 0 C-N-CA 124.675 1.19 . . . . 0.0 111.096 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.88 155.83 48.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.67 1.58 . . . . 0.0 109.71 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 57' ' ' GLY . 3.0 tt0 -79.14 132.32 36.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.259 3.8 p -69.43 0.45 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 123.384 1.564 . . . . 0.0 112.098 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 55' ' ' GLU . . . -111.77 22.4 19.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.959 2.218 . . . . 0.0 112.516 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.55 177.63 7.7 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 121.08 2.44 . . . . 0.0 113.398 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.44 150.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.044 167.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 178.15 10.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.203 1.001 . . . . 0.0 109.68 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -116.67 150.56 37.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.385 1.874 . . . . 0.0 108.468 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.35 154.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.59 1.556 . . . . 0.0 107.654 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.8 142.35 13.67 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 159.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.69 44.5 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 ttm -92.46 119.64 32.17 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.878 2.071 . . . . 0.0 110.514 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.72 128.85 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 120.275 -1.516 . . . . 0.0 108.728 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.1 mtt -59.37 141.25 87.78 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 112.694 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.21 134.17 47.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.751 3.634 . . . . 0.0 109.71 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.6 -2.49 39.07 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.786 -1.008 . . . . 0.0 114.763 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.1 p -74.46 -43.35 56.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.757 1.778 . . . . 0.0 112.099 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.0 107.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.086 1.754 . . . . 0.0 110.805 -170.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -74.04 -55.46 6.1 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.962 1.705 . . . . 0.0 111.444 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.433 HH21 ' CD2' ' A' ' 78' ' ' LEU . 1.5 mtp180 . . . . . 0 N--CA 1.466 0.375 0 C-N-CA 127.147 2.179 . . . . 0.0 111.451 -165.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.433 ' CD2' HH21 ' A' ' 73' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 116.96 5.31 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.24 153.93 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.391 1.091 . . . . 0.0 109.844 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.7 p -141.2 114.85 8.95 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -124.96 178.76 5.34 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.809 1.644 . . . . 0.0 111.791 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.2 m -124.36 145.15 49.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.11 148.03 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 172.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -139.25 178.26 7.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.96 1.704 . . . . 0.0 108.535 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 87' ' ' ALA . 37.0 t70 -161.01 -153.66 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.484 ' H ' ' CG ' ' A' ' 86' ' ' ASP . . . -68.8 -18.19 64.14 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.324 -1.485 . . . . 0.0 113.098 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -112.56 -63.3 1.45 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -163.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.59 -157.55 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 120.105 -0.275 . . . . 0.0 113.062 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.9 p -149.78 159.88 44.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.45 153.19 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.838 1.655 . . . . 0.0 111.351 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -81.07 143.99 32.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.531 176.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.61 121.35 21.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 164.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -91.61 133.52 35.48 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 155.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -130.15 168.34 16.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -158.26 113.39 2.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.47 0.15 Allowed Glycine 0 N--CA 1.468 0.786 0 C-N-CA 118.107 -1.997 . . . . 0.0 113.26 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.13 -28.22 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.286 1.043 . . . . 0.0 112.613 167.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 tp 61.23 128.13 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 129.333 3.053 . . . . 0.0 112.86 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.66 135.71 58.19 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.653 1.569 . . . . 0.0 108.106 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.58 -25.51 38.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.856 0.836 . . . . 0.0 111.689 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.49 -23.39 66.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.434 1.094 . . . . 0.0 112.145 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.34 130.28 41.55 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.331 1.423 . . . . 0.0 109.461 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -126.94 -161.87 1.11 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 107.472 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.7 151.95 19.6 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.959 -1.088 . . . . 0.0 108.773 150.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.37 57.86 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.502 166.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -125.37 166.47 16.51 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.395 1.078 . . . . 0.0 109.748 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.41 135.91 18.26 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.83 162.7 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.08 112.78 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.72 2.008 . . . . 0.0 105.687 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.59 157.51 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.152 . . . . 0.0 108.259 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -154.11 135.84 14.44 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 127.552 2.341 . . . . 0.0 107.331 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -120.47 0.95 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 103.339 -3.904 . . . . 0.0 103.339 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.55 153.75 46.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.351 1.076 . . . . 0.0 109.631 -160.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -80.68 122.54 27.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 109.428 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -76.03 -66.98 0.72 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -138.8 -96.16 0.18 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.695 0.798 . . . . 0.0 111.056 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -91.01 -70.54 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -126.94 41.03 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.902 -0.763 . . . . 0.0 109.032 -169.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 92' ' ' ASP . 23.1 t-160 -131.57 125.9 33.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.051 1.34 . . . . 0.0 108.636 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.9 mm -98.13 130.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.437 1.895 . . . . 0.0 108.15 171.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.15 108.02 12.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 152.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 147.88 48.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -11.0 7.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.81 1.644 . . . . 0.0 111.503 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.36 -21.43 0.15 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t 41.89 113.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 130.598 3.559 . . . . 0.0 115.687 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.3 144.01 50.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -167.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.86 42.83 2.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.328 -0.857 . . . . 0.0 111.217 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.258 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -165.84 147.69 7.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.984 0.811 . . . . 0.0 110.63 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -140.45 177.8 7.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.509 1.924 . . . . 0.0 109.595 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 22.2 p -134.55 171.85 8.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.291 1.036 . . . . 0.0 110.011 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 69.4 Cg_endo -72.62 -0.64 9.13 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.799 2.333 . . . . 0.0 114.793 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.45 -53.51 3.81 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 156.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 39' ' ' THR . 56.9 mt-10 -68.24 -30.49 69.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.591 -0.946 . . . . 0.0 113.139 -160.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.9 -13.81 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.865 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.87 -42.28 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 110.198 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -90.25 -18.12 26.23 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.012 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.68 147.46 9.05 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.776 2.131 . . . . 0.0 109.825 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 C--N 1.349 0.548 0 CA-C-N 119.766 1.783 . . . . 0.0 109.777 173.195 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 42.8 mtp . . . . . 0 C--O 1.238 0.481 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.02 166.29 23.43 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.862 1.708 . . . . 0.0 111.184 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -79.01 128.43 33.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 117' ' ' LYS . 49.0 t -60.64 -8.48 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.823 1.649 . . . . 0.0 111.857 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.46 33.49 4.8 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-O 116.131 -2.483 . . . . 0.0 112.719 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.83 177.62 6.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.128 2.464 . . . . 0.0 112.471 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -83.6 140.93 31.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.018 0.927 . . . . 0.0 110.664 165.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.64 173.92 11.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.638 0.775 . . . . 0.0 109.76 169.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -121.26 139.03 53.94 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.46 160.72 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 128.506 2.723 . . . . 0.0 107.856 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.08 156.58 26.92 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.85 -179.96 47.51 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.703 1.621 . . . . 0.0 109.214 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.4 tpp -81.09 120.05 24.34 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 129.062 2.945 . . . . 0.0 110.598 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.74 130.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 119.094 -2.253 . . . . 0.0 108.479 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.26 154.23 53.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.87 133.3 30.91 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.006 2.471 . . . . 0.0 109.668 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.73 -24.65 4.32 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 125.579 1.561 . . . . 0.0 115.776 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.09 -43.61 91.86 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.466 1.633 . . . . 0.0 111.732 -170.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.308 1.3 p -42.33 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.941 2.096 . . . . 0.0 112.96 -172.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -91.93 56.48 2.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.968 2.907 . . . . 0.0 108.242 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.9 ptt-85 . . . . . 0 CA--C 1.511 -0.554 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 166.891 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -62.29 138.97 58.52 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.058 -1.651 . . . . 0.0 109.088 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.72 132.7 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.314 22.7 m -123.39 153.71 40.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 48.8 p90 -152.4 176.98 11.08 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 119.936 -1.727 . . . . 0.0 110.945 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 m -121.56 143.8 49.08 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.34 153.67 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.064 1.746 . . . . 0.0 106.47 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -141.81 -179.43 6.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.587 1.955 . . . . 0.0 106.973 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -157.08 -159.35 0.85 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.08 4.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.96 -79.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.033 1.733 . . . . 0.0 109.371 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.98 -168.37 12.07 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.215 1.388 . . . . 0.0 111.643 -167.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 p -146.98 155.97 42.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.72 145.85 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.999 1.72 . . . . 0.0 110.264 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.5 154.68 26.18 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 5.4 m -133.28 144.95 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 120.625 -1.297 . . . . 0.0 109.337 160.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.38 1.872 . . . . 0.0 106.572 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -134.91 168.93 18.19 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.221 1.809 . . . . 0.0 108.761 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -148.94 117.63 6.61 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 171.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.38 175.46 25.59 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -170.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -6.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.047 1.339 . . . . 0.0 112.395 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt 63.02 165.89 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 127.535 2.334 . . . . 0.0 111.66 -166.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.35 137.64 79.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 159.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.88 -27.4 66.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.141 0.496 . . . . 0.0 110.704 167.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -19.07 60.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.481 1.512 . . . . 0.0 113.107 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -64.5 129.4 39.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.994 0.815 . . . . 0.0 110.086 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -136.1 161.07 36.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.023 1.329 . . . . 0.0 109.944 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.71 114.21 6.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.526 1.13 . . . . 0.0 108.206 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.98 -3.46 33.69 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.127 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -91.48 166.73 12.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.35 1.575 . . . . 0.0 110.601 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 140.99 27.54 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.14 177.06 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.255 1.822 . . . . 0.0 107.295 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.86 101.22 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.097 1.759 . . . . 0.0 106.714 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.9 168.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-O 122.706 1.241 . . . . 0.0 111.244 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -165.05 140.83 5.46 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.279 1.831 . . . . 0.0 107.693 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.58 -91.43 0.11 Allowed Glycine 0 C--O 1.224 -0.481 0 CA-C-O 116.941 -2.033 . . . . 0.0 109.276 168.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.29 162.28 35.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.466 2.133 . . . . 0.0 110.339 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.28 148.63 28.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.06 1.744 . . . . 0.0 108.672 165.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.99 -85.0 0.48 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 108.259 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.414 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 12.8 mtmm -141.07 170.8 15.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 127.352 2.261 . . . . 0.0 106.88 159.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 45.48 -102.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 125.131 1.348 . . . . 0.0 110.852 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -136.31 51.99 1.99 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.593 0.757 . . . . 0.0 109.318 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -121.46 129.94 53.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.48 0.712 . . . . 0.0 109.955 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -105.35 127.81 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.57 1.148 . . . . 0.0 110.999 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.49 80.76 5.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 162.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.54 141.87 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.563 0.697 . . . . 0.0 110.53 164.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -14.13 9.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.581 1.552 . . . . 0.0 111.529 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.81 -33.65 0.45 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 117.643 -1.17 . . . . 0.0 114.04 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t 54.92 116.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 C-N-CA 129.073 2.949 . . . . 0.0 111.108 -174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.15 -176.42 4.15 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.653 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -143.43 19.47 1.88 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.982 1.313 . . . . 0.0 110.616 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.2 mttm . . . . . 0 N--CA 1.476 0.85 0 CA-C-N 119.426 1.012 . . . . 0.0 111.577 -161.494 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 122.528 1.156 . . . . 0.0 109.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -158.21 147.18 19.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.664 1.185 . . . . 0.0 108.578 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.43 173.03 12.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.013 1.725 . . . . 0.0 108.891 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.549 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 3.4 p -131.99 172.41 7.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.753 1.221 . . . . 0.0 108.635 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 10.8 Cg_endo -59.87 -36.87 89.33 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.646 1.564 . . . . 0.0 109.881 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.88 10.52 13.69 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.595 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HB2' ' H ' ' A' ' 39' ' ' THR . 26.6 mt-10 -130.17 -30.95 1.92 Allowed 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.909 1.854 . . . . 0.0 112.727 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.04 -58.27 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -49.61 36.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 110.06 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -82.98 -7.16 59.7 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.53 132.05 4.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 13.8 tptp . . . . . 0 C--O 1.224 -0.267 0 C-N-CA 128.316 2.647 . . . . 0.0 113.648 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.59 160.9 40.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.256 1.304 . . . . 0.0 110.117 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -78.66 128.72 33.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.44 -6.06 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.005 1.722 . . . . 0.0 111.433 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.06 52.76 0.74 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 162.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -131.66 178.82 6.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.75 1.275 . . . . 0.0 111.355 161.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -95.0 137.61 33.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.999 1.72 . . . . 0.0 110.392 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.74 169.82 23.04 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.274 1.03 . . . . 0.0 111.416 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -119.27 143.44 47.33 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 127.952 2.501 . . . . 0.0 107.923 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.2 160.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.063 2.145 . . . . 0.0 108.514 -170.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.02 163.98 26.55 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 160.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.25 38.89 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 124.167 0.889 . . . . 0.0 111.189 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.7 ttm -91.9 125.98 36.81 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.53 1.132 . . . . 0.0 109.474 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -65.69 123.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 120.705 1.593 . . . . 0.0 107.46 178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 ttm -63.14 139.18 97.51 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.11 158.29 48.86 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.62 57.91 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 116.857 -2.08 . . . . 0.0 115.494 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -120.23 -6.34 9.89 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.478 2.139 . . . . 0.0 113.323 167.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.3 85.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 120.796 1.635 . . . . 0.0 111.484 169.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -78.46 61.69 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.796 2.839 . . . . 0.0 107.408 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--N 1.325 -0.46 0 O-C-N 120.75 -1.219 . . . . 0.0 108.8 168.598 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -62.07 140.77 58.37 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 p -149.61 132.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 m -122.05 135.83 54.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -147.71 173.46 12.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.917 1.235 . . . . 0.0 110.087 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.2 m -118.6 142.8 47.28 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.864 1.266 . . . . 0.0 107.814 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 145.48 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.374 1.469 . . . . 0.0 107.098 175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -149.45 176.42 10.61 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.9 0.88 . . . . 0.0 111.417 -168.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -160.4 -166.48 1.67 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.655 1.582 . . . . 0.0 110.318 172.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.82 8.47 0.51 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.641 1.576 . . . . 0.0 113.66 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.87 -71.14 0.74 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.79 -171.01 12.5 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 124.196 0.903 . . . . 0.0 112.433 -172.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.2 p -140.98 149.79 42.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.975 0.91 . . . . 0.0 110.773 164.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -132.7 149.75 32.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.864 1.266 . . . . 0.0 108.054 -173.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.3 148.32 25.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.73 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.9 t -135.58 123.32 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.025 0.93 . . . . 0.0 110.764 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -89.31 136.78 32.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 151.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -132.52 165.19 24.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.037 2.135 . . . . 0.0 106.694 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -140.07 113.11 8.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.99 166.55 23.06 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.4 tt -72.96 -15.47 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.888 -174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 mt 78.83 165.09 0.12 Allowed Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 130.827 3.651 . . . . 0.0 110.743 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -61.13 140.37 89.01 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 N-CA-C 107.299 -1.846 . . . . 0.0 107.299 158.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.94 -31.45 66.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.903 1.281 . . . . 0.0 109.927 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -33.26 71.24 Favored 'General case' 0 N--CA 1.437 -1.076 1 C-N-CA 131.984 4.113 . . . . 0.0 111.567 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -59.73 136.6 58.05 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.023 1.283 . . . . 0.0 107.776 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -149.77 142.15 24.27 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.476 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.539 ' H ' HG11 ' A' ' 66' ' ' VAL . . . 114.8 -9.33 21.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 114.876 -3.18 . . . . 0.0 115.463 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.515 ' H ' HG11 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -94.53 169.7 10.0 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 123.622 3.711 . . . . 0.0 111.637 -173.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.57 8.04 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 165.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.48 176.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.434 1.894 . . . . 0.0 108.447 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.413 ' CG2' ' HE2' ' A' ' 129' ' ' LYS . 2.1 t -129.29 128.88 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.124 1.77 . . . . 0.0 107.228 164.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.82 167.06 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.475 1.131 . . . . 0.0 111.8 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -161.41 144.53 12.5 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.61 -120.31 0.91 Allowed Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -138.35 152.46 48.48 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.758 0.779 . . . . 0.0 109.395 -169.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 143.41 33.94 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.339 1.056 . . . . 0.0 110.176 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.407 ' CD ' ' HD1' ' A' ' 120' ' ' HIS . 15.9 tt0 -91.58 -77.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.563 -0.71 . . . . 0.0 110.992 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.23 -79.83 0.01 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.86 2.064 . . . . 0.0 108.58 -170.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.3 47.76 2.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.783 1.659 . . . . 0.0 113.153 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.02 67.11 1.02 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.9 2.08 . . . . 0.0 110.904 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.407 ' HD1' ' CD ' ' A' ' 116' ' ' GLU . 6.5 t-160 -136.64 132.84 35.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.131 1.773 . . . . 0.0 106.613 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -99.95 127.07 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.446 1.498 . . . . 0.0 109.046 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.72 74.99 5.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 164.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.21 140.02 17.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.032 0.92 . . . . 0.0 111.693 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -17.32 12.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.69 1.996 . . . . 0.0 110.92 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.85 -42.8 0.53 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.801 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 89.3 t 50.69 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.045 1.338 . . . . 0.0 111.18 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.7 mt -98.67 159.54 14.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.0 17.96 14.79 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.911 0.884 . . . . 0.0 113.361 -162.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.413 ' HE2' ' CG2' ' A' ' 110' ' ' VAL . 42.5 mmtt . . . . . 0 N--CA 1.473 0.691 0 C-N-CA 126.534 1.933 . . . . 0.0 111.462 -170.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 122.006 0.908 . . . . 0.0 112.185 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -156.56 162.14 39.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.957 1.303 . . . . 0.0 109.38 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -145.72 173.09 12.39 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.756 2.822 . . . . 0.0 108.601 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -135.36 165.4 36.64 Favored Pre-proline 0 CA--C 1.53 0.187 0 O-C-N 121.315 -0.866 . . . . 0.0 112.233 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.16 -8.62 12.62 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.384 2.723 . . . . 0.0 116.205 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.51 -38.0 4.09 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 120.586 1.539 . . . . 0.0 110.01 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.04 22.94 1.9 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.432 -1.628 . . . . 0.0 110.27 -162.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.67 -50.92 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 164.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -79.97 -41.23 26.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.369 1.867 . . . . 0.0 110.568 -169.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -82.19 4.09 24.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.995 1.318 . . . . 0.0 110.159 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.93 170.72 6.67 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 125.995 1.759 . . . . 0.0 109.756 -166.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tttt . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -162.954 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -62.39 154.87 61.02 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.673 167.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.78 130.78 35.62 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.658 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.56 -9.72 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 122.844 0.458 . . . . 0.0 111.332 166.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.11 3.24 56.87 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.589 -1.673 . . . . 0.0 115.286 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -115.29 173.51 6.47 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.88 2.34 . . . . 0.0 112.374 -161.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -98.41 135.36 40.11 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.17 174.91 14.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.752 0.786 . . . . 0.0 111.335 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -131.89 153.3 50.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.253 1.421 . . . . 0.0 109.775 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -138.14 138.34 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 127.447 2.299 . . . . 0.0 107.74 -171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.41 2.8 Favored Glycine 0 N--CA 1.466 0.687 0 CA-C-N 120.795 1.634 . . . . 0.0 112.048 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.7 165.25 27.64 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.5 ttm -79.95 123.32 27.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.482 1.513 . . . . 0.0 107.789 166.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.21 125.47 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 38.6 mtt -52.77 121.51 22.95 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.123 0.569 . . . . 0.0 110.603 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.07 91.49 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.803 3.669 . . . . 0.0 109.192 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.73 62.7 0.68 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 -23.29 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.376 2.271 . . . . 0.0 111.05 170.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.12 93.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 119.704 1.138 . . . . 0.0 109.341 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -80.8 73.38 7.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.967 2.507 . . . . 0.0 106.618 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 172.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.34 139.84 35.4 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.429 -1.42 . . . . 0.0 108.155 166.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.06 121.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.3 m -116.79 129.81 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 50.1 p90 -139.77 175.4 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 119.283 0.947 . . . . 0.0 111.076 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -123.9 142.69 50.91 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 137.01 57.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -130.69 179.87 5.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.129 1.771 . . . . 0.0 108.276 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -152.91 -116.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.182 163.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.89 -1.97 30.91 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.824 1.193 . . . . 0.0 112.27 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -124.7 -70.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.796 1.238 . . . . 0.0 107.783 -156.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.47 -168.39 12.55 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.3 p -142.75 156.79 45.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.121 0.568 . . . . 0.0 111.65 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -138.01 147.64 25.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.782 2.033 . . . . 0.0 109.587 -171.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.23 153.73 24.56 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 3.2 m -135.67 145.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 163.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -112.77 125.8 54.73 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 162.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -124.27 158.91 31.42 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.168 1.387 . . . . 0.0 108.667 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -142.94 99.12 3.4 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.0 170.34 29.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.603 1.097 . . . . 0.0 110.452 -175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -74.96 -17.51 16.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.617 1.167 . . . . 0.0 112.072 -165.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 73.27 135.74 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.955 2.502 . . . . 0.0 109.36 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.73 151.46 85.61 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.793 1.662 . . . . 0.0 108.999 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -29.08 68.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.831 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.45 -38.4 80.65 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.971 -1.49 . . . . 0.0 111.18 176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.448 ' CD2' HG12 ' A' ' 109' ' ' VAL . 23.9 t80 -67.06 134.56 52.12 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.341 1.456 . . . . 0.0 110.938 -172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.14 169.43 17.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.072 0.949 . . . . 0.0 110.661 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.66 84.41 6.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.899 1.68 . . . . 0.0 108.001 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.97 5.48 3.87 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.124 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.28 171.57 7.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.058 1.929 . . . . 0.0 110.761 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.47 110.93 3.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.448 HG12 ' CD2' ' A' ' 103' ' ' PHE . 2.3 m -112.92 171.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 173.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.02 163.63 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 157.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.97 157.56 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 156.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -141.89 148.83 39.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.351 2.26 . . . . 0.0 106.661 169.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.16 -114.69 0.66 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -135.75 159.63 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.724 1.762 . . . . 0.0 110.371 -165.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 142.0 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 -66.62 0.89 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.473 0.709 . . . . 0.0 109.463 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -50.32 0.08 Allowed 'General case' 0 C--N 1.347 0.483 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.52 -77.27 0.82 Allowed Glycine 0 C--N 1.329 0.149 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -141.14 33.48 1.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.897 1.679 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -115.78 129.54 56.49 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.9 mm -102.68 133.61 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.758 1.623 . . . . 0.0 108.535 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.2 108.0 12.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 157.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.31 141.98 54.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 165.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -27.5 7.85 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 126.198 1.799 . . . . 0.0 108.971 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.82 -18.29 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t 51.41 99.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.428 2.291 . . . . 0.0 115.951 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.4 125.07 52.01 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.592 -163.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.78 57.69 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.162 -1.586 . . . . 0.0 110.592 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 124.958 1.303 . . . . 0.0 113.706 173.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.7 121.42 14.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.119 1.368 . . . . 0.0 109.812 -162.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -110.21 -179.58 3.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 109.282 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 p -147.55 162.3 32.5 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.811 1.645 . . . . 0.0 107.161 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 66.5 8.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 109.628 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.3 -52.27 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -1.6 25.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 125.598 1.559 . . . . 0.0 111.388 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.65 -30.98 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -97.83 -46.92 5.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.217 1.007 . . . . 0.0 111.282 -168.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.4 -36.52 22.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.154 1.382 . . . . 0.0 109.919 -172.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.21 133.83 3.2 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -167.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tptp . . . . . 0 CA--C 1.51 -0.594 0 CA-C-N 119.085 1.443 . . . . 0.0 109.994 178.172 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.62 148.71 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.843 1.695 . . . . 0.0 110.12 163.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.46 137.79 37.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.72 -8.21 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.622 0.769 . . . . 0.0 111.18 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.07 36.25 3.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 125.598 1.57 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -136.02 163.88 29.27 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.411 1.606 . . . . 0.0 110.215 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -77.47 150.39 34.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.419 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 164.68 31.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.086 1.355 . . . . 0.0 111.093 169.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -106.51 155.04 20.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.011 1.724 . . . . 0.0 107.277 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.0 153.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 127.075 2.15 . . . . 0.0 107.815 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.46 139.65 11.14 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 162.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.16 173.58 43.6 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 118.177 0.989 . . . . 0.0 111.51 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 ttm -109.0 123.82 49.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 110.859 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.463 ' CG1' ' H ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -66.28 129.45 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.889 1.677 . . . . 0.0 110.494 -171.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 mtt -62.68 139.81 97.0 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.09 0.859 . . . . 0.0 110.154 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.75 140.43 80.32 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.696 1.597 . . . . 0.0 108.565 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.27 43.5 92.77 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.221 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.8 p -117.08 -84.33 0.64 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.305 1.7 p -22.49 95.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 130.817 3.647 . . . . 0.0 114.802 -170.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.22 90.99 7.54 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 129.089 2.955 . . . . 0.0 108.662 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.924 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.238 0.453 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -55.12 139.47 41.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.039 1.336 . . . . 0.0 108.048 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.13 127.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.1 m -102.49 146.56 27.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 24.6 p90 -146.23 172.53 13.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.982 1.265 . . . . 0.0 109.684 168.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.59 145.4 42.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.21 126.34 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.57 1.148 . . . . 0.0 109.094 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 28.6 p90 -117.3 173.89 6.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.491 2.316 . . . . 0.0 110.34 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -152.61 -164.51 1.97 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.977 1.311 . . . . 0.0 108.328 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.11 11.06 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.802 -1.186 . . . . 0.0 113.672 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 -75.65 0.58 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -127.76 -162.37 11.07 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.504 1.049 . . . . 0.0 113.0 -167.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 93.8 p -144.9 160.44 41.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.623 0.769 . . . . 0.0 110.754 169.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.01 145.34 28.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -76.94 151.9 35.52 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.455 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 6.2 m -131.73 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 121.943 -0.473 . . . . 0.0 109.766 165.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -104.45 132.7 50.4 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -132.53 168.49 18.13 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.465 1.506 . . . . 0.0 108.445 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -156.07 107.07 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 167.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.93 20.19 0.02 OUTLIER Glycine 0 N--CA 1.468 0.8 0 C-N-CA 116.254 -2.879 . . . . 0.0 118.195 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER 59.21 117.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.641 1.977 . . . . 0.0 111.882 -168.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -74.33 148.29 85.94 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.301 -0.874 . . . . 0.0 109.902 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -60.7 156.73 41.06 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.314 2.676 . . . . 0.0 109.749 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.86 -40.95 97.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.665 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.18 -27.91 64.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.916 1.286 . . . . 0.0 111.44 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -55.53 129.77 40.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.617 1.099 . . . . 0.0 109.478 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ptt85 -127.86 -164.23 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.623 1.169 . . . . 0.0 111.158 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -103.06 129.19 49.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 153.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.406 ' H ' HG11 ' A' ' 66' ' ' VAL . . . 97.4 8.82 56.0 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 115.524 -2.82 . . . . 0.0 114.754 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.463 ' H ' ' CG1' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -98.65 165.28 11.88 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 121.829 2.815 . . . . 0.0 110.111 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.21 133.97 26.6 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.56 161.96 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.835 2.454 . . . . 0.0 105.801 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.41 138.5 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.2 m -117.06 166.02 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.296 0.57 . . . . 0.0 110.059 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -158.44 146.31 18.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.148 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.91 -112.44 0.54 Allowed Glycine 0 C--O 1.228 -0.263 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -134.45 162.95 30.82 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 120.366 2.083 . . . . 0.0 107.608 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tp -82.46 133.91 35.21 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.685 1.194 . . . . 0.0 108.533 167.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -80.61 -66.64 0.86 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -168.35 -171.89 1.59 Allowed 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 133.161 4.584 . . . . 0.0 105.106 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -8.58 82.92 0.0 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.495 2.95 . . . . 0.0 113.623 164.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 m120 59.2 35.22 23.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.27 2.228 . . . . 0.0 114.767 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -126.41 132.66 51.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.168 0.987 . . . . 0.0 111.045 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.95 125.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 128.131 2.572 . . . . 0.0 110.92 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.72 73.64 6.44 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.916 1.286 . . . . 0.0 108.308 168.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -43.17 128.07 4.5 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.786 -0.571 . . . . 0.0 110.398 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -26.99 13.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.084 1.353 . . . . 0.0 111.22 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.68 -41.99 0.61 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -170.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.9 t 57.34 144.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.892 2.077 . . . . 0.0 111.754 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -139.21 159.89 41.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.31 39.73 3.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.705 1.602 . . . . 0.0 110.164 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 128.162 2.585 . . . . 0.0 112.251 -161.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 pp . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 122.099 0.952 . . . . 0.0 108.809 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -155.58 149.1 25.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -136.8 -179.93 5.99 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.457 1.903 . . . . 0.0 107.794 170.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -146.11 164.34 25.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 C-N-CA 126.236 1.814 . . . . 0.0 106.75 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.51 64.31 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.916 3.078 . . . . 0.0 110.142 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.9 -50.06 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -3.57 37.12 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.827 -0.808 . . . . 0.0 111.796 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mt -94.4 -34.17 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.001 0.92 . . . . 0.0 108.723 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.63 -57.66 2.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.465 1.106 . . . . 0.0 111.311 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -85.45 -28.03 25.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.591 2.357 . . . . 0.0 109.423 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.31 158.57 11.47 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.755 1.169 . . . . 0.0 112.189 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tptt . . . . . 0 C--O 1.218 -0.571 0 C-N-CA 125.556 1.542 . . . . 0.0 110.681 -176.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.9 162.27 32.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.763 1.642 . . . . 0.0 109.241 154.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -79.58 152.78 29.89 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 162.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 117' ' ' LYS . 76.2 t -90.65 0.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.896 0.878 . . . . 0.0 111.811 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.41 61.58 0.65 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 165.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -140.0 176.11 9.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.485 0.714 . . . . 0.0 110.965 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -90.75 135.28 33.82 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.905 0.882 . . . . 0.0 111.205 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.48 175.71 13.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.193 1.397 . . . . 0.0 112.424 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -114.53 148.95 37.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 127.941 2.497 . . . . 0.0 109.141 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.63 134.68 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.199 1.399 . . . . 0.0 107.536 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.98 143.66 16.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 158.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.95 167.9 38.97 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.457 1.129 . . . . 0.0 111.579 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.7 ttm -93.73 121.91 35.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.605 1.562 . . . . 0.0 109.708 -174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -66.2 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 109.222 -176.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 45.5 mtt -62.31 144.02 95.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 111.894 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.67 61.57 8.23 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.592 3.528 . . . . 0.0 110.804 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.15 63.06 0.02 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -152.72 -23.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.252 0.6 OUTLIER -68.56 100.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 120.261 1.391 . . . . 0.0 111.334 -176.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -82.91 81.46 8.59 Favored 'General case' 0 C--O 1.237 0.446 1 C-N-CA 132.667 4.387 . . . . 0.0 109.455 171.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.281 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.239 0.5 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -50.0 145.24 5.86 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 160.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.88 166.77 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 122.244 1.021 . . . . 0.0 109.114 169.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.67 116.16 7.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 163.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 50.1 p90 -125.07 175.85 7.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.503 1.956 . . . . 0.0 111.483 171.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 m -124.76 145.56 49.66 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.5 138.45 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.256 1.822 . . . . 0.0 107.465 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -130.04 174.65 9.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.612 1.565 . . . . 0.0 108.89 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -157.1 -163.84 1.48 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.46 -3.41 0.98 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.365 1.866 . . . . 0.0 115.269 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -118.84 -79.79 0.6 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.14 -159.24 8.59 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.927 1.251 . . . . 0.0 111.796 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -146.96 162.09 39.43 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.99 145.28 23.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.776 1.63 . . . . 0.0 109.255 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.49 159.74 24.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 3.9 m -136.27 138.5 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.301 1.04 . . . . 0.0 109.134 168.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.1 106.72 17.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.054 2.142 . . . . 0.0 105.308 167.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.37 165.96 10.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 107.487 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -157.12 117.33 3.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.92 -92.77 0.11 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 115.246 -3.359 . . . . 0.0 118.234 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.15 69.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 123.881 1.801 . . . . 0.0 107.253 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -49.85 135.09 20.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.371 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -63.3 138.82 68.38 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 108.169 -1.512 . . . . 0.0 108.169 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.31 -14.82 58.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.462 170.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.15 -23.78 47.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.655 1.582 . . . . 0.0 111.916 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.7 122.73 14.22 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -120.62 153.37 36.91 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.263 1.425 . . . . 0.0 107.232 171.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.13 117.49 17.88 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 122.21 8.93 6.91 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 116.376 -2.347 . . . . 0.0 115.864 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.57 ' H ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -133.57 167.68 20.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.774 2.787 . . . . 0.0 112.305 -165.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.67 81.92 1.68 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.523 1.535 . . . . 0.0 112.348 -167.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.16 168.93 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.786 0.834 . . . . 0.0 109.916 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.61 115.53 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 171.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.31 156.75 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 127.086 2.155 . . . . 0.0 108.557 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -154.57 138.94 16.71 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.593 2.357 . . . . 0.0 106.154 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.96 -112.69 0.52 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 105.936 -2.866 . . . . 0.0 105.936 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -140.9 157.68 45.03 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.432 1.616 . . . . 0.0 109.507 -167.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.48 154.71 18.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.953 1.301 . . . . 0.0 109.084 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.4 -79.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.903 0.881 . . . . 0.0 110.675 -171.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -178.29 169.04 1.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 130.871 3.668 . . . . 0.0 106.325 177.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.39 20.92 52.76 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.455 1.025 . . . . 0.0 113.696 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.7 m120 54.64 68.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.121 1.368 . . . . 0.0 112.269 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -131.18 132.56 44.81 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.55 1.14 . . . . 0.0 109.188 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mm -105.18 133.49 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 110.285 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.05 109.65 13.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.48 139.19 34.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.83 -18.25 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 111.513 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.31 -43.99 0.46 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.5 t 53.3 108.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.767 2.027 . . . . 0.0 115.164 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.1 152.38 42.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.74 1.616 . . . . 0.0 107.712 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -114.17 27.68 9.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.92 1.236 . . . . 0.0 110.806 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 126.317 1.847 . . . . 0.0 113.183 -176.42 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 t80 100.27 140.85 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 1 C-N-CA 134.046 4.939 . . . . 0.0 106.28 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 9.8 m-85 -141.88 175.08 10.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.363 2.265 . . . . 0.0 106.289 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -140.86 170.97 8.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.249 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.98 -5.97 8.63 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.723 2.949 . . . . 0.0 118.009 -166.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -35.13 5.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 120.424 1.465 . . . . 0.0 110.404 165.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.55 -5.64 59.31 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.462 -1.611 . . . . 0.0 111.342 -158.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.95 -18.1 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.507 1.123 . . . . 0.0 110.769 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -80.28 -32.41 38.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.892 0.877 . . . . 0.0 111.3 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.59 142.0 3.89 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 82.2 tttt . . . . . 0 CA--C 1.51 -0.591 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.535 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 mtp . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 155.41 68.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.276 1.317 . . . . 0.0 110.057 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 57' ' ' GLY . 88.6 mt-10 -81.7 131.03 35.25 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.45 1.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.102 1.761 . . . . 0.0 112.469 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 55' ' ' GLU . . . -129.55 25.57 4.47 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 116.471 -2.294 . . . . 0.0 113.386 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -125.2 175.09 7.64 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.42 2.11 . . . . 0.0 112.861 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.7 140.01 30.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.464 1.505 . . . . 0.0 112.621 167.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.77 171.5 18.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.269 1.828 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.33 145.6 51.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.854 1.662 . . . . 0.0 108.282 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.68 132.66 71.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.55 153.15 20.11 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 157.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.48 -175.85 42.36 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 ttm -118.87 125.26 49.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.57 124.25 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.242 0.928 . . . . 0.0 108.685 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.6 ttm -59.66 124.23 75.03 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.293 1.037 . . . . 0.0 109.047 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 112.12 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.017 3.145 . . . . 0.0 110.404 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.06 51.86 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.051 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -67.13 -26.26 66.59 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.781 1.79 . . . . 0.0 112.877 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.53 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 123.985 0.914 . . . . 0.0 110.148 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.64 -70.39 0.13 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.105 1.762 . . . . 0.0 109.443 168.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 . . . . . 0 N--CA 1.475 0.776 1 C-N-CA 131.736 4.014 . . . . 0.0 114.057 -164.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--O 1.238 0.466 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 140.71 50.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.838 0.855 . . . . 0.0 109.269 172.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 ' C ' ' HG1' ' A' ' 81' ' ' THR . 2.3 p -156.91 145.0 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 80' ' ' VAL . 99.7 m -147.1 135.87 22.14 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -147.13 174.58 11.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.491 1.116 . . . . 0.0 108.85 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -121.18 151.47 39.9 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.16 140.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -133.32 174.25 10.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.148 1.379 . . . . 0.0 109.388 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.37 -165.67 2.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.593 2.357 . . . . 0.0 104.921 165.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.21 0.26 1.44 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 114.263 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.37 -70.78 0.79 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 120.017 1.281 . . . . 0.0 108.718 -164.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.38 -166.51 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 128.423 2.916 . . . . 0.0 108.188 -170.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.0 p -153.42 159.88 42.47 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.114 -0.639 . . . . 0.0 109.537 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.28 153.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.347 1.459 . . . . 0.0 110.122 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.18 158.26 19.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.889 0.476 . . . . 0.0 109.978 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.35 120.62 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.857 1.263 . . . . 0.0 108.388 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -96.83 131.55 43.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 162.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -131.85 167.66 19.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.353 1.861 . . . . 0.0 107.695 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -160.39 104.54 1.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.62 7.01 0.02 OUTLIER Glycine 0 C--O 1.225 -0.449 0 C-N-CA 116.272 -2.87 . . . . 0.0 117.026 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.493 HD11 ' H ' ' A' ' 99' ' ' LEU 0.281 0.4 OUTLIER 58.22 145.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 123.706 1.717 . . . . 0.0 109.66 -156.032 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.493 ' H ' HD11 ' A' ' 98' ' ' ILE . 14.1 mt -98.53 157.01 35.06 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.769 -173.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.02 150.9 84.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.48 -23.03 67.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 111.481 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.32 -20.88 60.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.725 1.61 . . . . 0.0 112.534 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.22 127.04 31.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.308 1.867 . . . . 0.0 108.216 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -135.74 166.42 23.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.489 1.115 . . . . 0.0 109.911 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.85 121.53 25.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.64 17.67 20.76 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 115.609 1.003 . . . . 0.0 115.609 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.78 174.61 7.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.199 1.499 . . . . 0.0 112.378 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.81 105.51 3.29 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.586 1.565 . . . . 0.0 111.288 -167.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.35 171.28 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.46 97.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 128.031 2.532 . . . . 0.0 104.193 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -79.6 154.77 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 108.1 169.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.96 143.24 23.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 127.266 2.226 . . . . 0.0 106.115 168.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.33 -111.07 0.35 Allowed Glycine 0 N--CA 1.434 -1.447 1 N-CA-C 101.341 -4.704 . . . . 0.0 101.341 158.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -141.56 153.98 45.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 119.561 1.681 . . . . 0.0 109.34 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.11 127.03 33.65 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.27 -66.5 0.86 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.51 0.724 . . . . 0.0 110.69 -168.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -150.52 -66.54 0.2 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.45 -86.1 1.53 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.34 51.68 1.76 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -126.72 133.57 50.87 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.313 1.445 . . . . 0.0 107.301 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.65 131.12 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.322 1.449 . . . . 0.0 108.92 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.99 100.84 7.48 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 158.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.5 144.61 46.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.791 0.805 . . . . 0.0 110.177 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -22.78 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.171 2.189 . . . . 0.0 110.78 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -154.19 -7.7 0.15 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 t 26.91 85.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.581 2.352 . . . . 0.0 114.49 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.89 143.1 27.11 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.49 50.02 1.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.361 1.064 . . . . 0.0 110.361 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 127.074 2.15 . . . . 0.0 115.263 168.116 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.529 ' CD1' ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.931 0.872 . . . . 0.0 111.431 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.72 152.2 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.549 3.54 . . . . 0.0 106.057 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.7 173.61 11.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.062 2.145 . . . . 0.0 108.711 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 31.8 p -134.37 171.84 8.34 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 119.347 0.976 . . . . 0.0 112.054 169.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.35 1.59 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.989 3.126 . . . . 0.0 117.306 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.53 -24.98 5.66 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 121.296 1.862 . . . . 0.0 116.552 154.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 39' ' ' THR . 11.0 mm-40 -67.84 -12.92 61.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.789 2.295 . . . . 0.0 112.284 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CG2' HD22 ' A' ' 119' ' ' ASN . 3.0 mt -105.8 -23.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 126.929 2.092 . . . . 0.0 109.553 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mt -87.4 -54.12 4.46 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.723 -1.235 . . . . 0.0 110.933 174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -81.59 -76.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 106.854 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.6 161.42 23.75 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.2 tptp . . . . . 0 C--O 1.223 -0.32 0 CA-C-N 118.248 1.024 . . . . 0.0 108.514 170.498 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.3 mtp . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.25 162.44 33.92 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.127 1.218 . . . . 0.0 110.278 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -79.18 145.33 33.72 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 117' ' ' LYS . 4.6 p -86.54 -2.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.056 1.343 . . . . 0.0 112.49 -173.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 71.85 0.48 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 107.164 -2.375 . . . . 0.0 107.164 153.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.93 176.72 8.45 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.752 0.776 . . . . 0.0 109.62 157.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -79.56 138.88 37.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.399 165.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.31 166.21 28.71 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.293 0.637 . . . . 0.0 110.328 165.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -99.38 137.42 37.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.455 1.502 . . . . 0.0 108.504 166.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.37 158.38 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.443 1.497 . . . . 0.0 107.435 160.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.76 142.72 11.47 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 154.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.2 -177.25 40.89 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ttm -88.71 118.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.484 0.713 . . . . 0.0 110.257 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.69 128.42 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.622 1.169 . . . . 0.0 109.085 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.4 ttm -70.65 128.53 90.9 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 124.058 0.943 . . . . 0.0 111.091 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.07 113.77 3.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.015 3.143 . . . . 0.0 110.701 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.01 12.78 13.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.374 1.94 . . . . 0.0 111.898 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.8 p -112.58 -34.98 5.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 120.135 1.967 . . . . 0.0 111.791 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.83 116.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.047 0.939 . . . . 0.0 110.187 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -120.46 63.82 0.84 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.896 2.478 . . . . 0.0 107.919 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.631 0 O-C-N 121.021 -1.049 . . . . 0.0 109.509 169.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 132.36 53.31 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 p -152.1 141.4 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.6 m -133.95 148.77 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.94 -177.1 5.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.451 1.5 . . . . 0.0 109.725 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.1 m -127.98 152.93 47.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.66 152.49 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.58 174.95 10.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.798 0.808 . . . . 0.0 109.122 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -151.3 -175.19 5.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.405 1.882 . . . . 0.0 107.553 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.73 -13.98 12.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.651 0.78 . . . . 0.0 113.037 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.84 -66.13 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.586 1.554 . . . . 0.0 107.276 -160.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.16 -162.67 11.58 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.096 1.808 . . . . 0.0 111.44 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -141.65 159.16 42.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.26 1.03 . . . . 0.0 113.203 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.16 156.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 111.537 -165.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.1 155.98 22.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.839 0.29 . . . . 0.0 111.235 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.94 124.51 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.362 1.065 . . . . 0.0 108.971 162.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.498 ' HG ' ' CE1' ' A' ' 120' ' ' HIS . 18.1 p -98.09 145.65 26.34 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.724 1.147 . . . . 0.0 108.386 159.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -139.88 167.72 21.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.734 1.614 . . . . 0.0 107.913 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -154.68 93.32 1.56 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.76 -175.4 44.54 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 118.538 -1.791 . . . . 0.0 114.096 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.14 117.8 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.2 tp -96.08 135.39 22.74 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 117.58 -1.2 . . . . 0.0 108.454 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.27 150.97 46.46 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.002 1.801 . . . . 0.0 111.686 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.96 -33.88 77.08 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.958 -0.464 . . . . 0.0 110.157 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.3 -40.26 93.52 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -54.47 125.34 19.17 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.93 1.292 . . . . 0.0 109.567 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 157.09 45.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.78 118.27 8.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.723 167.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.68 57.62 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.916 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.41 166.62 10.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.552 1.676 . . . . 0.0 109.765 162.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.3 138.46 20.53 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 124.57 1.081 . . . . 0.0 110.873 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.72 166.97 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.431 1.892 . . . . 0.0 108.463 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.16 131.4 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 127.167 2.187 . . . . 0.0 105.121 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -115.96 158.37 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 125.481 1.512 . . . . 0.0 106.939 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -154.37 143.26 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.87 2.068 . . . . 0.0 105.616 176.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.79 -98.37 0.13 Allowed Glycine 0 CA--C 1.508 -0.362 0 CA-C-O 116.475 -2.291 . . . . 0.0 108.701 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.7 154.71 49.62 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.962 1.881 . . . . 0.0 108.946 169.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.13 134.25 46.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -80.79 -70.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 6.3 mtpp 172.86 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.059 3.343 . . . . 0.0 108.612 -167.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -83.81 57.66 5.04 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.887 -168.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.59 HD22 ' CG2' ' A' ' 43' ' ' ILE . 2.0 t-20 27.45 67.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.108 2.163 . . . . 0.0 113.269 -160.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.498 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 10.9 t-160 -134.48 124.08 25.01 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -172.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.6 mm -93.47 129.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.54 107.23 11.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 160.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.36 141.93 41.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.134 0.968 . . . . 0.0 109.353 172.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 -15.68 14.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.867 2.067 . . . . 0.0 109.805 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.37 -49.44 0.27 Allowed 'General case' 0 C--N 1.349 0.552 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.8 t 62.88 135.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.115 2.566 . . . . 0.0 112.091 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.7 mt -153.46 160.87 42.67 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -167.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.16 54.7 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 121.505 1.957 . . . . 0.0 112.625 -163.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt . . . . . 0 N--CA 1.492 1.666 0 C-N-CA 126.296 1.839 . . . . 0.0 115.792 178.752 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pp . . . . . 0 C--O 1.234 0.245 0 CA-C-O 122.268 1.032 . . . . 0.0 109.381 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -169.76 149.66 3.83 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.822 2.849 . . . . 0.0 106.077 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 86.4 m-85 -138.42 179.45 6.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.217 1.807 . . . . 0.0 109.587 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.501 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 71.3 p -131.49 170.31 11.6 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.241 1.017 . . . . 0.0 110.775 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -62.66 65.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.895 3.73 . . . . 0.0 110.815 161.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.52 -62.88 0.2 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -158.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB2' ' H ' ' A' ' 39' ' ' THR . 28.4 mt-10 -65.66 -21.79 66.58 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.865 1.333 . . . . 0.0 111.9 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.32 -13.97 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 111.17 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 mt -115.41 -42.67 3.13 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.162 -0.961 . . . . 0.0 111.856 -164.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -107.71 -46.37 3.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 109.504 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.57 144.13 3.9 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 14.3 tptp . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 168.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.1 mtp . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.66 162.63 40.74 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.307 1.145 . . . . 0.0 110.837 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.37 144.12 34.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.148 1.379 . . . . 0.0 108.197 166.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.67 0.85 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.879 1.323 . . . . 0.0 110.968 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.3 11.25 24.15 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 116.462 -2.299 . . . . 0.0 114.425 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -127.15 169.58 13.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.487 2.643 . . . . 0.0 111.715 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -82.97 150.35 26.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.383 162.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.12 -172.46 4.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.858 2.063 . . . . 0.0 108.749 171.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.05 48.87 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.517 1.127 . . . . 0.0 108.379 170.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.3 t -123.68 145.61 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.641 1.576 . . . . 0.0 107.439 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.18 124.23 5.67 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 165.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.7 164.09 33.94 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 117.693 0.746 . . . . 0.0 112.189 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 ttm -95.67 122.46 38.46 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.6 1.16 . . . . 0.0 110.286 -172.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.661 HG12 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -70.66 132.41 33.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.676 1.125 . . . . 0.0 110.131 -172.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.8 mtt -60.93 151.89 72.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.902 0.881 . . . . 0.0 110.995 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.98 106.54 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 124.186 3.258 . . . . 0.0 109.409 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.55 36.49 91.51 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.396 -1.224 . . . . 0.0 113.241 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.8 p -80.72 -15.75 55.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.334 1.567 . . . . 0.0 111.887 162.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -82.16 96.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.571 1.148 . . . . 0.0 110.057 -168.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 78.6 7.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.681 1.592 . . . . 0.0 107.44 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 160.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.1 129.2 33.78 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 164.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.421 ' C ' ' HG1' ' A' ' 81' ' ' THR . 3.2 p -142.52 143.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 80' ' ' VAL 0.301 35.8 m -140.99 133.57 28.61 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 50.5 p90 -143.33 173.61 11.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.685 -1.259 . . . . 0.0 111.031 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.5 m -128.37 136.89 51.55 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.46 146.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.888 2.075 . . . . 0.0 106.035 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -134.44 176.94 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.828 1.251 . . . . 0.0 109.505 -176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 88' ' ' GLU . 43.9 t0 -152.11 -168.71 3.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.967 1.307 . . . . 0.0 107.563 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 2.72 0.07 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.553 2.341 . . . . 0.0 113.722 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.7 -74.2 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.133 1.373 . . . . 0.0 107.76 -164.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.88 -157.44 7.29 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.369 -0.693 . . . . 0.0 111.369 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -138.57 161.18 37.74 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.202 1.001 . . . . 0.0 111.9 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.13 149.55 16.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -96.04 152.98 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.476 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 2.9 m -133.13 134.13 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -118.23 109.52 16.45 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.898 2.079 . . . . 0.0 107.355 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.49 171.2 7.87 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.997 1.719 . . . . 0.0 107.897 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.55 96.69 1.54 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.81 178.8 42.38 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 tp -79.6 125.48 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.85 149.79 83.29 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.252 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.49 146.32 89.18 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.593 2.195 . . . . 0.0 108.647 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.12 -24.23 67.02 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.104 -0.997 . . . . 0.0 111.597 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -19.52 60.87 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.759 2.423 . . . . 0.0 111.973 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -68.37 123.83 21.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.333 1.053 . . . . 0.0 110.599 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -136.5 140.73 43.23 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -66.76 113.85 5.18 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.661 ' H ' HG12 ' A' ' 66' ' ' VAL . . . 109.75 21.95 6.89 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 116.741 -2.144 . . . . 0.0 113.436 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.81 165.12 25.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.161 1.98 . . . . 0.0 111.308 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.53 1.55 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.518 1.532 . . . . 0.0 110.739 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.49 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 108.877 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.36 139.32 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.26 157.44 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.868 2.067 . . . . 0.0 107.505 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.98 146.51 25.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.893 2.477 . . . . 0.0 107.366 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 145.26 -131.44 4.23 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 104.447 -3.461 . . . . 0.0 104.447 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -140.84 158.33 44.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.096 1.948 . . . . 0.0 110.841 -157.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.402 ' HB2' HD12 ' A' ' 60' ' ' LEU . 15.9 tp -90.75 128.78 36.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.771 0.828 . . . . 0.0 110.259 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.53 -66.75 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 109.85 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.14 158.99 17.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 128.859 2.864 . . . . 0.0 106.42 171.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.11 -99.21 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 124.34 0.971 . . . . 0.0 111.132 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.4 23.07 3.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.682 1.193 . . . . 0.0 110.815 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -92.03 128.03 37.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.2 mm -101.51 130.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 125.343 1.457 . . . . 0.0 109.722 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.18 119.88 22.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 155.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.59 132.86 33.92 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.933 1.293 . . . . 0.0 108.789 171.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.27 -25.36 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.831 1.653 . . . . 0.0 111.693 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.67 -41.75 0.32 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.0 t 62.98 139.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 124.654 2.168 . . . . 0.0 112.432 -172.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -140.32 157.53 45.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.719 2.008 . . . . 0.0 106.181 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.33 42.06 3.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 109.334 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 127.75 2.42 . . . . 0.0 114.531 -179.823 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 118.037 -0.982 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.42 171.44 10.46 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.028 1.285 . . . . 0.0 110.763 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m 139.97 161.67 0.0 OUTLIER 'General case' 0 C--O 1.235 0.326 1 C-N-CA 134.043 4.937 . . . . 0.0 109.423 168.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 m120 61.81 177.66 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.0 mt -93.2 152.48 3.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 52.36 -161.73 0.1 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.308 1.843 . . . . 0.0 111.12 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 pp -106.0 -173.32 2.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.24 156.25 14.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.85 -167.26 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.948 0.795 . . . . 0.0 109.291 170.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.93 170.94 8.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 125.796 1.638 . . . . 0.0 109.361 168.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -64.63 -4.13 7.88 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.166 2.577 . . . . 0.0 115.581 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.05 -46.31 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 161.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -76.83 -20.27 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.499 -1.589 . . . . 0.0 113.331 -160.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -73.04 -13.47 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.575 -0.703 . . . . 0.0 111.462 174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.27 -47.39 2.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.66 0.784 . . . . 0.0 109.446 -173.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -90.08 -36.85 14.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.12 0.968 . . . . 0.0 111.07 -168.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.77 4.22 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.801 1.667 . . . . 0.0 111.014 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -76.79 137.55 39.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.0 -1.882 . . . . 0.0 111.43 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -19.05 -19.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 1 C-N-CA 131.758 4.023 . . . . 0.0 120.579 -135.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -121.36 -75.09 0.59 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.5 t -164.94 31.07 0.06 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.154 0.982 . . . . 0.0 109.434 -170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.92 -35.53 76.94 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.392 -0.817 . . . . 0.0 112.589 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 176.23 175.97 0.29 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 130.702 3.601 . . . . 0.0 106.429 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 24.3 mtp -116.09 151.06 46.18 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 159.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.14 165.62 27.83 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.789 1.659 . . . . 0.0 111.493 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.3 136.05 36.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 127.099 2.16 . . . . 0.0 109.358 172.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.0 t -64.17 -14.36 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.073 164.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.93 4.18 71.34 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 116.06 -2.522 . . . . 0.0 114.901 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -117.82 168.41 10.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 123.15 3.475 . . . . 0.0 112.645 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 147.32 22.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 164.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -158.09 176.19 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 128.288 2.635 . . . . 0.0 110.06 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -131.26 142.47 50.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.91 2.084 . . . . 0.0 109.073 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 p -152.52 124.19 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 173.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -76.63 150.83 38.71 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 169.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 166.86 37.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.081 1.801 . . . . 0.0 110.285 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttm -95.38 125.32 39.92 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.124 1.37 . . . . 0.0 108.665 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.69 124.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 119.498 1.045 . . . . 0.0 108.494 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.9 mtt -60.06 139.51 90.96 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.381 0.992 . . . . 0.0 110.667 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.6 146.03 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.751 2.968 . . . . 0.0 109.562 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.39 -22.93 0.49 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.328 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -61.13 -38.65 87.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.812 1.806 . . . . 0.0 112.106 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.73 94.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.661 1.584 . . . . 0.0 109.301 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -84.2 144.08 29.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 158.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -130.65 151.19 51.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.04 139.94 93.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.66 -16.65 38.07 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 120.952 1.101 . . . . 0.0 111.884 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -127.52 -0.07 6.22 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.788 1.635 . . . . 0.0 110.709 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.4 165.4 32.19 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 119.069 0.85 . . . . 0.0 110.843 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.3 3.77 41.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.323 1.449 . . . . 0.0 111.328 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -54.61 143.53 24.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 123.787 0.835 . . . . 0.0 108.817 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.24 155.63 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 125.155 1.382 . . . . 0.0 107.518 172.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.72 120.85 16.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 161.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -134.91 170.26 16.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.882 0.873 . . . . 0.0 110.71 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 m -117.83 145.8 44.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.92 139.47 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -135.11 175.6 9.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.557 1.543 . . . . 0.0 108.803 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 88' ' ' GLU . 30.4 t0 -149.42 -169.83 3.48 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 163.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 6.65 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -119.45 -68.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.873 1.669 . . . . 0.0 109.527 -171.016 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -168.1 12.76 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.219 1.39 . . . . 0.0 110.401 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.6 p -142.95 160.83 39.6 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.664 0.732 . . . . 0.0 112.684 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.44 154.3 32.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.294 2.238 . . . . 0.0 108.159 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.17 158.73 15.47 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.8 t -138.63 119.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.404 1.482 . . . . 0.0 108.072 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 m -88.06 128.52 35.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 154.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -125.05 161.95 25.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 160.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.58 112.05 5.55 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.07 -159.86 28.28 Favored Glycine 0 CA--C 1.507 -0.453 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.882 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -80.57 111.01 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -170.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.64 148.24 48.46 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.205 -1.362 . . . . 0.0 107.832 -169.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.96 131.93 49.25 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -17.31 63.34 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.201 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.49 -25.22 54.01 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.562 1.545 . . . . 0.0 113.796 168.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -51.91 121.87 7.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.385 1.448 . . . . 0.0 111.797 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -135.78 157.48 46.75 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.195 1.474 . . . . 0.0 112.256 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -71.62 95.96 1.51 Allowed 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 128.184 2.594 . . . . 0.0 107.622 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.65 33.81 4.02 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 113.326 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 164.03 17.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.125 1.963 . . . . 0.0 110.357 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.07 83.62 1.44 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.774 1.654 . . . . 0.0 109.401 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.6 -179.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.705 1.202 . . . . 0.0 109.014 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.1 t -126.89 135.75 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.314 2.246 . . . . 0.0 105.577 167.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -104.68 163.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -161.22 144.78 12.96 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.01 -133.06 3.88 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.97 153.31 51.86 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 120.056 1.928 . . . . 0.0 110.211 -159.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.98 131.48 41.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.62 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.65 -62.53 1.49 Allowed 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.119 0.568 . . . . 0.0 109.683 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 -72.34 0.17 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.87 -74.44 0.99 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.34 44.93 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 107.997 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -128.54 135.99 50.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.2 mm -111.0 130.15 64.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 127.327 2.251 . . . . 0.0 109.148 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.27 90.43 4.95 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 156.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.8 150.2 7.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.925 0.869 . . . . 0.0 111.174 161.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -12.14 8.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.779 2.832 . . . . 0.0 111.514 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.05 -45.72 0.2 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.1 t 58.97 133.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.584 1.954 . . . . 0.0 111.456 -171.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.84 150.74 48.48 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 120.184 -1.572 . . . . 0.0 107.9 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.424 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -110.26 29.09 8.0 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.464 0.706 . . . . 0.0 111.798 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 46.59 31.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.865 1.266 . . . . 0.0 113.785 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.566 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -71.64 41.61 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 129.453 3.101 . . . . 0.0 109.755 167.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t0 67.69 -65.82 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.363 2.665 . . . . 0.0 112.076 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 65.47 154.19 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.37 2.668 . . . . 0.0 111.799 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -147.1 -50.17 0.19 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.163 -172.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 11.9 t80 66.63 109.26 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.269 2.628 . . . . 0.0 110.898 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.9 m -78.93 129.09 74.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.39 177.25 6.9 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.395 2.73 . . . . 0.0 111.924 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.28 -44.43 9.17 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.445 2.097 . . . . 0.0 113.844 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -78.03 60.49 2.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.942 0.897 . . . . 0.0 109.944 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 p -165.2 -53.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 126.199 1.8 . . . . 0.0 106.871 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -67.39 -56.87 7.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.856 0.862 . . . . 0.0 110.317 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -148.89 20.79 1.0 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.415 1.086 . . . . 0.0 110.34 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.45 29.65 3.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.017 1.327 . . . . 0.0 111.681 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 C--O 1.254 1.317 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 147.885 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -146.01 158.52 43.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -155.74 94.33 1.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.54 -56.47 0.31 Allowed 'General case' 0 N--CA 1.461 0.117 0 O-C-N 121.638 -0.664 . . . . 0.0 112.456 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.56 152.59 8.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -37.23 151.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.301 2.64 . . . . 0.0 112.935 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 pp -71.07 -178.63 2.04 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.906 1.336 . . . . 0.0 109.684 161.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.99 146.36 14.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -139.42 -176.49 4.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.055 0.942 . . . . 0.0 110.798 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -137.78 172.69 6.37 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 -9.78 17.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.766 2.311 . . . . 0.0 116.19 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.8 -40.87 3.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 121.001 1.728 . . . . 0.0 112.646 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.53 -15.51 56.51 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.316 1.558 . . . . 0.0 112.278 -158.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mt -82.4 -22.82 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.146 1.779 . . . . 0.0 110.896 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -56.87 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.864 1.211 . . . . 0.0 109.784 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -75.25 -64.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.328 1.851 . . . . 0.0 108.255 -171.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.36 151.92 6.37 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -54.26 152.28 6.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 117.223 0.511 . . . . 0.0 110.005 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -42.7 -16.0 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 120.913 3.672 . . . . 0.0 120.913 -170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.67 -63.02 1.31 Allowed 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 119.539 -1.975 . . . . 0.0 109.611 156.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.5 t -170.07 21.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.826 1.651 . . . . 0.0 111.142 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.53 -55.01 40.5 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 119.71 -1.869 . . . . 0.0 111.59 -156.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.82 168.63 0.19 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 128.912 2.885 . . . . 0.0 107.922 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 156.37 35.31 Favored Pre-proline 0 C--N 1.322 -0.621 0 C-N-CA 125.34 1.456 . . . . 0.0 109.63 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.99 159.27 41.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.924 1.749 . . . . 0.0 111.52 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 155.33 28.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.15 2.18 . . . . 0.0 108.983 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.9 -8.44 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.824 1.25 . . . . 0.0 110.899 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.03 38.07 2.09 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 125.955 1.74 . . . . 0.0 109.654 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -121.87 164.79 16.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.663 0.744 . . . . 0.0 109.509 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.22 149.91 24.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.299 172.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -163.96 164.05 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.831 0.852 . . . . 0.0 111.774 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -122.23 99.84 6.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.736 2.414 . . . . 0.0 110.785 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -80.23 159.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.619 -1.301 . . . . 0.0 110.292 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 152.11 24.27 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.278 -0.889 . . . . 0.0 111.789 148.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.26 -178.52 45.18 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.998 1.761 . . . . 0.0 110.395 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.0 ttm -100.83 127.43 47.28 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 117.935 0.867 . . . . 0.0 111.579 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.73 125.88 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.2 mtt -57.04 151.1 36.25 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.484 0.584 . . . . 0.0 110.999 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.5 122.29 9.92 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.418 2.745 . . . . 0.0 108.077 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.7 4.85 48.61 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.872 -1.516 . . . . 0.0 115.538 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.9 p -64.68 -24.9 67.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.339 2.07 . . . . 0.0 110.962 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.68 105.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.588 1.555 . . . . 0.0 109.412 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -60.22 -65.34 0.7 Allowed 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 126.606 1.963 . . . . 0.0 108.901 171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 42.67 129.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 131.31 3.844 . . . . 0.0 115.759 -172.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -80.44 118.91 74.62 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.31 -8.13 22.76 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.558 1.506 . . . . 0.0 111.893 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -130.16 7.22 5.02 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.261 1.425 . . . . 0.0 111.126 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.11 -166.89 2.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mp -112.14 -4.92 14.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.245 1.018 . . . . 0.0 110.879 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.86 142.98 39.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 109.489 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -156.45 144.05 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.0 p -121.81 151.3 40.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 165.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -146.4 178.09 8.53 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.786 0.834 . . . . 0.0 109.054 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -125.86 138.47 53.81 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.27 144.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.807 2.043 . . . . 0.0 106.694 176.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -140.45 171.05 14.68 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.091 1.357 . . . . 0.0 110.357 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.54 -164.6 2.04 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.961 1.304 . . . . 0.0 109.077 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.78 -4.37 6.49 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -112.84 -80.84 0.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -170.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.09 -156.11 6.88 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.575 1.083 . . . . 0.0 111.897 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.4 p -150.08 165.28 33.26 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 117.368 0.584 . . . . 0.0 111.688 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.49 138.31 44.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.041 1.736 . . . . 0.0 108.639 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 151.44 39.37 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.58 127.31 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.666 1.186 . . . . 0.0 109.772 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 p -97.47 135.53 39.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.015 1.326 . . . . 0.0 109.126 164.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -142.09 169.65 17.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.928 1.691 . . . . 0.0 108.679 171.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -150.56 105.87 3.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.06 -165.32 36.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.724 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -19.47 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.881 0.472 . . . . 0.0 112.187 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 mt 67.13 151.87 0.12 Allowed Pre-proline 0 CA--C 1.527 0.088 0 C-N-CA 129.237 3.015 . . . . 0.0 112.177 -165.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -62.93 139.51 74.24 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.536 1.491 . . . . 0.0 108.25 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.78 -13.04 60.99 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.027 0.918 . . . . 0.0 110.333 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.31 -25.41 51.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 119.662 -1.899 . . . . 0.0 112.411 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.17 128.23 34.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.204 1.802 . . . . 0.0 112.238 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.07 170.29 16.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.954 1.301 . . . . 0.0 110.021 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.08 80.07 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.71 1.204 . . . . 0.0 108.866 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 32.1 0.47 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.449 1.023 . . . . 0.0 112.068 -170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.31 166.79 21.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.931 1.366 . . . . 0.0 110.869 171.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.31 121.37 5.44 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.488 1.994 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.69 170.23 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.179 1.392 . . . . 0.0 108.541 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.77 100.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.636 1.974 . . . . 0.0 107.898 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -79.67 159.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -155.15 137.97 15.33 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.02 -105.77 0.23 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -150.51 157.91 43.55 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.459 1.63 . . . . 0.0 108.941 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.6 tp -80.55 146.4 31.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.318 175.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -103.44 -64.09 1.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.825 0.739 . . . . 0.0 111.05 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.412 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 167.05 158.41 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 129.699 3.199 . . . . 0.0 106.692 -168.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.54 22.53 46.06 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.945 -0.919 . . . . 0.0 114.036 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.3 m120 73.52 29.32 1.6 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.386 1.875 . . . . 0.0 112.702 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -96.09 132.0 41.93 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.833 1.653 . . . . 0.0 109.018 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.7 mm -99.76 129.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 126.306 1.842 . . . . 0.0 109.599 172.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.03 114.41 17.95 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 157.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.42 160.33 29.85 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.009 1.385 . . . . 0.0 109.357 162.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 -26.29 5.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.503 -1.681 . . . . 0.0 110.496 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -139.61 -41.48 0.45 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t 59.28 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.183 1.793 . . . . 0.0 111.878 -173.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.72 157.97 45.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 120.648 -1.282 . . . . 0.0 108.052 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.58 37.35 4.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.954 1.302 . . . . 0.0 110.124 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.487 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.4 mmpm? 47.06 57.41 5.74 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.157 1.383 . . . . 0.0 112.512 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -76.78 -91.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -162.81 45.39 0.13 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.05 0.929 . . . . 0.0 108.947 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.9 112.63 24.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -124.5 31.38 5.75 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.924 1.29 . . . . 0.0 109.063 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -152.38 162.52 41.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.875 1.27 . . . . 0.0 108.045 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -129.42 112.41 18.01 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 168.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.33 141.33 74.46 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.909 1.74 . . . . 0.0 110.983 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -64.36 -57.2 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.463 2.109 . . . . 0.0 113.285 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.52 7.13 1.99 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.385 1.474 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.45 -17.67 6.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.949 2.499 . . . . 0.0 108.853 -165.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.85 -40.3 88.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.89 1.276 . . . . 0.0 109.839 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -98.61 113.67 25.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -52.59 124.77 14.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.463 0.477 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 ptt? . . . . . 0 C--O 1.256 1.411 0 C-N-CA 126.725 2.01 . . . . 0.0 108.953 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -149.98 -42.73 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.411 1.459 . . . . 0.0 113.332 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 m 65.75 -65.41 0.18 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.79 1.636 . . . . 0.0 114.812 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 61.72 135.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.976 1.71 . . . . 0.0 110.193 -151.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.263 55.9 mt 61.11 165.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 0.0 110.341 -172.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -71.16 173.12 8.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 110.156 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.0 pp -71.2 -175.9 1.32 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.252 1.821 . . . . 0.0 111.892 176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.451 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 40.4 t80 -171.19 158.29 5.42 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.591 3.156 . . . . 0.0 107.101 173.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.67 -178.9 6.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.629 1.972 . . . . 0.0 110.247 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 p -134.38 163.35 51.83 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 125.16 1.384 . . . . 0.0 111.682 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -76.07 71.63 5.59 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.602 3.534 . . . . 0.0 108.576 173.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.52 -66.78 0.15 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 105.44 -3.064 . . . . 0.0 105.44 -163.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.47 -33.5 71.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.131 1.465 . . . . 0.0 111.984 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.45 -11.71 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.354 1.061 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.65 -31.51 3.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.193 . . . . 0.0 111.646 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -98.09 -18.59 18.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.556 1.942 . . . . 0.0 112.218 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.7 147.69 16.99 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.869 1.223 . . . . 0.0 110.403 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 20.0 tptp -62.59 139.33 58.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.359 -1.781 . . . . 0.0 109.987 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.6 mtm-85 -18.18 -77.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.752 1.621 . . . . 0.0 113.972 -152.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.4 -87.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -174.38 36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.454 1.121 . . . . 0.0 108.541 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -41.63 42.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 119.443 -2.035 . . . . 0.0 109.444 -167.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.269 0.1 OUTLIER -174.42 -173.31 0.75 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.511 2.324 . . . . 0.0 111.461 161.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.2 mtp -126.5 162.77 44.72 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.819 1.648 . . . . 0.0 109.983 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.96 155.94 11.43 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.918 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.58 144.35 31.32 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.254 1.422 . . . . 0.0 111.523 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 p -63.35 -20.82 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 113.001 170.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.41 59.85 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.88 176.61 9.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.041 1.42 . . . . 0.0 112.328 157.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.36 149.96 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.454 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.39 163.88 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.157 1.383 . . . . 0.0 113.262 166.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -101.53 140.77 35.38 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 126.549 1.94 . . . . 0.0 109.164 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -126.73 139.89 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.098 1.359 . . . . 0.0 108.251 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.44 137.25 12.01 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 163.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.64 -163.28 12.2 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.971 1.748 . . . . 0.0 109.364 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 ttm -126.71 127.53 45.26 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 126.525 1.93 . . . . 0.0 109.525 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.466 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 21.9 t -65.54 130.07 30.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.0 mtt -65.06 124.48 86.88 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.78 103.8 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.775 2.983 . . . . 0.0 106.649 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.49 -5.39 8.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-O 118.246 -1.308 . . . . 0.0 112.632 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.6 p -88.81 -44.19 10.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.467 1.634 . . . . 0.0 111.949 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.89 104.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.508 1.123 . . . . 0.0 110.951 -167.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.46 -66.22 0.58 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.773 1.629 . . . . 0.0 109.954 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 54.2 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.8 2.04 . . . . 0.0 112.048 -153.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.15 136.92 20.45 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -84.57 -9.48 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 121.027 1.403 . . . . 0.0 112.96 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -110.28 -19.18 13.09 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.147 0.885 . . . . 0.0 110.914 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -131.97 176.3 8.48 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.777 0.717 . . . . 0.0 109.167 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.37 4.82 53.36 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.266 -0.896 . . . . 0.0 111.095 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.58 145.14 55.93 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.233 -0.917 . . . . 0.0 108.974 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.8 p -157.81 132.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -176.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -130.98 109.45 10.53 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.768 1.627 . . . . 0.0 108.455 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.567 ' CE1' HG21 ' A' ' 93' ' ' VAL . 54.8 p90 -123.21 165.99 15.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.141 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 m -114.25 143.34 45.01 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 145.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.73 173.52 11.62 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.239 1.016 . . . . 0.0 109.591 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.14 -169.72 3.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.049 1.34 . . . . 0.0 107.47 164.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.84 -9.07 5.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.511 1.524 . . . . 0.0 114.015 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.12 -71.33 0.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.352 1.861 . . . . 0.0 107.002 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.07 -152.11 5.61 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.9 p -155.21 164.36 38.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.069 0.548 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.38 154.87 11.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.894 1.678 . . . . 0.0 109.547 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.64 164.27 16.91 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.014 0.912 . . . . 0.0 110.307 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 82' ' ' PHE . 1.3 m -132.7 156.46 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.103 1.361 . . . . 0.0 107.957 169.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.6 t -120.74 134.72 55.27 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 157.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -131.99 162.58 30.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.07 1.748 . . . . 0.0 107.403 168.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -141.13 103.61 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 168.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.53 163.88 26.25 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.2 tt -75.64 -22.1 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -164.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 55.6 mt 89.43 149.84 0.07 OUTLIER Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 131.377 3.871 . . . . 0.0 113.109 173.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -63.2 150.52 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 121.809 1.673 . . . . 0.0 109.576 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.29 -28.97 65.49 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.847 1.259 . . . . 0.0 109.74 163.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.16 -14.08 59.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 128.107 2.563 . . . . 0.0 114.098 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -85.63 127.66 34.54 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 122.947 2.612 . . . . 0.0 106.877 177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -134.54 162.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.254 1.026 . . . . 0.0 111.148 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.11 108.7 6.15 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.111 1.765 . . . . 0.0 108.273 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.466 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 96.99 37.86 4.53 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.103 0.858 . . . . 0.0 111.737 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -139.7 170.65 15.51 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.392 1.096 . . . . 0.0 111.646 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.17 136.95 40.33 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.111 0.862 . . . . 0.0 111.294 172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.04 168.1 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.974 1.71 . . . . 0.0 107.15 170.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.46 107.65 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.52 157.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -150.28 139.09 20.83 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 128.014 2.526 . . . . 0.0 105.54 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.85 -118.21 0.81 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 104.343 -3.503 . . . . 0.0 104.343 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -141.17 156.97 45.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 119.717 1.759 . . . . 0.0 111.452 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.57 143.11 32.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -93.39 -72.34 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.295 1.038 . . . . 0.0 109.365 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.86 -86.07 0.17 Allowed 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.143 1.377 . . . . 0.0 109.134 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.87 -69.75 1.3 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -171.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -147.42 5.11 0.81 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -89.6 136.79 32.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 -167.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mm -107.96 127.23 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.742 1.217 . . . . 0.0 109.006 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.62 104.28 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 164.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.57 133.46 42.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.386 0.675 . . . . 0.0 109.301 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -21.82 15.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.574 1.55 . . . . 0.0 111.728 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -144.41 -38.31 0.29 Allowed 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.3 t 58.1 106.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.368 1.867 . . . . 0.0 113.015 -178.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -120.6 156.89 30.68 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 0.0 108.259 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.75 32.25 6.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.284 1.402 . . . . 0.0 112.483 -175.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.79 16.11 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.533 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 6.0 p80 -82.76 60.28 5.22 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 127.269 2.228 . . . . 0.0 109.183 -172.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t70 60.03 11.12 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.529 2.331 . . . . 0.0 115.79 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -54.47 116.73 2.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.463 1.505 . . . . 0.0 108.116 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.3 -21.87 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.63 0.772 . . . . 0.0 111.918 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -162.6 137.19 6.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.013 1.725 . . . . 0.0 107.199 163.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.4 m -133.96 113.3 12.6 Favored Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.85 173.76 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.323 2.015 . . . . 0.0 110.568 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.62 -32.91 37.52 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.157 1.905 . . . . 0.0 112.43 168.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.98 34.79 0.36 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.21 1.404 . . . . 0.0 112.735 -160.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.425 ' HA ' ' HG3' ' A' ' 143' ' ' MET . 5.5 m -149.19 -43.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.766 1.626 . . . . 0.0 110.818 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -58.93 -30.56 67.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.389 0.676 . . . . 0.0 111.644 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.7 138.38 37.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.728 1.611 . . . . 0.0 107.446 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 44.7 67.42 0.7 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.37 2.268 . . . . 0.0 111.874 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.425 ' HG3' ' HA ' ' A' ' 139' ' ' VAL . 19.3 ttm . . . . . 0 C--O 1.25 1.13 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -146.52 112.99 5.94 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.191 2.196 . . . . 0.0 108.416 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -157.69 174.38 15.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 127.036 2.134 . . . . 0.0 106.841 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -159.6 -59.88 0.07 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 110.649 162.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.1 pt -71.76 -155.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 109.698 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -47.5 158.56 0.18 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.937 1.695 . . . . 0.0 111.974 168.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pp -86.49 -175.93 5.65 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.623 1.569 . . . . 0.0 109.888 174.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -159.42 157.59 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.308 2.243 . . . . 0.0 106.492 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.433 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 91.8 m-85 -143.36 177.86 8.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.997 1.719 . . . . 0.0 109.547 171.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.505 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 45.1 p -132.7 171.41 9.19 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 110.63 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.58 0.01 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.834 2.356 . . . . 0.0 114.803 162.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.84 25.33 7.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.718 1.151 . . . . 0.0 111.734 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' HB2' ' H ' ' A' ' 39' ' ' THR . 43.5 mt-10 -132.39 -41.17 0.98 Allowed 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.876 1.338 . . . . 0.0 110.69 173.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.16 -23.5 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 118.326 0.512 . . . . 0.0 110.944 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -105.38 -53.9 2.58 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.521 1.528 . . . . 0.0 107.603 176.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -88.38 14.8 8.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -166.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.62 124.7 3.25 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.433 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 29.9 tttm -62.57 149.38 43.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.908 174.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt85 -19.46 -39.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 120.379 3.474 . . . . 0.0 120.379 -143.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -120.39 -72.91 0.67 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 166.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.3 t -164.49 23.22 0.06 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.295 0.638 . . . . 0.0 111.755 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -49.31 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 119.509 -1.994 . . . . 0.0 112.557 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.433 HE21 ' C ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -176.6 176.1 1.61 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.977 2.111 . . . . 0.0 107.915 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 83.4 mmm -114.57 158.55 39.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.838 1.255 . . . . 0.0 107.93 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.03 148.27 62.94 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.284 1.323 . . . . 0.0 109.649 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.87 146.65 33.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 75.2 t -76.48 1.52 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.02 1.328 . . . . 0.0 112.018 -174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.63 38.39 1.37 Allowed Glycine 0 CA--C 1.51 -0.261 0 O-C-N 118.544 -2.597 . . . . 0.0 110.287 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.77 168.35 9.54 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 164.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -79.89 152.38 29.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.69 168.39 27.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.552 1.141 . . . . 0.0 111.229 165.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -114.4 136.45 52.98 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.954 2.102 . . . . 0.0 107.725 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.01 151.91 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.73 2.012 . . . . 0.0 107.777 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.32 149.69 17.9 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.4 179.17 48.9 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.388 0.995 . . . . 0.0 110.85 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.2 ttm -91.08 126.12 36.07 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.805 1.642 . . . . 0.0 109.968 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.84 130.04 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 O-C-N 120.445 -1.41 . . . . 0.0 108.198 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.1 mtt -62.9 139.19 97.33 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 118.54 0.609 . . . . 0.0 111.637 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.83 146.8 60.85 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.395 2.73 . . . . 0.0 108.941 163.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.22 20.97 75.52 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.414 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.5 m -120.22 -26.18 5.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.704 1.252 . . . . 0.0 112.15 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.05 93.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 119.318 0.963 . . . . 0.0 108.91 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -73.25 -66.11 0.72 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.124 1.77 . . . . 0.0 109.317 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 67.47 134.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 128.563 2.745 . . . . 0.0 110.868 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.97 125.28 91.18 Favored Pre-proline 0 C--N 1.335 -0.059 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.53 -16.48 54.05 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.709 1.646 . . . . 0.0 111.384 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.15 -18.5 20.07 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.219 -0.896 . . . . 0.0 112.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.15 -176.06 5.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.472 1.033 . . . . 0.0 111.821 -155.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.81 -1.04 38.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.154 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -60.25 139.15 57.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.281 1.039 . . . . 0.0 108.249 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 158.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.097 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 140.63 52.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 151.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.44 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 43.8 p90 -140.94 -179.11 5.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.999 0.919 . . . . 0.0 109.296 160.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.9 m -130.85 151.27 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.32 129.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -116.58 -177.51 3.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.093 1.757 . . . . 0.0 107.42 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -155.13 -141.65 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 155.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -18.74 65.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 121.266 1.848 . . . . 0.0 114.663 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.69 -69.69 0.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -151.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.63 -153.47 5.9 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.2 p -147.27 163.53 36.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.282 1.041 . . . . 0.0 112.008 170.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.92 138.56 38.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.54 1.936 . . . . 0.0 109.504 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.65 150.78 37.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 5.0 m -127.24 152.77 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 164.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.406 ' HG ' ' CE1' ' A' ' 120' ' ' HIS . 20.2 p -125.99 128.36 47.35 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 161.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -125.83 170.58 11.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.37 1.868 . . . . 0.0 108.011 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -158.76 107.5 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.5 14.98 0.02 OUTLIER Glycine 0 N--CA 1.473 1.145 0 C-N-CA 114.409 -3.758 . . . . 0.0 121.265 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.404 HD12 ' H ' ' A' ' 99' ' ' LEU 0.265 0.4 OUTLIER 58.01 143.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.957 2.103 . . . . 0.0 110.186 -152.222 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.404 ' H ' HD12 ' A' ' 98' ' ' ILE . 20.8 mt -92.08 162.67 29.87 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.525 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -58.32 147.87 82.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 166.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -66.15 -18.14 65.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.771 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.44 -31.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.858 -1.544 . . . . 0.0 112.493 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.9 137.9 58.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.572 1.078 . . . . 0.0 109.164 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -142.54 168.96 18.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.1 132.83 53.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 159.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.69 15.54 56.47 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.7 163.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -121.23 163.68 18.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.42 1.11 . . . . 0.0 111.545 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.91 124.08 10.15 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.84 162.39 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.99 134.31 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.1 t -107.79 160.51 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -158.64 151.07 21.74 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 166.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.07 -145.34 12.09 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 -165.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.97 157.88 35.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.734 1.267 . . . . 0.0 109.463 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.7 tp -84.56 137.08 33.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.15 -65.91 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -163.9 154.84 15.87 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 133.956 4.902 . . . . 0.0 104.725 175.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -98.44 0.22 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.16 1.82 2.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.406 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 18.6 t-160 -70.78 124.64 24.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.956 1.253 . . . . 0.0 109.772 178.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.28 122.45 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.66 1.584 . . . . 0.0 110.531 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.92 81.67 5.18 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 165.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.63 133.5 30.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.041 1.336 . . . . 0.0 109.892 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 -25.25 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.611 1.564 . . . . 0.0 111.196 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.45 -37.39 0.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 60.3 t 52.19 113.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 127.068 2.147 . . . . 0.0 115.523 176.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.47 154.32 47.1 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.519 -1.363 . . . . 0.0 108.889 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.492 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -118.16 37.11 4.1 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.253 1.842 . . . . 0.0 111.894 -166.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 41.92 42.83 2.42 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.851 2.46 . . . . 0.0 112.304 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.492 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 1.4 p-80 -96.38 38.78 1.18 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.309 1.844 . . . . 0.0 110.526 -172.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 61.54 68.11 0.73 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.289 1.836 . . . . 0.0 112.123 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.98 175.55 7.62 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.318 1.447 . . . . 0.0 110.154 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.0 -42.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.37 1.468 . . . . 0.0 109.446 150.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -147.7 119.25 7.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.531 1.132 . . . . 0.0 110.531 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 m -91.82 134.58 28.74 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.31 176.62 8.97 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 122.47 2.113 . . . . 0.0 110.998 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.47 -36.28 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.408 2.072 . . . . 0.0 113.908 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -83.81 37.79 0.61 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.037 0.935 . . . . 0.0 111.164 -162.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -153.83 -30.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.846 2.058 . . . . 0.0 111.007 -167.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -74.55 -50.37 18.31 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.611 0.641 . . . . 0.0 110.334 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.1 93.06 0.28 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -177.21 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.425 1.89 . . . . 0.0 109.335 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.081 -1.438 . . . . 0.0 108.002 159.831 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 120.569 0.223 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.06 154.09 42.06 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p -158.35 -177.94 6.91 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.662 1.585 . . . . 0.0 107.528 161.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -135.89 172.75 12.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 151.04 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 161.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.41 114.93 0.01 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.781 2.832 . . . . 0.0 113.613 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.67 147.12 33.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.771 2.028 . . . . 0.0 111.318 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -150.54 139.46 20.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.219 -166.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -140.68 -174.74 4.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.595 1.958 . . . . 0.0 107.7 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' H ' ' HG3' ' A' ' 42' ' ' GLU . 26.0 p -141.26 174.48 3.83 Favored Pre-proline 0 C--O 1.235 0.325 0 O-C-N 120.542 -1.349 . . . . 0.0 110.542 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -57.69 0.88 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -108.22 -41.94 1.46 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 121.789 2.086 . . . . 0.0 112.904 163.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 5.8 pt-20 -80.44 -2.61 46.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 119.607 1.704 . . . . 0.0 113.249 -162.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.55 -18.11 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.135 0.974 . . . . 0.0 110.38 166.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.61 -47.68 5.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.79 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -87.51 -26.37 23.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.364 1.466 . . . . 0.0 110.907 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.9 146.17 9.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.664 1.602 . . . . 0.0 110.301 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.468 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 44.8 tttm -57.11 139.68 51.68 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 117.971 -1.014 . . . . 0.0 112.228 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -18.18 -66.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 -150.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -74.83 -89.36 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 t -159.99 27.37 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.33 1.062 . . . . 0.0 109.9 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -26.45 60.87 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 119.584 -1.947 . . . . 0.0 113.266 -161.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 178.1 173.52 0.61 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.951 2.5 . . . . 0.0 110.796 163.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.25 145.1 29.25 Favored Pre-proline 0 C--O 1.241 0.645 0 C-N-CA 126.891 2.076 . . . . 0.0 108.267 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.2 134.48 45.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.667 2.245 . . . . 0.0 109.371 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.29 130.7 35.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -70.22 -11.1 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.418 0.627 . . . . 0.0 112.192 -172.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.27 3.73 61.93 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 116.885 -2.064 . . . . 0.0 113.009 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -110.01 167.2 10.35 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.893 2.347 . . . . 0.0 112.766 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -85.29 137.54 32.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 108.669 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.99 173.37 16.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.217 1.007 . . . . 0.0 110.175 171.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -122.34 157.36 31.96 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 111.136 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -131.96 143.24 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.571 1.948 . . . . 0.0 107.326 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.19 127.51 5.91 Favored Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 168.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.51 -178.89 38.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.7 ttm -105.22 129.71 53.54 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.028 0.931 . . . . 0.0 110.277 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.99 129.01 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.289 0.95 . . . . 0.0 108.925 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' MET . . . . . 0.451 ' HG3' ' CD1' ' A' ' 85' ' ' TYR . 5.3 mtm -68.9 149.45 97.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.489 0.586 . . . . 0.0 110.967 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.31 137.97 24.18 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.355 2.703 . . . . 0.0 108.966 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.59 57.9 15.68 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -142.62 -30.58 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 164.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.303 2.2 p -75.16 95.54 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 120.833 -1.167 . . . . 0.0 111.855 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.05 28.56 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 131.469 3.908 . . . . 0.0 113.896 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.37 146.07 25.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.41 1.084 . . . . 0.0 110.84 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -104.18 134.95 19.43 Favored Pre-proline 0 N--CA 1.448 -0.529 0 O-C-N 123.77 0.668 . . . . 0.0 109.215 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.66 -14.21 19.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.566 2.178 . . . . 0.0 112.535 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -109.1 -7.6 15.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 127.653 2.381 . . . . 0.0 111.881 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.6 m -151.56 171.92 16.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 120.007 1.276 . . . . 0.0 110.299 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.76 -8.14 47.66 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.201 -0.937 . . . . 0.0 111.402 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 137.27 57.15 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 109.387 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -161.15 127.2 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.0 p -105.47 159.94 15.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.487 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 53.3 p90 -153.82 -178.4 7.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.042 0.837 . . . . 0.0 110.059 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 m -129.92 142.4 50.66 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.7 136.78 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.451 ' CD1' ' HG3' ' A' ' 67' ' ' MET . 15.8 p90 -135.21 169.9 16.75 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.096 1.359 . . . . 0.0 109.559 -173.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.75 -166.76 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.339 1.855 . . . . 0.0 107.692 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -3.52 1.76 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.834 2.054 . . . . 0.0 114.972 -171.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.403 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -111.6 -62.28 1.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.819 1.248 . . . . 0.0 107.73 -173.454 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.26 -167.98 17.08 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.896 1.712 . . . . 0.0 112.005 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.9 p -137.51 164.04 29.69 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.92 0.888 . . . . 0.0 112.006 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.98 144.64 25.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.121 1.368 . . . . 0.0 109.501 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.97 152.52 30.98 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.209 1.004 . . . . 0.0 108.641 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.487 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 3.4 m -132.65 147.95 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.354 163.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -119.92 112.45 19.21 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.263 1.825 . . . . 0.0 108.557 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -112.88 166.51 11.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 108.32 174.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.13 97.89 1.96 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 168.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.65 -174.07 46.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.508 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.04 118.93 21.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.5 tp -97.14 135.3 21.99 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 109.113 -173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.45 156.9 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.154 1.903 . . . . 0.0 112.435 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.92 -40.8 75.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 123.098 1.428 . . . . 0.0 108.957 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.413 HD13 ' HD1' ' A' ' 130' ' ' HIS . 91.9 mt -64.44 -27.02 68.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.766 1.626 . . . . 0.0 111.715 177.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -66.29 106.64 1.75 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 119.374 0.988 . . . . 0.0 108.867 -174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -133.16 158.84 41.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.21 1.004 . . . . 0.0 109.829 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.71 105.48 3.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.628 1.571 . . . . 0.0 107.462 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.05 26.19 7.57 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.384 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.21 163.87 17.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.663 1.731 . . . . 0.0 110.508 160.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.88 138.2 19.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.61 174.47 12.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.36 1.464 . . . . 0.0 107.237 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.15 137.43 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.3 t -117.04 156.82 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.249 1.42 . . . . 0.0 107.508 165.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.21 141.88 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 127.072 2.149 . . . . 0.0 106.645 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.33 -103.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 166.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -142.89 161.35 38.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.983 1.892 . . . . 0.0 109.418 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.16 144.3 31.75 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -101.82 -72.53 0.68 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.319 0.509 . . . . 0.0 109.979 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -163.69 -83.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.147 2.179 . . . . 0.0 108.158 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.56 73.34 2.07 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.175 1.369 . . . . 0.0 111.555 -162.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.2 m120 44.49 46.39 8.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.304 1.841 . . . . 0.0 110.542 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -122.16 129.39 52.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.543 1.137 . . . . 0.0 108.395 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 16.5 mm -103.69 132.9 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.506 1.522 . . . . 0.0 109.487 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.17 114.37 18.06 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 159.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.009 170.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 -35.83 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.76 2.874 . . . . 0.0 118.76 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.9 t 50.65 122.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.39 1.876 . . . . 0.0 115.337 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.79 156.02 49.59 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 119.893 -1.754 . . . . 0.0 108.308 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.83 30.06 7.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 112.268 -168.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 41.88 60.34 2.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 123.008 1.385 . . . . 0.0 112.178 -172.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.413 ' HD1' HD13 ' A' ' 102' ' ' LEU . 1.1 p-80 -106.83 53.9 0.69 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.215 2.206 . . . . 0.0 108.853 167.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.1 t0 51.2 72.59 0.35 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.38 1.872 . . . . 0.0 112.91 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.18 149.36 51.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 109.869 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -170.73 -39.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.612 1.565 . . . . 0.0 110.746 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -143.49 176.77 8.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.466 1.906 . . . . 0.0 108.734 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 m -151.27 132.46 7.64 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.226 1.81 . . . . 0.0 106.99 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.09 174.93 1.58 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.202 2.602 . . . . 0.0 112.528 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.95 -168.93 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.307 2.005 . . . . 0.0 110.533 161.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.82 46.37 19.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.731 1.212 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.3 p -165.7 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.947 2.099 . . . . 0.0 109.554 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.98 -37.89 75.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.188 1.795 . . . . 0.0 111.094 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' A' ' 142' ' ' ALA . 21.1 tttp -150.49 -175.84 5.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.417 3.487 . . . . 0.0 105.535 167.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.41 ' H ' ' HG2' ' A' ' 141' ' ' LYS . . . 49.43 74.6 0.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 0.0 112.513 -179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 C--O 1.257 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 108.517 170.317 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.911 0.386 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -153.08 119.8 5.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 t -153.18 157.51 40.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -142.41 35.78 1.49 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.129 1.371 . . . . 0.0 109.431 -169.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.2 157.81 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -49.22 112.79 0.68 Allowed 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 127.818 2.447 . . . . 0.0 108.562 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.73 173.91 10.49 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.122 1.369 . . . . 0.0 110.608 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -161.84 150.69 15.6 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.418 1.887 . . . . 0.0 109.107 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.04 172.35 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.897 1.279 . . . . 0.0 111.549 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.4 p -135.59 158.72 73.71 Favored Pre-proline 0 C--O 1.243 0.762 0 C-N-CA 125.168 1.387 . . . . 0.0 111.591 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.76 78.58 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.975 3.784 . . . . 0.0 109.567 164.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.71 -63.16 0.22 Allowed Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 106.587 -2.605 . . . . 0.0 106.587 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.48 -21.47 66.34 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 122.149 -0.618 . . . . 0.0 110.39 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -77.45 -13.31 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.108 1.763 . . . . 0.0 110.683 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.11 -54.33 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.411 1.484 . . . . 0.0 107.499 -163.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -77.65 -78.87 0.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.962 2.505 . . . . 0.0 107.171 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.16 152.7 8.68 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.45 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.466 ' HB3' ' H ' ' A' ' 52' ' ' GLN . 3.5 tptm -49.31 114.89 1.13 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.291 1.436 . . . . 0.0 110.972 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -79.67 -15.85 56.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 119.194 0.906 . . . . 0.0 112.384 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.73 -48.62 73.92 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.024 0.829 . . . . 0.0 110.826 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -152.43 -1.76 0.27 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -151.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 35.47 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 128.142 2.577 . . . . 0.0 111.837 -166.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.466 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 33.8 mt-30 -119.92 -37.96 3.03 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.813 1.245 . . . . 0.0 112.661 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.3 mtp 59.96 155.02 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 129.284 3.033 . . . . 0.0 114.202 -173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.22 149.11 15.13 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.8 1.667 . . . . 0.0 109.285 168.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.01 148.65 31.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.19 -9.82 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.239 1.016 . . . . 0.0 111.149 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.44 61.59 0.43 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 168.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.64 174.41 14.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.799 1.3 . . . . 0.0 112.942 163.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -80.75 147.29 30.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.734 1.214 . . . . 0.0 108.88 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.1 165.23 24.89 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -97.46 144.58 27.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.002 2.921 . . . . 0.0 108.746 167.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.1 t -128.98 146.36 34.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.703 1.601 . . . . 0.0 108.167 167.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.41 139.07 10.63 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.33 -169.01 28.37 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 ttm -107.46 124.61 50.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.062 1.431 . . . . 0.0 109.682 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.485 ' CG1' ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -55.24 130.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.4 ttm -63.0 124.52 84.06 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.89 134.44 46.61 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.831 2.354 . . . . 0.0 108.465 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.58 7.93 85.48 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.032 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.5 p -98.17 -32.73 11.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.755 1.777 . . . . 0.0 113.71 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.5 p -77.2 123.37 33.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 118.889 0.768 . . . . 0.0 110.166 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -95.41 127.2 41.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 152.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -114.53 128.98 56.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 161.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.05 133.89 78.17 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.065 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.67 -2.47 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.376 2.051 . . . . 0.0 111.092 167.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.74 8.97 6.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.739 2.016 . . . . 0.0 110.731 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -150.86 178.99 8.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.217 1.407 . . . . 0.0 108.7 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.8 -6.86 35.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.86 1.664 . . . . 0.0 111.685 162.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 144.78 46.53 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.745 1.611 . . . . 0.0 109.226 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 1.6 p -155.85 136.39 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.6 p -118.37 152.47 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 167.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 26.0 p90 -153.02 -178.57 7.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.842 0.746 . . . . 0.0 109.796 166.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m -124.04 154.61 39.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -135.27 134.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -121.98 178.33 4.94 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.38 -148.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.35 61.66 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.764 -1.21 . . . . 0.0 113.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.3 -64.17 1.3 Allowed 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.475 1.11 . . . . 0.0 109.085 -162.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.81 -157.44 7.58 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.7 p -145.22 162.54 36.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.286 0.543 . . . . 0.0 112.265 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.65 154.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.166 2.186 . . . . 0.0 108.826 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 155.56 16.91 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.03 1.332 . . . . 0.0 109.481 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.5 t -139.23 128.66 30.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 123.574 0.75 . . . . 0.0 109.082 175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.447 ' HG ' ' CE1' ' A' ' 120' ' ' HIS . 47.5 m -110.85 117.23 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.066 1.347 . . . . 0.0 107.451 162.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -121.37 159.64 25.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.618 1.567 . . . . 0.0 107.071 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -146.68 90.12 1.9 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.51 -171.85 44.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.872 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.91 115.77 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.34 131.85 39.21 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.5 138.06 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.442 -1.407 . . . . 0.0 108.442 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.92 -20.81 65.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.06 0.933 . . . . 0.0 109.396 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.2 -21.71 63.94 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.304 1.442 . . . . 0.0 110.439 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -71.0 134.98 47.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.895 1.278 . . . . 0.0 109.252 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -138.35 -177.04 4.67 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.95 127.63 52.87 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.485 ' H ' ' CG1' ' A' ' 66' ' ' VAL . . . 80.71 31.67 35.64 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 118.077 -1.402 . . . . 0.0 110.992 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.479 ' H ' ' CG1' ' A' ' 66' ' ' VAL . 0.1 OUTLIER -118.14 168.08 10.89 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.042 1.421 . . . . 0.0 110.368 170.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.01 133.44 18.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.04 165.78 29.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.269 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.81 117.21 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 166.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -92.06 159.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.189 0.995 . . . . 0.0 108.65 162.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -154.04 146.6 24.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.889 1.676 . . . . 0.0 107.195 162.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.03 -104.26 0.2 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 161.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.64 154.04 46.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 119.219 1.51 . . . . 0.0 109.623 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 144.52 39.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -104.3 -83.75 0.49 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.782 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 -82.15 0.11 Allowed 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.544 1.066 . . . . 0.0 111.13 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.53 73.4 2.22 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -169.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m120 51.96 56.41 7.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.836 1.254 . . . . 0.0 109.205 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.447 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 20.6 t-160 -135.3 123.7 23.32 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.2 130.76 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.127 1.371 . . . . 0.0 107.745 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.38 110.13 13.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 157.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.45 154.36 39.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 122.076 0.941 . . . . 0.0 109.822 168.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -17.96 7.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.425 1.89 . . . . 0.0 111.997 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -143.18 -43.27 0.29 Allowed 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.8 t 54.13 121.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 123.686 1.708 . . . . 0.0 113.638 -172.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 mt -130.58 155.37 46.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.796 1.238 . . . . 0.0 108.094 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.9 39.9 3.26 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.312 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 40.34 57.5 2.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.595 1.958 . . . . 0.0 113.356 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.88 62.4 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t0 41.49 65.35 0.86 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.639 1.576 . . . . 0.0 112.41 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -94.69 137.45 33.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -151.08 166.18 31.57 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.618 1.567 . . . . 0.0 109.202 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -53.58 143.2 20.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.435 1.094 . . . . 0.0 110.583 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -135.16 138.9 30.27 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.773 1.629 . . . . 0.0 108.284 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.78 130.62 19.64 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.492 2.128 . . . . 0.0 109.948 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -60.29 -56.7 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.202 2.602 . . . . 0.0 114.917 -168.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -83.26 45.11 1.0 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.207 0.603 . . . . 0.0 110.521 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.1 t -140.35 -64.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.98 -31.09 64.69 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.129 1.372 . . . . 0.0 113.553 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 54.47 1.5 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.92 -36.48 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.495 1.118 . . . . 0.0 110.751 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 C--O 1.252 1.227 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 163.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -167.59 178.12 5.54 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 128.749 2.819 . . . . 0.0 107.622 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.2 m -69.99 -43.37 71.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.13 1.332 . . . . 0.0 110.505 163.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 50.6 -155.88 0.12 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.153 0.981 . . . . 0.0 109.509 -161.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.419 HG22 ' H ' ' A' ' 35' ' ' ASP . 4.7 mm -135.09 -177.24 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.782 2.433 . . . . 0.0 105.016 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 34' ' ' ILE . 4.1 m-20 -54.96 150.97 9.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.746 2.018 . . . . 0.0 112.295 -172.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 175.68 2.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 123.5 1.619 . . . . 0.0 109.535 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -166.26 153.62 9.84 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.195 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.423 ' CE1' ' HD2' ' A' ' 47' ' ' LYS . 97.6 m-85 -144.91 -179.9 6.91 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.715 1.606 . . . . 0.0 108.73 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.428 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 12.1 p -139.38 177.09 2.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.64 -13.53 22.26 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 CA-C-N 120.661 1.272 . . . . 0.0 111.567 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.87 -45.59 5.66 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 165.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.428 ' HB2' ' H ' ' A' ' 39' ' ' THR . 45.4 mt-10 -63.83 -30.78 71.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.029 1.414 . . . . 0.0 111.177 -167.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.01 -21.43 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.43 1.013 . . . . 0.0 111.238 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.94 -44.98 4.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.562 1.074 . . . . 0.0 111.433 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -98.12 -9.94 25.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.5 1.92 . . . . 0.0 113.23 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.9 133.9 5.18 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 26.5 tttm -59.4 131.11 49.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.299 -1.118 . . . . 0.0 109.161 160.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -18.82 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 1 C-N-CA 133.961 4.904 . . . . 0.0 121.346 -142.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.03 -76.21 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 120.732 1.605 . . . . 0.0 107.047 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 t -170.99 20.7 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.818 1.647 . . . . 0.0 108.969 -170.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -69.78 -55.94 8.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.245 -1.534 . . . . 0.0 110.065 -157.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.418 HE21 ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -164.55 164.86 21.61 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.644 1.978 . . . . 0.0 107.369 167.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.1 mtp -116.94 166.65 12.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.792 1.237 . . . . 0.0 108.432 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 172.15 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.261 1.486 . . . . 0.0 110.85 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -89.17 139.49 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.011 1.324 . . . . 0.0 107.684 163.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.9 0.59 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.824 1.249 . . . . 0.0 110.275 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.48 56.96 0.72 Allowed Glycine 0 N--CA 1.451 -0.305 0 O-C-N 120.196 -1.565 . . . . 0.0 111.847 164.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -141.36 -175.47 4.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.162 0.981 . . . . 0.0 111.314 166.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.88 141.03 36.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.117 0.967 . . . . 0.0 110.376 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -179.62 8.02 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.408 1.483 . . . . 0.0 111.082 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -122.65 151.53 41.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.071 2.148 . . . . 0.0 110.751 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -148.98 128.55 3.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 120.261 3.43 . . . . 0.0 120.261 169.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.85 141.51 18.66 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.405 1.002 . . . . 0.0 110.82 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.34 177.67 47.82 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 119.427 -0.652 . . . . 0.0 113.153 166.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 35.2 ttm -102.36 129.74 48.91 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.481 1.112 . . . . 0.0 110.152 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.9 132.14 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.358 1.063 . . . . 0.0 109.643 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtt -62.47 132.61 94.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.292 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.15 131.3 29.97 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.901 1.734 . . . . 0.0 108.714 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.17 72.73 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.702 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -86.14 -74.39 0.42 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 159.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.282 2.6 p -37.66 88.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 130.616 3.566 . . . . 0.0 114.816 -170.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -77.6 137.84 38.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 127.467 2.307 . . . . 0.0 105.553 163.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 -136.86 128.18 28.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.28 98.24 11.72 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.38 -14.54 45.53 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 CA-C-N 120.62 1.257 . . . . 0.0 110.861 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.41 -12.97 35.91 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 117.129 -1.415 . . . . 0.0 112.716 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -135.73 4.41 3.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 121.512 1.96 . . . . 0.0 114.302 -177.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER 47.06 -2.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.346 3.058 . . . . 0.0 116.224 -162.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -56.63 149.16 18.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.276 1.83 . . . . 0.0 109.69 175.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.6 148.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 166.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 p -131.94 119.8 21.61 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.27 168.04 20.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.233 0.613 . . . . 0.0 109.603 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -122.99 147.31 46.78 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.91 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.09 174.34 10.61 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.298 1.039 . . . . 0.0 110.27 -170.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.11 -168.9 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.174 2.189 . . . . 0.0 106.266 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.03 -4.35 16.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.9 -66.77 0.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.45 -163.47 11.99 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.371 1.462 . . . . 0.0 110.681 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.9 p -150.94 158.71 44.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.013 0.906 . . . . 0.0 111.251 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.66 150.23 20.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 108.721 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 157.57 23.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 98.4 t -133.1 120.8 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 168.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 m -91.56 121.79 33.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 152.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.11 171.44 7.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 164.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -162.15 99.06 1.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.82 -144.71 9.11 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.214 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.82 91.8 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.47 130.03 87.36 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.901 -1.499 . . . . 0.0 107.868 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -54.84 138.31 76.92 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.031 1.82 . . . . 0.0 109.359 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -56.78 -31.84 65.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.672 0.749 . . . . 0.0 111.197 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.32 -22.32 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 114.63 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.98 131.79 44.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.927 1.24 . . . . 0.0 108.835 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -140.96 170.29 16.02 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.014 -1.054 . . . . 0.0 109.468 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -73.41 123.16 23.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.49 26.55 25.01 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 123.381 0.515 . . . . 0.0 113.269 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.47 171.69 10.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.555 1.142 . . . . 0.0 109.684 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.74 128.02 9.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.999 1.762 . . . . 0.0 109.054 -173.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.35 175.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.05 139.57 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.622 1.969 . . . . 0.0 106.668 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -113.37 164.84 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -160.4 143.0 13.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.527 1.931 . . . . 0.0 107.627 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.59 -124.1 1.67 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 105.098 -3.201 . . . . 0.0 105.098 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -128.9 156.91 42.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 120.127 1.963 . . . . 0.0 109.192 -161.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.73 137.73 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.843 0.857 . . . . 0.0 109.482 171.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -84.0 0.42 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.995 0.816 . . . . 0.0 109.063 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.91 167.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.714 3.206 . . . . 0.0 106.299 -172.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.24 50.14 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.96 -0.911 . . . . 0.0 113.151 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 m120 62.66 58.19 1.66 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 0.0 111.087 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -131.32 127.49 37.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.5 mm -102.63 125.92 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 126.675 1.99 . . . . 0.0 109.037 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.52 83.97 5.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.47 148.2 9.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.112 0.958 . . . . 0.0 112.25 165.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -18.76 8.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 128.384 2.674 . . . . 0.0 110.912 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.33 -51.64 0.48 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.8 t 60.69 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.097 2.159 . . . . 0.0 112.394 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.97 146.49 47.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.746 -1.221 . . . . 0.0 107.897 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.41 34.66 3.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.854 0.862 . . . . 0.0 110.563 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt 38.94 53.78 2.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.704 1.602 . . . . 0.0 114.708 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -96.92 -91.73 0.24 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.78 118.03 5.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.83 164.44 35.76 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 127.128 2.171 . . . . 0.0 106.166 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.5 173.92 10.97 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -162.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -119.47 118.63 31.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.179 0.99 . . . . 0.0 111.801 -163.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.3 m -79.21 123.86 84.58 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.387 1.875 . . . . 0.0 106.866 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.67 -178.1 2.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 1 C-N-CA 125.874 4.383 . . . . 0.0 110.907 178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -80.04 -179.36 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.945 1.763 . . . . 0.0 110.537 172.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 50.23 64.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 129.164 2.986 . . . . 0.0 110.794 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.52 -34.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.028 1.731 . . . . 0.0 109.821 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.62 -70.84 0.16 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.171 2.188 . . . . 0.0 111.6 -167.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.6 150.89 42.62 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 76.51 26.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 113.256 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmt . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.354 -1.308 . . . . 0.0 107.988 151.603 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -157.26 169.54 24.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 129.017 2.927 . . . . 0.0 107.115 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 t -150.47 -173.41 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.086 0.954 . . . . 0.0 109.135 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.57 -179.21 0.32 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.181 2.993 . . . . 0.0 106.54 168.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.98 148.55 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 156.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 68.34 139.14 0.03 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 128.185 2.594 . . . . 0.0 114.913 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 pp -90.65 176.81 6.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.133 1.373 . . . . 0.0 108.83 166.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -174.53 135.39 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.11 2.164 . . . . 0.0 106.074 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.09 176.71 6.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.509 1.524 . . . . 0.0 109.202 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.519 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 61.5 p -136.24 173.85 5.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.645 1.578 . . . . 0.0 108.545 173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.74 -13.36 19.95 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.685 1.59 . . . . 0.0 112.205 -166.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.25 -45.75 7.33 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 162.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' HB2' ' H ' ' A' ' 39' ' ' THR . 30.3 mt-10 -60.17 -29.17 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.334 2.067 . . . . 0.0 113.036 -168.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mt -73.34 -22.26 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.475 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -35.51 3.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.478 -169.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.86 -31.27 18.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.482 2.313 . . . . 0.0 110.518 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.64 149.46 7.47 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.251 1.405 . . . . 0.0 111.869 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -62.13 133.53 55.36 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 122.013 -0.698 . . . . 0.0 110.826 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -18.52 -68.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.836 1.654 . . . . 0.0 115.308 -136.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.486 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 8.3 mp0 -71.43 -58.63 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t 170.75 33.84 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.929 2.892 . . . . 0.0 110.326 163.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.486 ' NE2' ' H ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -80.89 14.61 2.13 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.557 -1.964 . . . . 0.0 113.855 -160.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 146.8 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 1 C-N-CA 133.802 4.841 . . . . 0.0 109.581 171.566 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 40.9 mtp -114.38 159.0 38.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.337 1.455 . . . . 0.0 107.211 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 158.01 59.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 CA-C-N 121.432 1.547 . . . . 0.0 110.085 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.43 144.9 33.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 165.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.9 -7.25 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.625 0.77 . . . . 0.0 111.582 174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.55 43.18 1.72 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.748 1.166 . . . . 0.0 110.512 165.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -141.52 169.32 17.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.127 1.964 . . . . 0.0 113.047 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -87.92 140.58 29.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.041 2.537 . . . . 0.0 108.609 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.12 -174.59 5.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.495 0.718 . . . . 0.0 110.621 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.38 147.21 50.46 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.148 1.779 . . . . 0.0 107.485 169.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.28 130.48 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.177 1.791 . . . . 0.0 106.532 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.65 157.01 20.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 163.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.68 41.62 Favored Glycine 0 C--O 1.236 0.26 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.2 ttm -99.01 125.31 44.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.37 121.12 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 3.7 ttm -64.16 126.84 91.11 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.93 154.43 73.21 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.28 1.987 . . . . 0.0 108.368 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.76 44.55 80.57 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.778 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -133.12 -38.43 0.96 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.895 1.348 . . . . 0.0 113.225 169.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.269 1.6 p -64.57 92.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.567 1.076 . . . . 0.0 112.059 -172.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -82.07 86.46 6.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.892 2.477 . . . . 0.0 107.703 171.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.75 142.3 40.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.29 108.73 6.74 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.68 -5.37 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 122.215 1.827 . . . . 0.0 111.22 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -119.9 13.74 12.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 110.492 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.61 -160.01 0.98 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.055 1.298 . . . . 0.0 108.655 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.9 -7.85 8.4 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.583 0.753 . . . . 0.0 110.89 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.99 131.03 46.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 164.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.25 130.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 92.0 m -126.46 134.45 50.96 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -171.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.35 176.38 10.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.231 -1.543 . . . . 0.0 110.352 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 m -123.18 145.78 48.34 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.68 142.24 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -137.99 171.99 13.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.635 1.174 . . . . 0.0 109.516 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.09 -169.07 3.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.299 1.439 . . . . 0.0 107.383 168.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 9.99 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.582 1.553 . . . . 0.0 114.412 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.47 -67.11 0.78 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.003 1.321 . . . . 0.0 109.504 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.32 -175.47 13.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.1 p -143.51 158.08 43.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.297 1.039 . . . . 0.0 109.973 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.37 149.01 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.627 1.171 . . . . 0.0 109.707 -171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.13 148.0 26.35 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.99 1.316 . . . . 0.0 107.883 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.5 t -138.01 119.09 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.104 0.961 . . . . 0.0 108.779 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 t -91.94 129.65 37.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 159.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -124.23 163.78 20.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.653 1.181 . . . . 0.0 108.747 166.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -144.87 100.17 3.45 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.88 -179.4 43.58 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -71.36 -24.38 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 122.064 -0.668 . . . . 0.0 111.84 -159.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 7.8 tp 65.36 129.24 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.727 0 C-N-CA 128.803 2.841 . . . . 0.0 110.623 -166.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -66.03 169.04 14.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.255 3.303 . . . . 0.0 110.689 -168.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.49 -36.07 77.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.982 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -35.34 63.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.568 2.747 . . . . 0.0 113.025 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -63.76 131.88 49.23 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.466 1.03 . . . . 0.0 109.092 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -143.14 161.0 39.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.882 0.873 . . . . 0.0 111.313 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -64.06 117.39 7.01 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.86 4.95 16.17 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.958 -0.912 . . . . 0.0 114.938 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.7 167.04 20.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.925 1.363 . . . . 0.0 112.151 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.05 137.28 15.34 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 125.737 1.637 . . . . 0.0 109.977 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.82 168.61 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.95 108.91 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 127.652 2.381 . . . . 0.0 106.541 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.8 t -80.26 158.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 124.717 1.207 . . . . 0.0 108.986 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -156.67 147.15 21.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 129.439 3.096 . . . . 0.0 105.716 172.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.84 -112.39 0.52 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -147.63 159.34 43.88 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 119.734 1.767 . . . . 0.0 110.41 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.02 142.61 28.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.117 0.967 . . . . 0.0 108.589 172.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 -84.25 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.55 1.14 . . . . 0.0 108.185 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -166.92 154.53 9.32 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 128.94 2.896 . . . . 0.0 106.709 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.6 42.91 99.85 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.16 40.88 30.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 111.929 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -109.82 124.36 51.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 18.1 mm -96.28 131.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.711 1.204 . . . . 0.0 108.649 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.88 114.21 17.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 154.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 149.22 39.94 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.874 0.845 . . . . 0.0 108.849 161.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -21.85 11.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.606 1.163 . . . . 0.0 111.173 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -146.17 -47.13 0.2 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.242 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.0 t 59.24 150.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.243 1.817 . . . . 0.0 109.371 -167.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.0 mt -147.89 151.59 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 119.192 -2.193 . . . . 0.0 107.045 172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.14 33.88 3.76 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.681 1.128 . . . . 0.0 112.674 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt 54.45 30.23 12.51 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -70.45 45.74 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.419 -2.051 . . . . 0.0 111.582 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.0 t0 55.06 46.76 23.47 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.14 0.976 . . . . 0.0 112.529 165.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 133' ' ' ASN . 0.0 OUTLIER -89.71 -55.66 3.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.066 0.946 . . . . 0.0 110.911 -167.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . 0.492 ' H ' ' CD ' ' A' ' 132' ' ' GLU 0.263 92.6 m-20 39.02 -165.81 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.629 2.772 . . . . 0.0 113.672 -161.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -59.93 129.43 41.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.909 -1.12 . . . . 0.0 109.104 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.8 m -127.07 134.88 26.61 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -66.88 176.38 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.047 3.165 . . . . 0.0 111.272 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.62 -173.78 1.87 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.529 2.152 . . . . 0.0 110.866 164.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 61.34 32.91 19.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.267 1.827 . . . . 0.0 111.57 -176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 140' ' ' GLU . 9.1 p -146.99 -143.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.41 ' H ' HG23 ' A' ' 139' ' ' VAL . 1.9 tp10 72.65 -73.66 0.1 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 129.557 3.143 . . . . 0.0 110.911 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -39.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 124.599 1.187 . . . . 0.0 111.724 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.17 66.7 1.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.707 1.203 . . . . 0.0 109.003 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.1 mtp . . . . . 0 C--O 1.251 1.146 0 C-N-CA 126.704 2.001 . . . . 0.0 109.568 -162.42 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.03 -76.87 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 158.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.5 t -54.81 156.17 3.84 Favored 'General case' 0 C--O 1.246 0.895 0 O-C-N 124.489 1.118 . . . . 0.0 108.184 156.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -80.18 -161.7 0.38 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.021 1.329 . . . . 0.0 109.595 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -143.07 146.59 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.0 -166.8 0.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.923 1.689 . . . . 0.0 110.528 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.36 -170.91 2.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.281 -1.512 . . . . 0.0 109.175 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -170.32 154.77 4.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.179 0.991 . . . . 0.0 109.908 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.27 -170.11 2.41 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.553 1.07 . . . . 0.0 110.302 170.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 39.9 p -141.99 170.99 7.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 158.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -81.22 -1.43 11.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.511 1.474 . . . . 0.0 112.439 -159.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.86 -7.58 41.28 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.673 1.606 . . . . 0.0 110.578 165.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.97 18.0 22.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.436 -1.626 . . . . 0.0 110.066 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.3 mt -109.12 -23.15 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.658 ' H ' ' CD2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.35 -50.68 4.91 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 126.629 1.972 . . . . 0.0 111.036 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.95 -63.9 1.12 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.03 175.73 39.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -70.86 126.02 28.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 116.9 -1.524 . . . . 0.0 108.311 159.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 ptt-85 -65.09 -23.17 67.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 121.017 1.735 . . . . 0.0 114.662 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.72 -67.64 0.27 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.401 1.455 . . . . 0.0 111.894 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 t -147.57 33.9 0.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 122.255 1.026 . . . . 0.0 109.824 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 48.59 63.76 1.96 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.174 2.19 . . . . 0.0 111.515 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -86.06 -68.55 0.73 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.351 -2.204 . . . . 0.0 108.76 -167.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 mtp 87.98 125.1 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 129.188 2.995 . . . . 0.0 109.252 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.41 147.21 87.01 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.53 1.487 . . . . 0.0 109.633 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.36 147.48 32.39 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.54 -8.47 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.369 1.468 . . . . 0.0 111.232 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.1 40.72 1.82 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 125.217 1.389 . . . . 0.0 110.504 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -134.96 170.55 15.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.341 1.57 . . . . 0.0 111.837 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.54 151.81 22.27 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 170.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.88 176.75 12.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.291 1.036 . . . . 0.0 112.376 172.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.471 HH21 ' CD1' ' A' ' 127' ' ' LEU . 50.8 ttt180 -124.48 148.53 47.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.146 2.578 . . . . 0.0 107.049 172.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 6.0 p -147.56 167.27 5.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 119.975 1.261 . . . . 0.0 111.353 172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -142.2 155.25 25.49 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 119.981 1.264 . . . . 0.0 111.677 169.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.84 -175.93 47.01 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.563 1.077 . . . . 0.0 113.28 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.5 ttm -103.21 123.78 47.37 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.484 1.514 . . . . 0.0 110.673 -170.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.9 t -71.7 129.58 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.885 -1.134 . . . . 0.0 109.848 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 49.5 mtt -63.75 152.22 87.0 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 118.62 0.645 . . . . 0.0 112.085 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.99 141.32 68.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.251 2.634 . . . . 0.0 110.745 170.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.75 3.85 1.27 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.369 1.461 . . . . 0.0 115.649 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.7 p -73.24 -26.21 61.03 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.743 1.771 . . . . 0.0 112.121 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.39 103.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.897 1.279 . . . . 0.0 109.909 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -86.78 30.32 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.669 2.787 . . . . 0.0 111.219 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -52.6 129.75 30.15 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.458 0.703 . . . . 0.0 109.192 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.45 119.53 77.27 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.65 -6.44 19.05 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.294 1.996 . . . . 0.0 112.641 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -118.38 6.77 11.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.52 1.528 . . . . 0.0 111.766 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -149.43 -166.94 2.69 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.597 1.159 . . . . 0.0 107.979 -174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.4 mt -121.69 -2.64 9.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.642 0.777 . . . . 0.0 112.084 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -60.57 136.14 57.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.66 134.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 43.3 p -124.9 162.15 25.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 167.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' A' ' 93' ' ' VAL . 27.6 p90 -152.13 179.32 8.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.741 1.155 . . . . 0.0 109.349 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -115.71 145.88 42.37 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 139.1 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.05 170.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.116 1.766 . . . . 0.0 109.636 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -161.3 -154.12 0.34 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.558 1.543 . . . . 0.0 106.879 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 -22.38 62.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.814 -1.179 . . . . 0.0 112.872 -164.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -76.12 0.53 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.88 -166.98 12.66 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.46 -0.775 . . . . 0.0 112.229 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.3 p -140.78 160.64 39.61 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 112.023 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.14 153.97 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.036 1.334 . . . . 0.0 109.646 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.15 150.56 37.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.51 165.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -118.0 160.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 156.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 25.9 m -129.62 127.44 40.63 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 159.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -127.41 168.62 14.6 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.633 1.573 . . . . 0.0 108.505 174.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.96 92.13 1.16 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.0 -176.38 45.09 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.418 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.02 113.35 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 9.7 tp -77.24 143.39 69.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -58.46 146.31 90.92 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.113 1.209 . . . . 0.0 109.065 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.45 -30.82 71.89 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.46 -36.97 85.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.705 2.002 . . . . 0.0 110.978 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -56.23 133.0 52.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.002 1.721 . . . . 0.0 109.039 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.83 167.13 21.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.319 0.963 . . . . 0.0 112.312 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -74.72 112.9 11.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.74 49.13 5.85 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 112.181 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -119.63 -170.29 1.92 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.386 -1.067 . . . . 0.0 109.542 145.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.87 140.68 14.95 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.66 178.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.764 1.625 . . . . 0.0 107.922 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.428 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.2 t -131.65 142.18 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -107.65 163.98 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.868 0.842 . . . . 0.0 109.55 162.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -157.48 144.27 18.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 106.609 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.93 -109.02 0.38 Allowed Glycine 0 CA--C 1.518 0.253 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -140.91 162.93 34.3 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 120.165 1.983 . . . . 0.0 109.541 -173.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 12.5 tp -89.24 140.26 29.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.566 0.746 . . . . 0.0 110.154 171.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 -77.95 0.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.82 166.47 3.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.287 3.835 . . . . 0.0 105.13 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.9 42.04 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 120.198 1.363 . . . . 0.0 113.653 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.71 4.96 5.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.841 2.057 . . . . 0.0 114.263 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -71.35 139.31 49.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.042 2.137 . . . . 0.0 109.691 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.1 mm -106.29 133.89 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 126.765 2.026 . . . . 0.0 110.164 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.84 106.94 11.2 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 154.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.65 58.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.513 0.673 . . . . 0.0 110.22 153.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 -11.61 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.615 2.366 . . . . 0.0 110.974 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -147.82 -46.23 0.16 Allowed 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.8 t 57.17 141.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.876 1.67 . . . . 0.0 111.601 -165.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.471 ' CD1' HH21 ' A' ' 61' ' ' ARG . 53.9 mt -139.38 162.59 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -125.53 29.27 6.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.384 1.074 . . . . 0.0 112.226 -177.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 49.58 43.95 24.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 115.137 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.23 35.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.536 1.134 . . . . 0.0 110.201 175.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.7 t0 61.35 89.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.445 1.898 . . . . 0.0 111.544 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -131.05 160.56 34.28 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.817 1.647 . . . . 0.0 109.118 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.48 123.59 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.964 1.306 . . . . 0.0 108.211 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -61.86 166.08 4.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.483 1.135 . . . . 0.0 113.313 -165.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 m -116.67 131.89 23.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 0.0 107.544 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.31 -179.0 1.64 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.096 3.197 . . . . 0.0 112.013 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.52 -40.09 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.208 1.939 . . . . 0.0 114.612 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -71.93 67.49 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.669 1.588 . . . . 0.0 109.478 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -173.33 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.473 1.909 . . . . 0.0 107.374 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -75.03 0.1 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.607 1.163 . . . . 0.0 110.697 -166.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -150.46 53.17 0.89 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.209 1.004 . . . . 0.0 110.21 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.78 1.5 0.79 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 119.436 1.017 . . . . 0.0 109.966 179.734 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -136.03 161.65 35.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.871 0.869 . . . . 0.0 110.736 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.7 m -147.42 128.74 14.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.375 1.87 . . . . 0.0 107.502 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -151.4 -26.35 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' CG2' ' H ' ' A' ' 35' ' ' ASP . 26.5 mm -120.95 -178.43 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -176.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' H ' ' CG2' ' A' ' 34' ' ' ILE . 25.7 t0 -62.41 157.49 19.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.583 167.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pp -74.21 177.98 5.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.836 1.303 . . . . 0.0 111.264 175.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -173.13 136.77 0.66 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.768 2.427 . . . . 0.0 106.311 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 79.3 m-85 -131.6 -175.11 3.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.033 1.733 . . . . 0.0 109.545 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 72.5 p -142.1 169.07 11.8 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 112.78 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.77 71.54 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.569 2.846 . . . . 0.0 110.747 157.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.21 -56.17 0.19 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 127.899 2.666 . . . . 0.0 106.976 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.496 ' HB2' ' H ' ' A' ' 39' ' ' THR . 32.3 mt-10 -68.24 -9.36 46.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.1 mt -104.84 -22.35 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.118 1.367 . . . . 0.0 108.327 -177.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.42 -48.38 5.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.731 2.412 . . . . 0.0 111.711 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.93 -64.51 1.07 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.684 1.994 . . . . 0.0 107.081 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.59 164.5 18.85 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.663 1.602 . . . . 0.0 109.226 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.606 ' HZ1' ' NE2' ' A' ' 52' ' ' GLN . 1.2 tptt -49.5 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.673 1.989 . . . . 0.0 111.229 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -47.57 -20.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -121.49 -52.61 2.03 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 121.048 1.749 . . . . 0.0 109.775 146.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.66 -51.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.555 1.142 . . . . 0.0 108.66 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 43.75 -71.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.315 3.046 . . . . 0.0 116.399 -174.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.606 ' NE2' ' HZ1' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -179.71 15.47 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.642 2.377 . . . . 0.0 114.062 -170.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.55 -178.14 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 125.063 1.345 . . . . 0.0 111.836 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.3 155.73 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.44 2.093 . . . . 0.0 109.747 150.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.88 143.97 30.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 159.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 4.2 p -73.57 -15.58 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.053 0.541 . . . . 0.0 111.369 175.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.04 37.38 3.74 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.384 -1.787 . . . . 0.0 111.741 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -137.1 174.06 11.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.654 2.227 . . . . 0.0 112.399 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -106.89 138.86 42.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.409 1.484 . . . . 0.0 110.226 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.06 167.5 30.26 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.797 1.239 . . . . 0.0 112.034 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -99.52 150.43 22.22 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.1 1.76 . . . . 0.0 109.779 165.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.73 154.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.841 2.056 . . . . 0.0 106.925 168.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.63 152.97 21.44 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 155.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.24 179.51 48.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttm -101.51 130.04 47.71 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.835 0.854 . . . . 0.0 109.545 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.7 t -69.04 125.28 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.782 1.173 . . . . 0.0 108.266 -176.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.5 mtt -57.44 139.18 80.87 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 119.006 0.821 . . . . 0.0 110.25 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.89 124.69 10.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.302 2.668 . . . . 0.0 107.522 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.6 65.37 3.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.9 p -135.41 -35.01 0.83 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.45 0.625 . . . . 0.0 111.952 167.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.34 107.34 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -174.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -91.77 59.84 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 131.623 3.969 . . . . 0.0 108.697 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 1.7 ptt85 -74.99 166.65 23.33 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.708 -1.245 . . . . 0.0 110.472 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.69 114.18 7.93 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.48 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.34 -15.76 38.88 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.688 1.592 . . . . 0.0 111.833 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -99.54 -20.11 16.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.29 -1.338 . . . . 0.0 110.368 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 m -131.79 -3.21 3.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.394 1.452 . . . . 0.0 114.77 -168.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp 62.03 -24.57 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 131.609 3.964 . . . . 0.0 114.781 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -53.86 126.66 23.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.892 1.277 . . . . 0.0 107.938 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 1.5 p -132.28 146.72 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -134.47 123.61 24.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.52 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 48.1 p90 -131.51 173.51 11.03 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 120.899 1.681 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -127.78 141.55 51.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.28 139.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.962 1.705 . . . . 0.0 106.618 -178.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -138.88 172.22 13.17 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.597 1.159 . . . . 0.0 111.321 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -157.0 -165.9 1.95 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.15 1.78 . . . . 0.0 109.405 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -12.67 60.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.201 1.4 . . . . 0.0 113.561 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.16 -67.09 0.87 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -172.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.52 -152.41 5.66 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -140.25 167.18 22.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.611 0.764 . . . . 0.0 110.31 167.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.83 142.76 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.8 152.55 22.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.063 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.52 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 2.7 m -138.47 137.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 110.992 171.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -100.28 136.87 39.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 164.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -142.05 164.31 30.53 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.458 1.503 . . . . 0.0 107.167 169.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.62 110.13 3.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.41 41.35 Favored Glycine 0 C--N 1.324 -0.115 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -22.48 6.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.924 0.862 . . . . 0.0 112.394 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 81.55 152.86 0.12 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.939 2.895 . . . . 0.0 108.852 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.87 141.8 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.633 1.555 . . . . 0.0 108.993 174.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -31.26 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.55 1.14 . . . . 0.0 109.161 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.38 -40.98 98.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.35 1.86 . . . . 0.0 112.737 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -65.52 137.05 57.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.696 0.798 . . . . 0.0 110.91 -165.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -142.55 173.49 11.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.801 1.24 . . . . 0.0 109.206 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -58.55 135.58 57.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.759 152.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 6.11 69.35 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.704 0.669 . . . . 0.0 113.785 155.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -103.16 172.61 6.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 109.443 171.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.52 129.07 9.72 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.76 172.5 15.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.62 126.71 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -101.73 159.26 4.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 165.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.05 134.38 10.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.52 -119.29 0.9 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -142.17 154.0 44.49 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 119.232 1.516 . . . . 0.0 110.46 -163.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 135.19 35.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -85.45 0.24 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -151.1 -88.6 0.06 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.408 1.883 . . . . 0.0 109.417 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.41 82.8 1.14 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -160.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 34.0 m120 29.69 67.1 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.188 2.595 . . . . 0.0 110.726 -169.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -141.37 131.19 24.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.213 1.405 . . . . 0.0 107.667 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.2 mm -106.2 135.45 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.217 1.807 . . . . 0.0 109.263 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.89 105.42 10.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 156.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.84 148.87 50.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.96 -25.01 10.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 109.115 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -148.38 -16.14 0.33 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -169.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 61.9 t 38.54 101.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.207 2.203 . . . . 0.0 114.468 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -106.17 145.9 30.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.524 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -109.15 30.98 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.24 -0.913 . . . . 0.0 111.694 -172.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 51.19 47.41 24.91 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.975 0.893 . . . . 0.0 110.949 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.601 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -82.12 -106.65 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 166.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -149.38 111.3 4.58 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -152.05 131.28 12.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -171.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -160.72 -30.66 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -149.11 133.16 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.898 1.279 . . . . 0.0 108.146 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.9 m -120.4 105.34 41.81 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.19 178.64 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.689 2.926 . . . . 0.0 110.797 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.97 -40.39 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.233 1.289 . . . . 0.0 114.632 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.83 58.1 1.82 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.928 0.891 . . . . 0.0 111.378 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -46.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.348 3.059 . . . . 0.0 105.95 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -56.87 -53.18 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.678 1.991 . . . . 0.0 109.009 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -144.35 82.91 1.71 Allowed 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.32 0.05 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.437 0.295 . . . . 0.0 111.319 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.156 1.383 . . . . 0.0 109.326 -177.464 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.98 165.36 2.46 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.317 0.386 . . . . 0.0 110.569 161.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.2 m -160.16 134.39 7.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.43 4.33 2.4 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.84 -140.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.42 173.08 12.78 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.626 -0.671 . . . . 0.0 110.027 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.21 179.9 5.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.464 1.126 . . . . 0.0 109.823 171.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -169.58 145.4 3.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.051 1.74 . . . . 0.0 107.534 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -142.3 -173.83 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.588 2.355 . . . . 0.0 108.573 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 20.6 p -135.32 171.2 9.34 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.059 0.943 . . . . 0.0 109.292 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 63.9 Cg_endo -73.8 71.31 4.12 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.925 2.417 . . . . 0.0 108.989 169.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.68 -66.73 0.1 Allowed Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 -167.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -71.52 -3.71 22.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.359 0.664 . . . . 0.0 112.442 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.55 -41.97 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.535 ' CD1' ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -85.9 -43.53 13.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.599 0.759 . . . . 0.0 109.688 -165.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -102.31 3.32 37.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.323 1.449 . . . . 0.0 112.883 -168.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.2 165.95 39.18 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 163.48 19.56 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 110.847 174.063 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -56.61 -13.22 2.24 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -123.48 -75.91 0.59 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.11 1.323 . . . . 0.0 110.496 148.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 t -159.07 26.42 0.21 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.81 1.244 . . . . 0.0 109.575 -171.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -64.77 -45.57 85.79 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.842 -1.161 . . . . 0.0 110.304 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.06 145.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 128.654 2.782 . . . . 0.0 111.047 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 27.9 mtp -75.65 162.11 73.58 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.577 0.751 . . . . 0.0 109.917 168.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.5 158.69 32.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.909 1.739 . . . . 0.0 109.917 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -79.12 157.75 27.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.261 9.5 p -93.65 0.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.332 0.587 . . . . 0.0 112.203 -178.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.04 55.65 0.68 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.934 1.731 . . . . 0.0 110.13 162.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -144.86 168.81 19.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.188 1.494 . . . . 0.0 112.254 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.41 129.6 36.58 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.402 1.096 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.19 -177.08 4.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.277 172.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.71 142.7 51.25 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.402 2.281 . . . . 0.0 106.491 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.27 124.67 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.33 135.47 12.89 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.61 174.37 46.58 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.718 1.152 . . . . 0.0 110.606 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.2 ttm -95.76 126.2 40.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.514 1.526 . . . . 0.0 110.996 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.97 127.3 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 124.227 1.011 . . . . 0.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.9 mtt -59.92 127.5 85.61 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 122.501 0.321 . . . . 0.0 110.58 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.0 113.73 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.072 3.181 . . . . 0.0 110.364 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.62 -16.88 47.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.336 1.922 . . . . 0.0 113.967 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.7 p -69.43 -19.68 63.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.469 1.134 . . . . 0.0 114.005 -165.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.71 83.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.954 1.302 . . . . 0.0 109.864 -167.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.77 -58.27 9.32 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.667 1.987 . . . . 0.0 111.472 -167.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.84 129.37 0.02 OUTLIER 'General case' 0 C--O 1.237 0.408 0 C-N-CA 129.612 3.165 . . . . 0.0 110.852 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.83 117.53 52.04 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-O 117.497 -1.24 . . . . 0.0 107.918 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.89 -13.82 33.15 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 CA-C-N 121.491 1.568 . . . . 0.0 112.447 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -107.92 -10.09 15.58 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.226 1.41 . . . . 0.0 112.162 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -136.49 -156.83 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.775 -1.203 . . . . 0.0 109.11 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.26 6.33 5.85 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.325 1.85 . . . . 0.0 108.817 170.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -55.39 140.69 39.02 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 164.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 156.73 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 p -126.37 141.06 52.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 152.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.67 170.6 15.55 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 108.329 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -112.47 144.5 41.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.41 143.09 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 169.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.44 173.46 11.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.111 1.765 . . . . 0.0 107.88 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 88' ' ' GLU . 3.7 t0 -155.07 -162.54 1.38 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 13.65 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.51 1.924 . . . . 0.0 113.725 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.1 OUTLIER -126.13 -76.53 0.58 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.876 1.271 . . . . 0.0 107.914 -172.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.52 -151.21 5.4 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.7 p -146.08 166.97 24.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.639 0.719 . . . . 0.0 112.519 172.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 6.3 p -146.63 157.86 10.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 126.112 1.765 . . . . 0.0 109.045 178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.0 151.06 19.81 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 126.006 1.722 . . . . 0.0 108.468 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.6 t -142.56 103.33 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.055 0.942 . . . . 0.0 111.33 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.4 m -78.44 120.68 23.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.228 1.011 . . . . 0.0 109.361 161.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -116.41 171.5 7.8 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.333 1.453 . . . . 0.0 107.843 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.84 101.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.61 169.73 26.43 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -73.74 -25.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 122.94 0.496 . . . . 0.0 110.67 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.5 mt 87.52 156.55 0.09 OUTLIER Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 131.401 3.88 . . . . 0.0 110.185 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -56.08 143.59 83.08 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 N-CA-C 107.058 -1.939 . . . . 0.0 107.058 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -62.21 -37.02 83.72 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.511 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mp -61.44 -20.16 62.79 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.12 1.768 . . . . 0.0 115.159 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.38 125.05 23.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.613 1.097 . . . . 0.0 109.524 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -126.95 160.27 31.54 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.19 0.995 . . . . 0.0 110.488 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -81.24 104.81 11.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.891 1.677 . . . . 0.0 107.434 168.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.5 13.78 5.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.062 0.839 . . . . 0.0 114.07 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -130.92 166.93 19.87 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.711 1.256 . . . . 0.0 112.131 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.72 139.94 29.55 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 170.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.47 109.04 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 3.2 t -81.19 158.18 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 125.08 1.352 . . . . 0.0 108.939 164.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -153.25 152.09 30.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.3 3.04 . . . . 0.0 106.16 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.97 -111.42 0.48 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.78 160.78 33.36 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 119.917 1.858 . . . . 0.0 109.153 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.72 142.61 44.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 159.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -99.65 -88.33 0.34 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.886 1.275 . . . . 0.0 108.031 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.35 157.33 4.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.667 2.787 . . . . 0.0 107.433 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.16 25.54 73.45 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.87 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m120 58.65 71.45 0.58 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.347 2.259 . . . . 0.0 110.114 -168.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -141.18 136.49 31.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.68 130.2 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 126.678 1.991 . . . . 0.0 108.497 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.84 111.5 15.05 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 157.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.44 37.33 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.23 1.812 . . . . 0.0 108.329 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -24.64 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.954 1.301 . . . . 0.0 111.399 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.38 -47.54 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 t 61.26 129.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 124.237 1.97 . . . . 0.0 111.328 -174.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.4 mt -133.85 159.03 41.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.477 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -126.03 55.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.397 0.544 . . . . 0.0 110.097 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 50.25 15.21 0.18 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.477 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.4 OUTLIER -76.66 59.93 1.6 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 130.452 3.501 . . . . 0.0 110.752 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.29 23.86 13.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.966 1.307 . . . . 0.0 111.631 163.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -80.38 116.08 20.26 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.474 1.91 . . . . 0.0 106.927 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -135.82 -45.24 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.943 0.497 . . . . 0.0 110.659 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -146.25 111.21 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 130.98 30.01 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -64.22 178.3 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.715 2.943 . . . . 0.0 112.03 -178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.22 -174.1 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.446 2.764 . . . . 0.0 111.622 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 48.36 56.02 8.05 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.609 1.964 . . . . 0.0 110.942 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.45 -39.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 124.356 1.062 . . . . 0.0 108.394 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -51.93 -56.26 15.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 109.43 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -152.28 83.53 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -160.36 -34.11 0.05 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.2 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.861 178.473 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.32 146.81 22.8 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -148.46 133.28 17.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -162.73 -45.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 110.232 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.38 155.84 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.549 1.166 . . . . 0.0 108.826 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.93 148.21 44.38 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 110.15 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.75 -174.27 4.92 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.46 1.124 . . . . 0.0 110.2 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -168.04 154.62 7.68 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.144 2.578 . . . . 0.0 106.018 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.42 ' CE2' ' CD ' ' A' ' 47' ' ' LYS . 74.5 m-85 -141.54 173.66 11.29 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.066 2.146 . . . . 0.0 109.051 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 p -134.88 164.05 46.81 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 123.959 0.904 . . . . 0.0 109.606 168.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.88 72.94 2.52 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.677 2.918 . . . . 0.0 109.804 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.13 -62.55 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 105.182 -3.167 . . . . 0.0 105.182 -168.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 48' ' ' ARG . 5.9 mm-40 -47.85 -48.66 30.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.331 1.065 . . . . 0.0 109.956 173.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.19 -15.37 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 127.149 2.18 . . . . 0.0 112.17 -172.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.48 -32.8 3.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.096 1.359 . . . . 0.0 110.883 -166.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.77 -60.67 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.653 2.381 . . . . 0.0 108.242 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.43 135.97 2.11 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.493 1.521 . . . . 0.0 110.547 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' CD ' ' CE2' ' A' ' 38' ' ' TYR . 5.3 tptp -54.99 117.03 3.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.675 1.19 . . . . 0.0 111.096 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.4 ' H ' ' CD ' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -59.41 -24.22 63.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.869 1.213 . . . . 0.0 114.161 -172.302 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -69.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.095 1.358 . . . . 0.0 110.748 172.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 t -151.96 22.23 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 111.799 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 59.55 28.24 17.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.916 2.086 . . . . 0.0 112.278 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -67.08 -21.64 65.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.903 1.681 . . . . 0.0 115.125 -171.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 54.45 159.26 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.209 1.804 . . . . 0.0 113.472 -163.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.88 155.83 48.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.67 1.58 . . . . 0.0 109.71 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 57' ' ' GLY . 3.0 tt0 -79.14 132.32 36.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 170.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.259 3.8 p -69.43 0.45 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 123.384 1.564 . . . . 0.0 112.098 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.448 ' H ' ' C ' ' A' ' 55' ' ' GLU . . . -111.77 22.4 19.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.959 2.218 . . . . 0.0 112.516 173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.55 177.63 7.7 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 121.08 2.44 . . . . 0.0 113.398 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.44 150.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.044 167.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -156.36 178.15 10.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.203 1.001 . . . . 0.0 109.68 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -116.67 150.56 37.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.385 1.874 . . . . 0.0 108.468 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.35 154.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.59 1.556 . . . . 0.0 107.654 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.8 142.35 13.67 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 159.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.69 44.5 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 ttm -92.46 119.64 32.17 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.878 2.071 . . . . 0.0 110.514 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.72 128.85 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 120.275 -1.516 . . . . 0.0 108.728 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.1 mtt -59.37 141.25 87.78 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 112.694 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.21 134.17 47.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.751 3.634 . . . . 0.0 109.71 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.6 -2.49 39.07 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.786 -1.008 . . . . 0.0 114.763 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.1 p -74.46 -43.35 56.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.757 1.778 . . . . 0.0 112.099 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.0 107.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.086 1.754 . . . . 0.0 110.805 -170.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -74.04 -55.46 6.1 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.962 1.705 . . . . 0.0 111.444 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.433 HH21 ' CD2' ' A' ' 78' ' ' LEU . 1.5 mtp180 65.87 177.42 0.21 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.147 2.179 . . . . 0.0 111.451 -165.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -132.13 124.97 19.76 Favored Pre-proline 0 N--CA 1.445 -0.678 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 162.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.76 -20.81 19.6 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.42 1.413 . . . . 0.0 111.656 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -73.3 -34.18 65.59 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 m -130.4 -130.4 0.2 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.004 -2.962 . . . . 0.0 103.004 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.433 ' CD2' HH21 ' A' ' 73' ' ' ARG . 0.6 OUTLIER -152.12 15.12 0.62 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.824 2.05 . . . . 0.0 109.741 168.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 116.96 5.31 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.24 153.93 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.391 1.091 . . . . 0.0 109.844 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.7 p -141.2 114.85 8.95 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -124.96 178.76 5.34 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.809 1.644 . . . . 0.0 111.791 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.2 m -124.36 145.15 49.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.11 148.03 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 172.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -139.25 178.26 7.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.96 1.704 . . . . 0.0 108.535 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 87' ' ' ALA . 37.0 t70 -161.01 -153.66 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.484 ' H ' ' CG ' ' A' ' 86' ' ' ASP . . . -68.8 -18.19 64.14 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.324 -1.485 . . . . 0.0 113.098 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -112.56 -63.3 1.45 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -163.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.59 -157.55 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 120.105 -0.275 . . . . 0.0 113.062 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.9 p -149.78 159.88 44.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.45 153.19 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.838 1.655 . . . . 0.0 111.351 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' HB3' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -81.07 143.99 32.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.531 176.727 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 58.6 t -137.61 121.35 21.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 164.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -91.61 133.52 35.48 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 155.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -130.15 168.34 16.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -158.26 113.39 2.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.47 0.15 Allowed Glycine 0 N--CA 1.468 0.786 0 C-N-CA 118.107 -1.997 . . . . 0.0 113.26 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.13 -28.22 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.286 1.043 . . . . 0.0 112.613 167.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.1 tp 61.23 128.13 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 129.333 3.053 . . . . 0.0 112.86 -170.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -61.66 135.71 58.19 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.653 1.569 . . . . 0.0 108.106 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.58 -25.51 38.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.856 0.836 . . . . 0.0 111.689 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.49 -23.39 66.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.434 1.094 . . . . 0.0 112.145 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.34 130.28 41.55 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.331 1.423 . . . . 0.0 109.461 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -126.94 -161.87 1.11 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 107.472 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.7 151.95 19.6 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.959 -1.088 . . . . 0.0 108.773 150.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.37 57.86 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.502 166.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -125.37 166.47 16.51 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.395 1.078 . . . . 0.0 109.748 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.41 135.91 18.26 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.83 162.7 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.08 112.78 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.72 2.008 . . . . 0.0 105.687 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -94.59 157.51 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.152 . . . . 0.0 108.259 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -154.11 135.84 14.44 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 127.552 2.341 . . . . 0.0 107.331 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -120.47 0.95 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 103.339 -3.904 . . . . 0.0 103.339 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.55 153.75 46.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.351 1.076 . . . . 0.0 109.631 -160.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.6 tp -80.68 122.54 27.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 109.428 176.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -76.03 -66.98 0.72 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -138.8 -96.16 0.18 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.695 0.798 . . . . 0.0 111.056 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -91.01 -70.54 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -126.94 41.03 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.902 -0.763 . . . . 0.0 109.032 -169.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 92' ' ' ASP . 23.1 t-160 -131.57 125.9 33.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.051 1.34 . . . . 0.0 108.636 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.9 mm -98.13 130.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.437 1.895 . . . . 0.0 108.15 171.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.15 108.02 12.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 152.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.06 147.88 48.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 160.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -11.0 7.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.81 1.644 . . . . 0.0 111.503 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.36 -21.43 0.15 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 86.0 t 41.89 113.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 130.598 3.559 . . . . 0.0 115.687 177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.3 144.01 50.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -167.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.6 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -116.86 42.83 2.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.328 -0.857 . . . . 0.0 111.217 -164.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt 54.72 21.33 3.44 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.6 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.6 OUTLIER -86.35 55.39 3.52 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.978 2.111 . . . . 0.0 109.108 -175.502 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.83 61.59 3.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.123 1.369 . . . . 0.0 111.94 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -127.43 162.08 27.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.019 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -156.38 38.65 0.34 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.049 0.94 . . . . 0.0 109.171 161.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -164.14 143.56 7.74 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.076 -162.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.6 m -79.12 127.83 78.07 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.367 1.067 . . . . 0.0 108.641 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -70.12 -176.17 1.5 Allowed 'Trans proline' 0 CA--C 1.552 1.403 1 C-N-CA 125.84 4.36 . . . . 0.0 111.491 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.89 -37.03 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 N-CA-C 116.348 1.634 . . . . 0.0 116.348 -176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.34 57.68 2.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.062 1.345 . . . . 0.0 110.31 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -164.77 -78.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.65 1.98 . . . . 0.0 107.509 -177.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.474 ' H ' HG23 ' A' ' 139' ' ' VAL . 0.8 OUTLIER 26.02 -80.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 129.877 3.271 . . . . 0.0 112.733 -150.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -101.17 -84.43 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.833 1.653 . . . . 0.0 109.937 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -115.87 136.08 53.39 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.749 1.219 . . . . 0.0 109.105 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.211 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -139.07 -80.75 0.31 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 158.07 43.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 164.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -159.55 167.88 27.5 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.003 2.121 . . . . 0.0 106.335 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.4 mt -102.3 164.19 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.31 168.12 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.596 1.958 . . . . 0.0 110.567 -156.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 pp -114.33 -176.36 2.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 119.238 -2.163 . . . . 0.0 106.589 161.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -165.84 147.69 7.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.984 0.811 . . . . 0.0 110.63 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -140.45 177.8 7.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.509 1.924 . . . . 0.0 109.595 178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 22.2 p -134.55 171.85 8.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.291 1.036 . . . . 0.0 110.011 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 69.4 Cg_endo -72.62 -0.64 9.13 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.799 2.333 . . . . 0.0 114.793 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.45 -53.51 3.81 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 156.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 39' ' ' THR . 56.9 mt-10 -68.24 -30.49 69.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.591 -0.946 . . . . 0.0 113.139 -160.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.9 -13.81 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.865 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.87 -42.28 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 110.198 -177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -90.25 -18.12 26.23 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.012 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.68 147.46 9.05 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.776 2.131 . . . . 0.0 109.825 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -63.43 164.92 8.46 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.766 1.783 . . . . 0.0 109.777 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -19.31 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.24 1.816 . . . . 0.0 114.525 -159.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 7.3 mt-10 -93.82 -78.73 0.43 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.519 0.728 . . . . 0.0 110.003 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.3 t -168.48 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.194 0.997 . . . . 0.0 111.334 -168.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.573 ' CD ' ' H ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -52.89 -50.61 63.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.843 2.457 . . . . 0.0 112.48 177.787 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -174.71 173.45 2.81 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 120.987 1.721 . . . . 0.0 110.737 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 42.8 mtp -121.9 149.2 53.15 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 126.15 1.78 . . . . 0.0 106.383 164.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.02 166.29 23.43 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.862 1.708 . . . . 0.0 111.184 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -79.01 128.43 33.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.414 ' CG1' ' HA ' ' A' ' 117' ' ' LYS . 49.0 t -60.64 -8.48 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.823 1.649 . . . . 0.0 111.857 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.46 33.49 4.8 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-O 116.131 -2.483 . . . . 0.0 112.719 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.83 177.62 6.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.128 2.464 . . . . 0.0 112.471 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -83.6 140.93 31.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.018 0.927 . . . . 0.0 110.664 165.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -146.64 173.92 11.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.638 0.775 . . . . 0.0 109.76 169.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -121.26 139.03 53.94 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.46 160.72 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 128.506 2.723 . . . . 0.0 107.856 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.08 156.58 26.92 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.85 -179.96 47.51 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.703 1.621 . . . . 0.0 109.214 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.4 tpp -81.09 120.05 24.34 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 129.062 2.945 . . . . 0.0 110.598 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 73.0 t -64.74 130.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 119.094 -2.253 . . . . 0.0 108.479 175.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.26 154.23 53.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.87 133.3 30.91 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.006 2.471 . . . . 0.0 109.668 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.73 -24.65 4.32 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 125.579 1.561 . . . . 0.0 115.776 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.09 -43.61 91.86 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.466 1.633 . . . . 0.0 111.732 -170.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.308 1.3 p -42.33 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.941 2.096 . . . . 0.0 112.96 -172.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -91.93 56.48 2.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.968 2.907 . . . . 0.0 108.242 -177.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.9 ptt-85 -66.82 143.11 57.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 166.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 76' ' ' ASN . 11.1 m-20 -76.41 119.76 78.73 Favored Pre-proline 0 N--CA 1.436 -1.155 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 171.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.95 1.7 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.018 1.812 . . . . 0.0 111.8 164.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 74' ' ' ASP . 35.0 m-20 -134.31 14.0 3.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.482 2.313 . . . . 0.0 110.163 -167.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.03 -166.14 0.78 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.624 1.569 . . . . 0.0 107.61 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 2.32 19.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.014 1.726 . . . . 0.0 111.506 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -62.29 138.97 58.52 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.058 -1.651 . . . . 0.0 109.088 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.1 p -155.72 132.7 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.314 22.7 m -123.39 153.71 40.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 174.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.488 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 48.8 p90 -152.4 176.98 11.08 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 119.936 -1.727 . . . . 0.0 110.945 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 m -121.56 143.8 49.08 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -121.34 153.67 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.064 1.746 . . . . 0.0 106.47 174.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -141.81 -179.43 6.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.587 1.955 . . . . 0.0 106.973 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -157.08 -159.35 0.85 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.08 4.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.96 -79.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.033 1.733 . . . . 0.0 109.371 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.98 -168.37 12.07 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.215 1.388 . . . . 0.0 111.643 -167.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 p -146.98 155.97 42.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.72 145.85 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.999 1.72 . . . . 0.0 110.264 -167.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.5 154.68 26.18 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.488 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 5.4 m -133.28 144.95 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 120.625 -1.297 . . . . 0.0 109.337 160.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.38 1.872 . . . . 0.0 106.572 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -134.91 168.93 18.19 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.221 1.809 . . . . 0.0 108.761 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -148.94 117.63 6.61 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 171.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.38 175.46 25.59 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -170.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -6.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.047 1.339 . . . . 0.0 112.395 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.3 mt 63.02 165.89 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 127.535 2.334 . . . . 0.0 111.66 -166.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.35 137.64 79.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 159.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.88 -27.4 66.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.141 0.496 . . . . 0.0 110.704 167.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -19.07 60.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.481 1.512 . . . . 0.0 113.107 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -64.5 129.4 39.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.994 0.815 . . . . 0.0 110.086 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -136.1 161.07 36.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.023 1.329 . . . . 0.0 109.944 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.71 114.21 6.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.526 1.13 . . . . 0.0 108.206 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.98 -3.46 33.69 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.127 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -91.48 166.73 12.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.35 1.575 . . . . 0.0 110.601 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 140.99 27.54 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.14 177.06 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.255 1.822 . . . . 0.0 107.295 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.6 t -141.86 101.22 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.097 1.759 . . . . 0.0 106.714 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.9 168.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-O 122.706 1.241 . . . . 0.0 111.244 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -165.05 140.83 5.46 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.279 1.831 . . . . 0.0 107.693 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.58 -91.43 0.11 Allowed Glycine 0 C--O 1.224 -0.481 0 CA-C-O 116.941 -2.033 . . . . 0.0 109.276 168.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.29 162.28 35.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.466 2.133 . . . . 0.0 110.339 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.28 148.63 28.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.06 1.744 . . . . 0.0 108.672 165.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.99 -85.0 0.48 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 108.259 -174.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.414 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 12.8 mtmm -141.07 170.8 15.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 127.352 2.261 . . . . 0.0 106.88 159.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 45.48 -102.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 125.131 1.348 . . . . 0.0 110.852 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -136.31 51.99 1.99 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.593 0.757 . . . . 0.0 109.318 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -121.46 129.94 53.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.48 0.712 . . . . 0.0 109.955 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -105.35 127.81 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.57 1.148 . . . . 0.0 110.999 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.49 80.76 5.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 162.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.54 141.87 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.563 0.697 . . . . 0.0 110.53 164.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -14.13 9.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.581 1.552 . . . . 0.0 111.529 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.81 -33.65 0.45 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 117.643 -1.17 . . . . 0.0 114.04 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 87.7 t 54.92 116.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 C-N-CA 129.073 2.949 . . . . 0.0 111.108 -174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 10.1 mt -93.15 -176.42 4.15 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.653 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -143.43 19.47 1.88 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.982 1.313 . . . . 0.0 110.616 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.2 mttm 42.3 60.97 2.14 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.426 1.012 . . . . 0.0 111.577 -161.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -57.94 4.28 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 159.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.91 -64.64 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 128.073 2.549 . . . . 0.0 104.944 174.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 74.45 111.83 0.07 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 129.905 3.282 . . . . 0.0 111.366 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -63.47 -174.3 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.199 2.6 . . . . 0.0 111.961 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -125.4 164.87 19.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.25 1.42 . . . . 0.0 107.535 166.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.9 m -138.57 142.79 35.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.157 1.783 . . . . 0.0 107.053 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.0 175.64 7.22 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.501 2.134 . . . . 0.0 111.18 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -82.58 -33.47 0.49 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.335 2.023 . . . . 0.0 113.877 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.36 56.01 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.369 1.868 . . . . 0.0 110.727 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.97 -49.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.99 2.116 . . . . 0.0 107.581 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -50.67 63.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.265 0.484 . . . . 0.0 109.718 -170.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.05 -47.75 0.06 Allowed 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 125.891 1.676 . . . . 0.0 107.686 176.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.4 48.18 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.359 1.864 . . . . 0.0 112.604 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 41.3 mtt . . . . . 0 C--O 1.249 1.069 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 145.341 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.86 138.65 48.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.08 1.764 . . . . 0.0 108.627 161.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.1 m 60.43 175.92 0.1 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.179 1.392 . . . . 0.0 113.109 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.87 110.95 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.36 173.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 162.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -64.17 161.37 16.49 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.365 -1.459 . . . . 0.0 112.22 168.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pp -74.96 177.6 6.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.528 1.156 . . . . 0.0 109.65 178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -158.21 147.18 19.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.664 1.185 . . . . 0.0 108.578 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -134.43 173.03 12.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.013 1.725 . . . . 0.0 108.891 175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.549 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 3.4 p -131.99 172.41 7.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.753 1.221 . . . . 0.0 108.635 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 10.8 Cg_endo -59.87 -36.87 89.33 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.646 1.564 . . . . 0.0 109.881 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.88 10.52 13.69 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.595 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' HB2' ' H ' ' A' ' 39' ' ' THR . 26.6 mt-10 -130.17 -30.95 1.92 Allowed 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.909 1.854 . . . . 0.0 112.727 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.04 -58.27 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -49.61 36.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 110.06 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -82.98 -7.16 59.7 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.53 132.05 4.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' HZ2' ' CD ' ' A' ' 42' ' ' GLU . 13.8 tptp -37.9 126.49 1.22 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 128.316 2.647 . . . . 0.0 113.648 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -59.38 -28.44 66.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 119.078 0.853 . . . . 0.0 112.866 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.22 -57.84 5.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.025 0.375 . . . . 0.0 110.751 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 t -152.83 10.04 0.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -167.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER 34.71 52.35 0.56 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.577 3.151 . . . . 0.0 114.657 176.18 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -56.86 9.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.923 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 107.08 113.32 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 1 C-N-CA 133.38 4.672 . . . . 0.0 107.386 -176.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.59 160.9 40.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.256 1.304 . . . . 0.0 110.117 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -78.66 128.72 33.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.44 -6.06 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.005 1.722 . . . . 0.0 111.433 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.06 52.76 0.74 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 162.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -131.66 178.82 6.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.75 1.275 . . . . 0.0 111.355 161.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -95.0 137.61 33.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.999 1.72 . . . . 0.0 110.392 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.74 169.82 23.04 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.274 1.03 . . . . 0.0 111.416 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -119.27 143.44 47.33 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 127.952 2.501 . . . . 0.0 107.923 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.2 160.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.063 2.145 . . . . 0.0 108.514 -170.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.02 163.98 26.55 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 160.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.25 38.89 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 124.167 0.889 . . . . 0.0 111.189 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.7 ttm -91.9 125.98 36.81 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.53 1.132 . . . . 0.0 109.474 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.539 HG11 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -65.69 123.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 120.705 1.593 . . . . 0.0 107.46 178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 ttm -63.14 139.18 97.51 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.11 158.29 48.86 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.62 57.91 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 116.857 -2.08 . . . . 0.0 115.494 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -120.23 -6.34 9.89 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.478 2.139 . . . . 0.0 113.323 167.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.3 85.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 120.796 1.635 . . . . 0.0 111.484 169.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -78.46 61.69 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.796 2.839 . . . . 0.0 107.408 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -69.91 148.81 48.52 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.75 -1.219 . . . . 0.0 108.8 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -92.63 108.64 33.14 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -60.02 -22.04 67.65 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 CA-C-N 121.341 1.515 . . . . 0.0 111.296 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.98 -15.93 22.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.074 1.35 . . . . 0.0 111.476 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 m -134.56 -142.59 0.19 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.556 1.142 . . . . 0.0 109.012 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.96 -6.9 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.516 1.927 . . . . 0.0 110.159 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -62.07 140.77 58.37 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.2 p -149.61 132.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 m -122.05 135.83 54.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -147.71 173.46 12.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.917 1.235 . . . . 0.0 110.087 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.2 m -118.6 142.8 47.28 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.864 1.266 . . . . 0.0 107.814 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -127.58 145.48 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.374 1.469 . . . . 0.0 107.098 175.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -149.45 176.42 10.61 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.9 0.88 . . . . 0.0 111.417 -168.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -160.4 -166.48 1.67 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.655 1.582 . . . . 0.0 110.318 172.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.82 8.47 0.51 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.641 1.576 . . . . 0.0 113.66 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.87 -71.14 0.74 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.79 -171.01 12.5 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 124.196 0.903 . . . . 0.0 112.433 -172.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.2 p -140.98 149.79 42.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.975 0.91 . . . . 0.0 110.773 164.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -132.7 149.75 32.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.864 1.266 . . . . 0.0 108.054 -173.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.3 148.32 25.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.73 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 60.9 t -135.58 123.32 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.025 0.93 . . . . 0.0 110.764 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -89.31 136.78 32.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 151.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -132.52 165.19 24.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.037 2.135 . . . . 0.0 106.694 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -140.07 113.11 8.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.99 166.55 23.06 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.4 tt -72.96 -15.47 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.888 -174.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.0 mt 78.83 165.09 0.12 Allowed Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 130.827 3.651 . . . . 0.0 110.743 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -61.13 140.37 89.01 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 N-CA-C 107.299 -1.846 . . . . 0.0 107.299 158.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.94 -31.45 66.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.903 1.281 . . . . 0.0 109.927 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -33.26 71.24 Favored 'General case' 0 N--CA 1.437 -1.076 1 C-N-CA 131.984 4.113 . . . . 0.0 111.567 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -59.73 136.6 58.05 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.023 1.283 . . . . 0.0 107.776 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.415 ' H ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -149.77 142.15 24.27 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.476 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.539 ' H ' HG11 ' A' ' 66' ' ' VAL . . . 114.8 -9.33 21.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 114.876 -3.18 . . . . 0.0 115.463 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.515 ' H ' HG11 ' A' ' 66' ' ' VAL . 0.5 OUTLIER -94.53 169.7 10.0 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 123.622 3.711 . . . . 0.0 111.637 -173.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.57 8.04 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 165.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.48 176.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.434 1.894 . . . . 0.0 108.447 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.413 ' CG2' ' HE2' ' A' ' 129' ' ' LYS . 2.1 t -129.29 128.88 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.124 1.77 . . . . 0.0 107.228 164.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.82 167.06 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.475 1.131 . . . . 0.0 111.8 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -161.41 144.53 12.5 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.61 -120.31 0.91 Allowed Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -138.35 152.46 48.48 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.758 0.779 . . . . 0.0 109.395 -169.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 143.41 33.94 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.339 1.056 . . . . 0.0 110.176 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.407 ' CD ' ' HD1' ' A' ' 120' ' ' HIS . 15.9 tt0 -91.58 -77.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.563 -0.71 . . . . 0.0 110.992 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.23 -79.83 0.01 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.86 2.064 . . . . 0.0 108.58 -170.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.3 47.76 2.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.783 1.659 . . . . 0.0 113.153 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.02 67.11 1.02 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.9 2.08 . . . . 0.0 110.904 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.407 ' HD1' ' CD ' ' A' ' 116' ' ' GLU . 6.5 t-160 -136.64 132.84 35.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.131 1.773 . . . . 0.0 106.613 178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -99.95 127.07 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.446 1.498 . . . . 0.0 109.046 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.72 74.99 5.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 164.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.21 140.02 17.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.032 0.92 . . . . 0.0 111.693 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -17.32 12.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.69 1.996 . . . . 0.0 110.92 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.85 -42.8 0.53 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.801 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 89.3 t 50.69 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.045 1.338 . . . . 0.0 111.18 -176.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.7 mt -98.67 159.54 14.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.0 17.96 14.79 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.911 0.884 . . . . 0.0 113.361 -162.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.413 ' HE2' ' CG2' ' A' ' 110' ' ' VAL . 42.5 mmtt 37.89 49.48 1.15 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.534 1.933 . . . . 0.0 111.462 -170.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -85.3 39.28 0.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.732 1.213 . . . . 0.0 108.866 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 t0 53.39 81.51 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.218 1.807 . . . . 0.0 110.544 -160.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.94 119.67 31.9 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 171.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.75 -165.14 1.62 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 -166.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -61.24 108.13 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 56.4 m -79.79 137.34 54.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.25 178.75 1.04 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.56 2.84 . . . . 0.0 112.183 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.37 -33.45 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.32 2.013 . . . . 0.0 113.786 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -82.19 59.93 4.7 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.107 0.963 . . . . 0.0 109.453 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -165.15 -48.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.163 1.385 . . . . 0.0 107.812 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -37.16 65.79 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.154 1.382 . . . . 0.0 110.619 -177.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 39.0 0.19 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.258 1.023 . . . . 0.0 111.094 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.94 -77.23 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 110.269 171.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.3 ttm . . . . . 0 C--O 1.248 1.002 0 C-N-CA 128.565 2.746 . . . . 0.0 113.104 -169.334 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.469 0.525 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -72.12 -53.94 11.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.603 0.638 . . . . 0.0 110.488 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 m -113.83 169.41 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.64 1.576 . . . . 0.0 109.573 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -126.91 120.58 29.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.737 1.215 . . . . 0.0 110.84 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 mm -72.23 159.31 5.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.146 0.974 . . . . 0.0 110.293 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.55 129.89 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.58 1.952 . . . . 0.0 107.727 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 pp -66.85 -176.54 0.51 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.159 1.784 . . . . 0.0 112.185 -169.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -156.56 162.14 39.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.957 1.303 . . . . 0.0 109.38 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -145.72 173.09 12.39 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.756 2.822 . . . . 0.0 108.601 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -135.36 165.4 36.64 Favored Pre-proline 0 CA--C 1.53 0.187 0 O-C-N 121.315 -0.866 . . . . 0.0 112.233 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.16 -8.62 12.62 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.384 2.723 . . . . 0.0 116.205 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.51 -38.0 4.09 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 120.586 1.539 . . . . 0.0 110.01 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.04 22.94 1.9 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.432 -1.628 . . . . 0.0 110.27 -162.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.67 -50.92 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 164.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -79.97 -41.23 26.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.369 1.867 . . . . 0.0 110.568 -169.428 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -82.19 4.09 24.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.995 1.318 . . . . 0.0 110.159 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.93 170.72 6.67 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 125.995 1.759 . . . . 0.0 109.756 -166.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -85.98 157.69 20.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -162.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -81.08 -24.74 37.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.77 -1.206 . . . . 0.0 112.774 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.038 0.935 . . . . 0.0 111.27 -173.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 t -151.66 12.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.489 0.716 . . . . 0.0 110.933 -169.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 55.92 79.77 0.16 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.722 1.609 . . . . 0.0 110.374 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -131.55 166.27 21.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.099 1.76 . . . . 0.0 109.789 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 mmt -107.0 124.35 35.6 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.093 1.357 . . . . 0.0 109.034 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -62.39 154.87 61.02 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.673 167.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.78 130.78 35.62 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.658 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.56 -9.72 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 122.844 0.458 . . . . 0.0 111.332 166.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.11 3.24 56.87 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.589 -1.673 . . . . 0.0 115.286 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -115.29 173.51 6.47 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.88 2.34 . . . . 0.0 112.374 -161.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -98.41 135.36 40.11 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.17 174.91 14.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.752 0.786 . . . . 0.0 111.335 -178.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -131.89 153.3 50.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.253 1.421 . . . . 0.0 109.775 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 88.3 t -138.14 138.34 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 127.447 2.299 . . . . 0.0 107.74 -171.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.41 2.8 Favored Glycine 0 N--CA 1.466 0.687 0 CA-C-N 120.795 1.634 . . . . 0.0 112.048 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.7 165.25 27.64 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -172.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.5 ttm -79.95 123.32 27.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.482 1.513 . . . . 0.0 107.789 166.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.21 125.47 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 38.6 mtt -52.77 121.51 22.95 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.123 0.569 . . . . 0.0 110.603 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.07 91.49 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.803 3.669 . . . . 0.0 109.192 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.73 62.7 0.68 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 -23.29 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.376 2.271 . . . . 0.0 111.05 170.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.12 93.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 119.704 1.138 . . . . 0.0 109.341 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -80.8 73.38 7.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.967 2.507 . . . . 0.0 106.618 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.88 136.93 48.94 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.02 127.13 89.9 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.43 -7.51 21.02 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 CA-C-N 119.625 0.902 . . . . 0.0 112.151 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -129.66 0.35 4.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.191 0.905 . . . . 0.0 111.88 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.33 173.39 11.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 120.224 1.375 . . . . 0.0 111.099 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.74 -2.01 58.15 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.804 -0.56 . . . . 0.0 112.052 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.34 139.84 35.4 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.429 -1.42 . . . . 0.0 108.155 166.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.06 121.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.3 m -116.79 129.81 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 50.1 p90 -139.77 175.4 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 119.283 0.947 . . . . 0.0 111.076 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -123.9 142.69 50.91 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.65 137.01 57.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -130.69 179.87 5.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.129 1.771 . . . . 0.0 108.276 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -152.91 -116.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.182 163.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.89 -1.97 30.91 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.824 1.193 . . . . 0.0 112.27 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -124.7 -70.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.796 1.238 . . . . 0.0 107.783 -156.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.47 -168.39 12.55 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.3 p -142.75 156.79 45.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.121 0.568 . . . . 0.0 111.65 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -138.01 147.64 25.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.782 2.033 . . . . 0.0 109.587 -171.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.23 153.73 24.56 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.48 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 3.2 m -135.67 145.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 163.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -112.77 125.8 54.73 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 162.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -124.27 158.91 31.42 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.168 1.387 . . . . 0.0 108.667 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -142.94 99.12 3.4 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.0 170.34 29.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.603 1.097 . . . . 0.0 110.452 -175.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -74.96 -17.51 16.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.617 1.167 . . . . 0.0 112.072 -165.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 73.27 135.74 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.955 2.502 . . . . 0.0 109.36 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.73 151.46 85.61 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.793 1.662 . . . . 0.0 108.999 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -29.08 68.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.831 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.45 -38.4 80.65 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.971 -1.49 . . . . 0.0 111.18 176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.448 ' CD2' HG12 ' A' ' 109' ' ' VAL . 23.9 t80 -67.06 134.56 52.12 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.341 1.456 . . . . 0.0 110.938 -172.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.14 169.43 17.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.072 0.949 . . . . 0.0 110.661 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.66 84.41 6.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.899 1.68 . . . . 0.0 108.001 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.97 5.48 3.87 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.124 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.28 171.57 7.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.058 1.929 . . . . 0.0 110.761 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.47 110.93 3.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.448 HG12 ' CD2' ' A' ' 103' ' ' PHE . 2.3 m -112.92 171.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 173.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.02 163.63 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 157.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.2 t -113.97 157.56 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 156.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -141.89 148.83 39.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.351 2.26 . . . . 0.0 106.661 169.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.16 -114.69 0.66 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -135.75 159.63 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.724 1.762 . . . . 0.0 110.371 -165.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.54 142.0 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 -66.62 0.89 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.473 0.709 . . . . 0.0 109.463 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -50.32 0.08 Allowed 'General case' 0 C--N 1.347 0.483 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.52 -77.27 0.82 Allowed Glycine 0 C--N 1.329 0.149 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -141.14 33.48 1.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.897 1.679 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -115.78 129.54 56.49 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.9 mm -102.68 133.61 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.758 1.623 . . . . 0.0 108.535 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.2 108.0 12.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 157.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.31 141.98 54.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 165.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -27.5 7.85 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 126.198 1.799 . . . . 0.0 108.971 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.82 -18.29 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t 51.41 99.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.428 2.291 . . . . 0.0 115.951 170.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -109.4 125.07 52.01 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.592 -163.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.78 57.69 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.162 -1.586 . . . . 0.0 110.592 -171.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 50.16 26.72 2.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.958 1.303 . . . . 0.0 113.706 173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.558 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -80.65 58.99 3.44 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.611 1.964 . . . . 0.0 108.817 175.746 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.05 10.69 2.33 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -76.16 162.33 28.07 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.623 -1.298 . . . . 0.0 110.566 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -159.19 -13.85 0.06 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.127 1.371 . . . . 0.0 110.723 159.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -145.52 168.49 20.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.856 2.063 . . . . 0.0 106.702 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -135.35 129.8 18.87 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.78 174.15 4.91 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.051 2.5 . . . . 0.0 110.589 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -81.69 -32.25 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.011 1.141 . . . . 0.0 114.454 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 66.68 1.33 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.592 1.557 . . . . 0.0 108.937 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 p -178.1 -53.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 127.631 2.373 . . . . 0.0 106.382 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -58.54 -42.89 88.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.792 0.837 . . . . 0.0 110.819 -167.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 -1.06 13.32 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.814 0.845 . . . . 0.0 110.998 -177.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.6 3.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.999 0.818 . . . . 0.0 110.695 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.872 1.669 . . . . 0.0 112.323 -163.891 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mpp_? -160.16 142.28 13.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.933 2.093 . . . . 0.0 106.379 157.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -149.29 158.32 44.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 165.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -162.47 176.33 10.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.226 0.466 . . . . 0.0 110.027 142.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 HG23 ' H ' ' A' ' 35' ' ' ASP . 10.3 mm -79.31 -154.4 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 172.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.522 ' H ' HG23 ' A' ' 34' ' ' ILE . 4.1 p30 -74.0 149.2 41.42 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.331 -2.106 . . . . 0.0 110.333 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.65 -174.22 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.915 1.686 . . . . 0.0 113.394 -168.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -140.7 121.42 14.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.119 1.368 . . . . 0.0 109.812 -162.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -110.21 -179.58 3.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 109.282 176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 p -147.55 162.3 32.5 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.811 1.645 . . . . 0.0 107.161 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 66.5 8.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 109.628 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -168.3 -52.27 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 178.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -1.6 25.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 125.598 1.559 . . . . 0.0 111.388 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.65 -30.98 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.429 HD21 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -97.83 -46.92 5.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.217 1.007 . . . . 0.0 111.282 -168.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.4 -36.52 22.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.154 1.382 . . . . 0.0 109.919 -172.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.21 133.83 3.2 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -167.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tptp -62.13 129.58 41.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 119.085 1.443 . . . . 0.0 109.994 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.0 mtm105 -72.03 -26.71 62.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.602 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -56.11 -73.3 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.058 1.299 . . . . 0.0 111.842 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -152.11 48.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 48.18 70.51 0.43 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.22 1.486 . . . . 0.0 112.755 154.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -130.73 145.83 52.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.049 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.0 160.52 55.05 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.62 148.71 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.843 1.695 . . . . 0.0 110.12 163.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.46 137.79 37.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.72 -8.21 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.622 0.769 . . . . 0.0 111.18 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.07 36.25 3.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 125.598 1.57 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -136.02 163.88 29.27 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.411 1.606 . . . . 0.0 110.215 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -77.47 150.39 34.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.419 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.73 164.68 31.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.086 1.355 . . . . 0.0 111.093 169.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -106.51 155.04 20.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.011 1.724 . . . . 0.0 107.277 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.0 153.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 127.075 2.15 . . . . 0.0 107.815 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.46 139.65 11.14 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 162.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.16 173.58 43.6 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 118.177 0.989 . . . . 0.0 111.51 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 ttm -109.0 123.82 49.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 110.859 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.463 ' CG1' ' H ' ' A' ' 107' ' ' GLN . 0.2 OUTLIER -66.28 129.45 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.889 1.677 . . . . 0.0 110.494 -171.05 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 mtt -62.68 139.81 97.0 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.09 0.859 . . . . 0.0 110.154 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.75 140.43 80.32 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.696 1.597 . . . . 0.0 108.565 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.27 43.5 92.77 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.221 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.8 p -117.08 -84.33 0.64 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.305 1.7 p -22.49 95.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 130.817 3.647 . . . . 0.0 114.802 -170.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.22 90.99 7.54 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 129.089 2.955 . . . . 0.0 108.662 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -90.9 147.93 22.81 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.33 120.78 83.16 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.3 -8.74 23.26 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 CA-C-N 121.305 1.502 . . . . 0.0 113.037 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.0 -22.58 10.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.041 1.336 . . . . 0.0 109.713 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -139.58 -160.56 1.08 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.9 mt -113.32 -6.22 13.56 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.92 0.888 . . . . 0.0 112.055 -171.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -55.12 139.47 41.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.039 1.336 . . . . 0.0 108.048 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 4.9 p -158.13 127.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.1 m -102.49 146.56 27.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.455 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 24.6 p90 -146.23 172.53 13.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.982 1.265 . . . . 0.0 109.684 168.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.59 145.4 42.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.21 126.34 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.57 1.148 . . . . 0.0 109.094 175.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 28.6 p90 -117.3 173.89 6.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.491 2.316 . . . . 0.0 110.34 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -152.61 -164.51 1.97 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.977 1.311 . . . . 0.0 108.328 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.11 11.06 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.802 -1.186 . . . . 0.0 113.672 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.03 -75.65 0.58 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -174.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -127.76 -162.37 11.07 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.504 1.049 . . . . 0.0 113.0 -167.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 93.8 p -144.9 160.44 41.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.623 0.769 . . . . 0.0 110.754 169.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.01 145.34 28.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -76.94 151.9 35.52 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.455 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 6.2 m -131.73 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 121.943 -0.473 . . . . 0.0 109.766 165.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -104.45 132.7 50.4 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -132.53 168.49 18.13 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.465 1.506 . . . . 0.0 108.445 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -156.07 107.07 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 167.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.93 20.19 0.02 OUTLIER Glycine 0 N--CA 1.468 0.8 0 C-N-CA 116.254 -2.879 . . . . 0.0 118.195 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER 59.21 117.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.641 1.977 . . . . 0.0 111.882 -168.651 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.7 mt -74.33 148.29 85.94 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.301 -0.874 . . . . 0.0 109.902 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -60.7 156.73 41.06 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.314 2.676 . . . . 0.0 109.749 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.86 -40.95 97.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.665 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.18 -27.91 64.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.916 1.286 . . . . 0.0 111.44 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -55.53 129.77 40.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.617 1.099 . . . . 0.0 109.478 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ptt85 -127.86 -164.23 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.623 1.169 . . . . 0.0 111.158 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -103.06 129.19 49.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 153.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.406 ' H ' HG11 ' A' ' 66' ' ' VAL . . . 97.4 8.82 56.0 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 115.524 -2.82 . . . . 0.0 114.754 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.463 ' H ' ' CG1' ' A' ' 66' ' ' VAL . 0.7 OUTLIER -98.65 165.28 11.88 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 121.829 2.815 . . . . 0.0 110.111 174.657 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.21 133.97 26.6 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.56 161.96 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.835 2.454 . . . . 0.0 105.801 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.41 138.5 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 15.2 m -117.06 166.02 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.296 0.57 . . . . 0.0 110.059 166.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -158.44 146.31 18.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.148 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.91 -112.44 0.54 Allowed Glycine 0 C--O 1.228 -0.263 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -134.45 162.95 30.82 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 120.366 2.083 . . . . 0.0 107.608 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.4 tp -82.46 133.91 35.21 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.685 1.194 . . . . 0.0 108.533 167.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -80.61 -66.64 0.86 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -168.35 -171.89 1.59 Allowed 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 133.161 4.584 . . . . 0.0 105.106 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -8.58 82.92 0.0 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.495 2.95 . . . . 0.0 113.623 164.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 m120 59.2 35.22 23.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.27 2.228 . . . . 0.0 114.767 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -126.41 132.66 51.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.168 0.987 . . . . 0.0 111.045 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.2 mm -110.95 125.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 128.131 2.572 . . . . 0.0 110.92 -173.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -79.72 73.64 6.44 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.916 1.286 . . . . 0.0 108.308 168.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -43.17 128.07 4.5 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.786 -0.571 . . . . 0.0 110.398 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -26.99 13.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.084 1.353 . . . . 0.0 111.22 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.68 -41.99 0.61 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -170.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.9 t 57.34 144.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.892 2.077 . . . . 0.0 111.754 -168.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -139.21 159.89 41.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.31 39.73 3.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.705 1.602 . . . . 0.0 110.164 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt 17.97 64.15 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.162 2.585 . . . . 0.0 112.251 -161.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.709 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -66.74 -17.27 64.77 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.947 2.099 . . . . 0.0 111.204 167.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.1 t70 100.84 22.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 131.123 3.769 . . . . 0.0 111.043 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.97 129.93 24.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.013 1.725 . . . . 0.0 110.128 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.389 1.476 . . . . 0.0 111.14 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -131.17 -177.66 4.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.106 2.162 . . . . 0.0 108.21 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.1 m -104.23 105.45 49.3 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.66 174.89 6.86 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.167 2.578 . . . . 0.0 112.302 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.19 -38.73 4.56 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.155 1.237 . . . . 0.0 112.921 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -75.42 32.82 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.989 2.116 . . . . 0.0 112.484 -162.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.76 -34.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 128.167 2.587 . . . . 0.0 109.966 -168.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.1 -42.56 96.85 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 120.199 1.363 . . . . 0.0 111.037 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -168.72 70.01 0.08 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.291 1.836 . . . . 0.0 106.608 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -155.16 19.23 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.542 0.737 . . . . 0.0 112.813 -165.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 C--O 1.246 0.878 0 C-N-CA 125.546 1.538 . . . . 0.0 108.444 -179.539 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -144.45 133.39 22.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.435 1.494 . . . . 0.0 108.789 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -145.25 118.38 8.88 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.451 1.5 . . . . 0.0 107.987 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -115.23 153.03 31.62 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.815 1.246 . . . . 0.0 108.636 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.8 mt 62.86 172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.366 1.867 . . . . 0.0 110.184 176.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.14 149.04 7.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.8 1.64 . . . . 0.0 109.499 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 pp -78.27 176.8 8.95 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.099 0.952 . . . . 0.0 108.809 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -155.58 149.1 25.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -136.8 -179.93 5.99 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.457 1.903 . . . . 0.0 107.794 170.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -146.11 164.34 25.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 C-N-CA 126.236 1.814 . . . . 0.0 106.75 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.51 64.31 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.916 3.078 . . . . 0.0 110.142 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.9 -50.06 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -3.57 37.12 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.827 -0.808 . . . . 0.0 111.796 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mt -94.4 -34.17 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.001 0.92 . . . . 0.0 108.723 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.63 -57.66 2.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.465 1.106 . . . . 0.0 111.311 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -85.45 -28.03 25.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.591 2.357 . . . . 0.0 109.423 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.31 158.57 11.47 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.755 1.169 . . . . 0.0 112.189 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -47.86 124.69 7.71 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.556 1.542 . . . . 0.0 110.681 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.13 -28.71 70.25 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 121.278 1.854 . . . . 0.0 112.682 -168.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.75 -34.82 72.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.43 1.892 . . . . 0.0 113.311 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 t -168.23 -5.25 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.419 0.688 . . . . 0.0 112.435 -159.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.358 0.0 OUTLIER 45.5 32.39 1.1 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.148 2.979 . . . . 0.0 115.627 170.107 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -70.2 -4.67 22.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.532 1.533 . . . . 0.0 112.726 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt 59.71 158.95 0.1 Allowed Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 129.413 3.085 . . . . 0.0 112.492 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.9 162.27 32.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.763 1.642 . . . . 0.0 109.241 154.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -79.58 152.78 29.89 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 162.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.434 HG11 ' HE3' ' A' ' 117' ' ' LYS . 76.2 t -90.65 0.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.896 0.878 . . . . 0.0 111.811 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.41 61.58 0.65 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 165.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -140.0 176.11 9.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.485 0.714 . . . . 0.0 110.965 168.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -90.75 135.28 33.82 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.905 0.882 . . . . 0.0 111.205 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.48 175.71 13.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.193 1.397 . . . . 0.0 112.424 177.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -114.53 148.95 37.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 127.941 2.497 . . . . 0.0 109.141 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.63 134.68 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.199 1.399 . . . . 0.0 107.536 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.98 143.66 16.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 158.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.95 167.9 38.97 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.457 1.129 . . . . 0.0 111.579 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.7 ttm -93.73 121.91 35.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.605 1.562 . . . . 0.0 109.708 -174.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 107' ' ' GLN . 0.1 OUTLIER -66.2 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 109.222 -176.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 45.5 mtt -62.31 144.02 95.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 111.894 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.67 61.57 8.23 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.592 3.528 . . . . 0.0 110.804 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.15 63.06 0.02 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -152.72 -23.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.252 0.6 OUTLIER -68.56 100.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 120.261 1.391 . . . . 0.0 111.334 -176.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -82.91 81.46 8.59 Favored 'General case' 0 C--O 1.237 0.446 1 C-N-CA 132.667 4.387 . . . . 0.0 109.455 171.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -77.12 140.09 40.14 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.15 137.76 84.5 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.49 -20.74 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.159 1.239 . . . . 0.0 112.571 171.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.35 14.12 6.09 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.16 0.984 . . . . 0.0 110.653 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.14 -176.14 5.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.281 0.632 . . . . 0.0 109.902 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.54 8.78 29.48 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.162 1.785 . . . . 0.0 109.729 161.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -50.0 145.24 5.86 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 160.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.88 166.77 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 122.244 1.021 . . . . 0.0 109.114 169.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.67 116.16 7.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 163.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 50.1 p90 -125.07 175.85 7.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.503 1.956 . . . . 0.0 111.483 171.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 m -124.76 145.56 49.66 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -130.5 138.45 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.256 1.822 . . . . 0.0 107.465 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -130.04 174.65 9.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.612 1.565 . . . . 0.0 108.89 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -157.1 -163.84 1.48 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.46 -3.41 0.98 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.365 1.866 . . . . 0.0 115.269 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -118.84 -79.79 0.6 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.14 -159.24 8.59 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.927 1.251 . . . . 0.0 111.796 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -146.96 162.09 39.43 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.2 m -142.99 145.28 23.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.776 1.63 . . . . 0.0 109.255 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.49 159.74 24.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 3.9 m -136.27 138.5 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.301 1.04 . . . . 0.0 109.134 168.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.1 106.72 17.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.054 2.142 . . . . 0.0 105.308 167.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.37 165.96 10.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 107.487 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -157.12 117.33 3.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.92 -92.77 0.11 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 115.246 -3.359 . . . . 0.0 118.234 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.15 69.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 123.881 1.801 . . . . 0.0 107.253 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.4 tp -49.85 135.09 20.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.371 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -63.3 138.82 68.38 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 108.169 -1.512 . . . . 0.0 108.169 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.31 -14.82 58.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.462 170.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.15 -23.78 47.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.655 1.582 . . . . 0.0 111.916 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.7 122.73 14.22 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -120.62 153.37 36.91 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.263 1.425 . . . . 0.0 107.232 171.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.13 117.49 17.88 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.565 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 122.21 8.93 6.91 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 116.376 -2.347 . . . . 0.0 115.864 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.57 ' H ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -133.57 167.68 20.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.774 2.787 . . . . 0.0 112.305 -165.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.67 81.92 1.68 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.523 1.535 . . . . 0.0 112.348 -167.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.16 168.93 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.786 0.834 . . . . 0.0 109.916 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.61 115.53 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 171.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.1 t -105.31 156.75 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 127.086 2.155 . . . . 0.0 108.557 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -154.57 138.94 16.71 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.593 2.357 . . . . 0.0 106.154 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.96 -112.69 0.52 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 105.936 -2.866 . . . . 0.0 105.936 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -140.9 157.68 45.03 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.432 1.616 . . . . 0.0 109.507 -167.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.48 154.71 18.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.953 1.301 . . . . 0.0 109.084 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.4 -79.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.903 0.881 . . . . 0.0 110.675 -171.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.434 ' HE3' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -178.29 169.04 1.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 130.871 3.668 . . . . 0.0 106.325 177.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.39 20.92 52.76 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.455 1.025 . . . . 0.0 113.696 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 29.7 m120 54.64 68.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.121 1.368 . . . . 0.0 112.269 -164.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -131.18 132.56 44.81 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.55 1.14 . . . . 0.0 109.188 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 20.9 mm -105.18 133.49 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 110.285 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.05 109.65 13.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.48 139.19 34.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.83 -18.25 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 111.513 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.31 -43.99 0.46 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 58.5 t 53.3 108.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.767 2.027 . . . . 0.0 115.164 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.1 152.38 42.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.74 1.616 . . . . 0.0 107.712 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -114.17 27.68 9.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.92 1.236 . . . . 0.0 110.806 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt 44.57 49.7 8.43 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.317 1.847 . . . . 0.0 113.183 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -90.02 -93.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 170.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.32 -59.91 0.62 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -170.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 50.21 75.03 0.19 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 110.137 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -70.35 156.41 39.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 162.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -77.36 171.06 15.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.977 0.911 . . . . 0.0 109.271 164.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -133.53 130.85 21.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 166.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.34 174.79 5.68 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.441 2.761 . . . . 0.0 111.68 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -73.9 -32.43 7.23 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.515 1.477 . . . . 0.0 113.969 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -68.34 46.03 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.826 2.451 . . . . 0.0 112.31 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 p -179.05 -50.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 128.009 2.524 . . . . 0.0 106.84 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.94 -20.33 65.11 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.39 0.676 . . . . 0.0 111.78 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.74 133.86 47.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 155.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 56.75 80.1 0.16 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.039 2.135 . . . . 0.0 112.299 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 148.781 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 162.98 116.57 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 129.647 3.179 . . . . 0.0 103.606 -165.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -141.58 81.99 1.8 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.804 0.729 . . . . 0.0 109.495 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 60.14 -167.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.252 1.021 . . . . 0.0 111.189 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mt -127.67 134.4 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.56 123.55 22.71 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 125.393 1.477 . . . . 0.0 109.655 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.07 161.5 24.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 148.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 t80 100.27 140.85 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 1 C-N-CA 134.046 4.939 . . . . 0.0 106.28 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 9.8 m-85 -141.88 175.08 10.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.363 2.265 . . . . 0.0 106.289 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.8 p -140.86 170.97 8.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.249 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -62.98 -5.97 8.63 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.723 2.949 . . . . 0.0 118.009 -166.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -35.13 5.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 120.424 1.465 . . . . 0.0 110.404 165.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.55 -5.64 59.31 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.462 -1.611 . . . . 0.0 111.342 -158.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.95 -18.1 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.507 1.123 . . . . 0.0 110.769 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -80.28 -32.41 38.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.892 0.877 . . . . 0.0 111.3 -169.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.59 142.0 3.89 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.454 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 82.2 tttt -66.35 149.39 50.45 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.535 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -18.47 -71.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.225 1.41 . . . . 0.0 112.603 -142.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -68.7 -85.73 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -158.49 6.67 0.12 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.86 0.864 . . . . 0.0 111.087 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -51.66 66.93 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.589 -1.319 . . . . 0.0 114.041 -150.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.11 161.69 17.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 mtp -87.38 163.96 37.27 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 155.41 68.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.276 1.317 . . . . 0.0 110.057 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.447 ' C ' ' H ' ' A' ' 57' ' ' GLY . 88.6 mt-10 -81.7 131.03 35.25 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.45 1.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.102 1.761 . . . . 0.0 112.469 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.447 ' H ' ' C ' ' A' ' 55' ' ' GLU . . . -129.55 25.57 4.47 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 116.471 -2.294 . . . . 0.0 113.386 175.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -125.2 175.09 7.64 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.42 2.11 . . . . 0.0 112.861 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.7 140.01 30.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.464 1.505 . . . . 0.0 112.621 167.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -160.77 171.5 18.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.269 1.828 . . . . 0.0 110.223 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.33 145.6 51.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.854 1.662 . . . . 0.0 108.282 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.68 132.66 71.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.55 153.15 20.11 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 157.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.48 -175.85 42.36 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 ttm -118.87 125.26 49.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.57 124.25 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.242 0.928 . . . . 0.0 108.685 -169.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.6 ttm -59.66 124.23 75.03 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.293 1.037 . . . . 0.0 109.047 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 112.12 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.017 3.145 . . . . 0.0 110.404 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.06 51.86 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.051 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -67.13 -26.26 66.59 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.781 1.79 . . . . 0.0 112.877 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.53 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 123.985 0.914 . . . . 0.0 110.148 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.64 -70.39 0.13 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.105 1.762 . . . . 0.0 109.443 168.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 44.26 144.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 1 C-N-CA 131.736 4.014 . . . . 0.0 114.057 -164.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -88.3 131.58 42.02 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.78 -11.59 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.858 1.342 . . . . 0.0 112.69 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -134.55 10.36 3.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.61 1.564 . . . . 0.0 110.639 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.24 -172.65 4.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.765 1.226 . . . . 0.0 107.812 173.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.19 -9.65 16.06 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.37 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 140.71 50.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.838 0.855 . . . . 0.0 109.269 172.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 ' C ' ' HG1' ' A' ' 81' ' ' THR . 2.3 p -156.91 145.0 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 80' ' ' VAL . 99.7 m -147.1 135.87 22.14 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -147.13 174.58 11.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.491 1.116 . . . . 0.0 108.85 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -121.18 151.47 39.9 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.16 140.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -133.32 174.25 10.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.148 1.379 . . . . 0.0 109.388 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.37 -165.67 2.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.593 2.357 . . . . 0.0 104.921 165.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.21 0.26 1.44 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 114.263 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.37 -70.78 0.79 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 120.017 1.281 . . . . 0.0 108.718 -164.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.38 -166.51 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 128.423 2.916 . . . . 0.0 108.188 -170.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.0 p -153.42 159.88 42.47 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.114 -0.639 . . . . 0.0 109.537 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.28 153.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.347 1.459 . . . . 0.0 110.122 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.18 158.26 19.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.889 0.476 . . . . 0.0 109.978 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 44.7 t -141.35 120.62 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.857 1.263 . . . . 0.0 108.388 173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -96.83 131.55 43.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 162.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -131.85 167.66 19.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.353 1.861 . . . . 0.0 107.695 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -160.39 104.54 1.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.62 7.01 0.02 OUTLIER Glycine 0 C--O 1.225 -0.449 0 C-N-CA 116.272 -2.87 . . . . 0.0 117.026 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.493 HD11 ' H ' ' A' ' 99' ' ' LEU 0.281 0.4 OUTLIER 58.22 145.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 123.706 1.717 . . . . 0.0 109.66 -156.032 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.493 ' H ' HD11 ' A' ' 98' ' ' ILE . 14.1 mt -98.53 157.01 35.06 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.769 -173.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.02 150.9 84.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.48 -23.03 67.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 111.481 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.32 -20.88 60.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.725 1.61 . . . . 0.0 112.534 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.22 127.04 31.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.308 1.867 . . . . 0.0 108.216 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -135.74 166.42 23.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.489 1.115 . . . . 0.0 109.911 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.85 121.53 25.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 101.64 17.67 20.76 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 115.609 1.003 . . . . 0.0 115.609 173.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.78 174.61 7.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.199 1.499 . . . . 0.0 112.378 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.81 105.51 3.29 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.586 1.565 . . . . 0.0 111.288 -167.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.35 171.28 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 t -130.46 97.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 128.031 2.532 . . . . 0.0 104.193 176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.0 t -79.6 154.77 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 108.1 169.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -151.96 143.24 23.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 127.266 2.226 . . . . 0.0 106.115 168.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.33 -111.07 0.35 Allowed Glycine 0 N--CA 1.434 -1.447 1 N-CA-C 101.341 -4.704 . . . . 0.0 101.341 158.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -141.56 153.98 45.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 119.561 1.681 . . . . 0.0 109.34 -167.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.11 127.03 33.65 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.27 -66.5 0.86 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.51 0.724 . . . . 0.0 110.69 -168.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -150.52 -66.54 0.2 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.45 -86.1 1.53 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.34 51.68 1.76 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -126.72 133.57 50.87 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.313 1.445 . . . . 0.0 107.301 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.65 131.12 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.322 1.449 . . . . 0.0 108.92 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.99 100.84 7.48 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 158.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.5 144.61 46.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.791 0.805 . . . . 0.0 110.177 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -22.78 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.171 2.189 . . . . 0.0 110.78 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -154.19 -7.7 0.15 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 32.8 t 26.91 85.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.581 2.352 . . . . 0.0 114.49 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.89 143.1 27.11 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.434 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -116.49 50.02 1.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.361 1.064 . . . . 0.0 110.361 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.9 mmtp 39.54 38.38 0.39 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.074 2.15 . . . . 0.0 115.263 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.434 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -64.92 -49.52 70.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.603 1.161 . . . . 0.0 108.854 169.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -162.14 -26.93 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.14 126.88 26.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.518 1.527 . . . . 0.0 113.064 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.33 -175.01 2.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.762 1.225 . . . . 0.0 110.279 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.0 96.96 0.82 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.908 1.283 . . . . 0.0 110.108 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 63.4 m -79.51 141.34 56.49 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.467 1.507 . . . . 0.0 109.735 177.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -62.66 179.06 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.339 3.359 . . . . 0.0 113.584 173.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -83.4 -172.89 1.47 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.956 3.104 . . . . 0.0 111.194 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.17 36.43 24.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.719 2.008 . . . . 0.0 111.383 -170.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.0 -24.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.016 1.727 . . . . 0.0 109.45 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -59.79 146.7 40.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.9 tptm 40.81 64.97 0.86 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.015 1.326 . . . . 0.0 112.148 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.02 -168.89 2.9 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.436 1.495 . . . . 0.0 107.138 167.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 C--O 1.252 1.216 0 C-N-CA 127.402 2.281 . . . . 0.0 112.572 168.574 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 108.6 4.54 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 120.931 -1.106 . . . . 0.0 110.055 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -68.39 149.38 49.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.37 0.605 . . . . 0.0 110.217 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -147.94 171.43 15.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 163.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.459 ' CG2' ' H ' ' A' ' 35' ' ' ASP . 26.3 mt 61.96 -179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.683 1.593 . . . . 0.0 109.07 -175.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.459 ' H ' ' CG2' ' A' ' 34' ' ' ILE . 0.4 OUTLIER -65.49 173.26 2.77 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.297 -1.502 . . . . 0.0 110.135 161.18 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' CD1' ' H ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -73.99 -176.46 2.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.931 0.872 . . . . 0.0 111.431 170.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.72 152.2 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.549 3.54 . . . . 0.0 106.057 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.7 173.61 11.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.062 2.145 . . . . 0.0 108.711 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.443 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 31.8 p -134.37 171.84 8.34 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 119.347 0.976 . . . . 0.0 112.054 169.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.35 1.59 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.989 3.126 . . . . 0.0 117.306 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.53 -24.98 5.66 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 121.296 1.862 . . . . 0.0 116.552 154.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' HB2' ' H ' ' A' ' 39' ' ' THR . 11.0 mm-40 -67.84 -12.92 61.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.789 2.295 . . . . 0.0 112.284 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CG2' HD22 ' A' ' 119' ' ' ASN . 3.0 mt -105.8 -23.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 126.929 2.092 . . . . 0.0 109.553 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.9 mt -87.4 -54.12 4.46 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.723 -1.235 . . . . 0.0 110.933 174.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -81.59 -76.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 106.854 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.6 161.42 23.75 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -57.37 155.34 9.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.248 1.024 . . . . 0.0 108.514 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -19.53 -39.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' N ' HE22 ' A' ' 51' ' ' GLN . 12.7 mt-10 -121.55 -59.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.019 1.281 . . . . 0.0 109.336 157.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.5 t -157.57 1.39 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.422 HE22 ' N ' ' A' ' 49' ' ' GLU . 2.4 mp0 -58.34 -53.44 58.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 111.639 -147.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -170.72 142.23 1.95 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.556 1.142 . . . . 0.0 108.111 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.3 mtp -73.46 161.69 77.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 162.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.25 162.44 33.92 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.127 1.218 . . . . 0.0 110.278 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -79.18 145.33 33.72 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.406 ' CG2' ' HA ' ' A' ' 117' ' ' LYS . 4.6 p -86.54 -2.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.056 1.343 . . . . 0.0 112.49 -173.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 71.85 0.48 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 107.164 -2.375 . . . . 0.0 107.164 153.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.93 176.72 8.45 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.752 0.776 . . . . 0.0 109.62 157.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -79.56 138.88 37.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.399 165.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -148.31 166.21 28.71 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.293 0.637 . . . . 0.0 110.328 165.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -99.38 137.42 37.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.455 1.502 . . . . 0.0 108.504 166.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.37 158.38 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.443 1.497 . . . . 0.0 107.435 160.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.76 142.72 11.47 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 154.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.2 -177.25 40.89 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ttm -88.71 118.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.484 0.713 . . . . 0.0 110.257 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.69 128.42 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.622 1.169 . . . . 0.0 109.085 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.4 ttm -70.65 128.53 90.9 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 124.058 0.943 . . . . 0.0 111.091 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.07 113.77 3.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.015 3.143 . . . . 0.0 110.701 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.01 12.78 13.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.374 1.94 . . . . 0.0 111.898 -173.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.8 p -112.58 -34.98 5.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 120.135 1.967 . . . . 0.0 111.791 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.83 116.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.047 0.939 . . . . 0.0 110.187 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -120.46 63.82 0.84 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.896 2.478 . . . . 0.0 107.919 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -66.75 143.78 56.72 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.021 -1.049 . . . . 0.0 109.509 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.86 129.81 87.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.37 -23.91 76.09 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 CA-C-N 122.281 1.85 . . . . 0.0 111.974 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -96.58 -3.97 42.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.848 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -157.89 -169.74 2.93 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.904 1.335 . . . . 0.0 111.274 -163.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.91 -2.39 13.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 127.482 2.313 . . . . 0.0 110.293 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 132.36 53.31 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.9 p -152.1 141.4 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.6 m -133.95 148.77 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.94 -177.1 5.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.451 1.5 . . . . 0.0 109.725 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.1 m -127.98 152.93 47.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -126.66 152.49 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.58 174.95 10.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.798 0.808 . . . . 0.0 109.122 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -151.3 -175.19 5.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.405 1.882 . . . . 0.0 107.553 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.73 -13.98 12.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.651 0.78 . . . . 0.0 113.037 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.84 -66.13 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.586 1.554 . . . . 0.0 107.276 -160.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.16 -162.67 11.58 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.096 1.808 . . . . 0.0 111.44 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -141.65 159.16 42.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.26 1.03 . . . . 0.0 113.203 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.7 m -149.16 156.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 111.537 -165.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.1 155.98 22.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.839 0.29 . . . . 0.0 111.235 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.94 124.51 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.362 1.065 . . . . 0.0 108.971 162.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.498 ' HG ' ' CE1' ' A' ' 120' ' ' HIS . 18.1 p -98.09 145.65 26.34 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.724 1.147 . . . . 0.0 108.386 159.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -139.88 167.72 21.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.734 1.614 . . . . 0.0 107.913 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -154.68 93.32 1.56 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.76 -175.4 44.54 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 118.538 -1.791 . . . . 0.0 114.096 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.14 117.8 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 14.2 tp -96.08 135.39 22.74 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 117.58 -1.2 . . . . 0.0 108.454 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.27 150.97 46.46 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.002 1.801 . . . . 0.0 111.686 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.96 -33.88 77.08 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.958 -0.464 . . . . 0.0 110.157 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 mp -61.3 -40.26 93.52 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -54.47 125.34 19.17 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.93 1.292 . . . . 0.0 109.567 -166.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 157.09 45.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -64.78 118.27 8.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.723 167.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.68 57.62 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.916 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.41 166.62 10.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.552 1.676 . . . . 0.0 109.765 162.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.3 138.46 20.53 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 124.57 1.081 . . . . 0.0 110.873 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.72 166.97 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.431 1.892 . . . . 0.0 108.463 173.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.16 131.4 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 127.167 2.187 . . . . 0.0 105.121 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 1.4 t -115.96 158.37 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 125.481 1.512 . . . . 0.0 106.939 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -154.37 143.26 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.87 2.068 . . . . 0.0 105.616 176.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.79 -98.37 0.13 Allowed Glycine 0 CA--C 1.508 -0.362 0 CA-C-O 116.475 -2.291 . . . . 0.0 108.701 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.7 154.71 49.62 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.962 1.881 . . . . 0.0 108.946 169.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.13 134.25 46.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -80.79 -70.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . 0.406 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 6.3 mtpp 172.86 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.059 3.343 . . . . 0.0 108.612 -167.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -83.81 57.66 5.04 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.887 -168.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.59 HD22 ' CG2' ' A' ' 43' ' ' ILE . 2.0 t-20 27.45 67.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.108 2.163 . . . . 0.0 113.269 -160.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.498 ' CE1' ' HG ' ' A' ' 94' ' ' SER . 10.9 t-160 -134.48 124.08 25.01 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -172.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 13.6 mm -93.47 129.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.54 107.23 11.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 160.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.36 141.93 41.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.134 0.968 . . . . 0.0 109.353 172.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 -15.68 14.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.867 2.067 . . . . 0.0 109.805 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.37 -49.44 0.27 Allowed 'General case' 0 C--N 1.349 0.552 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.8 t 62.88 135.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.115 2.566 . . . . 0.0 112.091 -175.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.7 mt -153.46 160.87 42.67 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -167.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.538 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -119.16 54.7 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 121.505 1.957 . . . . 0.0 112.625 -163.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt 34.27 32.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 126.296 1.839 . . . . 0.0 115.792 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . 0.613 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -89.16 56.95 3.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.19 2.596 . . . . 0.0 106.681 -169.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t0 47.94 41.0 14.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.414 1.486 . . . . 0.0 111.274 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.85 149.01 50.26 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -162.2 168.4 22.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.021 1.328 . . . . 0.0 108.039 171.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.75 117.32 0.73 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.136 1.374 . . . . 0.0 111.697 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 m -122.11 139.05 29.77 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.603 1.961 . . . . 0.0 106.214 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.66 -177.13 1.7 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.168 3.245 . . . . 0.0 112.484 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.22 -44.14 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.794 2.33 . . . . 0.0 115.174 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.43 70.23 5.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 122.813 1.292 . . . . 0.0 108.743 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.9 p -175.77 -37.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.725 2.81 . . . . 0.0 108.238 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -68.83 -78.77 0.06 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 108.874 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 75.55 1.16 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.24 -26.5 0.58 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.049 1.34 . . . . 0.0 110.248 166.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 C--O 1.255 1.374 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 157.029 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -148.24 158.24 43.97 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.951 1.7 . . . . 0.0 107.023 161.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 p -109.26 160.08 16.42 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 164.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -174.06 -69.18 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.9 157.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.14 149.29 5.39 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.269 1.827 . . . . 0.0 112.875 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.67 172.92 9.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 122.268 1.032 . . . . 0.0 109.381 159.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -169.76 149.66 3.83 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.822 2.849 . . . . 0.0 106.077 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 86.4 m-85 -138.42 179.45 6.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.217 1.807 . . . . 0.0 109.587 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.501 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 71.3 p -131.49 170.31 11.6 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.241 1.017 . . . . 0.0 110.775 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -62.66 65.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.895 3.73 . . . . 0.0 110.815 161.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 167.52 -62.88 0.2 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -158.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB2' ' H ' ' A' ' 39' ' ' THR . 28.4 mt-10 -65.66 -21.79 66.58 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.865 1.333 . . . . 0.0 111.9 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.32 -13.97 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 111.17 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 mt -115.41 -42.67 3.13 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.162 -0.961 . . . . 0.0 111.856 -164.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -107.71 -46.37 3.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 109.504 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.57 144.13 3.9 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 14.3 tptp -61.85 129.98 43.54 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -19.2 -64.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 127.312 2.245 . . . . 0.0 115.622 -138.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -80.08 -86.46 0.08 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 t -164.24 16.57 0.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.881 0.764 . . . . 0.0 112.898 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -53.18 61.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.778 -1.826 . . . . 0.0 112.356 -168.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -168.18 135.73 2.17 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.681 0.792 . . . . 0.0 109.128 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.1 mtp -74.53 161.84 76.25 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 162.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.66 162.63 40.74 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.307 1.145 . . . . 0.0 110.837 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.37 144.12 34.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.148 1.379 . . . . 0.0 108.197 166.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.67 0.85 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.879 1.323 . . . . 0.0 110.968 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.3 11.25 24.15 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 116.462 -2.299 . . . . 0.0 114.425 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -127.15 169.58 13.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.487 2.643 . . . . 0.0 111.715 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -82.97 150.35 26.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.383 162.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.402 HD12 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.12 -172.46 4.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.858 2.063 . . . . 0.0 108.749 171.614 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.05 48.87 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.517 1.127 . . . . 0.0 108.379 170.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.3 t -123.68 145.61 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.641 1.576 . . . . 0.0 107.439 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.18 124.23 5.67 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 165.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.7 164.09 33.94 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 117.693 0.746 . . . . 0.0 112.189 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 ttm -95.67 122.46 38.46 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.6 1.16 . . . . 0.0 110.286 -172.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.661 HG12 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -70.66 132.41 33.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.676 1.125 . . . . 0.0 110.131 -172.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.8 mtt -60.93 151.89 72.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.902 0.881 . . . . 0.0 110.995 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.98 106.54 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 124.186 3.258 . . . . 0.0 109.409 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.55 36.49 91.51 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.396 -1.224 . . . . 0.0 113.241 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.8 p -80.72 -15.75 55.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.334 1.567 . . . . 0.0 111.887 162.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -82.16 96.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.571 1.148 . . . . 0.0 110.057 -168.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 78.6 7.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.681 1.592 . . . . 0.0 107.44 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.65 138.64 50.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 160.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -72.11 116.75 51.9 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.83 -2.0 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.335 2.024 . . . . 0.0 113.574 -166.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -138.61 5.51 2.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.202 2.601 . . . . 0.0 112.021 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.3 t -120.57 -161.48 0.89 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.927 1.691 . . . . 0.0 108.901 165.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -124.74 -9.32 7.3 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.23 1.812 . . . . 0.0 110.537 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.1 129.2 33.78 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 164.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.421 ' C ' ' HG1' ' A' ' 81' ' ' THR . 3.2 p -142.52 143.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.421 ' HG1' ' C ' ' A' ' 80' ' ' VAL 0.301 35.8 m -140.99 133.57 28.61 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD1' ' CG2' ' A' ' 93' ' ' VAL . 50.5 p90 -143.33 173.61 11.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.685 -1.259 . . . . 0.0 111.031 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.5 m -128.37 136.89 51.55 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -124.46 146.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.888 2.075 . . . . 0.0 106.035 -176.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -134.44 176.94 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.828 1.251 . . . . 0.0 109.505 -176.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 88' ' ' GLU . 43.9 t0 -152.11 -168.71 3.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.967 1.307 . . . . 0.0 107.563 173.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 2.72 0.07 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.553 2.341 . . . . 0.0 113.722 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 86' ' ' ASP . 0.4 OUTLIER -126.7 -74.2 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.133 1.373 . . . . 0.0 107.76 -164.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.88 -157.44 7.29 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.369 -0.693 . . . . 0.0 111.369 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -138.57 161.18 37.74 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.202 1.001 . . . . 0.0 111.9 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.13 149.55 16.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -96.04 152.98 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.476 ' CG2' ' CD1' ' A' ' 82' ' ' PHE . 2.9 m -133.13 134.13 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -118.23 109.52 16.45 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.898 2.079 . . . . 0.0 107.355 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -115.49 171.2 7.87 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.997 1.719 . . . . 0.0 107.897 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.55 96.69 1.54 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.81 178.8 42.38 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 tp -79.6 125.48 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 34.0 mt -75.85 149.79 83.29 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.252 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.49 146.32 89.18 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.593 2.195 . . . . 0.0 108.647 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.12 -24.23 67.02 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.104 -0.997 . . . . 0.0 111.597 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -19.52 60.87 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.759 2.423 . . . . 0.0 111.973 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -68.37 123.83 21.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.333 1.053 . . . . 0.0 110.599 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -136.5 140.73 43.23 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -66.76 113.85 5.18 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.661 ' H ' HG12 ' A' ' 66' ' ' VAL . . . 109.75 21.95 6.89 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 116.741 -2.144 . . . . 0.0 113.436 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.81 165.12 25.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.161 1.98 . . . . 0.0 111.308 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.53 1.55 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.518 1.532 . . . . 0.0 110.739 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.49 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 108.877 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.36 139.32 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.5 t -120.26 157.44 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.868 2.067 . . . . 0.0 107.505 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.98 146.51 25.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.893 2.477 . . . . 0.0 107.366 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 145.26 -131.44 4.23 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 104.447 -3.461 . . . . 0.0 104.447 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -140.84 158.33 44.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.096 1.948 . . . . 0.0 110.841 -157.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.402 ' HB2' HD12 ' A' ' 60' ' ' LEU . 15.9 tp -90.75 128.78 36.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.771 0.828 . . . . 0.0 110.259 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.53 -66.75 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 109.85 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.14 158.99 17.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 128.859 2.864 . . . . 0.0 106.42 171.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.11 -99.21 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 124.34 0.971 . . . . 0.0 111.132 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.4 23.07 3.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.682 1.193 . . . . 0.0 110.815 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -92.03 128.03 37.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.2 mm -101.51 130.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 125.343 1.457 . . . . 0.0 109.722 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.18 119.88 22.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 155.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.59 132.86 33.92 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.933 1.293 . . . . 0.0 108.789 171.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.27 -25.36 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.831 1.653 . . . . 0.0 111.693 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.67 -41.75 0.32 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 20.0 t 62.98 139.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 124.654 2.168 . . . . 0.0 112.432 -172.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -140.32 157.53 45.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.719 2.008 . . . . 0.0 106.181 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.33 42.06 3.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 109.334 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? 51.34 33.65 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.75 2.42 . . . . 0.0 114.531 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -84.29 65.1 8.67 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.274 1.03 . . . . 0.0 108.676 177.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.6 t0 47.86 38.93 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.622 1.969 . . . . 0.0 113.221 161.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.36 130.29 42.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.18 136.71 48.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.3 t80 54.66 98.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.647 1.579 . . . . 0.0 114.796 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 m -85.77 118.24 70.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 161.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.37 -176.56 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.1 2.533 . . . . 0.0 110.256 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -77.92 -179.57 5.57 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.106 1.871 . . . . 0.0 109.225 153.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 65.46 36.53 6.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.11 2.164 . . . . 0.0 111.16 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.88 -40.74 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.892 0.877 . . . . 0.0 111.809 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.26 -70.98 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.392 1.477 . . . . 0.0 110.507 -166.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -140.35 6.9 2.14 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.986 1.714 . . . . 0.0 110.48 -176.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.75 85.36 2.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 167.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.452 0 C-N-CA 131.6 3.96 . . . . 0.0 106.795 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 60' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.24 156.25 14.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' C ' HG23 ' A' ' 62' ' ' VAL . 87.9 m-85 -137.85 -167.26 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.948 0.795 . . . . 0.0 109.291 170.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -140.93 170.94 8.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 125.796 1.638 . . . . 0.0 109.361 168.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -64.63 -4.13 7.88 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.166 2.577 . . . . 0.0 115.581 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.05 -46.31 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 161.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 39' ' ' THR . 50.9 mt-10 -76.83 -20.27 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.499 -1.589 . . . . 0.0 113.331 -160.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 121' ' ' ILE . 3.7 mt -73.04 -13.47 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.575 -0.703 . . . . 0.0 111.462 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -118.27 -47.39 2.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.66 0.784 . . . . 0.0 109.446 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -90.08 -36.85 14.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.12 0.968 . . . . 0.0 111.07 -168.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.77 4.22 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.801 1.667 . . . . 0.0 111.014 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 CA--C 1.514 -0.408 0 O-C-N 120.0 -1.882 . . . . 0.0 111.43 178.001 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 24.3 mtp . . . . . 0 C--O 1.24 0.586 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.14 165.62 27.83 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.789 1.659 . . . . 0.0 111.493 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.3 136.05 36.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 127.099 2.16 . . . . 0.0 109.358 172.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HA ' ' HB3' ' A' ' 115' ' ' LEU . 10.0 t -64.17 -14.36 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.073 164.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.93 4.18 71.34 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 116.06 -2.522 . . . . 0.0 114.901 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -117.82 168.41 10.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 123.15 3.475 . . . . 0.0 112.645 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 147.32 22.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 164.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -158.09 176.19 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 128.288 2.635 . . . . 0.0 110.06 -173.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -131.26 142.47 50.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.91 2.084 . . . . 0.0 109.073 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 38' ' ' TYR . 3.2 p -152.52 124.19 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -76.63 150.83 38.71 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 169.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 166.86 37.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.081 1.801 . . . . 0.0 110.285 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttm -95.38 125.32 39.92 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.124 1.37 . . . . 0.0 108.665 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.69 124.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 119.498 1.045 . . . . 0.0 108.494 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.9 mtt -60.06 139.51 90.96 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.381 0.992 . . . . 0.0 110.667 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.6 146.03 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.751 2.968 . . . . 0.0 109.562 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.39 -22.93 0.49 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.328 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -61.13 -38.65 87.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.812 1.806 . . . . 0.0 112.106 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.73 94.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.661 1.584 . . . . 0.0 109.301 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -84.2 144.08 29.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 158.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.832 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.235 0.335 0 N-CA-C 111.328 0.121 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -54.61 143.53 24.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 123.787 0.835 . . . . 0.0 108.817 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.24 155.63 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 125.155 1.382 . . . . 0.0 107.518 172.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.72 120.85 16.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 161.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -134.91 170.26 16.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.882 0.873 . . . . 0.0 110.71 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 m -117.83 145.8 44.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.92 139.47 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -135.11 175.6 9.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.557 1.543 . . . . 0.0 108.803 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -149.42 -169.83 3.48 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 6.65 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -68.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.873 1.669 . . . . 0.0 109.527 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -168.1 12.76 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.219 1.39 . . . . 0.0 110.401 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.6 p -142.95 160.83 39.6 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.664 0.732 . . . . 0.0 112.684 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.44 154.3 32.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.294 2.238 . . . . 0.0 108.159 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.17 158.73 15.47 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.8 t -138.63 119.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.404 1.482 . . . . 0.0 108.072 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 m -88.06 128.52 35.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 154.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -125.05 161.95 25.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 160.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.58 112.05 5.55 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.07 -159.86 28.28 Favored Glycine 0 CA--C 1.507 -0.453 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.882 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tp -80.57 111.01 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -170.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.64 148.24 48.46 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.205 -1.362 . . . . 0.0 107.832 -169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.96 131.93 49.25 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -17.31 63.34 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.201 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.49 -25.22 54.01 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.562 1.545 . . . . 0.0 113.796 168.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -51.91 121.87 7.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.385 1.448 . . . . 0.0 111.797 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -135.78 157.48 46.75 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.195 1.474 . . . . 0.0 112.256 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -71.62 95.96 1.51 Allowed 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 128.184 2.594 . . . . 0.0 107.622 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.65 33.81 4.02 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 113.326 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 164.03 17.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.125 1.963 . . . . 0.0 110.357 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.07 83.62 1.44 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.774 1.654 . . . . 0.0 109.401 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.6 -179.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.705 1.202 . . . . 0.0 109.014 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.1 t -126.89 135.75 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.314 2.246 . . . . 0.0 105.577 167.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 123' ' ' ALA . 0.6 OUTLIER -104.68 163.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.452 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -161.22 144.78 12.96 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.01 -133.06 3.88 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.97 153.31 51.86 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 120.056 1.928 . . . . 0.0 110.211 -159.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -73.98 131.48 41.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.62 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.65 -62.53 1.49 Allowed 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.119 0.568 . . . . 0.0 109.683 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 -72.34 0.17 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.87 -74.44 0.99 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.34 44.93 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 107.997 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -128.54 135.99 50.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 43' ' ' ILE . 4.2 mm -111.0 130.15 64.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 127.327 2.251 . . . . 0.0 109.148 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.27 90.43 4.95 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 156.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -53.8 150.2 7.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.925 0.869 . . . . 0.0 111.174 161.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -12.14 8.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.779 2.832 . . . . 0.0 111.514 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.05 -45.72 0.2 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.1 t 58.97 133.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.584 1.954 . . . . 0.0 111.456 -171.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.84 150.74 48.48 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 120.184 -1.572 . . . . 0.0 107.9 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.26 29.09 8.0 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.464 0.706 . . . . 0.0 111.798 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 124.865 1.266 . . . . 0.0 113.785 -174.599 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.7 pp . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 122.906 1.336 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.99 146.36 14.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 36' ' ' LEU . 70.7 m-85 -139.42 -176.49 4.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.055 0.942 . . . . 0.0 110.798 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -137.78 172.69 6.37 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 -9.78 17.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.766 2.311 . . . . 0.0 116.19 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.8 -40.87 3.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 121.001 1.728 . . . . 0.0 112.646 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.53 -15.51 56.51 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.316 1.558 . . . . 0.0 112.278 -158.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mt -82.4 -22.82 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.146 1.779 . . . . 0.0 110.896 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -56.87 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.864 1.211 . . . . 0.0 109.784 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -75.25 -64.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.328 1.851 . . . . 0.0 108.255 -171.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.36 151.92 6.37 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tttt . . . . . 0 C--O 1.224 -0.262 0 CA-C-N 117.223 0.511 . . . . 0.0 110.005 176.619 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.99 159.27 41.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.924 1.749 . . . . 0.0 111.52 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 155.33 28.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.15 2.18 . . . . 0.0 108.983 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.9 -8.44 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.824 1.25 . . . . 0.0 110.899 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.03 38.07 2.09 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 125.955 1.74 . . . . 0.0 109.654 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -121.87 164.79 16.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.663 0.744 . . . . 0.0 109.509 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.22 149.91 24.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.299 172.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -163.96 164.05 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.831 0.852 . . . . 0.0 111.774 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -122.23 99.84 6.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.736 2.414 . . . . 0.0 110.785 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -80.23 159.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.619 -1.301 . . . . 0.0 110.292 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 152.11 24.27 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.278 -0.889 . . . . 0.0 111.789 148.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.26 -178.52 45.18 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.998 1.761 . . . . 0.0 110.395 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.0 ttm -100.83 127.43 47.28 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 117.935 0.867 . . . . 0.0 111.579 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.73 125.88 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.2 mtt -57.04 151.1 36.25 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.484 0.584 . . . . 0.0 110.999 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.5 122.29 9.92 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.418 2.745 . . . . 0.0 108.077 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.7 4.85 48.61 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.872 -1.516 . . . . 0.0 115.538 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.9 p -64.68 -24.9 67.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.339 2.07 . . . . 0.0 110.962 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.68 105.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.588 1.555 . . . . 0.0 109.412 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 81' ' ' THR . 26.1 tt0 -60.22 -65.34 0.7 Allowed 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 126.606 1.963 . . . . 0.0 108.901 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 131.31 3.844 . . . . 0.0 115.759 -172.169 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.234 0.064 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.86 142.98 39.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 109.489 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.1 p -156.45 144.05 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 72' ' ' GLN . 30.0 p -121.81 151.3 40.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 165.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -146.4 178.09 8.53 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.786 0.834 . . . . 0.0 109.054 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -125.86 138.47 53.81 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.27 144.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.807 2.043 . . . . 0.0 106.694 176.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -140.45 171.05 14.68 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.091 1.357 . . . . 0.0 110.357 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.54 -164.6 2.04 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.961 1.304 . . . . 0.0 109.077 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.78 -4.37 6.49 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -112.84 -80.84 0.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -170.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.09 -156.11 6.88 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.575 1.083 . . . . 0.0 111.897 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.4 p -150.08 165.28 33.26 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 117.368 0.584 . . . . 0.0 111.688 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.49 138.31 44.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.041 1.736 . . . . 0.0 108.639 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 151.44 39.37 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.58 127.31 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.666 1.186 . . . . 0.0 109.772 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.538 ' OG ' HD13 ' A' ' 122' ' ' LEU . 2.1 p -97.47 135.53 39.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.015 1.326 . . . . 0.0 109.126 164.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 80' ' ' VAL . 32.1 t80 -142.09 169.65 17.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.928 1.691 . . . . 0.0 108.679 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -150.56 105.87 3.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.06 -165.32 36.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.724 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -19.47 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.881 0.472 . . . . 0.0 112.187 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 mt 67.13 151.87 0.12 Allowed Pre-proline 0 CA--C 1.527 0.088 0 C-N-CA 129.237 3.015 . . . . 0.0 112.177 -165.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -62.93 139.51 74.24 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.536 1.491 . . . . 0.0 108.25 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.78 -13.04 60.99 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.027 0.918 . . . . 0.0 110.333 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.31 -25.41 51.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 119.662 -1.899 . . . . 0.0 112.411 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.17 128.23 34.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.204 1.802 . . . . 0.0 112.238 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.07 170.29 16.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.954 1.301 . . . . 0.0 110.021 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.08 80.07 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.71 1.204 . . . . 0.0 108.866 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 32.1 0.47 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.449 1.023 . . . . 0.0 112.068 -170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.31 166.79 21.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.931 1.366 . . . . 0.0 110.869 171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.31 121.37 5.44 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.488 1.994 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.69 170.23 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.179 1.392 . . . . 0.0 108.541 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.77 100.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.636 1.974 . . . . 0.0 107.898 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -79.67 159.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -155.15 137.97 15.33 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.02 -105.77 0.23 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -150.51 157.91 43.55 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.459 1.63 . . . . 0.0 108.941 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' A' ' 60' ' ' LEU . 12.6 tp -80.55 146.4 31.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.318 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -103.44 -64.09 1.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.825 0.739 . . . . 0.0 111.05 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 167.05 158.41 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 129.699 3.199 . . . . 0.0 106.692 -168.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.54 22.53 46.06 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.945 -0.919 . . . . 0.0 114.036 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 73.52 29.32 1.6 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.386 1.875 . . . . 0.0 112.702 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -96.09 132.0 41.93 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.833 1.653 . . . . 0.0 109.018 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.7 mm -99.76 129.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 126.306 1.842 . . . . 0.0 109.599 172.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.538 HD13 ' OG ' ' A' ' 94' ' ' SER . 3.5 mm? -79.03 114.41 17.95 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 157.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.42 160.33 29.85 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.009 1.385 . . . . 0.0 109.357 162.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 -26.29 5.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.503 -1.681 . . . . 0.0 110.496 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -139.61 -41.48 0.45 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 111' ' ' VAL . 87.7 t 59.28 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.183 1.793 . . . . 0.0 111.878 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.72 157.97 45.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 120.648 -1.282 . . . . 0.0 108.052 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.58 37.35 4.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.954 1.302 . . . . 0.0 110.124 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.4 mmpm? . . . . . 0 C--N 1.341 0.207 0 C-N-CA 125.157 1.383 . . . . 0.0 112.512 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 60' ' ' LEU . 3.0 pp . . . . . 0 C--O 1.237 0.432 0 CA-C-O 121.038 0.447 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 40.4 t80 -171.19 158.29 5.42 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.591 3.156 . . . . 0.0 107.101 173.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.67 -178.9 6.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.629 1.972 . . . . 0.0 110.247 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 p -134.38 163.35 51.83 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 125.16 1.384 . . . . 0.0 111.682 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 91' ' ' VAL . 67.0 Cg_endo -76.07 71.63 5.59 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.602 3.534 . . . . 0.0 108.576 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.52 -66.78 0.15 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 105.44 -3.064 . . . . 0.0 105.44 -163.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.47 -33.5 71.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.131 1.465 . . . . 0.0 111.984 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.45 -11.71 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.354 1.061 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.65 -31.51 3.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.193 . . . . 0.0 111.646 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -98.09 -18.59 18.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.556 1.942 . . . . 0.0 112.218 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.7 147.69 16.99 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.869 1.223 . . . . 0.0 110.403 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 20.0 tptp . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 116.359 -1.781 . . . . 0.0 109.987 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.2 mtp . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.96 155.94 11.43 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.918 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.58 144.35 31.32 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.254 1.422 . . . . 0.0 111.523 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 115' ' ' LEU . 3.5 p -63.35 -20.82 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 113.001 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.41 59.85 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.88 176.61 9.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.041 1.42 . . . . 0.0 112.328 157.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.36 149.96 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.454 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -160.39 163.88 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.157 1.383 . . . . 0.0 113.262 166.556 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -101.53 140.77 35.38 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 126.549 1.94 . . . . 0.0 109.164 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -126.73 139.89 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.098 1.359 . . . . 0.0 108.251 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.44 137.25 12.01 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 163.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.64 -163.28 12.2 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.971 1.748 . . . . 0.0 109.364 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 ttm -126.71 127.53 45.26 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 126.525 1.93 . . . . 0.0 109.525 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 21.9 t -65.54 130.07 30.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.0 mtt -65.06 124.48 86.88 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.78 103.8 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.775 2.983 . . . . 0.0 106.649 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.49 -5.39 8.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-O 118.246 -1.308 . . . . 0.0 112.632 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.6 p -88.81 -44.19 10.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.467 1.634 . . . . 0.0 111.949 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.89 104.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.508 1.123 . . . . 0.0 110.951 -167.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.46 -66.22 0.58 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.773 1.629 . . . . 0.0 109.954 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 126.8 2.04 . . . . 0.0 112.048 -153.312 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 119.945 -0.074 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.58 145.14 55.93 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.233 -0.917 . . . . 0.0 108.974 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -157.81 132.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -130.98 109.45 10.53 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.768 1.627 . . . . 0.0 108.455 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.691 ' CE1' HG21 ' A' ' 93' ' ' VAL . 54.8 p90 -123.21 165.99 15.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.141 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 m -114.25 143.34 45.01 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 145.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.73 173.52 11.62 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.239 1.016 . . . . 0.0 109.591 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.14 -169.72 3.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.049 1.34 . . . . 0.0 107.47 164.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.84 -9.07 5.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.511 1.524 . . . . 0.0 114.015 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.12 -71.33 0.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.352 1.861 . . . . 0.0 107.002 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.07 -152.11 5.61 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.9 p -155.21 164.36 38.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.069 0.548 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 40' ' ' PRO . 31.1 m -147.38 154.87 11.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.894 1.678 . . . . 0.0 109.547 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.64 164.27 16.91 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.014 0.912 . . . . 0.0 110.307 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG21 ' CE1' ' A' ' 82' ' ' PHE . 1.3 m -132.7 156.46 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.103 1.361 . . . . 0.0 107.957 169.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.6 t -120.74 134.72 55.27 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 157.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 36.4 t80 -131.99 162.58 30.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.07 1.748 . . . . 0.0 107.403 168.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -141.13 103.61 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 168.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.53 163.88 26.25 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.2 tt -75.64 -22.1 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -164.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.501 ' CD2' HG11 ' A' ' 126' ' ' VAL . 55.6 mt 89.43 149.84 0.07 OUTLIER Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 131.377 3.871 . . . . 0.0 113.109 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -63.2 150.52 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 121.809 1.673 . . . . 0.0 109.576 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.29 -28.97 65.49 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.847 1.259 . . . . 0.0 109.74 163.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -79.16 -14.08 59.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 128.107 2.563 . . . . 0.0 114.098 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 109' ' ' VAL . 13.5 t80 -85.63 127.66 34.54 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 122.947 2.612 . . . . 0.0 106.877 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -134.54 162.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.254 1.026 . . . . 0.0 111.148 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.11 108.7 6.15 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.111 1.765 . . . . 0.0 108.273 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.478 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 96.99 37.86 4.53 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.103 0.858 . . . . 0.0 111.737 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -139.7 170.65 15.51 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.392 1.096 . . . . 0.0 111.646 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.17 136.95 40.33 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.111 0.862 . . . . 0.0 111.294 172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 103' ' ' PHE . 3.5 m -135.04 168.1 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.974 1.71 . . . . 0.0 107.15 170.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.46 107.65 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.52 157.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -150.28 139.09 20.83 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 128.014 2.526 . . . . 0.0 105.54 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.85 -118.21 0.81 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 104.343 -3.503 . . . . 0.0 104.343 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -141.17 156.97 45.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 119.717 1.759 . . . . 0.0 111.452 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.57 143.11 32.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -93.39 -72.34 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.295 1.038 . . . . 0.0 109.365 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.86 -86.07 0.17 Allowed 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.143 1.377 . . . . 0.0 109.134 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.87 -69.75 1.3 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -171.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -147.42 5.11 0.81 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -89.6 136.79 32.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 -167.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mm -107.96 127.23 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.742 1.217 . . . . 0.0 109.006 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.62 104.28 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 164.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.57 133.46 42.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.386 0.675 . . . . 0.0 109.301 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -21.82 15.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.574 1.55 . . . . 0.0 111.728 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -144.41 -38.31 0.29 Allowed 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 99' ' ' LEU . 78.3 t 58.1 106.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.368 1.867 . . . . 0.0 113.015 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -120.6 156.89 30.68 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 0.0 108.259 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -116.75 32.25 6.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.284 1.402 . . . . 0.0 112.483 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.038 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.1 pp . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.695 0.76 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -159.42 157.59 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.308 2.243 . . . . 0.0 106.492 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -143.36 177.86 8.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.997 1.719 . . . . 0.0 109.547 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 45.1 p -132.7 171.41 9.19 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 110.63 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.58 0.01 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.834 2.356 . . . . 0.0 114.803 162.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.84 25.33 7.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.718 1.151 . . . . 0.0 111.734 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' H ' ' A' ' 39' ' ' THR . 43.5 mt-10 -132.39 -41.17 0.98 Allowed 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.876 1.338 . . . . 0.0 110.69 173.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.16 -23.5 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 118.326 0.512 . . . . 0.0 110.944 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -105.38 -53.9 2.58 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.521 1.528 . . . . 0.0 107.603 176.514 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CE1' HD12 ' A' ' 44' ' ' LEU . 18.5 m-30 -88.38 14.8 8.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -166.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.62 124.7 3.25 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.9 tttm . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.908 174.717 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 83.4 mmm . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.03 148.27 62.94 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.284 1.323 . . . . 0.0 109.649 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.87 146.65 33.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 117' ' ' LYS . 75.2 t -76.48 1.52 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.02 1.328 . . . . 0.0 112.018 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.63 38.39 1.37 Allowed Glycine 0 CA--C 1.51 -0.261 0 O-C-N 118.544 -2.597 . . . . 0.0 110.287 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.77 168.35 9.54 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 164.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -79.89 152.38 29.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.69 168.39 27.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.552 1.141 . . . . 0.0 111.229 165.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -114.4 136.45 52.98 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.954 2.102 . . . . 0.0 107.725 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.01 151.91 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.73 2.012 . . . . 0.0 107.777 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.32 149.69 17.9 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.4 179.17 48.9 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.388 0.995 . . . . 0.0 110.85 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.2 ttm -91.08 126.12 36.07 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.805 1.642 . . . . 0.0 109.968 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.84 130.04 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 O-C-N 120.445 -1.41 . . . . 0.0 108.198 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.1 mtt -62.9 139.19 97.33 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 118.54 0.609 . . . . 0.0 111.637 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.83 146.8 60.85 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.395 2.73 . . . . 0.0 108.941 163.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.22 20.97 75.52 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.414 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.5 m -120.22 -26.18 5.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.704 1.252 . . . . 0.0 112.15 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.05 93.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 119.318 0.963 . . . . 0.0 108.91 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -73.25 -66.11 0.72 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.124 1.77 . . . . 0.0 109.317 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 128.563 2.745 . . . . 0.0 110.868 -176.272 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 119.16 -0.448 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -60.25 139.15 57.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.281 1.039 . . . . 0.0 108.249 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 158.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.097 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 140.63 52.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 151.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 43.8 p90 -140.94 -179.11 5.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.999 0.919 . . . . 0.0 109.296 160.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.9 m -130.85 151.27 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.32 129.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -116.58 -177.51 3.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.093 1.757 . . . . 0.0 107.42 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -155.13 -141.65 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 155.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -18.74 65.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 121.266 1.848 . . . . 0.0 114.663 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.69 -69.69 0.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -151.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.63 -153.47 5.9 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.2 p -147.27 163.53 36.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.282 1.041 . . . . 0.0 112.008 170.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.92 138.56 38.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.54 1.936 . . . . 0.0 109.504 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.65 150.78 37.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 84' ' ' ILE . 5.0 m -127.24 152.77 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 164.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 p -125.99 128.36 47.35 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -125.83 170.58 11.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.37 1.868 . . . . 0.0 108.011 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -158.76 107.5 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.5 14.98 0.02 OUTLIER Glycine 0 N--CA 1.473 1.145 0 C-N-CA 114.409 -3.758 . . . . 0.0 121.265 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 99' ' ' LEU 0.265 0.4 OUTLIER 58.01 143.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.957 2.103 . . . . 0.0 110.186 -152.222 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.571 ' CD2' HG11 ' A' ' 126' ' ' VAL . 20.8 mt -92.08 162.67 29.87 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.525 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -58.32 147.87 82.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 166.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -66.15 -18.14 65.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.771 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.44 -31.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.858 -1.544 . . . . 0.0 112.493 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.9 137.9 58.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.572 1.078 . . . . 0.0 109.164 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -142.54 168.96 18.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.1 132.83 53.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 159.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.69 15.54 56.47 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.7 163.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -121.23 163.68 18.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.42 1.11 . . . . 0.0 111.545 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.91 124.08 10.15 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.84 162.39 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.99 134.31 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 126' ' ' VAL . 1.1 t -107.79 160.51 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -158.64 151.07 21.74 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 166.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 122' ' ' LEU . . . 156.07 -145.34 12.09 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.97 157.88 35.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.734 1.267 . . . . 0.0 109.463 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HB2' HD11 ' A' ' 60' ' ' LEU . 16.7 tp -84.56 137.08 33.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.15 -65.91 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' HG13 ' A' ' 56' ' ' VAL . 45.3 mtmt -163.9 154.84 15.87 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 133.956 4.902 . . . . 0.0 104.725 175.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -98.44 0.22 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.16 1.82 2.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -70.78 124.64 24.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.956 1.253 . . . . 0.0 109.772 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.28 122.45 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.66 1.584 . . . . 0.0 110.531 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 3.6 mm? -78.92 81.67 5.18 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 165.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.63 133.5 30.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.041 1.336 . . . . 0.0 109.892 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 -25.25 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.611 1.564 . . . . 0.0 111.196 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.45 -37.39 0.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 99' ' ' LEU . 60.3 t 52.19 113.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 127.068 2.147 . . . . 0.0 115.523 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.47 154.32 47.1 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.519 -1.363 . . . . 0.0 108.889 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -118.16 37.11 4.1 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.253 1.842 . . . . 0.0 111.894 -166.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 127.851 2.46 . . . . 0.0 112.304 -173.846 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.28 0.562 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -150.54 139.46 20.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.219 -166.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -140.68 -174.74 4.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.595 1.958 . . . . 0.0 107.7 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 26.0 p -141.26 174.48 3.83 Favored Pre-proline 0 C--O 1.235 0.325 0 O-C-N 120.542 -1.349 . . . . 0.0 110.542 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 7.6 Cg_endo -57.69 0.88 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 171.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -108.22 -41.94 1.46 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 121.789 2.086 . . . . 0.0 112.904 163.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 5.8 pt-20 -80.44 -2.61 46.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 119.607 1.704 . . . . 0.0 113.249 -162.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.55 -18.11 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.135 0.974 . . . . 0.0 110.38 166.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.61 -47.68 5.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.79 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -87.51 -26.37 23.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.364 1.466 . . . . 0.0 110.907 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.9 146.17 9.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.664 1.602 . . . . 0.0 110.301 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 44.8 tttm . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 117.971 -1.014 . . . . 0.0 112.228 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.645 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.2 134.48 45.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.667 2.245 . . . . 0.0 109.371 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.29 130.7 35.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.664 ' HA ' HD23 ' A' ' 115' ' ' LEU . 14.8 p -70.22 -11.1 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.418 0.627 . . . . 0.0 112.192 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.27 3.73 61.93 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 116.885 -2.064 . . . . 0.0 113.009 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HG3' HD12 ' A' ' 60' ' ' LEU . 1.5 pt20 -110.01 167.2 10.35 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.893 2.347 . . . . 0.0 112.766 -168.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -85.29 137.54 32.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 108.669 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -157.99 173.37 16.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.217 1.007 . . . . 0.0 110.175 171.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -122.34 157.36 31.96 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 111.136 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -131.96 143.24 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.571 1.948 . . . . 0.0 107.326 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.19 127.51 5.91 Favored Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 168.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.51 -178.89 38.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.7 ttm -105.22 129.71 53.54 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.028 0.931 . . . . 0.0 110.277 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.99 129.01 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.289 0.95 . . . . 0.0 108.925 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' MET . . . . . 0.476 ' HG3' ' CD1' ' A' ' 85' ' ' TYR . 5.3 mtm -68.9 149.45 97.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.489 0.586 . . . . 0.0 110.967 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.31 137.97 24.18 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.355 2.703 . . . . 0.0 108.966 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.59 57.9 15.68 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -142.62 -30.58 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 164.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.706 HG22 ' HG2' ' A' ' 73' ' ' ARG 0.303 2.2 p -75.16 95.54 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 120.833 -1.167 . . . . 0.0 111.855 -173.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.05 28.56 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 131.469 3.908 . . . . 0.0 113.896 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.706 ' HG2' HG22 ' A' ' 71' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 124.41 1.084 . . . . 0.0 110.84 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 111.402 0.149 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 137.27 57.15 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 109.387 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -161.15 127.2 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.0 p -105.47 159.94 15.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 93' ' ' VAL . 53.3 p90 -153.82 -178.4 7.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.042 0.837 . . . . 0.0 110.059 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 m -129.92 142.4 50.66 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.467 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -126.7 136.78 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' HG3' ' A' ' 67' ' ' MET . 15.8 p90 -135.21 169.9 16.75 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.096 1.359 . . . . 0.0 109.559 -173.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.75 -166.76 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.339 1.855 . . . . 0.0 107.692 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -3.52 1.76 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.834 2.054 . . . . 0.0 114.972 -171.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -111.6 -62.28 1.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.819 1.248 . . . . 0.0 107.73 -173.454 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.26 -167.98 17.08 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.896 1.712 . . . . 0.0 112.005 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.9 p -137.51 164.04 29.69 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.92 0.888 . . . . 0.0 112.006 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.98 144.64 25.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.121 1.368 . . . . 0.0 109.501 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.97 152.52 30.98 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.209 1.004 . . . . 0.0 108.641 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.551 HG21 ' CE1' ' A' ' 82' ' ' PHE . 3.4 m -132.65 147.95 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.354 163.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -119.92 112.45 19.21 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.263 1.825 . . . . 0.0 108.557 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.592 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.4 t80 -112.88 166.51 11.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 108.32 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.13 97.89 1.96 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 168.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.65 -174.07 46.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.508 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.04 118.93 21.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.5 tp -97.14 135.3 21.99 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 109.113 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.45 156.9 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.154 1.903 . . . . 0.0 112.435 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.92 -40.8 75.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 123.098 1.428 . . . . 0.0 108.957 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.44 -27.02 68.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.766 1.626 . . . . 0.0 111.715 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.478 ' HE1' HG21 ' A' ' 71' ' ' VAL . 34.3 t80 -66.29 106.64 1.75 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 119.374 0.988 . . . . 0.0 108.867 -174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -133.16 158.84 41.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.21 1.004 . . . . 0.0 109.829 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.71 105.48 3.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.628 1.571 . . . . 0.0 107.462 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.05 26.19 7.57 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.384 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.21 163.87 17.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.663 1.731 . . . . 0.0 110.508 160.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.88 138.2 19.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.61 174.47 12.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.36 1.464 . . . . 0.0 107.237 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.15 137.43 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 121' ' ' ILE . 1.3 t -117.04 156.82 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.249 1.42 . . . . 0.0 107.508 165.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.21 141.88 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 127.072 2.149 . . . . 0.0 106.645 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.33 -103.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 166.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -142.89 161.35 38.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.983 1.892 . . . . 0.0 109.418 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 56' ' ' VAL . 13.4 tp -81.16 144.3 31.75 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -101.82 -72.53 0.68 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.319 0.509 . . . . 0.0 109.979 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -163.69 -83.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.147 2.179 . . . . 0.0 108.158 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.56 73.34 2.07 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.175 1.369 . . . . 0.0 111.555 -162.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.2 m120 44.49 46.39 8.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.304 1.841 . . . . 0.0 110.542 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -122.16 129.39 52.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.543 1.137 . . . . 0.0 108.395 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.4 HG21 HG12 ' A' ' 111' ' ' VAL . 16.5 mm -103.69 132.9 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.506 1.522 . . . . 0.0 109.487 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.17 114.37 18.06 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 159.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.009 170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 -35.83 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.76 2.874 . . . . 0.0 118.76 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.9 t 50.65 122.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.39 1.876 . . . . 0.0 115.337 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.79 156.02 49.59 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 119.893 -1.754 . . . . 0.0 108.308 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.83 30.06 7.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 112.268 -168.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 123.008 1.385 . . . . 0.0 112.178 -172.862 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.237 0.445 0 CA-C-O 122.275 1.036 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -161.84 150.69 15.6 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.418 1.887 . . . . 0.0 109.107 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.04 172.35 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.897 1.279 . . . . 0.0 111.549 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.4 p -135.59 158.72 73.71 Favored Pre-proline 0 C--O 1.243 0.762 0 C-N-CA 125.168 1.387 . . . . 0.0 111.591 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.76 78.58 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.975 3.784 . . . . 0.0 109.567 164.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.71 -63.16 0.22 Allowed Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 106.587 -2.605 . . . . 0.0 106.587 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.48 -21.47 66.34 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 122.149 -0.618 . . . . 0.0 110.39 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -77.45 -13.31 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.108 1.763 . . . . 0.0 110.683 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.11 -54.33 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.411 1.484 . . . . 0.0 107.499 -163.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -77.65 -78.87 0.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.962 2.505 . . . . 0.0 107.171 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.16 152.7 8.68 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.45 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptm . . . . . 0 N--CA 1.472 0.674 0 C-N-CA 125.291 1.436 . . . . 0.0 110.972 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.3 mtp . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.22 149.11 15.13 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.8 1.667 . . . . 0.0 109.285 168.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.01 148.65 31.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.19 -9.82 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.239 1.016 . . . . 0.0 111.149 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.44 61.59 0.43 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 168.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.64 174.41 14.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.799 1.3 . . . . 0.0 112.942 163.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -80.75 147.29 30.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.734 1.214 . . . . 0.0 108.88 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.1 165.23 24.89 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -97.46 144.58 27.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.002 2.921 . . . . 0.0 108.746 167.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.1 t -128.98 146.36 34.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.703 1.601 . . . . 0.0 108.167 167.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.41 139.07 10.63 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.33 -169.01 28.37 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 ttm -107.46 124.61 50.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.062 1.431 . . . . 0.0 109.682 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.737 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -55.24 130.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.4 ttm -63.0 124.52 84.06 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.89 134.44 46.61 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.831 2.354 . . . . 0.0 108.465 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.58 7.93 85.48 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.032 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.5 p -98.17 -32.73 11.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.755 1.777 . . . . 0.0 113.71 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 p -77.2 123.37 33.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 118.889 0.768 . . . . 0.0 110.166 -167.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -95.41 127.2 41.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 152.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 161.147 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.487 HD23 ' HG2' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.685 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 144.78 46.53 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.745 1.611 . . . . 0.0 109.226 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 99' ' ' LEU . 1.6 p -155.85 136.39 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 6.6 p -118.37 152.47 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 167.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 26.0 p90 -153.02 -178.57 7.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.842 0.746 . . . . 0.0 109.796 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m -124.04 154.61 39.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -135.27 134.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -121.98 178.33 4.94 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.38 -148.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.35 61.66 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.764 -1.21 . . . . 0.0 113.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.3 -64.17 1.3 Allowed 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.475 1.11 . . . . 0.0 109.085 -162.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.81 -157.44 7.58 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.7 p -145.22 162.54 36.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.286 0.543 . . . . 0.0 112.265 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.65 154.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.166 2.186 . . . . 0.0 108.826 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 155.56 16.91 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.03 1.332 . . . . 0.0 109.481 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 14.5 t -139.23 128.66 30.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 123.574 0.75 . . . . 0.0 109.082 175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -110.85 117.23 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.066 1.347 . . . . 0.0 107.451 162.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 19.5 t80 -121.37 159.64 25.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.618 1.567 . . . . 0.0 107.071 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 78' ' ' LEU . 15.4 tt0 -146.68 90.12 1.9 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.51 -171.85 44.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.872 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.91 115.77 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.675 HD22 HG21 ' A' ' 80' ' ' VAL . 15.1 tp -89.34 131.85 39.21 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.5 138.06 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.442 -1.407 . . . . 0.0 108.442 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.92 -20.81 65.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.06 0.933 . . . . 0.0 109.396 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.2 -21.71 63.94 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.304 1.442 . . . . 0.0 110.439 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -71.0 134.98 47.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.895 1.278 . . . . 0.0 109.252 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.407 ' O ' HG11 ' A' ' 66' ' ' VAL . 12.2 mmt180 -138.35 -177.04 4.67 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.95 127.63 52.87 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.737 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 80.71 31.67 35.64 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 118.077 -1.402 . . . . 0.0 110.992 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.14 168.08 10.89 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.042 1.421 . . . . 0.0 110.368 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.01 133.44 18.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.04 165.78 29.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.269 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 129' ' ' LYS . 3.1 t -124.81 117.21 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 166.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -92.06 159.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.189 0.995 . . . . 0.0 108.65 162.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -154.04 146.6 24.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.889 1.676 . . . . 0.0 107.195 162.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.03 -104.26 0.2 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 161.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.64 154.04 46.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 119.219 1.51 . . . . 0.0 109.623 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 144.52 39.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -104.3 -83.75 0.49 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.782 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 -82.15 0.11 Allowed 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.544 1.066 . . . . 0.0 111.13 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.53 73.4 2.22 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -169.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m120 51.96 56.41 7.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.836 1.254 . . . . 0.0 109.205 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -135.3 123.7 23.32 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.2 130.76 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.127 1.371 . . . . 0.0 107.745 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.38 110.13 13.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 157.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -73.45 154.36 39.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 122.076 0.941 . . . . 0.0 109.822 168.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -17.96 7.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.425 1.89 . . . . 0.0 111.997 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -143.18 -43.27 0.29 Allowed 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.49 HG11 HD11 ' A' ' 99' ' ' LEU . 99.8 t 54.13 121.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 123.686 1.708 . . . . 0.0 113.638 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 mt -130.58 155.37 46.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.796 1.238 . . . . 0.0 108.094 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.9 39.9 3.26 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.312 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.696 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 126.595 1.958 . . . . 0.0 113.356 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 123.5 1.619 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -166.26 153.62 9.84 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.195 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CE1' ' HD2' ' A' ' 47' ' ' LYS . 97.6 m-85 -144.91 -179.9 6.91 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.715 1.606 . . . . 0.0 108.73 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.624 ' HA ' HG23 ' A' ' 62' ' ' VAL . 12.1 p -139.38 177.09 2.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.64 -13.53 22.26 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 CA-C-N 120.661 1.272 . . . . 0.0 111.567 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.87 -45.59 5.66 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 165.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 39' ' ' THR . 45.4 mt-10 -63.83 -30.78 71.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.029 1.414 . . . . 0.0 111.177 -167.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.01 -21.43 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.43 1.013 . . . . 0.0 111.238 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.94 -44.98 4.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.562 1.074 . . . . 0.0 111.433 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -98.12 -9.94 25.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.5 1.92 . . . . 0.0 113.23 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.9 133.9 5.18 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 26.5 tttm . . . . . 0 N--CA 1.449 -0.517 0 O-C-N 121.299 -1.118 . . . . 0.0 109.161 160.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.1 mtp . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 172.15 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.261 1.486 . . . . 0.0 110.85 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -89.17 139.49 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.011 1.324 . . . . 0.0 107.684 163.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.9 0.59 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.824 1.249 . . . . 0.0 110.275 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.48 56.96 0.72 Allowed Glycine 0 N--CA 1.451 -0.305 0 O-C-N 120.196 -1.565 . . . . 0.0 111.847 164.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -141.36 -175.47 4.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.162 0.981 . . . . 0.0 111.314 166.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.88 141.03 36.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.117 0.967 . . . . 0.0 110.376 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -179.62 8.02 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.408 1.483 . . . . 0.0 111.082 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -122.65 151.53 41.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.071 2.148 . . . . 0.0 110.751 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -148.98 128.55 3.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 120.261 3.43 . . . . 0.0 120.261 169.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.85 141.51 18.66 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.405 1.002 . . . . 0.0 110.82 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.34 177.67 47.82 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 119.427 -0.652 . . . . 0.0 113.153 166.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 35.2 ttm -102.36 129.74 48.91 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.481 1.112 . . . . 0.0 110.152 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.9 132.14 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.358 1.063 . . . . 0.0 109.643 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtt -62.47 132.61 94.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.292 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.15 131.3 29.97 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.901 1.734 . . . . 0.0 108.714 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.17 72.73 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.702 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -86.14 -74.39 0.42 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 159.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.282 2.6 p -37.66 88.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 130.616 3.566 . . . . 0.0 114.816 -170.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -77.6 137.84 38.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 127.467 2.307 . . . . 0.0 105.553 163.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 149.16 18.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.276 1.83 . . . . 0.0 109.69 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.6 148.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 166.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 p -131.94 119.8 21.61 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.27 168.04 20.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.233 0.613 . . . . 0.0 109.603 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -122.99 147.31 46.78 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.91 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.09 174.34 10.61 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.298 1.039 . . . . 0.0 110.27 -170.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.11 -168.9 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.174 2.189 . . . . 0.0 106.266 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.03 -4.35 16.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.9 -66.77 0.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.45 -163.47 11.99 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.371 1.462 . . . . 0.0 110.681 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.9 p -150.94 158.71 44.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.013 0.906 . . . . 0.0 111.251 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.66 150.23 20.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 108.721 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 157.57 23.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' CG2' HD11 ' A' ' 84' ' ' ILE . 98.4 t -133.1 120.8 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 168.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 m -91.56 121.79 33.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 152.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.11 171.44 7.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 164.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -162.15 99.06 1.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.82 -144.71 9.11 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.214 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.82 91.8 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.47 130.03 87.36 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.901 -1.499 . . . . 0.0 107.868 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -54.84 138.31 76.92 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.031 1.82 . . . . 0.0 109.359 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -56.78 -31.84 65.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.672 0.749 . . . . 0.0 111.197 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.32 -22.32 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 114.63 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.98 131.79 44.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.927 1.24 . . . . 0.0 108.835 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -140.96 170.29 16.02 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.014 -1.054 . . . . 0.0 109.468 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -73.41 123.16 23.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.49 26.55 25.01 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 123.381 0.515 . . . . 0.0 113.269 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.47 171.69 10.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.555 1.142 . . . . 0.0 109.684 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.74 128.02 9.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.999 1.762 . . . . 0.0 109.054 -173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.35 175.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.05 139.57 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.622 1.969 . . . . 0.0 106.668 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG12 HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -113.37 164.84 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -160.4 143.0 13.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.527 1.931 . . . . 0.0 107.627 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.59 -124.1 1.67 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 105.098 -3.201 . . . . 0.0 105.098 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -128.9 156.91 42.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 120.127 1.963 . . . . 0.0 109.192 -161.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.73 137.73 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.843 0.857 . . . . 0.0 109.482 171.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -84.0 0.42 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.995 0.816 . . . . 0.0 109.063 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.91 167.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.714 3.206 . . . . 0.0 106.299 -172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.24 50.14 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.96 -0.911 . . . . 0.0 113.151 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 m120 62.66 58.19 1.66 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 0.0 111.087 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -131.32 127.49 37.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.44 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.5 mm -102.63 125.92 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 126.675 1.99 . . . . 0.0 109.037 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.52 83.97 5.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.47 148.2 9.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.112 0.958 . . . . 0.0 112.25 165.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -18.76 8.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 128.384 2.674 . . . . 0.0 110.912 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.33 -51.64 0.48 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.8 t 60.69 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.097 2.159 . . . . 0.0 112.394 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.97 146.49 47.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.746 -1.221 . . . . 0.0 107.897 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.41 34.66 3.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.854 0.862 . . . . 0.0 110.563 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 125.704 1.602 . . . . 0.0 114.708 174.603 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.8 pp . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -174.53 135.39 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.11 2.164 . . . . 0.0 106.074 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.09 176.71 6.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.509 1.524 . . . . 0.0 109.202 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 61.5 p -136.24 173.85 5.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.645 1.578 . . . . 0.0 108.545 173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 73.4 Cg_endo -75.74 -13.36 19.95 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.685 1.59 . . . . 0.0 112.205 -166.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.25 -45.75 7.33 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 162.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 39' ' ' THR . 30.3 mt-10 -60.17 -29.17 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.334 2.067 . . . . 0.0 113.036 -168.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mt -73.34 -22.26 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.475 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -35.51 3.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.478 -169.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.86 -31.27 18.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.482 2.313 . . . . 0.0 110.518 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.64 149.46 7.47 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.251 1.405 . . . . 0.0 111.869 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 tttm . . . . . 0 CA--C 1.51 -0.572 0 O-C-N 122.013 -0.698 . . . . 0.0 110.826 -179.449 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 40.9 mtp . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 158.01 59.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 CA-C-N 121.432 1.547 . . . . 0.0 110.085 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.43 144.9 33.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 165.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' HD13 ' A' ' 115' ' ' LEU . 7.1 p -82.9 -7.25 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.625 0.77 . . . . 0.0 111.582 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.55 43.18 1.72 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.748 1.166 . . . . 0.0 110.512 165.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.5 pt20 -141.52 169.32 17.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.127 1.964 . . . . 0.0 113.047 172.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -87.92 140.58 29.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.041 2.537 . . . . 0.0 108.609 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -155.12 -174.59 5.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.495 0.718 . . . . 0.0 110.621 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -134.38 147.21 50.46 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.148 1.779 . . . . 0.0 107.485 169.629 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.28 130.48 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.177 1.791 . . . . 0.0 106.532 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.65 157.01 20.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 163.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.68 41.62 Favored Glycine 0 C--O 1.236 0.26 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.2 ttm -99.01 125.31 44.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.37 121.12 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 3.7 ttm -64.16 126.84 91.11 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.93 154.43 73.21 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.28 1.987 . . . . 0.0 108.368 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.76 44.55 80.57 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.778 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -133.12 -38.43 0.96 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.895 1.348 . . . . 0.0 113.225 169.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.269 1.6 p -64.57 92.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.567 1.076 . . . . 0.0 112.059 -172.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 5.9 pt20 -82.07 86.46 6.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.892 2.477 . . . . 0.0 107.703 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.99 131.03 46.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 164.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.25 130.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.417 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 92.0 m -126.46 134.45 50.96 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.35 176.38 10.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.231 -1.543 . . . . 0.0 110.352 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 m -123.18 145.78 48.34 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.68 142.24 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.285 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -137.99 171.99 13.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.635 1.174 . . . . 0.0 109.516 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.09 -169.07 3.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.299 1.439 . . . . 0.0 107.383 168.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 9.99 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.582 1.553 . . . . 0.0 114.412 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.47 -67.11 0.78 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.003 1.321 . . . . 0.0 109.504 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.32 -175.47 13.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.1 p -143.51 158.08 43.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.297 1.039 . . . . 0.0 109.973 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.9 m -141.37 149.01 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.627 1.171 . . . . 0.0 109.707 -171.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.13 148.0 26.35 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.99 1.316 . . . . 0.0 107.883 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 84' ' ' ILE . 23.5 t -138.01 119.09 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.104 0.961 . . . . 0.0 108.779 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 t -91.94 129.65 37.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 159.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -124.23 163.78 20.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.653 1.181 . . . . 0.0 108.747 166.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -144.87 100.17 3.45 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.88 -179.4 43.58 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -71.36 -24.38 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 122.064 -0.668 . . . . 0.0 111.84 -159.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 99' ' ' LEU . 7.8 tp 65.36 129.24 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.727 0 C-N-CA 128.803 2.841 . . . . 0.0 110.623 -166.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 4.5 Cg_exo -66.03 169.04 14.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.255 3.303 . . . . 0.0 110.689 -168.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.49 -36.07 77.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.982 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -35.34 63.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.568 2.747 . . . . 0.0 113.025 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -63.76 131.88 49.23 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.466 1.03 . . . . 0.0 109.092 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -143.14 161.0 39.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.882 0.873 . . . . 0.0 111.313 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -64.06 117.39 7.01 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.86 4.95 16.17 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.958 -0.912 . . . . 0.0 114.938 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.7 167.04 20.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.925 1.363 . . . . 0.0 112.151 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.05 137.28 15.34 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 125.737 1.637 . . . . 0.0 109.977 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.82 168.61 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.95 108.91 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 127.652 2.381 . . . . 0.0 106.541 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 126' ' ' VAL . 2.8 t -80.26 158.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 124.717 1.207 . . . . 0.0 108.986 161.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 5.6 tt0 -156.67 147.15 21.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 129.439 3.096 . . . . 0.0 105.716 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.84 -112.39 0.52 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -147.63 159.34 43.88 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 119.734 1.767 . . . . 0.0 110.41 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -86.02 142.61 28.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.117 0.967 . . . . 0.0 108.589 172.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 -84.25 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.55 1.14 . . . . 0.0 108.185 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -166.92 154.53 9.32 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 128.94 2.896 . . . . 0.0 106.709 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.6 42.91 99.85 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.16 40.88 30.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 111.929 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -109.82 124.36 51.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.476 HG21 ' CG1' ' A' ' 111' ' ' VAL . 18.1 mm -96.28 131.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.711 1.204 . . . . 0.0 108.649 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.88 114.21 17.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 154.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 149.22 39.94 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.874 0.845 . . . . 0.0 108.849 161.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -21.85 11.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.606 1.163 . . . . 0.0 111.173 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -146.17 -47.13 0.2 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.242 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 111' ' ' VAL . 46.0 t 59.24 150.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.243 1.817 . . . . 0.0 109.371 -167.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.0 mt -147.89 151.59 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 119.192 -2.193 . . . . 0.0 107.045 172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.14 33.88 3.76 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.681 1.128 . . . . 0.0 112.674 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.44 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -170.32 154.77 4.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.179 0.991 . . . . 0.0 109.908 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' C ' HG23 ' A' ' 62' ' ' VAL . 99.3 m-85 -133.27 -170.11 2.41 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.553 1.07 . . . . 0.0 110.302 170.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 40' ' ' PRO . 39.9 p -141.99 170.99 7.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 158.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' O ' HD21 ' A' ' 44' ' ' LEU . 48.5 Cg_endo -81.22 -1.43 11.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.511 1.474 . . . . 0.0 112.439 -159.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -103.86 -7.58 41.28 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.673 1.606 . . . . 0.0 110.578 165.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.97 18.0 22.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.436 -1.626 . . . . 0.0 110.066 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 121' ' ' ILE . 7.3 mt -109.12 -23.15 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.869 HD22 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.35 -50.68 4.91 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 126.629 1.972 . . . . 0.0 111.036 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.95 -63.9 1.12 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.03 175.73 39.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 116.9 -1.524 . . . . 0.0 108.311 159.797 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 mtp . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.41 147.21 87.01 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.53 1.487 . . . . 0.0 109.633 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.36 147.48 32.39 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.54 -8.47 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.369 1.468 . . . . 0.0 111.232 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.1 40.72 1.82 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 125.217 1.389 . . . . 0.0 110.504 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -134.96 170.55 15.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.341 1.57 . . . . 0.0 111.837 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -88.54 151.81 22.27 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.88 176.75 12.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.291 1.036 . . . . 0.0 112.376 172.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.416 HH21 ' CD1' ' A' ' 127' ' ' LEU . 50.8 ttt180 -124.48 148.53 47.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.146 2.578 . . . . 0.0 107.049 172.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 111' ' ' VAL . 6.0 p -147.56 167.27 5.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 119.975 1.261 . . . . 0.0 111.353 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -142.2 155.25 25.49 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 119.981 1.264 . . . . 0.0 111.677 169.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.84 -175.93 47.01 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.563 1.077 . . . . 0.0 113.28 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.5 ttm -103.21 123.78 47.37 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.484 1.514 . . . . 0.0 110.673 -170.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 69.9 t -71.7 129.58 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.885 -1.134 . . . . 0.0 109.848 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 49.5 mtt -63.75 152.22 87.0 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 118.62 0.645 . . . . 0.0 112.085 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.99 141.32 68.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.251 2.634 . . . . 0.0 110.745 170.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.75 3.85 1.27 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.369 1.461 . . . . 0.0 115.649 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.7 p -73.24 -26.21 61.03 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.743 1.771 . . . . 0.0 112.121 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.39 103.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.897 1.279 . . . . 0.0 109.909 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -86.78 30.32 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.669 2.787 . . . . 0.0 111.219 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? . . . . . 0 CA--C 1.511 -0.547 0 C-N-CA 123.458 0.703 . . . . 0.0 109.192 170.19 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -60.57 136.14 57.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.7 p -156.66 134.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' SER . 43.3 p -124.9 162.15 25.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 93' ' ' VAL . 27.6 p90 -152.13 179.32 8.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.741 1.155 . . . . 0.0 109.349 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -115.71 145.88 42.37 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 139.1 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.05 170.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.116 1.766 . . . . 0.0 109.636 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -161.3 -154.12 0.34 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.558 1.543 . . . . 0.0 106.879 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 -22.38 62.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.814 -1.179 . . . . 0.0 112.872 -164.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -76.12 0.53 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.88 -166.98 12.66 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.46 -0.775 . . . . 0.0 112.229 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.3 p -140.78 160.64 39.61 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 112.023 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.14 153.97 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.036 1.334 . . . . 0.0 109.646 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.15 150.56 37.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.51 165.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -118.0 160.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 156.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.9 m -129.62 127.44 40.63 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 159.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.521 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.2 t80 -127.41 168.62 14.6 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.633 1.573 . . . . 0.0 108.505 174.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.96 92.13 1.16 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.0 -176.38 45.09 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.418 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.02 113.35 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 80' ' ' VAL . 9.7 tp -77.24 143.39 69.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -58.46 146.31 90.92 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.113 1.209 . . . . 0.0 109.065 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.45 -30.82 71.89 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.46 -36.97 85.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.705 2.002 . . . . 0.0 110.978 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 43.2 t80 -56.23 133.0 52.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.002 1.721 . . . . 0.0 109.039 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.83 167.13 21.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.319 0.963 . . . . 0.0 112.312 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -74.72 112.9 11.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.74 49.13 5.85 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 112.181 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 128' ' ' ALA . 3.8 pt20 -119.63 -170.29 1.92 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.386 -1.067 . . . . 0.0 109.542 145.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.87 140.68 14.95 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.66 178.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.764 1.625 . . . . 0.0 107.922 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.2 t -131.65 142.18 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.688 ' CG1' HG21 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -107.65 163.98 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.868 0.842 . . . . 0.0 109.55 162.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -157.48 144.27 18.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 106.609 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.93 -109.02 0.38 Allowed Glycine 0 CA--C 1.518 0.253 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.2 mt-10 -140.91 162.93 34.3 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 120.165 1.983 . . . . 0.0 109.541 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 60' ' ' LEU . 12.5 tp -89.24 140.26 29.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.566 0.746 . . . . 0.0 110.154 171.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 -77.95 0.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.82 166.47 3.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.287 3.835 . . . . 0.0 105.13 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.9 42.04 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 120.198 1.363 . . . . 0.0 113.653 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 70.71 4.96 5.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.841 2.057 . . . . 0.0 114.263 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -71.35 139.31 49.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.042 2.137 . . . . 0.0 109.691 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.688 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.1 mm -106.29 133.89 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 126.765 2.026 . . . . 0.0 110.164 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 122' ' ' LEU . 4.2 mm? -78.84 106.94 11.2 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 154.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.65 58.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.513 0.673 . . . . 0.0 110.22 153.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 -11.61 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.615 2.366 . . . . 0.0 110.974 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -147.82 -46.23 0.16 Allowed 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.8 t 57.17 141.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.876 1.67 . . . . 0.0 111.601 -165.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.416 ' CD1' HH21 ' A' ' 61' ' ' ARG . 53.9 mt -139.38 162.59 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -125.53 29.27 6.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.384 1.074 . . . . 0.0 112.226 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 115.137 173.611 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 122.836 1.303 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -173.13 136.77 0.66 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.768 2.427 . . . . 0.0 106.311 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.535 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 79.3 m-85 -131.6 -175.11 3.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.033 1.733 . . . . 0.0 109.545 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.458 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 72.5 p -142.1 169.07 11.8 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 112.78 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.77 71.54 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.569 2.846 . . . . 0.0 110.747 157.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.21 -56.17 0.19 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 127.899 2.666 . . . . 0.0 106.976 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HB2' ' H ' ' A' ' 39' ' ' THR . 32.3 mt-10 -68.24 -9.36 46.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.422 HG22 ' OD1' ' A' ' 119' ' ' ASN . 5.1 mt -104.84 -22.35 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.118 1.367 . . . . 0.0 108.327 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.42 -48.38 5.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.731 2.412 . . . . 0.0 111.711 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.93 -64.51 1.07 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.684 1.994 . . . . 0.0 107.081 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.59 164.5 18.85 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.663 1.602 . . . . 0.0 109.226 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 1.2 tptt . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 126.673 1.989 . . . . 0.0 111.229 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.796 0.332 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.3 155.73 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.44 2.093 . . . . 0.0 109.747 150.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.88 143.97 30.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 159.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.2 p -73.57 -15.58 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.053 0.541 . . . . 0.0 111.369 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.04 37.38 3.74 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.384 -1.787 . . . . 0.0 111.741 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -137.1 174.06 11.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.654 2.227 . . . . 0.0 112.399 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -106.89 138.86 42.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.409 1.484 . . . . 0.0 110.226 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.06 167.5 30.26 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.797 1.239 . . . . 0.0 112.034 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -99.52 150.43 22.22 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.1 1.76 . . . . 0.0 109.779 165.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.73 154.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.841 2.056 . . . . 0.0 106.925 168.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.63 152.97 21.44 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 155.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.24 179.51 48.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttm -101.51 130.04 47.71 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.835 0.854 . . . . 0.0 109.545 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 93.7 t -69.04 125.28 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.782 1.173 . . . . 0.0 108.266 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.5 mtt -57.44 139.18 80.87 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 119.006 0.821 . . . . 0.0 110.25 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.89 124.69 10.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.302 2.668 . . . . 0.0 107.522 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.6 65.37 3.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.9 p -135.41 -35.01 0.83 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.45 0.625 . . . . 0.0 111.952 167.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.34 107.34 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -174.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -91.77 59.84 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 131.623 3.969 . . . . 0.0 108.697 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 1.7 ptt85 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 120.708 -1.245 . . . . 0.0 110.472 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -53.86 126.66 23.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.892 1.277 . . . . 0.0 107.938 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 95' ' ' TYR . 1.5 p -132.28 146.72 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -134.47 123.61 24.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 93' ' ' VAL . 48.1 p90 -131.51 173.51 11.03 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 120.899 1.681 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -127.78 141.55 51.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.28 139.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.962 1.705 . . . . 0.0 106.618 -178.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -138.88 172.22 13.17 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.597 1.159 . . . . 0.0 111.321 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -157.0 -165.9 1.95 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.15 1.78 . . . . 0.0 109.405 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -12.67 60.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.201 1.4 . . . . 0.0 113.561 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.16 -67.09 0.87 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -172.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.52 -152.41 5.66 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -140.25 167.18 22.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.611 0.764 . . . . 0.0 110.31 167.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.83 142.76 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.8 152.55 22.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.063 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 82' ' ' PHE . 2.7 m -138.47 137.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 110.992 171.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -100.28 136.87 39.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 164.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 80' ' ' VAL . 31.2 t80 -142.05 164.31 30.53 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.458 1.503 . . . . 0.0 107.167 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.62 110.13 3.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.41 41.35 Favored Glycine 0 C--N 1.324 -0.115 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -22.48 6.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.924 0.862 . . . . 0.0 112.394 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.461 HD11 HG11 ' A' ' 126' ' ' VAL . 5.1 tp 81.55 152.86 0.12 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.939 2.895 . . . . 0.0 108.852 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.87 141.8 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.633 1.555 . . . . 0.0 108.993 174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -31.26 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.55 1.14 . . . . 0.0 109.161 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.38 -40.98 98.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.35 1.86 . . . . 0.0 112.737 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 14.9 t80 -65.52 137.05 57.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.696 0.798 . . . . 0.0 110.91 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -142.55 173.49 11.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.801 1.24 . . . . 0.0 109.206 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -58.55 135.58 57.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.759 152.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 6.11 69.35 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.704 0.669 . . . . 0.0 113.785 155.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -103.16 172.61 6.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 109.443 171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.52 129.07 9.72 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.76 172.5 15.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.62 126.71 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.405 HG22 HG22 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -101.73 159.26 4.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 165.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.05 134.38 10.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.52 -119.29 0.9 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -142.17 154.0 44.49 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 119.232 1.516 . . . . 0.0 110.46 -163.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.96 135.19 35.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -85.45 0.24 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -151.1 -88.6 0.06 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.408 1.883 . . . . 0.0 109.417 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.41 82.8 1.14 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -160.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' ' 43' ' ' ILE . 70.8 m-80 29.69 67.1 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.188 2.595 . . . . 0.0 110.726 -169.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -141.37 131.19 24.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.213 1.405 . . . . 0.0 107.667 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.2 mm -106.2 135.45 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.217 1.807 . . . . 0.0 109.263 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.89 105.42 10.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 156.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.84 148.87 50.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.96 -25.01 10.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 109.115 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.566 ' HG3' HD21 ' A' ' 127' ' ' LEU . 8.1 pt-20 -148.38 -16.14 0.33 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -169.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 99' ' ' LEU . 61.9 t 38.54 101.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.207 2.203 . . . . 0.0 114.468 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 125' ' ' GLU . 1.1 mm? -106.17 145.9 30.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.15 30.98 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.24 -0.913 . . . . 0.0 111.694 -172.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.975 0.893 . . . . 0.0 110.949 -174.513 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 122.464 1.126 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -169.58 145.4 3.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.051 1.74 . . . . 0.0 107.534 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -142.3 -173.83 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.588 2.355 . . . . 0.0 108.573 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 20.6 p -135.32 171.2 9.34 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.059 0.943 . . . . 0.0 109.292 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB3' HG12 ' A' ' 91' ' ' VAL . 63.9 Cg_endo -73.8 71.31 4.12 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.925 2.417 . . . . 0.0 108.989 169.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.68 -66.73 0.1 Allowed Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 -167.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 39' ' ' THR . 3.3 mm-40 -71.52 -3.71 22.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.359 0.664 . . . . 0.0 112.442 -171.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.55 -41.97 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -85.9 -43.53 13.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.599 0.759 . . . . 0.0 109.688 -165.386 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -102.31 3.32 37.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.323 1.449 . . . . 0.0 112.883 -168.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.2 165.95 39.18 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 110.847 174.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 27.9 mtp . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.5 158.69 32.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.909 1.739 . . . . 0.0 109.917 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -79.12 157.75 27.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 115' ' ' LEU 0.261 9.5 p -93.65 0.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.332 0.587 . . . . 0.0 112.203 -178.238 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.04 55.65 0.68 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.934 1.731 . . . . 0.0 110.13 162.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -144.86 168.81 19.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.188 1.494 . . . . 0.0 112.254 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.41 129.6 36.58 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.402 1.096 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -136.19 -177.08 4.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.277 172.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.71 142.7 51.25 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.402 2.281 . . . . 0.0 106.491 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.27 124.67 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.33 135.47 12.89 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.61 174.37 46.58 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.718 1.152 . . . . 0.0 110.606 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.2 ttm -95.76 126.2 40.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.514 1.526 . . . . 0.0 110.996 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.97 127.3 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 124.227 1.011 . . . . 0.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.9 mtt -59.92 127.5 85.61 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 122.501 0.321 . . . . 0.0 110.58 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.0 113.73 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.072 3.181 . . . . 0.0 110.364 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 104.62 -16.88 47.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.336 1.922 . . . . 0.0 113.967 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.7 p -69.43 -19.68 63.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.469 1.134 . . . . 0.0 114.005 -165.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.71 83.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.954 1.302 . . . . 0.0 109.864 -167.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.77 -58.27 9.32 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.667 1.987 . . . . 0.0 111.472 -167.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.408 0 C-N-CA 129.612 3.165 . . . . 0.0 110.852 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -55.39 140.69 39.02 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 164.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 156.73 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 p -126.37 141.06 52.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 152.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.67 170.6 15.55 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 108.329 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -112.47 144.5 41.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -121.41 143.09 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 169.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.44 173.46 11.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.111 1.765 . . . . 0.0 107.88 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -155.07 -162.54 1.38 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 13.65 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.51 1.924 . . . . 0.0 113.725 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 -76.53 0.58 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.876 1.271 . . . . 0.0 107.914 -172.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.52 -151.21 5.4 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 40' ' ' PRO . 84.7 p -146.08 166.97 24.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.639 0.719 . . . . 0.0 112.519 172.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 40' ' ' PRO . 6.3 p -146.63 157.86 10.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 126.112 1.765 . . . . 0.0 109.045 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.0 151.06 19.81 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 126.006 1.722 . . . . 0.0 108.468 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 84' ' ' ILE . 44.6 t -142.56 103.33 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.055 0.942 . . . . 0.0 111.33 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.4 m -78.44 120.68 23.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.228 1.011 . . . . 0.0 109.361 161.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -116.41 171.5 7.8 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.333 1.453 . . . . 0.0 107.843 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.84 101.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.61 169.73 26.43 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -73.74 -25.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 122.94 0.496 . . . . 0.0 110.67 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.471 ' CD2' HG11 ' A' ' 126' ' ' VAL . 30.5 mt 87.52 156.55 0.09 OUTLIER Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 131.401 3.88 . . . . 0.0 110.185 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -56.08 143.59 83.08 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 N-CA-C 107.058 -1.939 . . . . 0.0 107.058 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -62.21 -37.02 83.72 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.511 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mp -61.44 -20.16 62.79 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.12 1.768 . . . . 0.0 115.159 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.38 125.05 23.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.613 1.097 . . . . 0.0 109.524 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -126.95 160.27 31.54 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.19 0.995 . . . . 0.0 110.488 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 69.7 mt-10 -81.24 104.81 11.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.891 1.677 . . . . 0.0 107.434 168.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.5 13.78 5.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.062 0.839 . . . . 0.0 114.07 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -130.92 166.93 19.87 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.711 1.256 . . . . 0.0 112.131 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.72 139.94 29.55 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 170.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.47 109.04 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 126' ' ' VAL . 3.2 t -81.19 158.18 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 125.08 1.352 . . . . 0.0 108.939 164.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -153.25 152.09 30.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.3 3.04 . . . . 0.0 106.16 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.97 -111.42 0.48 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.78 160.78 33.36 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 119.917 1.858 . . . . 0.0 109.153 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -74.72 142.61 44.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 159.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -99.65 -88.33 0.34 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.886 1.275 . . . . 0.0 108.031 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.35 157.33 4.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.667 2.787 . . . . 0.0 107.433 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.16 25.54 73.45 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.87 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m120 58.65 71.45 0.58 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.347 2.259 . . . . 0.0 110.114 -168.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -141.18 136.49 31.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.68 130.2 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 126.678 1.991 . . . . 0.0 108.497 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.84 111.5 15.05 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 157.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.44 37.33 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.23 1.812 . . . . 0.0 108.329 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -24.64 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.954 1.301 . . . . 0.0 111.399 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.38 -47.54 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 99' ' ' LEU . 32.8 t 61.26 129.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 124.237 1.97 . . . . 0.0 111.328 -174.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.4 mt -133.85 159.03 41.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.03 55.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.397 0.544 . . . . 0.0 110.097 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 176.188 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.401 0 CA-C-O 122.46 1.124 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -168.04 154.62 7.68 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.144 2.578 . . . . 0.0 106.018 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 74.5 m-85 -141.54 173.66 11.29 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.066 2.146 . . . . 0.0 109.051 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 p -134.88 164.05 46.81 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 123.959 0.904 . . . . 0.0 109.606 168.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.88 72.94 2.52 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.677 2.918 . . . . 0.0 109.804 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.13 -62.55 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 105.182 -3.167 . . . . 0.0 105.182 -168.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -47.85 -48.66 30.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.331 1.065 . . . . 0.0 109.956 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.19 -15.37 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 127.149 2.18 . . . . 0.0 112.17 -172.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.48 -32.8 3.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.096 1.359 . . . . 0.0 110.883 -166.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.77 -60.67 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.653 2.381 . . . . 0.0 108.242 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.43 135.97 2.11 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.493 1.521 . . . . 0.0 110.547 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 5.3 tptp . . . . . 0 N--CA 1.471 0.604 0 C-N-CA 124.675 1.19 . . . . 0.0 111.096 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.88 155.83 48.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.67 1.58 . . . . 0.0 109.71 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -79.14 132.32 36.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.259 3.8 p -69.43 0.45 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 123.384 1.564 . . . . 0.0 112.098 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.77 22.4 19.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.959 2.218 . . . . 0.0 112.516 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.55 177.63 7.7 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 121.08 2.44 . . . . 0.0 113.398 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.44 150.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.044 167.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.36 178.15 10.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.203 1.001 . . . . 0.0 109.68 171.235 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -116.67 150.56 37.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.385 1.874 . . . . 0.0 108.468 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.35 154.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.59 1.556 . . . . 0.0 107.654 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.8 142.35 13.67 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 159.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.69 44.5 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 ttm -92.46 119.64 32.17 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.878 2.071 . . . . 0.0 110.514 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.72 128.85 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 120.275 -1.516 . . . . 0.0 108.728 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.1 mtt -59.37 141.25 87.78 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 112.694 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.21 134.17 47.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.751 3.634 . . . . 0.0 109.71 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.6 -2.49 39.07 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.786 -1.008 . . . . 0.0 114.763 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.1 p -74.46 -43.35 56.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.757 1.778 . . . . 0.0 112.099 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.0 107.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.086 1.754 . . . . 0.0 110.805 -170.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -74.04 -55.46 6.1 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.962 1.705 . . . . 0.0 111.444 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.421 HH21 ' CD2' ' A' ' 78' ' ' LEU . 1.5 mtp180 . . . . . 0 N--CA 1.466 0.375 0 C-N-CA 127.147 2.179 . . . . 0.0 111.451 -165.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' CD2' HH21 ' A' ' 73' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 116.96 5.31 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.24 153.93 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.391 1.091 . . . . 0.0 109.844 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.7 p -141.2 114.85 8.95 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -124.96 178.76 5.34 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.809 1.644 . . . . 0.0 111.791 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.2 m -124.36 145.15 49.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -120.11 148.03 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 172.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -139.25 178.26 7.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.96 1.704 . . . . 0.0 108.535 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 87' ' ' ALA . 37.0 t70 -161.01 -153.66 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 86' ' ' ASP . . . -68.8 -18.19 64.14 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.324 -1.485 . . . . 0.0 113.098 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -112.56 -63.3 1.45 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -163.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.59 -157.55 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 120.105 -0.275 . . . . 0.0 113.062 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.9 p -149.78 159.88 44.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.45 153.19 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.838 1.655 . . . . 0.0 111.351 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -81.07 143.99 32.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.531 176.727 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 58.6 t -137.61 121.35 21.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 164.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -91.61 133.52 35.48 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 155.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 18.9 t80 -130.15 168.34 16.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -158.26 113.39 2.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.47 0.15 Allowed Glycine 0 N--CA 1.468 0.786 0 C-N-CA 118.107 -1.997 . . . . 0.0 113.26 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.13 -28.22 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.286 1.043 . . . . 0.0 112.613 167.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.1 tp 61.23 128.13 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 129.333 3.053 . . . . 0.0 112.86 -170.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 5.1 Cg_exo -61.66 135.71 58.19 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.653 1.569 . . . . 0.0 108.106 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.58 -25.51 38.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.856 0.836 . . . . 0.0 111.689 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.49 -23.39 66.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.434 1.094 . . . . 0.0 112.145 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.34 130.28 41.55 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.331 1.423 . . . . 0.0 109.461 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -126.94 -161.87 1.11 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 107.472 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.7 151.95 19.6 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.959 -1.088 . . . . 0.0 108.773 150.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.37 57.86 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.502 166.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -125.37 166.47 16.51 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.395 1.078 . . . . 0.0 109.748 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.41 135.91 18.26 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.83 162.7 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.08 112.78 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.72 2.008 . . . . 0.0 105.687 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -94.59 157.51 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.152 . . . . 0.0 108.259 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -154.11 135.84 14.44 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 127.552 2.341 . . . . 0.0 107.331 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -120.47 0.95 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 103.339 -3.904 . . . . 0.0 103.339 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.55 153.75 46.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.351 1.076 . . . . 0.0 109.631 -160.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.6 tp -80.68 122.54 27.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 109.428 176.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -76.03 -66.98 0.72 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -138.8 -96.16 0.18 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.695 0.798 . . . . 0.0 111.056 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -91.01 -70.54 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -126.94 41.03 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.902 -0.763 . . . . 0.0 109.032 -169.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 92' ' ' ASP . 23.1 t-160 -131.57 125.9 33.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.051 1.34 . . . . 0.0 108.636 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.428 HG21 ' CG1' ' A' ' 111' ' ' VAL . 7.9 mm -98.13 130.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.437 1.895 . . . . 0.0 108.15 171.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.15 108.02 12.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 152.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -71.06 147.88 48.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 160.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -11.0 7.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.81 1.644 . . . . 0.0 111.503 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.36 -21.43 0.15 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 111' ' ' VAL . 86.0 t 41.89 113.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 130.598 3.559 . . . . 0.0 115.687 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.3 144.01 50.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -167.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.86 42.83 2.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.328 -0.857 . . . . 0.0 111.217 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.258 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 36' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -165.84 147.69 7.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.984 0.811 . . . . 0.0 110.63 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' A' ' 36' ' ' LEU . 91.8 m-85 -140.45 177.8 7.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.509 1.924 . . . . 0.0 109.595 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 22.2 p -134.55 171.85 8.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.291 1.036 . . . . 0.0 110.011 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HB3' HG22 ' A' ' 91' ' ' VAL . 69.4 Cg_endo -72.62 -0.64 9.13 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.799 2.333 . . . . 0.0 114.793 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.45 -53.51 3.81 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 156.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 39' ' ' THR . 56.9 mt-10 -68.24 -30.49 69.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.591 -0.946 . . . . 0.0 113.139 -160.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.9 -13.81 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.865 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -119.87 -42.28 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 110.198 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -90.25 -18.12 26.23 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.012 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.68 147.46 9.05 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.776 2.131 . . . . 0.0 109.825 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 C--N 1.349 0.548 0 CA-C-N 119.766 1.783 . . . . 0.0 109.777 173.195 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 42.8 mtp . . . . . 0 C--O 1.238 0.481 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.02 166.29 23.43 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.862 1.708 . . . . 0.0 111.184 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -79.01 128.43 33.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 115' ' ' LEU . 49.0 t -60.64 -8.48 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.823 1.649 . . . . 0.0 111.857 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.46 33.49 4.8 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-O 116.131 -2.483 . . . . 0.0 112.719 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.83 177.62 6.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.128 2.464 . . . . 0.0 112.471 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -83.6 140.93 31.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.018 0.927 . . . . 0.0 110.664 165.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -146.64 173.92 11.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.638 0.775 . . . . 0.0 109.76 169.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -121.26 139.03 53.94 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.46 160.72 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 128.506 2.723 . . . . 0.0 107.856 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.08 156.58 26.92 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.85 -179.96 47.51 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.703 1.621 . . . . 0.0 109.214 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.4 tpp -81.09 120.05 24.34 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 129.062 2.945 . . . . 0.0 110.598 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 103' ' ' PHE . 73.0 t -64.74 130.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 119.094 -2.253 . . . . 0.0 108.479 175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.26 154.23 53.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.87 133.3 30.91 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.006 2.471 . . . . 0.0 109.668 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.73 -24.65 4.32 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 125.579 1.561 . . . . 0.0 115.776 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.09 -43.61 91.86 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.466 1.633 . . . . 0.0 111.732 -170.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.308 1.3 p -42.33 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.941 2.096 . . . . 0.0 112.96 -172.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 8.4 pt20 -91.93 56.48 2.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.968 2.907 . . . . 0.0 108.242 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 11.9 ptt-85 . . . . . 0 CA--C 1.511 -0.554 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 166.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -62.29 138.97 58.52 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.058 -1.651 . . . . 0.0 109.088 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 99' ' ' LEU . 2.1 p -155.72 132.7 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 72' ' ' GLN 0.314 22.7 m -123.39 153.71 40.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 48.8 p90 -152.4 176.98 11.08 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 119.936 -1.727 . . . . 0.0 110.945 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 m -121.56 143.8 49.08 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -121.34 153.67 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.064 1.746 . . . . 0.0 106.47 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -141.81 -179.43 6.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.587 1.955 . . . . 0.0 106.973 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -157.08 -159.35 0.85 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.08 4.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.96 -79.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.033 1.733 . . . . 0.0 109.371 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.98 -168.37 12.07 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.215 1.388 . . . . 0.0 111.643 -167.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 p -146.98 155.97 42.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.4 m -148.72 145.85 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.999 1.72 . . . . 0.0 110.264 -167.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.5 154.68 26.18 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 84' ' ' ILE . 5.4 m -133.28 144.95 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 120.625 -1.297 . . . . 0.0 109.337 160.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.38 1.872 . . . . 0.0 106.572 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -134.91 168.93 18.19 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.221 1.809 . . . . 0.0 108.761 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -148.94 117.63 6.61 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 171.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.38 175.46 25.59 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -170.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -6.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.047 1.339 . . . . 0.0 112.395 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.645 ' CD2' HG11 ' A' ' 126' ' ' VAL . 32.3 mt 63.02 165.89 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 127.535 2.334 . . . . 0.0 111.66 -166.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.35 137.64 79.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 159.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.88 -27.4 66.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.141 0.496 . . . . 0.0 110.704 167.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -19.07 60.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.481 1.512 . . . . 0.0 113.107 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' VAL . 41.8 t80 -64.5 129.4 39.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.994 0.815 . . . . 0.0 110.086 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -136.1 161.07 36.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.023 1.329 . . . . 0.0 109.944 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.71 114.21 6.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.526 1.13 . . . . 0.0 108.206 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.98 -3.46 33.69 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.127 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -91.48 166.73 12.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.35 1.575 . . . . 0.0 110.601 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 140.99 27.54 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.14 177.06 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.255 1.822 . . . . 0.0 107.295 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 127' ' ' LEU . 2.6 t -141.86 101.22 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.097 1.759 . . . . 0.0 106.714 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.9 168.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-O 122.706 1.241 . . . . 0.0 111.244 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -165.05 140.83 5.46 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.279 1.831 . . . . 0.0 107.693 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.58 -91.43 0.11 Allowed Glycine 0 C--O 1.224 -0.481 0 CA-C-O 116.941 -2.033 . . . . 0.0 109.276 168.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.29 162.28 35.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.466 2.133 . . . . 0.0 110.339 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -82.28 148.63 28.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.06 1.744 . . . . 0.0 108.672 165.773 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.439 ' CG ' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -104.99 -85.0 0.48 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 108.259 -174.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 12.8 mtmm -141.07 170.8 15.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 127.352 2.261 . . . . 0.0 106.88 159.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 45.48 -102.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 125.131 1.348 . . . . 0.0 110.852 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -136.31 51.99 1.99 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.593 0.757 . . . . 0.0 109.318 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -121.46 129.94 53.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.48 0.712 . . . . 0.0 109.955 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -105.35 127.81 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.57 1.148 . . . . 0.0 110.999 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.439 HD21 ' CG ' ' A' ' 116' ' ' GLU . 3.6 mm? -79.49 80.76 5.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 162.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.54 141.87 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.563 0.697 . . . . 0.0 110.53 164.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -14.13 9.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.581 1.552 . . . . 0.0 111.529 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.81 -33.65 0.45 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 117.643 -1.17 . . . . 0.0 114.04 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 99' ' ' LEU . 87.7 t 54.92 116.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 C-N-CA 129.073 2.949 . . . . 0.0 111.108 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 10.1 mt -93.15 -176.42 4.15 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.653 168.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -143.43 19.47 1.88 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.982 1.313 . . . . 0.0 110.616 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.2 mttm . . . . . 0 N--CA 1.476 0.85 0 CA-C-N 119.426 1.012 . . . . 0.0 111.577 -161.494 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.5 pp . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 122.528 1.156 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -158.21 147.18 19.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.664 1.185 . . . . 0.0 108.578 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE1' HD13 ' A' ' 36' ' ' LEU . 95.8 m-85 -134.43 173.03 12.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.013 1.725 . . . . 0.0 108.891 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 3.4 p -131.99 172.41 7.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.753 1.221 . . . . 0.0 108.635 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 10.8 Cg_endo -59.87 -36.87 89.33 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.646 1.564 . . . . 0.0 109.881 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.88 10.52 13.69 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.595 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HB2' ' H ' ' A' ' 39' ' ' THR . 26.6 mt-10 -130.17 -30.95 1.92 Allowed 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.909 1.854 . . . . 0.0 112.727 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.04 -58.27 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.71 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -71.94 -49.61 36.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 110.06 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.71 ' CE1' HD12 ' A' ' 44' ' ' LEU . 10.1 m-30 -82.98 -7.16 59.7 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.53 132.05 4.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 13.8 tptp . . . . . 0 C--O 1.224 -0.267 0 C-N-CA 128.316 2.647 . . . . 0.0 113.648 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.59 160.9 40.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.256 1.304 . . . . 0.0 110.117 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -78.66 128.72 33.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.44 -6.06 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.005 1.722 . . . . 0.0 111.433 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.06 52.76 0.74 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 162.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -131.66 178.82 6.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.75 1.275 . . . . 0.0 111.355 161.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -95.0 137.61 33.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.999 1.72 . . . . 0.0 110.392 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.74 169.82 23.04 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.274 1.03 . . . . 0.0 111.416 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -119.27 143.44 47.33 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 127.952 2.501 . . . . 0.0 107.923 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.2 160.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.063 2.145 . . . . 0.0 108.514 -170.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.02 163.98 26.55 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 160.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.25 38.89 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 124.167 0.889 . . . . 0.0 111.189 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.7 ttm -91.9 125.98 36.81 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.53 1.132 . . . . 0.0 109.474 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -65.69 123.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 120.705 1.593 . . . . 0.0 107.46 178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 ttm -63.14 139.18 97.51 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.11 158.29 48.86 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.62 57.91 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 116.857 -2.08 . . . . 0.0 115.494 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -120.23 -6.34 9.89 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.478 2.139 . . . . 0.0 113.323 167.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.3 85.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 120.796 1.635 . . . . 0.0 111.484 169.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -78.46 61.69 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.796 2.839 . . . . 0.0 107.408 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 14.2 ptm180 . . . . . 0 C--N 1.325 -0.46 0 O-C-N 120.75 -1.219 . . . . 0.0 108.8 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -62.07 140.77 58.37 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.2 p -149.61 132.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 m -122.05 135.83 54.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -147.71 173.46 12.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.917 1.235 . . . . 0.0 110.087 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.2 m -118.6 142.8 47.28 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.864 1.266 . . . . 0.0 107.814 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.58 145.48 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.374 1.469 . . . . 0.0 107.098 175.497 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -149.45 176.42 10.61 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.9 0.88 . . . . 0.0 111.417 -168.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -160.4 -166.48 1.67 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.655 1.582 . . . . 0.0 110.318 172.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.82 8.47 0.51 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.641 1.576 . . . . 0.0 113.66 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.87 -71.14 0.74 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.79 -171.01 12.5 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 124.196 0.903 . . . . 0.0 112.433 -172.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.2 p -140.98 149.79 42.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.975 0.91 . . . . 0.0 110.773 164.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -132.7 149.75 32.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.864 1.266 . . . . 0.0 108.054 -173.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.3 148.32 25.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.73 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 84' ' ' ILE . 60.9 t -135.58 123.32 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.025 0.93 . . . . 0.0 110.764 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -89.31 136.78 32.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 151.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -132.52 165.19 24.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.037 2.135 . . . . 0.0 106.694 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -140.07 113.11 8.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.99 166.55 23.06 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.4 tt -72.96 -15.47 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.888 -174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.438 ' CD2' HG11 ' A' ' 126' ' ' VAL . 38.0 mt 78.83 165.09 0.12 Allowed Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 130.827 3.651 . . . . 0.0 110.743 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -61.13 140.37 89.01 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 N-CA-C 107.299 -1.846 . . . . 0.0 107.299 158.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.94 -31.45 66.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.903 1.281 . . . . 0.0 109.927 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -33.26 71.24 Favored 'General case' 0 N--CA 1.437 -1.076 1 C-N-CA 131.984 4.113 . . . . 0.0 111.567 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -59.73 136.6 58.05 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.023 1.283 . . . . 0.0 107.776 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -149.77 142.15 24.27 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 11.7 pt-20 -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.476 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 114.8 -9.33 21.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 114.876 -3.18 . . . . 0.0 115.463 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -94.53 169.7 10.0 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 123.622 3.711 . . . . 0.0 111.637 -173.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.57 8.04 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 165.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.48 176.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.434 1.894 . . . . 0.0 108.447 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.422 ' CG2' ' HE2' ' A' ' 129' ' ' LYS . 2.1 t -129.29 128.88 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.124 1.77 . . . . 0.0 107.228 164.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.82 167.06 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.475 1.131 . . . . 0.0 111.8 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -161.41 144.53 12.5 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.61 -120.31 0.91 Allowed Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -138.35 152.46 48.48 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.758 0.779 . . . . 0.0 109.395 -169.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 143.41 33.94 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.339 1.056 . . . . 0.0 110.176 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -91.58 -77.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.563 -0.71 . . . . 0.0 110.992 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.23 -79.83 0.01 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.86 2.064 . . . . 0.0 108.58 -170.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.3 47.76 2.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.783 1.659 . . . . 0.0 113.153 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 52.02 67.11 1.02 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.9 2.08 . . . . 0.0 110.904 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -136.64 132.84 35.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.131 1.773 . . . . 0.0 106.613 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -99.95 127.07 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.446 1.498 . . . . 0.0 109.046 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.72 74.99 5.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 164.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.21 140.02 17.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.032 0.92 . . . . 0.0 111.693 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -17.32 12.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.69 1.996 . . . . 0.0 110.92 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.85 -42.8 0.53 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.801 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.438 HG11 ' CD2' ' A' ' 99' ' ' LEU . 89.3 t 50.69 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.045 1.338 . . . . 0.0 111.18 -176.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.7 mt -98.67 159.54 14.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.0 17.96 14.79 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.911 0.884 . . . . 0.0 113.361 -162.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HE2' ' CG2' ' A' ' 110' ' ' VAL . 42.5 mmtt . . . . . 0 N--CA 1.473 0.691 0 C-N-CA 126.534 1.933 . . . . 0.0 111.462 -170.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 60' ' ' LEU . 2.5 pp . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 122.006 0.908 . . . . 0.0 112.185 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -156.56 162.14 39.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.957 1.303 . . . . 0.0 109.38 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -145.72 173.09 12.39 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.756 2.822 . . . . 0.0 108.601 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -135.36 165.4 36.64 Favored Pre-proline 0 CA--C 1.53 0.187 0 O-C-N 121.315 -0.866 . . . . 0.0 112.233 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.16 -8.62 12.62 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.384 2.723 . . . . 0.0 116.205 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.51 -38.0 4.09 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 120.586 1.539 . . . . 0.0 110.01 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.04 22.94 1.9 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.432 -1.628 . . . . 0.0 110.27 -162.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.67 -50.92 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 164.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.856 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -79.97 -41.23 26.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.369 1.867 . . . . 0.0 110.568 -169.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -82.19 4.09 24.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.995 1.318 . . . . 0.0 110.159 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.93 170.72 6.67 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 125.995 1.759 . . . . 0.0 109.756 -166.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tttt . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -162.954 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -62.39 154.87 61.02 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.673 167.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.78 130.78 35.62 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.658 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.56 -9.72 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 122.844 0.458 . . . . 0.0 111.332 166.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.11 3.24 56.87 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.589 -1.673 . . . . 0.0 115.286 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.613 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.0 pt20 -115.29 173.51 6.47 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.88 2.34 . . . . 0.0 112.374 -161.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -98.41 135.36 40.11 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -158.17 174.91 14.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.752 0.786 . . . . 0.0 111.335 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -131.89 153.3 50.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.253 1.421 . . . . 0.0 109.775 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 91' ' ' VAL . 88.3 t -138.14 138.34 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 127.447 2.299 . . . . 0.0 107.74 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.41 2.8 Favored Glycine 0 N--CA 1.466 0.687 0 CA-C-N 120.795 1.634 . . . . 0.0 112.048 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.7 165.25 27.64 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.5 ttm -79.95 123.32 27.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.482 1.513 . . . . 0.0 107.789 166.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.21 125.47 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 38.6 mtt -52.77 121.51 22.95 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.123 0.569 . . . . 0.0 110.603 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.07 91.49 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.803 3.669 . . . . 0.0 109.192 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.73 62.7 0.68 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 -23.29 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.376 2.271 . . . . 0.0 111.05 170.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.12 93.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 119.704 1.138 . . . . 0.0 109.341 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -80.8 73.38 7.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.967 2.507 . . . . 0.0 106.618 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 172.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.34 139.84 35.4 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.429 -1.42 . . . . 0.0 108.155 166.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.06 121.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.3 m -116.79 129.81 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -139.77 175.4 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 119.283 0.947 . . . . 0.0 111.076 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -123.9 142.69 50.91 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -122.65 137.01 57.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 178.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -130.69 179.87 5.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.129 1.771 . . . . 0.0 108.276 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -152.91 -116.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.182 163.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.89 -1.97 30.91 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.824 1.193 . . . . 0.0 112.27 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -124.7 -70.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.796 1.238 . . . . 0.0 107.783 -156.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.47 -168.39 12.55 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.3 p -142.75 156.79 45.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.121 0.568 . . . . 0.0 111.65 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 62' ' ' VAL . 23.6 m -138.01 147.64 25.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.782 2.033 . . . . 0.0 109.587 -171.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.23 153.73 24.56 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.609 HG11 HG21 ' A' ' 111' ' ' VAL . 3.2 m -135.67 145.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 163.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -112.77 125.8 54.73 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 162.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -124.27 158.91 31.42 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.168 1.387 . . . . 0.0 108.667 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -142.94 99.12 3.4 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.0 170.34 29.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.603 1.097 . . . . 0.0 110.452 -175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -74.96 -17.51 16.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.617 1.167 . . . . 0.0 112.072 -165.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 73.27 135.74 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.955 2.502 . . . . 0.0 109.36 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.73 151.46 85.61 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.793 1.662 . . . . 0.0 108.999 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -29.08 68.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.831 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -59.45 -38.4 80.65 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.971 -1.49 . . . . 0.0 111.18 176.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.456 ' CD2' HG11 ' A' ' 109' ' ' VAL . 23.9 t80 -67.06 134.56 52.12 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.341 1.456 . . . . 0.0 110.938 -172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.14 169.43 17.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.072 0.949 . . . . 0.0 110.661 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.66 84.41 6.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.899 1.68 . . . . 0.0 108.001 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.97 5.48 3.87 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.124 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.28 171.57 7.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.058 1.929 . . . . 0.0 110.761 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.47 110.93 3.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 103' ' ' PHE . 2.3 m -112.92 171.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 173.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.849 HG22 ' HB2' ' A' ' 127' ' ' LEU . 3.1 m -113.02 163.63 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 157.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 126' ' ' VAL . 2.2 t -113.97 157.56 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 156.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -141.89 148.83 39.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.351 2.26 . . . . 0.0 106.661 169.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.16 -114.69 0.66 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -135.75 159.63 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.724 1.762 . . . . 0.0 110.371 -165.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.54 142.0 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 -66.62 0.89 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.473 0.709 . . . . 0.0 109.463 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -50.32 0.08 Allowed 'General case' 0 C--N 1.347 0.483 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.52 -77.27 0.82 Allowed Glycine 0 C--N 1.329 0.149 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -141.14 33.48 1.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.897 1.679 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -115.78 129.54 56.49 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 111' ' ' VAL . 8.9 mm -102.68 133.61 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.758 1.623 . . . . 0.0 108.535 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.2 108.0 12.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 157.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.31 141.98 54.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 165.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -27.5 7.85 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 126.198 1.799 . . . . 0.0 108.971 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.82 -18.29 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 111' ' ' VAL . 21.4 t 51.41 99.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.428 2.291 . . . . 0.0 115.951 170.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.849 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.4 125.07 52.01 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.592 -163.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -99.78 57.69 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.162 -1.586 . . . . 0.0 110.592 -171.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 124.958 1.303 . . . . 0.0 113.706 173.949 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 32.3 t80 -140.7 121.42 14.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.119 1.368 . . . . 0.0 109.812 -162.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CE1' HD11 ' A' ' 36' ' ' LEU . 83.0 m-85 -110.21 -179.58 3.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 109.282 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 p -147.55 162.3 32.5 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.811 1.645 . . . . 0.0 107.161 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 66.5 8.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 109.628 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -168.3 -52.27 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -1.6 25.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 125.598 1.559 . . . . 0.0 111.388 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.65 -30.98 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.83 -46.92 5.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.217 1.007 . . . . 0.0 111.282 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.4 -36.52 22.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.154 1.382 . . . . 0.0 109.919 -172.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.21 133.83 3.2 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -167.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 7.3 tptp . . . . . 0 CA--C 1.51 -0.594 0 CA-C-N 119.085 1.443 . . . . 0.0 109.994 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.62 148.71 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.843 1.695 . . . . 0.0 110.12 163.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.46 137.79 37.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.72 -8.21 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.622 0.769 . . . . 0.0 111.18 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.07 36.25 3.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 125.598 1.57 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -136.02 163.88 29.27 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.411 1.606 . . . . 0.0 110.215 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -77.47 150.39 34.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.419 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -160.73 164.68 31.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.086 1.355 . . . . 0.0 111.093 169.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -106.51 155.04 20.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.011 1.724 . . . . 0.0 107.277 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.0 153.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 127.075 2.15 . . . . 0.0 107.815 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.46 139.65 11.14 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 162.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.16 173.58 43.6 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 118.177 0.989 . . . . 0.0 111.51 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 ttm -109.0 123.82 49.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 110.859 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.837 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -66.28 129.45 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.889 1.677 . . . . 0.0 110.494 -171.05 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 mtt -62.68 139.81 97.0 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.09 0.859 . . . . 0.0 110.154 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.75 140.43 80.32 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.696 1.597 . . . . 0.0 108.565 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.27 43.5 92.77 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.221 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.8 p -117.08 -84.33 0.64 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.305 1.7 p -22.49 95.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 130.817 3.647 . . . . 0.0 114.802 -170.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.22 90.99 7.54 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 129.089 2.955 . . . . 0.0 108.662 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.924 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.238 0.453 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -55.12 139.47 41.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.039 1.336 . . . . 0.0 108.048 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 4.9 p -158.13 127.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.1 m -102.49 146.56 27.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 24.6 p90 -146.23 172.53 13.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.982 1.265 . . . . 0.0 109.684 168.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.59 145.4 42.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -131.21 126.34 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.57 1.148 . . . . 0.0 109.094 175.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 28.6 p90 -117.3 173.89 6.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.491 2.316 . . . . 0.0 110.34 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -152.61 -164.51 1.97 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.977 1.311 . . . . 0.0 108.328 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.11 11.06 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.802 -1.186 . . . . 0.0 113.672 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -116.03 -75.65 0.58 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -174.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -127.76 -162.37 11.07 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.504 1.049 . . . . 0.0 113.0 -167.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 93.8 p -144.9 160.44 41.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.623 0.769 . . . . 0.0 110.754 169.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.01 145.34 28.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -76.94 151.9 35.52 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 84' ' ' ILE . 6.2 m -131.73 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 121.943 -0.473 . . . . 0.0 109.766 165.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -104.45 132.7 50.4 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 16.6 t80 -132.53 168.49 18.13 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.465 1.506 . . . . 0.0 108.445 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -156.07 107.07 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 167.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.93 20.19 0.02 OUTLIER Glycine 0 N--CA 1.468 0.8 0 C-N-CA 116.254 -2.879 . . . . 0.0 118.195 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER 59.21 117.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.641 1.977 . . . . 0.0 111.882 -168.651 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.531 ' CD2' HG11 ' A' ' 126' ' ' VAL . 23.7 mt -74.33 148.29 85.94 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.301 -0.874 . . . . 0.0 109.902 -175.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -60.7 156.73 41.06 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.314 2.676 . . . . 0.0 109.749 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.86 -40.95 97.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.665 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.18 -27.91 64.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.916 1.286 . . . . 0.0 111.44 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -55.53 129.77 40.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.617 1.099 . . . . 0.0 109.478 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ptt85 -127.86 -164.23 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.623 1.169 . . . . 0.0 111.158 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -103.06 129.19 49.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 153.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.837 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 97.4 8.82 56.0 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 115.524 -2.82 . . . . 0.0 114.754 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.65 165.28 11.88 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 121.829 2.815 . . . . 0.0 110.111 174.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.21 133.97 26.6 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.56 161.96 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.835 2.454 . . . . 0.0 105.801 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.41 138.5 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 121' ' ' ILE . 15.2 m -117.06 166.02 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.296 0.57 . . . . 0.0 110.059 166.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -158.44 146.31 18.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.148 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.91 -112.44 0.54 Allowed Glycine 0 C--O 1.228 -0.263 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -134.45 162.95 30.82 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 120.366 2.083 . . . . 0.0 107.608 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 3.4 tp -82.46 133.91 35.21 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.685 1.194 . . . . 0.0 108.533 167.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.619 ' HG2' HD21 ' A' ' 122' ' ' LEU . 6.9 tm-20 -80.61 -66.64 0.86 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -168.35 -171.89 1.59 Allowed 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 133.161 4.584 . . . . 0.0 105.106 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -8.58 82.92 0.0 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.495 2.95 . . . . 0.0 113.623 164.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 59.2 35.22 23.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.27 2.228 . . . . 0.0 114.767 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -126.41 132.66 51.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.168 0.987 . . . . 0.0 111.045 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 111' ' ' VAL . 20.2 mm -110.95 125.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 128.131 2.572 . . . . 0.0 110.92 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HG2' ' A' ' 116' ' ' GLU . 3.5 mm? -79.72 73.64 6.44 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.916 1.286 . . . . 0.0 108.308 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -43.17 128.07 4.5 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.786 -0.571 . . . . 0.0 110.398 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -26.99 13.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.084 1.353 . . . . 0.0 111.22 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.68 -41.99 0.61 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -170.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 99' ' ' LEU . 58.9 t 57.34 144.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.892 2.077 . . . . 0.0 111.754 -168.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -139.21 159.89 41.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.31 39.73 3.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.705 1.602 . . . . 0.0 110.164 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 128.162 2.585 . . . . 0.0 112.251 -161.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.8 pp . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 122.099 0.952 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -155.58 149.1 25.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.619 ' CE1' HD13 ' A' ' 36' ' ' LEU . 85.8 m-85 -136.8 -179.93 5.99 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.457 1.903 . . . . 0.0 107.794 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -146.11 164.34 25.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 C-N-CA 126.236 1.814 . . . . 0.0 106.75 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.51 64.31 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.916 3.078 . . . . 0.0 110.142 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.9 -50.06 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -3.57 37.12 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.827 -0.808 . . . . 0.0 111.796 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mt -94.4 -34.17 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.001 0.92 . . . . 0.0 108.723 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.63 -57.66 2.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.465 1.106 . . . . 0.0 111.311 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -85.45 -28.03 25.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.591 2.357 . . . . 0.0 109.423 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.31 158.57 11.47 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.755 1.169 . . . . 0.0 112.189 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 7.2 tptt . . . . . 0 C--O 1.218 -0.571 0 C-N-CA 125.556 1.542 . . . . 0.0 110.681 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.9 162.27 32.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.763 1.642 . . . . 0.0 109.241 154.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -79.58 152.78 29.89 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 162.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.747 HG11 ' HE3' ' A' ' 117' ' ' LYS . 76.2 t -90.65 0.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.896 0.878 . . . . 0.0 111.811 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.41 61.58 0.65 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 165.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.416 ' HG3' HD12 ' A' ' 60' ' ' LEU . 3.0 pt20 -140.0 176.11 9.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.485 0.714 . . . . 0.0 110.965 168.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -90.75 135.28 33.82 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.905 0.882 . . . . 0.0 111.205 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -158.48 175.71 13.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.193 1.397 . . . . 0.0 112.424 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -114.53 148.95 37.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 127.941 2.497 . . . . 0.0 109.141 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.63 134.68 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.199 1.399 . . . . 0.0 107.536 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.98 143.66 16.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 158.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.95 167.9 38.97 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.457 1.129 . . . . 0.0 111.579 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.7 ttm -93.73 121.91 35.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.605 1.562 . . . . 0.0 109.708 -174.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -66.2 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 109.222 -176.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 45.5 mtt -62.31 144.02 95.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 111.894 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.67 61.57 8.23 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.592 3.528 . . . . 0.0 110.804 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.15 63.06 0.02 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -152.72 -23.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.252 0.6 OUTLIER -68.56 100.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 120.261 1.391 . . . . 0.0 111.334 -176.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -82.91 81.46 8.59 Favored 'General case' 0 C--O 1.237 0.446 1 C-N-CA 132.667 4.387 . . . . 0.0 109.455 171.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.281 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.239 0.5 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -50.0 145.24 5.86 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 160.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.88 166.77 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 122.244 1.021 . . . . 0.0 109.114 169.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.67 116.16 7.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 163.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -125.07 175.85 7.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.503 1.956 . . . . 0.0 111.483 171.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 m -124.76 145.56 49.66 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -130.5 138.45 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.256 1.822 . . . . 0.0 107.465 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -130.04 174.65 9.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.612 1.565 . . . . 0.0 108.89 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -157.1 -163.84 1.48 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.46 -3.41 0.98 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.365 1.866 . . . . 0.0 115.269 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -118.84 -79.79 0.6 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.14 -159.24 8.59 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.927 1.251 . . . . 0.0 111.796 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -146.96 162.09 39.43 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 119' ' ' ASN . 14.2 m -142.99 145.28 23.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.776 1.63 . . . . 0.0 109.255 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.49 159.74 24.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 84' ' ' ILE . 3.9 m -136.27 138.5 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.301 1.04 . . . . 0.0 109.134 168.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.1 106.72 17.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.054 2.142 . . . . 0.0 105.308 167.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.37 165.96 10.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 107.487 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -157.12 117.33 3.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.92 -92.77 0.11 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 115.246 -3.359 . . . . 0.0 118.234 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.15 69.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 123.881 1.801 . . . . 0.0 107.253 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' CD1' HG11 ' A' ' 126' ' ' VAL . 21.4 tp -49.85 135.09 20.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.371 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -63.3 138.82 68.38 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 108.169 -1.512 . . . . 0.0 108.169 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.31 -14.82 58.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.462 170.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.15 -23.78 47.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.655 1.582 . . . . 0.0 111.916 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.7 122.73 14.22 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -120.62 153.37 36.91 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.263 1.425 . . . . 0.0 107.232 171.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.13 117.49 17.88 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 122.21 8.93 6.91 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 116.376 -2.347 . . . . 0.0 115.864 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.598 ' H ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -133.57 167.68 20.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.774 2.787 . . . . 0.0 112.305 -165.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.67 81.92 1.68 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.523 1.535 . . . . 0.0 112.348 -167.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.16 168.93 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.786 0.834 . . . . 0.0 109.916 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.61 115.53 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 171.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -105.31 156.75 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 127.086 2.155 . . . . 0.0 108.557 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -154.57 138.94 16.71 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.593 2.357 . . . . 0.0 106.154 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.96 -112.69 0.52 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 105.936 -2.866 . . . . 0.0 105.936 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -140.9 157.68 45.03 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.432 1.616 . . . . 0.0 109.507 -167.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -91.48 154.71 18.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.953 1.301 . . . . 0.0 109.084 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.4 -79.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.903 0.881 . . . . 0.0 110.675 -171.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.747 ' HE3' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -178.29 169.04 1.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 130.871 3.668 . . . . 0.0 106.325 177.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.39 20.92 52.76 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.455 1.025 . . . . 0.0 113.696 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' HB3' HG12 ' A' ' 91' ' ' VAL . 52.3 m-80 54.64 68.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.121 1.368 . . . . 0.0 112.269 -164.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -131.18 132.56 44.81 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.55 1.14 . . . . 0.0 109.188 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 20.9 mm -105.18 133.49 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 110.285 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.05 109.65 13.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.48 139.19 34.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.83 -18.25 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 111.513 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.31 -43.99 0.46 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 111' ' ' VAL . 58.5 t 53.3 108.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.767 2.027 . . . . 0.0 115.164 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.1 152.38 42.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.74 1.616 . . . . 0.0 107.712 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -114.17 27.68 9.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.92 1.236 . . . . 0.0 110.806 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 126.317 1.847 . . . . 0.0 113.183 -176.42 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 t80 100.27 140.85 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 1 C-N-CA 134.046 4.939 . . . . 0.0 106.28 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 9.8 m-85 -141.88 175.08 10.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.363 2.265 . . . . 0.0 106.289 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 6.8 p -140.86 170.97 8.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.249 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 9.2 Cg_endo -62.98 -5.97 8.63 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.723 2.949 . . . . 0.0 118.009 -166.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -35.13 5.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 120.424 1.465 . . . . 0.0 110.404 165.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.55 -5.64 59.31 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.462 -1.611 . . . . 0.0 111.342 -158.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.95 -18.1 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.507 1.123 . . . . 0.0 110.769 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -111.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.407 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 44' ' ' LEU . 9.4 m-30 -80.28 -32.41 38.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.892 0.877 . . . . 0.0 111.3 -169.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.59 142.0 3.89 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 82.2 tttt . . . . . 0 CA--C 1.51 -0.591 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.535 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 mtp . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 155.41 68.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.276 1.317 . . . . 0.0 110.057 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -81.7 131.03 35.25 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.45 1.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.102 1.761 . . . . 0.0 112.469 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.55 25.57 4.47 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 116.471 -2.294 . . . . 0.0 113.386 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -125.2 175.09 7.64 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.42 2.11 . . . . 0.0 112.861 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -85.7 140.01 30.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.464 1.505 . . . . 0.0 112.621 167.38 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.77 171.5 18.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.269 1.828 . . . . 0.0 110.223 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -129.33 145.6 51.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.854 1.662 . . . . 0.0 108.282 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.68 132.66 71.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.55 153.15 20.11 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 157.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.48 -175.85 42.36 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 ttm -118.87 125.26 49.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 58.0 t -65.57 124.25 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.242 0.928 . . . . 0.0 108.685 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.6 ttm -59.66 124.23 75.03 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.293 1.037 . . . . 0.0 109.047 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 112.12 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.017 3.145 . . . . 0.0 110.404 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.06 51.86 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.051 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -67.13 -26.26 66.59 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.781 1.79 . . . . 0.0 112.877 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.53 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 123.985 0.914 . . . . 0.0 110.148 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.64 -70.39 0.13 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.105 1.762 . . . . 0.0 109.443 168.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 . . . . . 0 N--CA 1.475 0.776 1 C-N-CA 131.736 4.014 . . . . 0.0 114.057 -164.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--O 1.238 0.466 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 140.71 50.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.838 0.855 . . . . 0.0 109.269 172.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.91 145.0 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.7 m -147.1 135.87 22.14 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -147.13 174.58 11.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.491 1.116 . . . . 0.0 108.85 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -121.18 151.47 39.9 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -130.16 140.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -133.32 174.25 10.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.148 1.379 . . . . 0.0 109.388 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.37 -165.67 2.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.593 2.357 . . . . 0.0 104.921 165.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.21 0.26 1.44 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 114.263 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.37 -70.78 0.79 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 120.017 1.281 . . . . 0.0 108.718 -164.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.38 -166.51 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 128.423 2.916 . . . . 0.0 108.188 -170.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.0 p -153.42 159.88 42.47 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.114 -0.639 . . . . 0.0 109.537 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.28 153.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.347 1.459 . . . . 0.0 110.122 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.18 158.26 19.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.889 0.476 . . . . 0.0 109.978 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.414 ' CG2' HD11 ' A' ' 84' ' ' ILE . 44.7 t -141.35 120.62 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.857 1.263 . . . . 0.0 108.388 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -96.83 131.55 43.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 162.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -131.85 167.66 19.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.353 1.861 . . . . 0.0 107.695 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -160.39 104.54 1.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.62 7.01 0.02 OUTLIER Glycine 0 C--O 1.225 -0.449 0 C-N-CA 116.272 -2.87 . . . . 0.0 117.026 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 99' ' ' LEU 0.281 0.4 OUTLIER 58.22 145.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 123.706 1.717 . . . . 0.0 109.66 -156.032 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.578 ' H ' HD13 ' A' ' 98' ' ' ILE . 14.1 mt -98.53 157.01 35.06 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.769 -173.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.02 150.9 84.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.48 -23.03 67.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 111.481 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.32 -20.88 60.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.725 1.61 . . . . 0.0 112.534 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 109' ' ' VAL . 27.3 t80 -72.22 127.04 31.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.308 1.867 . . . . 0.0 108.216 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -135.74 166.42 23.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.489 1.115 . . . . 0.0 109.911 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.85 121.53 25.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.455 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 101.64 17.67 20.76 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 115.609 1.003 . . . . 0.0 115.609 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.78 174.61 7.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.199 1.499 . . . . 0.0 112.378 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.81 105.51 3.29 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.586 1.565 . . . . 0.0 111.288 -167.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.6 m -105.35 171.28 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.434 ' CG2' ' HE3' ' A' ' 129' ' ' LYS . 2.4 t -130.46 97.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 128.031 2.532 . . . . 0.0 104.193 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 126' ' ' VAL . 2.0 t -79.6 154.77 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 108.1 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 9.1 tt0 -151.96 143.24 23.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 127.266 2.226 . . . . 0.0 106.115 168.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.33 -111.07 0.35 Allowed Glycine 0 N--CA 1.434 -1.447 1 N-CA-C 101.341 -4.704 . . . . 0.0 101.341 158.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 21.8 mt-10 -141.56 153.98 45.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 119.561 1.681 . . . . 0.0 109.34 -167.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 60' ' ' LEU . 19.5 tp -84.11 127.03 33.65 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.27 -66.5 0.86 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.51 0.724 . . . . 0.0 110.69 -168.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -150.52 -66.54 0.2 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.45 -86.1 1.53 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -139.34 51.68 1.76 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -126.72 133.57 50.87 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.313 1.445 . . . . 0.0 107.301 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.65 131.12 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.322 1.449 . . . . 0.0 108.92 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.99 100.84 7.48 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 158.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.5 144.61 46.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.791 0.805 . . . . 0.0 110.177 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -22.78 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.171 2.189 . . . . 0.0 110.78 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -154.19 -7.7 0.15 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 111' ' ' VAL . 32.8 t 26.91 85.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.581 2.352 . . . . 0.0 114.49 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.89 143.1 27.11 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.49 50.02 1.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.361 1.064 . . . . 0.0 110.361 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HE3' ' CG2' ' A' ' 110' ' ' VAL . 16.9 mmtp . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 127.074 2.15 . . . . 0.0 115.263 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.931 0.872 . . . . 0.0 111.431 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.72 152.2 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.549 3.54 . . . . 0.0 106.057 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.7 173.61 11.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.062 2.145 . . . . 0.0 108.711 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 31.8 p -134.37 171.84 8.34 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 119.347 0.976 . . . . 0.0 112.054 169.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.35 1.59 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.989 3.126 . . . . 0.0 117.306 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.53 -24.98 5.66 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 121.296 1.862 . . . . 0.0 116.552 154.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 39' ' ' THR . 11.0 mm-40 -67.84 -12.92 61.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.789 2.295 . . . . 0.0 112.284 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.461 HG22 ' OD1' ' A' ' 119' ' ' ASN . 3.0 mt -105.8 -23.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 126.929 2.092 . . . . 0.0 109.553 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 91' ' ' VAL . 6.9 mt -87.4 -54.12 4.46 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.723 -1.235 . . . . 0.0 110.933 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -81.59 -76.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 106.854 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.6 161.42 23.75 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.2 tptp . . . . . 0 C--O 1.223 -0.32 0 CA-C-N 118.248 1.024 . . . . 0.0 108.514 170.498 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.3 mtp . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.25 162.44 33.92 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.127 1.218 . . . . 0.0 110.278 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -79.18 145.33 33.72 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.6 p -86.54 -2.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.056 1.343 . . . . 0.0 112.49 -173.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 71.85 0.48 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 107.164 -2.375 . . . . 0.0 107.164 153.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.93 176.72 8.45 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.752 0.776 . . . . 0.0 109.62 157.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -79.56 138.88 37.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.399 165.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -148.31 166.21 28.71 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.293 0.637 . . . . 0.0 110.328 165.05 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -99.38 137.42 37.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.455 1.502 . . . . 0.0 108.504 166.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.37 158.38 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.443 1.497 . . . . 0.0 107.435 160.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.76 142.72 11.47 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 154.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.2 -177.25 40.89 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ttm -88.71 118.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.484 0.713 . . . . 0.0 110.257 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.69 128.42 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.622 1.169 . . . . 0.0 109.085 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.4 ttm -70.65 128.53 90.9 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 124.058 0.943 . . . . 0.0 111.091 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.07 113.77 3.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.015 3.143 . . . . 0.0 110.701 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 112.01 12.78 13.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.374 1.94 . . . . 0.0 111.898 -173.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.8 p -112.58 -34.98 5.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 120.135 1.967 . . . . 0.0 111.791 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.83 116.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.047 0.939 . . . . 0.0 110.187 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -120.46 63.82 0.84 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.896 2.478 . . . . 0.0 107.919 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.631 0 O-C-N 121.021 -1.049 . . . . 0.0 109.509 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 132.36 53.31 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.9 p -152.1 141.4 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.6 m -133.95 148.77 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.94 -177.1 5.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.451 1.5 . . . . 0.0 109.725 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.1 m -127.98 152.93 47.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.55 HD11 HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -126.66 152.49 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.736 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.58 174.95 10.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.798 0.808 . . . . 0.0 109.122 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -151.3 -175.19 5.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.405 1.882 . . . . 0.0 107.553 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.73 -13.98 12.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.651 0.78 . . . . 0.0 113.037 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.84 -66.13 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.586 1.554 . . . . 0.0 107.276 -160.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.16 -162.67 11.58 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.096 1.808 . . . . 0.0 111.44 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -141.65 159.16 42.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.26 1.03 . . . . 0.0 113.203 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.578 HG12 HD21 ' A' ' 44' ' ' LEU . 34.7 m -149.16 156.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 111.537 -165.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.1 155.98 22.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.839 0.29 . . . . 0.0 111.235 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 84' ' ' ILE . 57.6 t -139.94 124.51 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.362 1.065 . . . . 0.0 108.971 162.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 p -98.09 145.65 26.34 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.724 1.147 . . . . 0.0 108.386 159.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -139.88 167.72 21.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.734 1.614 . . . . 0.0 107.913 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -154.68 93.32 1.56 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.76 -175.4 44.54 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 118.538 -1.791 . . . . 0.0 114.096 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.14 117.8 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.2 tp -96.08 135.39 22.74 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 117.58 -1.2 . . . . 0.0 108.454 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.27 150.97 46.46 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.002 1.801 . . . . 0.0 111.686 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.96 -33.88 77.08 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.958 -0.464 . . . . 0.0 110.157 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.491 HD12 ' H ' ' A' ' 102' ' ' LEU . 6.1 mp -61.3 -40.26 93.52 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 109' ' ' VAL . 22.2 t80 -54.47 125.34 19.17 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.93 1.292 . . . . 0.0 109.567 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 157.09 45.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 25.6 mt-10 -64.78 118.27 8.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.723 167.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.68 57.62 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.916 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.41 166.62 10.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.552 1.676 . . . . 0.0 109.765 162.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.3 138.46 20.53 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 124.57 1.081 . . . . 0.0 110.873 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -130.72 166.97 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.431 1.892 . . . . 0.0 108.463 173.542 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.16 131.4 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 127.167 2.187 . . . . 0.0 105.121 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 93' ' ' VAL . 1.4 t -115.96 158.37 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 125.481 1.512 . . . . 0.0 106.939 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -154.37 143.26 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.87 2.068 . . . . 0.0 105.616 176.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.79 -98.37 0.13 Allowed Glycine 0 CA--C 1.508 -0.362 0 CA-C-O 116.475 -2.291 . . . . 0.0 108.701 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.7 154.71 49.62 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.962 1.881 . . . . 0.0 108.946 169.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.566 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -71.13 134.25 46.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.307 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -80.79 -70.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 6.3 mtpp 172.86 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.059 3.343 . . . . 0.0 108.612 -167.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -83.81 57.66 5.04 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.887 -168.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.461 ' OD1' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER 27.45 67.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.108 2.163 . . . . 0.0 113.269 -160.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -134.48 124.08 25.01 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -172.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 60' ' ' LEU . 13.6 mm -93.47 129.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 170.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.54 107.23 11.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 160.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.36 141.93 41.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.134 0.968 . . . . 0.0 109.353 172.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 -15.68 14.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.867 2.067 . . . . 0.0 109.805 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.37 -49.44 0.27 Allowed 'General case' 0 C--N 1.349 0.552 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 111' ' ' VAL . 93.8 t 62.88 135.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.115 2.566 . . . . 0.0 112.091 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.7 mt -153.46 160.87 42.67 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -167.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.16 54.7 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 121.505 1.957 . . . . 0.0 112.625 -163.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt . . . . . 0 N--CA 1.492 1.666 0 C-N-CA 126.296 1.839 . . . . 0.0 115.792 178.752 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 38' ' ' TYR . 2.1 pp . . . . . 0 C--O 1.234 0.245 0 CA-C-O 122.268 1.032 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -169.76 149.66 3.83 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.822 2.849 . . . . 0.0 106.077 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.616 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 86.4 m-85 -138.42 179.45 6.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.217 1.807 . . . . 0.0 109.587 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.54 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 71.3 p -131.49 170.31 11.6 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.241 1.017 . . . . 0.0 110.775 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -62.66 65.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.895 3.73 . . . . 0.0 110.815 161.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . 167.52 -62.88 0.2 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -158.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 39' ' ' THR . 28.4 mt-10 -65.66 -21.79 66.58 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.865 1.333 . . . . 0.0 111.9 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.32 -13.97 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 111.17 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 mt -115.41 -42.67 3.13 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.162 -0.961 . . . . 0.0 111.856 -164.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -107.71 -46.37 3.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 109.504 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.57 144.13 3.9 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.616 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 14.3 tptp . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 168.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.1 mtp . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.66 162.63 40.74 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.307 1.145 . . . . 0.0 110.837 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.37 144.12 34.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.148 1.379 . . . . 0.0 108.197 166.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.67 0.85 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.879 1.323 . . . . 0.0 110.968 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.3 11.25 24.15 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 116.462 -2.299 . . . . 0.0 114.425 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -127.15 169.58 13.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.487 2.643 . . . . 0.0 111.715 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -82.97 150.35 26.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.383 162.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.12 -172.46 4.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.858 2.063 . . . . 0.0 108.749 171.614 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.05 48.87 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.517 1.127 . . . . 0.0 108.379 170.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.3 t -123.68 145.61 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.641 1.576 . . . . 0.0 107.439 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.18 124.23 5.67 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 165.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.7 164.09 33.94 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 117.693 0.746 . . . . 0.0 112.189 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 ttm -95.67 122.46 38.46 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.6 1.16 . . . . 0.0 110.286 -172.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -70.66 132.41 33.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.676 1.125 . . . . 0.0 110.131 -172.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.8 mtt -60.93 151.89 72.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.902 0.881 . . . . 0.0 110.995 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.98 106.54 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 124.186 3.258 . . . . 0.0 109.409 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.55 36.49 91.51 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.396 -1.224 . . . . 0.0 113.241 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.8 p -80.72 -15.75 55.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.334 1.567 . . . . 0.0 111.887 162.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -82.16 96.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.571 1.148 . . . . 0.0 110.057 -168.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 78.6 7.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.681 1.592 . . . . 0.0 107.44 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 160.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.1 129.2 33.78 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 164.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 95' ' ' TYR . 3.2 p -142.52 143.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 35.8 m -140.99 133.57 28.61 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.5 p90 -143.33 173.61 11.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.685 -1.259 . . . . 0.0 111.031 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.5 m -128.37 136.89 51.55 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.46 146.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.888 2.075 . . . . 0.0 106.035 -176.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -134.44 176.94 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.828 1.251 . . . . 0.0 109.505 -176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.11 -168.71 3.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.967 1.307 . . . . 0.0 107.563 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 2.72 0.07 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.553 2.341 . . . . 0.0 113.722 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -126.7 -74.2 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.133 1.373 . . . . 0.0 107.76 -164.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.88 -157.44 7.29 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.369 -0.693 . . . . 0.0 111.369 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -138.57 161.18 37.74 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.202 1.001 . . . . 0.0 111.9 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.13 149.55 16.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -96.04 152.98 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 2.9 m -133.13 134.13 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -118.23 109.52 16.45 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.898 2.079 . . . . 0.0 107.355 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.9 t80 -115.49 171.2 7.87 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.997 1.719 . . . . 0.0 107.897 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.55 96.69 1.54 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.81 178.8 42.38 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 tp -79.6 125.48 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' HG11 ' A' ' 126' ' ' VAL . 34.0 mt -75.85 149.79 83.29 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.252 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.49 146.32 89.18 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.593 2.195 . . . . 0.0 108.647 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.12 -24.23 67.02 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.104 -0.997 . . . . 0.0 111.597 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -19.52 60.87 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.759 2.423 . . . . 0.0 111.973 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -68.37 123.83 21.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.333 1.053 . . . . 0.0 110.599 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -136.5 140.73 43.23 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -66.76 113.85 5.18 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.699 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 109.75 21.95 6.89 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 116.741 -2.144 . . . . 0.0 113.436 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.81 165.12 25.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.161 1.98 . . . . 0.0 111.308 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.53 1.55 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.518 1.532 . . . . 0.0 110.739 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.49 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 108.877 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.36 139.32 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 126' ' ' VAL . 2.5 t -120.26 157.44 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.868 2.067 . . . . 0.0 107.505 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.98 146.51 25.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.893 2.477 . . . . 0.0 107.366 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 145.26 -131.44 4.23 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 104.447 -3.461 . . . . 0.0 104.447 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -140.84 158.33 44.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.096 1.948 . . . . 0.0 110.841 -157.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.57 ' HB2' HD11 ' A' ' 60' ' ' LEU . 15.9 tp -90.75 128.78 36.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.771 0.828 . . . . 0.0 110.259 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.53 -66.75 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 109.85 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.14 158.99 17.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 128.859 2.864 . . . . 0.0 106.42 171.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.11 -99.21 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 124.34 0.971 . . . . 0.0 111.132 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.4 23.07 3.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.682 1.193 . . . . 0.0 110.815 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -92.03 128.03 37.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.2 mm -101.51 130.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 125.343 1.457 . . . . 0.0 109.722 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.18 119.88 22.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 155.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.59 132.86 33.92 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.933 1.293 . . . . 0.0 108.789 171.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.27 -25.36 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.831 1.653 . . . . 0.0 111.693 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.67 -41.75 0.32 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 99' ' ' LEU . 20.0 t 62.98 139.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 124.654 2.168 . . . . 0.0 112.432 -172.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -140.32 157.53 45.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.719 2.008 . . . . 0.0 106.181 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.33 42.06 3.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 109.334 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 127.75 2.42 . . . . 0.0 114.531 -179.823 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 118.037 -0.982 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.42 171.44 10.46 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.028 1.285 . . . . 0.0 110.763 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m 139.97 161.67 0.0 OUTLIER 'General case' 0 C--O 1.235 0.326 1 C-N-CA 134.043 4.937 . . . . 0.0 109.423 168.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 m120 61.81 177.66 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.0 mt -93.2 152.48 3.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 52.36 -161.73 0.1 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.308 1.843 . . . . 0.0 111.12 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 60' ' ' LEU . 1.1 pp -106.0 -173.32 2.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.24 156.25 14.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' C ' HG23 ' A' ' 62' ' ' VAL . 87.9 m-85 -137.85 -167.26 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.948 0.795 . . . . 0.0 109.291 170.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -140.93 170.94 8.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 125.796 1.638 . . . . 0.0 109.361 168.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -64.63 -4.13 7.88 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.166 2.577 . . . . 0.0 115.581 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.05 -46.31 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 161.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 39' ' ' THR . 50.9 mt-10 -76.83 -20.27 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.499 -1.589 . . . . 0.0 113.331 -160.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 121' ' ' ILE . 3.7 mt -73.04 -13.47 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.575 -0.703 . . . . 0.0 111.462 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -118.27 -47.39 2.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.66 0.784 . . . . 0.0 109.446 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -90.08 -36.85 14.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.12 0.968 . . . . 0.0 111.07 -168.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.77 4.22 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.801 1.667 . . . . 0.0 111.014 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -76.79 137.55 39.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.0 -1.882 . . . . 0.0 111.43 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -19.05 -19.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 1 C-N-CA 131.758 4.023 . . . . 0.0 120.579 -135.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -121.36 -75.09 0.59 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.5 t -164.94 31.07 0.06 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.154 0.982 . . . . 0.0 109.434 -170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.92 -35.53 76.94 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.392 -0.817 . . . . 0.0 112.589 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 176.23 175.97 0.29 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 130.702 3.601 . . . . 0.0 106.429 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 24.3 mtp -116.09 151.06 46.18 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 159.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.14 165.62 27.83 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.789 1.659 . . . . 0.0 111.493 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.3 136.05 36.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 127.099 2.16 . . . . 0.0 109.358 172.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HA ' ' HB3' ' A' ' 115' ' ' LEU . 10.0 t -64.17 -14.36 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.073 164.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.93 4.18 71.34 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 116.06 -2.522 . . . . 0.0 114.901 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -117.82 168.41 10.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 123.15 3.475 . . . . 0.0 112.645 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 147.32 22.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 164.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -158.09 176.19 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 128.288 2.635 . . . . 0.0 110.06 -173.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -131.26 142.47 50.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.91 2.084 . . . . 0.0 109.073 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 38' ' ' TYR . 3.2 p -152.52 124.19 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -76.63 150.83 38.71 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 169.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 166.86 37.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.081 1.801 . . . . 0.0 110.285 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttm -95.38 125.32 39.92 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.124 1.37 . . . . 0.0 108.665 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.69 124.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 119.498 1.045 . . . . 0.0 108.494 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.9 mtt -60.06 139.51 90.96 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.381 0.992 . . . . 0.0 110.667 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.6 146.03 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.751 2.968 . . . . 0.0 109.562 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.39 -22.93 0.49 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.328 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -61.13 -38.65 87.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.812 1.806 . . . . 0.0 112.106 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.73 94.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.661 1.584 . . . . 0.0 109.301 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -84.2 144.08 29.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 158.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -130.65 151.19 51.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.04 139.94 93.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.66 -16.65 38.07 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 120.952 1.101 . . . . 0.0 111.884 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -127.52 -0.07 6.22 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.788 1.635 . . . . 0.0 110.709 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.4 165.4 32.19 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 119.069 0.85 . . . . 0.0 110.843 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.3 3.77 41.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.323 1.449 . . . . 0.0 111.328 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -54.61 143.53 24.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 123.787 0.835 . . . . 0.0 108.817 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.24 155.63 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 125.155 1.382 . . . . 0.0 107.518 172.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.72 120.85 16.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 161.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -134.91 170.26 16.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.882 0.873 . . . . 0.0 110.71 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 m -117.83 145.8 44.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.92 139.47 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -135.11 175.6 9.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.557 1.543 . . . . 0.0 108.803 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -149.42 -169.83 3.48 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 6.65 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -68.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.873 1.669 . . . . 0.0 109.527 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -168.1 12.76 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.219 1.39 . . . . 0.0 110.401 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.6 p -142.95 160.83 39.6 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.664 0.732 . . . . 0.0 112.684 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.44 154.3 32.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.294 2.238 . . . . 0.0 108.159 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.17 158.73 15.47 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.8 t -138.63 119.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.404 1.482 . . . . 0.0 108.072 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 m -88.06 128.52 35.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 154.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -125.05 161.95 25.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 160.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.58 112.05 5.55 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.07 -159.86 28.28 Favored Glycine 0 CA--C 1.507 -0.453 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.882 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tp -80.57 111.01 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -170.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.64 148.24 48.46 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.205 -1.362 . . . . 0.0 107.832 -169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.96 131.93 49.25 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -17.31 63.34 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.201 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.49 -25.22 54.01 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.562 1.545 . . . . 0.0 113.796 168.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -51.91 121.87 7.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.385 1.448 . . . . 0.0 111.797 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -135.78 157.48 46.75 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.195 1.474 . . . . 0.0 112.256 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -71.62 95.96 1.51 Allowed 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 128.184 2.594 . . . . 0.0 107.622 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.65 33.81 4.02 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 113.326 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 164.03 17.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.125 1.963 . . . . 0.0 110.357 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.07 83.62 1.44 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.774 1.654 . . . . 0.0 109.401 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.6 -179.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.705 1.202 . . . . 0.0 109.014 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.1 t -126.89 135.75 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.314 2.246 . . . . 0.0 105.577 167.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 123' ' ' ALA . 0.6 OUTLIER -104.68 163.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -161.22 144.78 12.96 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.01 -133.06 3.88 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.97 153.31 51.86 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 120.056 1.928 . . . . 0.0 110.211 -159.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -73.98 131.48 41.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.62 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.65 -62.53 1.49 Allowed 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.119 0.568 . . . . 0.0 109.683 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 -72.34 0.17 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.87 -74.44 0.99 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.34 44.93 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 107.997 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -128.54 135.99 50.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 43' ' ' ILE . 4.2 mm -111.0 130.15 64.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 127.327 2.251 . . . . 0.0 109.148 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.27 90.43 4.95 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 156.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -53.8 150.2 7.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.925 0.869 . . . . 0.0 111.174 161.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -12.14 8.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.779 2.832 . . . . 0.0 111.514 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.05 -45.72 0.2 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.1 t 58.97 133.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.584 1.954 . . . . 0.0 111.456 -171.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.84 150.74 48.48 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 120.184 -1.572 . . . . 0.0 107.9 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -110.26 29.09 8.0 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.464 0.706 . . . . 0.0 111.798 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 46.59 31.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.865 1.266 . . . . 0.0 113.785 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.481 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -71.64 41.61 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 129.453 3.101 . . . . 0.0 109.755 167.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t0 67.69 -65.82 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.363 2.665 . . . . 0.0 112.076 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 65.47 154.19 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.37 2.668 . . . . 0.0 111.799 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -147.1 -50.17 0.19 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.163 -172.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 11.9 t80 66.63 109.26 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.269 2.628 . . . . 0.0 110.898 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.9 m -78.93 129.09 74.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.39 177.25 6.9 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.395 2.73 . . . . 0.0 111.924 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.28 -44.43 9.17 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.445 2.097 . . . . 0.0 113.844 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -78.03 60.49 2.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.942 0.897 . . . . 0.0 109.944 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 p -165.2 -53.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 126.199 1.8 . . . . 0.0 106.871 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -67.39 -56.87 7.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.856 0.862 . . . . 0.0 110.317 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -148.89 20.79 1.0 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.415 1.086 . . . . 0.0 110.34 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.45 29.65 3.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.017 1.327 . . . . 0.0 111.681 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 C--O 1.254 1.317 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 147.885 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -146.01 158.52 43.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -155.74 94.33 1.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.54 -56.47 0.31 Allowed 'General case' 0 N--CA 1.461 0.117 0 O-C-N 121.638 -0.664 . . . . 0.0 112.456 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.56 152.59 8.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -37.23 151.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.301 2.64 . . . . 0.0 112.935 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.7 pp -71.07 -178.63 2.04 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.906 1.336 . . . . 0.0 109.684 161.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.99 146.36 14.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 36' ' ' LEU . 70.7 m-85 -139.42 -176.49 4.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.055 0.942 . . . . 0.0 110.798 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -137.78 172.69 6.37 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 -9.78 17.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.766 2.311 . . . . 0.0 116.19 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.8 -40.87 3.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 121.001 1.728 . . . . 0.0 112.646 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.53 -15.51 56.51 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.316 1.558 . . . . 0.0 112.278 -158.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mt -82.4 -22.82 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.146 1.779 . . . . 0.0 110.896 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -56.87 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.864 1.211 . . . . 0.0 109.784 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -75.25 -64.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.328 1.851 . . . . 0.0 108.255 -171.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.36 151.92 6.37 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HB3' ' H ' ' A' ' 51' ' ' GLN . 1.2 tttt -54.26 152.28 6.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 117.223 0.511 . . . . 0.0 110.005 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -42.7 -16.0 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 120.913 3.672 . . . . 0.0 120.913 -170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.536 ' H ' HE22 ' A' ' 51' ' ' GLN . 0.1 OUTLIER -122.67 -63.02 1.31 Allowed 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 119.539 -1.975 . . . . 0.0 109.611 156.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.5 t -170.07 21.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.826 1.651 . . . . 0.0 111.142 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.536 HE22 ' H ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -58.53 -55.01 40.5 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 119.71 -1.869 . . . . 0.0 111.59 -156.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.82 168.63 0.19 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 128.912 2.885 . . . . 0.0 107.922 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 156.37 35.31 Favored Pre-proline 0 C--N 1.322 -0.621 0 C-N-CA 125.34 1.456 . . . . 0.0 109.63 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.99 159.27 41.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.924 1.749 . . . . 0.0 111.52 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 155.33 28.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.15 2.18 . . . . 0.0 108.983 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.9 -8.44 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.824 1.25 . . . . 0.0 110.899 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.03 38.07 2.09 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 125.955 1.74 . . . . 0.0 109.654 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -121.87 164.79 16.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.663 0.744 . . . . 0.0 109.509 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.22 149.91 24.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.299 172.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -163.96 164.05 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.831 0.852 . . . . 0.0 111.774 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -122.23 99.84 6.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.736 2.414 . . . . 0.0 110.785 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -80.23 159.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.619 -1.301 . . . . 0.0 110.292 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 152.11 24.27 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.278 -0.889 . . . . 0.0 111.789 148.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.26 -178.52 45.18 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.998 1.761 . . . . 0.0 110.395 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.0 ttm -100.83 127.43 47.28 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 117.935 0.867 . . . . 0.0 111.579 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.73 125.88 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.2 mtt -57.04 151.1 36.25 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.484 0.584 . . . . 0.0 110.999 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.5 122.29 9.92 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.418 2.745 . . . . 0.0 108.077 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.7 4.85 48.61 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.872 -1.516 . . . . 0.0 115.538 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.9 p -64.68 -24.9 67.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.339 2.07 . . . . 0.0 110.962 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.68 105.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.588 1.555 . . . . 0.0 109.412 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 81' ' ' THR . 26.1 tt0 -60.22 -65.34 0.7 Allowed 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 126.606 1.963 . . . . 0.0 108.901 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 42.67 129.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 131.31 3.844 . . . . 0.0 115.759 -172.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -80.44 118.91 74.62 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.31 -8.13 22.76 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.558 1.506 . . . . 0.0 111.893 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -130.16 7.22 5.02 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.261 1.425 . . . . 0.0 111.126 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.11 -166.89 2.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mp -112.14 -4.92 14.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.245 1.018 . . . . 0.0 110.879 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.86 142.98 39.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 109.489 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.1 p -156.45 144.05 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 72' ' ' GLN . 30.0 p -121.81 151.3 40.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 165.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -146.4 178.09 8.53 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.786 0.834 . . . . 0.0 109.054 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -125.86 138.47 53.81 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.27 144.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.807 2.043 . . . . 0.0 106.694 176.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -140.45 171.05 14.68 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.091 1.357 . . . . 0.0 110.357 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.54 -164.6 2.04 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.961 1.304 . . . . 0.0 109.077 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.78 -4.37 6.49 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -112.84 -80.84 0.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -170.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.09 -156.11 6.88 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.575 1.083 . . . . 0.0 111.897 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.4 p -150.08 165.28 33.26 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 117.368 0.584 . . . . 0.0 111.688 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.49 138.31 44.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.041 1.736 . . . . 0.0 108.639 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 151.44 39.37 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.58 127.31 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.666 1.186 . . . . 0.0 109.772 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.538 ' OG ' HD13 ' A' ' 122' ' ' LEU . 2.1 p -97.47 135.53 39.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.015 1.326 . . . . 0.0 109.126 164.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 80' ' ' VAL . 32.1 t80 -142.09 169.65 17.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.928 1.691 . . . . 0.0 108.679 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -150.56 105.87 3.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.06 -165.32 36.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.724 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -19.47 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.881 0.472 . . . . 0.0 112.187 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 mt 67.13 151.87 0.12 Allowed Pre-proline 0 CA--C 1.527 0.088 0 C-N-CA 129.237 3.015 . . . . 0.0 112.177 -165.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -62.93 139.51 74.24 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.536 1.491 . . . . 0.0 108.25 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.78 -13.04 60.99 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.027 0.918 . . . . 0.0 110.333 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.31 -25.41 51.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 119.662 -1.899 . . . . 0.0 112.411 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.17 128.23 34.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.204 1.802 . . . . 0.0 112.238 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.07 170.29 16.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.954 1.301 . . . . 0.0 110.021 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.08 80.07 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.71 1.204 . . . . 0.0 108.866 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 32.1 0.47 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.449 1.023 . . . . 0.0 112.068 -170.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.31 166.79 21.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.931 1.366 . . . . 0.0 110.869 171.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.31 121.37 5.44 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.488 1.994 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.69 170.23 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.179 1.392 . . . . 0.0 108.541 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.77 100.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.636 1.974 . . . . 0.0 107.898 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -79.67 159.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -155.15 137.97 15.33 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.02 -105.77 0.23 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -150.51 157.91 43.55 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.459 1.63 . . . . 0.0 108.941 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' A' ' 60' ' ' LEU . 12.6 tp -80.55 146.4 31.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.318 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -103.44 -64.09 1.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.825 0.739 . . . . 0.0 111.05 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 167.05 158.41 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 129.699 3.199 . . . . 0.0 106.692 -168.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.54 22.53 46.06 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.945 -0.919 . . . . 0.0 114.036 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 73.52 29.32 1.6 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.386 1.875 . . . . 0.0 112.702 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -96.09 132.0 41.93 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.833 1.653 . . . . 0.0 109.018 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.7 mm -99.76 129.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 126.306 1.842 . . . . 0.0 109.599 172.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.538 HD13 ' OG ' ' A' ' 94' ' ' SER . 3.5 mm? -79.03 114.41 17.95 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 157.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.42 160.33 29.85 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.009 1.385 . . . . 0.0 109.357 162.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 -26.29 5.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.503 -1.681 . . . . 0.0 110.496 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -139.61 -41.48 0.45 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 111' ' ' VAL . 87.7 t 59.28 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.183 1.793 . . . . 0.0 111.878 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.72 157.97 45.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 120.648 -1.282 . . . . 0.0 108.052 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.58 37.35 4.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.954 1.302 . . . . 0.0 110.124 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.4 mmpm? 47.06 57.41 5.74 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.157 1.383 . . . . 0.0 112.512 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -76.78 -91.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -162.81 45.39 0.13 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.05 0.929 . . . . 0.0 108.947 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.9 112.63 24.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -124.5 31.38 5.75 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.924 1.29 . . . . 0.0 109.063 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -152.38 162.52 41.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.875 1.27 . . . . 0.0 108.045 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -129.42 112.41 18.01 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 168.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.33 141.33 74.46 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.909 1.74 . . . . 0.0 110.983 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -64.36 -57.2 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.463 2.109 . . . . 0.0 113.285 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.52 7.13 1.99 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.385 1.474 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.45 -17.67 6.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.949 2.499 . . . . 0.0 108.853 -165.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.85 -40.3 88.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.89 1.276 . . . . 0.0 109.839 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -98.61 113.67 25.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -52.59 124.77 14.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.463 0.477 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 ptt? . . . . . 0 C--O 1.256 1.411 0 C-N-CA 126.725 2.01 . . . . 0.0 108.953 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -149.98 -42.73 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.411 1.459 . . . . 0.0 113.332 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 m 65.75 -65.41 0.18 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.79 1.636 . . . . 0.0 114.812 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 61.72 135.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.976 1.71 . . . . 0.0 110.193 -151.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.263 55.9 mt 61.11 165.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 0.0 110.341 -172.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -71.16 173.12 8.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 110.156 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 60' ' ' LEU . 3.0 pp -71.2 -175.9 1.32 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.252 1.821 . . . . 0.0 111.892 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.47 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 40.4 t80 -171.19 158.29 5.42 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.591 3.156 . . . . 0.0 107.101 173.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.67 -178.9 6.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.629 1.972 . . . . 0.0 110.247 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 p -134.38 163.35 51.83 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 125.16 1.384 . . . . 0.0 111.682 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 91' ' ' VAL . 67.0 Cg_endo -76.07 71.63 5.59 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.602 3.534 . . . . 0.0 108.576 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.52 -66.78 0.15 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 105.44 -3.064 . . . . 0.0 105.44 -163.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.47 -33.5 71.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.131 1.465 . . . . 0.0 111.984 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.45 -11.71 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.354 1.061 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.65 -31.51 3.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.193 . . . . 0.0 111.646 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -98.09 -18.59 18.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.556 1.942 . . . . 0.0 112.218 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.7 147.69 16.99 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.869 1.223 . . . . 0.0 110.403 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 20.0 tptp -62.59 139.33 58.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.359 -1.781 . . . . 0.0 109.987 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.6 mtm-85 -18.18 -77.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.752 1.621 . . . . 0.0 113.972 -152.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.4 -87.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -174.38 36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.454 1.121 . . . . 0.0 108.541 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -41.63 42.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 119.443 -2.035 . . . . 0.0 109.444 -167.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.269 0.1 OUTLIER -174.42 -173.31 0.75 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.511 2.324 . . . . 0.0 111.461 161.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.2 mtp -126.5 162.77 44.72 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.819 1.648 . . . . 0.0 109.983 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.96 155.94 11.43 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.918 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.58 144.35 31.32 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.254 1.422 . . . . 0.0 111.523 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 115' ' ' LEU . 3.5 p -63.35 -20.82 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 113.001 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.41 59.85 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.88 176.61 9.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.041 1.42 . . . . 0.0 112.328 157.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.36 149.96 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.454 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -160.39 163.88 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.157 1.383 . . . . 0.0 113.262 166.556 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -101.53 140.77 35.38 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 126.549 1.94 . . . . 0.0 109.164 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -126.73 139.89 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.098 1.359 . . . . 0.0 108.251 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.44 137.25 12.01 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 163.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.64 -163.28 12.2 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.971 1.748 . . . . 0.0 109.364 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 ttm -126.71 127.53 45.26 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 126.525 1.93 . . . . 0.0 109.525 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 21.9 t -65.54 130.07 30.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.0 mtt -65.06 124.48 86.88 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.78 103.8 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.775 2.983 . . . . 0.0 106.649 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.49 -5.39 8.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-O 118.246 -1.308 . . . . 0.0 112.632 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.6 p -88.81 -44.19 10.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.467 1.634 . . . . 0.0 111.949 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.89 104.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.508 1.123 . . . . 0.0 110.951 -167.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.46 -66.22 0.58 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.773 1.629 . . . . 0.0 109.954 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 54.2 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.8 2.04 . . . . 0.0 112.048 -153.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.15 136.92 20.45 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -84.57 -9.48 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 121.027 1.403 . . . . 0.0 112.96 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -110.28 -19.18 13.09 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.147 0.885 . . . . 0.0 110.914 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -131.97 176.3 8.48 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.777 0.717 . . . . 0.0 109.167 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.37 4.82 53.36 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.266 -0.896 . . . . 0.0 111.095 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.58 145.14 55.93 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.233 -0.917 . . . . 0.0 108.974 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -157.81 132.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -130.98 109.45 10.53 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.768 1.627 . . . . 0.0 108.455 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.691 ' CE1' HG21 ' A' ' 93' ' ' VAL . 54.8 p90 -123.21 165.99 15.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.141 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 m -114.25 143.34 45.01 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 145.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.73 173.52 11.62 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.239 1.016 . . . . 0.0 109.591 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.14 -169.72 3.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.049 1.34 . . . . 0.0 107.47 164.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.84 -9.07 5.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.511 1.524 . . . . 0.0 114.015 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.12 -71.33 0.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.352 1.861 . . . . 0.0 107.002 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.07 -152.11 5.61 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.9 p -155.21 164.36 38.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.069 0.548 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 40' ' ' PRO . 31.1 m -147.38 154.87 11.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.894 1.678 . . . . 0.0 109.547 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.64 164.27 16.91 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.014 0.912 . . . . 0.0 110.307 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG21 ' CE1' ' A' ' 82' ' ' PHE . 1.3 m -132.7 156.46 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.103 1.361 . . . . 0.0 107.957 169.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.6 t -120.74 134.72 55.27 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 157.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 36.4 t80 -131.99 162.58 30.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.07 1.748 . . . . 0.0 107.403 168.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -141.13 103.61 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 168.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.53 163.88 26.25 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.2 tt -75.64 -22.1 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -164.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.501 ' CD2' HG11 ' A' ' 126' ' ' VAL . 55.6 mt 89.43 149.84 0.07 OUTLIER Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 131.377 3.871 . . . . 0.0 113.109 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -63.2 150.52 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 121.809 1.673 . . . . 0.0 109.576 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.29 -28.97 65.49 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.847 1.259 . . . . 0.0 109.74 163.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -79.16 -14.08 59.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 128.107 2.563 . . . . 0.0 114.098 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 109' ' ' VAL . 13.5 t80 -85.63 127.66 34.54 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 122.947 2.612 . . . . 0.0 106.877 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -134.54 162.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.254 1.026 . . . . 0.0 111.148 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.11 108.7 6.15 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.111 1.765 . . . . 0.0 108.273 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.478 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 96.99 37.86 4.53 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.103 0.858 . . . . 0.0 111.737 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -139.7 170.65 15.51 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.392 1.096 . . . . 0.0 111.646 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.17 136.95 40.33 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.111 0.862 . . . . 0.0 111.294 172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 103' ' ' PHE . 3.5 m -135.04 168.1 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.974 1.71 . . . . 0.0 107.15 170.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.46 107.65 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.52 157.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -150.28 139.09 20.83 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 128.014 2.526 . . . . 0.0 105.54 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.85 -118.21 0.81 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 104.343 -3.503 . . . . 0.0 104.343 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -141.17 156.97 45.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 119.717 1.759 . . . . 0.0 111.452 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.57 143.11 32.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -93.39 -72.34 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.295 1.038 . . . . 0.0 109.365 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.86 -86.07 0.17 Allowed 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.143 1.377 . . . . 0.0 109.134 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.87 -69.75 1.3 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -171.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -147.42 5.11 0.81 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -89.6 136.79 32.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 -167.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mm -107.96 127.23 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.742 1.217 . . . . 0.0 109.006 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.62 104.28 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 164.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.57 133.46 42.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.386 0.675 . . . . 0.0 109.301 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -21.82 15.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.574 1.55 . . . . 0.0 111.728 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -144.41 -38.31 0.29 Allowed 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 99' ' ' LEU . 78.3 t 58.1 106.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.368 1.867 . . . . 0.0 113.015 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -120.6 156.89 30.68 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 0.0 108.259 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -116.75 32.25 6.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.284 1.402 . . . . 0.0 112.483 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.79 16.11 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -82.76 60.28 5.22 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 127.269 2.228 . . . . 0.0 109.183 -172.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t70 60.03 11.12 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.529 2.331 . . . . 0.0 115.79 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -54.47 116.73 2.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.463 1.505 . . . . 0.0 108.116 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.3 -21.87 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.63 0.772 . . . . 0.0 111.918 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -162.6 137.19 6.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.013 1.725 . . . . 0.0 107.199 163.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.4 m -133.96 113.3 12.6 Favored Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.85 173.76 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.323 2.015 . . . . 0.0 110.568 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.62 -32.91 37.52 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.157 1.905 . . . . 0.0 112.43 168.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.98 34.79 0.36 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.21 1.404 . . . . 0.0 112.735 -160.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.468 ' HA ' ' HG3' ' A' ' 143' ' ' MET . 5.5 m -149.19 -43.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.766 1.626 . . . . 0.0 110.818 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -58.93 -30.56 67.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.389 0.676 . . . . 0.0 111.644 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.7 138.38 37.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.728 1.611 . . . . 0.0 107.446 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 44.7 67.42 0.7 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.37 2.268 . . . . 0.0 111.874 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.468 ' HG3' ' HA ' ' A' ' 139' ' ' VAL . 19.3 ttm . . . . . 0 C--O 1.25 1.13 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -146.52 112.99 5.94 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.191 2.196 . . . . 0.0 108.416 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -157.69 174.38 15.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 127.036 2.134 . . . . 0.0 106.841 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -159.6 -59.88 0.07 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 110.649 162.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.1 pt -71.76 -155.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 109.698 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -47.5 158.56 0.18 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.937 1.695 . . . . 0.0 111.974 168.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.1 pp -86.49 -175.93 5.65 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.623 1.569 . . . . 0.0 109.888 174.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -159.42 157.59 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.308 2.243 . . . . 0.0 106.492 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -143.36 177.86 8.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.997 1.719 . . . . 0.0 109.547 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 45.1 p -132.7 171.41 9.19 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 110.63 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.58 0.01 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.834 2.356 . . . . 0.0 114.803 162.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.84 25.33 7.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.718 1.151 . . . . 0.0 111.734 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' H ' ' A' ' 39' ' ' THR . 43.5 mt-10 -132.39 -41.17 0.98 Allowed 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.876 1.338 . . . . 0.0 110.69 173.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 7.4 mt -63.16 -23.5 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 118.326 0.512 . . . . 0.0 110.944 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -105.38 -53.9 2.58 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.521 1.528 . . . . 0.0 107.603 176.514 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CE1' HD12 ' A' ' 44' ' ' LEU . 18.5 m-30 -88.38 14.8 8.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -166.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.62 124.7 3.25 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -62.57 149.38 43.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.908 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt85 -19.46 -39.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 120.379 3.474 . . . . 0.0 120.379 -143.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -120.39 -72.91 0.67 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 166.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.3 t -164.49 23.22 0.06 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.295 0.638 . . . . 0.0 111.755 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -49.31 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 119.509 -1.994 . . . . 0.0 112.557 -170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.6 176.1 1.61 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.977 2.111 . . . . 0.0 107.915 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 83.4 mmm -114.57 158.55 39.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.838 1.255 . . . . 0.0 107.93 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.03 148.27 62.94 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.284 1.323 . . . . 0.0 109.649 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.87 146.65 33.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 117' ' ' LYS . 75.2 t -76.48 1.52 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.02 1.328 . . . . 0.0 112.018 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.63 38.39 1.37 Allowed Glycine 0 CA--C 1.51 -0.261 0 O-C-N 118.544 -2.597 . . . . 0.0 110.287 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.77 168.35 9.54 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 164.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -79.89 152.38 29.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.69 168.39 27.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.552 1.141 . . . . 0.0 111.229 165.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -114.4 136.45 52.98 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.954 2.102 . . . . 0.0 107.725 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.01 151.91 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.73 2.012 . . . . 0.0 107.777 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.32 149.69 17.9 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.4 179.17 48.9 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.388 0.995 . . . . 0.0 110.85 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.2 ttm -91.08 126.12 36.07 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.805 1.642 . . . . 0.0 109.968 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.84 130.04 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 O-C-N 120.445 -1.41 . . . . 0.0 108.198 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.1 mtt -62.9 139.19 97.33 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 118.54 0.609 . . . . 0.0 111.637 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.83 146.8 60.85 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.395 2.73 . . . . 0.0 108.941 163.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.22 20.97 75.52 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.414 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.5 m -120.22 -26.18 5.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.704 1.252 . . . . 0.0 112.15 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.05 93.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 119.318 0.963 . . . . 0.0 108.91 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -73.25 -66.11 0.72 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.124 1.77 . . . . 0.0 109.317 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 67.47 134.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 128.563 2.745 . . . . 0.0 110.868 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.97 125.28 91.18 Favored Pre-proline 0 C--N 1.335 -0.059 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.53 -16.48 54.05 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.709 1.646 . . . . 0.0 111.384 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.15 -18.5 20.07 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.219 -0.896 . . . . 0.0 112.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.15 -176.06 5.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.472 1.033 . . . . 0.0 111.821 -155.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.81 -1.04 38.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.154 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -60.25 139.15 57.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.281 1.039 . . . . 0.0 108.249 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 158.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.097 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 140.63 52.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 151.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 43.8 p90 -140.94 -179.11 5.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.999 0.919 . . . . 0.0 109.296 160.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.9 m -130.85 151.27 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.32 129.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -116.58 -177.51 3.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.093 1.757 . . . . 0.0 107.42 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -155.13 -141.65 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 155.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -18.74 65.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 121.266 1.848 . . . . 0.0 114.663 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.69 -69.69 0.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -151.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.63 -153.47 5.9 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.2 p -147.27 163.53 36.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.282 1.041 . . . . 0.0 112.008 170.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.92 138.56 38.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.54 1.936 . . . . 0.0 109.504 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.65 150.78 37.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 84' ' ' ILE . 5.0 m -127.24 152.77 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 164.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 p -125.99 128.36 47.35 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -125.83 170.58 11.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.37 1.868 . . . . 0.0 108.011 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -158.76 107.5 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.5 14.98 0.02 OUTLIER Glycine 0 N--CA 1.473 1.145 0 C-N-CA 114.409 -3.758 . . . . 0.0 121.265 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 99' ' ' LEU 0.265 0.4 OUTLIER 58.01 143.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.957 2.103 . . . . 0.0 110.186 -152.222 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.571 ' CD2' HG11 ' A' ' 126' ' ' VAL . 20.8 mt -92.08 162.67 29.87 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.525 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -58.32 147.87 82.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 166.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -66.15 -18.14 65.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.771 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.44 -31.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.858 -1.544 . . . . 0.0 112.493 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.9 137.9 58.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.572 1.078 . . . . 0.0 109.164 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -142.54 168.96 18.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.1 132.83 53.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 159.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.69 15.54 56.47 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.7 163.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -121.23 163.68 18.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.42 1.11 . . . . 0.0 111.545 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.91 124.08 10.15 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.84 162.39 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.99 134.31 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 126' ' ' VAL . 1.1 t -107.79 160.51 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -158.64 151.07 21.74 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 166.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 122' ' ' LEU . . . 156.07 -145.34 12.09 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.97 157.88 35.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.734 1.267 . . . . 0.0 109.463 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HB2' HD11 ' A' ' 60' ' ' LEU . 16.7 tp -84.56 137.08 33.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.15 -65.91 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' HG13 ' A' ' 56' ' ' VAL . 45.3 mtmt -163.9 154.84 15.87 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 133.956 4.902 . . . . 0.0 104.725 175.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -98.44 0.22 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -138.16 1.82 2.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -70.78 124.64 24.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.956 1.253 . . . . 0.0 109.772 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.28 122.45 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.66 1.584 . . . . 0.0 110.531 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 3.6 mm? -78.92 81.67 5.18 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 165.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.63 133.5 30.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.041 1.336 . . . . 0.0 109.892 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 -25.25 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.611 1.564 . . . . 0.0 111.196 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.45 -37.39 0.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 99' ' ' LEU . 60.3 t 52.19 113.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 127.068 2.147 . . . . 0.0 115.523 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.47 154.32 47.1 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.519 -1.363 . . . . 0.0 108.889 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.489 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -118.16 37.11 4.1 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.253 1.842 . . . . 0.0 111.894 -166.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 41.92 42.83 2.42 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.851 2.46 . . . . 0.0 112.304 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.489 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 1.4 p-80 -96.38 38.78 1.18 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.309 1.844 . . . . 0.0 110.526 -172.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 61.54 68.11 0.73 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.289 1.836 . . . . 0.0 112.123 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.98 175.55 7.62 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.318 1.447 . . . . 0.0 110.154 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.0 -42.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.37 1.468 . . . . 0.0 109.446 150.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -147.7 119.25 7.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.531 1.132 . . . . 0.0 110.531 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 m -91.82 134.58 28.74 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.31 176.62 8.97 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 122.47 2.113 . . . . 0.0 110.998 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.47 -36.28 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.408 2.072 . . . . 0.0 113.908 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -83.81 37.79 0.61 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.037 0.935 . . . . 0.0 111.164 -162.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -153.83 -30.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.846 2.058 . . . . 0.0 111.007 -167.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -74.55 -50.37 18.31 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.611 0.641 . . . . 0.0 110.334 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.1 93.06 0.28 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -177.21 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.425 1.89 . . . . 0.0 109.335 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.081 -1.438 . . . . 0.0 108.002 159.831 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 120.569 0.223 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.06 154.09 42.06 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p -158.35 -177.94 6.91 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.662 1.585 . . . . 0.0 107.528 161.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -135.89 172.75 12.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 151.04 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 161.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.41 114.93 0.01 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.781 2.832 . . . . 0.0 113.613 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.67 147.12 33.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.771 2.028 . . . . 0.0 111.318 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -150.54 139.46 20.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.219 -166.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -140.68 -174.74 4.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.595 1.958 . . . . 0.0 107.7 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 26.0 p -141.26 174.48 3.83 Favored Pre-proline 0 C--O 1.235 0.325 0 O-C-N 120.542 -1.349 . . . . 0.0 110.542 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 7.6 Cg_endo -57.69 0.88 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 171.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -108.22 -41.94 1.46 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 121.789 2.086 . . . . 0.0 112.904 163.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 5.8 pt-20 -80.44 -2.61 46.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 119.607 1.704 . . . . 0.0 113.249 -162.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.55 -18.11 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.135 0.974 . . . . 0.0 110.38 166.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.61 -47.68 5.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.79 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -87.51 -26.37 23.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.364 1.466 . . . . 0.0 110.907 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.9 146.17 9.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.664 1.602 . . . . 0.0 110.301 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 44.8 tttm -57.11 139.68 51.68 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 117.971 -1.014 . . . . 0.0 112.228 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -18.18 -66.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 -150.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -74.83 -89.36 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 t -159.99 27.37 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.33 1.062 . . . . 0.0 109.9 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -26.45 60.87 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 119.584 -1.947 . . . . 0.0 113.266 -161.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 178.1 173.52 0.61 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.951 2.5 . . . . 0.0 110.796 163.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.25 145.1 29.25 Favored Pre-proline 0 C--O 1.241 0.645 0 C-N-CA 126.891 2.076 . . . . 0.0 108.267 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.2 134.48 45.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.667 2.245 . . . . 0.0 109.371 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.29 130.7 35.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.664 ' HA ' HD23 ' A' ' 115' ' ' LEU . 14.8 p -70.22 -11.1 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.418 0.627 . . . . 0.0 112.192 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.27 3.73 61.93 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 116.885 -2.064 . . . . 0.0 113.009 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HG3' HD12 ' A' ' 60' ' ' LEU . 1.5 pt20 -110.01 167.2 10.35 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.893 2.347 . . . . 0.0 112.766 -168.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -85.29 137.54 32.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 108.669 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -157.99 173.37 16.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.217 1.007 . . . . 0.0 110.175 171.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -122.34 157.36 31.96 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 111.136 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -131.96 143.24 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.571 1.948 . . . . 0.0 107.326 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.19 127.51 5.91 Favored Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 168.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.51 -178.89 38.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.7 ttm -105.22 129.71 53.54 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.028 0.931 . . . . 0.0 110.277 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.99 129.01 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.289 0.95 . . . . 0.0 108.925 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' MET . . . . . 0.476 ' HG3' ' CD1' ' A' ' 85' ' ' TYR . 5.3 mtm -68.9 149.45 97.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.489 0.586 . . . . 0.0 110.967 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.31 137.97 24.18 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.355 2.703 . . . . 0.0 108.966 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.59 57.9 15.68 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -142.62 -30.58 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 164.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.706 HG22 ' HG2' ' A' ' 73' ' ' ARG 0.303 2.2 p -75.16 95.54 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 120.833 -1.167 . . . . 0.0 111.855 -173.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.05 28.56 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 131.469 3.908 . . . . 0.0 113.896 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.706 ' HG2' HG22 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.37 146.07 25.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.41 1.084 . . . . 0.0 110.84 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -104.18 134.95 19.43 Favored Pre-proline 0 N--CA 1.448 -0.529 0 O-C-N 123.77 0.668 . . . . 0.0 109.215 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.66 -14.21 19.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.566 2.178 . . . . 0.0 112.535 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -109.1 -7.6 15.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 127.653 2.381 . . . . 0.0 111.881 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.6 m -151.56 171.92 16.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 120.007 1.276 . . . . 0.0 110.299 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.76 -8.14 47.66 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.201 -0.937 . . . . 0.0 111.402 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 137.27 57.15 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 109.387 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -161.15 127.2 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.0 p -105.47 159.94 15.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 93' ' ' VAL . 53.3 p90 -153.82 -178.4 7.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.042 0.837 . . . . 0.0 110.059 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 m -129.92 142.4 50.66 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.467 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -126.7 136.78 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' HG3' ' A' ' 67' ' ' MET . 15.8 p90 -135.21 169.9 16.75 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.096 1.359 . . . . 0.0 109.559 -173.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.75 -166.76 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.339 1.855 . . . . 0.0 107.692 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -3.52 1.76 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.834 2.054 . . . . 0.0 114.972 -171.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -111.6 -62.28 1.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.819 1.248 . . . . 0.0 107.73 -173.454 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.26 -167.98 17.08 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.896 1.712 . . . . 0.0 112.005 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.9 p -137.51 164.04 29.69 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.92 0.888 . . . . 0.0 112.006 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.98 144.64 25.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.121 1.368 . . . . 0.0 109.501 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.97 152.52 30.98 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.209 1.004 . . . . 0.0 108.641 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.551 HG21 ' CE1' ' A' ' 82' ' ' PHE . 3.4 m -132.65 147.95 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.354 163.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -119.92 112.45 19.21 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.263 1.825 . . . . 0.0 108.557 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.592 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.4 t80 -112.88 166.51 11.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 108.32 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.13 97.89 1.96 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 168.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.65 -174.07 46.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.508 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.04 118.93 21.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.5 tp -97.14 135.3 21.99 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 109.113 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.45 156.9 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.154 1.903 . . . . 0.0 112.435 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.92 -40.8 75.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 123.098 1.428 . . . . 0.0 108.957 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.44 -27.02 68.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.766 1.626 . . . . 0.0 111.715 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.478 ' HE1' HG21 ' A' ' 71' ' ' VAL . 34.3 t80 -66.29 106.64 1.75 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 119.374 0.988 . . . . 0.0 108.867 -174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -133.16 158.84 41.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.21 1.004 . . . . 0.0 109.829 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.71 105.48 3.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.628 1.571 . . . . 0.0 107.462 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.05 26.19 7.57 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.384 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.21 163.87 17.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.663 1.731 . . . . 0.0 110.508 160.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.88 138.2 19.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.61 174.47 12.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.36 1.464 . . . . 0.0 107.237 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.15 137.43 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 121' ' ' ILE . 1.3 t -117.04 156.82 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.249 1.42 . . . . 0.0 107.508 165.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.21 141.88 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 127.072 2.149 . . . . 0.0 106.645 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.33 -103.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 166.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -142.89 161.35 38.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.983 1.892 . . . . 0.0 109.418 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 56' ' ' VAL . 13.4 tp -81.16 144.3 31.75 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -101.82 -72.53 0.68 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.319 0.509 . . . . 0.0 109.979 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -163.69 -83.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.147 2.179 . . . . 0.0 108.158 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.56 73.34 2.07 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.175 1.369 . . . . 0.0 111.555 -162.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.2 m120 44.49 46.39 8.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.304 1.841 . . . . 0.0 110.542 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -122.16 129.39 52.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.543 1.137 . . . . 0.0 108.395 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.4 HG21 HG12 ' A' ' 111' ' ' VAL . 16.5 mm -103.69 132.9 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.506 1.522 . . . . 0.0 109.487 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.17 114.37 18.06 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 159.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.009 170.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 -35.83 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.76 2.874 . . . . 0.0 118.76 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.9 t 50.65 122.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.39 1.876 . . . . 0.0 115.337 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.79 156.02 49.59 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 119.893 -1.754 . . . . 0.0 108.308 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.83 30.06 7.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 112.268 -168.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 41.88 60.34 2.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 123.008 1.385 . . . . 0.0 112.178 -172.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -106.83 53.9 0.69 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.215 2.206 . . . . 0.0 108.853 167.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.1 t0 51.2 72.59 0.35 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.38 1.872 . . . . 0.0 112.91 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.18 149.36 51.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 109.869 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -170.73 -39.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.612 1.565 . . . . 0.0 110.746 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -143.49 176.77 8.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.466 1.906 . . . . 0.0 108.734 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 m -151.27 132.46 7.64 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.226 1.81 . . . . 0.0 106.99 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.09 174.93 1.58 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.202 2.602 . . . . 0.0 112.528 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.95 -168.93 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.307 2.005 . . . . 0.0 110.533 161.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.82 46.37 19.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.731 1.212 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.3 p -165.7 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.947 2.099 . . . . 0.0 109.554 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.98 -37.89 75.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.188 1.795 . . . . 0.0 111.094 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -150.49 -175.84 5.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.417 3.487 . . . . 0.0 105.535 167.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 49.43 74.6 0.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 0.0 112.513 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 C--O 1.257 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 108.517 170.317 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.911 0.386 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -153.08 119.8 5.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 t -153.18 157.51 40.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -142.41 35.78 1.49 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.129 1.371 . . . . 0.0 109.431 -169.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.2 157.81 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -49.22 112.79 0.68 Allowed 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 127.818 2.447 . . . . 0.0 108.562 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.73 173.91 10.49 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.122 1.369 . . . . 0.0 110.608 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -161.84 150.69 15.6 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.418 1.887 . . . . 0.0 109.107 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.04 172.35 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.897 1.279 . . . . 0.0 111.549 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.4 p -135.59 158.72 73.71 Favored Pre-proline 0 C--O 1.243 0.762 0 C-N-CA 125.168 1.387 . . . . 0.0 111.591 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.76 78.58 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.975 3.784 . . . . 0.0 109.567 164.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.71 -63.16 0.22 Allowed Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 106.587 -2.605 . . . . 0.0 106.587 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.48 -21.47 66.34 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 122.149 -0.618 . . . . 0.0 110.39 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -77.45 -13.31 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.108 1.763 . . . . 0.0 110.683 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.11 -54.33 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.411 1.484 . . . . 0.0 107.499 -163.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -77.65 -78.87 0.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.962 2.505 . . . . 0.0 107.171 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.16 152.7 8.68 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.45 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' A' ' 52' ' ' GLN . 3.5 tptm -49.31 114.89 1.13 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.291 1.436 . . . . 0.0 110.972 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -79.67 -15.85 56.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 119.194 0.906 . . . . 0.0 112.384 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.73 -48.62 73.92 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.024 0.829 . . . . 0.0 110.826 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -152.43 -1.76 0.27 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -151.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 35.47 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 128.142 2.577 . . . . 0.0 111.837 -166.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 82.1 mt-30 -119.92 -37.96 3.03 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.813 1.245 . . . . 0.0 112.661 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.3 mtp 59.96 155.02 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 129.284 3.033 . . . . 0.0 114.202 -173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.22 149.11 15.13 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.8 1.667 . . . . 0.0 109.285 168.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.01 148.65 31.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.19 -9.82 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.239 1.016 . . . . 0.0 111.149 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.44 61.59 0.43 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 168.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.64 174.41 14.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.799 1.3 . . . . 0.0 112.942 163.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -80.75 147.29 30.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.734 1.214 . . . . 0.0 108.88 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.1 165.23 24.89 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -97.46 144.58 27.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.002 2.921 . . . . 0.0 108.746 167.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.1 t -128.98 146.36 34.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.703 1.601 . . . . 0.0 108.167 167.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.41 139.07 10.63 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.33 -169.01 28.37 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 ttm -107.46 124.61 50.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.062 1.431 . . . . 0.0 109.682 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.737 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -55.24 130.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.4 ttm -63.0 124.52 84.06 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.89 134.44 46.61 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.831 2.354 . . . . 0.0 108.465 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.58 7.93 85.48 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.032 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.5 p -98.17 -32.73 11.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.755 1.777 . . . . 0.0 113.71 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 p -77.2 123.37 33.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 118.889 0.768 . . . . 0.0 110.166 -167.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -95.41 127.2 41.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 152.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -114.53 128.98 56.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 161.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.05 133.89 78.17 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.065 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.67 -2.47 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.376 2.051 . . . . 0.0 111.092 167.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.74 8.97 6.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.739 2.016 . . . . 0.0 110.731 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -150.86 178.99 8.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.217 1.407 . . . . 0.0 108.7 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.745 HD22 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -96.8 -6.86 35.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.86 1.664 . . . . 0.0 111.685 162.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 144.78 46.53 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.745 1.611 . . . . 0.0 109.226 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 99' ' ' LEU . 1.6 p -155.85 136.39 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 6.6 p -118.37 152.47 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 167.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 26.0 p90 -153.02 -178.57 7.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.842 0.746 . . . . 0.0 109.796 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m -124.04 154.61 39.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -135.27 134.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -121.98 178.33 4.94 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.38 -148.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.35 61.66 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.764 -1.21 . . . . 0.0 113.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.3 -64.17 1.3 Allowed 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.475 1.11 . . . . 0.0 109.085 -162.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.81 -157.44 7.58 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.7 p -145.22 162.54 36.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.286 0.543 . . . . 0.0 112.265 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.65 154.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.166 2.186 . . . . 0.0 108.826 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 155.56 16.91 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.03 1.332 . . . . 0.0 109.481 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 14.5 t -139.23 128.66 30.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 123.574 0.75 . . . . 0.0 109.082 175.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -110.85 117.23 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.066 1.347 . . . . 0.0 107.451 162.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 19.5 t80 -121.37 159.64 25.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.618 1.567 . . . . 0.0 107.071 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 78' ' ' LEU . 15.4 tt0 -146.68 90.12 1.9 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.51 -171.85 44.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.872 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.91 115.77 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.675 HD22 HG21 ' A' ' 80' ' ' VAL . 15.1 tp -89.34 131.85 39.21 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.5 138.06 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.442 -1.407 . . . . 0.0 108.442 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.92 -20.81 65.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.06 0.933 . . . . 0.0 109.396 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.2 -21.71 63.94 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.304 1.442 . . . . 0.0 110.439 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -71.0 134.98 47.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.895 1.278 . . . . 0.0 109.252 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.407 ' O ' HG11 ' A' ' 66' ' ' VAL . 12.2 mmt180 -138.35 -177.04 4.67 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.95 127.63 52.87 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.737 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 80.71 31.67 35.64 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 118.077 -1.402 . . . . 0.0 110.992 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.14 168.08 10.89 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.042 1.421 . . . . 0.0 110.368 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.01 133.44 18.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.04 165.78 29.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.269 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 129' ' ' LYS . 3.1 t -124.81 117.21 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 166.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -92.06 159.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.189 0.995 . . . . 0.0 108.65 162.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -154.04 146.6 24.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.889 1.676 . . . . 0.0 107.195 162.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.03 -104.26 0.2 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 161.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.64 154.04 46.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 119.219 1.51 . . . . 0.0 109.623 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 144.52 39.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -104.3 -83.75 0.49 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.782 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 -82.15 0.11 Allowed 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.544 1.066 . . . . 0.0 111.13 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.53 73.4 2.22 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -169.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m120 51.96 56.41 7.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.836 1.254 . . . . 0.0 109.205 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -135.3 123.7 23.32 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.2 130.76 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.127 1.371 . . . . 0.0 107.745 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.38 110.13 13.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 157.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -73.45 154.36 39.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 122.076 0.941 . . . . 0.0 109.822 168.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -17.96 7.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.425 1.89 . . . . 0.0 111.997 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -143.18 -43.27 0.29 Allowed 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.49 HG11 HD11 ' A' ' 99' ' ' LEU . 99.8 t 54.13 121.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 123.686 1.708 . . . . 0.0 113.638 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 mt -130.58 155.37 46.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.796 1.238 . . . . 0.0 108.094 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.9 39.9 3.26 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.312 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.696 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 40.34 57.5 2.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.595 1.958 . . . . 0.0 113.356 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.88 62.4 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t0 41.49 65.35 0.86 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.639 1.576 . . . . 0.0 112.41 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -94.69 137.45 33.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -151.08 166.18 31.57 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.618 1.567 . . . . 0.0 109.202 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -53.58 143.2 20.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.435 1.094 . . . . 0.0 110.583 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -135.16 138.9 30.27 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.773 1.629 . . . . 0.0 108.284 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.78 130.62 19.64 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.492 2.128 . . . . 0.0 109.948 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -60.29 -56.7 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.202 2.602 . . . . 0.0 114.917 -168.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -83.26 45.11 1.0 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.207 0.603 . . . . 0.0 110.521 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.1 t -140.35 -64.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.98 -31.09 64.69 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.129 1.372 . . . . 0.0 113.553 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 54.47 1.5 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.92 -36.48 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.495 1.118 . . . . 0.0 110.751 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 C--O 1.252 1.227 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 163.876 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -167.59 178.12 5.54 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 128.749 2.819 . . . . 0.0 107.622 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.2 m -69.99 -43.37 71.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.13 1.332 . . . . 0.0 110.505 163.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 50.6 -155.88 0.12 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.153 0.981 . . . . 0.0 109.509 -161.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG22 ' H ' ' A' ' 35' ' ' ASP . 4.7 mm -135.09 -177.24 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.782 2.433 . . . . 0.0 105.016 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' H ' HG22 ' A' ' 34' ' ' ILE . 4.1 m-20 -54.96 150.97 9.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.746 2.018 . . . . 0.0 112.295 -172.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 175.68 2.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 123.5 1.619 . . . . 0.0 109.535 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -166.26 153.62 9.84 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.195 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CE1' ' HD2' ' A' ' 47' ' ' LYS . 97.6 m-85 -144.91 -179.9 6.91 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.715 1.606 . . . . 0.0 108.73 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.624 ' HA ' HG23 ' A' ' 62' ' ' VAL . 12.1 p -139.38 177.09 2.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.64 -13.53 22.26 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 CA-C-N 120.661 1.272 . . . . 0.0 111.567 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.87 -45.59 5.66 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 165.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 39' ' ' THR . 45.4 mt-10 -63.83 -30.78 71.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.029 1.414 . . . . 0.0 111.177 -167.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.01 -21.43 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.43 1.013 . . . . 0.0 111.238 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.94 -44.98 4.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.562 1.074 . . . . 0.0 111.433 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -98.12 -9.94 25.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.5 1.92 . . . . 0.0 113.23 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.9 133.9 5.18 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 26.5 tttm -59.4 131.11 49.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.299 -1.118 . . . . 0.0 109.161 160.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -18.82 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 1 C-N-CA 133.961 4.904 . . . . 0.0 121.346 -142.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.03 -76.21 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 120.732 1.605 . . . . 0.0 107.047 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 t -170.99 20.7 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.818 1.647 . . . . 0.0 108.969 -170.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' CD ' ' HG2' ' A' ' 47' ' ' LYS . 1.4 pt20 -69.78 -55.94 8.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.245 -1.534 . . . . 0.0 110.065 -157.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.55 164.86 21.61 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.644 1.978 . . . . 0.0 107.369 167.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.1 mtp -116.94 166.65 12.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.792 1.237 . . . . 0.0 108.432 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 172.15 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.261 1.486 . . . . 0.0 110.85 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -89.17 139.49 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.011 1.324 . . . . 0.0 107.684 163.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.9 0.59 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.824 1.249 . . . . 0.0 110.275 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.48 56.96 0.72 Allowed Glycine 0 N--CA 1.451 -0.305 0 O-C-N 120.196 -1.565 . . . . 0.0 111.847 164.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -141.36 -175.47 4.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.162 0.981 . . . . 0.0 111.314 166.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.88 141.03 36.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.117 0.967 . . . . 0.0 110.376 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -179.62 8.02 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.408 1.483 . . . . 0.0 111.082 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -122.65 151.53 41.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.071 2.148 . . . . 0.0 110.751 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -148.98 128.55 3.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 120.261 3.43 . . . . 0.0 120.261 169.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.85 141.51 18.66 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.405 1.002 . . . . 0.0 110.82 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.34 177.67 47.82 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 119.427 -0.652 . . . . 0.0 113.153 166.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 35.2 ttm -102.36 129.74 48.91 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.481 1.112 . . . . 0.0 110.152 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.9 132.14 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.358 1.063 . . . . 0.0 109.643 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtt -62.47 132.61 94.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.292 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.15 131.3 29.97 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.901 1.734 . . . . 0.0 108.714 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.17 72.73 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.702 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -86.14 -74.39 0.42 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 159.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.282 2.6 p -37.66 88.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 130.616 3.566 . . . . 0.0 114.816 -170.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -77.6 137.84 38.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 127.467 2.307 . . . . 0.0 105.553 163.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 -136.86 128.18 28.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.28 98.24 11.72 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.38 -14.54 45.53 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 CA-C-N 120.62 1.257 . . . . 0.0 110.861 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.41 -12.97 35.91 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 117.129 -1.415 . . . . 0.0 112.716 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -135.73 4.41 3.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 121.512 1.96 . . . . 0.0 114.302 -177.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER 47.06 -2.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.346 3.058 . . . . 0.0 116.224 -162.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -56.63 149.16 18.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.276 1.83 . . . . 0.0 109.69 175.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.6 148.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 166.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 p -131.94 119.8 21.61 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.27 168.04 20.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.233 0.613 . . . . 0.0 109.603 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -122.99 147.31 46.78 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.91 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.09 174.34 10.61 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.298 1.039 . . . . 0.0 110.27 -170.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.11 -168.9 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.174 2.189 . . . . 0.0 106.266 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.03 -4.35 16.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.9 -66.77 0.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.45 -163.47 11.99 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.371 1.462 . . . . 0.0 110.681 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.9 p -150.94 158.71 44.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.013 0.906 . . . . 0.0 111.251 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.66 150.23 20.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 108.721 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 157.57 23.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' CG2' HD11 ' A' ' 84' ' ' ILE . 98.4 t -133.1 120.8 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 168.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 m -91.56 121.79 33.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 152.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.11 171.44 7.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 164.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -162.15 99.06 1.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.82 -144.71 9.11 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.214 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.82 91.8 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.47 130.03 87.36 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.901 -1.499 . . . . 0.0 107.868 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -54.84 138.31 76.92 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.031 1.82 . . . . 0.0 109.359 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -56.78 -31.84 65.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.672 0.749 . . . . 0.0 111.197 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.32 -22.32 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 114.63 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.98 131.79 44.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.927 1.24 . . . . 0.0 108.835 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -140.96 170.29 16.02 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.014 -1.054 . . . . 0.0 109.468 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -73.41 123.16 23.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.49 26.55 25.01 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 123.381 0.515 . . . . 0.0 113.269 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.47 171.69 10.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.555 1.142 . . . . 0.0 109.684 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.74 128.02 9.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.999 1.762 . . . . 0.0 109.054 -173.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.35 175.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.05 139.57 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.622 1.969 . . . . 0.0 106.668 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG12 HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -113.37 164.84 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -160.4 143.0 13.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.527 1.931 . . . . 0.0 107.627 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.59 -124.1 1.67 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 105.098 -3.201 . . . . 0.0 105.098 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -128.9 156.91 42.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 120.127 1.963 . . . . 0.0 109.192 -161.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.73 137.73 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.843 0.857 . . . . 0.0 109.482 171.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -84.0 0.42 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.995 0.816 . . . . 0.0 109.063 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.91 167.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.714 3.206 . . . . 0.0 106.299 -172.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.24 50.14 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.96 -0.911 . . . . 0.0 113.151 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 m120 62.66 58.19 1.66 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 0.0 111.087 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -131.32 127.49 37.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.44 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.5 mm -102.63 125.92 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 126.675 1.99 . . . . 0.0 109.037 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.52 83.97 5.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.47 148.2 9.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.112 0.958 . . . . 0.0 112.25 165.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -18.76 8.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 128.384 2.674 . . . . 0.0 110.912 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.33 -51.64 0.48 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.8 t 60.69 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.097 2.159 . . . . 0.0 112.394 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.97 146.49 47.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.746 -1.221 . . . . 0.0 107.897 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.41 34.66 3.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.854 0.862 . . . . 0.0 110.563 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt 38.94 53.78 2.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.704 1.602 . . . . 0.0 114.708 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -96.92 -91.73 0.24 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.78 118.03 5.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.83 164.44 35.76 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 127.128 2.171 . . . . 0.0 106.166 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.5 173.92 10.97 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -162.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -119.47 118.63 31.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.179 0.99 . . . . 0.0 111.801 -163.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.3 m -79.21 123.86 84.58 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.387 1.875 . . . . 0.0 106.866 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 56.7 Cg_endo -69.67 -178.1 2.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 1 C-N-CA 125.874 4.383 . . . . 0.0 110.907 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 136' ' ' PRO . 44.1 Cg_endo -80.04 -179.36 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.945 1.763 . . . . 0.0 110.537 172.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 50.23 64.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 129.164 2.986 . . . . 0.0 110.794 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.52 -34.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.028 1.731 . . . . 0.0 109.821 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.62 -70.84 0.16 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.171 2.188 . . . . 0.0 111.6 -167.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.6 150.89 42.62 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 76.51 26.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 113.256 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmt . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.354 -1.308 . . . . 0.0 107.988 151.603 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -157.26 169.54 24.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 129.017 2.927 . . . . 0.0 107.115 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 t -150.47 -173.41 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.086 0.954 . . . . 0.0 109.135 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.57 -179.21 0.32 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.181 2.993 . . . . 0.0 106.54 168.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.98 148.55 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 156.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 68.34 139.14 0.03 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 128.185 2.594 . . . . 0.0 114.913 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.8 pp -90.65 176.81 6.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.133 1.373 . . . . 0.0 108.83 166.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -174.53 135.39 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.11 2.164 . . . . 0.0 106.074 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.09 176.71 6.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.509 1.524 . . . . 0.0 109.202 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 61.5 p -136.24 173.85 5.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.645 1.578 . . . . 0.0 108.545 173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 73.4 Cg_endo -75.74 -13.36 19.95 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.685 1.59 . . . . 0.0 112.205 -166.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.25 -45.75 7.33 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 162.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 39' ' ' THR . 30.3 mt-10 -60.17 -29.17 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.334 2.067 . . . . 0.0 113.036 -168.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mt -73.34 -22.26 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.475 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -35.51 3.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.478 -169.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.86 -31.27 18.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.482 2.313 . . . . 0.0 110.518 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.64 149.46 7.47 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.251 1.405 . . . . 0.0 111.869 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -62.13 133.53 55.36 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 122.013 -0.698 . . . . 0.0 110.826 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -18.52 -68.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.836 1.654 . . . . 0.0 115.308 -136.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -71.43 -58.63 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -174.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t 170.75 33.84 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.929 2.892 . . . . 0.0 110.326 163.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -80.89 14.61 2.13 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.557 -1.964 . . . . 0.0 113.855 -160.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 146.8 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 1 C-N-CA 133.802 4.841 . . . . 0.0 109.581 171.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 40.9 mtp -114.38 159.0 38.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.337 1.455 . . . . 0.0 107.211 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 158.01 59.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 CA-C-N 121.432 1.547 . . . . 0.0 110.085 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.43 144.9 33.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 165.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' HD13 ' A' ' 115' ' ' LEU . 7.1 p -82.9 -7.25 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.625 0.77 . . . . 0.0 111.582 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.55 43.18 1.72 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.748 1.166 . . . . 0.0 110.512 165.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.5 pt20 -141.52 169.32 17.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.127 1.964 . . . . 0.0 113.047 172.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -87.92 140.58 29.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.041 2.537 . . . . 0.0 108.609 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -155.12 -174.59 5.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.495 0.718 . . . . 0.0 110.621 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -134.38 147.21 50.46 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.148 1.779 . . . . 0.0 107.485 169.629 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.28 130.48 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.177 1.791 . . . . 0.0 106.532 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.65 157.01 20.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 163.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.68 41.62 Favored Glycine 0 C--O 1.236 0.26 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.2 ttm -99.01 125.31 44.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.37 121.12 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 3.7 ttm -64.16 126.84 91.11 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.93 154.43 73.21 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.28 1.987 . . . . 0.0 108.368 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.76 44.55 80.57 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.778 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -133.12 -38.43 0.96 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.895 1.348 . . . . 0.0 113.225 169.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.269 1.6 p -64.57 92.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.567 1.076 . . . . 0.0 112.059 -172.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 5.9 pt20 -82.07 86.46 6.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.892 2.477 . . . . 0.0 107.703 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.75 142.3 40.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.29 108.73 6.74 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.68 -5.37 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 122.215 1.827 . . . . 0.0 111.22 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -119.9 13.74 12.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 110.492 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.61 -160.01 0.98 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.055 1.298 . . . . 0.0 108.655 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.9 -7.85 8.4 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.583 0.753 . . . . 0.0 110.89 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.99 131.03 46.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 164.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.25 130.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.417 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 92.0 m -126.46 134.45 50.96 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -171.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.35 176.38 10.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.231 -1.543 . . . . 0.0 110.352 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 m -123.18 145.78 48.34 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.68 142.24 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.285 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -137.99 171.99 13.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.635 1.174 . . . . 0.0 109.516 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.09 -169.07 3.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.299 1.439 . . . . 0.0 107.383 168.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 9.99 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.582 1.553 . . . . 0.0 114.412 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.47 -67.11 0.78 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.003 1.321 . . . . 0.0 109.504 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.32 -175.47 13.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.1 p -143.51 158.08 43.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.297 1.039 . . . . 0.0 109.973 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.9 m -141.37 149.01 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.627 1.171 . . . . 0.0 109.707 -171.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.13 148.0 26.35 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.99 1.316 . . . . 0.0 107.883 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 84' ' ' ILE . 23.5 t -138.01 119.09 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.104 0.961 . . . . 0.0 108.779 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 t -91.94 129.65 37.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 159.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -124.23 163.78 20.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.653 1.181 . . . . 0.0 108.747 166.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -144.87 100.17 3.45 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.88 -179.4 43.58 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -71.36 -24.38 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 122.064 -0.668 . . . . 0.0 111.84 -159.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 99' ' ' LEU . 7.8 tp 65.36 129.24 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.727 0 C-N-CA 128.803 2.841 . . . . 0.0 110.623 -166.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 4.5 Cg_exo -66.03 169.04 14.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.255 3.303 . . . . 0.0 110.689 -168.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.49 -36.07 77.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.982 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -35.34 63.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.568 2.747 . . . . 0.0 113.025 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -63.76 131.88 49.23 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.466 1.03 . . . . 0.0 109.092 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -143.14 161.0 39.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.882 0.873 . . . . 0.0 111.313 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -64.06 117.39 7.01 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.86 4.95 16.17 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.958 -0.912 . . . . 0.0 114.938 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.7 167.04 20.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.925 1.363 . . . . 0.0 112.151 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.05 137.28 15.34 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 125.737 1.637 . . . . 0.0 109.977 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.82 168.61 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.95 108.91 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 127.652 2.381 . . . . 0.0 106.541 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 126' ' ' VAL . 2.8 t -80.26 158.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 124.717 1.207 . . . . 0.0 108.986 161.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 5.6 tt0 -156.67 147.15 21.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 129.439 3.096 . . . . 0.0 105.716 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.84 -112.39 0.52 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -147.63 159.34 43.88 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 119.734 1.767 . . . . 0.0 110.41 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -86.02 142.61 28.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.117 0.967 . . . . 0.0 108.589 172.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 -84.25 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.55 1.14 . . . . 0.0 108.185 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -166.92 154.53 9.32 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 128.94 2.896 . . . . 0.0 106.709 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.6 42.91 99.85 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.16 40.88 30.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 111.929 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -109.82 124.36 51.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.476 HG21 ' CG1' ' A' ' 111' ' ' VAL . 18.1 mm -96.28 131.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.711 1.204 . . . . 0.0 108.649 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.88 114.21 17.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 154.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 149.22 39.94 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.874 0.845 . . . . 0.0 108.849 161.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -21.85 11.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.606 1.163 . . . . 0.0 111.173 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -146.17 -47.13 0.2 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.242 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 111' ' ' VAL . 46.0 t 59.24 150.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.243 1.817 . . . . 0.0 109.371 -167.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.0 mt -147.89 151.59 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 119.192 -2.193 . . . . 0.0 107.045 172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.14 33.88 3.76 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.681 1.128 . . . . 0.0 112.674 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt 54.45 30.23 12.51 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -70.45 45.74 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.419 -2.051 . . . . 0.0 111.582 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.0 t0 55.06 46.76 23.47 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.14 0.976 . . . . 0.0 112.529 165.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -55.66 3.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.066 0.946 . . . . 0.0 110.911 -167.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.263 92.6 m-20 39.02 -165.81 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.629 2.772 . . . . 0.0 113.672 -161.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -59.93 129.43 41.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.909 -1.12 . . . . 0.0 109.104 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.49 HG22 HG11 ' A' ' 139' ' ' VAL . 23.8 m -127.07 134.88 26.61 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -66.88 176.38 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.047 3.165 . . . . 0.0 111.272 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.62 -173.78 1.87 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.529 2.152 . . . . 0.0 110.866 164.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 61.34 32.91 19.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.267 1.827 . . . . 0.0 111.57 -176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 135' ' ' THR . 9.1 p -146.99 -143.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 139' ' ' VAL . 1.9 tp10 72.65 -73.66 0.1 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 129.557 3.143 . . . . 0.0 110.911 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -39.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 124.599 1.187 . . . . 0.0 111.724 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.17 66.7 1.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.707 1.203 . . . . 0.0 109.003 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.1 mtp . . . . . 0 C--O 1.251 1.146 0 C-N-CA 126.704 2.001 . . . . 0.0 109.568 -162.42 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.03 -76.87 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 158.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.5 t -54.81 156.17 3.84 Favored 'General case' 0 C--O 1.246 0.895 0 O-C-N 124.489 1.118 . . . . 0.0 108.184 156.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -80.18 -161.7 0.38 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.021 1.329 . . . . 0.0 109.595 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -143.07 146.59 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.0 -166.8 0.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.923 1.689 . . . . 0.0 110.528 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.36 -170.91 2.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.281 -1.512 . . . . 0.0 109.175 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -170.32 154.77 4.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.179 0.991 . . . . 0.0 109.908 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' C ' HG23 ' A' ' 62' ' ' VAL . 99.3 m-85 -133.27 -170.11 2.41 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.553 1.07 . . . . 0.0 110.302 170.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 40' ' ' PRO . 39.9 p -141.99 170.99 7.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 158.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' O ' HD21 ' A' ' 44' ' ' LEU . 48.5 Cg_endo -81.22 -1.43 11.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.511 1.474 . . . . 0.0 112.439 -159.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -103.86 -7.58 41.28 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.673 1.606 . . . . 0.0 110.578 165.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.97 18.0 22.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.436 -1.626 . . . . 0.0 110.066 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 121' ' ' ILE . 7.3 mt -109.12 -23.15 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.869 HD22 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.35 -50.68 4.91 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 126.629 1.972 . . . . 0.0 111.036 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.95 -63.9 1.12 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.03 175.73 39.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB3' ' H ' ' A' ' 52' ' ' GLN . 12.0 tptp -70.86 126.02 28.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 116.9 -1.524 . . . . 0.0 108.311 159.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 ptt-85 -65.09 -23.17 67.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 121.017 1.735 . . . . 0.0 114.662 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.72 -67.64 0.27 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.401 1.455 . . . . 0.0 111.894 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 t -147.57 33.9 0.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 122.255 1.026 . . . . 0.0 109.824 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 48.59 63.76 1.96 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.174 2.19 . . . . 0.0 111.515 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 17.1 mt-30 -86.06 -68.55 0.73 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.351 -2.204 . . . . 0.0 108.76 -167.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 mtp 87.98 125.1 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 129.188 2.995 . . . . 0.0 109.252 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.41 147.21 87.01 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.53 1.487 . . . . 0.0 109.633 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.36 147.48 32.39 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.54 -8.47 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.369 1.468 . . . . 0.0 111.232 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.1 40.72 1.82 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 125.217 1.389 . . . . 0.0 110.504 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -134.96 170.55 15.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.341 1.57 . . . . 0.0 111.837 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -88.54 151.81 22.27 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.88 176.75 12.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.291 1.036 . . . . 0.0 112.376 172.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.416 HH21 ' CD1' ' A' ' 127' ' ' LEU . 50.8 ttt180 -124.48 148.53 47.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.146 2.578 . . . . 0.0 107.049 172.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 111' ' ' VAL . 6.0 p -147.56 167.27 5.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 119.975 1.261 . . . . 0.0 111.353 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -142.2 155.25 25.49 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 119.981 1.264 . . . . 0.0 111.677 169.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.84 -175.93 47.01 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.563 1.077 . . . . 0.0 113.28 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.5 ttm -103.21 123.78 47.37 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.484 1.514 . . . . 0.0 110.673 -170.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 69.9 t -71.7 129.58 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.885 -1.134 . . . . 0.0 109.848 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 49.5 mtt -63.75 152.22 87.0 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 118.62 0.645 . . . . 0.0 112.085 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.99 141.32 68.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.251 2.634 . . . . 0.0 110.745 170.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.75 3.85 1.27 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.369 1.461 . . . . 0.0 115.649 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.7 p -73.24 -26.21 61.03 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.743 1.771 . . . . 0.0 112.121 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.39 103.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.897 1.279 . . . . 0.0 109.909 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -86.78 30.32 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.669 2.787 . . . . 0.0 111.219 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -52.6 129.75 30.15 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.458 0.703 . . . . 0.0 109.192 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.45 119.53 77.27 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.65 -6.44 19.05 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.294 1.996 . . . . 0.0 112.641 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -118.38 6.77 11.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.52 1.528 . . . . 0.0 111.766 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -149.43 -166.94 2.69 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.597 1.159 . . . . 0.0 107.979 -174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.4 mt -121.69 -2.64 9.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.642 0.777 . . . . 0.0 112.084 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -60.57 136.14 57.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.7 p -156.66 134.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' SER . 43.3 p -124.9 162.15 25.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 93' ' ' VAL . 27.6 p90 -152.13 179.32 8.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.741 1.155 . . . . 0.0 109.349 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -115.71 145.88 42.37 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 139.1 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.05 170.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.116 1.766 . . . . 0.0 109.636 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -161.3 -154.12 0.34 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.558 1.543 . . . . 0.0 106.879 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 -22.38 62.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.814 -1.179 . . . . 0.0 112.872 -164.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -76.12 0.53 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.88 -166.98 12.66 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.46 -0.775 . . . . 0.0 112.229 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.3 p -140.78 160.64 39.61 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 112.023 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.14 153.97 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.036 1.334 . . . . 0.0 109.646 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.15 150.56 37.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.51 165.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -118.0 160.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 156.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.9 m -129.62 127.44 40.63 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 159.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.521 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.2 t80 -127.41 168.62 14.6 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.633 1.573 . . . . 0.0 108.505 174.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.96 92.13 1.16 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.0 -176.38 45.09 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.418 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.02 113.35 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 80' ' ' VAL . 9.7 tp -77.24 143.39 69.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -58.46 146.31 90.92 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.113 1.209 . . . . 0.0 109.065 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.45 -30.82 71.89 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.46 -36.97 85.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.705 2.002 . . . . 0.0 110.978 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 43.2 t80 -56.23 133.0 52.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.002 1.721 . . . . 0.0 109.039 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.83 167.13 21.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.319 0.963 . . . . 0.0 112.312 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -74.72 112.9 11.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.74 49.13 5.85 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 112.181 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 128' ' ' ALA . 3.8 pt20 -119.63 -170.29 1.92 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.386 -1.067 . . . . 0.0 109.542 145.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.87 140.68 14.95 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.66 178.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.764 1.625 . . . . 0.0 107.922 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.2 t -131.65 142.18 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.688 ' CG1' HG21 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -107.65 163.98 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.868 0.842 . . . . 0.0 109.55 162.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -157.48 144.27 18.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 106.609 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.93 -109.02 0.38 Allowed Glycine 0 CA--C 1.518 0.253 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.2 mt-10 -140.91 162.93 34.3 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 120.165 1.983 . . . . 0.0 109.541 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 60' ' ' LEU . 12.5 tp -89.24 140.26 29.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.566 0.746 . . . . 0.0 110.154 171.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 -77.95 0.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.82 166.47 3.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.287 3.835 . . . . 0.0 105.13 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.9 42.04 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 120.198 1.363 . . . . 0.0 113.653 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 70.71 4.96 5.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.841 2.057 . . . . 0.0 114.263 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -71.35 139.31 49.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.042 2.137 . . . . 0.0 109.691 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.688 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.1 mm -106.29 133.89 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 126.765 2.026 . . . . 0.0 110.164 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 122' ' ' LEU . 4.2 mm? -78.84 106.94 11.2 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 154.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.65 58.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.513 0.673 . . . . 0.0 110.22 153.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 -11.61 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.615 2.366 . . . . 0.0 110.974 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -147.82 -46.23 0.16 Allowed 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.8 t 57.17 141.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.876 1.67 . . . . 0.0 111.601 -165.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.416 ' CD1' HH21 ' A' ' 61' ' ' ARG . 53.9 mt -139.38 162.59 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -125.53 29.27 6.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.384 1.074 . . . . 0.0 112.226 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 49.58 43.95 24.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 115.137 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.433 ' NE2' ' HB3' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -91.23 35.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.536 1.134 . . . . 0.0 110.201 175.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.7 t0 61.35 89.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.445 1.898 . . . . 0.0 111.544 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -131.05 160.56 34.28 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.817 1.647 . . . . 0.0 109.118 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.48 123.59 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.964 1.306 . . . . 0.0 108.211 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -61.86 166.08 4.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.483 1.135 . . . . 0.0 113.313 -165.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 m -116.67 131.89 23.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 0.0 107.544 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.31 -179.0 1.64 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.096 3.197 . . . . 0.0 112.013 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.52 -40.09 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.208 1.939 . . . . 0.0 114.612 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -71.93 67.49 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.669 1.588 . . . . 0.0 109.478 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -173.33 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.473 1.909 . . . . 0.0 107.374 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -75.03 0.1 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.607 1.163 . . . . 0.0 110.697 -166.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -150.46 53.17 0.89 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.209 1.004 . . . . 0.0 110.21 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.78 1.5 0.79 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 119.436 1.017 . . . . 0.0 109.966 179.734 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -136.03 161.65 35.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.871 0.869 . . . . 0.0 110.736 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.7 m -147.42 128.74 14.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.375 1.87 . . . . 0.0 107.502 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -151.4 -26.35 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.5 mm -120.95 -178.43 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.41 157.49 19.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.583 167.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 1.3 pp -74.21 177.98 5.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.836 1.303 . . . . 0.0 111.264 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -173.13 136.77 0.66 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.768 2.427 . . . . 0.0 106.311 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.535 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 79.3 m-85 -131.6 -175.11 3.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.033 1.733 . . . . 0.0 109.545 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.458 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 72.5 p -142.1 169.07 11.8 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 112.78 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.77 71.54 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.569 2.846 . . . . 0.0 110.747 157.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.21 -56.17 0.19 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 127.899 2.666 . . . . 0.0 106.976 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HB2' ' H ' ' A' ' 39' ' ' THR . 32.3 mt-10 -68.24 -9.36 46.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.422 HG22 ' OD1' ' A' ' 119' ' ' ASN . 5.1 mt -104.84 -22.35 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.118 1.367 . . . . 0.0 108.327 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.42 -48.38 5.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.731 2.412 . . . . 0.0 111.711 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.93 -64.51 1.07 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.684 1.994 . . . . 0.0 107.081 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.59 164.5 18.85 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.663 1.602 . . . . 0.0 109.226 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 1.2 tptt -49.5 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.673 1.989 . . . . 0.0 111.229 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -47.57 -20.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' H ' HE22 ' A' ' 51' ' ' GLN . 41.1 mt-10 -121.49 -52.61 2.03 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 121.048 1.749 . . . . 0.0 109.775 146.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.66 -51.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.555 1.142 . . . . 0.0 108.66 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.465 HE22 ' H ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 43.75 -71.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.315 3.046 . . . . 0.0 116.399 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.71 15.47 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.642 2.377 . . . . 0.0 114.062 -170.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.55 -178.14 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 125.063 1.345 . . . . 0.0 111.836 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.3 155.73 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.44 2.093 . . . . 0.0 109.747 150.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.88 143.97 30.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 159.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.2 p -73.57 -15.58 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.053 0.541 . . . . 0.0 111.369 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.04 37.38 3.74 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.384 -1.787 . . . . 0.0 111.741 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -137.1 174.06 11.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.654 2.227 . . . . 0.0 112.399 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -106.89 138.86 42.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.409 1.484 . . . . 0.0 110.226 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.06 167.5 30.26 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.797 1.239 . . . . 0.0 112.034 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -99.52 150.43 22.22 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.1 1.76 . . . . 0.0 109.779 165.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.73 154.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.841 2.056 . . . . 0.0 106.925 168.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.63 152.97 21.44 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 155.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.24 179.51 48.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttm -101.51 130.04 47.71 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.835 0.854 . . . . 0.0 109.545 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 93.7 t -69.04 125.28 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.782 1.173 . . . . 0.0 108.266 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.5 mtt -57.44 139.18 80.87 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 119.006 0.821 . . . . 0.0 110.25 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.89 124.69 10.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.302 2.668 . . . . 0.0 107.522 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.6 65.37 3.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.9 p -135.41 -35.01 0.83 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.45 0.625 . . . . 0.0 111.952 167.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.34 107.34 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -174.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -91.77 59.84 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 131.623 3.969 . . . . 0.0 108.697 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 1.7 ptt85 -74.99 166.65 23.33 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.708 -1.245 . . . . 0.0 110.472 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.69 114.18 7.93 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.48 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.34 -15.76 38.88 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.688 1.592 . . . . 0.0 111.833 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -99.54 -20.11 16.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.29 -1.338 . . . . 0.0 110.368 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 m -131.79 -3.21 3.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.394 1.452 . . . . 0.0 114.77 -168.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp 62.03 -24.57 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 131.609 3.964 . . . . 0.0 114.781 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -53.86 126.66 23.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.892 1.277 . . . . 0.0 107.938 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 95' ' ' TYR . 1.5 p -132.28 146.72 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -134.47 123.61 24.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 93' ' ' VAL . 48.1 p90 -131.51 173.51 11.03 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 120.899 1.681 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -127.78 141.55 51.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.28 139.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.962 1.705 . . . . 0.0 106.618 -178.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -138.88 172.22 13.17 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.597 1.159 . . . . 0.0 111.321 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -157.0 -165.9 1.95 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.15 1.78 . . . . 0.0 109.405 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -12.67 60.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.201 1.4 . . . . 0.0 113.561 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.16 -67.09 0.87 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -172.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.52 -152.41 5.66 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -140.25 167.18 22.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.611 0.764 . . . . 0.0 110.31 167.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.83 142.76 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.8 152.55 22.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.063 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 82' ' ' PHE . 2.7 m -138.47 137.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 110.992 171.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -100.28 136.87 39.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 164.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 80' ' ' VAL . 31.2 t80 -142.05 164.31 30.53 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.458 1.503 . . . . 0.0 107.167 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.62 110.13 3.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.41 41.35 Favored Glycine 0 C--N 1.324 -0.115 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -22.48 6.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.924 0.862 . . . . 0.0 112.394 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.461 HD11 HG11 ' A' ' 126' ' ' VAL . 5.1 tp 81.55 152.86 0.12 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.939 2.895 . . . . 0.0 108.852 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.87 141.8 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.633 1.555 . . . . 0.0 108.993 174.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -31.26 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.55 1.14 . . . . 0.0 109.161 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.38 -40.98 98.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.35 1.86 . . . . 0.0 112.737 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 14.9 t80 -65.52 137.05 57.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.696 0.798 . . . . 0.0 110.91 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -142.55 173.49 11.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.801 1.24 . . . . 0.0 109.206 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -58.55 135.58 57.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.759 152.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 6.11 69.35 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.704 0.669 . . . . 0.0 113.785 155.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -103.16 172.61 6.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 109.443 171.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.52 129.07 9.72 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.76 172.5 15.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.62 126.71 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.405 HG22 HG22 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -101.73 159.26 4.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 165.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.05 134.38 10.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.52 -119.29 0.9 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -142.17 154.0 44.49 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 119.232 1.516 . . . . 0.0 110.46 -163.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.96 135.19 35.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -85.45 0.24 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -151.1 -88.6 0.06 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.408 1.883 . . . . 0.0 109.417 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.41 82.8 1.14 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -160.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.422 ' OD1' HG22 ' A' ' 43' ' ' ILE . 70.8 m-80 29.69 67.1 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.188 2.595 . . . . 0.0 110.726 -169.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -141.37 131.19 24.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.213 1.405 . . . . 0.0 107.667 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.2 mm -106.2 135.45 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.217 1.807 . . . . 0.0 109.263 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.89 105.42 10.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 156.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.84 148.87 50.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.96 -25.01 10.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 109.115 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.566 ' HG3' HD21 ' A' ' 127' ' ' LEU . 8.1 pt-20 -148.38 -16.14 0.33 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -169.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 99' ' ' LEU . 61.9 t 38.54 101.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.207 2.203 . . . . 0.0 114.468 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 125' ' ' GLU . 1.1 mm? -106.17 145.9 30.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.521 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -109.15 30.98 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.24 -0.913 . . . . 0.0 111.694 -172.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 51.19 47.41 24.91 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.975 0.893 . . . . 0.0 110.949 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.637 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -82.12 -106.65 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 166.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -149.38 111.3 4.58 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -152.05 131.28 12.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -171.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -160.72 -30.66 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -149.11 133.16 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.898 1.279 . . . . 0.0 108.146 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.9 m -120.4 105.34 41.81 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.19 178.64 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.689 2.926 . . . . 0.0 110.797 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.97 -40.39 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.233 1.289 . . . . 0.0 114.632 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.83 58.1 1.82 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.928 0.891 . . . . 0.0 111.378 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -46.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.348 3.059 . . . . 0.0 105.95 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -56.87 -53.18 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.678 1.991 . . . . 0.0 109.009 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -144.35 82.91 1.71 Allowed 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.32 0.05 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.437 0.295 . . . . 0.0 111.319 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.156 1.383 . . . . 0.0 109.326 -177.464 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.98 165.36 2.46 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.317 0.386 . . . . 0.0 110.569 161.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.2 m -160.16 134.39 7.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.43 4.33 2.4 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.84 -140.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.42 173.08 12.78 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.626 -0.671 . . . . 0.0 110.027 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.21 179.9 5.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.464 1.126 . . . . 0.0 109.823 171.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -169.58 145.4 3.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.051 1.74 . . . . 0.0 107.534 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -142.3 -173.83 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.588 2.355 . . . . 0.0 108.573 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 20.6 p -135.32 171.2 9.34 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.059 0.943 . . . . 0.0 109.292 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB3' HG12 ' A' ' 91' ' ' VAL . 63.9 Cg_endo -73.8 71.31 4.12 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.925 2.417 . . . . 0.0 108.989 169.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.68 -66.73 0.1 Allowed Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 -167.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 39' ' ' THR . 3.3 mm-40 -71.52 -3.71 22.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.359 0.664 . . . . 0.0 112.442 -171.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.55 -41.97 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -85.9 -43.53 13.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.599 0.759 . . . . 0.0 109.688 -165.386 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -102.31 3.32 37.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.323 1.449 . . . . 0.0 112.883 -168.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.2 165.95 39.18 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 163.48 19.56 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 110.847 174.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -56.61 -13.22 2.24 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -123.48 -75.91 0.59 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.11 1.323 . . . . 0.0 110.496 148.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 t -159.07 26.42 0.21 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.81 1.244 . . . . 0.0 109.575 -171.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -64.77 -45.57 85.79 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.842 -1.161 . . . . 0.0 110.304 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.06 145.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 128.654 2.782 . . . . 0.0 111.047 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 27.9 mtp -75.65 162.11 73.58 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.577 0.751 . . . . 0.0 109.917 168.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.5 158.69 32.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.909 1.739 . . . . 0.0 109.917 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -79.12 157.75 27.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 115' ' ' LEU 0.261 9.5 p -93.65 0.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.332 0.587 . . . . 0.0 112.203 -178.238 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.04 55.65 0.68 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.934 1.731 . . . . 0.0 110.13 162.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -144.86 168.81 19.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.188 1.494 . . . . 0.0 112.254 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.41 129.6 36.58 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.402 1.096 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -136.19 -177.08 4.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.277 172.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.71 142.7 51.25 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.402 2.281 . . . . 0.0 106.491 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.27 124.67 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.33 135.47 12.89 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.61 174.37 46.58 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.718 1.152 . . . . 0.0 110.606 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.2 ttm -95.76 126.2 40.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.514 1.526 . . . . 0.0 110.996 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.97 127.3 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 124.227 1.011 . . . . 0.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.9 mtt -59.92 127.5 85.61 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 122.501 0.321 . . . . 0.0 110.58 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.0 113.73 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.072 3.181 . . . . 0.0 110.364 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 104.62 -16.88 47.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.336 1.922 . . . . 0.0 113.967 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.7 p -69.43 -19.68 63.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.469 1.134 . . . . 0.0 114.005 -165.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.71 83.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.954 1.302 . . . . 0.0 109.864 -167.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.77 -58.27 9.32 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.667 1.987 . . . . 0.0 111.472 -167.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.84 129.37 0.02 OUTLIER 'General case' 0 C--O 1.237 0.408 0 C-N-CA 129.612 3.165 . . . . 0.0 110.852 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.83 117.53 52.04 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-O 117.497 -1.24 . . . . 0.0 107.918 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.89 -13.82 33.15 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 CA-C-N 121.491 1.568 . . . . 0.0 112.447 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -107.92 -10.09 15.58 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.226 1.41 . . . . 0.0 112.162 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -136.49 -156.83 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.775 -1.203 . . . . 0.0 109.11 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.26 6.33 5.85 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.325 1.85 . . . . 0.0 108.817 170.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -55.39 140.69 39.02 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 164.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 156.73 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 p -126.37 141.06 52.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 152.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.67 170.6 15.55 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 108.329 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -112.47 144.5 41.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -121.41 143.09 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 169.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.44 173.46 11.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.111 1.765 . . . . 0.0 107.88 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -155.07 -162.54 1.38 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 13.65 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.51 1.924 . . . . 0.0 113.725 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 -76.53 0.58 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.876 1.271 . . . . 0.0 107.914 -172.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.52 -151.21 5.4 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 40' ' ' PRO . 84.7 p -146.08 166.97 24.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.639 0.719 . . . . 0.0 112.519 172.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 40' ' ' PRO . 6.3 p -146.63 157.86 10.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 126.112 1.765 . . . . 0.0 109.045 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.0 151.06 19.81 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 126.006 1.722 . . . . 0.0 108.468 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 84' ' ' ILE . 44.6 t -142.56 103.33 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.055 0.942 . . . . 0.0 111.33 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.4 m -78.44 120.68 23.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.228 1.011 . . . . 0.0 109.361 161.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -116.41 171.5 7.8 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.333 1.453 . . . . 0.0 107.843 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.84 101.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.61 169.73 26.43 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -73.74 -25.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 122.94 0.496 . . . . 0.0 110.67 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.471 ' CD2' HG11 ' A' ' 126' ' ' VAL . 30.5 mt 87.52 156.55 0.09 OUTLIER Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 131.401 3.88 . . . . 0.0 110.185 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -56.08 143.59 83.08 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 N-CA-C 107.058 -1.939 . . . . 0.0 107.058 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -62.21 -37.02 83.72 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.511 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mp -61.44 -20.16 62.79 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.12 1.768 . . . . 0.0 115.159 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.38 125.05 23.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.613 1.097 . . . . 0.0 109.524 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -126.95 160.27 31.54 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.19 0.995 . . . . 0.0 110.488 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 69.7 mt-10 -81.24 104.81 11.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.891 1.677 . . . . 0.0 107.434 168.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.5 13.78 5.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.062 0.839 . . . . 0.0 114.07 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -130.92 166.93 19.87 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.711 1.256 . . . . 0.0 112.131 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.72 139.94 29.55 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 170.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.47 109.04 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 126' ' ' VAL . 3.2 t -81.19 158.18 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 125.08 1.352 . . . . 0.0 108.939 164.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -153.25 152.09 30.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.3 3.04 . . . . 0.0 106.16 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.97 -111.42 0.48 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.78 160.78 33.36 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 119.917 1.858 . . . . 0.0 109.153 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -74.72 142.61 44.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 159.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -99.65 -88.33 0.34 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.886 1.275 . . . . 0.0 108.031 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.35 157.33 4.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.667 2.787 . . . . 0.0 107.433 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.16 25.54 73.45 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.87 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m120 58.65 71.45 0.58 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.347 2.259 . . . . 0.0 110.114 -168.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -141.18 136.49 31.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.68 130.2 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 126.678 1.991 . . . . 0.0 108.497 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.84 111.5 15.05 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 157.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.44 37.33 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.23 1.812 . . . . 0.0 108.329 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -24.64 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.954 1.301 . . . . 0.0 111.399 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.38 -47.54 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 99' ' ' LEU . 32.8 t 61.26 129.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 124.237 1.97 . . . . 0.0 111.328 -174.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.4 mt -133.85 159.03 41.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.495 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -126.03 55.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.397 0.544 . . . . 0.0 110.097 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 50.25 15.21 0.18 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.495 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.4 OUTLIER -76.66 59.93 1.6 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 130.452 3.501 . . . . 0.0 110.752 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.29 23.86 13.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.966 1.307 . . . . 0.0 111.631 163.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -80.38 116.08 20.26 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.474 1.91 . . . . 0.0 106.927 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -135.82 -45.24 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.943 0.497 . . . . 0.0 110.659 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -146.25 111.21 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -95.91 130.98 30.01 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 135' ' ' THR . 15.2 Cg_exo -64.22 178.3 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.715 2.943 . . . . 0.0 112.03 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.22 -174.1 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.446 2.764 . . . . 0.0 111.622 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 48.36 56.02 8.05 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.609 1.964 . . . . 0.0 110.942 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.45 -39.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 124.356 1.062 . . . . 0.0 108.394 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -51.93 -56.26 15.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 109.43 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -152.28 83.53 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -160.36 -34.11 0.05 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.2 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.861 178.473 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.32 146.81 22.8 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -148.46 133.28 17.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -162.73 -45.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 110.232 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.38 155.84 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.549 1.166 . . . . 0.0 108.826 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.93 148.21 44.38 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 110.15 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.75 -174.27 4.92 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.46 1.124 . . . . 0.0 110.2 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -168.04 154.62 7.68 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.144 2.578 . . . . 0.0 106.018 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 74.5 m-85 -141.54 173.66 11.29 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.066 2.146 . . . . 0.0 109.051 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 p -134.88 164.05 46.81 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 123.959 0.904 . . . . 0.0 109.606 168.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.88 72.94 2.52 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.677 2.918 . . . . 0.0 109.804 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.13 -62.55 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 105.182 -3.167 . . . . 0.0 105.182 -168.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -47.85 -48.66 30.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.331 1.065 . . . . 0.0 109.956 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.19 -15.37 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 127.149 2.18 . . . . 0.0 112.17 -172.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.48 -32.8 3.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.096 1.359 . . . . 0.0 110.883 -166.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.77 -60.67 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.653 2.381 . . . . 0.0 108.242 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.43 135.97 2.11 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.493 1.521 . . . . 0.0 110.547 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 5.3 tptp -54.99 117.03 3.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.675 1.19 . . . . 0.0 111.096 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -24.22 63.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.869 1.213 . . . . 0.0 114.161 -172.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -69.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.095 1.358 . . . . 0.0 110.748 172.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 t -151.96 22.23 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 111.799 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 59.55 28.24 17.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.916 2.086 . . . . 0.0 112.278 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -67.08 -21.64 65.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.903 1.681 . . . . 0.0 115.125 -171.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 54.45 159.26 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.209 1.804 . . . . 0.0 113.472 -163.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.88 155.83 48.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.67 1.58 . . . . 0.0 109.71 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -79.14 132.32 36.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.259 3.8 p -69.43 0.45 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 123.384 1.564 . . . . 0.0 112.098 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.77 22.4 19.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.959 2.218 . . . . 0.0 112.516 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.55 177.63 7.7 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 121.08 2.44 . . . . 0.0 113.398 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.44 150.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.044 167.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.36 178.15 10.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.203 1.001 . . . . 0.0 109.68 171.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -116.67 150.56 37.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.385 1.874 . . . . 0.0 108.468 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.35 154.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.59 1.556 . . . . 0.0 107.654 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.8 142.35 13.67 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 159.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.69 44.5 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 ttm -92.46 119.64 32.17 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.878 2.071 . . . . 0.0 110.514 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.72 128.85 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 120.275 -1.516 . . . . 0.0 108.728 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.1 mtt -59.37 141.25 87.78 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 112.694 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.21 134.17 47.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.751 3.634 . . . . 0.0 109.71 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.6 -2.49 39.07 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.786 -1.008 . . . . 0.0 114.763 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.1 p -74.46 -43.35 56.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.757 1.778 . . . . 0.0 112.099 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.0 107.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.086 1.754 . . . . 0.0 110.805 -170.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -74.04 -55.46 6.1 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.962 1.705 . . . . 0.0 111.444 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.421 HH21 ' CD2' ' A' ' 78' ' ' LEU . 1.5 mtp180 65.87 177.42 0.21 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.147 2.179 . . . . 0.0 111.451 -165.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -132.13 124.97 19.76 Favored Pre-proline 0 N--CA 1.445 -0.678 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 162.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.76 -20.81 19.6 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.42 1.413 . . . . 0.0 111.656 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -73.3 -34.18 65.59 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 m -130.4 -130.4 0.2 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.004 -2.962 . . . . 0.0 103.004 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' CD2' HH21 ' A' ' 73' ' ' ARG . 0.6 OUTLIER -152.12 15.12 0.62 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.824 2.05 . . . . 0.0 109.741 168.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 116.96 5.31 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.24 153.93 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.391 1.091 . . . . 0.0 109.844 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.7 p -141.2 114.85 8.95 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -124.96 178.76 5.34 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.809 1.644 . . . . 0.0 111.791 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.2 m -124.36 145.15 49.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -120.11 148.03 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 172.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -139.25 178.26 7.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.96 1.704 . . . . 0.0 108.535 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 87' ' ' ALA . 37.0 t70 -161.01 -153.66 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 86' ' ' ASP . . . -68.8 -18.19 64.14 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.324 -1.485 . . . . 0.0 113.098 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -112.56 -63.3 1.45 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -163.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.59 -157.55 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 120.105 -0.275 . . . . 0.0 113.062 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.9 p -149.78 159.88 44.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.45 153.19 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.838 1.655 . . . . 0.0 111.351 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -81.07 143.99 32.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.531 176.727 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 58.6 t -137.61 121.35 21.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 164.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -91.61 133.52 35.48 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 155.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 18.9 t80 -130.15 168.34 16.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -158.26 113.39 2.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.47 0.15 Allowed Glycine 0 N--CA 1.468 0.786 0 C-N-CA 118.107 -1.997 . . . . 0.0 113.26 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.13 -28.22 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.286 1.043 . . . . 0.0 112.613 167.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.1 tp 61.23 128.13 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 129.333 3.053 . . . . 0.0 112.86 -170.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 5.1 Cg_exo -61.66 135.71 58.19 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.653 1.569 . . . . 0.0 108.106 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.58 -25.51 38.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.856 0.836 . . . . 0.0 111.689 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.49 -23.39 66.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.434 1.094 . . . . 0.0 112.145 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.34 130.28 41.55 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.331 1.423 . . . . 0.0 109.461 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -126.94 -161.87 1.11 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 107.472 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.7 151.95 19.6 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.959 -1.088 . . . . 0.0 108.773 150.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.37 57.86 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.502 166.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -125.37 166.47 16.51 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.395 1.078 . . . . 0.0 109.748 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.41 135.91 18.26 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.83 162.7 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.08 112.78 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.72 2.008 . . . . 0.0 105.687 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -94.59 157.51 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.152 . . . . 0.0 108.259 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -154.11 135.84 14.44 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 127.552 2.341 . . . . 0.0 107.331 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -120.47 0.95 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 103.339 -3.904 . . . . 0.0 103.339 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.55 153.75 46.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.351 1.076 . . . . 0.0 109.631 -160.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.6 tp -80.68 122.54 27.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 109.428 176.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -76.03 -66.98 0.72 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -138.8 -96.16 0.18 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.695 0.798 . . . . 0.0 111.056 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -91.01 -70.54 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -126.94 41.03 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.902 -0.763 . . . . 0.0 109.032 -169.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 92' ' ' ASP . 23.1 t-160 -131.57 125.9 33.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.051 1.34 . . . . 0.0 108.636 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.428 HG21 ' CG1' ' A' ' 111' ' ' VAL . 7.9 mm -98.13 130.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.437 1.895 . . . . 0.0 108.15 171.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.15 108.02 12.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 152.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -71.06 147.88 48.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 160.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -11.0 7.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.81 1.644 . . . . 0.0 111.503 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.36 -21.43 0.15 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 111' ' ' VAL . 86.0 t 41.89 113.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 130.598 3.559 . . . . 0.0 115.687 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.3 144.01 50.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -167.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.478 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -116.86 42.83 2.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.328 -0.857 . . . . 0.0 111.217 -164.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt 54.72 21.33 3.44 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.478 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -86.35 55.39 3.52 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.978 2.111 . . . . 0.0 109.108 -175.502 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.83 61.59 3.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.123 1.369 . . . . 0.0 111.94 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -127.43 162.08 27.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.019 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -156.38 38.65 0.34 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.049 0.94 . . . . 0.0 109.171 161.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -164.14 143.56 7.74 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.076 -162.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.6 m -79.12 127.83 78.07 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.367 1.067 . . . . 0.0 108.641 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 90.0 Cg_endo -70.12 -176.17 1.5 Allowed 'Trans proline' 0 CA--C 1.552 1.403 1 C-N-CA 125.84 4.36 . . . . 0.0 111.491 178.864 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 136' ' ' PRO . 44.2 Cg_endo -78.89 -37.03 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 N-CA-C 116.348 1.634 . . . . 0.0 116.348 -176.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.34 57.68 2.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.062 1.345 . . . . 0.0 110.31 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.77 -78.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.65 1.98 . . . . 0.0 107.509 -177.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 26.02 -80.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 129.877 3.271 . . . . 0.0 112.733 -150.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -101.17 -84.43 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.833 1.653 . . . . 0.0 109.937 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -115.87 136.08 53.39 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.749 1.219 . . . . 0.0 109.105 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.211 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -139.07 -80.75 0.31 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 158.07 43.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 164.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -159.55 167.88 27.5 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.003 2.121 . . . . 0.0 106.335 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.4 mt -102.3 164.19 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.31 168.12 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.596 1.958 . . . . 0.0 110.567 -156.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 36' ' ' LEU . 1.9 pp -114.33 -176.36 2.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 119.238 -2.163 . . . . 0.0 106.589 161.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -165.84 147.69 7.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.984 0.811 . . . . 0.0 110.63 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' A' ' 36' ' ' LEU . 91.8 m-85 -140.45 177.8 7.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.509 1.924 . . . . 0.0 109.595 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 22.2 p -134.55 171.85 8.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.291 1.036 . . . . 0.0 110.011 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HB3' HG22 ' A' ' 91' ' ' VAL . 69.4 Cg_endo -72.62 -0.64 9.13 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.799 2.333 . . . . 0.0 114.793 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.45 -53.51 3.81 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 156.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 39' ' ' THR . 56.9 mt-10 -68.24 -30.49 69.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.591 -0.946 . . . . 0.0 113.139 -160.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.9 -13.81 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.865 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -119.87 -42.28 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 110.198 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -90.25 -18.12 26.23 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.012 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.68 147.46 9.05 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.776 2.131 . . . . 0.0 109.825 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -63.43 164.92 8.46 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.766 1.783 . . . . 0.0 109.777 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -19.31 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.24 1.816 . . . . 0.0 114.525 -159.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' H ' HE22 ' A' ' 51' ' ' GLN . 7.3 mt-10 -93.82 -78.73 0.43 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.519 0.728 . . . . 0.0 110.003 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.3 t -168.48 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.194 0.997 . . . . 0.0 111.334 -168.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.541 HE22 ' H ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -52.89 -50.61 63.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.843 2.457 . . . . 0.0 112.48 177.787 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -174.71 173.45 2.81 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 120.987 1.721 . . . . 0.0 110.737 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 42.8 mtp -121.9 149.2 53.15 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 126.15 1.78 . . . . 0.0 106.383 164.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.02 166.29 23.43 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.862 1.708 . . . . 0.0 111.184 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -79.01 128.43 33.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 115' ' ' LEU . 49.0 t -60.64 -8.48 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.823 1.649 . . . . 0.0 111.857 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.46 33.49 4.8 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-O 116.131 -2.483 . . . . 0.0 112.719 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.83 177.62 6.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.128 2.464 . . . . 0.0 112.471 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -83.6 140.93 31.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.018 0.927 . . . . 0.0 110.664 165.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -146.64 173.92 11.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.638 0.775 . . . . 0.0 109.76 169.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -121.26 139.03 53.94 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.46 160.72 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 128.506 2.723 . . . . 0.0 107.856 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.08 156.58 26.92 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.85 -179.96 47.51 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.703 1.621 . . . . 0.0 109.214 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.4 tpp -81.09 120.05 24.34 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 129.062 2.945 . . . . 0.0 110.598 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 103' ' ' PHE . 73.0 t -64.74 130.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 119.094 -2.253 . . . . 0.0 108.479 175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.26 154.23 53.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.87 133.3 30.91 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.006 2.471 . . . . 0.0 109.668 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.73 -24.65 4.32 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 125.579 1.561 . . . . 0.0 115.776 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.09 -43.61 91.86 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.466 1.633 . . . . 0.0 111.732 -170.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.308 1.3 p -42.33 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.941 2.096 . . . . 0.0 112.96 -172.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 8.4 pt20 -91.93 56.48 2.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.968 2.907 . . . . 0.0 108.242 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 11.9 ptt-85 -66.82 143.11 57.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 166.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.41 119.76 78.73 Favored Pre-proline 0 N--CA 1.436 -1.155 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.95 1.7 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.018 1.812 . . . . 0.0 111.8 164.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -134.31 14.0 3.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.482 2.313 . . . . 0.0 110.163 -167.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.03 -166.14 0.78 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.624 1.569 . . . . 0.0 107.61 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 2.32 19.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.014 1.726 . . . . 0.0 111.506 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -62.29 138.97 58.52 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.058 -1.651 . . . . 0.0 109.088 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 99' ' ' LEU . 2.1 p -155.72 132.7 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 72' ' ' GLN 0.314 22.7 m -123.39 153.71 40.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 48.8 p90 -152.4 176.98 11.08 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 119.936 -1.727 . . . . 0.0 110.945 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 m -121.56 143.8 49.08 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -121.34 153.67 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.064 1.746 . . . . 0.0 106.47 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -141.81 -179.43 6.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.587 1.955 . . . . 0.0 106.973 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -157.08 -159.35 0.85 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.08 4.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.96 -79.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.033 1.733 . . . . 0.0 109.371 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.98 -168.37 12.07 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.215 1.388 . . . . 0.0 111.643 -167.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 p -146.98 155.97 42.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.4 m -148.72 145.85 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.999 1.72 . . . . 0.0 110.264 -167.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.5 154.68 26.18 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 84' ' ' ILE . 5.4 m -133.28 144.95 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 120.625 -1.297 . . . . 0.0 109.337 160.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.38 1.872 . . . . 0.0 106.572 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -134.91 168.93 18.19 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.221 1.809 . . . . 0.0 108.761 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -148.94 117.63 6.61 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 171.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.38 175.46 25.59 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -170.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -6.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.047 1.339 . . . . 0.0 112.395 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.645 ' CD2' HG11 ' A' ' 126' ' ' VAL . 32.3 mt 63.02 165.89 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 127.535 2.334 . . . . 0.0 111.66 -166.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.35 137.64 79.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 159.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.88 -27.4 66.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.141 0.496 . . . . 0.0 110.704 167.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -19.07 60.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.481 1.512 . . . . 0.0 113.107 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' VAL . 41.8 t80 -64.5 129.4 39.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.994 0.815 . . . . 0.0 110.086 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -136.1 161.07 36.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.023 1.329 . . . . 0.0 109.944 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.71 114.21 6.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.526 1.13 . . . . 0.0 108.206 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.98 -3.46 33.69 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.127 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -91.48 166.73 12.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.35 1.575 . . . . 0.0 110.601 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 140.99 27.54 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.14 177.06 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.255 1.822 . . . . 0.0 107.295 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 127' ' ' LEU . 2.6 t -141.86 101.22 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.097 1.759 . . . . 0.0 106.714 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.9 168.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-O 122.706 1.241 . . . . 0.0 111.244 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -165.05 140.83 5.46 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.279 1.831 . . . . 0.0 107.693 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.58 -91.43 0.11 Allowed Glycine 0 C--O 1.224 -0.481 0 CA-C-O 116.941 -2.033 . . . . 0.0 109.276 168.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.29 162.28 35.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.466 2.133 . . . . 0.0 110.339 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -82.28 148.63 28.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.06 1.744 . . . . 0.0 108.672 165.773 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' CG ' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -104.99 -85.0 0.48 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 108.259 -174.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 12.8 mtmm -141.07 170.8 15.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 127.352 2.261 . . . . 0.0 106.88 159.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 45.48 -102.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 125.131 1.348 . . . . 0.0 110.852 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -136.31 51.99 1.99 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.593 0.757 . . . . 0.0 109.318 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -121.46 129.94 53.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.48 0.712 . . . . 0.0 109.955 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -105.35 127.81 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.57 1.148 . . . . 0.0 110.999 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.439 HD21 ' CG ' ' A' ' 116' ' ' GLU . 3.6 mm? -79.49 80.76 5.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 162.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.54 141.87 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.563 0.697 . . . . 0.0 110.53 164.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -14.13 9.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.581 1.552 . . . . 0.0 111.529 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.81 -33.65 0.45 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 117.643 -1.17 . . . . 0.0 114.04 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 99' ' ' LEU . 87.7 t 54.92 116.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 C-N-CA 129.073 2.949 . . . . 0.0 111.108 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 10.1 mt -93.15 -176.42 4.15 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.653 168.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -143.43 19.47 1.88 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.982 1.313 . . . . 0.0 110.616 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.2 mttm 42.3 60.97 2.14 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.426 1.012 . . . . 0.0 111.577 -161.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -57.94 4.28 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 159.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.91 -64.64 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 128.073 2.549 . . . . 0.0 104.944 174.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 74.45 111.83 0.07 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 129.905 3.282 . . . . 0.0 111.366 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -63.47 -174.3 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.199 2.6 . . . . 0.0 111.961 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -125.4 164.87 19.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.25 1.42 . . . . 0.0 107.535 166.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.9 m -138.57 142.79 35.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.157 1.783 . . . . 0.0 107.053 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.0 175.64 7.22 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.501 2.134 . . . . 0.0 111.18 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -82.58 -33.47 0.49 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.335 2.023 . . . . 0.0 113.877 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.36 56.01 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.369 1.868 . . . . 0.0 110.727 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.97 -49.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.99 2.116 . . . . 0.0 107.581 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -50.67 63.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.265 0.484 . . . . 0.0 109.718 -170.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.05 -47.75 0.06 Allowed 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 125.891 1.676 . . . . 0.0 107.686 176.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.4 48.18 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.359 1.864 . . . . 0.0 112.604 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 41.3 mtt . . . . . 0 C--O 1.249 1.069 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 145.341 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.86 138.65 48.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.08 1.764 . . . . 0.0 108.627 161.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.1 m 60.43 175.92 0.1 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.179 1.392 . . . . 0.0 113.109 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.87 110.95 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.36 173.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 162.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -64.17 161.37 16.49 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.365 -1.459 . . . . 0.0 112.22 168.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.5 pp -74.96 177.6 6.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.528 1.156 . . . . 0.0 109.65 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -158.21 147.18 19.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.664 1.185 . . . . 0.0 108.578 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE1' HD13 ' A' ' 36' ' ' LEU . 95.8 m-85 -134.43 173.03 12.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.013 1.725 . . . . 0.0 108.891 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 3.4 p -131.99 172.41 7.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.753 1.221 . . . . 0.0 108.635 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 10.8 Cg_endo -59.87 -36.87 89.33 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.646 1.564 . . . . 0.0 109.881 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.88 10.52 13.69 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.595 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HB2' ' H ' ' A' ' 39' ' ' THR . 26.6 mt-10 -130.17 -30.95 1.92 Allowed 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.909 1.854 . . . . 0.0 112.727 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.04 -58.27 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.71 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -71.94 -49.61 36.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 110.06 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.71 ' CE1' HD12 ' A' ' 44' ' ' LEU . 10.1 m-30 -82.98 -7.16 59.7 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.53 132.05 4.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 13.8 tptp -37.9 126.49 1.22 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 128.316 2.647 . . . . 0.0 113.648 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -59.38 -28.44 66.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 119.078 0.853 . . . . 0.0 112.866 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.22 -57.84 5.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.025 0.375 . . . . 0.0 110.751 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 t -152.83 10.04 0.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -167.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER 34.71 52.35 0.56 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.577 3.151 . . . . 0.0 114.657 176.18 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -56.86 9.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.923 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 107.08 113.32 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 1 C-N-CA 133.38 4.672 . . . . 0.0 107.386 -176.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.59 160.9 40.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.256 1.304 . . . . 0.0 110.117 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -78.66 128.72 33.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.44 -6.06 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.005 1.722 . . . . 0.0 111.433 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.06 52.76 0.74 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 162.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -131.66 178.82 6.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.75 1.275 . . . . 0.0 111.355 161.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -95.0 137.61 33.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.999 1.72 . . . . 0.0 110.392 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.74 169.82 23.04 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.274 1.03 . . . . 0.0 111.416 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -119.27 143.44 47.33 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 127.952 2.501 . . . . 0.0 107.923 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.2 160.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.063 2.145 . . . . 0.0 108.514 -170.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.02 163.98 26.55 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 160.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.25 38.89 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 124.167 0.889 . . . . 0.0 111.189 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.7 ttm -91.9 125.98 36.81 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.53 1.132 . . . . 0.0 109.474 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -65.69 123.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 120.705 1.593 . . . . 0.0 107.46 178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 ttm -63.14 139.18 97.51 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.11 158.29 48.86 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.62 57.91 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 116.857 -2.08 . . . . 0.0 115.494 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -120.23 -6.34 9.89 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.478 2.139 . . . . 0.0 113.323 167.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.3 85.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 120.796 1.635 . . . . 0.0 111.484 169.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -78.46 61.69 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.796 2.839 . . . . 0.0 107.408 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 14.2 ptm180 -69.91 148.81 48.52 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.75 -1.219 . . . . 0.0 108.8 168.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -92.63 108.64 33.14 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -60.02 -22.04 67.65 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 CA-C-N 121.341 1.515 . . . . 0.0 111.296 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.98 -15.93 22.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.074 1.35 . . . . 0.0 111.476 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 m -134.56 -142.59 0.19 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.556 1.142 . . . . 0.0 109.012 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.96 -6.9 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.516 1.927 . . . . 0.0 110.159 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -62.07 140.77 58.37 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.2 p -149.61 132.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 m -122.05 135.83 54.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -147.71 173.46 12.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.917 1.235 . . . . 0.0 110.087 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.2 m -118.6 142.8 47.28 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.864 1.266 . . . . 0.0 107.814 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.58 145.48 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.374 1.469 . . . . 0.0 107.098 175.497 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -149.45 176.42 10.61 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.9 0.88 . . . . 0.0 111.417 -168.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -160.4 -166.48 1.67 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.655 1.582 . . . . 0.0 110.318 172.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.82 8.47 0.51 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.641 1.576 . . . . 0.0 113.66 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.87 -71.14 0.74 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.79 -171.01 12.5 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 124.196 0.903 . . . . 0.0 112.433 -172.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.2 p -140.98 149.79 42.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.975 0.91 . . . . 0.0 110.773 164.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -132.7 149.75 32.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.864 1.266 . . . . 0.0 108.054 -173.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.3 148.32 25.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.73 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 84' ' ' ILE . 60.9 t -135.58 123.32 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.025 0.93 . . . . 0.0 110.764 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -89.31 136.78 32.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 151.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -132.52 165.19 24.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.037 2.135 . . . . 0.0 106.694 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -140.07 113.11 8.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.99 166.55 23.06 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.4 tt -72.96 -15.47 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.888 -174.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' CD2' HG11 ' A' ' 126' ' ' VAL . 38.0 mt 78.83 165.09 0.12 Allowed Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 130.827 3.651 . . . . 0.0 110.743 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -61.13 140.37 89.01 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 N-CA-C 107.299 -1.846 . . . . 0.0 107.299 158.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.94 -31.45 66.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.903 1.281 . . . . 0.0 109.927 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -33.26 71.24 Favored 'General case' 0 N--CA 1.437 -1.076 1 C-N-CA 131.984 4.113 . . . . 0.0 111.567 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -59.73 136.6 58.05 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.023 1.283 . . . . 0.0 107.776 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -149.77 142.15 24.27 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 11.7 pt-20 -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.476 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 114.8 -9.33 21.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 114.876 -3.18 . . . . 0.0 115.463 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -94.53 169.7 10.0 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 123.622 3.711 . . . . 0.0 111.637 -173.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.57 8.04 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 165.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.48 176.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.434 1.894 . . . . 0.0 108.447 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.422 ' CG2' ' HE2' ' A' ' 129' ' ' LYS . 2.1 t -129.29 128.88 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.124 1.77 . . . . 0.0 107.228 164.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.82 167.06 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.475 1.131 . . . . 0.0 111.8 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -161.41 144.53 12.5 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.61 -120.31 0.91 Allowed Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -138.35 152.46 48.48 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.758 0.779 . . . . 0.0 109.395 -169.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 143.41 33.94 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.339 1.056 . . . . 0.0 110.176 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -91.58 -77.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.563 -0.71 . . . . 0.0 110.992 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.23 -79.83 0.01 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.86 2.064 . . . . 0.0 108.58 -170.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.3 47.76 2.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.783 1.659 . . . . 0.0 113.153 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 52.02 67.11 1.02 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.9 2.08 . . . . 0.0 110.904 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -136.64 132.84 35.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.131 1.773 . . . . 0.0 106.613 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -99.95 127.07 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.446 1.498 . . . . 0.0 109.046 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.72 74.99 5.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 164.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.21 140.02 17.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.032 0.92 . . . . 0.0 111.693 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -17.32 12.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.69 1.996 . . . . 0.0 110.92 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.85 -42.8 0.53 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.801 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.438 HG11 ' CD2' ' A' ' 99' ' ' LEU . 89.3 t 50.69 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.045 1.338 . . . . 0.0 111.18 -176.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.7 mt -98.67 159.54 14.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.0 17.96 14.79 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.911 0.884 . . . . 0.0 113.361 -162.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HE2' ' CG2' ' A' ' 110' ' ' VAL . 42.5 mmtt 37.89 49.48 1.15 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.534 1.933 . . . . 0.0 111.462 -170.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -85.3 39.28 0.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.732 1.213 . . . . 0.0 108.866 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 t0 53.39 81.51 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.218 1.807 . . . . 0.0 110.544 -160.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.94 119.67 31.9 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 171.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.75 -165.14 1.62 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 -166.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -61.24 108.13 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 56.4 m -79.79 137.34 54.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.25 178.75 1.04 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.56 2.84 . . . . 0.0 112.183 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.37 -33.45 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.32 2.013 . . . . 0.0 113.786 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -82.19 59.93 4.7 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.107 0.963 . . . . 0.0 109.453 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -165.15 -48.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.163 1.385 . . . . 0.0 107.812 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -37.16 65.79 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.154 1.382 . . . . 0.0 110.619 -177.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 39.0 0.19 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.258 1.023 . . . . 0.0 111.094 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.94 -77.23 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 110.269 171.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.3 ttm . . . . . 0 C--O 1.248 1.002 0 C-N-CA 128.565 2.746 . . . . 0.0 113.104 -169.334 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.469 0.525 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -72.12 -53.94 11.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.603 0.638 . . . . 0.0 110.488 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 m -113.83 169.41 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.64 1.576 . . . . 0.0 109.573 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -126.91 120.58 29.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.737 1.215 . . . . 0.0 110.84 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 mm -72.23 159.31 5.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.146 0.974 . . . . 0.0 110.293 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.55 129.89 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.58 1.952 . . . . 0.0 107.727 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 60' ' ' LEU . 2.5 pp -66.85 -176.54 0.51 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.159 1.784 . . . . 0.0 112.185 -169.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -156.56 162.14 39.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.957 1.303 . . . . 0.0 109.38 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -145.72 173.09 12.39 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.756 2.822 . . . . 0.0 108.601 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -135.36 165.4 36.64 Favored Pre-proline 0 CA--C 1.53 0.187 0 O-C-N 121.315 -0.866 . . . . 0.0 112.233 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.16 -8.62 12.62 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.384 2.723 . . . . 0.0 116.205 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.51 -38.0 4.09 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 120.586 1.539 . . . . 0.0 110.01 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.04 22.94 1.9 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.432 -1.628 . . . . 0.0 110.27 -162.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.67 -50.92 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 164.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.856 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -79.97 -41.23 26.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.369 1.867 . . . . 0.0 110.568 -169.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -82.19 4.09 24.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.995 1.318 . . . . 0.0 110.159 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.93 170.72 6.67 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 125.995 1.759 . . . . 0.0 109.756 -166.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -85.98 157.69 20.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -162.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -81.08 -24.74 37.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.77 -1.206 . . . . 0.0 112.774 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.038 0.935 . . . . 0.0 111.27 -173.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 t -151.66 12.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.489 0.716 . . . . 0.0 110.933 -169.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 55.92 79.77 0.16 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.722 1.609 . . . . 0.0 110.374 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -131.55 166.27 21.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.099 1.76 . . . . 0.0 109.789 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 mmt -107.0 124.35 35.6 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.093 1.357 . . . . 0.0 109.034 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -62.39 154.87 61.02 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.673 167.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.78 130.78 35.62 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.658 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.56 -9.72 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 122.844 0.458 . . . . 0.0 111.332 166.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.11 3.24 56.87 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.589 -1.673 . . . . 0.0 115.286 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.613 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.0 pt20 -115.29 173.51 6.47 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.88 2.34 . . . . 0.0 112.374 -161.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -98.41 135.36 40.11 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -158.17 174.91 14.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.752 0.786 . . . . 0.0 111.335 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -131.89 153.3 50.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.253 1.421 . . . . 0.0 109.775 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 91' ' ' VAL . 88.3 t -138.14 138.34 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 127.447 2.299 . . . . 0.0 107.74 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.41 2.8 Favored Glycine 0 N--CA 1.466 0.687 0 CA-C-N 120.795 1.634 . . . . 0.0 112.048 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.7 165.25 27.64 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -172.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.5 ttm -79.95 123.32 27.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.482 1.513 . . . . 0.0 107.789 166.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.21 125.47 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 38.6 mtt -52.77 121.51 22.95 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.123 0.569 . . . . 0.0 110.603 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.07 91.49 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.803 3.669 . . . . 0.0 109.192 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.73 62.7 0.68 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 -23.29 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.376 2.271 . . . . 0.0 111.05 170.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.12 93.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 119.704 1.138 . . . . 0.0 109.341 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -80.8 73.38 7.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.967 2.507 . . . . 0.0 106.618 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.88 136.93 48.94 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.02 127.13 89.9 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.43 -7.51 21.02 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 CA-C-N 119.625 0.902 . . . . 0.0 112.151 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -129.66 0.35 4.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.191 0.905 . . . . 0.0 111.88 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.33 173.39 11.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 120.224 1.375 . . . . 0.0 111.099 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.74 -2.01 58.15 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.804 -0.56 . . . . 0.0 112.052 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.34 139.84 35.4 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.429 -1.42 . . . . 0.0 108.155 166.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.06 121.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.3 m -116.79 129.81 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -139.77 175.4 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 119.283 0.947 . . . . 0.0 111.076 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -123.9 142.69 50.91 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -122.65 137.01 57.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 178.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -130.69 179.87 5.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.129 1.771 . . . . 0.0 108.276 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -152.91 -116.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.182 163.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.89 -1.97 30.91 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.824 1.193 . . . . 0.0 112.27 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -124.7 -70.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.796 1.238 . . . . 0.0 107.783 -156.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.47 -168.39 12.55 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.3 p -142.75 156.79 45.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.121 0.568 . . . . 0.0 111.65 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 62' ' ' VAL . 23.6 m -138.01 147.64 25.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.782 2.033 . . . . 0.0 109.587 -171.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.23 153.73 24.56 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.609 HG11 HG21 ' A' ' 111' ' ' VAL . 3.2 m -135.67 145.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 163.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -112.77 125.8 54.73 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 162.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -124.27 158.91 31.42 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.168 1.387 . . . . 0.0 108.667 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -142.94 99.12 3.4 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.0 170.34 29.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.603 1.097 . . . . 0.0 110.452 -175.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -74.96 -17.51 16.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.617 1.167 . . . . 0.0 112.072 -165.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 73.27 135.74 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.955 2.502 . . . . 0.0 109.36 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.73 151.46 85.61 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.793 1.662 . . . . 0.0 108.999 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -29.08 68.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.831 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -59.45 -38.4 80.65 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.971 -1.49 . . . . 0.0 111.18 176.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.456 ' CD2' HG11 ' A' ' 109' ' ' VAL . 23.9 t80 -67.06 134.56 52.12 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.341 1.456 . . . . 0.0 110.938 -172.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.14 169.43 17.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.072 0.949 . . . . 0.0 110.661 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.66 84.41 6.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.899 1.68 . . . . 0.0 108.001 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.97 5.48 3.87 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.124 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.28 171.57 7.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.058 1.929 . . . . 0.0 110.761 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.47 110.93 3.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 103' ' ' PHE . 2.3 m -112.92 171.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 173.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.849 HG22 ' HB2' ' A' ' 127' ' ' LEU . 3.1 m -113.02 163.63 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 157.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 126' ' ' VAL . 2.2 t -113.97 157.56 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 156.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -141.89 148.83 39.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.351 2.26 . . . . 0.0 106.661 169.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.16 -114.69 0.66 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -135.75 159.63 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.724 1.762 . . . . 0.0 110.371 -165.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.54 142.0 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 -66.62 0.89 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.473 0.709 . . . . 0.0 109.463 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -50.32 0.08 Allowed 'General case' 0 C--N 1.347 0.483 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.52 -77.27 0.82 Allowed Glycine 0 C--N 1.329 0.149 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -141.14 33.48 1.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.897 1.679 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -115.78 129.54 56.49 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 111' ' ' VAL . 8.9 mm -102.68 133.61 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.758 1.623 . . . . 0.0 108.535 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.2 108.0 12.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 157.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.31 141.98 54.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 165.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -27.5 7.85 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 126.198 1.799 . . . . 0.0 108.971 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.82 -18.29 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 111' ' ' VAL . 21.4 t 51.41 99.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.428 2.291 . . . . 0.0 115.951 170.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.849 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.4 125.07 52.01 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.592 -163.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -99.78 57.69 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.162 -1.586 . . . . 0.0 110.592 -171.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 50.16 26.72 2.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.958 1.303 . . . . 0.0 113.706 173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.534 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -80.65 58.99 3.44 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.611 1.964 . . . . 0.0 108.817 175.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.05 10.69 2.33 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -76.16 162.33 28.07 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.623 -1.298 . . . . 0.0 110.566 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -159.19 -13.85 0.06 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.127 1.371 . . . . 0.0 110.723 159.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -145.52 168.49 20.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.856 2.063 . . . . 0.0 106.702 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -135.35 129.8 18.87 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.78 174.15 4.91 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.051 2.5 . . . . 0.0 110.589 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -81.69 -32.25 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.011 1.141 . . . . 0.0 114.454 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 66.68 1.33 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.592 1.557 . . . . 0.0 108.937 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 p -178.1 -53.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 127.631 2.373 . . . . 0.0 106.382 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -58.54 -42.89 88.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.792 0.837 . . . . 0.0 110.819 -167.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 -1.06 13.32 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.814 0.845 . . . . 0.0 110.998 -177.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.6 3.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.999 0.818 . . . . 0.0 110.695 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.872 1.669 . . . . 0.0 112.323 -163.891 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mpp_? -160.16 142.28 13.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.933 2.093 . . . . 0.0 106.379 157.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -149.29 158.32 44.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 165.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -162.47 176.33 10.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.226 0.466 . . . . 0.0 110.027 142.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 35' ' ' ASP . 10.3 mm -79.31 -154.4 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 172.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 34' ' ' ILE . 4.1 p30 -74.0 149.2 41.42 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.331 -2.106 . . . . 0.0 110.333 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -103.65 -174.22 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.915 1.686 . . . . 0.0 113.394 -168.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 32.3 t80 -140.7 121.42 14.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.119 1.368 . . . . 0.0 109.812 -162.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CE1' HD11 ' A' ' 36' ' ' LEU . 83.0 m-85 -110.21 -179.58 3.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 109.282 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 p -147.55 162.3 32.5 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.811 1.645 . . . . 0.0 107.161 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 66.5 8.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 109.628 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -168.3 -52.27 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -1.6 25.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 125.598 1.559 . . . . 0.0 111.388 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.65 -30.98 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.83 -46.92 5.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.217 1.007 . . . . 0.0 111.282 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.4 -36.52 22.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.154 1.382 . . . . 0.0 109.919 -172.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.21 133.83 3.2 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -167.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 7.3 tptp -62.13 129.58 41.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 119.085 1.443 . . . . 0.0 109.994 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.0 mtm105 -72.03 -26.71 62.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.602 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -56.11 -73.3 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.058 1.299 . . . . 0.0 111.842 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -152.11 48.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 48.18 70.51 0.43 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.22 1.486 . . . . 0.0 112.755 154.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -130.73 145.83 52.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.049 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.0 160.52 55.05 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.62 148.71 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.843 1.695 . . . . 0.0 110.12 163.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.46 137.79 37.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.72 -8.21 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.622 0.769 . . . . 0.0 111.18 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.07 36.25 3.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 125.598 1.57 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -136.02 163.88 29.27 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.411 1.606 . . . . 0.0 110.215 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -77.47 150.39 34.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.419 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -160.73 164.68 31.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.086 1.355 . . . . 0.0 111.093 169.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -106.51 155.04 20.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.011 1.724 . . . . 0.0 107.277 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.0 153.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 127.075 2.15 . . . . 0.0 107.815 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.46 139.65 11.14 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 162.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.16 173.58 43.6 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 118.177 0.989 . . . . 0.0 111.51 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 ttm -109.0 123.82 49.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 110.859 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.837 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -66.28 129.45 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.889 1.677 . . . . 0.0 110.494 -171.05 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 mtt -62.68 139.81 97.0 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.09 0.859 . . . . 0.0 110.154 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.75 140.43 80.32 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.696 1.597 . . . . 0.0 108.565 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.27 43.5 92.77 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.221 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.8 p -117.08 -84.33 0.64 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.305 1.7 p -22.49 95.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 130.817 3.647 . . . . 0.0 114.802 -170.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.22 90.99 7.54 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 129.089 2.955 . . . . 0.0 108.662 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -90.9 147.93 22.81 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.33 120.78 83.16 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.3 -8.74 23.26 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 CA-C-N 121.305 1.502 . . . . 0.0 113.037 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.0 -22.58 10.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.041 1.336 . . . . 0.0 109.713 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -139.58 -160.56 1.08 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.9 mt -113.32 -6.22 13.56 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.92 0.888 . . . . 0.0 112.055 -171.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -55.12 139.47 41.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.039 1.336 . . . . 0.0 108.048 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 4.9 p -158.13 127.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.1 m -102.49 146.56 27.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 24.6 p90 -146.23 172.53 13.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.982 1.265 . . . . 0.0 109.684 168.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.59 145.4 42.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -131.21 126.34 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.57 1.148 . . . . 0.0 109.094 175.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 28.6 p90 -117.3 173.89 6.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.491 2.316 . . . . 0.0 110.34 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -152.61 -164.51 1.97 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.977 1.311 . . . . 0.0 108.328 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.11 11.06 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.802 -1.186 . . . . 0.0 113.672 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.473 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -116.03 -75.65 0.58 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -174.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -127.76 -162.37 11.07 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.504 1.049 . . . . 0.0 113.0 -167.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 93.8 p -144.9 160.44 41.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.623 0.769 . . . . 0.0 110.754 169.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.01 145.34 28.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -76.94 151.9 35.52 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 84' ' ' ILE . 6.2 m -131.73 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 121.943 -0.473 . . . . 0.0 109.766 165.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -104.45 132.7 50.4 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 16.6 t80 -132.53 168.49 18.13 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.465 1.506 . . . . 0.0 108.445 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -156.07 107.07 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 167.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.93 20.19 0.02 OUTLIER Glycine 0 N--CA 1.468 0.8 0 C-N-CA 116.254 -2.879 . . . . 0.0 118.195 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER 59.21 117.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.641 1.977 . . . . 0.0 111.882 -168.651 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.531 ' CD2' HG11 ' A' ' 126' ' ' VAL . 23.7 mt -74.33 148.29 85.94 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.301 -0.874 . . . . 0.0 109.902 -175.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -60.7 156.73 41.06 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.314 2.676 . . . . 0.0 109.749 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.86 -40.95 97.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.665 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.18 -27.91 64.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.916 1.286 . . . . 0.0 111.44 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -55.53 129.77 40.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.617 1.099 . . . . 0.0 109.478 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ptt85 -127.86 -164.23 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.623 1.169 . . . . 0.0 111.158 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -103.06 129.19 49.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 153.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.837 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 97.4 8.82 56.0 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 115.524 -2.82 . . . . 0.0 114.754 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.65 165.28 11.88 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 121.829 2.815 . . . . 0.0 110.111 174.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.21 133.97 26.6 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.56 161.96 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.835 2.454 . . . . 0.0 105.801 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.41 138.5 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 121' ' ' ILE . 15.2 m -117.06 166.02 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.296 0.57 . . . . 0.0 110.059 166.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -158.44 146.31 18.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.148 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.91 -112.44 0.54 Allowed Glycine 0 C--O 1.228 -0.263 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -134.45 162.95 30.82 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 120.366 2.083 . . . . 0.0 107.608 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 3.4 tp -82.46 133.91 35.21 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.685 1.194 . . . . 0.0 108.533 167.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.619 ' HG2' HD21 ' A' ' 122' ' ' LEU . 6.9 tm-20 -80.61 -66.64 0.86 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -168.35 -171.89 1.59 Allowed 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 133.161 4.584 . . . . 0.0 105.106 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -8.58 82.92 0.0 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.495 2.95 . . . . 0.0 113.623 164.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 59.2 35.22 23.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.27 2.228 . . . . 0.0 114.767 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -126.41 132.66 51.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.168 0.987 . . . . 0.0 111.045 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 111' ' ' VAL . 20.2 mm -110.95 125.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 128.131 2.572 . . . . 0.0 110.92 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HG2' ' A' ' 116' ' ' GLU . 3.5 mm? -79.72 73.64 6.44 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.916 1.286 . . . . 0.0 108.308 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -43.17 128.07 4.5 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.786 -0.571 . . . . 0.0 110.398 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -26.99 13.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.084 1.353 . . . . 0.0 111.22 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.68 -41.99 0.61 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -170.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 99' ' ' LEU . 58.9 t 57.34 144.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.892 2.077 . . . . 0.0 111.754 -168.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -139.21 159.89 41.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.31 39.73 3.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.705 1.602 . . . . 0.0 110.164 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt 17.97 64.15 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.162 2.585 . . . . 0.0 112.251 -161.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.759 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -66.74 -17.27 64.77 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.947 2.099 . . . . 0.0 111.204 167.31 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.1 t70 100.84 22.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 131.123 3.769 . . . . 0.0 111.043 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.97 129.93 24.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.013 1.725 . . . . 0.0 110.128 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.389 1.476 . . . . 0.0 111.14 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -131.17 -177.66 4.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.106 2.162 . . . . 0.0 108.21 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.1 m -104.23 105.45 49.3 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.66 174.89 6.86 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.167 2.578 . . . . 0.0 112.302 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.19 -38.73 4.56 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.155 1.237 . . . . 0.0 112.921 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -75.42 32.82 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.989 2.116 . . . . 0.0 112.484 -162.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.76 -34.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 128.167 2.587 . . . . 0.0 109.966 -168.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.1 -42.56 96.85 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 120.199 1.363 . . . . 0.0 111.037 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -168.72 70.01 0.08 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.291 1.836 . . . . 0.0 106.608 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -155.16 19.23 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.542 0.737 . . . . 0.0 112.813 -165.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 C--O 1.246 0.878 0 C-N-CA 125.546 1.538 . . . . 0.0 108.444 -179.539 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -144.45 133.39 22.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.435 1.494 . . . . 0.0 108.789 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -145.25 118.38 8.88 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.451 1.5 . . . . 0.0 107.987 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -115.23 153.03 31.62 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.815 1.246 . . . . 0.0 108.636 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 35' ' ' ASP . 25.8 mt 62.86 172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.366 1.867 . . . . 0.0 110.184 176.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.14 149.04 7.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.8 1.64 . . . . 0.0 109.499 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.8 pp -78.27 176.8 8.95 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.099 0.952 . . . . 0.0 108.809 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -155.58 149.1 25.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.619 ' CE1' HD13 ' A' ' 36' ' ' LEU . 85.8 m-85 -136.8 -179.93 5.99 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.457 1.903 . . . . 0.0 107.794 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -146.11 164.34 25.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 C-N-CA 126.236 1.814 . . . . 0.0 106.75 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.51 64.31 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.916 3.078 . . . . 0.0 110.142 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.9 -50.06 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -3.57 37.12 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.827 -0.808 . . . . 0.0 111.796 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mt -94.4 -34.17 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.001 0.92 . . . . 0.0 108.723 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.63 -57.66 2.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.465 1.106 . . . . 0.0 111.311 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -85.45 -28.03 25.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.591 2.357 . . . . 0.0 109.423 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.31 158.57 11.47 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.755 1.169 . . . . 0.0 112.189 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 7.2 tptt -47.86 124.69 7.71 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.556 1.542 . . . . 0.0 110.681 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.13 -28.71 70.25 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 121.278 1.854 . . . . 0.0 112.682 -168.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.75 -34.82 72.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.43 1.892 . . . . 0.0 113.311 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 t -168.23 -5.25 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.419 0.688 . . . . 0.0 112.435 -159.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.358 0.0 OUTLIER 45.5 32.39 1.1 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.148 2.979 . . . . 0.0 115.627 170.107 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -70.2 -4.67 22.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.532 1.533 . . . . 0.0 112.726 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt 59.71 158.95 0.1 Allowed Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 129.413 3.085 . . . . 0.0 112.492 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.9 162.27 32.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.763 1.642 . . . . 0.0 109.241 154.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -79.58 152.78 29.89 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 162.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.747 HG11 ' HE3' ' A' ' 117' ' ' LYS . 76.2 t -90.65 0.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.896 0.878 . . . . 0.0 111.811 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.41 61.58 0.65 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 165.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.416 ' HG3' HD12 ' A' ' 60' ' ' LEU . 3.0 pt20 -140.0 176.11 9.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.485 0.714 . . . . 0.0 110.965 168.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -90.75 135.28 33.82 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.905 0.882 . . . . 0.0 111.205 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -158.48 175.71 13.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.193 1.397 . . . . 0.0 112.424 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -114.53 148.95 37.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 127.941 2.497 . . . . 0.0 109.141 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.63 134.68 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.199 1.399 . . . . 0.0 107.536 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.98 143.66 16.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 158.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.95 167.9 38.97 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.457 1.129 . . . . 0.0 111.579 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.7 ttm -93.73 121.91 35.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.605 1.562 . . . . 0.0 109.708 -174.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -66.2 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 109.222 -176.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 45.5 mtt -62.31 144.02 95.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 111.894 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.67 61.57 8.23 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.592 3.528 . . . . 0.0 110.804 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.15 63.06 0.02 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -152.72 -23.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.252 0.6 OUTLIER -68.56 100.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 120.261 1.391 . . . . 0.0 111.334 -176.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -82.91 81.46 8.59 Favored 'General case' 0 C--O 1.237 0.446 1 C-N-CA 132.667 4.387 . . . . 0.0 109.455 171.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -77.12 140.09 40.14 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.15 137.76 84.5 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.49 -20.74 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.159 1.239 . . . . 0.0 112.571 171.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.35 14.12 6.09 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.16 0.984 . . . . 0.0 110.653 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.14 -176.14 5.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.281 0.632 . . . . 0.0 109.902 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.54 8.78 29.48 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.162 1.785 . . . . 0.0 109.729 161.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -50.0 145.24 5.86 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 160.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.88 166.77 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 122.244 1.021 . . . . 0.0 109.114 169.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.67 116.16 7.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 163.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -125.07 175.85 7.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.503 1.956 . . . . 0.0 111.483 171.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 m -124.76 145.56 49.66 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -130.5 138.45 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.256 1.822 . . . . 0.0 107.465 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -130.04 174.65 9.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.612 1.565 . . . . 0.0 108.89 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -157.1 -163.84 1.48 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.46 -3.41 0.98 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.365 1.866 . . . . 0.0 115.269 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -118.84 -79.79 0.6 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.14 -159.24 8.59 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.927 1.251 . . . . 0.0 111.796 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -146.96 162.09 39.43 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 119' ' ' ASN . 14.2 m -142.99 145.28 23.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.776 1.63 . . . . 0.0 109.255 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.49 159.74 24.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 84' ' ' ILE . 3.9 m -136.27 138.5 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.301 1.04 . . . . 0.0 109.134 168.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.1 106.72 17.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.054 2.142 . . . . 0.0 105.308 167.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.37 165.96 10.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 107.487 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -157.12 117.33 3.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.92 -92.77 0.11 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 115.246 -3.359 . . . . 0.0 118.234 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.15 69.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 123.881 1.801 . . . . 0.0 107.253 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' CD1' HG11 ' A' ' 126' ' ' VAL . 21.4 tp -49.85 135.09 20.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.371 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -63.3 138.82 68.38 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 108.169 -1.512 . . . . 0.0 108.169 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.31 -14.82 58.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.462 170.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.15 -23.78 47.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.655 1.582 . . . . 0.0 111.916 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.7 122.73 14.22 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -120.62 153.37 36.91 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.263 1.425 . . . . 0.0 107.232 171.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.13 117.49 17.88 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 122.21 8.93 6.91 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 116.376 -2.347 . . . . 0.0 115.864 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.598 ' H ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -133.57 167.68 20.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.774 2.787 . . . . 0.0 112.305 -165.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.67 81.92 1.68 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.523 1.535 . . . . 0.0 112.348 -167.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.16 168.93 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.786 0.834 . . . . 0.0 109.916 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.61 115.53 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 171.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -105.31 156.75 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 127.086 2.155 . . . . 0.0 108.557 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -154.57 138.94 16.71 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.593 2.357 . . . . 0.0 106.154 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.96 -112.69 0.52 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 105.936 -2.866 . . . . 0.0 105.936 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -140.9 157.68 45.03 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.432 1.616 . . . . 0.0 109.507 -167.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -91.48 154.71 18.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.953 1.301 . . . . 0.0 109.084 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.4 -79.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.903 0.881 . . . . 0.0 110.675 -171.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.747 ' HE3' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -178.29 169.04 1.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 130.871 3.668 . . . . 0.0 106.325 177.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.39 20.92 52.76 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.455 1.025 . . . . 0.0 113.696 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' HB3' HG12 ' A' ' 91' ' ' VAL . 52.3 m-80 54.64 68.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.121 1.368 . . . . 0.0 112.269 -164.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -131.18 132.56 44.81 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.55 1.14 . . . . 0.0 109.188 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 20.9 mm -105.18 133.49 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 110.285 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.05 109.65 13.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.48 139.19 34.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.83 -18.25 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 111.513 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.31 -43.99 0.46 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 111' ' ' VAL . 58.5 t 53.3 108.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.767 2.027 . . . . 0.0 115.164 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.693 HD22 ' HG3' ' A' ' 132' ' ' GLU . 70.6 mt -124.1 152.38 42.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.74 1.616 . . . . 0.0 107.712 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 130' ' ' HIS . . . -114.17 27.68 9.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.92 1.236 . . . . 0.0 110.806 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt 44.57 49.7 8.43 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.317 1.847 . . . . 0.0 113.183 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.508 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.02 -93.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 170.879 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.32 -59.91 0.62 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -170.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.693 ' HG3' HD22 ' A' ' 127' ' ' LEU . 10.6 mm-40 50.21 75.03 0.19 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 110.137 -172.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -70.35 156.41 39.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 162.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -77.36 171.06 15.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.977 0.911 . . . . 0.0 109.271 164.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -133.53 130.85 21.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 166.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.34 174.79 5.68 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.441 2.761 . . . . 0.0 111.68 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -73.9 -32.43 7.23 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.515 1.477 . . . . 0.0 113.969 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -68.34 46.03 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.826 2.451 . . . . 0.0 112.31 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 p -179.05 -50.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 128.009 2.524 . . . . 0.0 106.84 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.94 -20.33 65.11 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.39 0.676 . . . . 0.0 111.78 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.74 133.86 47.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 155.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 56.75 80.1 0.16 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.039 2.135 . . . . 0.0 112.299 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 148.781 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 162.98 116.57 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 129.647 3.179 . . . . 0.0 103.606 -165.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -141.58 81.99 1.8 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.804 0.729 . . . . 0.0 109.495 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 60.14 -167.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.252 1.021 . . . . 0.0 111.189 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mt -127.67 134.4 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.56 123.55 22.71 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 125.393 1.477 . . . . 0.0 109.655 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.07 161.5 24.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 148.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 t80 100.27 140.85 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 1 C-N-CA 134.046 4.939 . . . . 0.0 106.28 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 9.8 m-85 -141.88 175.08 10.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.363 2.265 . . . . 0.0 106.289 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 6.8 p -140.86 170.97 8.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.249 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 9.2 Cg_endo -62.98 -5.97 8.63 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.723 2.949 . . . . 0.0 118.009 -166.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -35.13 5.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 120.424 1.465 . . . . 0.0 110.404 165.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.55 -5.64 59.31 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.462 -1.611 . . . . 0.0 111.342 -158.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.95 -18.1 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.507 1.123 . . . . 0.0 110.769 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -111.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.407 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 44' ' ' LEU . 9.4 m-30 -80.28 -32.41 38.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.892 0.877 . . . . 0.0 111.3 -169.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.59 142.0 3.89 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 82.2 tttt -66.35 149.39 50.45 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.535 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -18.47 -71.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.225 1.41 . . . . 0.0 112.603 -142.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -68.7 -85.73 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -158.49 6.67 0.12 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.86 0.864 . . . . 0.0 111.087 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -51.66 66.93 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.589 -1.319 . . . . 0.0 114.041 -150.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.11 161.69 17.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 mtp -87.38 163.96 37.27 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 155.41 68.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.276 1.317 . . . . 0.0 110.057 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -81.7 131.03 35.25 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.45 1.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.102 1.761 . . . . 0.0 112.469 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.55 25.57 4.47 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 116.471 -2.294 . . . . 0.0 113.386 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -125.2 175.09 7.64 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.42 2.11 . . . . 0.0 112.861 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -85.7 140.01 30.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.464 1.505 . . . . 0.0 112.621 167.38 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.77 171.5 18.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.269 1.828 . . . . 0.0 110.223 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -129.33 145.6 51.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.854 1.662 . . . . 0.0 108.282 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.68 132.66 71.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.55 153.15 20.11 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 157.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.48 -175.85 42.36 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 ttm -118.87 125.26 49.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 58.0 t -65.57 124.25 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.242 0.928 . . . . 0.0 108.685 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.6 ttm -59.66 124.23 75.03 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.293 1.037 . . . . 0.0 109.047 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 112.12 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.017 3.145 . . . . 0.0 110.404 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.06 51.86 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.051 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -67.13 -26.26 66.59 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.781 1.79 . . . . 0.0 112.877 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.53 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 123.985 0.914 . . . . 0.0 110.148 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.64 -70.39 0.13 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.105 1.762 . . . . 0.0 109.443 168.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 44.26 144.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 1 C-N-CA 131.736 4.014 . . . . 0.0 114.057 -164.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -88.3 131.58 42.02 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.78 -11.59 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.858 1.342 . . . . 0.0 112.69 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -134.55 10.36 3.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.61 1.564 . . . . 0.0 110.639 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.24 -172.65 4.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.765 1.226 . . . . 0.0 107.812 173.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.19 -9.65 16.06 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.37 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 140.71 50.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.838 0.855 . . . . 0.0 109.269 172.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.91 145.0 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.7 m -147.1 135.87 22.14 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -147.13 174.58 11.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.491 1.116 . . . . 0.0 108.85 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -121.18 151.47 39.9 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -130.16 140.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -133.32 174.25 10.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.148 1.379 . . . . 0.0 109.388 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.37 -165.67 2.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.593 2.357 . . . . 0.0 104.921 165.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.21 0.26 1.44 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 114.263 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.37 -70.78 0.79 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 120.017 1.281 . . . . 0.0 108.718 -164.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.38 -166.51 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 128.423 2.916 . . . . 0.0 108.188 -170.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.0 p -153.42 159.88 42.47 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.114 -0.639 . . . . 0.0 109.537 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.28 153.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.347 1.459 . . . . 0.0 110.122 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.18 158.26 19.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.889 0.476 . . . . 0.0 109.978 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.414 ' CG2' HD11 ' A' ' 84' ' ' ILE . 44.7 t -141.35 120.62 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.857 1.263 . . . . 0.0 108.388 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -96.83 131.55 43.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 162.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -131.85 167.66 19.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.353 1.861 . . . . 0.0 107.695 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -160.39 104.54 1.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.62 7.01 0.02 OUTLIER Glycine 0 C--O 1.225 -0.449 0 C-N-CA 116.272 -2.87 . . . . 0.0 117.026 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 99' ' ' LEU 0.281 0.4 OUTLIER 58.22 145.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 123.706 1.717 . . . . 0.0 109.66 -156.032 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.578 ' H ' HD13 ' A' ' 98' ' ' ILE . 14.1 mt -98.53 157.01 35.06 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.769 -173.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.02 150.9 84.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.48 -23.03 67.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 111.481 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.32 -20.88 60.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.725 1.61 . . . . 0.0 112.534 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 109' ' ' VAL . 27.3 t80 -72.22 127.04 31.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.308 1.867 . . . . 0.0 108.216 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -135.74 166.42 23.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.489 1.115 . . . . 0.0 109.911 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.85 121.53 25.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.455 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 101.64 17.67 20.76 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 115.609 1.003 . . . . 0.0 115.609 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.78 174.61 7.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.199 1.499 . . . . 0.0 112.378 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.81 105.51 3.29 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.586 1.565 . . . . 0.0 111.288 -167.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.6 m -105.35 171.28 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.434 ' CG2' ' HE3' ' A' ' 129' ' ' LYS . 2.4 t -130.46 97.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 128.031 2.532 . . . . 0.0 104.193 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 126' ' ' VAL . 2.0 t -79.6 154.77 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 108.1 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 9.1 tt0 -151.96 143.24 23.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 127.266 2.226 . . . . 0.0 106.115 168.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.33 -111.07 0.35 Allowed Glycine 0 N--CA 1.434 -1.447 1 N-CA-C 101.341 -4.704 . . . . 0.0 101.341 158.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 21.8 mt-10 -141.56 153.98 45.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 119.561 1.681 . . . . 0.0 109.34 -167.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 60' ' ' LEU . 19.5 tp -84.11 127.03 33.65 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.27 -66.5 0.86 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.51 0.724 . . . . 0.0 110.69 -168.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -150.52 -66.54 0.2 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.45 -86.1 1.53 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -139.34 51.68 1.76 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -126.72 133.57 50.87 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.313 1.445 . . . . 0.0 107.301 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.65 131.12 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.322 1.449 . . . . 0.0 108.92 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.99 100.84 7.48 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 158.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.5 144.61 46.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.791 0.805 . . . . 0.0 110.177 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -22.78 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.171 2.189 . . . . 0.0 110.78 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -154.19 -7.7 0.15 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 111' ' ' VAL . 32.8 t 26.91 85.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.581 2.352 . . . . 0.0 114.49 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.89 143.1 27.11 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.49 50.02 1.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.361 1.064 . . . . 0.0 110.361 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HE3' ' CG2' ' A' ' 110' ' ' VAL . 16.9 mmtp 39.54 38.38 0.39 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.074 2.15 . . . . 0.0 115.263 168.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -49.52 70.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.603 1.161 . . . . 0.0 108.854 169.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -162.14 -26.93 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.14 126.88 26.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.518 1.527 . . . . 0.0 113.064 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.33 -175.01 2.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.762 1.225 . . . . 0.0 110.279 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.0 96.96 0.82 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.908 1.283 . . . . 0.0 110.108 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 63.4 m -79.51 141.34 56.49 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.467 1.507 . . . . 0.0 109.735 177.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 135' ' ' THR . 21.1 Cg_exo -62.66 179.06 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.339 3.359 . . . . 0.0 113.584 173.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -83.4 -172.89 1.47 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.956 3.104 . . . . 0.0 111.194 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.17 36.43 24.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.719 2.008 . . . . 0.0 111.383 -170.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.0 -24.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.016 1.727 . . . . 0.0 109.45 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -59.79 146.7 40.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.9 tptm 40.81 64.97 0.86 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.015 1.326 . . . . 0.0 112.148 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.02 -168.89 2.9 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.436 1.495 . . . . 0.0 107.138 167.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 C--O 1.252 1.216 0 C-N-CA 127.402 2.281 . . . . 0.0 112.572 168.574 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 108.6 4.54 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 120.931 -1.106 . . . . 0.0 110.055 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -68.39 149.38 49.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.37 0.605 . . . . 0.0 110.217 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -147.94 171.43 15.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 163.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 35' ' ' ASP . 26.3 mt 61.96 -179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.683 1.593 . . . . 0.0 109.07 -175.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -65.49 173.26 2.77 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.297 -1.502 . . . . 0.0 110.135 161.18 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.558 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -73.99 -176.46 2.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.931 0.872 . . . . 0.0 111.431 170.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.72 152.2 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.549 3.54 . . . . 0.0 106.057 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.7 173.61 11.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.062 2.145 . . . . 0.0 108.711 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 31.8 p -134.37 171.84 8.34 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 119.347 0.976 . . . . 0.0 112.054 169.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.35 1.59 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.989 3.126 . . . . 0.0 117.306 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.53 -24.98 5.66 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 121.296 1.862 . . . . 0.0 116.552 154.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 39' ' ' THR . 11.0 mm-40 -67.84 -12.92 61.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.789 2.295 . . . . 0.0 112.284 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.461 HG22 ' OD1' ' A' ' 119' ' ' ASN . 3.0 mt -105.8 -23.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 126.929 2.092 . . . . 0.0 109.553 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 91' ' ' VAL . 6.9 mt -87.4 -54.12 4.46 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.723 -1.235 . . . . 0.0 110.933 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -81.59 -76.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 106.854 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.6 161.42 23.75 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -57.37 155.34 9.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.248 1.024 . . . . 0.0 108.514 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -19.53 -39.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.9 ' H ' HE22 ' A' ' 51' ' ' GLN . 12.7 mt-10 -121.55 -59.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.019 1.281 . . . . 0.0 109.336 157.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.5 t -157.57 1.39 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.9 HE22 ' H ' ' A' ' 49' ' ' GLU . 2.4 mp0 -58.34 -53.44 58.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 111.639 -147.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -170.72 142.23 1.95 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.556 1.142 . . . . 0.0 108.111 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.3 mtp -73.46 161.69 77.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 162.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.25 162.44 33.92 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.127 1.218 . . . . 0.0 110.278 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -79.18 145.33 33.72 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.6 p -86.54 -2.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.056 1.343 . . . . 0.0 112.49 -173.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 71.85 0.48 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 107.164 -2.375 . . . . 0.0 107.164 153.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.93 176.72 8.45 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.752 0.776 . . . . 0.0 109.62 157.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -79.56 138.88 37.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.399 165.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -148.31 166.21 28.71 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.293 0.637 . . . . 0.0 110.328 165.05 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -99.38 137.42 37.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.455 1.502 . . . . 0.0 108.504 166.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.37 158.38 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.443 1.497 . . . . 0.0 107.435 160.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.76 142.72 11.47 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 154.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.2 -177.25 40.89 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ttm -88.71 118.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.484 0.713 . . . . 0.0 110.257 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.69 128.42 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.622 1.169 . . . . 0.0 109.085 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.4 ttm -70.65 128.53 90.9 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 124.058 0.943 . . . . 0.0 111.091 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.07 113.77 3.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.015 3.143 . . . . 0.0 110.701 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 112.01 12.78 13.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.374 1.94 . . . . 0.0 111.898 -173.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.8 p -112.58 -34.98 5.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 120.135 1.967 . . . . 0.0 111.791 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.83 116.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.047 0.939 . . . . 0.0 110.187 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -120.46 63.82 0.84 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.896 2.478 . . . . 0.0 107.919 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -66.75 143.78 56.72 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.021 -1.049 . . . . 0.0 109.509 169.299 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.86 129.81 87.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.37 -23.91 76.09 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 CA-C-N 122.281 1.85 . . . . 0.0 111.974 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -96.58 -3.97 42.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.848 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -157.89 -169.74 2.93 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.904 1.335 . . . . 0.0 111.274 -163.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.91 -2.39 13.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 127.482 2.313 . . . . 0.0 110.293 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 132.36 53.31 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.9 p -152.1 141.4 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.6 m -133.95 148.77 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.94 -177.1 5.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.451 1.5 . . . . 0.0 109.725 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.1 m -127.98 152.93 47.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.55 HD11 HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -126.66 152.49 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.58 174.95 10.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.798 0.808 . . . . 0.0 109.122 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -151.3 -175.19 5.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.405 1.882 . . . . 0.0 107.553 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.73 -13.98 12.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.651 0.78 . . . . 0.0 113.037 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.84 -66.13 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.586 1.554 . . . . 0.0 107.276 -160.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.16 -162.67 11.58 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.096 1.808 . . . . 0.0 111.44 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -141.65 159.16 42.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.26 1.03 . . . . 0.0 113.203 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.578 HG12 HD21 ' A' ' 44' ' ' LEU . 34.7 m -149.16 156.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 111.537 -165.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.1 155.98 22.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.839 0.29 . . . . 0.0 111.235 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 84' ' ' ILE . 57.6 t -139.94 124.51 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.362 1.065 . . . . 0.0 108.971 162.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 p -98.09 145.65 26.34 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.724 1.147 . . . . 0.0 108.386 159.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -139.88 167.72 21.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.734 1.614 . . . . 0.0 107.913 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -154.68 93.32 1.56 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.76 -175.4 44.54 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 118.538 -1.791 . . . . 0.0 114.096 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.14 117.8 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.2 tp -96.08 135.39 22.74 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 117.58 -1.2 . . . . 0.0 108.454 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.27 150.97 46.46 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.002 1.801 . . . . 0.0 111.686 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.96 -33.88 77.08 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.958 -0.464 . . . . 0.0 110.157 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.491 ' H ' HD12 ' A' ' 102' ' ' LEU . 6.1 mp -61.3 -40.26 93.52 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 109' ' ' VAL . 22.2 t80 -54.47 125.34 19.17 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.93 1.292 . . . . 0.0 109.567 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 157.09 45.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 25.6 mt-10 -64.78 118.27 8.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.723 167.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.68 57.62 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.916 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.41 166.62 10.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.552 1.676 . . . . 0.0 109.765 162.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.3 138.46 20.53 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 124.57 1.081 . . . . 0.0 110.873 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -130.72 166.97 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.431 1.892 . . . . 0.0 108.463 173.542 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.16 131.4 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 127.167 2.187 . . . . 0.0 105.121 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 93' ' ' VAL . 1.4 t -115.96 158.37 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 125.481 1.512 . . . . 0.0 106.939 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -154.37 143.26 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.87 2.068 . . . . 0.0 105.616 176.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.79 -98.37 0.13 Allowed Glycine 0 CA--C 1.508 -0.362 0 CA-C-O 116.475 -2.291 . . . . 0.0 108.701 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.7 154.71 49.62 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.962 1.881 . . . . 0.0 108.946 169.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.566 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -71.13 134.25 46.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.307 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -80.79 -70.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 6.3 mtpp 172.86 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.059 3.343 . . . . 0.0 108.612 -167.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -83.81 57.66 5.04 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.887 -168.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.461 ' OD1' HG22 ' A' ' 43' ' ' ILE . 0.2 OUTLIER 27.45 67.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.108 2.163 . . . . 0.0 113.269 -160.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -134.48 124.08 25.01 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -172.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 60' ' ' LEU . 13.6 mm -93.47 129.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 170.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.54 107.23 11.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 160.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.36 141.93 41.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.134 0.968 . . . . 0.0 109.353 172.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 -15.68 14.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.867 2.067 . . . . 0.0 109.805 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.37 -49.44 0.27 Allowed 'General case' 0 C--N 1.349 0.552 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 111' ' ' VAL . 93.8 t 62.88 135.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.115 2.566 . . . . 0.0 112.091 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.7 mt -153.46 160.87 42.67 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -167.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.559 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -119.16 54.7 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 121.505 1.957 . . . . 0.0 112.625 -163.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt 34.27 32.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 126.296 1.839 . . . . 0.0 115.792 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.633 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -89.16 56.95 3.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.19 2.596 . . . . 0.0 106.681 -169.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t0 47.94 41.0 14.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.414 1.486 . . . . 0.0 111.274 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.85 149.01 50.26 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -162.2 168.4 22.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.021 1.328 . . . . 0.0 108.039 171.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.75 117.32 0.73 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.136 1.374 . . . . 0.0 111.697 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 m -122.11 139.05 29.77 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.603 1.961 . . . . 0.0 106.214 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.66 -177.13 1.7 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.168 3.245 . . . . 0.0 112.484 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.22 -44.14 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.794 2.33 . . . . 0.0 115.174 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.43 70.23 5.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 122.813 1.292 . . . . 0.0 108.743 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.9 p -175.77 -37.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.725 2.81 . . . . 0.0 108.238 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -68.83 -78.77 0.06 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 108.874 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 75.55 1.16 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.24 -26.5 0.58 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.049 1.34 . . . . 0.0 110.248 166.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 C--O 1.255 1.374 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 157.029 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -148.24 158.24 43.97 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.951 1.7 . . . . 0.0 107.023 161.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 p -109.26 160.08 16.42 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 164.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -174.06 -69.18 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.9 157.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.14 149.29 5.39 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.269 1.827 . . . . 0.0 112.875 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 38' ' ' TYR . 2.1 pp -72.67 172.92 9.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 122.268 1.032 . . . . 0.0 109.381 159.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -169.76 149.66 3.83 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.822 2.849 . . . . 0.0 106.077 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.616 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 86.4 m-85 -138.42 179.45 6.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.217 1.807 . . . . 0.0 109.587 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.54 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 71.3 p -131.49 170.31 11.6 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.241 1.017 . . . . 0.0 110.775 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -62.66 65.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.895 3.73 . . . . 0.0 110.815 161.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . 167.52 -62.88 0.2 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -158.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 39' ' ' THR . 28.4 mt-10 -65.66 -21.79 66.58 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.865 1.333 . . . . 0.0 111.9 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.32 -13.97 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 111.17 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 mt -115.41 -42.67 3.13 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.162 -0.961 . . . . 0.0 111.856 -164.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -107.71 -46.37 3.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 109.504 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.57 144.13 3.9 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.616 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 14.3 tptp -61.85 129.98 43.54 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -19.2 -64.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 127.312 2.245 . . . . 0.0 115.622 -138.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -80.08 -86.46 0.08 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 t -164.24 16.57 0.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.881 0.764 . . . . 0.0 112.898 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -53.18 61.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.778 -1.826 . . . . 0.0 112.356 -168.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -168.18 135.73 2.17 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.681 0.792 . . . . 0.0 109.128 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.1 mtp -74.53 161.84 76.25 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 162.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.66 162.63 40.74 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.307 1.145 . . . . 0.0 110.837 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.37 144.12 34.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.148 1.379 . . . . 0.0 108.197 166.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.67 0.85 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.879 1.323 . . . . 0.0 110.968 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.3 11.25 24.15 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 116.462 -2.299 . . . . 0.0 114.425 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -127.15 169.58 13.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.487 2.643 . . . . 0.0 111.715 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -82.97 150.35 26.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.383 162.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.12 -172.46 4.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.858 2.063 . . . . 0.0 108.749 171.614 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.05 48.87 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.517 1.127 . . . . 0.0 108.379 170.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.3 t -123.68 145.61 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.641 1.576 . . . . 0.0 107.439 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.18 124.23 5.67 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 165.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.7 164.09 33.94 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 117.693 0.746 . . . . 0.0 112.189 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 ttm -95.67 122.46 38.46 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.6 1.16 . . . . 0.0 110.286 -172.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -70.66 132.41 33.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.676 1.125 . . . . 0.0 110.131 -172.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.8 mtt -60.93 151.89 72.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.902 0.881 . . . . 0.0 110.995 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.98 106.54 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 124.186 3.258 . . . . 0.0 109.409 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.55 36.49 91.51 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.396 -1.224 . . . . 0.0 113.241 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.8 p -80.72 -15.75 55.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.334 1.567 . . . . 0.0 111.887 162.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -82.16 96.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.571 1.148 . . . . 0.0 110.057 -168.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 78.6 7.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.681 1.592 . . . . 0.0 107.44 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -70.65 138.64 50.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 160.048 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 17.8 t0 -72.11 116.75 51.9 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 169.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.83 -2.0 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.335 2.024 . . . . 0.0 113.574 -166.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -138.61 5.51 2.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.202 2.601 . . . . 0.0 112.021 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 4.3 t -120.57 -161.48 0.89 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.927 1.691 . . . . 0.0 108.901 165.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -124.74 -9.32 7.3 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.23 1.812 . . . . 0.0 110.537 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.1 129.2 33.78 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 164.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 95' ' ' TYR . 3.2 p -142.52 143.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 35.8 m -140.99 133.57 28.61 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.5 p90 -143.33 173.61 11.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.685 -1.259 . . . . 0.0 111.031 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.5 m -128.37 136.89 51.55 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.46 146.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.888 2.075 . . . . 0.0 106.035 -176.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -134.44 176.94 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.828 1.251 . . . . 0.0 109.505 -176.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.11 -168.71 3.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.967 1.307 . . . . 0.0 107.563 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 2.72 0.07 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.553 2.341 . . . . 0.0 113.722 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -126.7 -74.2 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.133 1.373 . . . . 0.0 107.76 -164.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.88 -157.44 7.29 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.369 -0.693 . . . . 0.0 111.369 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -138.57 161.18 37.74 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.202 1.001 . . . . 0.0 111.9 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.13 149.55 16.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -96.04 152.98 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 2.9 m -133.13 134.13 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -118.23 109.52 16.45 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.898 2.079 . . . . 0.0 107.355 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.9 t80 -115.49 171.2 7.87 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.997 1.719 . . . . 0.0 107.897 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.55 96.69 1.54 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.81 178.8 42.38 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 tp -79.6 125.48 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' HG11 ' A' ' 126' ' ' VAL . 34.0 mt -75.85 149.79 83.29 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.252 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.49 146.32 89.18 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.593 2.195 . . . . 0.0 108.647 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.12 -24.23 67.02 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.104 -0.997 . . . . 0.0 111.597 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -19.52 60.87 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.759 2.423 . . . . 0.0 111.973 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -68.37 123.83 21.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.333 1.053 . . . . 0.0 110.599 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -136.5 140.73 43.23 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -66.76 113.85 5.18 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.699 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 109.75 21.95 6.89 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 116.741 -2.144 . . . . 0.0 113.436 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.81 165.12 25.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.161 1.98 . . . . 0.0 111.308 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.53 1.55 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.518 1.532 . . . . 0.0 110.739 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.49 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 108.877 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.36 139.32 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 126' ' ' VAL . 2.5 t -120.26 157.44 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.868 2.067 . . . . 0.0 107.505 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.98 146.51 25.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.893 2.477 . . . . 0.0 107.366 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 145.26 -131.44 4.23 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 104.447 -3.461 . . . . 0.0 104.447 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -140.84 158.33 44.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.096 1.948 . . . . 0.0 110.841 -157.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.57 ' HB2' HD11 ' A' ' 60' ' ' LEU . 15.9 tp -90.75 128.78 36.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.771 0.828 . . . . 0.0 110.259 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.53 -66.75 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 109.85 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.14 158.99 17.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 128.859 2.864 . . . . 0.0 106.42 171.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.11 -99.21 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 124.34 0.971 . . . . 0.0 111.132 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.4 23.07 3.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.682 1.193 . . . . 0.0 110.815 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -92.03 128.03 37.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.2 mm -101.51 130.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 125.343 1.457 . . . . 0.0 109.722 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.18 119.88 22.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 155.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.59 132.86 33.92 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.933 1.293 . . . . 0.0 108.789 171.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.27 -25.36 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.831 1.653 . . . . 0.0 111.693 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.67 -41.75 0.32 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 99' ' ' LEU . 20.0 t 62.98 139.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 124.654 2.168 . . . . 0.0 112.432 -172.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -140.32 157.53 45.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.719 2.008 . . . . 0.0 106.181 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.33 42.06 3.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 109.334 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? 51.34 33.65 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.75 2.42 . . . . 0.0 114.531 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 1.5 p80 -84.29 65.1 8.67 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.274 1.03 . . . . 0.0 108.676 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.6 t0 47.86 38.93 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.622 1.969 . . . . 0.0 113.221 161.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.36 130.29 42.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.18 136.71 48.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.3 t80 54.66 98.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.647 1.579 . . . . 0.0 114.796 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 m -85.77 118.24 70.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 161.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.37 -176.56 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.1 2.533 . . . . 0.0 110.256 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -77.92 -179.57 5.57 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.106 1.871 . . . . 0.0 109.225 153.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 65.46 36.53 6.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.11 2.164 . . . . 0.0 111.16 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.88 -40.74 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.892 0.877 . . . . 0.0 111.809 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.26 -70.98 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.392 1.477 . . . . 0.0 110.507 -166.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -140.35 6.9 2.14 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.986 1.714 . . . . 0.0 110.48 -176.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.75 85.36 2.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 167.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.452 0 C-N-CA 131.6 3.96 . . . . 0.0 106.795 174.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 60' ' ' LEU . 1.1 pp . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.24 156.25 14.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' C ' HG23 ' A' ' 62' ' ' VAL . 87.9 m-85 -137.85 -167.26 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.948 0.795 . . . . 0.0 109.291 170.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -140.93 170.94 8.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 125.796 1.638 . . . . 0.0 109.361 168.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -64.63 -4.13 7.88 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.166 2.577 . . . . 0.0 115.581 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.05 -46.31 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 161.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 39' ' ' THR . 50.9 mt-10 -76.83 -20.27 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.499 -1.589 . . . . 0.0 113.331 -160.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 121' ' ' ILE . 3.7 mt -73.04 -13.47 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.575 -0.703 . . . . 0.0 111.462 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -118.27 -47.39 2.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.66 0.784 . . . . 0.0 109.446 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -90.08 -36.85 14.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.12 0.968 . . . . 0.0 111.07 -168.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.77 4.22 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.801 1.667 . . . . 0.0 111.014 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 CA--C 1.514 -0.408 0 O-C-N 120.0 -1.882 . . . . 0.0 111.43 178.001 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 24.3 mtp . . . . . 0 C--O 1.24 0.586 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.14 165.62 27.83 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.789 1.659 . . . . 0.0 111.493 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.3 136.05 36.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 127.099 2.16 . . . . 0.0 109.358 172.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HA ' ' HB3' ' A' ' 115' ' ' LEU . 10.0 t -64.17 -14.36 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.073 164.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.93 4.18 71.34 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 116.06 -2.522 . . . . 0.0 114.901 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -117.82 168.41 10.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 123.15 3.475 . . . . 0.0 112.645 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 147.32 22.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 164.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -158.09 176.19 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 128.288 2.635 . . . . 0.0 110.06 -173.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -131.26 142.47 50.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.91 2.084 . . . . 0.0 109.073 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 38' ' ' TYR . 3.2 p -152.52 124.19 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -76.63 150.83 38.71 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 169.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 166.86 37.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.081 1.801 . . . . 0.0 110.285 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttm -95.38 125.32 39.92 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.124 1.37 . . . . 0.0 108.665 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.69 124.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 119.498 1.045 . . . . 0.0 108.494 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.9 mtt -60.06 139.51 90.96 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.381 0.992 . . . . 0.0 110.667 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.6 146.03 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.751 2.968 . . . . 0.0 109.562 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.39 -22.93 0.49 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.328 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -61.13 -38.65 87.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.812 1.806 . . . . 0.0 112.106 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.73 94.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.661 1.584 . . . . 0.0 109.301 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -84.2 144.08 29.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 158.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.832 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp . . . . . 0 C--O 1.235 0.335 0 N-CA-C 111.328 0.121 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -54.61 143.53 24.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 123.787 0.835 . . . . 0.0 108.817 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.24 155.63 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 125.155 1.382 . . . . 0.0 107.518 172.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.72 120.85 16.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 161.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -134.91 170.26 16.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.882 0.873 . . . . 0.0 110.71 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 m -117.83 145.8 44.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.92 139.47 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -135.11 175.6 9.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.557 1.543 . . . . 0.0 108.803 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -149.42 -169.83 3.48 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 6.65 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -68.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.873 1.669 . . . . 0.0 109.527 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -168.1 12.76 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.219 1.39 . . . . 0.0 110.401 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.6 p -142.95 160.83 39.6 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.664 0.732 . . . . 0.0 112.684 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.44 154.3 32.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.294 2.238 . . . . 0.0 108.159 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.17 158.73 15.47 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.8 t -138.63 119.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.404 1.482 . . . . 0.0 108.072 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 m -88.06 128.52 35.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 154.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -125.05 161.95 25.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 160.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.58 112.05 5.55 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.07 -159.86 28.28 Favored Glycine 0 CA--C 1.507 -0.453 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.882 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tp -80.57 111.01 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -170.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.64 148.24 48.46 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.205 -1.362 . . . . 0.0 107.832 -169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.96 131.93 49.25 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -17.31 63.34 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.201 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.49 -25.22 54.01 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.562 1.545 . . . . 0.0 113.796 168.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -51.91 121.87 7.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.385 1.448 . . . . 0.0 111.797 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -135.78 157.48 46.75 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.195 1.474 . . . . 0.0 112.256 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -71.62 95.96 1.51 Allowed 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 128.184 2.594 . . . . 0.0 107.622 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.65 33.81 4.02 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 113.326 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 164.03 17.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.125 1.963 . . . . 0.0 110.357 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.07 83.62 1.44 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.774 1.654 . . . . 0.0 109.401 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.6 -179.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.705 1.202 . . . . 0.0 109.014 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.1 t -126.89 135.75 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.314 2.246 . . . . 0.0 105.577 167.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 123' ' ' ALA . 0.6 OUTLIER -104.68 163.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -161.22 144.78 12.96 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.01 -133.06 3.88 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.97 153.31 51.86 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 120.056 1.928 . . . . 0.0 110.211 -159.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -73.98 131.48 41.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.62 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.65 -62.53 1.49 Allowed 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.119 0.568 . . . . 0.0 109.683 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 -72.34 0.17 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.87 -74.44 0.99 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.34 44.93 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 107.997 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -128.54 135.99 50.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 43' ' ' ILE . 4.2 mm -111.0 130.15 64.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 127.327 2.251 . . . . 0.0 109.148 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.27 90.43 4.95 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 156.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -53.8 150.2 7.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.925 0.869 . . . . 0.0 111.174 161.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -12.14 8.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.779 2.832 . . . . 0.0 111.514 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.05 -45.72 0.2 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.1 t 58.97 133.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.584 1.954 . . . . 0.0 111.456 -171.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.84 150.74 48.48 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 120.184 -1.572 . . . . 0.0 107.9 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -110.26 29.09 8.0 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.464 0.706 . . . . 0.0 111.798 -167.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt . . . . . 0 N--CA 1.476 0.827 0 C-N-CA 124.865 1.266 . . . . 0.0 113.785 -174.599 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.7 pp . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 122.906 1.336 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.99 146.36 14.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 36' ' ' LEU . 70.7 m-85 -139.42 -176.49 4.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.055 0.942 . . . . 0.0 110.798 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -137.78 172.69 6.37 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 -9.78 17.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.766 2.311 . . . . 0.0 116.19 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.8 -40.87 3.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 121.001 1.728 . . . . 0.0 112.646 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.53 -15.51 56.51 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.316 1.558 . . . . 0.0 112.278 -158.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mt -82.4 -22.82 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.146 1.779 . . . . 0.0 110.896 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -56.87 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.864 1.211 . . . . 0.0 109.784 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -75.25 -64.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.328 1.851 . . . . 0.0 108.255 -171.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.36 151.92 6.37 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.2 tttt . . . . . 0 C--O 1.224 -0.262 0 CA-C-N 117.223 0.511 . . . . 0.0 110.005 176.619 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.99 159.27 41.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.924 1.749 . . . . 0.0 111.52 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 155.33 28.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.15 2.18 . . . . 0.0 108.983 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.9 -8.44 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.824 1.25 . . . . 0.0 110.899 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.03 38.07 2.09 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 125.955 1.74 . . . . 0.0 109.654 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -121.87 164.79 16.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.663 0.744 . . . . 0.0 109.509 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.22 149.91 24.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.299 172.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -163.96 164.05 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.831 0.852 . . . . 0.0 111.774 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -122.23 99.84 6.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.736 2.414 . . . . 0.0 110.785 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -80.23 159.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.619 -1.301 . . . . 0.0 110.292 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 152.11 24.27 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.278 -0.889 . . . . 0.0 111.789 148.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.26 -178.52 45.18 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.998 1.761 . . . . 0.0 110.395 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.0 ttm -100.83 127.43 47.28 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 117.935 0.867 . . . . 0.0 111.579 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.73 125.88 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.2 mtt -57.04 151.1 36.25 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.484 0.584 . . . . 0.0 110.999 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.5 122.29 9.92 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.418 2.745 . . . . 0.0 108.077 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.7 4.85 48.61 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.872 -1.516 . . . . 0.0 115.538 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.9 p -64.68 -24.9 67.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.339 2.07 . . . . 0.0 110.962 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.68 105.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.588 1.555 . . . . 0.0 109.412 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 81' ' ' THR . 26.1 tt0 -60.22 -65.34 0.7 Allowed 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 126.606 1.963 . . . . 0.0 108.901 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 . . . . . 0 N--CA 1.47 0.551 0 C-N-CA 131.31 3.844 . . . . 0.0 115.759 -172.169 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 0 CA--C 1.531 0.249 0 CA-C-O 120.234 0.064 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.86 142.98 39.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 109.489 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.1 p -156.45 144.05 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 72' ' ' GLN . 30.0 p -121.81 151.3 40.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 165.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -146.4 178.09 8.53 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.786 0.834 . . . . 0.0 109.054 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -125.86 138.47 53.81 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.27 144.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.807 2.043 . . . . 0.0 106.694 176.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -140.45 171.05 14.68 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.091 1.357 . . . . 0.0 110.357 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.54 -164.6 2.04 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.961 1.304 . . . . 0.0 109.077 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.78 -4.37 6.49 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -112.84 -80.84 0.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -170.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.09 -156.11 6.88 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.575 1.083 . . . . 0.0 111.897 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.4 p -150.08 165.28 33.26 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 117.368 0.584 . . . . 0.0 111.688 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.49 138.31 44.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.041 1.736 . . . . 0.0 108.639 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 151.44 39.37 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.58 127.31 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.666 1.186 . . . . 0.0 109.772 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.538 ' OG ' HD13 ' A' ' 122' ' ' LEU . 2.1 p -97.47 135.53 39.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.015 1.326 . . . . 0.0 109.126 164.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 80' ' ' VAL . 32.1 t80 -142.09 169.65 17.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.928 1.691 . . . . 0.0 108.679 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -150.56 105.87 3.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.06 -165.32 36.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.724 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -19.47 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.881 0.472 . . . . 0.0 112.187 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 mt 67.13 151.87 0.12 Allowed Pre-proline 0 CA--C 1.527 0.088 0 C-N-CA 129.237 3.015 . . . . 0.0 112.177 -165.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -62.93 139.51 74.24 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.536 1.491 . . . . 0.0 108.25 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.78 -13.04 60.99 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.027 0.918 . . . . 0.0 110.333 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.31 -25.41 51.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 119.662 -1.899 . . . . 0.0 112.411 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.17 128.23 34.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.204 1.802 . . . . 0.0 112.238 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.07 170.29 16.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.954 1.301 . . . . 0.0 110.021 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.08 80.07 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.71 1.204 . . . . 0.0 108.866 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 32.1 0.47 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.449 1.023 . . . . 0.0 112.068 -170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.31 166.79 21.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.931 1.366 . . . . 0.0 110.869 171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.31 121.37 5.44 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.488 1.994 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.69 170.23 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.179 1.392 . . . . 0.0 108.541 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.77 100.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.636 1.974 . . . . 0.0 107.898 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -79.67 159.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -155.15 137.97 15.33 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.02 -105.77 0.23 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -150.51 157.91 43.55 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.459 1.63 . . . . 0.0 108.941 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' A' ' 60' ' ' LEU . 12.6 tp -80.55 146.4 31.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.318 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -103.44 -64.09 1.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.825 0.739 . . . . 0.0 111.05 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 167.05 158.41 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 129.699 3.199 . . . . 0.0 106.692 -168.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.54 22.53 46.06 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.945 -0.919 . . . . 0.0 114.036 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.3 m120 73.52 29.32 1.6 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.386 1.875 . . . . 0.0 112.702 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -96.09 132.0 41.93 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.833 1.653 . . . . 0.0 109.018 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.7 mm -99.76 129.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 126.306 1.842 . . . . 0.0 109.599 172.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.538 HD13 ' OG ' ' A' ' 94' ' ' SER . 3.5 mm? -79.03 114.41 17.95 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 157.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.42 160.33 29.85 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.009 1.385 . . . . 0.0 109.357 162.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 -26.29 5.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.503 -1.681 . . . . 0.0 110.496 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -139.61 -41.48 0.45 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 111' ' ' VAL . 87.7 t 59.28 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.183 1.793 . . . . 0.0 111.878 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.72 157.97 45.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 120.648 -1.282 . . . . 0.0 108.052 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.58 37.35 4.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.954 1.302 . . . . 0.0 110.124 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.4 mmpm? . . . . . 0 C--N 1.341 0.207 0 C-N-CA 125.157 1.383 . . . . 0.0 112.512 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 60' ' ' LEU . 3.0 pp . . . . . 0 C--O 1.237 0.432 0 CA-C-O 121.038 0.447 . . . . 0.0 111.892 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.47 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 40.4 t80 -171.19 158.29 5.42 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.591 3.156 . . . . 0.0 107.101 173.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.67 -178.9 6.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.629 1.972 . . . . 0.0 110.247 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 p -134.38 163.35 51.83 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 125.16 1.384 . . . . 0.0 111.682 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 91' ' ' VAL . 67.0 Cg_endo -76.07 71.63 5.59 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.602 3.534 . . . . 0.0 108.576 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.52 -66.78 0.15 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 105.44 -3.064 . . . . 0.0 105.44 -163.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.47 -33.5 71.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.131 1.465 . . . . 0.0 111.984 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.45 -11.71 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.354 1.061 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.65 -31.51 3.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.193 . . . . 0.0 111.646 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -98.09 -18.59 18.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.556 1.942 . . . . 0.0 112.218 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.7 147.69 16.99 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.869 1.223 . . . . 0.0 110.403 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 20.0 tptp . . . . . 0 N--CA 1.464 0.247 0 CA-C-O 116.359 -1.781 . . . . 0.0 109.987 -178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.2 mtp . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 118.322 -0.847 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.96 155.94 11.43 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.918 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.58 144.35 31.32 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.254 1.422 . . . . 0.0 111.523 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 115' ' ' LEU . 3.5 p -63.35 -20.82 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 113.001 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.41 59.85 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.88 176.61 9.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.041 1.42 . . . . 0.0 112.328 157.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.36 149.96 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.454 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -160.39 163.88 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.157 1.383 . . . . 0.0 113.262 166.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -101.53 140.77 35.38 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 126.549 1.94 . . . . 0.0 109.164 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -126.73 139.89 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.098 1.359 . . . . 0.0 108.251 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.44 137.25 12.01 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 163.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.64 -163.28 12.2 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.971 1.748 . . . . 0.0 109.364 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 ttm -126.71 127.53 45.26 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 126.525 1.93 . . . . 0.0 109.525 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 21.9 t -65.54 130.07 30.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.0 mtt -65.06 124.48 86.88 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.78 103.8 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.775 2.983 . . . . 0.0 106.649 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.49 -5.39 8.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-O 118.246 -1.308 . . . . 0.0 112.632 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.6 p -88.81 -44.19 10.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.467 1.634 . . . . 0.0 111.949 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.89 104.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.508 1.123 . . . . 0.0 110.951 -167.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.46 -66.22 0.58 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.773 1.629 . . . . 0.0 109.954 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 126.8 2.04 . . . . 0.0 112.048 -153.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.467 0.387 0 CA-C-O 119.945 -0.074 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.58 145.14 55.93 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.233 -0.917 . . . . 0.0 108.974 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -157.81 132.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -130.98 109.45 10.53 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.768 1.627 . . . . 0.0 108.455 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.691 ' CE1' HG21 ' A' ' 93' ' ' VAL . 54.8 p90 -123.21 165.99 15.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.141 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 m -114.25 143.34 45.01 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 145.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.73 173.52 11.62 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.239 1.016 . . . . 0.0 109.591 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.14 -169.72 3.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.049 1.34 . . . . 0.0 107.47 164.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.84 -9.07 5.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.511 1.524 . . . . 0.0 114.015 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.12 -71.33 0.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.352 1.861 . . . . 0.0 107.002 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.07 -152.11 5.61 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.9 p -155.21 164.36 38.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.069 0.548 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 40' ' ' PRO . 31.1 m -147.38 154.87 11.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.894 1.678 . . . . 0.0 109.547 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.64 164.27 16.91 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.014 0.912 . . . . 0.0 110.307 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.691 HG21 ' CE1' ' A' ' 82' ' ' PHE . 1.3 m -132.7 156.46 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.103 1.361 . . . . 0.0 107.957 169.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.6 t -120.74 134.72 55.27 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 157.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 36.4 t80 -131.99 162.58 30.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.07 1.748 . . . . 0.0 107.403 168.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -141.13 103.61 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 168.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.53 163.88 26.25 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.2 tt -75.64 -22.1 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -164.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.501 ' CD2' HG11 ' A' ' 126' ' ' VAL . 55.6 mt 89.43 149.84 0.07 OUTLIER Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 131.377 3.871 . . . . 0.0 113.109 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -63.2 150.52 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 121.809 1.673 . . . . 0.0 109.576 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.29 -28.97 65.49 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.847 1.259 . . . . 0.0 109.74 163.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -79.16 -14.08 59.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 128.107 2.563 . . . . 0.0 114.098 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 109' ' ' VAL . 13.5 t80 -85.63 127.66 34.54 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 122.947 2.612 . . . . 0.0 106.877 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -134.54 162.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.254 1.026 . . . . 0.0 111.148 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.11 108.7 6.15 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.111 1.765 . . . . 0.0 108.273 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.478 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 96.99 37.86 4.53 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.103 0.858 . . . . 0.0 111.737 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -139.7 170.65 15.51 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.392 1.096 . . . . 0.0 111.646 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.17 136.95 40.33 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.111 0.862 . . . . 0.0 111.294 172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 103' ' ' PHE . 3.5 m -135.04 168.1 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.974 1.71 . . . . 0.0 107.15 170.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.46 107.65 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.52 157.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -150.28 139.09 20.83 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 128.014 2.526 . . . . 0.0 105.54 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.85 -118.21 0.81 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 104.343 -3.503 . . . . 0.0 104.343 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -141.17 156.97 45.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 119.717 1.759 . . . . 0.0 111.452 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.57 143.11 32.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -93.39 -72.34 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.295 1.038 . . . . 0.0 109.365 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.86 -86.07 0.17 Allowed 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.143 1.377 . . . . 0.0 109.134 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.87 -69.75 1.3 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -171.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -147.42 5.11 0.81 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -89.6 136.79 32.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 -167.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mm -107.96 127.23 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.742 1.217 . . . . 0.0 109.006 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.62 104.28 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 164.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.57 133.46 42.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.386 0.675 . . . . 0.0 109.301 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -21.82 15.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.574 1.55 . . . . 0.0 111.728 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -144.41 -38.31 0.29 Allowed 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 99' ' ' LEU . 78.3 t 58.1 106.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.368 1.867 . . . . 0.0 113.015 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -120.6 156.89 30.68 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 0.0 108.259 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -116.75 32.25 6.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.284 1.402 . . . . 0.0 112.483 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt . . . . . 0 CA--C 1.544 0.722 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.038 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.1 pp . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.695 0.76 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -159.42 157.59 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.308 2.243 . . . . 0.0 106.492 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -143.36 177.86 8.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.997 1.719 . . . . 0.0 109.547 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 45.1 p -132.7 171.41 9.19 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 110.63 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.58 0.01 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.834 2.356 . . . . 0.0 114.803 162.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.84 25.33 7.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.718 1.151 . . . . 0.0 111.734 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' H ' ' A' ' 39' ' ' THR . 43.5 mt-10 -132.39 -41.17 0.98 Allowed 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.876 1.338 . . . . 0.0 110.69 173.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.473 HG22 HD22 ' A' ' 119' ' ' ASN . 7.4 mt -63.16 -23.5 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 118.326 0.512 . . . . 0.0 110.944 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -105.38 -53.9 2.58 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.521 1.528 . . . . 0.0 107.603 176.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CE1' HD12 ' A' ' 44' ' ' LEU . 18.5 m-30 -88.38 14.8 8.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -166.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.62 124.7 3.25 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.9 tttm . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.908 174.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 83.4 mmm . . . . . 0 CA--C 1.538 0.51 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.03 148.27 62.94 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.284 1.323 . . . . 0.0 109.649 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.87 146.65 33.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 117' ' ' LYS . 75.2 t -76.48 1.52 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.02 1.328 . . . . 0.0 112.018 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.63 38.39 1.37 Allowed Glycine 0 CA--C 1.51 -0.261 0 O-C-N 118.544 -2.597 . . . . 0.0 110.287 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.77 168.35 9.54 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 164.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -79.89 152.38 29.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.69 168.39 27.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.552 1.141 . . . . 0.0 111.229 165.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -114.4 136.45 52.98 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.954 2.102 . . . . 0.0 107.725 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.01 151.91 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.73 2.012 . . . . 0.0 107.777 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.32 149.69 17.9 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.4 179.17 48.9 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.388 0.995 . . . . 0.0 110.85 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.2 ttm -91.08 126.12 36.07 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.805 1.642 . . . . 0.0 109.968 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.84 130.04 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 O-C-N 120.445 -1.41 . . . . 0.0 108.198 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.1 mtt -62.9 139.19 97.33 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 118.54 0.609 . . . . 0.0 111.637 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.83 146.8 60.85 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.395 2.73 . . . . 0.0 108.941 163.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.22 20.97 75.52 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.414 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.5 m -120.22 -26.18 5.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.704 1.252 . . . . 0.0 112.15 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.05 93.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 119.318 0.963 . . . . 0.0 108.91 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -73.25 -66.11 0.72 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.124 1.77 . . . . 0.0 109.317 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 . . . . . 0 N--CA 1.472 0.634 0 C-N-CA 128.563 2.745 . . . . 0.0 110.868 -176.272 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp . . . . . 0 N--CA 1.451 -0.395 0 CA-C-O 119.16 -0.448 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -60.25 139.15 57.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.281 1.039 . . . . 0.0 108.249 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 158.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.097 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 140.63 52.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 151.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 43.8 p90 -140.94 -179.11 5.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.999 0.919 . . . . 0.0 109.296 160.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.9 m -130.85 151.27 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.32 129.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -116.58 -177.51 3.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.093 1.757 . . . . 0.0 107.42 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -155.13 -141.65 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 155.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -18.74 65.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 121.266 1.848 . . . . 0.0 114.663 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.69 -69.69 0.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -151.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.63 -153.47 5.9 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.2 p -147.27 163.53 36.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.282 1.041 . . . . 0.0 112.008 170.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.92 138.56 38.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.54 1.936 . . . . 0.0 109.504 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.65 150.78 37.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 84' ' ' ILE . 5.0 m -127.24 152.77 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 164.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 p -125.99 128.36 47.35 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -125.83 170.58 11.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.37 1.868 . . . . 0.0 108.011 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -158.76 107.5 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.5 14.98 0.02 OUTLIER Glycine 0 N--CA 1.473 1.145 0 C-N-CA 114.409 -3.758 . . . . 0.0 121.265 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 99' ' ' LEU 0.265 0.4 OUTLIER 58.01 143.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.957 2.103 . . . . 0.0 110.186 -152.222 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.571 ' CD2' HG11 ' A' ' 126' ' ' VAL . 20.8 mt -92.08 162.67 29.87 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.525 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -58.32 147.87 82.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 166.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -66.15 -18.14 65.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.771 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.44 -31.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.858 -1.544 . . . . 0.0 112.493 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.9 137.9 58.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.572 1.078 . . . . 0.0 109.164 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -142.54 168.96 18.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.1 132.83 53.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 159.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.69 15.54 56.47 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.7 163.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -121.23 163.68 18.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.42 1.11 . . . . 0.0 111.545 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.91 124.08 10.15 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.84 162.39 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.99 134.31 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 126' ' ' VAL . 1.1 t -107.79 160.51 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -158.64 151.07 21.74 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 166.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 122' ' ' LEU . . . 156.07 -145.34 12.09 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.97 157.88 35.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.734 1.267 . . . . 0.0 109.463 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HB2' HD11 ' A' ' 60' ' ' LEU . 16.7 tp -84.56 137.08 33.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.15 -65.91 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' HG13 ' A' ' 56' ' ' VAL . 45.3 mtmt -163.9 154.84 15.87 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 133.956 4.902 . . . . 0.0 104.725 175.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -98.44 0.22 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.473 HD22 HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -138.16 1.82 2.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -70.78 124.64 24.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.956 1.253 . . . . 0.0 109.772 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.28 122.45 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.66 1.584 . . . . 0.0 110.531 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 3.6 mm? -78.92 81.67 5.18 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 165.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.63 133.5 30.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.041 1.336 . . . . 0.0 109.892 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 -25.25 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.611 1.564 . . . . 0.0 111.196 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.45 -37.39 0.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 99' ' ' LEU . 60.3 t 52.19 113.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 127.068 2.147 . . . . 0.0 115.523 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.47 154.32 47.1 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.519 -1.363 . . . . 0.0 108.889 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -118.16 37.11 4.1 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.253 1.842 . . . . 0.0 111.894 -166.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt . . . . . 0 N--CA 1.466 0.342 0 C-N-CA 127.851 2.46 . . . . 0.0 112.304 -173.846 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 CA--C 1.514 -0.409 0 CA-C-O 121.28 0.562 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -150.54 139.46 20.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.219 -166.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -140.68 -174.74 4.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.595 1.958 . . . . 0.0 107.7 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 26.0 p -141.26 174.48 3.83 Favored Pre-proline 0 C--O 1.235 0.325 0 O-C-N 120.542 -1.349 . . . . 0.0 110.542 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 7.6 Cg_endo -57.69 0.88 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 171.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -108.22 -41.94 1.46 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 121.789 2.086 . . . . 0.0 112.904 163.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 5.8 pt-20 -80.44 -2.61 46.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 119.607 1.704 . . . . 0.0 113.249 -162.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.55 -18.11 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.135 0.974 . . . . 0.0 110.38 166.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.61 -47.68 5.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.79 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -87.51 -26.37 23.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.364 1.466 . . . . 0.0 110.907 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.9 146.17 9.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.664 1.602 . . . . 0.0 110.301 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 44.8 tttm . . . . . 0 CA--C 1.51 -0.583 0 CA-C-O 117.971 -1.014 . . . . 0.0 112.228 -174.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.241 0.645 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.2 134.48 45.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.667 2.245 . . . . 0.0 109.371 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.29 130.7 35.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.664 ' HA ' HD23 ' A' ' 115' ' ' LEU . 14.8 p -70.22 -11.1 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.418 0.627 . . . . 0.0 112.192 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.27 3.73 61.93 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 116.885 -2.064 . . . . 0.0 113.009 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HG3' HD12 ' A' ' 60' ' ' LEU . 1.5 pt20 -110.01 167.2 10.35 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.893 2.347 . . . . 0.0 112.766 -168.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -85.29 137.54 32.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 108.669 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -157.99 173.37 16.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.217 1.007 . . . . 0.0 110.175 171.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -122.34 157.36 31.96 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 111.136 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -131.96 143.24 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.571 1.948 . . . . 0.0 107.326 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.19 127.51 5.91 Favored Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 168.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.51 -178.89 38.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.7 ttm -105.22 129.71 53.54 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.028 0.931 . . . . 0.0 110.277 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.99 129.01 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.289 0.95 . . . . 0.0 108.925 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . 0.476 ' HG3' ' CD1' ' A' ' 85' ' ' TYR . 5.3 mtm -68.9 149.45 97.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.489 0.586 . . . . 0.0 110.967 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.31 137.97 24.18 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.355 2.703 . . . . 0.0 108.966 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.59 57.9 15.68 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -142.62 -30.58 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 164.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.706 HG22 ' HG2' ' A' ' 73' ' ' ARG 0.303 2.2 p -75.16 95.54 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 120.833 -1.167 . . . . 0.0 111.855 -173.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.05 28.56 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 131.469 3.908 . . . . 0.0 113.896 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.706 ' HG2' HG22 ' A' ' 71' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.61 0 C-N-CA 124.41 1.084 . . . . 0.0 110.84 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.464 0.234 0 N-CA-C 111.402 0.149 . . . . 0.0 111.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 137.27 57.15 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 109.387 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -161.15 127.2 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.0 p -105.47 159.94 15.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 93' ' ' VAL . 53.3 p90 -153.82 -178.4 7.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.042 0.837 . . . . 0.0 110.059 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 m -129.92 142.4 50.66 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.467 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -126.7 136.78 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' HG3' ' A' ' 67' ' ' MET . 15.8 p90 -135.21 169.9 16.75 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.096 1.359 . . . . 0.0 109.559 -173.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.75 -166.76 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.339 1.855 . . . . 0.0 107.692 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -3.52 1.76 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.834 2.054 . . . . 0.0 114.972 -171.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -111.6 -62.28 1.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.819 1.248 . . . . 0.0 107.73 -173.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.26 -167.98 17.08 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.896 1.712 . . . . 0.0 112.005 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.9 p -137.51 164.04 29.69 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.92 0.888 . . . . 0.0 112.006 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.98 144.64 25.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.121 1.368 . . . . 0.0 109.501 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.97 152.52 30.98 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.209 1.004 . . . . 0.0 108.641 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.551 HG21 ' CE1' ' A' ' 82' ' ' PHE . 3.4 m -132.65 147.95 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.354 163.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -119.92 112.45 19.21 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.263 1.825 . . . . 0.0 108.557 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.592 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.4 t80 -112.88 166.51 11.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 108.32 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.13 97.89 1.96 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 168.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.65 -174.07 46.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.508 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.04 118.93 21.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.5 tp -97.14 135.3 21.99 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 109.113 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.45 156.9 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.154 1.903 . . . . 0.0 112.435 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.92 -40.8 75.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 123.098 1.428 . . . . 0.0 108.957 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.44 -27.02 68.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.766 1.626 . . . . 0.0 111.715 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.478 ' HE1' HG21 ' A' ' 71' ' ' VAL . 34.3 t80 -66.29 106.64 1.75 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 119.374 0.988 . . . . 0.0 108.867 -174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -133.16 158.84 41.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.21 1.004 . . . . 0.0 109.829 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.71 105.48 3.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.628 1.571 . . . . 0.0 107.462 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.05 26.19 7.57 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.384 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.21 163.87 17.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.663 1.731 . . . . 0.0 110.508 160.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.88 138.2 19.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.61 174.47 12.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.36 1.464 . . . . 0.0 107.237 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.15 137.43 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 121' ' ' ILE . 1.3 t -117.04 156.82 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.249 1.42 . . . . 0.0 107.508 165.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.21 141.88 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 127.072 2.149 . . . . 0.0 106.645 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.33 -103.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 166.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -142.89 161.35 38.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.983 1.892 . . . . 0.0 109.418 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 56' ' ' VAL . 13.4 tp -81.16 144.3 31.75 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -101.82 -72.53 0.68 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.319 0.509 . . . . 0.0 109.979 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -163.69 -83.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.147 2.179 . . . . 0.0 108.158 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.56 73.34 2.07 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.175 1.369 . . . . 0.0 111.555 -162.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.2 m120 44.49 46.39 8.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.304 1.841 . . . . 0.0 110.542 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -122.16 129.39 52.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.543 1.137 . . . . 0.0 108.395 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.4 HG21 HG12 ' A' ' 111' ' ' VAL . 16.5 mm -103.69 132.9 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.506 1.522 . . . . 0.0 109.487 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.17 114.37 18.06 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 159.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.009 170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 -35.83 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.76 2.874 . . . . 0.0 118.76 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.9 t 50.65 122.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.39 1.876 . . . . 0.0 115.337 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.79 156.02 49.59 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 119.893 -1.754 . . . . 0.0 108.308 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.83 30.06 7.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 112.268 -168.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt . . . . . 0 N--CA 1.466 0.36 0 CA-C-O 123.008 1.385 . . . . 0.0 112.178 -172.862 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pp . . . . . 0 C--O 1.237 0.445 0 CA-C-O 122.275 1.036 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -161.84 150.69 15.6 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.418 1.887 . . . . 0.0 109.107 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.04 172.35 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.897 1.279 . . . . 0.0 111.549 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.4 p -135.59 158.72 73.71 Favored Pre-proline 0 C--O 1.243 0.762 0 C-N-CA 125.168 1.387 . . . . 0.0 111.591 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.76 78.58 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.975 3.784 . . . . 0.0 109.567 164.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.71 -63.16 0.22 Allowed Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 106.587 -2.605 . . . . 0.0 106.587 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.48 -21.47 66.34 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 122.149 -0.618 . . . . 0.0 110.39 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -77.45 -13.31 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.108 1.763 . . . . 0.0 110.683 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.11 -54.33 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.411 1.484 . . . . 0.0 107.499 -163.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -77.65 -78.87 0.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.962 2.505 . . . . 0.0 107.171 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.16 152.7 8.68 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.45 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptm . . . . . 0 N--CA 1.472 0.674 0 C-N-CA 125.291 1.436 . . . . 0.0 110.972 179.703 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.3 mtp . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.22 149.11 15.13 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.8 1.667 . . . . 0.0 109.285 168.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.01 148.65 31.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.19 -9.82 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.239 1.016 . . . . 0.0 111.149 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.44 61.59 0.43 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 168.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.64 174.41 14.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.799 1.3 . . . . 0.0 112.942 163.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -80.75 147.29 30.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.734 1.214 . . . . 0.0 108.88 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.1 165.23 24.89 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -97.46 144.58 27.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.002 2.921 . . . . 0.0 108.746 167.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.1 t -128.98 146.36 34.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.703 1.601 . . . . 0.0 108.167 167.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.41 139.07 10.63 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.33 -169.01 28.37 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 ttm -107.46 124.61 50.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.062 1.431 . . . . 0.0 109.682 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.737 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -55.24 130.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.4 ttm -63.0 124.52 84.06 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.89 134.44 46.61 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.831 2.354 . . . . 0.0 108.465 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.58 7.93 85.48 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.032 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.5 p -98.17 -32.73 11.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.755 1.777 . . . . 0.0 113.71 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 p -77.2 123.37 33.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 118.889 0.768 . . . . 0.0 110.166 -167.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -95.41 127.2 41.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 152.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 . . . . . 0 CA--C 1.514 -0.438 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 161.147 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.487 HD23 ' HG2' ' A' ' 96' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 CA-C-O 118.343 -0.836 . . . . 0.0 111.685 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 144.78 46.53 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.745 1.611 . . . . 0.0 109.226 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 99' ' ' LEU . 1.6 p -155.85 136.39 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 6.6 p -118.37 152.47 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 167.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 26.0 p90 -153.02 -178.57 7.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.842 0.746 . . . . 0.0 109.796 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m -124.04 154.61 39.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -135.27 134.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -121.98 178.33 4.94 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.38 -148.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.35 61.66 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.764 -1.21 . . . . 0.0 113.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.3 -64.17 1.3 Allowed 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.475 1.11 . . . . 0.0 109.085 -162.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.81 -157.44 7.58 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.7 p -145.22 162.54 36.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.286 0.543 . . . . 0.0 112.265 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.65 154.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.166 2.186 . . . . 0.0 108.826 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 155.56 16.91 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.03 1.332 . . . . 0.0 109.481 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 14.5 t -139.23 128.66 30.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 123.574 0.75 . . . . 0.0 109.082 175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -110.85 117.23 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.066 1.347 . . . . 0.0 107.451 162.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 19.5 t80 -121.37 159.64 25.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.618 1.567 . . . . 0.0 107.071 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 78' ' ' LEU . 15.4 tt0 -146.68 90.12 1.9 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.51 -171.85 44.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.872 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.91 115.77 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.675 HD22 HG21 ' A' ' 80' ' ' VAL . 15.1 tp -89.34 131.85 39.21 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.5 138.06 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.442 -1.407 . . . . 0.0 108.442 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.92 -20.81 65.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.06 0.933 . . . . 0.0 109.396 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.2 -21.71 63.94 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.304 1.442 . . . . 0.0 110.439 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -71.0 134.98 47.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.895 1.278 . . . . 0.0 109.252 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.407 ' O ' HG11 ' A' ' 66' ' ' VAL . 12.2 mmt180 -138.35 -177.04 4.67 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.95 127.63 52.87 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.737 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 80.71 31.67 35.64 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 118.077 -1.402 . . . . 0.0 110.992 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.14 168.08 10.89 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.042 1.421 . . . . 0.0 110.368 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.01 133.44 18.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.04 165.78 29.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.269 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 129' ' ' LYS . 3.1 t -124.81 117.21 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 166.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -92.06 159.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.189 0.995 . . . . 0.0 108.65 162.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -154.04 146.6 24.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.889 1.676 . . . . 0.0 107.195 162.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.03 -104.26 0.2 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 161.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.64 154.04 46.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 119.219 1.51 . . . . 0.0 109.623 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 144.52 39.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -104.3 -83.75 0.49 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.782 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 -82.15 0.11 Allowed 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.544 1.066 . . . . 0.0 111.13 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.53 73.4 2.22 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -169.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m120 51.96 56.41 7.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.836 1.254 . . . . 0.0 109.205 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -135.3 123.7 23.32 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.2 130.76 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.127 1.371 . . . . 0.0 107.745 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.38 110.13 13.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 157.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -73.45 154.36 39.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 122.076 0.941 . . . . 0.0 109.822 168.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -17.96 7.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.425 1.89 . . . . 0.0 111.997 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -143.18 -43.27 0.29 Allowed 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.49 HG11 HD11 ' A' ' 99' ' ' LEU . 99.8 t 54.13 121.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 123.686 1.708 . . . . 0.0 113.638 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 mt -130.58 155.37 46.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.796 1.238 . . . . 0.0 108.094 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.9 39.9 3.26 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.312 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.696 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.47 0.555 0 C-N-CA 126.595 1.958 . . . . 0.0 113.356 -177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 123.5 1.619 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -166.26 153.62 9.84 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.195 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CE1' ' HD2' ' A' ' 47' ' ' LYS . 97.6 m-85 -144.91 -179.9 6.91 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.715 1.606 . . . . 0.0 108.73 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.624 ' HA ' HG23 ' A' ' 62' ' ' VAL . 12.1 p -139.38 177.09 2.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.64 -13.53 22.26 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 CA-C-N 120.661 1.272 . . . . 0.0 111.567 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.87 -45.59 5.66 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 165.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 39' ' ' THR . 45.4 mt-10 -63.83 -30.78 71.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.029 1.414 . . . . 0.0 111.177 -167.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.01 -21.43 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.43 1.013 . . . . 0.0 111.238 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.94 -44.98 4.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.562 1.074 . . . . 0.0 111.433 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -98.12 -9.94 25.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.5 1.92 . . . . 0.0 113.23 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.9 133.9 5.18 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 26.5 tttm . . . . . 0 N--CA 1.449 -0.517 0 O-C-N 121.299 -1.118 . . . . 0.0 109.161 160.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.1 mtp . . . . . 0 CA--C 1.539 0.521 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 172.15 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.261 1.486 . . . . 0.0 110.85 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -89.17 139.49 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.011 1.324 . . . . 0.0 107.684 163.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.9 0.59 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.824 1.249 . . . . 0.0 110.275 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.48 56.96 0.72 Allowed Glycine 0 N--CA 1.451 -0.305 0 O-C-N 120.196 -1.565 . . . . 0.0 111.847 164.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -141.36 -175.47 4.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.162 0.981 . . . . 0.0 111.314 166.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.88 141.03 36.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.117 0.967 . . . . 0.0 110.376 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -179.62 8.02 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.408 1.483 . . . . 0.0 111.082 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -122.65 151.53 41.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.071 2.148 . . . . 0.0 110.751 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -148.98 128.55 3.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 120.261 3.43 . . . . 0.0 120.261 169.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.85 141.51 18.66 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.405 1.002 . . . . 0.0 110.82 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.34 177.67 47.82 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 119.427 -0.652 . . . . 0.0 113.153 166.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 35.2 ttm -102.36 129.74 48.91 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.481 1.112 . . . . 0.0 110.152 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.9 132.14 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.358 1.063 . . . . 0.0 109.643 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtt -62.47 132.61 94.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.292 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.15 131.3 29.97 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.901 1.734 . . . . 0.0 108.714 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.17 72.73 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.702 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -86.14 -74.39 0.42 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 159.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.282 2.6 p -37.66 88.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 130.616 3.566 . . . . 0.0 114.816 -170.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -77.6 137.84 38.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 127.467 2.307 . . . . 0.0 105.553 163.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 . . . . . 0 CA--C 1.515 -0.378 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.862 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.63 149.16 18.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.276 1.83 . . . . 0.0 109.69 175.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.6 148.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 166.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 p -131.94 119.8 21.61 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.27 168.04 20.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.233 0.613 . . . . 0.0 109.603 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -122.99 147.31 46.78 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.91 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.09 174.34 10.61 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.298 1.039 . . . . 0.0 110.27 -170.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.11 -168.9 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.174 2.189 . . . . 0.0 106.266 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.03 -4.35 16.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.9 -66.77 0.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.45 -163.47 11.99 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.371 1.462 . . . . 0.0 110.681 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.9 p -150.94 158.71 44.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.013 0.906 . . . . 0.0 111.251 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.66 150.23 20.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 108.721 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 157.57 23.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.473 ' CG2' HD11 ' A' ' 84' ' ' ILE . 98.4 t -133.1 120.8 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 168.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 m -91.56 121.79 33.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 152.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.11 171.44 7.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 164.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -162.15 99.06 1.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.82 -144.71 9.11 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.214 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.82 91.8 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.47 130.03 87.36 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.901 -1.499 . . . . 0.0 107.868 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -54.84 138.31 76.92 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.031 1.82 . . . . 0.0 109.359 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -56.78 -31.84 65.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.672 0.749 . . . . 0.0 111.197 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.32 -22.32 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 114.63 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.98 131.79 44.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.927 1.24 . . . . 0.0 108.835 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -140.96 170.29 16.02 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.014 -1.054 . . . . 0.0 109.468 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -73.41 123.16 23.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.49 26.55 25.01 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 123.381 0.515 . . . . 0.0 113.269 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.47 171.69 10.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.555 1.142 . . . . 0.0 109.684 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.74 128.02 9.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.999 1.762 . . . . 0.0 109.054 -173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.35 175.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.05 139.57 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.622 1.969 . . . . 0.0 106.668 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG12 HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -113.37 164.84 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -160.4 143.0 13.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.527 1.931 . . . . 0.0 107.627 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.59 -124.1 1.67 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 105.098 -3.201 . . . . 0.0 105.098 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -128.9 156.91 42.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 120.127 1.963 . . . . 0.0 109.192 -161.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.73 137.73 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.843 0.857 . . . . 0.0 109.482 171.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -84.0 0.42 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.995 0.816 . . . . 0.0 109.063 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.91 167.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.714 3.206 . . . . 0.0 106.299 -172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.24 50.14 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.96 -0.911 . . . . 0.0 113.151 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 m120 62.66 58.19 1.66 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 0.0 111.087 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -131.32 127.49 37.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.44 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.5 mm -102.63 125.92 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 126.675 1.99 . . . . 0.0 109.037 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.52 83.97 5.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.47 148.2 9.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.112 0.958 . . . . 0.0 112.25 165.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -18.76 8.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 128.384 2.674 . . . . 0.0 110.912 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.33 -51.64 0.48 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.8 t 60.69 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.097 2.159 . . . . 0.0 112.394 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.97 146.49 47.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.746 -1.221 . . . . 0.0 107.897 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.41 34.66 3.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.854 0.862 . . . . 0.0 110.563 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt . . . . . 0 CA--C 1.54 0.572 0 C-N-CA 125.704 1.602 . . . . 0.0 114.708 174.603 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.8 pp . . . . . 0 N--CA 1.446 -0.648 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -174.53 135.39 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.11 2.164 . . . . 0.0 106.074 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.09 176.71 6.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.509 1.524 . . . . 0.0 109.202 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 61.5 p -136.24 173.85 5.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.645 1.578 . . . . 0.0 108.545 173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 73.4 Cg_endo -75.74 -13.36 19.95 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.685 1.59 . . . . 0.0 112.205 -166.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.25 -45.75 7.33 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 162.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 39' ' ' THR . 30.3 mt-10 -60.17 -29.17 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.334 2.067 . . . . 0.0 113.036 -168.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mt -73.34 -22.26 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.475 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -35.51 3.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.478 -169.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.86 -31.27 18.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.482 2.313 . . . . 0.0 110.518 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.64 149.46 7.47 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.251 1.405 . . . . 0.0 111.869 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 tttm . . . . . 0 CA--C 1.51 -0.572 0 O-C-N 122.013 -0.698 . . . . 0.0 110.826 -179.449 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 40.9 mtp . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 158.01 59.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 CA-C-N 121.432 1.547 . . . . 0.0 110.085 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.43 144.9 33.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 165.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' HD13 ' A' ' 115' ' ' LEU . 7.1 p -82.9 -7.25 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.625 0.77 . . . . 0.0 111.582 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.55 43.18 1.72 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.748 1.166 . . . . 0.0 110.512 165.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.5 pt20 -141.52 169.32 17.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.127 1.964 . . . . 0.0 113.047 172.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -87.92 140.58 29.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.041 2.537 . . . . 0.0 108.609 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -155.12 -174.59 5.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.495 0.718 . . . . 0.0 110.621 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -134.38 147.21 50.46 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.148 1.779 . . . . 0.0 107.485 169.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.28 130.48 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.177 1.791 . . . . 0.0 106.532 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.65 157.01 20.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 163.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.68 41.62 Favored Glycine 0 C--O 1.236 0.26 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.2 ttm -99.01 125.31 44.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.37 121.12 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 3.7 ttm -64.16 126.84 91.11 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.93 154.43 73.21 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.28 1.987 . . . . 0.0 108.368 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.76 44.55 80.57 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.778 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -133.12 -38.43 0.96 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.895 1.348 . . . . 0.0 113.225 169.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.269 1.6 p -64.57 92.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.567 1.076 . . . . 0.0 112.059 -172.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 5.9 pt20 -82.07 86.46 6.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.892 2.477 . . . . 0.0 107.703 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.514 -0.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 119.387 -0.34 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.99 131.03 46.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 164.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.25 130.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.417 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 92.0 m -126.46 134.45 50.96 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.35 176.38 10.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.231 -1.543 . . . . 0.0 110.352 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 m -123.18 145.78 48.34 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.68 142.24 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -137.99 171.99 13.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.635 1.174 . . . . 0.0 109.516 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.09 -169.07 3.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.299 1.439 . . . . 0.0 107.383 168.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 9.99 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.582 1.553 . . . . 0.0 114.412 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.47 -67.11 0.78 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.003 1.321 . . . . 0.0 109.504 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.32 -175.47 13.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.1 p -143.51 158.08 43.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.297 1.039 . . . . 0.0 109.973 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.9 m -141.37 149.01 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.627 1.171 . . . . 0.0 109.707 -171.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.13 148.0 26.35 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.99 1.316 . . . . 0.0 107.883 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 84' ' ' ILE . 23.5 t -138.01 119.09 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.104 0.961 . . . . 0.0 108.779 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 t -91.94 129.65 37.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 159.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -124.23 163.78 20.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.653 1.181 . . . . 0.0 108.747 166.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -144.87 100.17 3.45 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.88 -179.4 43.58 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -71.36 -24.38 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 122.064 -0.668 . . . . 0.0 111.84 -159.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 99' ' ' LEU . 7.8 tp 65.36 129.24 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.727 0 C-N-CA 128.803 2.841 . . . . 0.0 110.623 -166.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 4.5 Cg_exo -66.03 169.04 14.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.255 3.303 . . . . 0.0 110.689 -168.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.49 -36.07 77.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.982 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -35.34 63.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.568 2.747 . . . . 0.0 113.025 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -63.76 131.88 49.23 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.466 1.03 . . . . 0.0 109.092 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -143.14 161.0 39.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.882 0.873 . . . . 0.0 111.313 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -64.06 117.39 7.01 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.86 4.95 16.17 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.958 -0.912 . . . . 0.0 114.938 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.7 167.04 20.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.925 1.363 . . . . 0.0 112.151 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.05 137.28 15.34 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 125.737 1.637 . . . . 0.0 109.977 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.82 168.61 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.95 108.91 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 127.652 2.381 . . . . 0.0 106.541 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 126' ' ' VAL . 2.8 t -80.26 158.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 124.717 1.207 . . . . 0.0 108.986 161.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 5.6 tt0 -156.67 147.15 21.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 129.439 3.096 . . . . 0.0 105.716 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.84 -112.39 0.52 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -147.63 159.34 43.88 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 119.734 1.767 . . . . 0.0 110.41 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -86.02 142.61 28.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.117 0.967 . . . . 0.0 108.589 172.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 -84.25 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.55 1.14 . . . . 0.0 108.185 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -166.92 154.53 9.32 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 128.94 2.896 . . . . 0.0 106.709 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.6 42.91 99.85 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.16 40.88 30.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 111.929 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -109.82 124.36 51.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.476 HG21 ' CG1' ' A' ' 111' ' ' VAL . 18.1 mm -96.28 131.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.711 1.204 . . . . 0.0 108.649 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.88 114.21 17.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 154.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 149.22 39.94 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.874 0.845 . . . . 0.0 108.849 161.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -21.85 11.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.606 1.163 . . . . 0.0 111.173 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -146.17 -47.13 0.2 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.242 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 111' ' ' VAL . 46.0 t 59.24 150.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.243 1.817 . . . . 0.0 109.371 -167.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.0 mt -147.89 151.59 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 119.192 -2.193 . . . . 0.0 107.045 172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.14 33.88 3.76 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.681 1.128 . . . . 0.0 112.674 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.44 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.48 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -170.32 154.77 4.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.179 0.991 . . . . 0.0 109.908 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.566 ' C ' HG23 ' A' ' 62' ' ' VAL . 99.3 m-85 -133.27 -170.11 2.41 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.553 1.07 . . . . 0.0 110.302 170.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 40' ' ' PRO . 39.9 p -141.99 170.99 7.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 158.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.577 ' O ' HD21 ' A' ' 44' ' ' LEU . 48.5 Cg_endo -81.22 -1.43 11.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.511 1.474 . . . . 0.0 112.439 -159.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -103.86 -7.58 41.28 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.673 1.606 . . . . 0.0 110.578 165.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.97 18.0 22.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.436 -1.626 . . . . 0.0 110.066 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 121' ' ' ILE . 7.3 mt -109.12 -23.15 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.869 HD22 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.35 -50.68 4.91 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 126.629 1.972 . . . . 0.0 111.036 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.95 -63.9 1.12 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.03 175.73 39.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.0 tptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 116.9 -1.524 . . . . 0.0 108.311 159.797 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 mtp . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.41 147.21 87.01 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.53 1.487 . . . . 0.0 109.633 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.36 147.48 32.39 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.54 -8.47 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.369 1.468 . . . . 0.0 111.232 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.1 40.72 1.82 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 125.217 1.389 . . . . 0.0 110.504 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -134.96 170.55 15.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.341 1.57 . . . . 0.0 111.837 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -88.54 151.81 22.27 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.88 176.75 12.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.291 1.036 . . . . 0.0 112.376 172.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.416 HH21 ' CD1' ' A' ' 127' ' ' LEU . 50.8 ttt180 -124.48 148.53 47.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.146 2.578 . . . . 0.0 107.049 172.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 111' ' ' VAL . 6.0 p -147.56 167.27 5.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 119.975 1.261 . . . . 0.0 111.353 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -142.2 155.25 25.49 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 119.981 1.264 . . . . 0.0 111.677 169.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.84 -175.93 47.01 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.563 1.077 . . . . 0.0 113.28 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.5 ttm -103.21 123.78 47.37 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.484 1.514 . . . . 0.0 110.673 -170.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 69.9 t -71.7 129.58 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.885 -1.134 . . . . 0.0 109.848 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 49.5 mtt -63.75 152.22 87.0 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 118.62 0.645 . . . . 0.0 112.085 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.99 141.32 68.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.251 2.634 . . . . 0.0 110.745 170.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.75 3.85 1.27 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.369 1.461 . . . . 0.0 115.649 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.7 p -73.24 -26.21 61.03 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.743 1.771 . . . . 0.0 112.121 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.39 103.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.897 1.279 . . . . 0.0 109.909 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -86.78 30.32 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.669 2.787 . . . . 0.0 111.219 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? . . . . . 0 CA--C 1.511 -0.547 0 C-N-CA 123.458 0.703 . . . . 0.0 109.192 170.19 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.468 0.432 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -60.57 136.14 57.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.7 p -156.66 134.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' SER . 43.3 p -124.9 162.15 25.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 93' ' ' VAL . 27.6 p90 -152.13 179.32 8.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.741 1.155 . . . . 0.0 109.349 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -115.71 145.88 42.37 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 139.1 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.05 170.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.116 1.766 . . . . 0.0 109.636 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -161.3 -154.12 0.34 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.558 1.543 . . . . 0.0 106.879 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 -22.38 62.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.814 -1.179 . . . . 0.0 112.872 -164.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -76.12 0.53 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.88 -166.98 12.66 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.46 -0.775 . . . . 0.0 112.229 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.3 p -140.78 160.64 39.61 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 112.023 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.14 153.97 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.036 1.334 . . . . 0.0 109.646 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.15 150.56 37.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.51 165.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -118.0 160.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 156.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.9 m -129.62 127.44 40.63 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 159.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.521 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.2 t80 -127.41 168.62 14.6 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.633 1.573 . . . . 0.0 108.505 174.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.96 92.13 1.16 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.0 -176.38 45.09 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.418 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.02 113.35 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 80' ' ' VAL . 9.7 tp -77.24 143.39 69.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -58.46 146.31 90.92 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.113 1.209 . . . . 0.0 109.065 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.45 -30.82 71.89 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.46 -36.97 85.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.705 2.002 . . . . 0.0 110.978 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 43.2 t80 -56.23 133.0 52.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.002 1.721 . . . . 0.0 109.039 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.83 167.13 21.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.319 0.963 . . . . 0.0 112.312 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -74.72 112.9 11.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.74 49.13 5.85 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 112.181 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 128' ' ' ALA . 3.8 pt20 -119.63 -170.29 1.92 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.386 -1.067 . . . . 0.0 109.542 145.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.87 140.68 14.95 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.66 178.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.764 1.625 . . . . 0.0 107.922 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.2 t -131.65 142.18 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.688 ' CG1' HG21 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -107.65 163.98 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.868 0.842 . . . . 0.0 109.55 162.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -157.48 144.27 18.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 106.609 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.93 -109.02 0.38 Allowed Glycine 0 CA--C 1.518 0.253 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.2 mt-10 -140.91 162.93 34.3 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 120.165 1.983 . . . . 0.0 109.541 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 60' ' ' LEU . 12.5 tp -89.24 140.26 29.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.566 0.746 . . . . 0.0 110.154 171.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 -77.95 0.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.82 166.47 3.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.287 3.835 . . . . 0.0 105.13 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.9 42.04 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 120.198 1.363 . . . . 0.0 113.653 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.71 4.96 5.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.841 2.057 . . . . 0.0 114.263 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -71.35 139.31 49.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.042 2.137 . . . . 0.0 109.691 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.688 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.1 mm -106.29 133.89 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 126.765 2.026 . . . . 0.0 110.164 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 122' ' ' LEU . 4.2 mm? -78.84 106.94 11.2 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 154.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.65 58.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.513 0.673 . . . . 0.0 110.22 153.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 -11.61 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.615 2.366 . . . . 0.0 110.974 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -147.82 -46.23 0.16 Allowed 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.8 t 57.17 141.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.876 1.67 . . . . 0.0 111.601 -165.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.416 ' CD1' HH21 ' A' ' 61' ' ' ARG . 53.9 mt -139.38 162.59 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -125.53 29.27 6.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.384 1.074 . . . . 0.0 112.226 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 115.137 173.611 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 122.836 1.303 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -173.13 136.77 0.66 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.768 2.427 . . . . 0.0 106.311 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.535 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 79.3 m-85 -131.6 -175.11 3.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.033 1.733 . . . . 0.0 109.545 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.458 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 72.5 p -142.1 169.07 11.8 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 112.78 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.77 71.54 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.569 2.846 . . . . 0.0 110.747 157.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.21 -56.17 0.19 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 127.899 2.666 . . . . 0.0 106.976 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HB2' ' H ' ' A' ' 39' ' ' THR . 32.3 mt-10 -68.24 -9.36 46.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.709 HG22 HD22 ' A' ' 119' ' ' ASN . 5.1 mt -104.84 -22.35 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.118 1.367 . . . . 0.0 108.327 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.42 -48.38 5.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.731 2.412 . . . . 0.0 111.711 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.93 -64.51 1.07 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.684 1.994 . . . . 0.0 107.081 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.59 164.5 18.85 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.663 1.602 . . . . 0.0 109.226 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 1.2 tptt . . . . . 0 N--CA 1.476 0.847 0 C-N-CA 126.673 1.989 . . . . 0.0 111.229 179.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.796 0.332 . . . . 0.0 111.836 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.3 155.73 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.44 2.093 . . . . 0.0 109.747 150.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.88 143.97 30.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 159.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.2 p -73.57 -15.58 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.053 0.541 . . . . 0.0 111.369 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.04 37.38 3.74 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.384 -1.787 . . . . 0.0 111.741 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -137.1 174.06 11.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.654 2.227 . . . . 0.0 112.399 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -106.89 138.86 42.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.409 1.484 . . . . 0.0 110.226 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.06 167.5 30.26 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.797 1.239 . . . . 0.0 112.034 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -99.52 150.43 22.22 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.1 1.76 . . . . 0.0 109.779 165.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.73 154.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.841 2.056 . . . . 0.0 106.925 168.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.63 152.97 21.44 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 155.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.24 179.51 48.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttm -101.51 130.04 47.71 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.835 0.854 . . . . 0.0 109.545 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 93.7 t -69.04 125.28 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.782 1.173 . . . . 0.0 108.266 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.5 mtt -57.44 139.18 80.87 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 119.006 0.821 . . . . 0.0 110.25 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.89 124.69 10.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.302 2.668 . . . . 0.0 107.522 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.6 65.37 3.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.9 p -135.41 -35.01 0.83 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.45 0.625 . . . . 0.0 111.952 167.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.34 107.34 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -174.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -91.77 59.84 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 131.623 3.969 . . . . 0.0 108.697 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 1.7 ptt85 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 120.708 -1.245 . . . . 0.0 110.472 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -53.86 126.66 23.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.892 1.277 . . . . 0.0 107.938 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 95' ' ' TYR . 1.5 p -132.28 146.72 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -134.47 123.61 24.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 93' ' ' VAL . 48.1 p90 -131.51 173.51 11.03 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 120.899 1.681 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -127.78 141.55 51.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.28 139.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.962 1.705 . . . . 0.0 106.618 -178.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -138.88 172.22 13.17 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.597 1.159 . . . . 0.0 111.321 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -157.0 -165.9 1.95 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.15 1.78 . . . . 0.0 109.405 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -12.67 60.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.201 1.4 . . . . 0.0 113.561 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.16 -67.09 0.87 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -172.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.52 -152.41 5.66 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -140.25 167.18 22.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.611 0.764 . . . . 0.0 110.31 167.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.83 142.76 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.8 152.55 22.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.063 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 82' ' ' PHE . 2.7 m -138.47 137.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 110.992 171.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -100.28 136.87 39.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 164.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 80' ' ' VAL . 31.2 t80 -142.05 164.31 30.53 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.458 1.503 . . . . 0.0 107.167 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.62 110.13 3.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.41 41.35 Favored Glycine 0 C--N 1.324 -0.115 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -22.48 6.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.924 0.862 . . . . 0.0 112.394 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.461 HD11 HG11 ' A' ' 126' ' ' VAL . 5.1 tp 81.55 152.86 0.12 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.939 2.895 . . . . 0.0 108.852 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.87 141.8 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.633 1.555 . . . . 0.0 108.993 174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -31.26 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.55 1.14 . . . . 0.0 109.161 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.38 -40.98 98.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.35 1.86 . . . . 0.0 112.737 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 14.9 t80 -65.52 137.05 57.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.696 0.798 . . . . 0.0 110.91 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -142.55 173.49 11.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.801 1.24 . . . . 0.0 109.206 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -58.55 135.58 57.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.759 152.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 6.11 69.35 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.704 0.669 . . . . 0.0 113.785 155.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -103.16 172.61 6.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 109.443 171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.52 129.07 9.72 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.76 172.5 15.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.62 126.71 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.405 HG22 HG22 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -101.73 159.26 4.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 165.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.05 134.38 10.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.52 -119.29 0.9 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -142.17 154.0 44.49 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 119.232 1.516 . . . . 0.0 110.46 -163.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.96 135.19 35.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -85.45 0.24 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -151.1 -88.6 0.06 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.408 1.883 . . . . 0.0 109.417 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.41 82.8 1.14 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -160.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.709 HD22 HG22 ' A' ' 43' ' ' ILE . 34.0 m120 29.69 67.1 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.188 2.595 . . . . 0.0 110.726 -169.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -141.37 131.19 24.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.213 1.405 . . . . 0.0 107.667 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.2 mm -106.2 135.45 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.217 1.807 . . . . 0.0 109.263 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.89 105.42 10.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 156.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.84 148.87 50.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.96 -25.01 10.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 109.115 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.566 ' HG3' HD21 ' A' ' 127' ' ' LEU . 8.1 pt-20 -148.38 -16.14 0.33 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -169.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 99' ' ' LEU . 61.9 t 38.54 101.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.207 2.203 . . . . 0.0 114.468 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 125' ' ' GLU . 1.1 mm? -106.17 145.9 30.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -109.15 30.98 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.24 -0.913 . . . . 0.0 111.694 -172.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.975 0.893 . . . . 0.0 110.949 -174.513 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 122.464 1.126 . . . . 0.0 109.823 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -169.58 145.4 3.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.051 1.74 . . . . 0.0 107.534 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -142.3 -173.83 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.588 2.355 . . . . 0.0 108.573 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 20.6 p -135.32 171.2 9.34 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.059 0.943 . . . . 0.0 109.292 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB3' HG12 ' A' ' 91' ' ' VAL . 63.9 Cg_endo -73.8 71.31 4.12 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.925 2.417 . . . . 0.0 108.989 169.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.68 -66.73 0.1 Allowed Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 -167.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 39' ' ' THR . 3.3 mm-40 -71.52 -3.71 22.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.359 0.664 . . . . 0.0 112.442 -171.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.55 -41.97 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -85.9 -43.53 13.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.599 0.759 . . . . 0.0 109.688 -165.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -102.31 3.32 37.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.323 1.449 . . . . 0.0 112.883 -168.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.2 165.95 39.18 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 110.847 174.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 27.9 mtp . . . . . 0 CA--C 1.54 0.565 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.5 158.69 32.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.909 1.739 . . . . 0.0 109.917 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -79.12 157.75 27.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 115' ' ' LEU 0.261 9.5 p -93.65 0.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.332 0.587 . . . . 0.0 112.203 -178.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.04 55.65 0.68 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.934 1.731 . . . . 0.0 110.13 162.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -144.86 168.81 19.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.188 1.494 . . . . 0.0 112.254 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.41 129.6 36.58 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.402 1.096 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -136.19 -177.08 4.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.277 172.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.71 142.7 51.25 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.402 2.281 . . . . 0.0 106.491 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.27 124.67 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.33 135.47 12.89 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.61 174.37 46.58 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.718 1.152 . . . . 0.0 110.606 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.2 ttm -95.76 126.2 40.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.514 1.526 . . . . 0.0 110.996 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.97 127.3 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 124.227 1.011 . . . . 0.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.9 mtt -59.92 127.5 85.61 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 122.501 0.321 . . . . 0.0 110.58 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.0 113.73 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.072 3.181 . . . . 0.0 110.364 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 104.62 -16.88 47.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.336 1.922 . . . . 0.0 113.967 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.7 p -69.43 -19.68 63.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.469 1.134 . . . . 0.0 114.005 -165.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.71 83.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.954 1.302 . . . . 0.0 109.864 -167.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.77 -58.27 9.32 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.667 1.987 . . . . 0.0 111.472 -167.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.237 0.408 0 C-N-CA 129.612 3.165 . . . . 0.0 110.852 -179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -55.39 140.69 39.02 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 164.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 156.73 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 p -126.37 141.06 52.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 152.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.67 170.6 15.55 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 108.329 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -112.47 144.5 41.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -121.41 143.09 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 169.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.44 173.46 11.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.111 1.765 . . . . 0.0 107.88 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -155.07 -162.54 1.38 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 13.65 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.51 1.924 . . . . 0.0 113.725 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 -76.53 0.58 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.876 1.271 . . . . 0.0 107.914 -172.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.52 -151.21 5.4 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 40' ' ' PRO . 84.7 p -146.08 166.97 24.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.639 0.719 . . . . 0.0 112.519 172.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 40' ' ' PRO . 6.3 p -146.63 157.86 10.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 126.112 1.765 . . . . 0.0 109.045 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.0 151.06 19.81 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 126.006 1.722 . . . . 0.0 108.468 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 84' ' ' ILE . 44.6 t -142.56 103.33 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.055 0.942 . . . . 0.0 111.33 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.4 m -78.44 120.68 23.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.228 1.011 . . . . 0.0 109.361 161.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -116.41 171.5 7.8 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.333 1.453 . . . . 0.0 107.843 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.84 101.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.61 169.73 26.43 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -73.74 -25.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 122.94 0.496 . . . . 0.0 110.67 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.471 ' CD2' HG11 ' A' ' 126' ' ' VAL . 30.5 mt 87.52 156.55 0.09 OUTLIER Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 131.401 3.88 . . . . 0.0 110.185 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -56.08 143.59 83.08 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 N-CA-C 107.058 -1.939 . . . . 0.0 107.058 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -62.21 -37.02 83.72 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.511 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mp -61.44 -20.16 62.79 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.12 1.768 . . . . 0.0 115.159 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.38 125.05 23.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.613 1.097 . . . . 0.0 109.524 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -126.95 160.27 31.54 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.19 0.995 . . . . 0.0 110.488 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 69.7 mt-10 -81.24 104.81 11.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.891 1.677 . . . . 0.0 107.434 168.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.5 13.78 5.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.062 0.839 . . . . 0.0 114.07 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -130.92 166.93 19.87 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.711 1.256 . . . . 0.0 112.131 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.72 139.94 29.55 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 170.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.47 109.04 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 126' ' ' VAL . 3.2 t -81.19 158.18 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 125.08 1.352 . . . . 0.0 108.939 164.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -153.25 152.09 30.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.3 3.04 . . . . 0.0 106.16 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.97 -111.42 0.48 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.78 160.78 33.36 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 119.917 1.858 . . . . 0.0 109.153 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -74.72 142.61 44.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 159.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -99.65 -88.33 0.34 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.886 1.275 . . . . 0.0 108.031 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.35 157.33 4.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.667 2.787 . . . . 0.0 107.433 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.16 25.54 73.45 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.87 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m120 58.65 71.45 0.58 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.347 2.259 . . . . 0.0 110.114 -168.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -141.18 136.49 31.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.68 130.2 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 126.678 1.991 . . . . 0.0 108.497 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.84 111.5 15.05 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 157.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.44 37.33 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.23 1.812 . . . . 0.0 108.329 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -24.64 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.954 1.301 . . . . 0.0 111.399 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.38 -47.54 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 99' ' ' LEU . 32.8 t 61.26 129.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 124.237 1.97 . . . . 0.0 111.328 -174.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.4 mt -133.85 159.03 41.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -126.03 55.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.397 0.544 . . . . 0.0 110.097 -179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? . . . . . 0 N--CA 1.472 0.656 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 176.188 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.237 0.401 0 CA-C-O 122.46 1.124 . . . . 0.0 110.2 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -168.04 154.62 7.68 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.144 2.578 . . . . 0.0 106.018 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 74.5 m-85 -141.54 173.66 11.29 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.066 2.146 . . . . 0.0 109.051 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 p -134.88 164.05 46.81 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 123.959 0.904 . . . . 0.0 109.606 168.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.88 72.94 2.52 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.677 2.918 . . . . 0.0 109.804 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.13 -62.55 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 105.182 -3.167 . . . . 0.0 105.182 -168.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -47.85 -48.66 30.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.331 1.065 . . . . 0.0 109.956 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.19 -15.37 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 127.149 2.18 . . . . 0.0 112.17 -172.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.48 -32.8 3.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.096 1.359 . . . . 0.0 110.883 -166.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.77 -60.67 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.653 2.381 . . . . 0.0 108.242 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.43 135.97 2.11 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.493 1.521 . . . . 0.0 110.547 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 5.3 tptp . . . . . 0 N--CA 1.471 0.604 0 C-N-CA 124.675 1.19 . . . . 0.0 111.096 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.547 0.841 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.88 155.83 48.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.67 1.58 . . . . 0.0 109.71 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -79.14 132.32 36.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.259 3.8 p -69.43 0.45 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 123.384 1.564 . . . . 0.0 112.098 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.77 22.4 19.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.959 2.218 . . . . 0.0 112.516 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.55 177.63 7.7 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 121.08 2.44 . . . . 0.0 113.398 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.44 150.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.044 167.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.36 178.15 10.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.203 1.001 . . . . 0.0 109.68 171.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -116.67 150.56 37.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.385 1.874 . . . . 0.0 108.468 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.35 154.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.59 1.556 . . . . 0.0 107.654 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.8 142.35 13.67 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 159.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.69 44.5 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 ttm -92.46 119.64 32.17 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.878 2.071 . . . . 0.0 110.514 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.72 128.85 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 120.275 -1.516 . . . . 0.0 108.728 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.1 mtt -59.37 141.25 87.78 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 112.694 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.21 134.17 47.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.751 3.634 . . . . 0.0 109.71 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.6 -2.49 39.07 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.786 -1.008 . . . . 0.0 114.763 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.1 p -74.46 -43.35 56.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.757 1.778 . . . . 0.0 112.099 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.0 107.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.086 1.754 . . . . 0.0 110.805 -170.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -74.04 -55.46 6.1 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.962 1.705 . . . . 0.0 111.444 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.421 HH21 ' CD2' ' A' ' 78' ' ' LEU . 1.5 mtp180 . . . . . 0 N--CA 1.466 0.375 0 C-N-CA 127.147 2.179 . . . . 0.0 111.451 -165.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.421 ' CD2' HH21 ' A' ' 73' ' ' ARG . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.415 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 116.96 5.31 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.24 153.93 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.391 1.091 . . . . 0.0 109.844 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.7 p -141.2 114.85 8.95 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -124.96 178.76 5.34 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.809 1.644 . . . . 0.0 111.791 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.2 m -124.36 145.15 49.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -120.11 148.03 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 172.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -139.25 178.26 7.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.96 1.704 . . . . 0.0 108.535 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 87' ' ' ALA . 37.0 t70 -161.01 -153.66 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 86' ' ' ASP . . . -68.8 -18.19 64.14 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.324 -1.485 . . . . 0.0 113.098 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -112.56 -63.3 1.45 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -163.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.59 -157.55 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 120.105 -0.275 . . . . 0.0 113.062 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.9 p -149.78 159.88 44.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.45 153.19 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.838 1.655 . . . . 0.0 111.351 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -81.07 143.99 32.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.531 176.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 58.6 t -137.61 121.35 21.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 164.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -91.61 133.52 35.48 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 155.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 18.9 t80 -130.15 168.34 16.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -158.26 113.39 2.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.47 0.15 Allowed Glycine 0 N--CA 1.468 0.786 0 C-N-CA 118.107 -1.997 . . . . 0.0 113.26 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.13 -28.22 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.286 1.043 . . . . 0.0 112.613 167.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.1 tp 61.23 128.13 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 129.333 3.053 . . . . 0.0 112.86 -170.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 5.1 Cg_exo -61.66 135.71 58.19 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.653 1.569 . . . . 0.0 108.106 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.58 -25.51 38.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.856 0.836 . . . . 0.0 111.689 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.49 -23.39 66.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.434 1.094 . . . . 0.0 112.145 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.34 130.28 41.55 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.331 1.423 . . . . 0.0 109.461 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -126.94 -161.87 1.11 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 107.472 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.7 151.95 19.6 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.959 -1.088 . . . . 0.0 108.773 150.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.37 57.86 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.502 166.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -125.37 166.47 16.51 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.395 1.078 . . . . 0.0 109.748 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.41 135.91 18.26 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.83 162.7 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.08 112.78 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.72 2.008 . . . . 0.0 105.687 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -94.59 157.51 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.152 . . . . 0.0 108.259 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -154.11 135.84 14.44 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 127.552 2.341 . . . . 0.0 107.331 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -120.47 0.95 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 103.339 -3.904 . . . . 0.0 103.339 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.55 153.75 46.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.351 1.076 . . . . 0.0 109.631 -160.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.6 tp -80.68 122.54 27.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 109.428 176.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -76.03 -66.98 0.72 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -138.8 -96.16 0.18 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.695 0.798 . . . . 0.0 111.056 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -91.01 -70.54 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -126.94 41.03 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.902 -0.763 . . . . 0.0 109.032 -169.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 92' ' ' ASP . 23.1 t-160 -131.57 125.9 33.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.051 1.34 . . . . 0.0 108.636 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.428 HG21 ' CG1' ' A' ' 111' ' ' VAL . 7.9 mm -98.13 130.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.437 1.895 . . . . 0.0 108.15 171.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.15 108.02 12.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 152.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -71.06 147.88 48.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 160.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -11.0 7.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.81 1.644 . . . . 0.0 111.503 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.36 -21.43 0.15 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 111' ' ' VAL . 86.0 t 41.89 113.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 130.598 3.559 . . . . 0.0 115.687 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.3 144.01 50.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -167.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.86 42.83 2.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.328 -0.857 . . . . 0.0 111.217 -164.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.258 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 36' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -165.84 147.69 7.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.984 0.811 . . . . 0.0 110.63 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' A' ' 36' ' ' LEU . 91.8 m-85 -140.45 177.8 7.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.509 1.924 . . . . 0.0 109.595 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 22.2 p -134.55 171.85 8.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.291 1.036 . . . . 0.0 110.011 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HB3' HG22 ' A' ' 91' ' ' VAL . 69.4 Cg_endo -72.62 -0.64 9.13 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.799 2.333 . . . . 0.0 114.793 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.45 -53.51 3.81 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 156.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 39' ' ' THR . 56.9 mt-10 -68.24 -30.49 69.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.591 -0.946 . . . . 0.0 113.139 -160.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.9 -13.81 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.865 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -119.87 -42.28 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 110.198 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -90.25 -18.12 26.23 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.012 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.68 147.46 9.05 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.776 2.131 . . . . 0.0 109.825 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm . . . . . 0 C--N 1.349 0.548 0 CA-C-N 119.766 1.783 . . . . 0.0 109.777 173.195 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 42.8 mtp . . . . . 0 C--O 1.238 0.481 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.02 166.29 23.43 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.862 1.708 . . . . 0.0 111.184 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -79.01 128.43 33.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 115' ' ' LEU . 49.0 t -60.64 -8.48 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.823 1.649 . . . . 0.0 111.857 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.46 33.49 4.8 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-O 116.131 -2.483 . . . . 0.0 112.719 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.83 177.62 6.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.128 2.464 . . . . 0.0 112.471 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -83.6 140.93 31.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.018 0.927 . . . . 0.0 110.664 165.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -146.64 173.92 11.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.638 0.775 . . . . 0.0 109.76 169.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -121.26 139.03 53.94 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.46 160.72 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 128.506 2.723 . . . . 0.0 107.856 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.08 156.58 26.92 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.85 -179.96 47.51 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.703 1.621 . . . . 0.0 109.214 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.4 tpp -81.09 120.05 24.34 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 129.062 2.945 . . . . 0.0 110.598 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 103' ' ' PHE . 73.0 t -64.74 130.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 119.094 -2.253 . . . . 0.0 108.479 175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.26 154.23 53.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.87 133.3 30.91 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.006 2.471 . . . . 0.0 109.668 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.73 -24.65 4.32 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 125.579 1.561 . . . . 0.0 115.776 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.09 -43.61 91.86 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.466 1.633 . . . . 0.0 111.732 -170.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.308 1.3 p -42.33 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.941 2.096 . . . . 0.0 112.96 -172.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.414 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 8.4 pt20 -91.93 56.48 2.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.968 2.907 . . . . 0.0 108.242 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 11.9 ptt-85 . . . . . 0 CA--C 1.511 -0.554 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 166.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.225 -0.223 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.506 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -62.29 138.97 58.52 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.058 -1.651 . . . . 0.0 109.088 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 99' ' ' LEU . 2.1 p -155.72 132.7 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 72' ' ' GLN 0.314 22.7 m -123.39 153.71 40.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 48.8 p90 -152.4 176.98 11.08 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 119.936 -1.727 . . . . 0.0 110.945 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 m -121.56 143.8 49.08 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -121.34 153.67 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.064 1.746 . . . . 0.0 106.47 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -141.81 -179.43 6.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.587 1.955 . . . . 0.0 106.973 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -157.08 -159.35 0.85 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.08 4.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.96 -79.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.033 1.733 . . . . 0.0 109.371 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.98 -168.37 12.07 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.215 1.388 . . . . 0.0 111.643 -167.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 p -146.98 155.97 42.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.4 m -148.72 145.85 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.999 1.72 . . . . 0.0 110.264 -167.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.5 154.68 26.18 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 84' ' ' ILE . 5.4 m -133.28 144.95 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 120.625 -1.297 . . . . 0.0 109.337 160.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.38 1.872 . . . . 0.0 106.572 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -134.91 168.93 18.19 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.221 1.809 . . . . 0.0 108.761 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -148.94 117.63 6.61 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 171.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.38 175.46 25.59 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -170.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -6.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.047 1.339 . . . . 0.0 112.395 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.645 ' CD2' HG11 ' A' ' 126' ' ' VAL . 32.3 mt 63.02 165.89 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 127.535 2.334 . . . . 0.0 111.66 -166.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.35 137.64 79.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 159.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.88 -27.4 66.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.141 0.496 . . . . 0.0 110.704 167.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -19.07 60.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.481 1.512 . . . . 0.0 113.107 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' VAL . 41.8 t80 -64.5 129.4 39.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.994 0.815 . . . . 0.0 110.086 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -136.1 161.07 36.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.023 1.329 . . . . 0.0 109.944 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.71 114.21 6.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.526 1.13 . . . . 0.0 108.206 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.98 -3.46 33.69 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.127 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -91.48 166.73 12.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.35 1.575 . . . . 0.0 110.601 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 140.99 27.54 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.14 177.06 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.255 1.822 . . . . 0.0 107.295 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 127' ' ' LEU . 2.6 t -141.86 101.22 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.097 1.759 . . . . 0.0 106.714 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.9 168.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-O 122.706 1.241 . . . . 0.0 111.244 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -165.05 140.83 5.46 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.279 1.831 . . . . 0.0 107.693 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.58 -91.43 0.11 Allowed Glycine 0 C--O 1.224 -0.481 0 CA-C-O 116.941 -2.033 . . . . 0.0 109.276 168.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.29 162.28 35.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.466 2.133 . . . . 0.0 110.339 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -82.28 148.63 28.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.06 1.744 . . . . 0.0 108.672 165.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.439 ' CG ' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -104.99 -85.0 0.48 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 108.259 -174.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 12.8 mtmm -141.07 170.8 15.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 127.352 2.261 . . . . 0.0 106.88 159.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 45.48 -102.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 125.131 1.348 . . . . 0.0 110.852 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -136.31 51.99 1.99 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.593 0.757 . . . . 0.0 109.318 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -121.46 129.94 53.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.48 0.712 . . . . 0.0 109.955 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -105.35 127.81 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.57 1.148 . . . . 0.0 110.999 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.439 HD21 ' CG ' ' A' ' 116' ' ' GLU . 3.6 mm? -79.49 80.76 5.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 162.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.54 141.87 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.563 0.697 . . . . 0.0 110.53 164.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -14.13 9.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.581 1.552 . . . . 0.0 111.529 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.81 -33.65 0.45 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 117.643 -1.17 . . . . 0.0 114.04 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 99' ' ' LEU . 87.7 t 54.92 116.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 C-N-CA 129.073 2.949 . . . . 0.0 111.108 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 10.1 mt -93.15 -176.42 4.15 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.653 168.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -143.43 19.47 1.88 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.982 1.313 . . . . 0.0 110.616 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.2 mttm . . . . . 0 N--CA 1.476 0.85 0 CA-C-N 119.426 1.012 . . . . 0.0 111.577 -161.494 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.5 pp . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 122.528 1.156 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -158.21 147.18 19.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.664 1.185 . . . . 0.0 108.578 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE1' HD13 ' A' ' 36' ' ' LEU . 95.8 m-85 -134.43 173.03 12.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.013 1.725 . . . . 0.0 108.891 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 3.4 p -131.99 172.41 7.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.753 1.221 . . . . 0.0 108.635 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 10.8 Cg_endo -59.87 -36.87 89.33 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.646 1.564 . . . . 0.0 109.881 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.88 10.52 13.69 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.595 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HB2' ' H ' ' A' ' 39' ' ' THR . 26.6 mt-10 -130.17 -30.95 1.92 Allowed 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.909 1.854 . . . . 0.0 112.727 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.04 -58.27 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.71 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -71.94 -49.61 36.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 110.06 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.71 ' CE1' HD12 ' A' ' 44' ' ' LEU . 10.1 m-30 -82.98 -7.16 59.7 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.53 132.05 4.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 13.8 tptp . . . . . 0 C--O 1.224 -0.267 0 C-N-CA 128.316 2.647 . . . . 0.0 113.648 176.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.59 160.9 40.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.256 1.304 . . . . 0.0 110.117 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -78.66 128.72 33.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.44 -6.06 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.005 1.722 . . . . 0.0 111.433 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.06 52.76 0.74 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 162.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -131.66 178.82 6.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.75 1.275 . . . . 0.0 111.355 161.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -95.0 137.61 33.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.999 1.72 . . . . 0.0 110.392 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.74 169.82 23.04 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.274 1.03 . . . . 0.0 111.416 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -119.27 143.44 47.33 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 127.952 2.501 . . . . 0.0 107.923 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.2 160.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.063 2.145 . . . . 0.0 108.514 -170.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.02 163.98 26.55 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 160.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.25 38.89 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 124.167 0.889 . . . . 0.0 111.189 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.7 ttm -91.9 125.98 36.81 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.53 1.132 . . . . 0.0 109.474 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -65.69 123.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 120.705 1.593 . . . . 0.0 107.46 178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 ttm -63.14 139.18 97.51 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.11 158.29 48.86 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.62 57.91 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 116.857 -2.08 . . . . 0.0 115.494 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -120.23 -6.34 9.89 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.478 2.139 . . . . 0.0 113.323 167.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.3 85.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 120.796 1.635 . . . . 0.0 111.484 169.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -78.46 61.69 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.796 2.839 . . . . 0.0 107.408 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 14.2 ptm180 . . . . . 0 C--N 1.325 -0.46 0 O-C-N 120.75 -1.219 . . . . 0.0 108.8 168.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.466 0.333 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -62.07 140.77 58.37 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.2 p -149.61 132.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 m -122.05 135.83 54.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -147.71 173.46 12.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.917 1.235 . . . . 0.0 110.087 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.2 m -118.6 142.8 47.28 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.864 1.266 . . . . 0.0 107.814 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.58 145.48 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.374 1.469 . . . . 0.0 107.098 175.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -149.45 176.42 10.61 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.9 0.88 . . . . 0.0 111.417 -168.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -160.4 -166.48 1.67 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.655 1.582 . . . . 0.0 110.318 172.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.82 8.47 0.51 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.641 1.576 . . . . 0.0 113.66 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.87 -71.14 0.74 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.79 -171.01 12.5 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 124.196 0.903 . . . . 0.0 112.433 -172.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.2 p -140.98 149.79 42.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.975 0.91 . . . . 0.0 110.773 164.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -132.7 149.75 32.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.864 1.266 . . . . 0.0 108.054 -173.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.3 148.32 25.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.73 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 84' ' ' ILE . 60.9 t -135.58 123.32 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.025 0.93 . . . . 0.0 110.764 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -89.31 136.78 32.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 151.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -132.52 165.19 24.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.037 2.135 . . . . 0.0 106.694 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -140.07 113.11 8.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.99 166.55 23.06 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.4 tt -72.96 -15.47 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.888 -174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.438 ' CD2' HG11 ' A' ' 126' ' ' VAL . 38.0 mt 78.83 165.09 0.12 Allowed Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 130.827 3.651 . . . . 0.0 110.743 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -61.13 140.37 89.01 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 N-CA-C 107.299 -1.846 . . . . 0.0 107.299 158.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.94 -31.45 66.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.903 1.281 . . . . 0.0 109.927 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -33.26 71.24 Favored 'General case' 0 N--CA 1.437 -1.076 1 C-N-CA 131.984 4.113 . . . . 0.0 111.567 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -59.73 136.6 58.05 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.023 1.283 . . . . 0.0 107.776 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -149.77 142.15 24.27 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 11.7 pt-20 -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.476 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.523 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 114.8 -9.33 21.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 114.876 -3.18 . . . . 0.0 115.463 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -94.53 169.7 10.0 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 123.622 3.711 . . . . 0.0 111.637 -173.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.57 8.04 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 165.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.48 176.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.434 1.894 . . . . 0.0 108.447 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.422 ' CG2' ' HE2' ' A' ' 129' ' ' LYS . 2.1 t -129.29 128.88 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.124 1.77 . . . . 0.0 107.228 164.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.82 167.06 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.475 1.131 . . . . 0.0 111.8 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -161.41 144.53 12.5 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.61 -120.31 0.91 Allowed Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -138.35 152.46 48.48 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.758 0.779 . . . . 0.0 109.395 -169.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 143.41 33.94 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.339 1.056 . . . . 0.0 110.176 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -91.58 -77.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.563 -0.71 . . . . 0.0 110.992 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.23 -79.83 0.01 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.86 2.064 . . . . 0.0 108.58 -170.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.3 47.76 2.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.783 1.659 . . . . 0.0 113.153 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.02 67.11 1.02 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.9 2.08 . . . . 0.0 110.904 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -136.64 132.84 35.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.131 1.773 . . . . 0.0 106.613 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -99.95 127.07 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.446 1.498 . . . . 0.0 109.046 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.72 74.99 5.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 164.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.21 140.02 17.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.032 0.92 . . . . 0.0 111.693 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -17.32 12.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.69 1.996 . . . . 0.0 110.92 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.85 -42.8 0.53 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.801 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.438 HG11 ' CD2' ' A' ' 99' ' ' LEU . 89.3 t 50.69 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.045 1.338 . . . . 0.0 111.18 -176.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.7 mt -98.67 159.54 14.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.0 17.96 14.79 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.911 0.884 . . . . 0.0 113.361 -162.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HE2' ' CG2' ' A' ' 110' ' ' VAL . 42.5 mmtt . . . . . 0 N--CA 1.473 0.691 0 C-N-CA 126.534 1.933 . . . . 0.0 111.462 -170.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 60' ' ' LEU . 2.5 pp . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 122.006 0.908 . . . . 0.0 112.185 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -156.56 162.14 39.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.957 1.303 . . . . 0.0 109.38 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -145.72 173.09 12.39 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.756 2.822 . . . . 0.0 108.601 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -135.36 165.4 36.64 Favored Pre-proline 0 CA--C 1.53 0.187 0 O-C-N 121.315 -0.866 . . . . 0.0 112.233 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.16 -8.62 12.62 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.384 2.723 . . . . 0.0 116.205 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.51 -38.0 4.09 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 120.586 1.539 . . . . 0.0 110.01 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.04 22.94 1.9 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.432 -1.628 . . . . 0.0 110.27 -162.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.67 -50.92 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 164.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.856 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -79.97 -41.23 26.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.369 1.867 . . . . 0.0 110.568 -169.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -82.19 4.09 24.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.995 1.318 . . . . 0.0 110.159 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.93 170.72 6.67 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 125.995 1.759 . . . . 0.0 109.756 -166.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tttt . . . . . 0 C--N 1.33 -0.24 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -162.954 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 C--O 1.239 0.529 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -62.39 154.87 61.02 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.673 167.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.78 130.78 35.62 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.658 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.56 -9.72 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 122.844 0.458 . . . . 0.0 111.332 166.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.11 3.24 56.87 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.589 -1.673 . . . . 0.0 115.286 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.613 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.0 pt20 -115.29 173.51 6.47 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.88 2.34 . . . . 0.0 112.374 -161.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -98.41 135.36 40.11 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -158.17 174.91 14.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.752 0.786 . . . . 0.0 111.335 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -131.89 153.3 50.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.253 1.421 . . . . 0.0 109.775 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 91' ' ' VAL . 88.3 t -138.14 138.34 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 127.447 2.299 . . . . 0.0 107.74 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.41 2.8 Favored Glycine 0 N--CA 1.466 0.687 0 CA-C-N 120.795 1.634 . . . . 0.0 112.048 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.7 165.25 27.64 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.5 ttm -79.95 123.32 27.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.482 1.513 . . . . 0.0 107.789 166.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.21 125.47 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 38.6 mtt -52.77 121.51 22.95 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.123 0.569 . . . . 0.0 110.603 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.07 91.49 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.803 3.669 . . . . 0.0 109.192 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.73 62.7 0.68 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 -23.29 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.376 2.271 . . . . 0.0 111.05 170.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.12 93.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 119.704 1.138 . . . . 0.0 109.341 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -80.8 73.38 7.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.967 2.507 . . . . 0.0 106.618 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.515 -0.381 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 172.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 CA--C 1.531 0.222 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.34 139.84 35.4 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.429 -1.42 . . . . 0.0 108.155 166.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.06 121.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.3 m -116.79 129.81 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -139.77 175.4 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 119.283 0.947 . . . . 0.0 111.076 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -123.9 142.69 50.91 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -122.65 137.01 57.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 178.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -130.69 179.87 5.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.129 1.771 . . . . 0.0 108.276 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -152.91 -116.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.182 163.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.89 -1.97 30.91 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.824 1.193 . . . . 0.0 112.27 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -124.7 -70.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.796 1.238 . . . . 0.0 107.783 -156.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.47 -168.39 12.55 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.3 p -142.75 156.79 45.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.121 0.568 . . . . 0.0 111.65 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 62' ' ' VAL . 23.6 m -138.01 147.64 25.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.782 2.033 . . . . 0.0 109.587 -171.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.23 153.73 24.56 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.609 HG11 HG21 ' A' ' 111' ' ' VAL . 3.2 m -135.67 145.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 163.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -112.77 125.8 54.73 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 162.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -124.27 158.91 31.42 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.168 1.387 . . . . 0.0 108.667 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -142.94 99.12 3.4 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.0 170.34 29.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.603 1.097 . . . . 0.0 110.452 -175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -74.96 -17.51 16.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.617 1.167 . . . . 0.0 112.072 -165.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 73.27 135.74 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.955 2.502 . . . . 0.0 109.36 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.73 151.46 85.61 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.793 1.662 . . . . 0.0 108.999 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -29.08 68.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.831 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -59.45 -38.4 80.65 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.971 -1.49 . . . . 0.0 111.18 176.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.456 ' CD2' HG11 ' A' ' 109' ' ' VAL . 23.9 t80 -67.06 134.56 52.12 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.341 1.456 . . . . 0.0 110.938 -172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.14 169.43 17.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.072 0.949 . . . . 0.0 110.661 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.66 84.41 6.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.899 1.68 . . . . 0.0 108.001 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.97 5.48 3.87 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.124 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.28 171.57 7.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.058 1.929 . . . . 0.0 110.761 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.47 110.93 3.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 103' ' ' PHE . 2.3 m -112.92 171.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 173.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.849 HG22 ' HB2' ' A' ' 127' ' ' LEU . 3.1 m -113.02 163.63 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 157.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 126' ' ' VAL . 2.2 t -113.97 157.56 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 156.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -141.89 148.83 39.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.351 2.26 . . . . 0.0 106.661 169.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.16 -114.69 0.66 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -135.75 159.63 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.724 1.762 . . . . 0.0 110.371 -165.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.54 142.0 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 -66.62 0.89 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.473 0.709 . . . . 0.0 109.463 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -50.32 0.08 Allowed 'General case' 0 C--N 1.347 0.483 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.52 -77.27 0.82 Allowed Glycine 0 C--N 1.329 0.149 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -141.14 33.48 1.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.897 1.679 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -115.78 129.54 56.49 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 111' ' ' VAL . 8.9 mm -102.68 133.61 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.758 1.623 . . . . 0.0 108.535 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.2 108.0 12.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 157.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.31 141.98 54.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 165.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -27.5 7.85 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 126.198 1.799 . . . . 0.0 108.971 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.82 -18.29 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 111' ' ' VAL . 21.4 t 51.41 99.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.428 2.291 . . . . 0.0 115.951 170.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.849 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.4 125.07 52.01 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.592 -163.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -99.78 57.69 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.162 -1.586 . . . . 0.0 110.592 -171.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt . . . . . 0 N--CA 1.472 0.661 0 C-N-CA 124.958 1.303 . . . . 0.0 113.706 173.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.441 -0.912 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.444 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 32.3 t80 -140.7 121.42 14.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.119 1.368 . . . . 0.0 109.812 -162.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CE1' HD11 ' A' ' 36' ' ' LEU . 83.0 m-85 -110.21 -179.58 3.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 109.282 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 p -147.55 162.3 32.5 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.811 1.645 . . . . 0.0 107.161 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 66.5 8.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 109.628 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -168.3 -52.27 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -1.6 25.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 125.598 1.559 . . . . 0.0 111.388 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.65 -30.98 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.83 -46.92 5.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.217 1.007 . . . . 0.0 111.282 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.4 -36.52 22.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.154 1.382 . . . . 0.0 109.919 -172.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.21 133.83 3.2 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -167.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 7.3 tptp . . . . . 0 CA--C 1.51 -0.594 0 CA-C-N 119.085 1.443 . . . . 0.0 109.994 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mmt . . . . . 0 CA--C 1.531 0.241 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.62 148.71 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.843 1.695 . . . . 0.0 110.12 163.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.46 137.79 37.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.72 -8.21 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.622 0.769 . . . . 0.0 111.18 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.07 36.25 3.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 125.598 1.57 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -136.02 163.88 29.27 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.411 1.606 . . . . 0.0 110.215 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -77.47 150.39 34.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.419 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -160.73 164.68 31.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.086 1.355 . . . . 0.0 111.093 169.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -106.51 155.04 20.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.011 1.724 . . . . 0.0 107.277 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.0 153.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 127.075 2.15 . . . . 0.0 107.815 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.46 139.65 11.14 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 162.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.16 173.58 43.6 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 118.177 0.989 . . . . 0.0 111.51 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 ttm -109.0 123.82 49.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 110.859 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.837 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -66.28 129.45 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.889 1.677 . . . . 0.0 110.494 -171.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 mtt -62.68 139.81 97.0 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.09 0.859 . . . . 0.0 110.154 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.75 140.43 80.32 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.696 1.597 . . . . 0.0 108.565 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.27 43.5 92.77 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.221 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.8 p -117.08 -84.33 0.64 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.305 1.7 p -22.49 95.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 130.817 3.647 . . . . 0.0 114.802 -170.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.22 90.99 7.54 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 129.089 2.955 . . . . 0.0 108.662 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 . . . . . 0 N--CA 1.474 0.754 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.924 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.9 mt . . . . . 0 C--O 1.238 0.453 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -55.12 139.47 41.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.039 1.336 . . . . 0.0 108.048 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 4.9 p -158.13 127.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.1 m -102.49 146.56 27.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 24.6 p90 -146.23 172.53 13.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.982 1.265 . . . . 0.0 109.684 168.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.59 145.4 42.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -131.21 126.34 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.57 1.148 . . . . 0.0 109.094 175.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 28.6 p90 -117.3 173.89 6.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.491 2.316 . . . . 0.0 110.34 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -152.61 -164.51 1.97 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.977 1.311 . . . . 0.0 108.328 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.11 11.06 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.802 -1.186 . . . . 0.0 113.672 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.473 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -116.03 -75.65 0.58 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -174.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -127.76 -162.37 11.07 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.504 1.049 . . . . 0.0 113.0 -167.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 93.8 p -144.9 160.44 41.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.623 0.769 . . . . 0.0 110.754 169.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.01 145.34 28.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -76.94 151.9 35.52 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 84' ' ' ILE . 6.2 m -131.73 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 121.943 -0.473 . . . . 0.0 109.766 165.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -104.45 132.7 50.4 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 16.6 t80 -132.53 168.49 18.13 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.465 1.506 . . . . 0.0 108.445 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -156.07 107.07 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 167.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.93 20.19 0.02 OUTLIER Glycine 0 N--CA 1.468 0.8 0 C-N-CA 116.254 -2.879 . . . . 0.0 118.195 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER 59.21 117.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.641 1.977 . . . . 0.0 111.882 -168.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.531 ' CD2' HG11 ' A' ' 126' ' ' VAL . 23.7 mt -74.33 148.29 85.94 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.301 -0.874 . . . . 0.0 109.902 -175.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -60.7 156.73 41.06 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.314 2.676 . . . . 0.0 109.749 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.86 -40.95 97.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.665 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.18 -27.91 64.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.916 1.286 . . . . 0.0 111.44 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -55.53 129.77 40.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.617 1.099 . . . . 0.0 109.478 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ptt85 -127.86 -164.23 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.623 1.169 . . . . 0.0 111.158 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -103.06 129.19 49.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 153.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.837 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 97.4 8.82 56.0 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 115.524 -2.82 . . . . 0.0 114.754 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.65 165.28 11.88 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 121.829 2.815 . . . . 0.0 110.111 174.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.21 133.97 26.6 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.56 161.96 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.835 2.454 . . . . 0.0 105.801 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.41 138.5 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 121' ' ' ILE . 15.2 m -117.06 166.02 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.296 0.57 . . . . 0.0 110.059 166.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -158.44 146.31 18.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.148 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.91 -112.44 0.54 Allowed Glycine 0 C--O 1.228 -0.263 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -134.45 162.95 30.82 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 120.366 2.083 . . . . 0.0 107.608 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 3.4 tp -82.46 133.91 35.21 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.685 1.194 . . . . 0.0 108.533 167.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.619 ' HG2' HD21 ' A' ' 122' ' ' LEU . 6.9 tm-20 -80.61 -66.64 0.86 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -168.35 -171.89 1.59 Allowed 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 133.161 4.584 . . . . 0.0 105.106 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -8.58 82.92 0.0 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.495 2.95 . . . . 0.0 113.623 164.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 m120 59.2 35.22 23.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.27 2.228 . . . . 0.0 114.767 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -126.41 132.66 51.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.168 0.987 . . . . 0.0 111.045 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 111' ' ' VAL . 20.2 mm -110.95 125.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 128.131 2.572 . . . . 0.0 110.92 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HG2' ' A' ' 116' ' ' GLU . 3.5 mm? -79.72 73.64 6.44 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.916 1.286 . . . . 0.0 108.308 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -43.17 128.07 4.5 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.786 -0.571 . . . . 0.0 110.398 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -26.99 13.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.084 1.353 . . . . 0.0 111.22 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.68 -41.99 0.61 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -170.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 99' ' ' LEU . 58.9 t 57.34 144.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.892 2.077 . . . . 0.0 111.754 -168.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -139.21 159.89 41.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.31 39.73 3.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.705 1.602 . . . . 0.0 110.164 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt . . . . . 0 N--CA 1.474 0.748 0 C-N-CA 128.162 2.585 . . . . 0.0 112.251 -161.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.8 pp . . . . . 0 N--CA 1.439 -0.995 0 CA-C-O 122.099 0.952 . . . . 0.0 108.809 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -155.58 149.1 25.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.619 ' CE1' HD13 ' A' ' 36' ' ' LEU . 85.8 m-85 -136.8 -179.93 5.99 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.457 1.903 . . . . 0.0 107.794 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -146.11 164.34 25.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 C-N-CA 126.236 1.814 . . . . 0.0 106.75 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.51 64.31 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.916 3.078 . . . . 0.0 110.142 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.9 -50.06 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -3.57 37.12 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.827 -0.808 . . . . 0.0 111.796 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mt -94.4 -34.17 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.001 0.92 . . . . 0.0 108.723 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.63 -57.66 2.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.465 1.106 . . . . 0.0 111.311 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -85.45 -28.03 25.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.591 2.357 . . . . 0.0 109.423 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.31 158.57 11.47 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.755 1.169 . . . . 0.0 112.189 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 7.2 tptt . . . . . 0 C--O 1.218 -0.571 0 C-N-CA 125.556 1.542 . . . . 0.0 110.681 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt . . . . . 0 CA--C 1.54 0.589 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.9 162.27 32.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.763 1.642 . . . . 0.0 109.241 154.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -79.58 152.78 29.89 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 162.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.747 HG11 ' HE3' ' A' ' 117' ' ' LYS . 76.2 t -90.65 0.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.896 0.878 . . . . 0.0 111.811 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.41 61.58 0.65 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 165.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.416 ' HG3' HD12 ' A' ' 60' ' ' LEU . 3.0 pt20 -140.0 176.11 9.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.485 0.714 . . . . 0.0 110.965 168.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -90.75 135.28 33.82 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.905 0.882 . . . . 0.0 111.205 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -158.48 175.71 13.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.193 1.397 . . . . 0.0 112.424 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -114.53 148.95 37.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 127.941 2.497 . . . . 0.0 109.141 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.63 134.68 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.199 1.399 . . . . 0.0 107.536 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.98 143.66 16.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 158.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.95 167.9 38.97 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.457 1.129 . . . . 0.0 111.579 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.7 ttm -93.73 121.91 35.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.605 1.562 . . . . 0.0 109.708 -174.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -66.2 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 109.222 -176.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 45.5 mtt -62.31 144.02 95.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 111.894 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.67 61.57 8.23 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.592 3.528 . . . . 0.0 110.804 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.15 63.06 0.02 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -152.72 -23.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.252 0.6 OUTLIER -68.56 100.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 120.261 1.391 . . . . 0.0 111.334 -176.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -82.91 81.46 8.59 Favored 'General case' 0 C--O 1.237 0.446 1 C-N-CA 132.667 4.387 . . . . 0.0 109.455 171.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.281 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 0 C--O 1.239 0.5 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -50.0 145.24 5.86 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 160.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.88 166.77 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 122.244 1.021 . . . . 0.0 109.114 169.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.67 116.16 7.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 163.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -125.07 175.85 7.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.503 1.956 . . . . 0.0 111.483 171.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 m -124.76 145.56 49.66 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -130.5 138.45 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.256 1.822 . . . . 0.0 107.465 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -130.04 174.65 9.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.612 1.565 . . . . 0.0 108.89 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -157.1 -163.84 1.48 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.46 -3.41 0.98 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.365 1.866 . . . . 0.0 115.269 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -118.84 -79.79 0.6 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.14 -159.24 8.59 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.927 1.251 . . . . 0.0 111.796 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -146.96 162.09 39.43 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 119' ' ' ASN . 14.2 m -142.99 145.28 23.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.776 1.63 . . . . 0.0 109.255 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.49 159.74 24.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 84' ' ' ILE . 3.9 m -136.27 138.5 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.301 1.04 . . . . 0.0 109.134 168.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.1 106.72 17.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.054 2.142 . . . . 0.0 105.308 167.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.37 165.96 10.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 107.487 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -157.12 117.33 3.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.92 -92.77 0.11 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 115.246 -3.359 . . . . 0.0 118.234 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.15 69.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 123.881 1.801 . . . . 0.0 107.253 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.415 ' CD1' HG11 ' A' ' 126' ' ' VAL . 21.4 tp -49.85 135.09 20.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.371 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -63.3 138.82 68.38 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 108.169 -1.512 . . . . 0.0 108.169 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.31 -14.82 58.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.462 170.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.15 -23.78 47.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.655 1.582 . . . . 0.0 111.916 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.7 122.73 14.22 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -120.62 153.37 36.91 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.263 1.425 . . . . 0.0 107.232 171.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.13 117.49 17.88 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.613 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 122.21 8.93 6.91 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 116.376 -2.347 . . . . 0.0 115.864 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.598 ' H ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -133.57 167.68 20.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.774 2.787 . . . . 0.0 112.305 -165.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.67 81.92 1.68 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.523 1.535 . . . . 0.0 112.348 -167.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.16 168.93 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.786 0.834 . . . . 0.0 109.916 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.61 115.53 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 171.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -105.31 156.75 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 127.086 2.155 . . . . 0.0 108.557 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -154.57 138.94 16.71 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.593 2.357 . . . . 0.0 106.154 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.96 -112.69 0.52 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 105.936 -2.866 . . . . 0.0 105.936 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -140.9 157.68 45.03 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.432 1.616 . . . . 0.0 109.507 -167.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -91.48 154.71 18.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.953 1.301 . . . . 0.0 109.084 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.4 -79.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.903 0.881 . . . . 0.0 110.675 -171.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.747 ' HE3' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -178.29 169.04 1.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 130.871 3.668 . . . . 0.0 106.325 177.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.39 20.92 52.76 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.455 1.025 . . . . 0.0 113.696 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.497 ' HB3' HG12 ' A' ' 91' ' ' VAL . 29.7 m120 54.64 68.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.121 1.368 . . . . 0.0 112.269 -164.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -131.18 132.56 44.81 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.55 1.14 . . . . 0.0 109.188 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 20.9 mm -105.18 133.49 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 110.285 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.05 109.65 13.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.48 139.19 34.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.83 -18.25 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 111.513 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.31 -43.99 0.46 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 111' ' ' VAL . 58.5 t 53.3 108.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.767 2.027 . . . . 0.0 115.164 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 70.6 mt -124.1 152.38 42.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.74 1.616 . . . . 0.0 107.712 -177.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -114.17 27.68 9.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.92 1.236 . . . . 0.0 110.806 -172.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt . . . . . 0 N--CA 1.472 0.658 0 C-N-CA 126.317 1.847 . . . . 0.0 113.183 -176.42 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.6 mt . . . . . 0 N--CA 1.441 -0.917 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 t80 100.27 140.85 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 1 C-N-CA 134.046 4.939 . . . . 0.0 106.28 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 9.8 m-85 -141.88 175.08 10.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.363 2.265 . . . . 0.0 106.289 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 6.8 p -140.86 170.97 8.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.249 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 9.2 Cg_endo -62.98 -5.97 8.63 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.723 2.949 . . . . 0.0 118.009 -166.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -35.13 5.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 120.424 1.465 . . . . 0.0 110.404 165.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.55 -5.64 59.31 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.462 -1.611 . . . . 0.0 111.342 -158.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.95 -18.1 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.507 1.123 . . . . 0.0 110.769 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -111.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 44' ' ' LEU . 9.4 m-30 -80.28 -32.41 38.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.892 0.877 . . . . 0.0 111.3 -169.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.59 142.0 3.89 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 82.2 tttt . . . . . 0 CA--C 1.51 -0.591 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.535 -175.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 mtp . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 155.41 68.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.276 1.317 . . . . 0.0 110.057 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -81.7 131.03 35.25 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.45 1.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.102 1.761 . . . . 0.0 112.469 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.55 25.57 4.47 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 116.471 -2.294 . . . . 0.0 113.386 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -125.2 175.09 7.64 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.42 2.11 . . . . 0.0 112.861 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -85.7 140.01 30.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.464 1.505 . . . . 0.0 112.621 167.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.77 171.5 18.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.269 1.828 . . . . 0.0 110.223 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -129.33 145.6 51.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.854 1.662 . . . . 0.0 108.282 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.68 132.66 71.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.55 153.15 20.11 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 157.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.48 -175.85 42.36 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 ttm -118.87 125.26 49.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 58.0 t -65.57 124.25 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.242 0.928 . . . . 0.0 108.685 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.6 ttm -59.66 124.23 75.03 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.293 1.037 . . . . 0.0 109.047 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 112.12 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.017 3.145 . . . . 0.0 110.404 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.06 51.86 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.051 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -67.13 -26.26 66.59 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.781 1.79 . . . . 0.0 112.877 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.53 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 123.985 0.914 . . . . 0.0 110.148 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.64 -70.39 0.13 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.105 1.762 . . . . 0.0 109.443 168.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 . . . . . 0 N--CA 1.475 0.776 1 C-N-CA 131.736 4.014 . . . . 0.0 114.057 -164.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 C--O 1.238 0.466 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 140.71 50.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.838 0.855 . . . . 0.0 109.269 172.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.91 145.0 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.7 m -147.1 135.87 22.14 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -147.13 174.58 11.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.491 1.116 . . . . 0.0 108.85 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -121.18 151.47 39.9 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -130.16 140.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -133.32 174.25 10.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.148 1.379 . . . . 0.0 109.388 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.37 -165.67 2.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.593 2.357 . . . . 0.0 104.921 165.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.21 0.26 1.44 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 114.263 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.37 -70.78 0.79 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 120.017 1.281 . . . . 0.0 108.718 -164.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.38 -166.51 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 128.423 2.916 . . . . 0.0 108.188 -170.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.0 p -153.42 159.88 42.47 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.114 -0.639 . . . . 0.0 109.537 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.28 153.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.347 1.459 . . . . 0.0 110.122 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.18 158.26 19.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.889 0.476 . . . . 0.0 109.978 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.414 ' CG2' HD11 ' A' ' 84' ' ' ILE . 44.7 t -141.35 120.62 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.857 1.263 . . . . 0.0 108.388 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -96.83 131.55 43.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 162.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -131.85 167.66 19.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.353 1.861 . . . . 0.0 107.695 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -160.39 104.54 1.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.62 7.01 0.02 OUTLIER Glycine 0 C--O 1.225 -0.449 0 C-N-CA 116.272 -2.87 . . . . 0.0 117.026 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 99' ' ' LEU 0.281 0.4 OUTLIER 58.22 145.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 123.706 1.717 . . . . 0.0 109.66 -156.032 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.578 ' H ' HD13 ' A' ' 98' ' ' ILE . 14.1 mt -98.53 157.01 35.06 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.769 -173.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.02 150.9 84.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.48 -23.03 67.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 111.481 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.32 -20.88 60.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.725 1.61 . . . . 0.0 112.534 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 109' ' ' VAL . 27.3 t80 -72.22 127.04 31.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.308 1.867 . . . . 0.0 108.216 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -135.74 166.42 23.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.489 1.115 . . . . 0.0 109.911 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.85 121.53 25.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.455 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 101.64 17.67 20.76 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 115.609 1.003 . . . . 0.0 115.609 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.78 174.61 7.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.199 1.499 . . . . 0.0 112.378 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.81 105.51 3.29 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.586 1.565 . . . . 0.0 111.288 -167.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.6 m -105.35 171.28 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.434 ' CG2' ' HE3' ' A' ' 129' ' ' LYS . 2.4 t -130.46 97.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 128.031 2.532 . . . . 0.0 104.193 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 126' ' ' VAL . 2.0 t -79.6 154.77 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 108.1 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 9.1 tt0 -151.96 143.24 23.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 127.266 2.226 . . . . 0.0 106.115 168.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.33 -111.07 0.35 Allowed Glycine 0 N--CA 1.434 -1.447 1 N-CA-C 101.341 -4.704 . . . . 0.0 101.341 158.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 21.8 mt-10 -141.56 153.98 45.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 119.561 1.681 . . . . 0.0 109.34 -167.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 60' ' ' LEU . 19.5 tp -84.11 127.03 33.65 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.27 -66.5 0.86 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.51 0.724 . . . . 0.0 110.69 -168.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -150.52 -66.54 0.2 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.45 -86.1 1.53 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.34 51.68 1.76 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -126.72 133.57 50.87 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.313 1.445 . . . . 0.0 107.301 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.65 131.12 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.322 1.449 . . . . 0.0 108.92 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.99 100.84 7.48 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 158.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.5 144.61 46.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.791 0.805 . . . . 0.0 110.177 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -22.78 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.171 2.189 . . . . 0.0 110.78 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -154.19 -7.7 0.15 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 111' ' ' VAL . 32.8 t 26.91 85.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.581 2.352 . . . . 0.0 114.49 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.89 143.1 27.11 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -116.49 50.02 1.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.361 1.064 . . . . 0.0 110.361 -178.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HE3' ' CG2' ' A' ' 110' ' ' VAL . 16.9 mmtp . . . . . 0 N--CA 1.473 0.679 0 C-N-CA 127.074 2.15 . . . . 0.0 115.263 168.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.41 HD22 ' C ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.931 0.872 . . . . 0.0 111.431 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.72 152.2 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.549 3.54 . . . . 0.0 106.057 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.7 173.61 11.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.062 2.145 . . . . 0.0 108.711 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 31.8 p -134.37 171.84 8.34 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 119.347 0.976 . . . . 0.0 112.054 169.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.35 1.59 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.989 3.126 . . . . 0.0 117.306 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.53 -24.98 5.66 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 121.296 1.862 . . . . 0.0 116.552 154.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 39' ' ' THR . 11.0 mm-40 -67.84 -12.92 61.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.789 2.295 . . . . 0.0 112.284 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.842 HG22 HD21 ' A' ' 119' ' ' ASN . 3.0 mt -105.8 -23.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 126.929 2.092 . . . . 0.0 109.553 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 91' ' ' VAL . 6.9 mt -87.4 -54.12 4.46 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.723 -1.235 . . . . 0.0 110.933 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -81.59 -76.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 106.854 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.6 161.42 23.75 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.2 tptp . . . . . 0 C--O 1.223 -0.32 0 CA-C-N 118.248 1.024 . . . . 0.0 108.514 170.498 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.3 mtp . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.25 162.44 33.92 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.127 1.218 . . . . 0.0 110.278 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -79.18 145.33 33.72 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.6 p -86.54 -2.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.056 1.343 . . . . 0.0 112.49 -173.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 71.85 0.48 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 107.164 -2.375 . . . . 0.0 107.164 153.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.93 176.72 8.45 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.752 0.776 . . . . 0.0 109.62 157.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -79.56 138.88 37.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.399 165.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -148.31 166.21 28.71 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.293 0.637 . . . . 0.0 110.328 165.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -99.38 137.42 37.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.455 1.502 . . . . 0.0 108.504 166.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.37 158.38 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.443 1.497 . . . . 0.0 107.435 160.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.76 142.72 11.47 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 154.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.2 -177.25 40.89 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ttm -88.71 118.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.484 0.713 . . . . 0.0 110.257 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.69 128.42 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.622 1.169 . . . . 0.0 109.085 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.4 ttm -70.65 128.53 90.9 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 124.058 0.943 . . . . 0.0 111.091 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.07 113.77 3.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.015 3.143 . . . . 0.0 110.701 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 112.01 12.78 13.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.374 1.94 . . . . 0.0 111.898 -173.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.8 p -112.58 -34.98 5.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 120.135 1.967 . . . . 0.0 111.791 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.83 116.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.047 0.939 . . . . 0.0 110.187 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -120.46 63.82 0.84 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.896 2.478 . . . . 0.0 107.919 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.631 0 O-C-N 121.021 -1.049 . . . . 0.0 109.509 169.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 C--O 1.232 0.135 0 CA-C-O 119.278 -0.391 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 132.36 53.31 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.9 p -152.1 141.4 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.6 m -133.95 148.77 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.94 -177.1 5.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.451 1.5 . . . . 0.0 109.725 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.1 m -127.98 152.93 47.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.55 HD11 HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -126.66 152.49 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.58 174.95 10.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.798 0.808 . . . . 0.0 109.122 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -151.3 -175.19 5.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.405 1.882 . . . . 0.0 107.553 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.73 -13.98 12.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.651 0.78 . . . . 0.0 113.037 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.84 -66.13 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.586 1.554 . . . . 0.0 107.276 -160.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.16 -162.67 11.58 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.096 1.808 . . . . 0.0 111.44 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -141.65 159.16 42.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.26 1.03 . . . . 0.0 113.203 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.578 HG12 HD21 ' A' ' 44' ' ' LEU . 34.7 m -149.16 156.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 111.537 -165.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.1 155.98 22.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.839 0.29 . . . . 0.0 111.235 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 84' ' ' ILE . 57.6 t -139.94 124.51 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.362 1.065 . . . . 0.0 108.971 162.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 p -98.09 145.65 26.34 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.724 1.147 . . . . 0.0 108.386 159.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -139.88 167.72 21.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.734 1.614 . . . . 0.0 107.913 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -154.68 93.32 1.56 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.76 -175.4 44.54 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 118.538 -1.791 . . . . 0.0 114.096 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.14 117.8 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.2 tp -96.08 135.39 22.74 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 117.58 -1.2 . . . . 0.0 108.454 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.27 150.97 46.46 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.002 1.801 . . . . 0.0 111.686 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.96 -33.88 77.08 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.958 -0.464 . . . . 0.0 110.157 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.491 HD12 ' H ' ' A' ' 102' ' ' LEU . 6.1 mp -61.3 -40.26 93.52 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 109' ' ' VAL . 22.2 t80 -54.47 125.34 19.17 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.93 1.292 . . . . 0.0 109.567 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 157.09 45.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 25.6 mt-10 -64.78 118.27 8.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.723 167.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.68 57.62 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.916 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.41 166.62 10.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.552 1.676 . . . . 0.0 109.765 162.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.3 138.46 20.53 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 124.57 1.081 . . . . 0.0 110.873 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -130.72 166.97 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.431 1.892 . . . . 0.0 108.463 173.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.16 131.4 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 127.167 2.187 . . . . 0.0 105.121 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 93' ' ' VAL . 1.4 t -115.96 158.37 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 125.481 1.512 . . . . 0.0 106.939 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -154.37 143.26 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.87 2.068 . . . . 0.0 105.616 176.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.79 -98.37 0.13 Allowed Glycine 0 CA--C 1.508 -0.362 0 CA-C-O 116.475 -2.291 . . . . 0.0 108.701 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.7 154.71 49.62 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.962 1.881 . . . . 0.0 108.946 169.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.566 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -71.13 134.25 46.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -80.79 -70.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 6.3 mtpp 172.86 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.059 3.343 . . . . 0.0 108.612 -167.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -83.81 57.66 5.04 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.887 -168.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.842 HD21 HG22 ' A' ' 43' ' ' ILE . 2.0 t-20 27.45 67.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.108 2.163 . . . . 0.0 113.269 -160.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -134.48 124.08 25.01 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -172.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 60' ' ' LEU . 13.6 mm -93.47 129.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 170.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.54 107.23 11.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 160.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.36 141.93 41.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.134 0.968 . . . . 0.0 109.353 172.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 -15.68 14.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.867 2.067 . . . . 0.0 109.805 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.37 -49.44 0.27 Allowed 'General case' 0 C--N 1.349 0.552 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 111' ' ' VAL . 93.8 t 62.88 135.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.115 2.566 . . . . 0.0 112.091 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.7 mt -153.46 160.87 42.67 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -167.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -119.16 54.7 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 121.505 1.957 . . . . 0.0 112.625 -163.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt . . . . . 0 N--CA 1.492 1.666 0 C-N-CA 126.296 1.839 . . . . 0.0 115.792 178.752 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 38' ' ' TYR . 2.1 pp . . . . . 0 C--O 1.234 0.245 0 CA-C-O 122.268 1.032 . . . . 0.0 109.381 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -169.76 149.66 3.83 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.822 2.849 . . . . 0.0 106.077 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.616 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 86.4 m-85 -138.42 179.45 6.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.217 1.807 . . . . 0.0 109.587 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.54 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 71.3 p -131.49 170.31 11.6 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.241 1.017 . . . . 0.0 110.775 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -62.66 65.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.895 3.73 . . . . 0.0 110.815 161.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . 167.52 -62.88 0.2 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -158.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 39' ' ' THR . 28.4 mt-10 -65.66 -21.79 66.58 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.865 1.333 . . . . 0.0 111.9 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.32 -13.97 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 111.17 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 mt -115.41 -42.67 3.13 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.162 -0.961 . . . . 0.0 111.856 -164.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -107.71 -46.37 3.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 109.504 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.57 144.13 3.9 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.616 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 14.3 tptp . . . . . 0 CA--C 1.514 -0.417 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 168.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.1 mtp . . . . . 0 CA--C 1.541 0.633 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.66 162.63 40.74 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.307 1.145 . . . . 0.0 110.837 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.37 144.12 34.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.148 1.379 . . . . 0.0 108.197 166.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.67 0.85 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.879 1.323 . . . . 0.0 110.968 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.3 11.25 24.15 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 116.462 -2.299 . . . . 0.0 114.425 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -127.15 169.58 13.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.487 2.643 . . . . 0.0 111.715 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -82.97 150.35 26.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.383 162.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.12 -172.46 4.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.858 2.063 . . . . 0.0 108.749 171.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.05 48.87 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.517 1.127 . . . . 0.0 108.379 170.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.3 t -123.68 145.61 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.641 1.576 . . . . 0.0 107.439 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.18 124.23 5.67 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 165.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.7 164.09 33.94 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 117.693 0.746 . . . . 0.0 112.189 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 ttm -95.67 122.46 38.46 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.6 1.16 . . . . 0.0 110.286 -172.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -70.66 132.41 33.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.676 1.125 . . . . 0.0 110.131 -172.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.8 mtt -60.93 151.89 72.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.902 0.881 . . . . 0.0 110.995 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.98 106.54 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 124.186 3.258 . . . . 0.0 109.409 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.55 36.49 91.51 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.396 -1.224 . . . . 0.0 113.241 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.8 p -80.72 -15.75 55.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.334 1.567 . . . . 0.0 111.887 162.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -82.16 96.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.571 1.148 . . . . 0.0 110.057 -168.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 78.6 7.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.681 1.592 . . . . 0.0 107.44 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.571 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 160.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? . . . . . 0 N--CA 1.463 0.197 0 CA-C-O 118.634 -0.698 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.1 129.2 33.78 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 164.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 95' ' ' TYR . 3.2 p -142.52 143.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 35.8 m -140.99 133.57 28.61 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.5 p90 -143.33 173.61 11.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.685 -1.259 . . . . 0.0 111.031 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.5 m -128.37 136.89 51.55 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.46 146.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.888 2.075 . . . . 0.0 106.035 -176.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -134.44 176.94 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.828 1.251 . . . . 0.0 109.505 -176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.11 -168.71 3.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.967 1.307 . . . . 0.0 107.563 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 2.72 0.07 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.553 2.341 . . . . 0.0 113.722 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -126.7 -74.2 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.133 1.373 . . . . 0.0 107.76 -164.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.88 -157.44 7.29 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.369 -0.693 . . . . 0.0 111.369 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -138.57 161.18 37.74 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.202 1.001 . . . . 0.0 111.9 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.13 149.55 16.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -96.04 152.98 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 2.9 m -133.13 134.13 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -118.23 109.52 16.45 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.898 2.079 . . . . 0.0 107.355 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.9 t80 -115.49 171.2 7.87 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.997 1.719 . . . . 0.0 107.897 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.55 96.69 1.54 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.81 178.8 42.38 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 tp -79.6 125.48 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' HG11 ' A' ' 126' ' ' VAL . 34.0 mt -75.85 149.79 83.29 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.252 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.49 146.32 89.18 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.593 2.195 . . . . 0.0 108.647 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.12 -24.23 67.02 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.104 -0.997 . . . . 0.0 111.597 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -19.52 60.87 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.759 2.423 . . . . 0.0 111.973 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -68.37 123.83 21.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.333 1.053 . . . . 0.0 110.599 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -136.5 140.73 43.23 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -66.76 113.85 5.18 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.699 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 109.75 21.95 6.89 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 116.741 -2.144 . . . . 0.0 113.436 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.81 165.12 25.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.161 1.98 . . . . 0.0 111.308 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.53 1.55 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.518 1.532 . . . . 0.0 110.739 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.49 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 108.877 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.36 139.32 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 126' ' ' VAL . 2.5 t -120.26 157.44 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.868 2.067 . . . . 0.0 107.505 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.98 146.51 25.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.893 2.477 . . . . 0.0 107.366 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 145.26 -131.44 4.23 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 104.447 -3.461 . . . . 0.0 104.447 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -140.84 158.33 44.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.096 1.948 . . . . 0.0 110.841 -157.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.57 ' HB2' HD11 ' A' ' 60' ' ' LEU . 15.9 tp -90.75 128.78 36.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.771 0.828 . . . . 0.0 110.259 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.53 -66.75 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 109.85 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.14 158.99 17.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 128.859 2.864 . . . . 0.0 106.42 171.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.11 -99.21 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 124.34 0.971 . . . . 0.0 111.132 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.4 23.07 3.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.682 1.193 . . . . 0.0 110.815 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -92.03 128.03 37.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.2 mm -101.51 130.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 125.343 1.457 . . . . 0.0 109.722 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.18 119.88 22.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 155.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.59 132.86 33.92 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.933 1.293 . . . . 0.0 108.789 171.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.27 -25.36 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.831 1.653 . . . . 0.0 111.693 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.67 -41.75 0.32 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 99' ' ' LEU . 20.0 t 62.98 139.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 124.654 2.168 . . . . 0.0 112.432 -172.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -140.32 157.53 45.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.719 2.008 . . . . 0.0 106.181 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.33 42.06 3.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 109.334 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? . . . . . 0 N--CA 1.469 0.493 0 C-N-CA 127.75 2.42 . . . . 0.0 114.531 -179.823 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 12.0 tp . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 118.037 -0.982 . . . . 0.0 108.631 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -125.42 171.44 10.46 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.028 1.285 . . . . 0.0 110.763 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.8 m 139.97 161.67 0.0 OUTLIER 'General case' 0 C--O 1.235 0.326 1 C-N-CA 134.043 4.937 . . . . 0.0 109.423 168.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.7 m120 61.81 177.66 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.432 2.293 . . . . 0.0 112.398 177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 21.0 mt -93.2 152.48 3.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 170.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 52.36 -161.73 0.1 Allowed 'General case' 0 C--O 1.239 0.51 0 C-N-CA 126.308 1.843 . . . . 0.0 111.12 -172.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.445 HD11 ' HA ' ' A' ' 60' ' ' LEU . 1.1 pp -106.0 -173.32 2.27 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 170.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -165.24 156.25 14.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' C ' HG23 ' A' ' 62' ' ' VAL . 87.9 m-85 -137.85 -167.26 2.11 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.948 0.795 . . . . 0.0 109.291 170.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.446 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -140.93 170.94 8.37 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 125.796 1.638 . . . . 0.0 109.361 168.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -64.63 -4.13 7.88 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.166 2.577 . . . . 0.0 115.581 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.05 -46.31 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 161.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' HB2' ' H ' ' A' ' 39' ' ' THR . 50.9 mt-10 -76.83 -20.27 56.54 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 120.499 -1.589 . . . . 0.0 113.331 -160.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.439 HD12 HD11 ' A' ' 121' ' ' ILE . 3.7 mt -73.04 -13.47 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 O-C-N 121.575 -0.703 . . . . 0.0 111.462 174.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -118.27 -47.39 2.56 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.66 0.784 . . . . 0.0 109.446 -173.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -90.08 -36.85 14.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.12 0.968 . . . . 0.0 111.07 -168.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.67 144.77 4.22 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.801 1.667 . . . . 0.0 111.014 179.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -76.79 137.55 39.33 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 120.0 -1.882 . . . . 0.0 111.43 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 49.8 mtp85 -19.05 -19.74 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.327 1 C-N-CA 131.758 4.023 . . . . 0.0 120.579 -135.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -121.36 -75.09 0.59 Allowed 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 159.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.5 t -164.94 31.07 0.06 Allowed 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.154 0.982 . . . . 0.0 109.434 -170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -60.92 -35.53 76.94 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.392 -0.817 . . . . 0.0 112.589 -164.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 176.23 175.97 0.29 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 130.702 3.601 . . . . 0.0 106.429 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 24.3 mtp -116.09 151.06 46.18 Favored Pre-proline 0 C--O 1.24 0.586 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 159.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.14 165.62 27.83 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 121.789 1.659 . . . . 0.0 111.493 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.3 136.05 36.91 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 127.099 2.16 . . . . 0.0 109.358 172.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HA ' ' HB3' ' A' ' 115' ' ' LEU . 10.0 t -64.17 -14.36 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.073 164.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.93 4.18 71.34 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 116.06 -2.522 . . . . 0.0 114.901 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -117.82 168.41 10.51 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 123.15 3.475 . . . . 0.0 112.645 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.52 147.32 22.99 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.206 1.002 . . . . 0.0 111.433 164.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -158.09 176.19 12.83 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 128.288 2.635 . . . . 0.0 110.06 -173.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 26.0 ttt85 -131.26 142.47 50.15 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.91 2.084 . . . . 0.0 109.073 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 38' ' ' TYR . 3.2 p -152.52 124.19 1.02 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.582 0 N-CA-C 117.498 2.407 . . . . 0.0 117.498 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -76.63 150.83 38.71 Favored Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.631 -0.987 . . . . 0.0 110.631 169.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.2 166.86 37.73 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.081 1.801 . . . . 0.0 110.285 171.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 25.4 ttm -95.38 125.32 39.92 Favored 'General case' 0 C--O 1.222 -0.344 0 C-N-CA 125.124 1.37 . . . . 0.0 108.665 178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.2 t -66.69 124.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-N 119.498 1.045 . . . . 0.0 108.494 -175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 31.9 mtt -60.06 139.51 90.96 Favored Pre-proline 0 C--O 1.239 0.537 0 CA-C-N 119.381 0.992 . . . . 0.0 110.667 171.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -63.6 146.03 92.19 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 123.751 2.968 . . . . 0.0 109.562 173.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.39 -22.93 0.49 Allowed Glycine 0 CA--C 1.532 1.139 0 CA-C-O 118.416 -1.213 . . . . 0.0 114.328 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -61.13 -38.65 87.13 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.812 1.806 . . . . 0.0 112.106 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -61.73 94.31 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 125.661 1.584 . . . . 0.0 109.301 -178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -84.2 144.08 29.19 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 158.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -130.65 151.19 51.37 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 167.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.04 139.94 93.22 Favored Pre-proline 0 C--N 1.329 -0.289 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -176.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.66 -16.65 38.07 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 120.952 1.101 . . . . 0.0 111.884 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 32.6 m-20 -127.52 -0.07 6.22 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.788 1.635 . . . . 0.0 110.709 -171.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.4 165.4 32.19 Favored 'General case' 0 N--CA 1.457 -0.088 0 CA-C-N 119.069 0.85 . . . . 0.0 110.843 -172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.8 mp -86.3 3.77 41.93 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.323 1.449 . . . . 0.0 111.328 -175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -54.61 143.53 24.42 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 123.787 0.835 . . . . 0.0 108.817 170.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.24 155.63 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 C-N-CA 125.155 1.382 . . . . 0.0 107.518 172.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -137.72 120.85 16.76 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 161.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -134.91 170.26 16.15 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.882 0.873 . . . . 0.0 110.71 172.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.5 m -117.83 145.8 44.31 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.92 139.47 51.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -135.11 175.6 9.43 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 125.557 1.543 . . . . 0.0 108.803 -175.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -149.42 -169.83 3.48 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 163.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.34 6.65 0.05 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.45 -68.91 0.88 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.873 1.669 . . . . 0.0 109.527 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.33 -168.1 12.76 Favored Glycine 0 C--N 1.338 0.675 0 C-N-CA 125.219 1.39 . . . . 0.0 110.401 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.6 p -142.95 160.83 39.6 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 117.664 0.732 . . . . 0.0 112.684 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -136.44 154.3 32.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 C-N-CA 127.294 2.238 . . . . 0.0 108.159 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -94.17 158.73 15.47 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.8 t -138.63 119.79 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 125.404 1.482 . . . . 0.0 108.072 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 11.7 m -88.06 128.52 35.41 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 154.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -125.05 161.95 25.64 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 105.631 -1.989 . . . . 0.0 105.631 160.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -146.58 112.05 5.55 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 150.07 -159.86 28.28 Favored Glycine 0 CA--C 1.507 -0.453 0 C-N-CA 119.641 -1.266 . . . . 0.0 112.882 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 98' ' ' ILE . 10.8 tp -80.57 111.01 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 -170.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 19.2 tp -85.64 148.24 48.46 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 114.205 -1.362 . . . . 0.0 107.832 -169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -54.96 131.93 49.25 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 N-CA-C 108.021 -1.569 . . . . 0.0 108.021 174.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.89 -17.31 63.34 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.201 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.9 mp -76.49 -25.22 54.01 Favored 'General case' 0 C--N 1.342 0.278 0 C-N-CA 125.562 1.545 . . . . 0.0 113.796 168.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -51.91 121.87 7.38 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 120.385 1.448 . . . . 0.0 111.797 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 23.2 mmt180 -135.78 157.48 46.75 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 123.195 1.474 . . . . 0.0 112.256 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.3 mp0 -71.62 95.96 1.51 Allowed 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 128.184 2.594 . . . . 0.0 107.622 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 103.65 33.81 4.02 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 113.326 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.18 164.03 17.55 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 120.125 1.963 . . . . 0.0 110.357 164.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -89.07 83.62 1.44 Allowed Glycine 0 C--N 1.334 0.455 0 C-N-CA 125.774 1.654 . . . . 0.0 109.401 -172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.1 m -79.6 -179.6 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 C-N-CA 124.705 1.202 . . . . 0.0 109.014 -176.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.424 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.1 t -126.89 135.75 62.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 127.314 2.246 . . . . 0.0 105.577 167.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 123' ' ' ALA . 0.6 OUTLIER -104.68 163.18 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 169.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -161.22 144.78 12.96 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 164.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 153.01 -133.06 3.88 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 103.387 -3.885 . . . . 0.0 103.387 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -133.97 153.31 51.86 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 120.056 1.928 . . . . 0.0 110.211 -159.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HB3' ' HA ' ' A' ' 56' ' ' VAL . 0.2 OUTLIER -73.98 131.48 41.44 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.065 -0.971 . . . . 0.0 108.62 -178.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -86.65 -62.53 1.49 Allowed 'General case' 0 CA--C 1.52 -0.177 0 C-N-CA 123.119 0.568 . . . . 0.0 109.683 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.84 -72.34 0.17 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -103.87 -74.44 0.99 Allowed Glycine 0 C--N 1.332 0.342 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -175.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -137.34 44.93 2.24 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.549 1.14 . . . . 0.0 107.997 -177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 -128.54 135.99 50.15 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.439 HD11 HD12 ' A' ' 43' ' ' ILE . 4.2 mm -111.0 130.15 64.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 127.327 2.251 . . . . 0.0 109.148 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -79.27 90.43 4.95 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.368 -2.456 . . . . 0.0 104.368 156.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HB2' HG22 ' A' ' 111' ' ' VAL . . . -53.8 150.2 7.76 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.925 0.869 . . . . 0.0 111.174 161.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.89 -12.14 8.45 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.779 2.832 . . . . 0.0 111.514 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -146.05 -45.72 0.2 Allowed 'General case' 0 C--N 1.344 0.336 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 78.1 t 58.97 133.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.584 1.954 . . . . 0.0 111.456 -171.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.1 mt -136.84 150.74 48.48 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 120.184 -1.572 . . . . 0.0 107.9 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -110.26 29.09 8.0 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.464 0.706 . . . . 0.0 111.798 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 28.0 mmtt 46.59 31.6 1.41 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.865 1.266 . . . . 0.0 113.785 -174.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.481 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 0.2 OUTLIER -71.64 41.61 0.08 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 129.453 3.101 . . . . 0.0 109.755 167.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.7 t0 67.69 -65.82 0.23 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 128.363 2.665 . . . . 0.0 112.076 -175.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 65.47 154.19 0.07 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 128.37 2.668 . . . . 0.0 111.799 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -147.1 -50.17 0.19 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 118.29 -0.862 . . . . 0.0 111.163 -172.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 11.9 t80 66.63 109.26 0.04 OUTLIER 'General case' 0 C--O 1.235 0.302 0 C-N-CA 128.269 2.628 . . . . 0.0 110.898 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 60.9 m -78.93 129.09 74.43 Favored Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 174.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.39 177.25 6.9 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 123.395 2.73 . . . . 0.0 111.924 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -65.28 -44.43 9.17 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.445 2.097 . . . . 0.0 113.844 174.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -78.03 60.49 2.4 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.942 0.897 . . . . 0.0 109.944 -166.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.4 p -165.2 -53.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 C-N-CA 126.199 1.8 . . . . 0.0 106.871 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -67.39 -56.87 7.93 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.856 0.862 . . . . 0.0 110.317 -167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.5 tmtt? -148.89 20.79 1.0 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.415 1.086 . . . . 0.0 110.34 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.45 29.65 3.27 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.017 1.327 . . . . 0.0 111.681 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 C--O 1.254 1.317 0 N-CA-C 104.145 -2.539 . . . . 0.0 104.145 147.885 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.2 tt . . . . . 0 N--CA 1.467 0.409 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 52.7 ptt85 -146.01 158.52 43.87 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 168.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 5.0 t -155.74 94.33 1.55 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -176.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -145.54 -56.47 0.31 Allowed 'General case' 0 N--CA 1.461 0.117 0 O-C-N 121.638 -0.664 . . . . 0.0 112.456 -174.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 40.1 mt -65.56 152.59 8.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -37.23 151.66 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 128.301 2.64 . . . . 0.0 112.935 173.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.7 pp -71.07 -178.63 2.04 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 122.906 1.336 . . . . 0.0 109.684 161.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 39.2 t80 -160.99 146.36 14.28 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.434 ' CE1' HD13 ' A' ' 36' ' ' LEU . 70.7 m-85 -139.42 -176.49 4.56 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.055 0.942 . . . . 0.0 110.798 172.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -137.78 172.69 6.37 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -176.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.78 -9.78 17.54 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.766 2.311 . . . . 0.0 116.19 170.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.8 -40.87 3.47 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 121.001 1.728 . . . . 0.0 112.646 165.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.53 -15.51 56.51 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 119.316 1.558 . . . . 0.0 112.278 -158.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 mt -82.4 -22.82 9.28 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 126.146 1.779 . . . . 0.0 110.896 173.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -91.11 -56.87 3.0 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 119.864 1.211 . . . . 0.0 109.784 176.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -75.25 -64.78 0.99 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.328 1.851 . . . . 0.0 108.255 -171.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.36 151.92 6.37 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.413 ' HB3' ' H ' ' A' ' 51' ' ' GLN . 1.2 tttt -54.26 152.28 6.43 Favored 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 117.223 0.511 . . . . 0.0 110.005 176.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -42.7 -16.0 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 120.913 3.672 . . . . 0.0 120.913 -170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.536 ' H ' HE22 ' A' ' 51' ' ' GLN . 0.1 OUTLIER -122.67 -63.02 1.31 Allowed 'General case' 0 N--CA 1.455 -0.218 0 O-C-N 119.539 -1.975 . . . . 0.0 109.611 156.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.5 t -170.07 21.56 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.826 1.651 . . . . 0.0 111.142 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.536 HE22 ' H ' ' A' ' 49' ' ' GLU . 0.8 OUTLIER -58.53 -55.01 40.5 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 119.71 -1.869 . . . . 0.0 111.59 -156.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.82 168.63 0.19 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 128.912 2.885 . . . . 0.0 107.922 178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.99 156.37 35.31 Favored Pre-proline 0 C--N 1.322 -0.621 0 C-N-CA 125.34 1.456 . . . . 0.0 109.63 175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -74.99 159.27 41.61 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 121.924 1.749 . . . . 0.0 111.52 172.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.39 155.33 28.43 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.15 2.18 . . . . 0.0 108.983 167.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 46.4 t -86.9 -8.44 11.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 124.824 1.25 . . . . 0.0 110.899 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.03 38.07 2.09 Favored Glycine 0 CA--C 1.518 0.266 0 C-N-CA 125.955 1.74 . . . . 0.0 109.654 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -121.87 164.79 16.94 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.663 0.744 . . . . 0.0 109.509 171.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -86.22 149.91 24.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.299 172.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -163.96 164.05 23.32 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.831 0.852 . . . . 0.0 111.774 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.7 ttm180 -122.23 99.84 6.64 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 127.736 2.414 . . . . 0.0 110.785 -175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.0 t -80.23 159.63 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 120.619 -1.301 . . . . 0.0 110.292 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -147.62 152.11 24.27 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.278 -0.889 . . . . 0.0 111.789 148.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.26 -178.52 45.18 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 125.998 1.761 . . . . 0.0 110.395 -173.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.0 ttm -100.83 127.43 47.28 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 117.935 0.867 . . . . 0.0 111.579 -168.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.6 t -65.73 125.88 23.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.2 mtt -57.04 151.1 36.25 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 118.484 0.584 . . . . 0.0 110.999 169.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.5 122.29 9.92 Favored 'Trans proline' 0 N--CA 1.448 -1.165 0 C-N-CA 123.418 2.745 . . . . 0.0 108.077 176.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.7 4.85 48.61 Favored Glycine 0 CA--C 1.527 0.821 0 CA-C-O 117.872 -1.516 . . . . 0.0 115.538 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 79.9 p -64.68 -24.9 67.72 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 120.339 2.07 . . . . 0.0 110.962 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.0 t -59.68 105.78 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 125.588 1.555 . . . . 0.0 109.412 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.438 ' HB3' ' H ' ' A' ' 81' ' ' THR . 26.1 tt0 -60.22 -65.34 0.7 Allowed 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 126.606 1.963 . . . . 0.0 108.901 171.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 42.67 129.25 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 131.31 3.844 . . . . 0.0 115.759 -172.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -80.44 118.91 74.62 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -71.31 -8.13 22.76 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.558 1.506 . . . . 0.0 111.893 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -130.16 7.22 5.02 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.261 1.425 . . . . 0.0 111.126 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -139.11 -166.89 2.12 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 172.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.3 mp -112.14 -4.92 14.29 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.245 1.018 . . . . 0.0 110.879 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -56.86 142.98 39.13 Favored 'General case' 0 N--CA 1.449 -0.481 0 O-C-N 121.013 -1.054 . . . . 0.0 109.489 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.433 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.1 p -156.45 144.05 11.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.438 ' H ' ' HB3' ' A' ' 72' ' ' GLN . 30.0 p -121.81 151.3 40.76 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.29 -1.745 . . . . 0.0 106.29 165.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -146.4 178.09 8.53 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 123.786 0.834 . . . . 0.0 109.054 169.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 45.8 m -125.86 138.47 53.81 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 171.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.27 144.0 27.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 126.807 2.043 . . . . 0.0 106.694 176.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -140.45 171.05 14.68 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.091 1.357 . . . . 0.0 110.357 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -147.54 -164.6 2.04 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.961 1.304 . . . . 0.0 109.077 173.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.78 -4.37 6.49 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.328 1.232 . . . . 0.0 114.328 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -112.84 -80.84 0.59 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -170.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -139.09 -156.11 6.88 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 124.575 1.083 . . . . 0.0 111.897 -171.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.4 p -150.08 165.28 33.26 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 117.368 0.584 . . . . 0.0 111.688 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.7 m -137.49 138.31 44.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 C-N-CA 126.041 1.736 . . . . 0.0 108.639 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -74.61 151.44 39.37 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.58 127.31 36.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 124.666 1.186 . . . . 0.0 109.772 174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.538 ' OG ' HD13 ' A' ' 122' ' ' LEU . 2.1 p -97.47 135.53 39.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.015 1.326 . . . . 0.0 109.126 164.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 80' ' ' VAL . 32.1 t80 -142.09 169.65 17.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.928 1.691 . . . . 0.0 108.679 171.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -150.56 105.87 3.36 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.06 -165.32 36.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 121.12 -0.562 . . . . 0.0 111.724 174.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -83.54 -19.47 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 122.881 0.472 . . . . 0.0 112.187 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.8 mt 67.13 151.87 0.12 Allowed Pre-proline 0 CA--C 1.527 0.088 0 C-N-CA 129.237 3.015 . . . . 0.0 112.177 -165.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -62.93 139.51 74.24 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 121.536 1.491 . . . . 0.0 108.25 168.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -66.78 -13.04 60.99 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 122.027 0.918 . . . . 0.0 110.333 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.1 mp -77.31 -25.41 51.19 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 119.662 -1.899 . . . . 0.0 112.411 173.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -64.17 128.23 34.92 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.204 1.802 . . . . 0.0 112.238 -178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -139.07 170.29 16.24 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.954 1.301 . . . . 0.0 110.021 175.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.08 80.07 2.25 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.71 1.204 . . . . 0.0 108.866 -169.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 32.1 0.47 Allowed Glycine 0 CA--C 1.528 0.857 0 C-N-CA 124.449 1.023 . . . . 0.0 112.068 -170.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.31 166.79 21.99 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.931 1.366 . . . . 0.0 110.869 171.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.31 121.37 5.44 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 126.488 1.994 . . . . 0.0 110.316 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.9 m -120.69 170.23 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 125.179 1.392 . . . . 0.0 108.541 -177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 t -128.77 100.67 5.9 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 C-N-CA 126.636 1.974 . . . . 0.0 107.898 173.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -79.67 159.66 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 168.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -155.15 137.97 15.33 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 175.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.02 -105.77 0.23 Allowed Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 173.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 14.2 tt0 -150.51 157.91 43.55 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 119.459 1.63 . . . . 0.0 108.941 -174.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.559 ' HB2' HD21 ' A' ' 60' ' ' LEU . 12.6 tp -80.55 146.4 31.3 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.318 175.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -103.44 -64.09 1.12 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 118.825 0.739 . . . . 0.0 111.05 175.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 117' ' ' LYS . 0.0 OUTLIER 167.05 158.41 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 129.699 3.199 . . . . 0.0 106.692 -168.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.54 22.53 46.06 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 118.945 -0.919 . . . . 0.0 114.036 166.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.3 m120 73.52 29.32 1.6 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.386 1.875 . . . . 0.0 112.702 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.2 t-160 -96.09 132.0 41.93 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.833 1.653 . . . . 0.0 109.018 172.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 11.7 mm -99.76 129.37 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.094 0 C-N-CA 126.306 1.842 . . . . 0.0 109.599 172.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.538 HD13 ' OG ' ' A' ' 94' ' ' SER . 3.5 mm? -79.03 114.41 17.95 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 157.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -68.42 160.33 29.85 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-O 123.009 1.385 . . . . 0.0 109.357 162.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.93 -26.29 5.22 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.503 -1.681 . . . . 0.0 110.496 167.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -139.61 -41.48 0.45 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 111' ' ' VAL . 87.7 t 59.28 127.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 126.183 1.793 . . . . 0.0 111.878 -173.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 22.1 mt -135.72 157.97 45.55 Favored 'General case' 0 CA--C 1.512 -0.483 0 O-C-N 120.648 -1.282 . . . . 0.0 108.052 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.58 37.35 4.37 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 124.954 1.302 . . . . 0.0 110.124 -174.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.53 ' HA ' ' HE2' ' A' ' 129' ' ' LYS . 1.4 mmpm? 47.06 57.41 5.74 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.157 1.383 . . . . 0.0 112.512 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.404 ' CD2' ' N ' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -76.78 -91.9 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -162.81 45.39 0.13 Allowed 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.05 0.929 . . . . 0.0 108.947 -174.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -90.9 112.63 24.56 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 106.514 -1.661 . . . . 0.0 106.514 171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -124.5 31.38 5.75 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.924 1.29 . . . . 0.0 109.063 175.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -152.38 162.52 41.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.875 1.27 . . . . 0.0 108.045 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 7.5 m -129.42 112.41 18.01 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 105.953 -1.869 . . . . 0.0 105.953 168.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -64.33 141.33 74.46 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.909 1.74 . . . . 0.0 110.983 -174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -64.36 -57.2 0.34 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.463 2.109 . . . . 0.0 113.285 -157.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -72.52 7.13 1.99 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.385 1.474 . . . . 0.0 112.47 -167.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.45 -17.67 6.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 127.949 2.499 . . . . 0.0 108.853 -165.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -59.85 -40.3 88.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.89 1.276 . . . . 0.0 109.839 172.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -98.61 113.67 25.82 Favored 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -52.59 124.77 14.52 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.463 0.477 . . . . 0.0 110.185 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 14.0 ptt? . . . . . 0 C--O 1.256 1.411 0 C-N-CA 126.725 2.01 . . . . 0.0 108.953 179.504 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.475 0.798 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.7 ttm105 -149.98 -42.73 0.13 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 120.411 1.459 . . . . 0.0 113.332 168.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.5 m 65.75 -65.41 0.18 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 125.79 1.636 . . . . 0.0 114.812 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 61.72 135.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.976 1.71 . . . . 0.0 110.193 -151.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . 0.263 55.9 mt 61.11 165.72 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 126.693 1.997 . . . . 0.0 110.341 -172.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -71.16 173.12 8.06 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.19 1.396 . . . . 0.0 110.156 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' A' ' 60' ' ' LEU . 3.0 pp -71.2 -175.9 1.32 Allowed 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.252 1.821 . . . . 0.0 111.892 176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.47 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 40.4 t80 -171.19 158.29 5.42 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 129.591 3.156 . . . . 0.0 107.101 173.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -147.67 -178.9 6.51 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 126.629 1.972 . . . . 0.0 110.247 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.4 p -134.38 163.35 51.83 Favored Pre-proline 0 C--O 1.242 0.676 0 C-N-CA 125.16 1.384 . . . . 0.0 111.682 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HB3' HG22 ' A' ' 91' ' ' VAL . 67.0 Cg_endo -76.07 71.63 5.59 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 124.602 3.534 . . . . 0.0 108.576 173.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.52 -66.78 0.15 Allowed Glycine 0 N--CA 1.432 -1.582 0 N-CA-C 105.44 -3.064 . . . . 0.0 105.44 -163.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -59.47 -33.5 71.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 119.131 1.465 . . . . 0.0 111.984 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.6 mt -69.45 -11.71 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 C-N-CA 124.354 1.061 . . . . 0.0 112.458 178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.65 -31.51 3.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.825 1.193 . . . . 0.0 111.646 -174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -98.09 -18.59 18.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.556 1.942 . . . . 0.0 112.218 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.7 147.69 16.99 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.869 1.223 . . . . 0.0 110.403 -169.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 20.0 tptp -62.59 139.33 58.62 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 116.359 -1.781 . . . . 0.0 109.987 -178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.6 mtm-85 -18.18 -77.27 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.752 1.621 . . . . 0.0 113.972 -152.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -66.4 -87.27 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 172.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 15.3 t -174.38 36.92 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.454 1.121 . . . . 0.0 108.541 -169.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.9 -41.63 42.89 Favored 'General case' 0 N--CA 1.448 -0.572 0 O-C-N 119.443 -2.035 . . . . 0.0 109.444 -167.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . 0.269 0.1 OUTLIER -174.42 -173.31 0.75 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 127.511 2.324 . . . . 0.0 111.461 161.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.2 mtp -126.5 162.77 44.72 Favored Pre-proline 0 N--CA 1.479 0.982 0 C-N-CA 125.819 1.648 . . . . 0.0 109.983 168.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -84.96 155.94 11.43 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.79 2.327 . . . . 0.0 111.918 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -81.58 144.35 31.32 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.254 1.422 . . . . 0.0 111.523 175.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HA ' HD13 ' A' ' 115' ' ' LEU . 3.5 p -63.35 -20.82 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 126.13 1.772 . . . . 0.0 113.001 170.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.41 59.85 0.37 Allowed Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 108.215 -1.954 . . . . 0.0 108.215 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -144.88 176.61 9.34 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 119.041 1.42 . . . . 0.0 112.328 157.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.36 149.96 26.39 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.454 167.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.464 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -160.39 163.88 32.81 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.157 1.383 . . . . 0.0 113.262 166.556 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 66.8 mtm180 -101.53 140.77 35.38 Favored 'General case' 0 CA--C 1.52 -0.194 0 C-N-CA 126.549 1.94 . . . . 0.0 109.164 171.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -126.73 139.89 50.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 125.098 1.359 . . . . 0.0 108.251 170.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.44 137.25 12.01 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 163.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -156.64 -163.28 12.2 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 125.971 1.748 . . . . 0.0 109.364 -176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 9.3 ttm -126.71 127.53 45.26 Favored 'General case' 0 C--O 1.224 -0.256 0 C-N-CA 126.525 1.93 . . . . 0.0 109.525 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.478 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 21.9 t -65.54 130.07 30.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -175.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 57.0 mtt -65.06 124.48 86.88 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 170.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.78 103.8 0.9 Allowed 'Trans proline' 0 N--CA 1.448 -1.184 0 C-N-CA 123.775 2.983 . . . . 0.0 106.649 171.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.49 -5.39 8.67 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-O 118.246 -1.308 . . . . 0.0 112.632 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 80.6 p -88.81 -44.19 10.69 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 119.467 1.634 . . . . 0.0 111.949 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 10.5 t -57.89 104.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.508 1.123 . . . . 0.0 110.951 -167.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -66.46 -66.22 0.58 Allowed 'General case' 0 C--O 1.234 0.257 0 C-N-CA 125.773 1.629 . . . . 0.0 109.954 173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 54.2 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.8 2.04 . . . . 0.0 112.048 -153.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -110.15 136.92 20.45 Favored Pre-proline 0 C--O 1.237 0.434 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -84.57 -9.48 9.09 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 CA-C-N 121.027 1.403 . . . . 0.0 112.96 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -110.28 -19.18 13.09 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-N 119.147 0.885 . . . . 0.0 110.914 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 50.2 m -131.97 176.3 8.48 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 118.777 0.717 . . . . 0.0 109.167 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.37 4.82 53.36 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.266 -0.896 . . . . 0.0 111.095 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -66.58 145.14 55.93 Favored 'General case' 0 CA--C 1.522 -0.131 0 O-C-N 121.233 -0.917 . . . . 0.0 108.974 176.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.8 p -157.81 132.17 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 34.4 p -130.98 109.45 10.53 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.768 1.627 . . . . 0.0 108.455 -172.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.691 ' CE1' HG21 ' A' ' 93' ' ' VAL . 54.8 p90 -123.21 165.99 15.98 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 118.395 0.543 . . . . 0.0 110.141 -175.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.8 m -114.25 143.34 45.01 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 173.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.32 145.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 178.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.73 173.52 11.62 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.239 1.016 . . . . 0.0 109.591 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -154.14 -169.72 3.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 125.049 1.34 . . . . 0.0 107.47 164.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.84 -9.07 5.79 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.511 1.524 . . . . 0.0 114.015 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.12 -71.33 0.73 Allowed 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.352 1.861 . . . . 0.0 107.002 -175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.07 -152.11 5.61 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -171.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.9 p -155.21 164.36 38.92 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.069 0.548 . . . . 0.0 111.484 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG22 ' HB3' ' A' ' 40' ' ' PRO . 31.1 m -147.38 154.87 11.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 125.894 1.678 . . . . 0.0 109.547 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -86.64 164.27 16.91 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 122.014 0.912 . . . . 0.0 110.307 167.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.691 HG21 ' CE1' ' A' ' 82' ' ' PHE . 1.3 m -132.7 156.46 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.103 1.361 . . . . 0.0 107.957 169.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.6 t -120.74 134.72 55.27 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 157.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 36.4 t80 -131.99 162.58 30.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 126.07 1.748 . . . . 0.0 107.403 168.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -141.13 103.61 4.48 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 168.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.53 163.88 26.25 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.2 tt -75.64 -22.1 16.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -164.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.501 ' CD2' HG11 ' A' ' 126' ' ' VAL . 55.6 mt 89.43 149.84 0.07 OUTLIER Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 131.377 3.871 . . . . 0.0 113.109 173.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -63.2 150.52 88.38 Favored 'Trans proline' 0 N--CA 1.444 -1.424 0 C-N-CA 121.809 1.673 . . . . 0.0 109.576 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -58.29 -28.97 65.49 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.847 1.259 . . . . 0.0 109.74 163.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.458 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.1 OUTLIER -79.16 -14.08 59.32 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 128.107 2.563 . . . . 0.0 114.098 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.425 ' CE2' HG11 ' A' ' 109' ' ' VAL . 13.5 t80 -85.63 127.66 34.54 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-N 122.947 2.612 . . . . 0.0 106.877 177.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 12.1 mmt180 -134.54 162.72 31.49 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.254 1.026 . . . . 0.0 111.148 170.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -73.11 108.7 6.15 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 126.111 1.765 . . . . 0.0 108.273 173.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.478 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 96.99 37.86 4.53 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 124.103 0.858 . . . . 0.0 111.737 178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -139.7 170.65 15.51 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 118.392 1.096 . . . . 0.0 111.646 166.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -64.17 136.95 40.33 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 124.111 0.862 . . . . 0.0 111.294 172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.425 HG11 ' CE2' ' A' ' 103' ' ' PHE . 3.5 m -135.04 168.1 24.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.974 1.71 . . . . 0.0 107.15 170.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 t -128.46 107.65 16.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 167.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.52 157.96 4.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 166.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -150.28 139.09 20.83 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 128.014 2.526 . . . . 0.0 105.54 175.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 159.85 -118.21 0.81 Allowed Glycine 0 N--CA 1.441 -1.018 0 N-CA-C 104.343 -3.503 . . . . 0.0 104.343 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -141.17 156.97 45.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 119.717 1.759 . . . . 0.0 111.452 -163.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.57 143.11 32.23 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -93.39 -72.34 0.61 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.295 1.038 . . . . 0.0 109.365 -175.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 27.8 mtmt -141.86 -86.07 0.17 Allowed 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 125.143 1.377 . . . . 0.0 109.134 172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -67.87 -69.75 1.3 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 -171.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -147.42 5.11 0.81 Allowed 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -172.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -89.6 136.79 32.83 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 -167.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 mm -107.96 127.23 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 124.742 1.217 . . . . 0.0 109.006 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -78.62 104.28 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 103.739 -2.689 . . . . 0.0 103.739 164.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.57 133.46 42.23 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 123.386 0.675 . . . . 0.0 109.301 171.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.57 -21.82 15.17 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 125.574 1.55 . . . . 0.0 111.728 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -144.41 -38.31 0.29 Allowed 'General case' 0 C--O 1.224 -0.285 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -171.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 99' ' ' LEU . 78.3 t 58.1 106.3 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.368 1.867 . . . . 0.0 113.015 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.4 mt -120.6 156.89 30.68 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 0.0 108.259 -176.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -116.75 32.25 6.26 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 120.284 1.402 . . . . 0.0 112.483 -175.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt 56.79 16.11 2.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.624 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 6.0 p80 -82.76 60.28 5.22 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 127.269 2.228 . . . . 0.0 109.183 -172.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 8.9 t70 60.03 11.12 2.5 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 127.529 2.331 . . . . 0.0 115.79 170.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.2 pp20? -54.47 116.73 2.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 125.463 1.505 . . . . 0.0 108.116 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -158.3 -21.87 0.08 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.63 0.772 . . . . 0.0 111.918 177.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -162.6 137.19 6.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 126.013 1.725 . . . . 0.0 107.199 163.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.4 m -133.96 113.3 12.6 Favored Pre-proline 0 C--O 1.238 0.495 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -67.85 173.76 8.69 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 122.323 2.015 . . . . 0.0 110.568 175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -66.62 -32.91 37.52 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.157 1.905 . . . . 0.0 112.43 168.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.98 34.79 0.36 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.21 1.404 . . . . 0.0 112.735 -160.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.468 ' HA ' ' HG3' ' A' ' 143' ' ' MET . 5.5 m -149.19 -43.18 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 C-N-CA 125.766 1.626 . . . . 0.0 110.818 -171.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -58.93 -30.56 67.94 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.389 0.676 . . . . 0.0 111.644 -175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -138.7 138.38 37.67 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.728 1.611 . . . . 0.0 107.446 173.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 44.7 67.42 0.7 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 127.37 2.268 . . . . 0.0 111.874 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.468 ' HG3' ' HA ' ' A' ' 139' ' ' VAL . 19.3 ttm . . . . . 0 C--O 1.25 1.13 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 119.524 -0.274 . . . . 0.0 110.493 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -146.52 112.99 5.94 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.191 2.196 . . . . 0.0 108.416 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -157.69 174.38 15.41 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 127.036 2.134 . . . . 0.0 106.841 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -159.6 -59.88 0.07 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 119.352 0.978 . . . . 0.0 110.649 162.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.1 pt -71.76 -155.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.508 1.123 . . . . 0.0 109.698 173.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -47.5 158.56 0.18 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 125.937 1.695 . . . . 0.0 111.974 168.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.454 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.1 pp -86.49 -175.93 5.65 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.623 1.569 . . . . 0.0 109.888 174.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -159.42 157.59 30.52 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 127.308 2.243 . . . . 0.0 106.492 171.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -143.36 177.86 8.14 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.997 1.719 . . . . 0.0 109.547 171.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.524 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 45.1 p -132.7 171.41 9.19 Favored Pre-proline 0 C--O 1.24 0.582 0 C-N-CA 124.602 1.161 . . . . 0.0 110.63 170.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -60.58 0.01 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.834 2.356 . . . . 0.0 114.803 162.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -119.84 25.33 7.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 124.718 1.151 . . . . 0.0 111.734 169.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.524 ' HB2' ' H ' ' A' ' 39' ' ' THR . 43.5 mt-10 -132.39 -41.17 0.98 Allowed 'General case' 0 C--O 1.227 -0.124 0 CA-C-N 118.876 1.338 . . . . 0.0 110.69 173.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.473 HG22 HD22 ' A' ' 119' ' ' ASN . 7.4 mt -63.16 -23.5 33.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-N 118.326 0.512 . . . . 0.0 110.944 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.455 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -105.38 -53.9 2.58 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 125.521 1.528 . . . . 0.0 107.603 176.514 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.455 ' CE1' HD12 ' A' ' 44' ' ' LEU . 18.5 m-30 -88.38 14.8 8.82 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -166.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.62 124.7 3.25 Favored Glycine 0 C--N 1.331 0.3 0 N-CA-C 108.56 -1.816 . . . . 0.0 108.56 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -62.57 149.38 43.32 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 117.086 -1.435 . . . . 0.0 109.908 174.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 50.8 mtt85 -19.46 -39.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 120.379 3.474 . . . . 0.0 120.379 -143.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.535 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 45.4 mt-10 -120.39 -72.91 0.67 Allowed 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 166.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.3 t -164.49 23.22 0.06 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.295 0.638 . . . . 0.0 111.755 -173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -58.69 -49.31 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 119.509 -1.994 . . . . 0.0 112.557 -170.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.522 HE21 ' C ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -176.6 176.1 1.61 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.977 2.111 . . . . 0.0 107.915 179.444 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 83.4 mmm -114.57 158.55 39.89 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 124.838 1.255 . . . . 0.0 107.93 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.03 148.27 62.94 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.284 1.323 . . . . 0.0 109.649 175.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -78.87 146.65 33.49 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG13 ' HA ' ' A' ' 117' ' ' LYS . 75.2 t -76.48 1.52 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 125.02 1.328 . . . . 0.0 112.018 -174.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -143.63 38.39 1.37 Allowed Glycine 0 CA--C 1.51 -0.261 0 O-C-N 118.544 -2.597 . . . . 0.0 110.287 169.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -110.77 168.35 9.54 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 164.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.6 ptp85 -79.89 152.38 29.65 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 166.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.619 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.69 168.39 27.33 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.552 1.141 . . . . 0.0 111.229 165.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.5 ttt85 -114.4 136.45 52.98 Favored 'General case' 0 C--O 1.231 0.117 0 C-N-CA 126.954 2.102 . . . . 0.0 107.725 179.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 72.6 t -124.01 151.91 29.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 126.73 2.012 . . . . 0.0 107.777 178.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.32 149.69 17.9 Favored Glycine 0 C--N 1.331 0.284 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 160.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -179.4 179.17 48.9 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.388 0.995 . . . . 0.0 110.85 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.2 ttm -91.08 126.12 36.07 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.805 1.642 . . . . 0.0 109.968 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.7 t -67.84 130.04 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 O-C-N 120.445 -1.41 . . . . 0.0 108.198 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 58.1 mtt -62.9 139.19 97.33 Favored Pre-proline 0 C--O 1.237 0.437 0 CA-C-N 118.54 0.609 . . . . 0.0 111.637 169.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -69.83 146.8 60.85 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 123.395 2.73 . . . . 0.0 108.941 163.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.22 20.97 75.52 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.463 -1.187 . . . . 0.0 112.414 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.5 m -120.22 -26.18 5.54 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.704 1.252 . . . . 0.0 112.15 173.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.2 t -61.05 93.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-N 119.318 0.963 . . . . 0.0 108.91 170.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -73.25 -66.11 0.72 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.124 1.77 . . . . 0.0 109.317 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 67.47 134.62 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 128.563 2.745 . . . . 0.0 110.868 -176.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.97 125.28 91.18 Favored Pre-proline 0 C--N 1.335 -0.059 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -65.53 -16.48 54.05 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 CA-C-N 121.709 1.646 . . . . 0.0 111.384 176.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -96.15 -18.5 20.07 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 118.219 -0.896 . . . . 0.0 112.481 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -157.15 -176.06 5.76 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.472 1.033 . . . . 0.0 111.821 -155.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.5 mp -99.81 -1.04 38.58 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.154 -173.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -60.25 139.15 57.74 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 122.281 1.039 . . . . 0.0 108.249 168.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.76 158.34 37.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 114.059 -1.428 . . . . 0.0 110.097 173.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.34 140.63 52.06 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 151.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 43.8 p90 -140.94 -179.11 5.88 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.999 0.919 . . . . 0.0 109.296 160.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.9 m -130.85 151.27 51.47 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.598 HD11 HG11 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.32 129.63 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -116.58 -177.51 3.2 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 126.093 1.757 . . . . 0.0 107.42 174.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -155.13 -141.65 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 104.702 -2.333 . . . . 0.0 104.702 155.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.57 -18.74 65.15 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 121.266 1.848 . . . . 0.0 114.663 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -106.69 -69.69 0.82 Allowed 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -151.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -142.63 -153.47 5.9 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.2 p -147.27 163.53 36.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 118.282 1.041 . . . . 0.0 112.008 170.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.0 m -139.92 138.56 38.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 126.54 1.936 . . . . 0.0 109.504 178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -75.65 150.78 37.87 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 174.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.598 HG11 HD11 ' A' ' 84' ' ' ILE . 5.0 m -127.24 152.77 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 164.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.2 p -125.99 128.36 47.35 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 161.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.6 t80 -125.83 170.58 11.47 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.37 1.868 . . . . 0.0 108.011 -175.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -158.76 107.5 1.92 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 170.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.5 14.98 0.02 OUTLIER Glycine 0 N--CA 1.473 1.145 0 C-N-CA 114.409 -3.758 . . . . 0.0 121.265 172.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.435 HD13 ' H ' ' A' ' 99' ' ' LEU 0.265 0.4 OUTLIER 58.01 143.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 126.957 2.103 . . . . 0.0 110.186 -152.222 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.571 ' CD2' HG11 ' A' ' 126' ' ' VAL . 20.8 mt -92.08 162.67 29.87 Favored Pre-proline 0 C--O 1.24 0.587 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.525 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_exo -58.32 147.87 82.54 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 N-CA-C 107.474 -1.779 . . . . 0.0 107.474 166.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -66.15 -18.14 65.16 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.771 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.44 -31.15 63.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 116.858 -1.544 . . . . 0.0 112.493 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -61.9 137.9 58.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.572 1.078 . . . . 0.0 109.164 -177.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 14.4 mmt85 -142.54 168.96 18.5 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 172.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -63.1 132.83 53.2 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 159.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.69 15.54 56.47 Favored Glycine 0 CA--C 1.525 0.673 0 CA-C-O 119.215 -0.769 . . . . 0.0 113.7 163.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -121.23 163.68 18.16 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-N 118.42 1.11 . . . . 0.0 111.545 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.91 124.08 10.15 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -128.84 162.39 36.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 175.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.5 t -111.99 134.31 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 126' ' ' VAL . 1.1 t -107.79 160.51 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 163.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -158.64 151.07 21.74 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 166.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 122' ' ' LEU . . . 156.07 -145.34 12.09 Favored Glycine 0 N--CA 1.427 -1.936 0 N-CA-C 105.525 -3.03 . . . . 0.0 105.525 -165.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -124.97 157.88 35.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 118.734 1.267 . . . . 0.0 109.463 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.619 ' HB2' HD11 ' A' ' 60' ' ' LEU . 16.7 tp -84.56 137.08 33.51 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.15 -65.91 0.96 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.473 ' HA ' HG13 ' A' ' 56' ' ' VAL . 45.3 mtmt -163.9 154.84 15.87 Favored 'General case' 0 N--CA 1.448 -0.534 1 C-N-CA 133.956 4.902 . . . . 0.0 104.725 175.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 63.05 -98.44 0.22 Allowed Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.473 HD22 HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -138.16 1.82 2.26 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 -179.01 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -70.78 124.64 24.77 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.956 1.253 . . . . 0.0 109.772 178.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.28 122.45 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 125.66 1.584 . . . . 0.0 110.531 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' O ' ' HA3' ' A' ' 113' ' ' GLY . 3.6 mm? -78.92 81.67 5.18 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 165.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.63 133.5 30.64 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 125.041 1.336 . . . . 0.0 109.892 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.48 -25.25 10.59 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.611 1.564 . . . . 0.0 111.196 178.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -139.45 -37.39 0.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 -167.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.571 HG11 ' CD2' ' A' ' 99' ' ' LEU . 60.3 t 52.19 113.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 127.068 2.147 . . . . 0.0 115.523 176.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.0 mt -129.47 154.32 47.1 Favored 'General case' 0 CA--C 1.531 0.214 0 O-C-N 120.519 -1.363 . . . . 0.0 108.889 -173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.489 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -118.16 37.11 4.1 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 121.253 1.842 . . . . 0.0 111.894 -166.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.2 mmmt 41.92 42.83 2.42 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 127.851 2.46 . . . . 0.0 112.304 -173.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.489 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 1.4 p-80 -96.38 38.78 1.18 Allowed 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 126.309 1.844 . . . . 0.0 110.526 -172.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 26.5 t0 61.54 68.11 0.73 Allowed 'General case' 0 C--O 1.232 0.141 0 C-N-CA 126.289 1.836 . . . . 0.0 112.123 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.98 175.55 7.62 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 125.318 1.447 . . . . 0.0 110.154 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -155.0 -42.54 0.09 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.37 1.468 . . . . 0.0 109.446 150.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -147.7 119.25 7.95 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 124.531 1.132 . . . . 0.0 110.531 -164.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 2.3 m -91.82 134.58 28.74 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.31 176.62 8.97 Favored 'Trans proline' 0 CA--C 1.55 1.279 0 C-N-CA 122.47 2.113 . . . . 0.0 110.998 167.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -84.47 -36.28 0.16 Allowed 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.408 2.072 . . . . 0.0 113.908 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -83.81 37.79 0.61 Allowed 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.037 0.935 . . . . 0.0 111.164 -162.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.8 m -153.83 -30.62 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 126.846 2.058 . . . . 0.0 111.007 -167.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -74.55 -50.37 18.31 Favored 'General case' 0 C--N 1.339 0.117 0 CA-C-N 118.611 0.641 . . . . 0.0 110.334 -176.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.1 93.06 0.28 Allowed 'General case' 0 C--N 1.339 0.128 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 -178.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -177.21 -37.02 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.425 1.89 . . . . 0.0 109.335 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.0 mmt . . . . . 0 C--O 1.251 1.156 0 CA-C-O 117.081 -1.438 . . . . 0.0 108.002 159.831 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.3 tp . . . . . 0 N--CA 1.471 0.611 0 CA-C-O 120.569 0.223 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -71.06 154.09 42.06 Favored 'General case' 0 C--N 1.333 -0.121 0 O-C-N 121.237 -0.914 . . . . 0.0 109.85 174.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.5 p -158.35 -177.94 6.91 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 125.662 1.585 . . . . 0.0 107.528 161.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -135.89 172.75 12.56 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 158.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.5 mt -80.61 151.04 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 N-CA-C 105.482 -2.044 . . . . 0.0 105.482 161.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 60.41 114.93 0.01 OUTLIER 'General case' 0 C--O 1.236 0.39 0 C-N-CA 128.781 2.832 . . . . 0.0 113.613 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.5 mt -58.67 147.12 33.92 Favored 'General case' 0 CA--C 1.514 -0.409 0 C-N-CA 126.771 2.028 . . . . 0.0 111.318 -171.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -150.54 139.46 20.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.219 -166.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -140.68 -174.74 4.06 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.595 1.958 . . . . 0.0 107.7 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 26.0 p -141.26 174.48 3.83 Favored Pre-proline 0 C--O 1.235 0.325 0 O-C-N 120.542 -1.349 . . . . 0.0 110.542 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 7.6 Cg_endo -57.69 0.88 0.24 Allowed 'Trans proline' 0 N--CA 1.448 -1.183 0 N-CA-C 117.35 2.019 . . . . 0.0 117.35 171.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -108.22 -41.94 1.46 Allowed Glycine 0 C--N 1.343 0.968 0 CA-C-N 121.789 2.086 . . . . 0.0 112.904 163.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' A' ' 47' ' ' LYS . 5.8 pt-20 -80.44 -2.61 46.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 119.607 1.704 . . . . 0.0 113.249 -162.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.55 -18.11 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.135 0.974 . . . . 0.0 110.38 166.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.61 -47.68 5.01 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.718 1.207 . . . . 0.0 110.79 173.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -87.51 -26.37 23.21 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.364 1.466 . . . . 0.0 110.907 -171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.9 146.17 9.31 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.664 1.602 . . . . 0.0 110.301 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.571 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 44.8 tttm -57.11 139.68 51.68 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 117.971 -1.014 . . . . 0.0 112.228 -174.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -18.18 -66.85 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 -150.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.8 mp0 -74.83 -89.36 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 174.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.6 t -159.99 27.37 0.18 Allowed 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 122.33 1.062 . . . . 0.0 109.9 176.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.53 -26.45 60.87 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 119.584 -1.947 . . . . 0.0 113.266 -161.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? 178.1 173.52 0.61 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.951 2.5 . . . . 0.0 110.796 163.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.25 145.1 29.25 Favored Pre-proline 0 C--O 1.241 0.645 0 C-N-CA 126.891 2.076 . . . . 0.0 108.267 166.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -63.2 134.48 45.81 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.667 2.245 . . . . 0.0 109.371 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -79.29 130.7 35.72 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.363 -1.718 . . . . 0.0 106.363 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.664 ' HA ' HD23 ' A' ' 115' ' ' LEU . 14.8 p -70.22 -11.1 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 CA-C-O 121.418 0.627 . . . . 0.0 112.192 -172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.27 3.73 61.93 Favored Glycine 0 N--CA 1.439 -1.145 0 CA-C-O 116.885 -2.064 . . . . 0.0 113.009 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HG3' HD12 ' A' ' 60' ' ' LEU . 1.5 pt20 -110.01 167.2 10.35 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 120.893 2.347 . . . . 0.0 112.766 -168.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -85.29 137.54 32.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.523 1.129 . . . . 0.0 108.669 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -157.99 173.37 16.86 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.217 1.007 . . . . 0.0 110.175 171.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -122.34 157.36 31.96 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 124.181 0.992 . . . . 0.0 111.136 171.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 79.6 t -131.96 143.24 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 126.571 1.948 . . . . 0.0 107.326 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -127.19 127.51 5.91 Favored Glycine 0 CA--C 1.51 -0.225 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 168.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -164.51 -178.89 38.28 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 27.7 ttm -105.22 129.71 53.54 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.028 0.931 . . . . 0.0 110.277 -174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.1 t -68.99 129.01 33.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 119.289 0.95 . . . . 0.0 108.925 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . 0.476 ' HG3' ' CD1' ' A' ' 85' ' ' TYR . 5.3 mtm -68.9 149.45 97.87 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 118.489 0.586 . . . . 0.0 110.967 172.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.31 137.97 24.18 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 123.355 2.703 . . . . 0.0 108.966 166.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.59 57.9 15.68 Favored Glycine 0 CA--C 1.522 0.489 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 -172.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.7 m -142.62 -30.58 0.54 Allowed 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 164.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.706 HG22 ' HG2' ' A' ' 73' ' ' ARG 0.303 2.2 p -75.16 95.54 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 O-C-N 120.833 -1.167 . . . . 0.0 111.855 -173.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.05 28.56 0.11 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 131.469 3.908 . . . . 0.0 113.896 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.706 ' HG2' HG22 ' A' ' 71' ' ' VAL . 0.0 OUTLIER -56.37 146.07 25.34 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.41 1.084 . . . . 0.0 110.84 -179.238 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -104.18 134.95 19.43 Favored Pre-proline 0 N--CA 1.448 -0.529 0 O-C-N 123.77 0.668 . . . . 0.0 109.215 -171.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.66 -14.21 19.82 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.566 2.178 . . . . 0.0 112.535 170.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -109.1 -7.6 15.3 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 127.653 2.381 . . . . 0.0 111.881 -176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 39.6 m -151.56 171.92 16.83 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 120.007 1.276 . . . . 0.0 110.299 -176.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 95.6 mt -91.76 -8.14 47.66 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.201 -0.937 . . . . 0.0 111.402 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.17 137.27 57.15 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 124.67 1.188 . . . . 0.0 109.387 173.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.6 p -161.15 127.2 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.0 p -105.47 159.94 15.54 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 163.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 93' ' ' VAL . 53.3 p90 -153.82 -178.4 7.03 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 119.042 0.837 . . . . 0.0 110.059 167.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.9 m -129.92 142.4 50.66 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.467 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -126.7 136.78 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -177.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.476 ' CD1' ' HG3' ' A' ' 67' ' ' MET . 15.8 p90 -135.21 169.9 16.75 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.096 1.359 . . . . 0.0 109.559 -173.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -158.75 -166.76 1.95 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.339 1.855 . . . . 0.0 107.692 166.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.07 -3.52 1.76 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.834 2.054 . . . . 0.0 114.972 -171.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.6 OUTLIER -111.6 -62.28 1.58 Allowed 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.819 1.248 . . . . 0.0 107.73 -173.454 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.26 -167.98 17.08 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.896 1.712 . . . . 0.0 112.005 -171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 83.9 p -137.51 164.04 29.69 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 123.92 0.888 . . . . 0.0 112.006 170.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.98 144.64 25.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.121 1.368 . . . . 0.0 109.501 -178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.97 152.52 30.98 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.209 1.004 . . . . 0.0 108.641 175.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.551 HG21 ' CE1' ' A' ' 82' ' ' PHE . 3.4 m -132.65 147.95 31.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.354 163.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -119.92 112.45 19.21 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 126.263 1.825 . . . . 0.0 108.557 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.592 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.4 t80 -112.88 166.51 11.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.97 1.708 . . . . 0.0 108.32 174.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -155.13 97.89 1.96 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.382 -2.821 . . . . 0.0 103.382 168.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 176.65 -174.07 46.75 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 119.679 -1.248 . . . . 0.0 112.508 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.04 118.93 21.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.42 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.5 tp -97.14 135.3 21.99 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 124.868 1.267 . . . . 0.0 109.113 -173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -57.45 156.9 24.3 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.154 1.903 . . . . 0.0 112.435 -173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -69.92 -40.8 75.33 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 123.098 1.428 . . . . 0.0 108.957 169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 91.9 mt -64.44 -27.02 68.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 125.766 1.626 . . . . 0.0 111.715 177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.478 ' HE1' HG21 ' A' ' 71' ' ' VAL . 34.3 t80 -66.29 106.64 1.75 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 119.374 0.988 . . . . 0.0 108.867 -174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 18.8 mmt180 -133.16 158.84 41.82 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 124.21 1.004 . . . . 0.0 109.829 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -70.71 105.48 3.19 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.628 1.571 . . . . 0.0 107.462 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 102.05 26.19 7.57 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-O 118.285 -1.286 . . . . 0.0 113.384 -176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.21 163.87 17.1 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 119.663 1.731 . . . . 0.0 110.508 160.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -80.88 138.2 19.06 Favored Glycine 0 CA--C 1.52 0.373 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.8 m -134.61 174.47 12.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 C-N-CA 125.36 1.464 . . . . 0.0 107.237 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.15 137.43 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 168.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.4 HG12 HG21 ' A' ' 121' ' ' ILE . 1.3 t -117.04 156.82 18.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 125.249 1.42 . . . . 0.0 107.508 165.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -149.21 141.88 24.5 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 127.072 2.149 . . . . 0.0 106.645 175.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 169.33 -103.39 0.19 Allowed Glycine 0 N--CA 1.452 -0.261 0 N-CA-C 107.41 -2.276 . . . . 0.0 107.41 166.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -142.89 161.35 38.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 119.983 1.892 . . . . 0.0 109.418 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.664 HD23 ' HA ' ' A' ' 56' ' ' VAL . 13.4 tp -81.16 144.3 31.75 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 170.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -101.82 -72.53 0.68 Allowed 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.319 0.509 . . . . 0.0 109.979 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -163.69 -83.99 0.03 OUTLIER 'General case' 0 C--O 1.234 0.259 0 C-N-CA 127.147 2.179 . . . . 0.0 108.158 169.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.56 73.34 2.07 Favored Glycine 0 C--N 1.335 0.527 0 C-N-CA 125.175 1.369 . . . . 0.0 111.555 -162.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 11.2 m120 44.49 46.39 8.03 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 126.304 1.841 . . . . 0.0 110.542 -172.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 21.0 t-160 -122.16 129.39 52.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.543 1.137 . . . . 0.0 108.395 -172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.4 HG21 HG12 ' A' ' 111' ' ' VAL . 16.5 mm -103.69 132.9 49.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 125.506 1.522 . . . . 0.0 109.487 176.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.17 114.37 18.06 Favored 'General case' 0 CA--C 1.513 -0.476 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 159.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.96 130.03 35.09 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 169.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.67 -22.38 18.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 117.972 -1.013 . . . . 0.0 112.009 170.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -141.99 -35.83 0.43 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 118.76 2.874 . . . . 0.0 118.76 -168.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 54.9 t 50.65 122.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.39 1.876 . . . . 0.0 115.337 -177.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 1.2 mt -134.79 156.02 49.59 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 119.893 -1.754 . . . . 0.0 108.308 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -113.83 30.06 7.53 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 118.727 0.694 . . . . 0.0 112.268 -168.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt 41.88 60.34 2.25 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 123.008 1.385 . . . . 0.0 112.178 -172.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -106.83 53.9 0.69 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.215 2.206 . . . . 0.0 108.853 167.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 36.1 t0 51.2 72.59 0.35 Allowed 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.38 1.872 . . . . 0.0 112.91 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.18 149.36 51.02 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.775 1.23 . . . . 0.0 109.869 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -170.73 -39.99 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.612 1.565 . . . . 0.0 110.746 172.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -143.49 176.77 8.94 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.466 1.906 . . . . 0.0 108.734 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 22.2 m -151.27 132.46 7.64 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 126.226 1.81 . . . . 0.0 106.99 174.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -61.09 174.93 1.58 Allowed 'Trans proline' 0 CA--C 1.545 1.027 0 C-N-CA 123.202 2.602 . . . . 0.0 112.528 175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -71.95 -168.93 0.4 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 122.307 2.005 . . . . 0.0 110.533 161.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 56.82 46.37 19.95 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.731 1.212 . . . . 0.0 110.258 177.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 12.3 p -165.7 -31.66 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 126.947 2.099 . . . . 0.0 109.554 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -57.98 -37.89 75.07 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.188 1.795 . . . . 0.0 111.094 -172.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 21.1 tttp -150.49 -175.84 5.25 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.417 3.487 . . . . 0.0 105.535 167.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 49.43 74.6 0.19 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.47 1.508 . . . . 0.0 112.513 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.4 mmt . . . . . 0 C--O 1.257 1.455 0 C-N-CA 125.09 1.356 . . . . 0.0 108.517 170.317 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.473 0.713 0 CA-C-O 120.911 0.386 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.6 ttm180 -153.08 119.8 5.67 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 46.8 t -153.18 157.51 40.39 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 164.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -142.41 35.78 1.49 Allowed 'General case' 0 C--O 1.238 0.45 0 C-N-CA 125.129 1.371 . . . . 0.0 109.431 -169.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.9 mt -64.2 157.81 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.635 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -49.22 112.79 0.68 Allowed 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 127.818 2.447 . . . . 0.0 108.562 179.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.73 173.91 10.49 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.122 1.369 . . . . 0.0 110.608 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -161.84 150.69 15.6 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 126.418 1.887 . . . . 0.0 109.107 -173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -143.04 172.35 12.83 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 124.897 1.279 . . . . 0.0 111.549 -175.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.4 p -135.59 158.72 73.71 Favored Pre-proline 0 C--O 1.243 0.762 0 C-N-CA 125.168 1.387 . . . . 0.0 111.591 177.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.76 78.58 0.37 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 124.975 3.784 . . . . 0.0 109.567 164.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 165.71 -63.16 0.22 Allowed Glycine 0 N--CA 1.435 -1.409 0 N-CA-C 106.587 -2.605 . . . . 0.0 106.587 -176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -63.48 -21.47 66.34 Favored 'General case' 0 CA--C 1.559 1.293 0 O-C-N 122.149 -0.618 . . . . 0.0 110.39 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.2 mt -77.45 -13.31 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.108 1.763 . . . . 0.0 110.683 178.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.11 -54.33 2.12 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.411 1.484 . . . . 0.0 107.499 -163.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -77.65 -78.87 0.12 Allowed 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 127.962 2.505 . . . . 0.0 107.171 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 172.16 152.7 8.68 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.671 -1.072 . . . . 0.0 111.45 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' A' ' 52' ' ' GLN . 3.5 tptm -49.31 114.89 1.13 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.291 1.436 . . . . 0.0 110.972 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 69.4 mtp180 -79.67 -15.85 56.8 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 119.194 0.906 . . . . 0.0 112.384 -174.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -64.73 -48.62 73.92 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.024 0.829 . . . . 0.0 110.826 170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.0 p -152.43 -1.76 0.27 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.107 1.151 . . . . 0.0 114.107 -151.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 35.47 79.77 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 128.142 2.577 . . . . 0.0 111.837 -166.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 33.8 mt-30 -119.92 -37.96 3.03 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.813 1.245 . . . . 0.0 112.661 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 36.3 mtp 59.96 155.02 0.1 Allowed Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 129.284 3.033 . . . . 0.0 114.202 -173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -82.22 149.11 15.13 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.8 1.667 . . . . 0.0 109.285 168.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -80.01 148.65 31.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 169.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.1 t -72.19 -9.82 13.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 124.239 1.016 . . . . 0.0 111.149 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -117.44 61.59 0.43 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 168.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -153.64 174.41 14.51 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 118.799 1.3 . . . . 0.0 112.942 163.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -80.75 147.29 30.6 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 124.734 1.214 . . . . 0.0 108.88 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.1 165.23 24.89 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 168.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.2 mtm-85 -97.46 144.58 27.04 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 129.002 2.921 . . . . 0.0 108.746 167.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.1 t -128.98 146.36 34.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 125.703 1.601 . . . . 0.0 108.167 167.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -131.41 139.07 10.63 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 164.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -165.33 -169.01 28.37 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 30.3 ttm -107.46 124.61 50.14 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.062 1.431 . . . . 0.0 109.682 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.737 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -55.24 130.04 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.4 ttm -63.0 124.52 84.06 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 172.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.89 134.44 46.61 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.831 2.354 . . . . 0.0 108.465 176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.58 7.93 85.48 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.032 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.5 p -98.17 -32.73 11.43 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.755 1.777 . . . . 0.0 113.71 179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 82' ' ' PHE . 1.5 p -77.2 123.37 33.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-N 118.889 0.768 . . . . 0.0 110.166 -167.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.55 ' O ' HG23 ' A' ' 80' ' ' VAL . 0.7 OUTLIER -95.41 127.2 41.26 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 152.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -114.53 128.98 56.62 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 161.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -74.05 133.89 78.17 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 118.883 -1.127 . . . . 0.0 108.065 -174.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.67 -2.47 11.46 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.376 2.051 . . . . 0.0 111.092 167.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -126.74 8.97 6.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.739 2.016 . . . . 0.0 110.731 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 8.3 t -150.86 178.99 8.61 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.217 1.407 . . . . 0.0 108.7 171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.745 HD22 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -96.8 -6.86 35.12 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.86 1.664 . . . . 0.0 111.685 162.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.57 144.78 46.53 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 120.745 1.611 . . . . 0.0 109.226 169.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.675 HG21 HD22 ' A' ' 99' ' ' LEU . 1.6 p -155.85 136.39 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 104.552 -2.388 . . . . 0.0 104.552 177.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.442 ' H ' ' HG3' ' A' ' 72' ' ' GLN . 6.6 p -118.37 152.47 35.78 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 167.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.491 ' HB3' ' HB ' ' A' ' 71' ' ' VAL . 26.0 p90 -153.02 -178.57 7.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 118.842 0.746 . . . . 0.0 109.796 166.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 m -124.04 154.61 39.64 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 172.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -135.27 134.22 52.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -121.98 178.33 4.94 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -154.38 -148.41 0.24 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -72.75 -15.35 61.66 Favored 'General case' 0 N--CA 1.446 -0.648 0 O-C-N 120.764 -1.21 . . . . 0.0 113.424 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -119.3 -64.17 1.3 Allowed 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 124.475 1.11 . . . . 0.0 109.085 -162.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.81 -157.44 7.58 Favored Glycine 0 CA--C 1.52 0.39 0 N-CA-C 111.139 -0.785 . . . . 0.0 111.139 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 91.7 p -145.22 162.54 36.89 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 117.286 0.543 . . . . 0.0 112.265 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.9 p -143.65 154.85 16.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 127.166 2.186 . . . . 0.0 108.826 -172.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.57 155.56 16.91 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 125.03 1.332 . . . . 0.0 109.481 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 14.5 t -139.23 128.66 30.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 123.574 0.75 . . . . 0.0 109.082 175.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.5 m -110.85 117.23 32.83 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 125.066 1.347 . . . . 0.0 107.451 162.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 19.5 t80 -121.37 159.64 25.71 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.618 1.567 . . . . 0.0 107.071 174.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.487 ' HG2' HD23 ' A' ' 78' ' ' LEU . 15.4 tt0 -146.68 90.12 1.9 Allowed 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 104.297 -2.482 . . . . 0.0 104.297 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.51 -171.85 44.17 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.872 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -70.91 115.77 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.766 0 N-CA-C 103.847 -2.649 . . . . 0.0 103.847 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.675 HD22 HG21 ' A' ' 80' ' ' VAL . 15.1 tp -89.34 131.85 39.21 Favored Pre-proline 0 N--CA 1.448 -0.55 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -54.5 138.06 73.68 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.442 -1.407 . . . . 0.0 108.442 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.92 -20.81 65.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 122.06 0.933 . . . . 0.0 109.396 163.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.1 mp -69.2 -21.71 63.94 Favored 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.304 1.442 . . . . 0.0 110.439 174.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -71.0 134.98 47.58 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.895 1.278 . . . . 0.0 109.252 171.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.407 ' O ' HG11 ' A' ' 66' ' ' VAL . 12.2 mmt180 -138.35 -177.04 4.67 Favored 'General case' 0 CA--C 1.51 -0.567 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -104.95 127.63 52.87 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.737 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 80.71 31.67 35.64 Favored Glycine 0 CA--C 1.522 0.497 0 CA-C-O 118.077 -1.402 . . . . 0.0 110.992 -175.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -118.14 168.08 10.89 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 119.042 1.421 . . . . 0.0 110.368 170.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.01 133.44 18.62 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 174.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -130.04 165.78 29.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 124.278 1.031 . . . . 0.0 108.269 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.696 HG23 ' HE2' ' A' ' 129' ' ' LYS . 3.1 t -124.81 117.21 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 166.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.415 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -92.06 159.79 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-O 122.189 0.995 . . . . 0.0 108.65 162.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -154.04 146.6 24.11 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 125.889 1.676 . . . . 0.0 107.195 162.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 173.03 -104.26 0.2 Allowed Glycine 0 N--CA 1.449 -0.482 0 N-CA-C 106.376 -2.69 . . . . 0.0 106.376 161.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -140.64 154.04 46.26 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 119.219 1.51 . . . . 0.0 109.623 -177.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.53 144.52 39.67 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -104.3 -83.75 0.49 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.584 0.754 . . . . 0.0 109.782 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.44 -82.15 0.11 Allowed 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.544 1.066 . . . . 0.0 111.13 175.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -88.53 73.4 2.22 Favored Glycine 0 C--N 1.33 0.232 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 -169.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.1 m120 51.96 56.41 7.83 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.836 1.254 . . . . 0.0 109.205 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -135.3 123.7 23.32 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.2 mm -97.2 130.76 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.127 1.371 . . . . 0.0 107.745 175.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -78.38 110.13 13.15 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 103.362 -2.829 . . . . 0.0 103.362 157.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -73.45 154.36 39.99 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 122.076 0.941 . . . . 0.0 109.822 168.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.69 -17.96 7.85 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 126.425 1.89 . . . . 0.0 111.997 175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -143.18 -43.27 0.29 Allowed 'General case' 0 C--O 1.223 -0.293 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.49 HG11 HD11 ' A' ' 99' ' ' LEU . 99.8 t 54.13 121.79 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 123.686 1.708 . . . . 0.0 113.638 -172.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 37.7 mt -130.58 155.37 46.64 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.796 1.238 . . . . 0.0 108.094 -175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.9 39.9 3.26 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 125.587 1.555 . . . . 0.0 109.312 -176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.696 ' HE2' HG23 ' A' ' 110' ' ' VAL . 0.1 OUTLIER 40.34 57.5 2.47 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.595 1.958 . . . . 0.0 113.356 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -93.88 62.4 3.15 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 168.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 18.8 t0 41.49 65.35 0.86 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.639 1.576 . . . . 0.0 112.41 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -94.69 137.45 33.78 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -170.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -151.08 166.18 31.57 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.618 1.567 . . . . 0.0 109.202 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -53.58 143.2 20.54 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.435 1.094 . . . . 0.0 110.583 172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 8.8 m -135.16 138.9 30.27 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 125.773 1.629 . . . . 0.0 108.284 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -69.78 130.62 19.64 Favored 'Trans proline' 0 CA--C 1.545 1.046 0 C-N-CA 122.492 2.128 . . . . 0.0 109.948 171.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -60.29 -56.7 0.97 Allowed 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.202 2.602 . . . . 0.0 114.917 -168.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -83.26 45.11 1.0 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.207 0.603 . . . . 0.0 110.521 -166.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.1 t -140.35 -64.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -56.98 -31.09 64.69 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 125.129 1.372 . . . . 0.0 113.553 -175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.72 54.47 1.5 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -175.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.92 -36.48 0.14 Allowed 'General case' 0 C--O 1.234 0.255 0 C-N-CA 124.495 1.118 . . . . 0.0 110.751 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 C--O 1.252 1.227 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 163.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.467 0.402 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.8 mtt-85 -167.59 178.12 5.54 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 128.749 2.819 . . . . 0.0 107.622 173.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.2 m -69.99 -43.37 71.57 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 120.13 1.332 . . . . 0.0 110.505 163.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.3 m-20 50.6 -155.88 0.12 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.153 0.981 . . . . 0.0 109.509 -161.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.643 HG22 ' H ' ' A' ' 35' ' ' ASP . 4.7 mm -135.09 -177.24 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 127.782 2.433 . . . . 0.0 105.016 176.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.643 ' H ' HG22 ' A' ' 34' ' ' ILE . 4.1 m-20 -54.96 150.97 9.39 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 126.746 2.018 . . . . 0.0 112.295 -172.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.77 175.68 2.87 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-O 123.5 1.619 . . . . 0.0 109.535 165.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -166.26 153.62 9.84 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 113.779 -1.555 . . . . 0.0 107.195 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' CE1' ' HD2' ' A' ' 47' ' ' LYS . 97.6 m-85 -144.91 -179.9 6.91 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.715 1.606 . . . . 0.0 108.73 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.624 ' HA ' HG23 ' A' ' 62' ' ' VAL . 12.1 p -139.38 177.09 2.19 Favored Pre-proline 0 N--CA 1.449 -0.508 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 172.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.64 -13.53 22.26 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 CA-C-N 120.661 1.272 . . . . 0.0 111.567 -174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -85.87 -45.59 5.66 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 165.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 39' ' ' THR . 45.4 mt-10 -63.83 -30.78 71.83 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 119.029 1.414 . . . . 0.0 111.177 -167.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -70.01 -21.43 23.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-N 119.43 1.013 . . . . 0.0 111.238 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.2 mt -107.94 -44.98 4.07 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.562 1.074 . . . . 0.0 111.433 -173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -98.12 -9.94 25.02 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.5 1.92 . . . . 0.0 113.23 -168.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.9 133.9 5.18 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.493 ' HD2' ' CE1' ' A' ' 38' ' ' TYR . 26.5 tttm -59.4 131.11 49.99 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 121.299 -1.118 . . . . 0.0 109.161 160.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 55.0 mtp85 -18.82 -21.77 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.817 1 C-N-CA 133.961 4.904 . . . . 0.0 121.346 -142.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.03 -76.21 0.58 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 120.732 1.605 . . . . 0.0 107.047 166.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 t -170.99 20.7 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.818 1.647 . . . . 0.0 108.969 -170.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' CD ' ' HG2' ' A' ' 47' ' ' LYS . 1.4 pt20 -69.78 -55.94 8.49 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 120.245 -1.534 . . . . 0.0 110.065 -157.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.55 164.86 21.61 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 126.644 1.978 . . . . 0.0 107.369 167.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 22.1 mtp -116.94 166.65 12.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.792 1.237 . . . . 0.0 108.432 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -74.6 172.15 16.77 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 CA-C-N 121.261 1.486 . . . . 0.0 110.85 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -89.17 139.49 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.011 1.324 . . . . 0.0 107.684 163.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.9 0.59 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 C-N-CA 124.824 1.249 . . . . 0.0 110.275 173.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.48 56.96 0.72 Allowed Glycine 0 N--CA 1.451 -0.305 0 O-C-N 120.196 -1.565 . . . . 0.0 111.847 164.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -141.36 -175.47 4.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.162 0.981 . . . . 0.0 111.314 166.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.88 141.03 36.85 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 124.117 0.967 . . . . 0.0 110.376 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.9 -179.62 8.02 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 125.408 1.483 . . . . 0.0 111.082 -176.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 mtm180 -122.65 151.53 41.4 Favored 'General case' 0 CA--C 1.512 -0.501 0 C-N-CA 127.071 2.148 . . . . 0.0 110.751 175.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 39' ' ' THR . 0.2 OUTLIER -148.98 128.55 3.73 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.615 0 N-CA-C 120.261 3.43 . . . . 0.0 120.261 169.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.85 141.51 18.66 Favored Glycine 0 CA--C 1.521 0.456 0 C-N-CA 124.405 1.002 . . . . 0.0 110.82 171.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.34 177.67 47.82 Favored Glycine 0 N--CA 1.471 0.986 0 CA-C-O 119.427 -0.652 . . . . 0.0 113.153 166.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 35.2 ttm -102.36 129.74 48.91 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.481 1.112 . . . . 0.0 110.152 -177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -66.9 132.14 32.34 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 124.358 1.063 . . . . 0.0 109.643 -175.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.4 mtt -62.47 132.61 94.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.292 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.15 131.3 29.97 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.901 1.734 . . . . 0.0 108.714 174.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.54 29.17 72.73 Favored Glycine 0 CA--C 1.531 1.06 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.702 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.3 p -86.14 -74.39 0.42 Allowed 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 159.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.282 2.6 p -37.66 88.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 130.616 3.566 . . . . 0.0 114.816 -170.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -77.6 137.84 38.8 Favored 'General case' 0 N--CA 1.436 -1.134 0 C-N-CA 127.467 2.307 . . . . 0.0 105.553 163.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 -136.86 128.18 28.2 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.28 98.24 11.72 Favored Pre-proline 0 N--CA 1.445 -0.686 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -169.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -65.38 -14.54 45.53 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 CA-C-N 120.62 1.257 . . . . 0.0 110.861 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -90.41 -12.97 35.91 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 117.129 -1.415 . . . . 0.0 112.716 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 79' ' ' LYS . 0.5 OUTLIER -135.73 4.41 3.06 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 121.512 1.96 . . . . 0.0 114.302 -177.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . 0.279 0.0 OUTLIER 47.06 -2.71 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 129.346 3.058 . . . . 0.0 116.224 -162.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 77' ' ' SER . 0.0 OUTLIER -56.63 149.16 18.18 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 126.276 1.83 . . . . 0.0 109.69 175.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -133.6 148.99 30.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 166.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.1 p -131.94 119.8 21.61 Favored 'General case' 0 N--CA 1.436 -1.129 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 161.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -137.27 168.04 20.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.233 0.613 . . . . 0.0 109.603 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 18.5 m -122.99 147.31 46.78 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.473 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.91 139.87 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -140.09 174.34 10.61 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.298 1.039 . . . . 0.0 110.27 -170.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -153.11 -168.9 3.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.174 2.189 . . . . 0.0 106.266 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.03 -4.35 16.59 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.9 -66.77 0.95 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.797 -1.556 . . . . 0.0 106.797 -171.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -154.45 -163.47 11.99 Favored Glycine 0 CA--C 1.525 0.706 0 C-N-CA 125.371 1.462 . . . . 0.0 110.681 -170.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 79.9 p -150.94 158.71 44.48 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 118.013 0.906 . . . . 0.0 111.251 -177.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 23.6 m -140.66 150.23 20.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 C-N-CA 124.953 1.301 . . . . 0.0 108.721 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.32 157.57 23.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.632 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.473 ' CG2' HD11 ' A' ' 84' ' ' ILE . 98.4 t -133.1 120.8 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 168.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 21.1 m -91.56 121.79 33.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 152.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -115.11 171.44 7.67 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 164.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -162.15 99.06 1.07 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.091 -2.559 . . . . 0.0 104.091 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 167.82 -144.71 9.11 Favored Glycine 0 CA--C 1.506 -0.486 0 C-N-CA 120.062 -1.066 . . . . 0.0 113.214 -175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 49.2 mm -109.82 91.8 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 18.4 tp -59.47 130.03 87.36 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-N 113.901 -1.499 . . . . 0.0 107.868 170.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -54.84 138.31 76.92 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.031 1.82 . . . . 0.0 109.359 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -56.78 -31.84 65.04 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-O 121.672 0.749 . . . . 0.0 111.197 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.32 -22.32 66.81 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.711 1.604 . . . . 0.0 114.63 173.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -69.98 131.79 44.92 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 119.927 1.24 . . . . 0.0 108.835 173.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -140.96 170.29 16.02 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.014 -1.054 . . . . 0.0 109.468 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.1 mp0 -73.41 123.16 23.3 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 89.49 26.55 25.01 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 123.381 0.515 . . . . 0.0 113.269 170.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.47 171.69 10.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 124.555 1.142 . . . . 0.0 109.684 170.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.74 128.02 9.34 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 125.999 1.762 . . . . 0.0 109.054 -173.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 m -127.35 175.82 8.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.3 t -128.05 139.57 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 126.622 1.969 . . . . 0.0 106.668 172.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG12 HG13 ' A' ' 62' ' ' VAL . 0.5 OUTLIER -113.37 164.84 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.11 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 173.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -160.4 143.0 13.16 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 126.527 1.931 . . . . 0.0 107.627 172.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.59 -124.1 1.67 Allowed Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 105.098 -3.201 . . . . 0.0 105.098 174.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -128.9 156.91 42.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 120.127 1.963 . . . . 0.0 109.192 -161.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.73 137.73 32.08 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 123.843 0.857 . . . . 0.0 109.482 171.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -99.71 -84.0 0.42 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.995 0.816 . . . . 0.0 109.063 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -173.91 167.61 4.31 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 129.714 3.206 . . . . 0.0 106.299 -172.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 57.11 24.24 50.14 Favored Glycine 0 CA--C 1.526 0.768 0 CA-C-O 118.96 -0.911 . . . . 0.0 113.151 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.4 m120 62.66 58.19 1.66 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.64 1.576 . . . . 0.0 111.087 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 12.2 t-160 -131.32 127.49 37.79 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.44 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.5 mm -102.63 125.92 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 C-N-CA 126.675 1.99 . . . . 0.0 109.037 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.52 83.97 5.45 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 163.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -53.47 148.2 9.59 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 122.112 0.958 . . . . 0.0 112.25 165.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -18.76 8.73 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 128.384 2.674 . . . . 0.0 110.912 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.33 -51.64 0.48 Allowed 'General case' 0 C--N 1.345 0.393 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -177.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 48.8 t 60.69 130.2 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 127.097 2.159 . . . . 0.0 112.394 -175.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 68.3 mt -135.97 146.49 47.29 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 120.746 -1.221 . . . . 0.0 107.897 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -106.41 34.66 3.27 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.854 0.862 . . . . 0.0 110.563 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt 38.94 53.78 2.04 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.704 1.602 . . . . 0.0 114.708 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -96.92 -91.73 0.24 Allowed 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 106.157 -1.794 . . . . 0.0 106.157 175.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -150.78 118.03 5.99 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 102.012 -3.329 . . . . 0.0 102.012 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -158.83 164.44 35.76 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 127.128 2.171 . . . . 0.0 106.166 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -133.5 173.92 10.97 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -162.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -119.47 118.63 31.6 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-O 122.179 0.99 . . . . 0.0 111.801 -163.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 45.3 m -79.21 123.86 84.58 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.387 1.875 . . . . 0.0 106.866 168.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 56.7 Cg_endo -69.67 -178.1 2.15 Favored 'Trans proline' 0 CA--C 1.541 0.841 1 C-N-CA 125.874 4.383 . . . . 0.0 110.907 178.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 136' ' ' PRO . 44.1 Cg_endo -80.04 -179.36 5.21 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 121.945 1.763 . . . . 0.0 110.537 172.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 50.23 64.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 129.164 2.986 . . . . 0.0 110.794 -173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -162.52 -34.3 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 126.028 1.731 . . . . 0.0 109.821 177.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.62 -70.84 0.16 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.171 2.188 . . . . 0.0 111.6 -167.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.6 150.89 42.62 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 76.51 26.42 0.88 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.73 2.012 . . . . 0.0 113.256 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.1 mmt . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.354 -1.308 . . . . 0.0 107.988 151.603 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 CA--C 1.517 -0.307 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 mtp180 -157.26 169.54 24.52 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 129.017 2.927 . . . . 0.0 107.115 169.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.4 t -150.47 -173.41 4.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.086 0.954 . . . . 0.0 109.135 -171.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.57 -179.21 0.32 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 129.181 2.993 . . . . 0.0 106.54 168.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 mt -60.98 148.55 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 156.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 68.34 139.14 0.03 OUTLIER 'General case' 0 C--O 1.235 0.333 0 C-N-CA 128.185 2.594 . . . . 0.0 114.913 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.447 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.8 pp -90.65 176.81 6.53 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.133 1.373 . . . . 0.0 108.83 166.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 27.4 t80 -174.53 135.39 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 127.11 2.164 . . . . 0.0 106.074 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -125.09 176.71 6.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.509 1.524 . . . . 0.0 109.202 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.547 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 61.5 p -136.24 173.85 5.16 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.645 1.578 . . . . 0.0 108.545 173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 73.4 Cg_endo -75.74 -13.36 19.95 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 121.685 1.59 . . . . 0.0 112.205 -166.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.25 -45.75 7.33 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 162.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.547 ' HB2' ' H ' ' A' ' 39' ' ' THR . 30.3 mt-10 -60.17 -29.17 68.5 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 120.334 2.067 . . . . 0.0 113.036 -168.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mt -73.34 -22.26 19.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 118.594 -0.717 . . . . 0.0 111.475 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.7 -35.51 3.36 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.475 1.11 . . . . 0.0 111.478 -169.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.86 -31.27 18.35 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.482 2.313 . . . . 0.0 110.518 178.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.64 149.46 7.47 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 125.251 1.405 . . . . 0.0 111.869 178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -62.13 133.53 55.36 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 122.013 -0.698 . . . . 0.0 110.826 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 61.1 mtm180 -18.52 -68.06 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.836 1.654 . . . . 0.0 115.308 -136.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' H ' ' NE2' ' A' ' 51' ' ' GLN . 8.3 mp0 -71.43 -58.63 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -174.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.8 t 170.75 33.84 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 128.929 2.892 . . . . 0.0 110.326 163.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.461 ' NE2' ' H ' ' A' ' 49' ' ' GLU . 0.4 OUTLIER -80.89 14.61 2.13 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 119.557 -1.964 . . . . 0.0 113.855 -160.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 146.8 171.66 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 1 C-N-CA 133.802 4.841 . . . . 0.0 109.581 171.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 40.9 mtp -114.38 159.0 38.41 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 125.337 1.455 . . . . 0.0 107.211 168.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.34 158.01 59.38 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 CA-C-N 121.432 1.547 . . . . 0.0 110.085 173.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -79.43 144.9 33.64 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 165.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.53 ' HA ' HD13 ' A' ' 115' ' ' LEU . 7.1 p -82.9 -7.25 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 123.625 0.77 . . . . 0.0 111.582 174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -105.55 43.18 1.72 Allowed Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.748 1.166 . . . . 0.0 110.512 165.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.445 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.5 pt20 -141.52 169.32 17.83 Favored 'General case' 0 C--N 1.341 0.22 0 CA-C-N 120.127 1.964 . . . . 0.0 113.047 172.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -87.92 140.58 29.36 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.041 2.537 . . . . 0.0 108.609 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -155.12 -174.59 5.04 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 123.495 0.718 . . . . 0.0 110.621 177.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -134.38 147.21 50.46 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 126.148 1.779 . . . . 0.0 107.485 169.629 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.28 130.48 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 126.177 1.791 . . . . 0.0 106.532 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.65 157.01 20.26 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 163.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 176.74 172.68 41.62 Favored Glycine 0 C--O 1.236 0.26 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 24.2 ttm -99.01 125.31 44.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.8 t -59.37 121.12 6.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 3.7 ttm -64.16 126.84 91.11 Favored Pre-proline 0 N--CA 1.446 -0.655 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 170.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.93 154.43 73.21 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 122.28 1.987 . . . . 0.0 108.368 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.76 44.55 80.57 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.778 -176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 m -133.12 -38.43 0.96 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.895 1.348 . . . . 0.0 113.225 169.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.269 1.6 p -64.57 92.76 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 119.567 1.076 . . . . 0.0 112.059 -172.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.417 ' HG3' ' HB ' ' A' ' 81' ' ' THR . 5.9 pt20 -82.07 86.46 6.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 127.892 2.477 . . . . 0.0 107.703 171.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.75 142.3 40.49 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 168.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.29 108.73 6.74 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 104.791 -2.3 . . . . 0.0 104.791 168.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -68.68 -5.37 15.21 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 CA-C-N 122.215 1.827 . . . . 0.0 111.22 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -119.9 13.74 12.31 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.63 2.372 . . . . 0.0 110.492 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.61 -160.01 0.98 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 120.055 1.298 . . . . 0.0 108.655 176.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mp -122.9 -7.85 8.4 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 123.583 0.753 . . . . 0.0 110.89 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.99 131.03 46.23 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 164.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.5 p -147.25 130.09 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 105.434 -2.062 . . . . 0.0 105.434 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.417 ' HB ' ' HG3' ' A' ' 72' ' ' GLN . 92.0 m -126.46 134.45 50.96 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 -171.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -149.35 176.38 10.61 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 120.231 -1.543 . . . . 0.0 110.352 -174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 14.8 m -123.18 145.78 48.34 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.416 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -130.68 142.24 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.285 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -137.99 171.99 13.59 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.635 1.174 . . . . 0.0 109.516 -172.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -151.09 -169.07 3.28 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.299 1.439 . . . . 0.0 107.383 168.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.67 9.99 0.31 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.582 1.553 . . . . 0.0 114.412 -177.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.47 -67.11 0.78 Allowed 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 125.003 1.321 . . . . 0.0 109.504 -175.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -138.32 -175.47 13.95 Favored Glycine 0 CA--C 1.519 0.335 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -174.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.1 p -143.51 158.08 43.93 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.297 1.039 . . . . 0.0 109.973 176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.409 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.9 m -141.37 149.01 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 124.627 1.171 . . . . 0.0 109.707 -171.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -85.13 148.0 26.35 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.99 1.316 . . . . 0.0 107.883 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.416 HG21 HD11 ' A' ' 84' ' ' ILE . 23.5 t -138.01 119.09 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 124.104 0.961 . . . . 0.0 108.779 174.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.1 t -91.94 129.65 37.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 105.647 -1.982 . . . . 0.0 105.647 159.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -124.23 163.78 20.9 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.653 1.181 . . . . 0.0 108.747 166.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -144.87 100.17 3.45 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 171.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.88 -179.4 43.58 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.3 tp -71.36 -24.38 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 O-C-N 122.064 -0.668 . . . . 0.0 111.84 -159.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 99' ' ' LEU . 7.8 tp 65.36 129.24 0.03 OUTLIER Pre-proline 0 N--CA 1.444 -0.727 0 C-N-CA 128.803 2.841 . . . . 0.0 110.623 -166.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 4.5 Cg_exo -66.03 169.04 14.2 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 124.255 3.303 . . . . 0.0 110.689 -168.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -60.49 -36.07 77.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.982 175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -35.34 63.13 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.568 2.747 . . . . 0.0 113.025 -171.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -63.76 131.88 49.23 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.466 1.03 . . . . 0.0 109.092 -169.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 mtt85 -143.14 161.0 39.36 Favored 'General case' 0 CA--C 1.514 -0.436 0 C-N-CA 123.882 0.873 . . . . 0.0 111.313 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -64.06 117.39 7.01 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 116.86 4.95 16.17 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.958 -0.912 . . . . 0.0 114.938 172.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -131.7 167.04 20.17 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.925 1.363 . . . . 0.0 112.151 -175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.05 137.28 15.34 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 125.737 1.637 . . . . 0.0 109.977 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.5 m -135.82 168.61 22.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.95 108.91 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 127.652 2.381 . . . . 0.0 106.541 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 126' ' ' VAL . 2.8 t -80.26 158.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 C-N-CA 124.717 1.207 . . . . 0.0 108.986 161.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 5.6 tt0 -156.67 147.15 21.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 129.439 3.096 . . . . 0.0 105.716 172.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 154.84 -112.39 0.52 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 107.94 -2.064 . . . . 0.0 107.94 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -147.63 159.34 43.88 Favored 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 119.734 1.767 . . . . 0.0 110.41 -173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.53 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -86.02 142.61 28.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.117 0.967 . . . . 0.0 108.589 172.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 -84.25 0.48 Allowed 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.55 1.14 . . . . 0.0 108.185 -176.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -166.92 154.53 9.32 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 128.94 2.896 . . . . 0.0 106.709 173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 61.6 42.91 99.85 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.149 -0.78 . . . . 0.0 111.149 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.1 m120 56.16 40.88 30.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.135 1.374 . . . . 0.0 111.929 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.2 t-160 -109.82 124.36 51.18 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.476 HG21 ' CG1' ' A' ' 111' ' ' VAL . 18.1 mm -96.28 131.07 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 C-N-CA 124.711 1.204 . . . . 0.0 108.649 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.88 114.21 17.63 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 154.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 149.22 39.94 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 121.874 0.845 . . . . 0.0 108.849 161.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.13 -21.85 11.28 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.606 1.163 . . . . 0.0 111.173 173.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -146.17 -47.13 0.2 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 117.809 -1.091 . . . . 0.0 112.242 -173.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 111' ' ' VAL . 46.0 t 59.24 150.03 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 126.243 1.817 . . . . 0.0 109.371 -167.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 28.0 mt -147.89 151.59 36.14 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 119.192 -2.193 . . . . 0.0 107.045 172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -107.14 33.88 3.76 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.681 1.128 . . . . 0.0 112.674 -174.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.8 mmmt 54.45 30.23 12.51 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -70.45 45.74 0.08 Allowed 'General case' 0 CA--C 1.539 0.541 0 O-C-N 119.419 -2.051 . . . . 0.0 111.582 162.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 33.0 t0 55.06 46.76 23.47 Favored 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 124.14 0.976 . . . . 0.0 112.529 165.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.71 -55.66 3.55 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.066 0.946 . . . . 0.0 110.911 -167.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . 0.263 92.6 m-20 39.02 -165.81 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 128.629 2.772 . . . . 0.0 113.672 -161.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -59.93 129.43 41.79 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 120.909 -1.12 . . . . 0.0 109.104 -171.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.49 HG22 HG11 ' A' ' 139' ' ' VAL . 23.8 m -127.07 134.88 26.61 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 -177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -66.88 176.38 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 124.047 3.165 . . . . 0.0 111.272 178.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.62 -173.78 1.87 Allowed 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.529 2.152 . . . . 0.0 110.866 164.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 61.34 32.91 19.09 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.267 1.827 . . . . 0.0 111.57 -176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.49 HG11 HG22 ' A' ' 135' ' ' THR . 9.1 p -146.99 -143.07 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -172.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.48 ' H ' HG22 ' A' ' 139' ' ' VAL . 1.9 tp10 72.65 -73.66 0.1 Allowed 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 129.557 3.143 . . . . 0.0 110.911 178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -163.67 -39.16 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.314 0 O-C-N 124.599 1.187 . . . . 0.0 111.724 -167.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.17 66.7 1.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.707 1.203 . . . . 0.0 109.003 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 93.1 mtp . . . . . 0 C--O 1.251 1.146 0 C-N-CA 126.704 2.001 . . . . 0.0 109.568 -162.42 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.3 tt . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.03 -76.87 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.171 -1.789 . . . . 0.0 106.171 158.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 27.5 t -54.81 156.17 3.84 Favored 'General case' 0 C--O 1.246 0.895 0 O-C-N 124.489 1.118 . . . . 0.0 108.184 156.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -80.18 -161.7 0.38 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.021 1.329 . . . . 0.0 109.595 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 mt -143.07 146.59 21.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.123 -1.806 . . . . 0.0 106.123 172.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -74.0 -166.8 0.42 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.923 1.689 . . . . 0.0 110.528 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.36 -170.91 2.2 Favored 'General case' 0 N--CA 1.449 -0.48 0 O-C-N 120.281 -1.512 . . . . 0.0 109.175 -172.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -170.32 154.77 4.94 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.179 0.991 . . . . 0.0 109.908 -170.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.566 ' C ' HG23 ' A' ' 62' ' ' VAL . 99.3 m-85 -133.27 -170.11 2.41 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 119.553 1.07 . . . . 0.0 110.302 170.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.435 ' HB ' ' CD ' ' A' ' 40' ' ' PRO . 39.9 p -141.99 170.99 7.93 Favored Pre-proline 0 CA--C 1.534 0.359 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 158.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.577 ' O ' HD21 ' A' ' 44' ' ' LEU . 48.5 Cg_endo -81.22 -1.43 11.12 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 121.511 1.474 . . . . 0.0 112.439 -159.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.421 ' HA2' HD23 ' A' ' 44' ' ' LEU . . . -103.86 -7.58 41.28 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.673 1.606 . . . . 0.0 110.578 165.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.97 18.0 22.76 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 120.436 -1.626 . . . . 0.0 110.066 -176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.405 ' CD1' HD11 ' A' ' 121' ' ' ILE . 7.3 mt -109.12 -23.15 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 171.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.869 HD22 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -95.35 -50.68 4.91 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 126.629 1.972 . . . . 0.0 111.036 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -73.95 -63.9 1.12 Allowed 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -172.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 170.03 175.73 39.17 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 170.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HB3' ' H ' ' A' ' 52' ' ' GLN . 12.0 tptp -70.86 126.02 28.45 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 116.9 -1.524 . . . . 0.0 108.311 159.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 ptt-85 -65.09 -23.17 67.08 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 121.017 1.735 . . . . 0.0 114.662 -175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -55.72 -67.64 0.27 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 120.401 1.455 . . . . 0.0 111.894 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.9 t -147.57 33.9 0.86 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 122.255 1.026 . . . . 0.0 109.824 -174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 48.59 63.76 1.96 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.174 2.19 . . . . 0.0 111.515 171.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.426 ' H ' ' HB3' ' A' ' 47' ' ' LYS . 17.1 mt-30 -86.06 -68.55 0.73 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 112.351 -2.204 . . . . 0.0 108.76 -167.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 mtp 87.98 125.1 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.565 0 C-N-CA 129.188 2.995 . . . . 0.0 109.252 174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -65.41 147.21 87.01 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.53 1.487 . . . . 0.0 109.633 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.36 147.48 32.39 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.076 0.465 . . . . 0.0 109.815 -176.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.3 t -71.54 -8.47 11.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 C-N-CA 125.369 1.468 . . . . 0.0 111.232 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.1 40.72 1.82 Allowed Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 125.217 1.389 . . . . 0.0 110.504 174.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -134.96 170.55 15.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 119.341 1.57 . . . . 0.0 111.837 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -88.54 151.81 22.27 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.623 170.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.525 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -155.88 176.75 12.23 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.291 1.036 . . . . 0.0 112.376 172.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.416 HH21 ' CD1' ' A' ' 127' ' ' LEU . 50.8 ttt180 -124.48 148.53 47.62 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 128.146 2.578 . . . . 0.0 107.049 172.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.67 HG12 HG12 ' A' ' 111' ' ' VAL . 6.0 p -147.56 167.27 5.17 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.398 0 CA-C-N 119.975 1.261 . . . . 0.0 111.353 172.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 110' ' ' VAL . . . -142.2 155.25 25.49 Favored Glycine 0 C--N 1.336 0.556 0 CA-C-N 119.981 1.264 . . . . 0.0 111.677 169.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 174.84 -175.93 47.01 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 124.563 1.077 . . . . 0.0 113.28 -175.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.5 ttm -103.21 123.78 47.37 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.484 1.514 . . . . 0.0 110.673 -170.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 69.9 t -71.7 129.58 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 120.885 -1.134 . . . . 0.0 109.848 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 49.5 mtt -63.75 152.22 87.0 Favored Pre-proline 0 C--O 1.239 0.546 0 CA-C-N 118.62 0.645 . . . . 0.0 112.085 175.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -53.99 141.32 68.06 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.251 2.634 . . . . 0.0 110.745 170.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.75 3.85 1.27 Allowed Glycine 0 CA--C 1.529 0.96 0 C-N-CA 125.369 1.461 . . . . 0.0 115.649 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 78.7 p -73.24 -26.21 61.03 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.743 1.771 . . . . 0.0 112.121 -170.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 t -67.39 103.78 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 124.897 1.279 . . . . 0.0 109.909 -174.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -86.78 30.32 0.75 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 128.669 2.787 . . . . 0.0 111.219 176.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -52.6 129.75 30.15 Favored 'General case' 0 CA--C 1.511 -0.547 0 C-N-CA 123.458 0.703 . . . . 0.0 109.192 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.45 119.53 77.27 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 105.011 -2.218 . . . . 0.0 105.011 172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -70.65 -6.44 19.05 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.294 1.996 . . . . 0.0 112.641 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -118.38 6.77 11.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.52 1.528 . . . . 0.0 111.766 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 t -149.43 -166.94 2.69 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 124.597 1.159 . . . . 0.0 107.979 -174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.4 mt -121.69 -2.64 9.33 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.642 0.777 . . . . 0.0 112.084 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mmmt -60.57 136.14 57.97 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 107.856 -1.165 . . . . 0.0 107.856 166.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' A' ' 95' ' ' TYR . 2.7 p -156.66 134.62 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.524 HG22 ' HA ' ' A' ' 94' ' ' SER . 43.3 p -124.9 162.15 25.05 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 167.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 93' ' ' VAL . 27.6 p90 -152.13 179.32 8.6 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 119.741 1.155 . . . . 0.0 109.349 172.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.6 m -115.71 145.88 42.37 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 167.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.67 139.1 52.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 173.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -139.05 170.52 15.83 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 126.116 1.766 . . . . 0.0 109.636 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -161.3 -154.12 0.34 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.558 1.543 . . . . 0.0 106.879 169.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.65 -22.38 62.51 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.814 -1.179 . . . . 0.0 112.872 -164.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.3 -76.12 0.53 Allowed 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 104.378 -2.453 . . . . 0.0 104.378 -175.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.88 -166.98 12.66 Favored Glycine 0 C--N 1.336 0.573 0 O-C-N 121.46 -0.775 . . . . 0.0 112.229 -169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 88.3 p -140.78 160.64 39.61 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.771 0.828 . . . . 0.0 112.023 -174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 34.3 m -136.14 153.97 32.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 125.036 1.334 . . . . 0.0 109.646 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -76.15 150.56 37.15 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.51 165.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.588 HG21 ' CE1' ' A' ' 82' ' ' PHE . 5.1 m -118.0 160.66 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 156.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.524 ' HA ' HG22 ' A' ' 81' ' ' THR . 25.9 m -129.62 127.44 40.63 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 159.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.521 ' HB3' HG13 ' A' ' 80' ' ' VAL . 11.2 t80 -127.41 168.62 14.6 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.633 1.573 . . . . 0.0 108.505 174.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -157.96 92.13 1.16 Allowed 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 172.0 -176.38 45.09 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.562 -0.828 . . . . 0.0 111.418 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.2 tp -77.02 113.35 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.462 HD22 HG21 ' A' ' 80' ' ' VAL . 9.7 tp -77.24 143.39 69.34 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -58.46 146.31 90.92 Favored 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 121.113 1.209 . . . . 0.0 109.065 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -63.45 -30.82 71.89 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 167.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.46 -36.97 85.48 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 126.705 2.002 . . . . 0.0 110.978 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.419 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 43.2 t80 -56.23 133.0 52.16 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.002 1.721 . . . . 0.0 109.039 177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.83 167.13 21.13 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.319 0.963 . . . . 0.0 112.312 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -74.72 112.9 11.39 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 161.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.74 49.13 5.85 Favored Glycine 0 CA--C 1.524 0.616 0 O-C-N 121.271 -0.893 . . . . 0.0 112.181 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.538 ' OE1' ' HB1' ' A' ' 128' ' ' ALA . 3.8 pt20 -119.63 -170.29 1.92 Allowed 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.386 -1.067 . . . . 0.0 109.542 145.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -102.87 140.68 14.95 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 171.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 2.3 m -143.66 178.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 125.764 1.625 . . . . 0.0 107.922 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HA ' ' HA2' ' A' ' 63' ' ' GLY . 2.2 t -131.65 142.18 43.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 175.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.688 ' CG1' HG21 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -107.65 163.98 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 CA-C-O 121.868 0.842 . . . . 0.0 109.55 162.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.9 tt0 -157.48 144.27 18.14 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 126.036 1.734 . . . . 0.0 106.609 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 158.93 -109.02 0.38 Allowed Glycine 0 CA--C 1.518 0.253 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 172.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 59' ' ' ARG . 2.2 mt-10 -140.91 162.93 34.3 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 120.165 1.983 . . . . 0.0 109.541 -173.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 60' ' ' LEU . 12.5 tp -89.24 140.26 29.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 123.566 0.746 . . . . 0.0 110.154 171.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.79 -77.95 0.52 Allowed 'General case' 0 C--O 1.223 -0.29 0 C-N-CA 124.051 0.94 . . . . 0.0 108.78 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.82 166.47 3.67 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 131.287 3.835 . . . . 0.0 105.13 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 54.39 27.9 42.04 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-N 120.198 1.363 . . . . 0.0 113.653 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 13.6 m120 70.71 4.96 5.23 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.841 2.057 . . . . 0.0 114.263 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 15.4 t-160 -71.35 139.31 49.79 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 127.042 2.137 . . . . 0.0 109.691 179.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.688 HG21 ' CG1' ' A' ' 111' ' ' VAL . 6.1 mm -106.29 133.89 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 126.765 2.026 . . . . 0.0 110.164 177.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.411 HD13 ' HA ' ' A' ' 122' ' ' LEU . 4.2 mm? -78.84 106.94 11.2 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 154.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -60.96 137.65 58.21 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 121.513 0.673 . . . . 0.0 110.22 153.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.24 -11.61 11.95 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 127.615 2.366 . . . . 0.0 110.974 174.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -147.82 -46.23 0.16 Allowed 'General case' 0 C--O 1.225 -0.234 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 66.8 t 57.17 141.38 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 125.876 1.67 . . . . 0.0 111.601 -165.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.416 ' CD1' HH21 ' A' ' 61' ' ' ARG . 53.9 mt -139.38 162.59 34.67 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 175.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.538 ' HB1' ' OE1' ' A' ' 107' ' ' GLN . . . -125.53 29.27 6.04 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.384 1.074 . . . . 0.0 112.226 -177.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt 49.58 43.95 24.19 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.688 1.995 . . . . 0.0 115.137 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.433 ' NE2' ' HB3' ' A' ' 128' ' ' ALA . 0.3 OUTLIER -91.23 35.09 0.92 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 124.536 1.134 . . . . 0.0 110.201 175.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.7 t0 61.35 89.13 0.08 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 126.445 1.898 . . . . 0.0 111.544 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -131.05 160.56 34.28 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.817 1.647 . . . . 0.0 109.118 174.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 28.2 t30 -124.48 123.59 40.46 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.964 1.306 . . . . 0.0 108.211 -173.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -61.86 166.08 4.8 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.483 1.135 . . . . 0.0 113.313 -165.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 78.3 m -116.67 131.89 23.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.369 1.468 . . . . 0.0 107.544 177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.31 -179.0 1.64 Allowed 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.096 3.197 . . . . 0.0 112.013 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.52 -40.09 0.47 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.208 1.939 . . . . 0.0 114.612 174.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -71.93 67.49 0.62 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.669 1.588 . . . . 0.0 109.478 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -173.33 -61.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 126.473 1.909 . . . . 0.0 107.374 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.32 -75.03 0.1 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.607 1.163 . . . . 0.0 110.697 -166.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -150.46 53.17 0.89 Allowed 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.209 1.004 . . . . 0.0 110.21 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.78 1.5 0.79 Allowed 'General case' 0 C--O 1.235 0.291 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 173.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 119.436 1.017 . . . . 0.0 109.966 179.734 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 118.672 -0.68 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.9 mtt85 -136.03 161.65 35.08 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.871 0.869 . . . . 0.0 110.736 -172.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.7 m -147.42 128.74 14.82 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.375 1.87 . . . . 0.0 107.502 169.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -151.4 -26.35 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.5 mm -120.95 -178.43 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -176.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -62.41 157.49 19.91 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.853 0.861 . . . . 0.0 110.583 167.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.406 ' H ' ' HG ' ' A' ' 36' ' ' LEU . 1.3 pp -74.21 177.98 5.42 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 122.836 1.303 . . . . 0.0 111.264 175.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -173.13 136.77 0.66 Allowed 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 127.768 2.427 . . . . 0.0 106.311 -169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.535 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 79.3 m-85 -131.6 -175.11 3.6 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.033 1.733 . . . . 0.0 109.545 -178.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.458 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 72.5 p -142.1 169.07 11.8 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 124.372 1.069 . . . . 0.0 112.78 -178.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.77 71.54 0.34 Allowed 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.569 2.846 . . . . 0.0 110.747 157.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 170.21 -56.17 0.19 Allowed Glycine 0 N--CA 1.438 -1.179 0 C-N-CA 127.899 2.666 . . . . 0.0 106.976 -175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.458 ' HB2' ' H ' ' A' ' 39' ' ' THR . 32.3 mt-10 -68.24 -9.36 46.67 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -173.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.709 HG22 HD22 ' A' ' 119' ' ' ASN . 5.1 mt -104.84 -22.35 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 C-N-CA 125.118 1.367 . . . . 0.0 108.327 -177.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -95.42 -48.38 5.89 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 127.731 2.412 . . . . 0.0 111.711 -175.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -93.93 -64.51 1.07 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.684 1.994 . . . . 0.0 107.081 -177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.59 164.5 18.85 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 125.663 1.602 . . . . 0.0 109.226 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.535 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 1.2 tptt -49.5 174.2 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 126.673 1.989 . . . . 0.0 111.229 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 -47.57 -20.73 0.27 Allowed 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 117.629 2.455 . . . . 0.0 117.629 -171.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' H ' HE22 ' A' ' 51' ' ' GLN . 41.1 mt-10 -121.49 -52.61 2.03 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 121.048 1.749 . . . . 0.0 109.775 146.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -161.66 -51.87 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.555 1.142 . . . . 0.0 108.66 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.465 HE22 ' H ' ' A' ' 49' ' ' GLU . 0.9 OUTLIER 43.75 -71.28 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 129.315 3.046 . . . . 0.0 116.399 -174.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.407 HE22 ' NZ ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -179.71 15.47 0.0 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 127.642 2.377 . . . . 0.0 114.062 -170.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.55 -178.14 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.618 0 C-N-CA 125.063 1.345 . . . . 0.0 111.836 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -84.3 155.73 12.64 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.44 2.093 . . . . 0.0 109.747 150.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.88 143.97 30.39 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 159.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.594 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.2 p -73.57 -15.58 16.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 123.053 0.541 . . . . 0.0 111.369 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -103.04 37.38 3.74 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-O 117.384 -1.787 . . . . 0.0 111.741 171.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -137.1 174.06 11.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.654 2.227 . . . . 0.0 112.399 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -106.89 138.86 42.26 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 125.409 1.484 . . . . 0.0 110.226 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.06 167.5 30.26 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 124.797 1.239 . . . . 0.0 112.034 -171.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 11.6 mtm180 -99.52 150.43 22.22 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 126.1 1.76 . . . . 0.0 109.779 165.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.5 t -129.73 154.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 126.841 2.056 . . . . 0.0 106.925 168.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -136.63 152.97 21.44 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 155.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.24 179.51 48.02 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.1 ttm -101.51 130.04 47.71 Favored 'General case' 0 C--O 1.22 -0.468 0 C-N-CA 123.835 0.854 . . . . 0.0 109.545 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 103' ' ' PHE . 93.7 t -69.04 125.28 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 119.782 1.173 . . . . 0.0 108.266 -176.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.5 mtt -57.44 139.18 80.87 Favored Pre-proline 0 C--O 1.238 0.457 0 CA-C-N 119.006 0.821 . . . . 0.0 110.25 176.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.89 124.69 10.84 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.302 2.668 . . . . 0.0 107.522 176.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.6 65.37 3.29 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 -168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 91.9 p -135.41 -35.01 0.83 Allowed 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 117.45 0.625 . . . . 0.0 111.952 167.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -70.34 107.34 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 O-C-N 121.359 -0.838 . . . . 0.0 110.241 -174.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -91.77 59.84 3.8 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 131.623 3.969 . . . . 0.0 108.697 175.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 1.7 ptt85 -74.99 166.65 23.33 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 120.708 -1.245 . . . . 0.0 110.472 175.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -139.69 114.18 7.93 Favored Pre-proline 0 N--CA 1.449 -0.478 0 CA-C-O 118.805 -0.617 . . . . 0.0 109.48 174.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -69.34 -15.76 38.88 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 121.688 1.592 . . . . 0.0 111.833 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.1 m120 -99.54 -20.11 16.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 117.29 -1.338 . . . . 0.0 110.368 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.4 m -131.79 -3.21 3.68 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 120.394 1.452 . . . . 0.0 114.77 -168.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 2.9 mp 62.03 -24.57 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 131.609 3.964 . . . . 0.0 114.781 173.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 tmtt? -53.86 126.66 23.11 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 124.892 1.277 . . . . 0.0 107.938 169.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.493 HG13 ' HB3' ' A' ' 95' ' ' TYR . 1.5 p -132.28 146.72 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 178.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -134.47 123.61 24.27 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 106.386 -1.709 . . . . 0.0 106.386 176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CE1' HG21 ' A' ' 93' ' ' VAL . 48.1 p90 -131.51 173.51 11.03 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 120.899 1.681 . . . . 0.0 110.372 177.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.7 m -127.78 141.55 51.55 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 173.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.471 HD11 HG11 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -122.28 139.94 47.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 125.962 1.705 . . . . 0.0 106.618 -178.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.8 p90 -138.88 172.22 13.17 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.597 1.159 . . . . 0.0 111.321 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -157.0 -165.9 1.95 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.15 1.78 . . . . 0.0 109.405 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.95 -12.67 60.35 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.201 1.4 . . . . 0.0 113.561 176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.16 -67.09 0.87 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 -172.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.52 -152.41 5.66 Favored Glycine 0 C--N 1.336 0.582 0 N-CA-C 111.719 -0.552 . . . . 0.0 111.719 -172.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 84.2 p -140.25 167.18 22.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.611 0.764 . . . . 0.0 110.31 167.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.3 p -141.83 142.76 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -85.8 152.55 22.93 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.889 -1.505 . . . . 0.0 108.063 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.523 HG21 ' CE1' ' A' ' 82' ' ' PHE . 2.7 m -138.47 137.33 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.182 0.515 . . . . 0.0 110.992 171.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.2 t -100.28 136.87 39.5 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 164.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.493 ' HB3' HG13 ' A' ' 80' ' ' VAL . 31.2 t80 -142.05 164.31 30.53 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.458 1.503 . . . . 0.0 107.167 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -151.62 110.13 3.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.61 -174.41 41.35 Favored Glycine 0 C--N 1.324 -0.115 0 N-CA-C 108.842 -1.703 . . . . 0.0 108.842 -168.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.43 -22.48 6.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 CA-C-N 117.924 0.862 . . . . 0.0 112.394 -173.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.461 HD11 HG11 ' A' ' 126' ' ' VAL . 5.1 tp 81.55 152.86 0.12 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 128.939 2.895 . . . . 0.0 108.852 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.87 141.8 95.76 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.633 1.555 . . . . 0.0 108.993 174.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.6 -31.26 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.55 1.14 . . . . 0.0 109.161 172.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.38 -40.98 98.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.35 1.86 . . . . 0.0 112.737 175.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.442 ' CZ ' HG21 ' A' ' 66' ' ' VAL . 14.9 t80 -65.52 137.05 57.16 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.696 0.798 . . . . 0.0 110.91 -165.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 13.5 mmt85 -142.55 173.49 11.48 Favored 'General case' 0 CA--C 1.515 -0.393 0 C-N-CA 124.801 1.24 . . . . 0.0 109.206 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.6 mp0 -58.55 135.58 57.36 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.759 152.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.2 6.11 69.35 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 123.704 0.669 . . . . 0.0 113.785 155.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -103.16 172.61 6.72 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 123.875 0.87 . . . . 0.0 109.443 171.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.52 129.07 9.72 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.3 m -129.76 172.5 15.59 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.1 t -127.62 126.71 67.63 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.405 HG22 HG22 ' A' ' 126' ' ' VAL . 1.0 OUTLIER -101.73 159.26 4.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 165.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -157.05 134.38 10.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 156.52 -119.29 0.9 Allowed Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 106.407 -2.677 . . . . 0.0 106.407 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -142.17 154.0 44.49 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 119.232 1.516 . . . . 0.0 110.46 -163.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.594 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.3 OUTLIER -81.96 135.19 35.4 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.304 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.39 -85.45 0.24 Allowed 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -151.1 -88.6 0.06 Allowed 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.408 1.883 . . . . 0.0 109.417 168.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.41 82.8 1.14 Allowed Glycine 0 C--N 1.339 0.717 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -160.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.709 HD22 HG22 ' A' ' 43' ' ' ILE . 34.0 m120 29.69 67.1 0.11 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 128.188 2.595 . . . . 0.0 110.726 -169.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -141.37 131.19 24.31 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 125.213 1.405 . . . . 0.0 107.667 -175.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 12.2 mm -106.2 135.45 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 126.217 1.807 . . . . 0.0 109.263 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.89 105.42 10.2 Favored 'General case' 0 CA--C 1.507 -0.702 0 N-CA-C 103.827 -2.657 . . . . 0.0 103.827 156.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -67.84 148.87 50.59 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 163.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.96 -25.01 10.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.606 1.162 . . . . 0.0 109.115 171.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.566 ' HG3' HD21 ' A' ' 127' ' ' LEU . 8.1 pt-20 -148.38 -16.14 0.33 Allowed 'General case' 0 C--N 1.345 0.373 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -169.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 99' ' ' LEU . 61.9 t 38.54 101.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 127.207 2.203 . . . . 0.0 114.468 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 125' ' ' GLU . 1.1 mm? -106.17 145.9 30.93 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -174.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.521 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -109.15 30.98 6.08 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 121.24 -0.913 . . . . 0.0 111.694 -172.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 3.0 mmmp? 51.19 47.41 24.91 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.975 0.893 . . . . 0.0 110.949 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.637 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -82.12 -106.65 0.03 OUTLIER 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 166.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -149.38 111.3 4.58 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 105.072 -2.196 . . . . 0.0 105.072 -176.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -152.05 131.28 12.78 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 -171.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 16.9 t30 -160.72 -30.66 0.06 Allowed 'General case' 0 C--O 1.233 0.191 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 175.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -149.11 133.16 17.21 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.898 1.279 . . . . 0.0 108.146 -174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 91.9 m -120.4 105.34 41.81 Favored Pre-proline 0 C--O 1.236 0.37 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.19 178.64 6.32 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.689 2.926 . . . . 0.0 110.797 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -72.97 -40.39 1.82 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.233 1.289 . . . . 0.0 114.632 173.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -77.83 58.1 1.82 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.928 0.891 . . . . 0.0 111.378 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.36 -46.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 129.348 3.059 . . . . 0.0 105.95 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -56.87 -53.18 60.89 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 126.678 1.991 . . . . 0.0 109.009 -175.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.8 tptt -144.35 82.91 1.71 Allowed 'General case' 0 CA--C 1.523 -0.09 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 174.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -160.51 -54.32 0.05 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.437 0.295 . . . . 0.0 111.319 -179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 16.0 mmt . . . . . 0 C--O 1.251 1.157 0 C-N-CA 125.156 1.383 . . . . 0.0 109.326 -177.464 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.98 165.36 2.46 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 123.317 0.386 . . . . 0.0 110.569 161.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.2 m -160.16 134.39 7.39 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 167.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -138.43 4.33 2.4 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.4 mm -96.84 -140.21 0.02 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.474 0 N-CA-C 104.779 -2.304 . . . . 0.0 104.779 169.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.42 173.08 12.78 Favored 'General case' 0 C--O 1.238 0.481 0 O-C-N 121.626 -0.671 . . . . 0.0 110.027 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.21 179.9 5.43 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 122.464 1.126 . . . . 0.0 109.823 171.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -169.58 145.4 3.14 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 126.051 1.74 . . . . 0.0 107.534 -169.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -142.3 -173.83 3.95 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 127.588 2.355 . . . . 0.0 108.573 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 20.6 p -135.32 171.2 9.34 Favored Pre-proline 0 C--O 1.239 0.538 0 C-N-CA 124.059 0.943 . . . . 0.0 109.292 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' HB3' HG12 ' A' ' 91' ' ' VAL . 63.9 Cg_endo -73.8 71.31 4.12 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 122.925 2.417 . . . . 0.0 108.989 169.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.68 -66.73 0.1 Allowed Glycine 0 N--CA 1.441 -1.021 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 -167.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' H ' ' A' ' 39' ' ' THR . 3.3 mm-40 -71.52 -3.71 22.76 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.359 0.664 . . . . 0.0 112.442 -171.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 mt -91.55 -41.97 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.631 HD13 ' H ' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -85.9 -43.53 13.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 C-N-CA 123.599 0.759 . . . . 0.0 109.688 -165.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -102.31 3.32 37.93 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 125.323 1.449 . . . . 0.0 112.883 -168.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.2 165.95 39.18 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -172.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.92 163.48 19.56 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 123.549 0.74 . . . . 0.0 110.847 174.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 75.5 mtt180 -56.61 -13.22 2.24 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 116.55 2.055 . . . . 0.0 116.55 -166.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -123.48 -75.91 0.59 Allowed 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 120.11 1.323 . . . . 0.0 110.496 148.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 10.2 t -159.07 26.42 0.21 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.81 1.244 . . . . 0.0 109.575 -171.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -64.77 -45.57 85.79 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 120.842 -1.161 . . . . 0.0 110.304 -166.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 166.06 145.31 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 128.654 2.782 . . . . 0.0 111.047 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 27.9 mtp -75.65 162.11 73.58 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 123.577 0.751 . . . . 0.0 109.917 168.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -77.5 158.69 32.51 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 121.909 1.739 . . . . 0.0 109.917 159.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -79.12 157.75 27.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 165.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.466 ' HA ' HD13 ' A' ' 115' ' ' LEU 0.261 9.5 p -93.65 0.22 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 CA-C-O 121.332 0.587 . . . . 0.0 112.203 -178.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.04 55.65 0.68 Allowed Glycine 0 CA--C 1.525 0.67 0 C-N-CA 125.934 1.731 . . . . 0.0 110.13 162.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -144.86 168.81 19.34 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.188 1.494 . . . . 0.0 112.254 170.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.41 129.6 36.58 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 122.402 1.096 . . . . 0.0 109.982 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.448 ' N ' HD13 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -136.19 -177.08 4.55 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.277 172.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.71 142.7 51.25 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 127.402 2.281 . . . . 0.0 106.491 176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.7 t -128.27 124.67 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 177.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.33 135.47 12.89 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 165.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -178.61 174.37 46.58 Favored Glycine 0 CA--C 1.523 0.591 0 C-N-CA 124.718 1.152 . . . . 0.0 110.606 -175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.2 ttm -95.76 126.2 40.86 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.514 1.526 . . . . 0.0 110.996 -173.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 88.0 t -63.97 127.3 24.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 C-N-CA 124.227 1.011 . . . . 0.0 109.209 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 35.9 mtt -59.92 127.5 85.61 Favored Pre-proline 0 C--O 1.238 0.483 0 C-N-CA 122.501 0.321 . . . . 0.0 110.58 171.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.0 113.73 2.5 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 124.072 3.181 . . . . 0.0 110.364 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.415 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 104.62 -16.88 47.32 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 126.336 1.922 . . . . 0.0 113.967 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.7 p -69.43 -19.68 63.79 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.469 1.134 . . . . 0.0 114.005 -165.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.3 t -76.71 83.57 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 124.954 1.302 . . . . 0.0 109.864 -167.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -59.77 -58.27 9.32 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.667 1.987 . . . . 0.0 111.472 -167.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.84 129.37 0.02 OUTLIER 'General case' 0 C--O 1.237 0.408 0 C-N-CA 129.612 3.165 . . . . 0.0 110.852 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -68.83 117.53 52.04 Favored Pre-proline 0 C--O 1.236 0.386 0 CA-C-O 117.497 -1.24 . . . . 0.0 107.918 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -61.89 -13.82 33.15 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 CA-C-N 121.491 1.568 . . . . 0.0 112.447 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -107.92 -10.09 15.58 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 125.226 1.41 . . . . 0.0 112.162 -178.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.0 t -136.49 -156.83 0.73 Allowed 'General case' 0 C--N 1.332 -0.167 0 O-C-N 120.775 -1.203 . . . . 0.0 109.11 -168.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.5 mp -128.26 6.33 5.85 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 126.325 1.85 . . . . 0.0 108.817 170.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -55.39 140.69 39.02 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 164.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.28 156.73 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.4 p -126.37 141.06 52.04 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 152.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -143.67 170.6 15.55 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 108.329 164.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 m -112.47 144.5 41.83 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 172.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -121.41 143.09 34.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 169.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -137.44 173.46 11.65 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.111 1.765 . . . . 0.0 107.88 -178.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -155.07 -162.54 1.38 Allowed 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.1 13.65 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.51 1.924 . . . . 0.0 113.725 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.13 -76.53 0.58 Allowed 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.876 1.271 . . . . 0.0 107.914 -172.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.52 -151.21 5.4 Favored Glycine 0 C--N 1.333 0.411 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -172.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 40' ' ' PRO . 84.7 p -146.08 166.97 24.54 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 117.639 0.719 . . . . 0.0 112.519 172.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.594 HG12 ' HB3' ' A' ' 40' ' ' PRO . 6.3 p -146.63 157.86 10.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 C-N-CA 126.112 1.765 . . . . 0.0 109.045 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.0 151.06 19.81 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 126.006 1.722 . . . . 0.0 108.468 -176.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.4 HG21 HD11 ' A' ' 84' ' ' ILE . 44.6 t -142.56 103.33 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 C-N-CA 124.055 0.942 . . . . 0.0 111.33 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 37.4 m -78.44 120.68 23.51 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.228 1.011 . . . . 0.0 109.361 161.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -116.41 171.5 7.8 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 125.333 1.453 . . . . 0.0 107.843 168.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -140.84 101.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.61 169.73 26.43 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.598 -0.601 . . . . 0.0 111.598 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.1 tp -73.74 -25.86 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 122.94 0.496 . . . . 0.0 110.67 -167.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.471 ' CD2' HG11 ' A' ' 126' ' ' VAL . 30.5 mt 87.52 156.55 0.09 OUTLIER Pre-proline 0 C--O 1.233 0.223 0 C-N-CA 131.401 3.88 . . . . 0.0 110.185 -175.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -56.08 143.59 83.08 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 N-CA-C 107.058 -1.939 . . . . 0.0 107.058 168.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.3 t0 -62.21 -37.02 83.72 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 118.567 -1.253 . . . . 0.0 108.511 173.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mp -61.44 -20.16 62.79 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 126.12 1.768 . . . . 0.0 115.159 176.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -64.38 125.05 23.39 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.613 1.097 . . . . 0.0 109.524 175.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 16.7 mmt180 -126.95 160.27 31.54 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 122.19 0.995 . . . . 0.0 110.488 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.415 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 69.7 mt-10 -81.24 104.81 11.97 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 125.891 1.677 . . . . 0.0 107.434 168.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 120.5 13.78 5.59 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 124.062 0.839 . . . . 0.0 114.07 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -130.92 166.93 19.87 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 118.711 1.256 . . . . 0.0 112.131 178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -71.72 139.94 29.55 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 108.419 -1.873 . . . . 0.0 108.419 173.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.4 m -136.92 170.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 173.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.47 109.04 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.47 HG22 HG22 ' A' ' 126' ' ' VAL . 3.2 t -81.19 158.18 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 125.08 1.352 . . . . 0.0 108.939 164.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -153.25 152.09 30.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 129.3 3.04 . . . . 0.0 106.16 169.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 157.97 -111.42 0.48 Allowed Glycine 0 N--CA 1.449 -0.472 0 N-CA-C 104.998 -3.241 . . . . 0.0 104.998 167.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.78 160.78 33.36 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 119.917 1.858 . . . . 0.0 109.153 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -74.72 142.61 44.37 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 159.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -99.65 -88.33 0.34 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.886 1.275 . . . . 0.0 108.031 174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.35 157.33 4.91 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 128.667 2.787 . . . . 0.0 107.433 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 67.16 25.54 73.45 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.87 174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 m120 58.65 71.45 0.58 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.347 2.259 . . . . 0.0 110.114 -168.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 16.3 t-160 -141.18 136.49 31.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.6 mm -105.68 130.2 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 C-N-CA 126.678 1.991 . . . . 0.0 108.497 179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.84 111.5 15.05 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 157.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.47 134.44 37.33 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.23 1.812 . . . . 0.0 108.329 171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.53 -24.64 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 124.954 1.301 . . . . 0.0 111.399 -176.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.38 -47.54 0.39 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 99' ' ' LEU . 32.8 t 61.26 129.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-O 124.237 1.97 . . . . 0.0 111.328 -174.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 30.4 mt -133.85 159.03 41.89 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.495 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -126.03 55.06 1.49 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 118.397 0.544 . . . . 0.0 110.097 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? 50.25 15.21 0.18 Allowed 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 176.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.495 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.4 OUTLIER -76.66 59.93 1.6 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 130.452 3.501 . . . . 0.0 110.752 -177.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.3 t0 64.29 23.86 13.16 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.966 1.307 . . . . 0.0 111.631 163.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -80.38 116.08 20.26 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 126.474 1.91 . . . . 0.0 106.927 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -135.82 -45.24 0.66 Allowed 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 122.943 0.497 . . . . 0.0 110.659 172.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -146.25 111.21 5.29 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 175.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -95.91 130.98 30.01 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 176.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 135' ' ' THR . 15.2 Cg_exo -64.22 178.3 1.63 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.715 2.943 . . . . 0.0 112.03 -178.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.22 -174.1 1.95 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.446 2.764 . . . . 0.0 111.622 172.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 48.36 56.02 8.05 Favored 'General case' 0 C--N 1.333 -0.15 0 C-N-CA 126.609 1.964 . . . . 0.0 110.942 -174.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.45 -39.79 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 124.356 1.062 . . . . 0.0 108.394 175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 tt0 -51.93 -56.26 15.25 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.495 1.518 . . . . 0.0 109.43 -171.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? -152.28 83.53 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 169.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -160.36 -34.11 0.05 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 17.2 mmt . . . . . 0 C--O 1.249 1.063 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.861 178.473 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.4 tp . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -56.32 146.81 22.8 Favored 'General case' 0 C--N 1.34 0.183 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 169.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -148.46 133.28 17.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.688 -1.967 . . . . 0.0 105.688 173.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -162.73 -45.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 124.785 1.234 . . . . 0.0 110.232 -177.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.9 mt -62.38 155.84 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-O 122.549 1.166 . . . . 0.0 108.826 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.93 148.21 44.38 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 126.443 1.897 . . . . 0.0 110.15 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.75 -174.27 4.92 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 122.46 1.124 . . . . 0.0 110.2 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -168.04 154.62 7.68 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 128.144 2.578 . . . . 0.0 106.018 -172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 74.5 m-85 -141.54 173.66 11.29 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 127.066 2.146 . . . . 0.0 109.051 176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.8 p -134.88 164.05 46.81 Favored Pre-proline 0 C--O 1.238 0.452 0 C-N-CA 123.959 0.904 . . . . 0.0 109.606 168.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.88 72.94 2.52 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.677 2.918 . . . . 0.0 109.804 174.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 177.13 -62.55 0.09 OUTLIER Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 105.182 -3.167 . . . . 0.0 105.182 -168.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -47.85 -48.66 30.85 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 118.331 1.065 . . . . 0.0 109.956 173.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.19 -15.37 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.695 0 C-N-CA 127.149 2.18 . . . . 0.0 112.17 -172.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.4 mt -124.48 -32.8 3.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.096 1.359 . . . . 0.0 110.883 -166.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -95.77 -60.67 1.6 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.653 2.381 . . . . 0.0 108.242 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.43 135.97 2.11 Favored Glycine 0 CA--C 1.531 1.094 0 C-N-CA 125.493 1.521 . . . . 0.0 110.547 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 5.3 tptp -54.99 117.03 3.09 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.675 1.19 . . . . 0.0 111.096 -178.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -24.22 63.29 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.869 1.213 . . . . 0.0 114.161 -172.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.29 -69.14 0.12 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.095 1.358 . . . . 0.0 110.748 172.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 t -151.96 22.23 0.67 Allowed 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.867 0.841 . . . . 0.0 111.799 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 59.55 28.24 17.6 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.916 2.086 . . . . 0.0 112.278 178.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -67.08 -21.64 65.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.903 1.681 . . . . 0.0 115.125 -171.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 54.45 159.26 0.06 OUTLIER Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 126.209 1.804 . . . . 0.0 113.472 -163.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.88 155.83 48.29 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.67 1.58 . . . . 0.0 109.71 165.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -79.14 132.32 36.52 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 170.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.259 3.8 p -69.43 0.45 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 123.384 1.564 . . . . 0.0 112.098 168.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -111.77 22.4 19.25 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 126.959 2.218 . . . . 0.0 112.516 173.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -136.55 177.63 7.7 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 121.08 2.44 . . . . 0.0 113.398 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -93.44 150.24 20.6 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.044 167.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.36 178.15 10.64 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.203 1.001 . . . . 0.0 109.68 171.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.8 mtm180 -116.67 150.56 37.96 Favored 'General case' 0 CA--C 1.52 -0.203 0 C-N-CA 126.385 1.874 . . . . 0.0 108.468 173.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 89.2 t -125.35 154.75 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 125.59 1.556 . . . . 0.0 107.654 169.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.8 142.35 13.67 Favored Glycine 0 CA--C 1.521 0.41 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 159.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -173.25 179.69 44.5 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 171.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 17.1 ttm -92.46 119.64 32.17 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.878 2.071 . . . . 0.0 110.514 176.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 55.8 t -64.72 128.85 28.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 O-C-N 120.275 -1.516 . . . . 0.0 108.728 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 30.1 mtt -59.37 141.25 87.78 Favored Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 124.409 1.084 . . . . 0.0 112.694 175.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -62.21 134.17 47.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 124.751 3.634 . . . . 0.0 109.71 172.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.6 -2.49 39.07 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 118.786 -1.008 . . . . 0.0 114.763 176.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.1 p -74.46 -43.35 56.53 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 119.757 1.778 . . . . 0.0 112.099 -173.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 1.2 p -67.0 107.08 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.086 1.754 . . . . 0.0 110.805 -170.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -74.04 -55.46 6.1 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.962 1.705 . . . . 0.0 111.444 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.421 HH21 ' CD2' ' A' ' 78' ' ' LEU . 1.5 mtp180 65.87 177.42 0.21 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 127.147 2.179 . . . . 0.0 111.451 -165.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -132.13 124.97 19.76 Favored Pre-proline 0 N--CA 1.445 -0.678 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 162.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -73.76 -20.81 19.6 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.42 1.413 . . . . 0.0 111.656 168.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -73.3 -34.18 65.59 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.5 m -130.4 -130.4 0.2 Allowed 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 103.004 -2.962 . . . . 0.0 103.004 -174.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.421 ' CD2' HH21 ' A' ' 73' ' ' ARG . 0.6 OUTLIER -152.12 15.12 0.62 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.824 2.05 . . . . 0.0 109.741 168.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.92 116.96 5.31 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 174.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -102.24 153.93 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.877 0 CA-C-O 122.391 1.091 . . . . 0.0 109.844 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.7 p -141.2 114.85 8.95 Favored 'General case' 0 N--CA 1.435 -1.196 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 168.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -124.96 178.76 5.34 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.809 1.644 . . . . 0.0 111.791 171.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.2 m -124.36 145.15 49.62 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.6 HD11 HG21 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -120.11 148.03 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.241 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 172.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.4 p90 -139.25 178.26 7.32 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 125.96 1.704 . . . . 0.0 108.535 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.45 ' CG ' ' H ' ' A' ' 87' ' ' ALA . 37.0 t70 -161.01 -153.66 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 86' ' ' ASP . . . -68.8 -18.19 64.14 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 120.324 -1.485 . . . . 0.0 113.098 -177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -112.56 -63.3 1.45 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -163.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -148.59 -157.55 7.61 Favored Glycine 0 CA--C 1.524 0.634 0 CA-C-O 120.105 -0.275 . . . . 0.0 113.062 -172.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.9 p -149.78 159.88 44.0 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.5 p -146.45 153.19 13.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.838 1.655 . . . . 0.0 111.351 -167.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.423 ' HB3' ' CD2' ' A' ' 120' ' ' HIS . 0.1 OUTLIER -81.07 143.99 32.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.267 -1.333 . . . . 0.0 109.531 176.727 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.6 HG21 HD11 ' A' ' 84' ' ' ILE . 58.6 t -137.61 121.35 21.79 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 164.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.4 m -91.61 133.52 35.48 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 155.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.412 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . 18.9 t80 -130.15 168.34 16.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -158.26 113.39 2.64 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -176.06 -101.47 0.15 Allowed Glycine 0 N--CA 1.468 0.786 0 C-N-CA 118.107 -1.997 . . . . 0.0 113.26 172.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.13 -28.22 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 118.286 1.043 . . . . 0.0 112.613 167.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 17.1 tp 61.23 128.13 0.02 OUTLIER Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 129.333 3.053 . . . . 0.0 112.86 -170.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 99' ' ' LEU . 5.1 Cg_exo -61.66 135.71 58.19 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.653 1.569 . . . . 0.0 108.106 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -55.58 -25.51 38.71 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.856 0.836 . . . . 0.0 111.689 166.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.3 mp -66.49 -23.39 66.25 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.434 1.094 . . . . 0.0 112.145 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -70.34 130.28 41.55 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 120.331 1.423 . . . . 0.0 109.461 170.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -126.94 -161.87 1.11 Allowed 'General case' 0 C--N 1.346 0.446 0 C-N-CA 125.47 1.508 . . . . 0.0 107.472 172.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.7 151.95 19.6 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 120.959 -1.088 . . . . 0.0 108.773 150.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 95.45 9.37 57.86 Favored Glycine 0 CA--C 1.523 0.567 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.502 166.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -125.37 166.47 16.51 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.395 1.078 . . . . 0.0 109.748 -177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.41 135.91 18.26 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.3 m -133.83 162.7 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 170.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -124.08 112.78 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 C-N-CA 126.72 2.008 . . . . 0.0 105.687 174.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -94.59 157.51 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 124.579 1.152 . . . . 0.0 108.259 172.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -154.11 135.84 14.44 Favored 'General case' 0 CA--C 1.507 -0.701 0 C-N-CA 127.552 2.341 . . . . 0.0 107.331 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 160.94 -120.47 0.95 Allowed Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 103.339 -3.904 . . . . 0.0 103.339 171.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -140.55 153.75 46.26 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 118.351 1.076 . . . . 0.0 109.631 -160.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.511 ' HB2' HD11 ' A' ' 60' ' ' LEU . 6.6 tp -80.68 122.54 27.23 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.443 1.097 . . . . 0.0 109.428 176.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -76.03 -66.98 0.72 Allowed 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -138.8 -96.16 0.18 Allowed 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 123.695 0.798 . . . . 0.0 111.056 171.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -91.01 -70.54 1.2 Allowed Glycine 0 N--CA 1.453 -0.224 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -171.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -126.94 41.03 3.6 Favored 'General case' 0 C--N 1.328 -0.327 0 O-C-N 121.902 -0.763 . . . . 0.0 109.032 -169.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 92' ' ' ASP . 23.1 t-160 -131.57 125.9 33.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.051 1.34 . . . . 0.0 108.636 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.428 HG21 ' CG1' ' A' ' 111' ' ' VAL . 7.9 mm -98.13 130.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 126.437 1.895 . . . . 0.0 108.15 171.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -79.15 108.02 12.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 N-CA-C 104.698 -2.334 . . . . 0.0 104.698 152.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.412 ' HB3' ' HB2' ' A' ' 95' ' ' TYR . . . -71.06 147.88 48.08 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 160.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.1 -11.0 7.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.81 1.644 . . . . 0.0 111.503 -178.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.36 -21.43 0.15 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 118.635 2.828 . . . . 0.0 118.635 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 111' ' ' VAL . 86.0 t 41.89 113.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 130.598 3.559 . . . . 0.0 115.687 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 31.6 mt -126.3 144.01 50.95 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 -167.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.543 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -116.86 42.83 2.4 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.328 -0.857 . . . . 0.0 111.217 -164.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 45.8 mmtt 54.72 21.33 3.44 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.25 0.833 . . . . 0.0 113.25 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.543 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.6 OUTLIER -86.35 55.39 3.52 Favored 'General case' 0 N--CA 1.447 -0.625 0 C-N-CA 126.978 2.111 . . . . 0.0 109.108 -175.502 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 30.8 t70 49.83 61.59 3.09 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.123 1.369 . . . . 0.0 111.94 172.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -127.43 162.08 27.2 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.019 173.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -156.38 38.65 0.34 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.049 0.94 . . . . 0.0 109.171 161.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -164.14 143.56 7.74 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 121.117 -0.99 . . . . 0.0 111.076 -162.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 61.6 m -79.12 127.83 78.07 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.367 1.067 . . . . 0.0 108.641 172.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 137' ' ' PRO . 90.0 Cg_endo -70.12 -176.17 1.5 Allowed 'Trans proline' 0 CA--C 1.552 1.403 1 C-N-CA 125.84 4.36 . . . . 0.0 111.491 178.864 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 136' ' ' PRO . 44.2 Cg_endo -78.89 -37.03 0.64 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 N-CA-C 116.348 1.634 . . . . 0.0 116.348 -176.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.34 57.68 2.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.062 1.345 . . . . 0.0 110.31 -172.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -164.77 -78.98 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 C-N-CA 126.65 1.98 . . . . 0.0 107.509 -177.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 26.02 -80.84 0.0 OUTLIER 'General case' 0 C--O 1.236 0.36 0 C-N-CA 129.877 3.271 . . . . 0.0 112.733 -150.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -101.17 -84.43 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.833 1.653 . . . . 0.0 109.937 -175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -115.87 136.08 53.39 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.749 1.219 . . . . 0.0 109.105 -173.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.211 176.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 25.9 mt . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -139.07 -80.75 0.31 Allowed 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 174.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.24 158.07 43.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 164.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -159.55 167.88 27.5 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 127.003 2.121 . . . . 0.0 106.335 174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.4 mt -102.3 164.19 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 N-CA-C 105.669 -1.974 . . . . 0.0 105.669 172.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.31 168.12 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 126.596 1.958 . . . . 0.0 110.567 -156.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' C ' HD12 ' A' ' 36' ' ' LEU . 1.9 pp -114.33 -176.36 2.88 Favored 'General case' 0 N--CA 1.448 -0.534 0 O-C-N 119.238 -2.163 . . . . 0.0 106.589 161.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -165.84 147.69 7.17 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 118.984 0.811 . . . . 0.0 110.63 172.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.499 ' CE1' HD13 ' A' ' 36' ' ' LEU . 91.8 m-85 -140.45 177.8 7.76 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.509 1.924 . . . . 0.0 109.595 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 22.2 p -134.55 171.85 8.31 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 124.291 1.036 . . . . 0.0 110.011 176.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HB3' HG22 ' A' ' 91' ' ' VAL . 69.4 Cg_endo -72.62 -0.64 9.13 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.799 2.333 . . . . 0.0 114.793 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.45 -53.51 3.81 Favored Glycine 0 N--CA 1.449 -0.489 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 156.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 39' ' ' THR . 56.9 mt-10 -68.24 -30.49 69.55 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.591 -0.946 . . . . 0.0 113.139 -160.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.6 mt -71.9 -13.81 17.01 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 CA-C-O 118.859 -0.591 . . . . 0.0 111.865 -177.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.556 HD23 ' N ' ' A' ' 44' ' ' LEU . 0.1 OUTLIER -119.87 -42.28 2.62 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.078 1.351 . . . . 0.0 110.198 -177.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -90.25 -18.12 26.23 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.012 -175.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.68 147.46 9.05 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 126.776 2.131 . . . . 0.0 109.825 177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.4 tttm -63.43 164.92 8.46 Favored 'General case' 0 C--N 1.349 0.548 0 CA-C-N 119.766 1.783 . . . . 0.0 109.777 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 21.9 mtp85 -19.31 -76.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.24 1.816 . . . . 0.0 114.525 -159.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.541 ' H ' HE22 ' A' ' 51' ' ' GLN . 7.3 mt-10 -93.82 -78.73 0.43 Allowed 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.519 0.728 . . . . 0.0 110.003 -178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 8.3 t -168.48 10.45 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 122.194 0.997 . . . . 0.0 111.334 -168.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.541 HE22 ' H ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -52.89 -50.61 63.53 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.843 2.457 . . . . 0.0 112.48 177.787 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -174.71 173.45 2.81 Favored 'General case' 0 C--N 1.345 0.37 0 CA-C-N 120.987 1.721 . . . . 0.0 110.737 171.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 42.8 mtp -121.9 149.2 53.15 Favored Pre-proline 0 C--O 1.238 0.481 0 C-N-CA 126.15 1.78 . . . . 0.0 106.383 164.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.02 166.29 23.43 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 121.862 1.708 . . . . 0.0 111.184 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -79.01 128.43 33.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 168.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 115' ' ' LEU . 49.0 t -60.64 -8.48 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 125.823 1.649 . . . . 0.0 111.857 169.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -118.46 33.49 4.8 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-O 116.131 -2.483 . . . . 0.0 112.719 174.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -128.83 177.62 6.95 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 121.128 2.464 . . . . 0.0 112.471 176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -83.6 140.93 31.92 Favored 'General case' 0 CA--C 1.519 -0.212 0 C-N-CA 124.018 0.927 . . . . 0.0 110.664 165.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.466 ' HA ' HD11 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -146.64 173.92 11.9 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.638 0.775 . . . . 0.0 109.76 169.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -121.26 139.03 53.94 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 174.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.46 160.72 41.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 C-N-CA 128.506 2.723 . . . . 0.0 107.856 -171.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -154.08 156.58 26.92 Favored Glycine 0 N--CA 1.452 -0.291 0 N-CA-C 110.425 -1.07 . . . . 0.0 110.425 155.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -176.85 -179.96 47.51 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.703 1.621 . . . . 0.0 109.214 177.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 7.4 tpp -81.09 120.05 24.34 Favored 'General case' 0 C--O 1.218 -0.569 0 C-N-CA 129.062 2.945 . . . . 0.0 110.598 174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 103' ' ' PHE . 73.0 t -64.74 130.45 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 119.094 -2.253 . . . . 0.0 108.479 175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 34.0 mtt -60.26 154.23 53.63 Favored Pre-proline 0 C--O 1.235 0.322 0 C-N-CA 123.742 0.817 . . . . 0.0 111.745 172.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.87 133.3 30.91 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.006 2.471 . . . . 0.0 109.668 171.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.73 -24.65 4.32 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 125.579 1.561 . . . . 0.0 115.776 162.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.09 -43.61 91.86 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.466 1.633 . . . . 0.0 111.732 -170.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.308 1.3 p -42.33 95.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 126.941 2.096 . . . . 0.0 112.96 -172.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.414 ' CG ' ' HB ' ' A' ' 81' ' ' THR . 8.4 pt20 -91.93 56.48 2.91 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 128.968 2.907 . . . . 0.0 108.242 -177.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 11.9 ptt-85 -66.82 143.11 57.08 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 166.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -76.41 119.76 78.73 Favored Pre-proline 0 N--CA 1.436 -1.155 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 171.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.95 1.7 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 122.018 1.812 . . . . 0.0 111.8 164.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -134.31 14.0 3.83 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.482 2.313 . . . . 0.0 110.163 -167.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.03 -166.14 0.78 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 125.624 1.569 . . . . 0.0 107.61 176.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.96 2.32 19.64 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 126.014 1.726 . . . . 0.0 111.506 171.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 tmtt? -62.29 138.97 58.52 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 120.058 -1.651 . . . . 0.0 109.088 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG21 HD11 ' A' ' 99' ' ' LEU . 2.1 p -155.72 132.7 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.414 ' HB ' ' CG ' ' A' ' 72' ' ' GLN 0.314 22.7 m -123.39 153.71 40.0 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 104.377 -2.453 . . . . 0.0 104.377 174.408 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 48.8 p90 -152.4 176.98 11.08 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 119.936 -1.727 . . . . 0.0 110.945 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.9 m -121.56 143.8 49.08 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -121.34 153.67 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 C-N-CA 126.064 1.746 . . . . 0.0 106.47 174.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -141.81 -179.43 6.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.587 1.955 . . . . 0.0 106.973 172.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -157.08 -159.35 0.85 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 167.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.08 4.61 0.85 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -128.96 -79.1 0.56 Allowed 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 126.033 1.733 . . . . 0.0 109.371 -176.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -131.98 -168.37 12.07 Favored Glycine 0 CA--C 1.526 0.734 0 C-N-CA 125.215 1.388 . . . . 0.0 111.643 -167.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 42.8 p -146.98 155.97 42.68 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -171.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.558 HG22 ' HB3' ' A' ' 40' ' ' PRO . 34.4 m -148.72 145.85 17.9 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 C-N-CA 125.999 1.72 . . . . 0.0 110.264 -167.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.5 154.68 26.18 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 171.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 84' ' ' ILE . 5.4 m -133.28 144.95 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 O-C-N 120.625 -1.297 . . . . 0.0 109.337 160.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -112.16 132.71 54.73 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 126.38 1.872 . . . . 0.0 106.572 166.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -134.91 168.93 18.19 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 126.221 1.809 . . . . 0.0 108.761 176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 71.8 tt0 -148.94 117.63 6.61 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 171.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.38 175.46 25.59 Favored Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -170.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -6.26 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.047 1.339 . . . . 0.0 112.395 -172.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.645 ' CD2' HG11 ' A' ' 126' ' ' VAL . 32.3 mt 63.02 165.89 0.11 Allowed Pre-proline 0 N--CA 1.448 -0.532 0 C-N-CA 127.535 2.334 . . . . 0.0 111.66 -166.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.35 137.64 79.6 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 N-CA-C 107.354 -1.825 . . . . 0.0 107.354 159.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -59.88 -27.4 66.67 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.141 0.496 . . . . 0.0 110.704 167.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.22 -19.07 60.65 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.481 1.512 . . . . 0.0 113.107 176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 66' ' ' VAL . 41.8 t80 -64.5 129.4 39.71 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 118.994 0.815 . . . . 0.0 110.086 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 78.1 mmt-85 -136.1 161.07 36.74 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.023 1.329 . . . . 0.0 109.944 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -68.71 114.21 6.87 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.526 1.13 . . . . 0.0 108.206 165.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 107.98 -3.46 33.69 Favored Glycine 0 CA--C 1.519 0.31 0 CA-C-O 118.406 -1.219 . . . . 0.0 114.127 169.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -91.48 166.73 12.71 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.35 1.575 . . . . 0.0 110.601 173.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.97 140.99 27.54 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 168.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.4 m -136.14 177.06 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.255 1.822 . . . . 0.0 107.295 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.441 ' HB ' ' HB2' ' A' ' 127' ' ' LEU . 2.6 t -141.86 101.22 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 126.097 1.759 . . . . 0.0 106.714 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.5 m -89.9 168.49 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.299 0 CA-C-O 122.706 1.241 . . . . 0.0 111.244 171.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -165.05 140.83 5.46 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 126.279 1.831 . . . . 0.0 107.693 -177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.58 -91.43 0.11 Allowed Glycine 0 C--O 1.224 -0.481 0 CA-C-O 116.941 -2.033 . . . . 0.0 109.276 168.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -142.29 162.28 35.87 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 120.466 2.133 . . . . 0.0 110.339 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -82.28 148.63 28.25 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 126.06 1.744 . . . . 0.0 108.672 165.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.439 ' CG ' HD21 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -104.99 -85.0 0.48 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.792 1.237 . . . . 0.0 108.259 -174.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.403 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 12.8 mtmm -141.07 170.8 15.04 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 127.352 2.261 . . . . 0.0 106.88 159.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 45.48 -102.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 125.131 1.348 . . . . 0.0 110.852 -178.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -136.31 51.99 1.99 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.593 0.757 . . . . 0.0 109.318 -175.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -121.46 129.94 53.27 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 123.48 0.712 . . . . 0.0 109.955 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.0 mm -105.35 127.81 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 124.57 1.148 . . . . 0.0 110.999 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.439 HD21 ' CG ' ' A' ' 116' ' ' GLU . 3.6 mm? -79.49 80.76 5.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 162.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -47.54 141.87 4.79 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.563 0.697 . . . . 0.0 110.53 164.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.86 -14.13 9.47 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.581 1.552 . . . . 0.0 111.529 -178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -142.81 -33.65 0.45 Allowed 'General case' 0 CA--C 1.527 0.077 0 CA-C-O 117.643 -1.17 . . . . 0.0 114.04 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.645 HG11 ' CD2' ' A' ' 99' ' ' LEU . 87.7 t 54.92 116.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.227 -0.082 0 C-N-CA 129.073 2.949 . . . . 0.0 111.108 -174.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.441 ' HB2' ' HB ' ' A' ' 110' ' ' VAL . 10.1 mt -93.15 -176.42 4.15 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 119.461 -0.896 . . . . 0.0 108.653 168.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -143.43 19.47 1.88 Allowed 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.982 1.313 . . . . 0.0 110.616 172.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.2 mttm 42.3 60.97 2.14 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 119.426 1.012 . . . . 0.0 111.577 -161.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.37 -57.94 4.28 Favored 'General case' 0 C--O 1.225 -0.236 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 159.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -179.91 -64.64 0.01 OUTLIER 'General case' 0 C--O 1.228 -0.076 0 C-N-CA 128.073 2.549 . . . . 0.0 104.944 174.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 74.45 111.83 0.07 Allowed 'General case' 0 C--O 1.239 0.533 0 C-N-CA 129.905 3.282 . . . . 0.0 111.366 -174.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -63.47 -174.3 0.09 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 128.199 2.6 . . . . 0.0 111.961 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -125.4 164.87 19.48 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.25 1.42 . . . . 0.0 107.535 166.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 28.9 m -138.57 142.79 35.66 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 126.157 1.783 . . . . 0.0 107.053 175.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.0 175.64 7.22 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 122.501 2.134 . . . . 0.0 111.18 173.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -82.58 -33.47 0.49 Allowed 'Trans proline' 0 CA--C 1.532 0.4 0 C-N-CA 122.335 2.023 . . . . 0.0 113.877 175.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -75.36 56.01 0.82 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.369 1.868 . . . . 0.0 110.727 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.1 p -168.97 -49.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 126.99 2.116 . . . . 0.0 107.581 -174.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.81 -50.67 63.82 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 118.265 0.484 . . . . 0.0 109.718 -170.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.05 -47.75 0.06 Allowed 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 125.891 1.676 . . . . 0.0 107.686 176.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.4 48.18 0.24 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.359 1.864 . . . . 0.0 112.604 -174.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 41.3 mtt . . . . . 0 C--O 1.249 1.069 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 145.341 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.0 mp . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.86 138.65 48.55 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 121.08 1.764 . . . . 0.0 108.627 161.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.1 m 60.43 175.92 0.1 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.179 1.392 . . . . 0.0 113.109 -173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -153.87 110.95 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 54.5 mt -75.36 173.24 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 162.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.6 p-10 -64.17 161.37 16.49 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 120.365 -1.459 . . . . 0.0 112.22 168.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.441 HD12 ' C ' ' A' ' 36' ' ' LEU . 2.5 pp -74.96 177.6 6.2 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 122.528 1.156 . . . . 0.0 109.65 178.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -158.21 147.18 19.21 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.664 1.185 . . . . 0.0 108.578 173.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' CE1' HD13 ' A' ' 36' ' ' LEU . 95.8 m-85 -134.43 173.03 12.08 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 126.013 1.725 . . . . 0.0 108.891 175.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 3.4 p -131.99 172.41 7.43 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.753 1.221 . . . . 0.0 108.635 173.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 10.8 Cg_endo -59.87 -36.87 89.33 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 121.646 1.564 . . . . 0.0 109.881 172.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.88 10.52 13.69 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 118.26 -1.3 . . . . 0.0 114.595 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.564 ' HB2' ' H ' ' A' ' 39' ' ' THR . 26.6 mt-10 -130.17 -30.95 1.92 Allowed 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 119.909 1.854 . . . . 0.0 112.727 -177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.1 mt -69.04 -58.27 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.71 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -71.94 -49.61 36.12 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 110.06 -178.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.71 ' CE1' HD12 ' A' ' 44' ' ' LEU . 10.1 m-30 -82.98 -7.16 59.7 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -171.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.53 132.05 4.52 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -176.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 13.8 tptp -37.9 126.49 1.22 Allowed 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 128.316 2.647 . . . . 0.0 113.648 176.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 59.0 mtt-85 -59.38 -28.44 66.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 119.078 0.853 . . . . 0.0 112.866 175.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -67.22 -57.84 5.95 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 118.025 0.375 . . . . 0.0 110.751 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.1 t -152.83 10.04 0.46 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -167.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.27 0.0 OUTLIER 34.71 52.35 0.56 Allowed 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 129.577 3.151 . . . . 0.0 114.657 176.18 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.81 -56.86 9.68 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.923 -178.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 107.08 113.32 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.494 1 C-N-CA 133.38 4.672 . . . . 0.0 107.386 -176.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -65.59 160.9 40.95 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 121.256 1.304 . . . . 0.0 110.117 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -78.66 128.72 33.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.44 -6.06 6.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 126.005 1.722 . . . . 0.0 111.433 177.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -122.06 52.76 0.74 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 109.334 -1.507 . . . . 0.0 109.334 162.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -131.66 178.82 6.46 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 118.75 1.275 . . . . 0.0 111.355 161.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -95.0 137.61 33.83 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.999 1.72 . . . . 0.0 110.392 171.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.74 169.82 23.04 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 124.274 1.03 . . . . 0.0 111.416 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -119.27 143.44 47.33 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 127.952 2.501 . . . . 0.0 107.923 -176.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.1 t -141.2 160.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 127.063 2.145 . . . . 0.0 108.514 -170.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -141.02 163.98 26.55 Favored Glycine 0 C--N 1.333 0.367 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 160.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 173.68 172.25 38.89 Favored Glycine 0 CA--C 1.521 0.427 0 C-N-CA 124.167 0.889 . . . . 0.0 111.189 176.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 44.7 ttm -91.9 125.98 36.81 Favored 'General case' 0 C--O 1.22 -0.465 0 C-N-CA 124.53 1.132 . . . . 0.0 109.474 -178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.523 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -65.69 123.44 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 120.705 1.593 . . . . 0.0 107.46 178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 2.4 ttm -63.14 139.18 97.51 Favored Pre-proline 0 C--O 1.236 0.393 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 168.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -64.11 158.29 48.86 Favored 'Trans proline' 0 N--CA 1.445 -1.372 0 N-CA-C 108.276 -1.471 . . . . 0.0 108.276 172.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 19.62 57.91 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 116.857 -2.08 . . . . 0.0 115.494 166.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -120.23 -6.34 9.89 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 120.478 2.139 . . . . 0.0 113.323 167.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 3.5 t -62.3 85.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-N 120.796 1.635 . . . . 0.0 111.484 169.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -78.46 61.69 2.91 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 128.796 2.839 . . . . 0.0 107.408 170.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 14.2 ptm180 -69.91 148.81 48.52 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 120.75 -1.219 . . . . 0.0 108.8 168.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -92.63 108.64 33.14 Favored Pre-proline 0 C--N 1.327 -0.379 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 178.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -60.02 -22.04 67.65 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 CA-C-N 121.341 1.515 . . . . 0.0 111.296 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -95.98 -15.93 22.0 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.074 1.35 . . . . 0.0 111.476 -173.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.1 m -134.56 -142.59 0.19 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.556 1.142 . . . . 0.0 109.012 -177.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -132.96 -6.9 3.1 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.516 1.927 . . . . 0.0 110.159 -178.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.9 tptt -62.07 140.77 58.37 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 175.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.2 p -149.61 132.02 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.5 m -122.05 135.83 54.86 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 105.495 -2.039 . . . . 0.0 105.495 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -147.71 173.46 12.75 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 119.917 1.235 . . . . 0.0 110.087 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 97.2 m -118.6 142.8 47.28 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.864 1.266 . . . . 0.0 107.814 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.496 HD11 HG21 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -127.58 145.48 34.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.374 1.469 . . . . 0.0 107.098 175.497 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.5 p90 -149.45 176.42 10.61 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 123.9 0.88 . . . . 0.0 111.417 -168.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 52.6 p30 -160.4 -166.48 1.67 Allowed 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 125.655 1.582 . . . . 0.0 110.318 172.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.82 8.47 0.51 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.641 1.576 . . . . 0.0 113.66 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -122.87 -71.14 0.74 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -133.79 -171.01 12.5 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 124.196 0.903 . . . . 0.0 112.433 -172.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.2 p -140.98 149.79 42.24 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 123.975 0.91 . . . . 0.0 110.773 164.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 13.7 p -132.7 149.75 32.36 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.864 1.266 . . . . 0.0 108.054 -173.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.3 148.32 25.67 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.942 -1.481 . . . . 0.0 109.73 -178.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.496 HG21 HD11 ' A' ' 84' ' ' ILE . 60.9 t -135.58 123.32 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.138 0 C-N-CA 124.025 0.93 . . . . 0.0 110.764 171.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.0 m -89.31 136.78 32.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 151.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -132.52 165.19 24.94 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 127.037 2.135 . . . . 0.0 106.694 163.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 63.3 tt0 -140.07 113.11 8.23 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 167.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.99 166.55 23.06 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.4 tt -72.96 -15.47 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.888 -174.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.438 ' CD2' HG11 ' A' ' 126' ' ' VAL . 38.0 mt 78.83 165.09 0.12 Allowed Pre-proline 0 C--O 1.236 0.356 0 C-N-CA 130.827 3.651 . . . . 0.0 110.743 -178.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -61.13 140.37 89.01 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 N-CA-C 107.299 -1.846 . . . . 0.0 107.299 158.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -57.94 -31.45 66.86 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.903 1.281 . . . . 0.0 109.927 170.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.35 -33.26 71.24 Favored 'General case' 0 N--CA 1.437 -1.076 1 C-N-CA 131.984 4.113 . . . . 0.0 111.567 -179.466 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -59.73 136.6 58.05 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 120.023 1.283 . . . . 0.0 107.776 175.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.435 ' H ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -149.77 142.15 24.27 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HA ' ' CG2' ' A' ' 66' ' ' VAL . 11.7 pt-20 -68.53 117.42 10.26 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 119.192 -1.003 . . . . 0.0 108.476 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.523 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 114.8 -9.33 21.49 Favored Glycine 0 CA--C 1.537 1.431 0 CA-C-O 114.876 -3.18 . . . . 0.0 115.463 -168.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.435 ' HG2' ' H ' ' A' ' 104' ' ' ARG . 0.5 OUTLIER -94.53 169.7 10.0 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 123.622 3.711 . . . . 0.0 111.637 -173.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.81 127.57 8.04 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 165.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -123.48 176.16 5.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 126.434 1.894 . . . . 0.0 108.447 -173.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.422 ' CG2' ' HE2' ' A' ' 129' ' ' LYS . 2.1 t -129.29 128.88 67.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 C-N-CA 126.124 1.77 . . . . 0.0 107.228 164.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.82 167.06 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 CA-C-O 122.475 1.131 . . . . 0.0 111.8 159.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -161.41 144.53 12.5 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 170.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 166.61 -120.31 0.91 Allowed Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -138.35 152.46 48.48 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 117.758 0.779 . . . . 0.0 109.395 -169.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.12 143.41 33.94 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.339 1.056 . . . . 0.0 110.176 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -91.58 -77.22 0.43 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.563 -0.71 . . . . 0.0 110.992 178.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -174.23 -79.83 0.01 OUTLIER 'General case' 0 C--N 1.339 0.148 0 C-N-CA 126.86 2.064 . . . . 0.0 108.58 -170.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -77.3 47.76 2.7 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 125.783 1.659 . . . . 0.0 113.153 -174.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 16.2 m120 52.02 67.11 1.02 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.9 2.08 . . . . 0.0 110.904 -175.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -136.64 132.84 35.57 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.131 1.773 . . . . 0.0 106.613 178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.6 mm -99.95 127.07 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 C-N-CA 125.446 1.498 . . . . 0.0 109.046 174.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -78.72 74.99 5.24 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 164.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -51.21 140.02 17.4 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 122.032 0.92 . . . . 0.0 111.693 175.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.16 -17.32 12.83 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 126.69 1.996 . . . . 0.0 110.92 -176.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -137.85 -42.8 0.53 Allowed 'General case' 0 C--O 1.223 -0.296 0 CA-C-O 116.807 -1.568 . . . . 0.0 114.801 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.438 HG11 ' CD2' ' A' ' 99' ' ' LEU . 89.3 t 50.69 91.68 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 125.045 1.338 . . . . 0.0 111.18 -176.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.7 mt -98.67 159.54 14.88 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -117.0 17.96 14.79 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.911 0.884 . . . . 0.0 113.361 -162.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.422 ' HE2' ' CG2' ' A' ' 110' ' ' VAL . 42.5 mmtt 37.89 49.48 1.15 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.534 1.933 . . . . 0.0 111.462 -170.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -85.3 39.28 0.77 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.732 1.213 . . . . 0.0 108.866 173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.5 t0 53.39 81.51 0.09 Allowed 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.218 1.807 . . . . 0.0 110.544 -160.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -91.94 119.67 31.9 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 171.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.75 -165.14 1.62 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.685 0.794 . . . . 0.0 110.138 -166.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -61.24 108.13 0.87 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 56.4 m -79.79 137.34 54.36 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 173.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.25 178.75 1.04 Allowed 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.56 2.84 . . . . 0.0 112.183 172.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.37 -33.45 0.53 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.32 2.013 . . . . 0.0 113.786 175.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -82.19 59.93 4.7 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.107 0.963 . . . . 0.0 109.453 -171.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -165.15 -48.48 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 C-N-CA 125.163 1.385 . . . . 0.0 107.812 -174.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.83 -37.16 65.79 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.154 1.382 . . . . 0.0 110.619 -177.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.71 39.0 0.19 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.258 1.023 . . . . 0.0 111.094 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -153.94 -77.23 0.11 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.364 1.066 . . . . 0.0 110.269 171.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 8.3 ttm . . . . . 0 C--O 1.248 1.002 0 C-N-CA 128.565 2.746 . . . . 0.0 113.104 -169.334 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.469 0.525 0 CA-C-O 118.898 -0.572 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp180 -72.12 -53.94 11.24 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 118.603 0.638 . . . . 0.0 110.488 -171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 36.6 m -113.83 169.41 9.01 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.64 1.576 . . . . 0.0 109.573 172.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -126.91 120.58 29.5 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.737 1.215 . . . . 0.0 110.84 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.3 mm -72.23 159.31 5.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.534 0 CA-C-O 122.146 0.974 . . . . 0.0 110.293 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -62.55 129.89 42.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.58 1.952 . . . . 0.0 107.727 174.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 60' ' ' LEU . 2.5 pp -66.85 -176.54 0.51 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.159 1.784 . . . . 0.0 112.185 -169.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -156.56 162.14 39.93 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 124.957 1.303 . . . . 0.0 109.38 172.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -145.72 173.09 12.39 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 128.756 2.822 . . . . 0.0 108.601 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.1 p -135.36 165.4 36.64 Favored Pre-proline 0 CA--C 1.53 0.187 0 O-C-N 121.315 -0.866 . . . . 0.0 112.233 174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -62.16 -8.62 12.62 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 123.384 2.723 . . . . 0.0 116.205 -171.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.51 -38.0 4.09 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 120.586 1.539 . . . . 0.0 110.01 165.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -87.04 22.94 1.9 Allowed 'General case' 0 N--CA 1.449 -0.493 0 O-C-N 120.432 -1.628 . . . . 0.0 110.27 -162.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 4.1 mt -104.67 -50.92 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 164.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.856 ' H ' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -79.97 -41.23 26.35 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.369 1.867 . . . . 0.0 110.568 -169.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -82.19 4.09 24.72 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.995 1.318 . . . . 0.0 110.159 176.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.93 170.72 6.67 Favored Glycine 0 C--N 1.342 0.876 0 C-N-CA 125.995 1.759 . . . . 0.0 109.756 -166.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.5 tttt -85.98 157.69 20.06 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -162.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 24.4 ptt85 -81.08 -24.74 37.55 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.77 -1.206 . . . . 0.0 112.774 -171.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -61.29 -52.53 64.33 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 124.038 0.935 . . . . 0.0 111.27 -173.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 12.7 t -151.66 12.01 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 123.489 0.716 . . . . 0.0 110.933 -169.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 55.92 79.77 0.16 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.722 1.609 . . . . 0.0 110.374 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -131.55 166.27 21.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.099 1.76 . . . . 0.0 109.789 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.4 mmt -107.0 124.35 35.6 Favored Pre-proline 0 C--O 1.239 0.529 0 C-N-CA 125.093 1.357 . . . . 0.0 109.034 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -62.39 154.87 61.02 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 121.147 1.231 . . . . 0.0 110.673 167.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -79.78 130.78 35.62 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.039 -0.982 . . . . 0.0 108.658 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.5 t -60.56 -9.72 2.38 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.864 0 C-N-CA 122.844 0.458 . . . . 0.0 111.332 166.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -100.11 3.24 56.87 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-O 117.589 -1.673 . . . . 0.0 115.286 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.613 ' HG3' HD12 ' A' ' 60' ' ' LEU . 2.0 pt20 -115.29 173.51 6.47 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 120.88 2.34 . . . . 0.0 112.374 -161.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -98.41 135.36 40.11 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 175.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -158.17 174.91 14.47 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.752 0.786 . . . . 0.0 111.335 -178.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -131.89 153.3 50.37 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 125.253 1.421 . . . . 0.0 109.775 173.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.599 HG11 HG21 ' A' ' 91' ' ' VAL . 88.3 t -138.14 138.34 43.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 127.447 2.299 . . . . 0.0 107.74 -171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -124.32 116.41 2.8 Favored Glycine 0 N--CA 1.466 0.687 0 CA-C-N 120.795 1.634 . . . . 0.0 112.048 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.7 165.25 27.64 Favored Glycine 0 N--CA 1.447 -0.577 0 N-CA-C 110.192 -1.163 . . . . 0.0 110.192 -172.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.5 ttm -79.95 123.32 27.69 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.482 1.513 . . . . 0.0 107.789 166.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.7 t -64.21 125.47 21.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 176.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 38.6 mtt -52.77 121.51 22.95 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.123 0.569 . . . . 0.0 110.603 170.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.07 91.49 0.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 124.803 3.669 . . . . 0.0 109.192 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.73 62.7 0.68 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 -23.29 0.11 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 127.376 2.271 . . . . 0.0 111.05 170.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 t -66.12 93.23 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 119.704 1.138 . . . . 0.0 109.341 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -80.8 73.38 7.79 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 127.967 2.507 . . . . 0.0 106.618 172.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -70.88 136.93 48.94 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 172.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -73.02 127.13 89.9 Favored Pre-proline 0 N--CA 1.447 -0.577 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.43 -7.51 21.02 Favored 'Trans proline' 0 N--CA 1.448 -1.202 0 CA-C-N 119.625 0.902 . . . . 0.0 112.151 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -129.66 0.35 4.92 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 119.191 0.905 . . . . 0.0 111.88 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.33 173.39 11.65 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 120.224 1.375 . . . . 0.0 111.099 -176.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 9.4 mp -89.74 -2.01 58.15 Favored 'General case' 0 CA--C 1.531 0.222 0 O-C-N 121.804 -0.56 . . . . 0.0 112.052 179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -54.34 139.84 35.4 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 120.429 -1.42 . . . . 0.0 108.155 166.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 5.9 p -155.06 121.8 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.3 m -116.79 129.81 56.33 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 -175.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -139.77 175.4 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 119.283 0.947 . . . . 0.0 111.076 -178.358 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 89.3 m -123.9 142.69 50.91 Favored 'General case' 0 C--O 1.242 0.688 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 173.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.448 HG13 HG23 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -122.65 137.01 57.59 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 178.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -130.69 179.87 5.7 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.129 1.771 . . . . 0.0 108.276 -179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -152.91 -116.95 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 118.689 -0.672 . . . . 0.0 110.182 163.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -101.89 -1.97 30.91 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.824 1.193 . . . . 0.0 112.27 176.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -124.7 -70.27 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.796 1.238 . . . . 0.0 107.783 -156.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.47 -168.39 12.55 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.3 p -142.75 156.79 45.05 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.121 0.568 . . . . 0.0 111.65 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.599 HG21 HG11 ' A' ' 62' ' ' VAL . 23.6 m -138.01 147.64 25.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.782 2.033 . . . . 0.0 109.587 -171.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.23 153.73 24.56 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.609 HG11 HG21 ' A' ' 111' ' ' VAL . 3.2 m -135.67 145.28 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 163.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.4 t -112.77 125.8 54.73 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 162.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -124.27 158.91 31.42 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 125.168 1.387 . . . . 0.0 108.667 172.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -142.94 99.12 3.4 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 104.689 -2.338 . . . . 0.0 104.689 177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.0 170.34 29.84 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 124.603 1.097 . . . . 0.0 110.452 -175.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.8 tp -74.96 -17.51 16.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 124.617 1.167 . . . . 0.0 112.072 -165.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 5.1 tp 73.27 135.74 0.05 OUTLIER Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 127.955 2.502 . . . . 0.0 109.36 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -64.73 151.46 85.61 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.793 1.662 . . . . 0.0 108.999 -175.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -60.09 -29.08 68.35 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.717 0.77 . . . . 0.0 110.831 177.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -59.45 -38.4 80.65 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 116.971 -1.49 . . . . 0.0 111.18 176.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.456 ' CD2' HG11 ' A' ' 109' ' ' VAL . 23.9 t80 -67.06 134.56 52.12 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.341 1.456 . . . . 0.0 110.938 -172.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -140.14 169.43 17.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.072 0.949 . . . . 0.0 110.661 172.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -89.66 84.41 6.32 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.899 1.68 . . . . 0.0 108.001 -174.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 130.97 5.48 3.87 Favored Glycine 0 CA--C 1.527 0.792 0 CA-C-O 118.064 -1.409 . . . . 0.0 114.124 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -106.28 171.57 7.28 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 120.058 1.929 . . . . 0.0 110.761 174.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -83.47 110.93 3.35 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 176.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 103' ' ' PHE . 2.3 m -112.92 171.69 3.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 173.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.849 HG22 ' HB2' ' A' ' 127' ' ' LEU . 3.1 m -113.02 163.63 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 O-C-N 121.117 -0.989 . . . . 0.0 108.71 157.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 126' ' ' VAL . 2.2 t -113.97 157.56 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 156.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -141.89 148.83 39.38 Favored 'General case' 0 CA--C 1.504 -0.826 0 C-N-CA 127.351 2.26 . . . . 0.0 106.661 169.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 151.16 -114.69 0.66 Allowed Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 106.253 -2.739 . . . . 0.0 106.253 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -135.75 159.63 41.04 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 119.724 1.762 . . . . 0.0 110.371 -165.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.54 142.0 28.19 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 176.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.15 -66.62 0.89 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.473 0.709 . . . . 0.0 109.463 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.02 -50.32 0.08 Allowed 'General case' 0 C--N 1.347 0.483 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -175.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -112.52 -77.27 0.82 Allowed Glycine 0 C--N 1.329 0.149 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -141.14 33.48 1.72 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.897 1.679 . . . . 0.0 109.462 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -115.78 129.54 56.49 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.457 HG21 HG12 ' A' ' 111' ' ' VAL . 8.9 mm -102.68 133.61 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 C-N-CA 125.758 1.623 . . . . 0.0 108.535 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.2 108.0 12.38 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 157.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -69.31 141.98 54.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.299 165.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.56 -27.5 7.85 Favored 'General case' 0 CA--C 1.514 -0.429 0 C-N-CA 126.198 1.799 . . . . 0.0 108.971 178.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -155.82 -18.29 0.11 Allowed 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.616 HG22 HG22 ' A' ' 111' ' ' VAL . 21.4 t 51.41 99.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 127.428 2.291 . . . . 0.0 115.951 170.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.849 ' HB2' HG22 ' A' ' 110' ' ' VAL . 1.0 OUTLIER -109.4 125.07 52.01 Favored 'General case' 0 C--O 1.221 -0.397 0 C-N-CA 118.412 -1.315 . . . . 0.0 111.592 -163.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 102' ' ' LEU . . . -99.78 57.69 1.01 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.162 -1.586 . . . . 0.0 110.592 -171.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt 50.16 26.72 2.26 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.958 1.303 . . . . 0.0 113.706 173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.534 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.3 OUTLIER -80.65 58.99 3.44 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 126.611 1.964 . . . . 0.0 108.817 175.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.05 10.69 2.33 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 115.543 1.683 . . . . 0.0 115.543 167.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -76.16 162.33 28.07 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 120.623 -1.298 . . . . 0.0 110.566 178.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -159.19 -13.85 0.06 Allowed 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.127 1.371 . . . . 0.0 110.723 159.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -145.52 168.49 20.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 126.856 2.063 . . . . 0.0 106.702 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -135.35 129.8 18.87 Favored Pre-proline 0 C--O 1.239 0.529 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -64.78 174.15 4.91 Favored 'Trans proline' 0 CA--C 1.536 0.617 0 C-N-CA 123.051 2.5 . . . . 0.0 110.589 176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -81.69 -32.25 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 121.011 1.141 . . . . 0.0 114.454 177.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -74.29 66.68 1.33 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.592 1.557 . . . . 0.0 108.937 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.3 p -178.1 -53.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.227 0 C-N-CA 127.631 2.373 . . . . 0.0 106.382 -177.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -58.54 -42.89 88.87 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.792 0.837 . . . . 0.0 110.819 -167.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.79 -1.06 13.32 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.814 0.845 . . . . 0.0 110.998 -177.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -81.42 -56.6 3.94 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.999 0.818 . . . . 0.0 110.695 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 C--O 1.253 1.28 0 C-N-CA 125.872 1.669 . . . . 0.0 112.323 -163.891 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.0 tp . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 4.0 mpp_? -160.16 142.28 13.01 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 126.933 2.093 . . . . 0.0 106.379 157.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.0 m -149.29 158.32 44.08 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 165.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -162.47 176.33 10.57 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 118.226 0.466 . . . . 0.0 110.027 142.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.632 HG22 ' H ' ' A' ' 35' ' ' ASP . 10.3 mm -79.31 -154.4 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 172.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 34' ' ' ILE . 4.1 p30 -74.0 149.2 41.42 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 119.331 -2.106 . . . . 0.0 110.333 175.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD11 ' CE1' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -103.65 -174.22 2.49 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.915 1.686 . . . . 0.0 113.394 -168.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.444 ' O ' ' HE2' ' A' ' 47' ' ' LYS . 32.3 t80 -140.7 121.42 14.34 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.119 1.368 . . . . 0.0 109.812 -162.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.679 ' CE1' HD11 ' A' ' 36' ' ' LEU . 83.0 m-85 -110.21 -179.58 3.82 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.343 1.857 . . . . 0.0 109.282 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.0 p -147.55 162.3 32.5 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 125.811 1.645 . . . . 0.0 107.161 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.36 66.5 8.77 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 124.288 3.325 . . . . 0.0 109.628 -175.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . -168.3 -52.27 0.03 OUTLIER Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 178.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -75.74 -1.6 25.74 Favored 'General case' 0 N--CA 1.436 -1.149 0 C-N-CA 125.598 1.559 . . . . 0.0 111.388 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.7 mt -93.65 -30.98 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 170.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.83 -46.92 5.77 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.217 1.007 . . . . 0.0 111.282 -168.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -84.4 -36.52 22.36 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.154 1.382 . . . . 0.0 109.919 -172.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 137.21 133.83 3.2 Favored Glycine 0 C--N 1.336 0.569 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 -167.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' O ' ' A' ' 37' ' ' PHE . 7.3 tptp -62.13 129.58 41.46 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 119.085 1.443 . . . . 0.0 109.994 178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 26.0 mtm105 -72.03 -26.71 62.31 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 118.43 -0.795 . . . . 0.0 112.602 -173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -56.11 -73.3 0.06 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 120.058 1.299 . . . . 0.0 111.842 -179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.9 t -152.11 48.24 0.77 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 48.18 70.51 0.43 Allowed 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 123.22 1.486 . . . . 0.0 112.755 154.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -130.73 145.83 52.05 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.313 -1.767 . . . . 0.0 108.049 163.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 2.9 mmt -85.0 160.52 55.05 Favored Pre-proline 0 C--N 1.327 -0.412 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.62 148.71 37.53 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 121.843 1.695 . . . . 0.0 110.12 163.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.46 137.79 37.35 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 98.2 t -66.72 -8.21 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.622 0.769 . . . . 0.0 111.18 172.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -123.07 36.25 3.14 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 125.598 1.57 . . . . 0.0 110.064 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -136.02 163.88 29.27 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 119.411 1.606 . . . . 0.0 110.215 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -77.47 150.39 34.93 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.419 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -160.73 164.68 31.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.086 1.355 . . . . 0.0 111.093 169.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 12.5 ttm180 -106.51 155.04 20.01 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 126.011 1.724 . . . . 0.0 107.277 168.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 2.3 t -140.0 153.93 23.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 C-N-CA 127.075 2.15 . . . . 0.0 107.815 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.46 139.65 11.14 Favored Glycine 0 C--O 1.223 -0.574 0 N-CA-C 109.153 -1.579 . . . . 0.0 109.153 162.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.16 173.58 43.6 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 118.177 0.989 . . . . 0.0 111.51 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 26.2 ttm -109.0 123.82 49.73 Favored 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 124.522 1.129 . . . . 0.0 110.859 -168.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.837 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -66.28 129.45 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 120.889 1.677 . . . . 0.0 110.494 -171.05 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.3 mtt -62.68 139.81 97.0 Favored Pre-proline 0 C--O 1.238 0.451 0 CA-C-N 119.09 0.859 . . . . 0.0 110.154 172.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.75 140.43 80.32 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.696 1.597 . . . . 0.0 108.565 162.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.27 43.5 92.77 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.221 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 63.8 p -117.08 -84.33 0.64 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 171.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.305 1.7 p -22.49 95.48 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 130.817 3.647 . . . . 0.0 114.802 -170.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -92.22 90.99 7.54 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 129.089 2.955 . . . . 0.0 108.662 176.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.6 mtp180 -90.9 147.93 22.81 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -76.33 120.78 83.16 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 176.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -72.3 -8.74 23.26 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 CA-C-N 121.305 1.502 . . . . 0.0 113.037 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.0 -22.58 10.52 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.041 1.336 . . . . 0.0 109.713 -174.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 15.1 m -139.58 -160.56 1.08 Allowed 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -166.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 43.9 mt -113.32 -6.22 13.56 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.92 0.888 . . . . 0.0 112.055 -171.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.5 mmmt -55.12 139.47 41.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 125.039 1.336 . . . . 0.0 108.048 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.42 HG13 ' HB3' ' A' ' 95' ' ' TYR . 4.9 p -158.13 127.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.1 m -102.49 146.56 27.93 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 24.6 p90 -146.23 172.53 13.31 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.982 1.265 . . . . 0.0 109.684 168.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -115.59 145.4 42.71 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 172.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.766 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -131.21 126.34 58.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.57 1.148 . . . . 0.0 109.094 175.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 90' ' ' SER . 28.6 p90 -117.3 173.89 6.44 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 127.491 2.316 . . . . 0.0 110.34 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -152.61 -164.51 1.97 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.977 1.311 . . . . 0.0 108.328 171.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.83 -6.11 11.06 Favored 'General case' 0 CA--C 1.538 0.485 0 O-C-N 120.802 -1.186 . . . . 0.0 113.672 -179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.473 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -116.03 -75.65 0.58 Allowed 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 -174.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -127.76 -162.37 11.07 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.504 1.049 . . . . 0.0 113.0 -167.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 85' ' ' TYR . 93.8 p -144.9 160.44 41.3 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.623 0.769 . . . . 0.0 110.754 169.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.5 m -138.01 145.34 28.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.559 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 175.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 -76.94 151.9 35.52 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 168.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.766 HG11 HD11 ' A' ' 84' ' ' ILE . 6.2 m -131.73 141.51 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 O-C-N 121.943 -0.473 . . . . 0.0 109.766 165.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -104.45 132.7 50.4 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 165.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 80' ' ' VAL . 16.6 t80 -132.53 168.49 18.13 Favored 'General case' 0 C--N 1.317 -0.839 0 C-N-CA 125.465 1.506 . . . . 0.0 108.445 170.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -156.07 107.07 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 167.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.93 20.19 0.02 OUTLIER Glycine 0 N--CA 1.468 0.8 0 C-N-CA 116.254 -2.879 . . . . 0.0 118.195 171.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . 0.273 0.4 OUTLIER 59.21 117.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.641 1.977 . . . . 0.0 111.882 -168.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.531 ' CD2' HG11 ' A' ' 126' ' ' VAL . 23.7 mt -74.33 148.29 85.94 Favored Pre-proline 0 N--CA 1.453 -0.294 0 O-C-N 121.301 -0.874 . . . . 0.0 109.902 -175.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -60.7 156.73 41.06 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.314 2.676 . . . . 0.0 109.749 -177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -61.86 -40.95 97.13 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.252 -0.905 . . . . 0.0 110.665 -175.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 11.0 mp -58.18 -27.91 64.28 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.916 1.286 . . . . 0.0 111.44 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -55.53 129.77 40.2 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 119.617 1.099 . . . . 0.0 109.478 174.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.9 ptt85 -127.86 -164.23 1.35 Allowed 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 124.623 1.169 . . . . 0.0 111.158 177.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -103.06 129.19 49.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 153.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.837 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 97.4 8.82 56.0 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-O 115.524 -2.82 . . . . 0.0 114.754 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.65 165.28 11.88 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 121.829 2.815 . . . . 0.0 110.111 174.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -69.21 133.97 26.6 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 160.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.4 m -130.56 161.96 39.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 127.835 2.454 . . . . 0.0 105.801 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.7 t -118.41 138.5 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 170.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.412 HG23 HG21 ' A' ' 121' ' ' ILE . 15.2 m -117.06 166.02 11.83 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.404 0 CA-C-O 121.296 0.57 . . . . 0.0 110.059 166.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -158.44 146.31 18.25 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 116.79 -1.576 . . . . 0.0 109.148 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 150.91 -112.44 0.54 Allowed Glycine 0 C--O 1.228 -0.263 0 N-CA-C 107.231 -2.348 . . . . 0.0 107.231 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -134.45 162.95 30.82 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 120.366 2.083 . . . . 0.0 107.608 -175.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 3.4 tp -82.46 133.91 35.21 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 124.685 1.194 . . . . 0.0 108.533 167.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.619 ' HG2' HD21 ' A' ' 122' ' ' LEU . 6.9 tm-20 -80.61 -66.64 0.86 Allowed 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -168.35 -171.89 1.59 Allowed 'General case' 0 N--CA 1.445 -0.702 1 C-N-CA 133.161 4.584 . . . . 0.0 105.106 -175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -8.58 82.92 0.0 OUTLIER Glycine 0 C--N 1.34 0.773 0 C-N-CA 128.495 2.95 . . . . 0.0 113.623 164.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.5 m120 59.2 35.22 23.48 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.27 2.228 . . . . 0.0 114.767 167.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 19.4 t-160 -126.41 132.66 51.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.168 0.987 . . . . 0.0 111.045 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.412 HG21 HG23 ' A' ' 111' ' ' VAL . 20.2 mm -110.95 125.03 68.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 C-N-CA 128.131 2.572 . . . . 0.0 110.92 -173.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.619 HD21 ' HG2' ' A' ' 116' ' ' GLU . 3.5 mm? -79.72 73.64 6.44 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 124.916 1.286 . . . . 0.0 108.308 168.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -43.17 128.07 4.5 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 121.786 -0.571 . . . . 0.0 110.398 166.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.61 -26.99 13.33 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.084 1.353 . . . . 0.0 111.22 -178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.68 -41.99 0.61 Allowed 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 113.029 0.752 . . . . 0.0 113.029 -170.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.531 HG11 ' CD2' ' A' ' 99' ' ' LEU . 58.9 t 57.34 144.25 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 C-N-CA 126.892 2.077 . . . . 0.0 111.754 -168.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -139.21 159.89 41.1 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 174.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -123.31 39.73 3.89 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.705 1.602 . . . . 0.0 110.164 -177.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 9.2 mtmt 17.97 64.15 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 128.162 2.585 . . . . 0.0 112.251 -161.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.759 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.0 OUTLIER -66.74 -17.27 64.77 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.947 2.099 . . . . 0.0 111.204 167.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.1 t70 100.84 22.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 131.123 3.769 . . . . 0.0 111.043 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -50.97 129.93 24.55 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.013 1.725 . . . . 0.0 110.128 173.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -114.42 -26.49 7.94 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 125.389 1.476 . . . . 0.0 111.14 176.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -131.17 -177.66 4.49 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 127.106 2.162 . . . . 0.0 108.21 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 98.1 m -104.23 105.45 49.3 Favored Pre-proline 0 C--O 1.241 0.641 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.66 174.89 6.86 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.167 2.578 . . . . 0.0 112.302 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -71.19 -38.73 4.56 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 121.155 1.237 . . . . 0.0 112.921 174.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -75.42 32.82 0.11 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.989 2.116 . . . . 0.0 112.484 -162.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 2.9 m -157.76 -34.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 128.167 2.587 . . . . 0.0 109.966 -168.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -64.1 -42.56 96.85 Favored 'General case' 0 C--N 1.35 0.6 0 CA-C-N 120.199 1.363 . . . . 0.0 111.037 -170.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 11.3 tmtt? -168.72 70.01 0.08 Allowed 'General case' 0 C--O 1.236 0.395 0 C-N-CA 126.291 1.836 . . . . 0.0 106.608 168.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -155.16 19.23 0.43 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.542 0.737 . . . . 0.0 112.813 -165.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 C--O 1.246 0.878 0 C-N-CA 125.546 1.538 . . . . 0.0 108.444 -179.539 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.473 0.682 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 29.2 mtm180 -144.45 133.39 22.62 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.435 1.494 . . . . 0.0 108.789 -175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 70.1 m -145.25 118.38 8.88 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.451 1.5 . . . . 0.0 107.987 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -115.23 153.03 31.62 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 124.815 1.246 . . . . 0.0 108.636 177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG22 ' H ' ' A' ' 35' ' ' ASP . 25.8 mt 62.86 172.21 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 C-N-CA 126.366 1.867 . . . . 0.0 110.184 176.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.409 ' H ' HG22 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.14 149.04 7.35 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.8 1.64 . . . . 0.0 109.499 179.005 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.619 HD13 ' CE1' ' A' ' 38' ' ' TYR . 2.8 pp -78.27 176.8 8.95 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-O 122.099 0.952 . . . . 0.0 108.809 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -155.58 149.1 25.02 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 172.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.619 ' CE1' HD13 ' A' ' 36' ' ' LEU . 85.8 m-85 -136.8 -179.93 5.99 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 126.457 1.903 . . . . 0.0 107.794 170.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.0 p -146.11 164.34 25.62 Favored Pre-proline 0 C--N 1.318 -0.761 0 C-N-CA 126.236 1.814 . . . . 0.0 106.75 -177.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.51 64.31 5.58 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 123.916 3.078 . . . . 0.0 110.142 178.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -177.9 -50.06 0.07 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 106.082 -2.807 . . . . 0.0 106.082 -177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.21 -3.57 37.12 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.827 -0.808 . . . . 0.0 111.796 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.8 mt -94.4 -34.17 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.001 0.92 . . . . 0.0 108.723 166.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -85.63 -57.66 2.97 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.465 1.106 . . . . 0.0 111.311 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -85.45 -28.03 25.32 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.591 2.357 . . . . 0.0 109.423 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 116.31 158.57 11.47 Favored Glycine 0 C--N 1.338 0.654 0 C-N-CA 124.755 1.169 . . . . 0.0 112.189 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 7.2 tptt -47.86 124.69 7.71 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 125.556 1.542 . . . . 0.0 110.681 -176.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -63.13 -28.71 70.25 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 121.278 1.854 . . . . 0.0 112.682 -168.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -70.75 -34.82 72.25 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 126.43 1.892 . . . . 0.0 113.311 -173.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 t -168.23 -5.25 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.419 0.688 . . . . 0.0 112.435 -159.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . 0.358 0.0 OUTLIER 45.5 32.39 1.1 Allowed 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 129.148 2.979 . . . . 0.0 115.627 170.107 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -70.2 -4.67 22.71 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.532 1.533 . . . . 0.0 112.726 -177.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.5 mmt 59.71 158.95 0.1 Allowed Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 129.413 3.085 . . . . 0.0 112.492 -170.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.9 162.27 32.38 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 121.763 1.642 . . . . 0.0 109.241 154.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -79.58 152.78 29.89 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 162.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.747 HG11 ' HE3' ' A' ' 117' ' ' LYS . 76.2 t -90.65 0.64 8.59 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 123.896 0.878 . . . . 0.0 111.811 -178.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -133.41 61.58 0.65 Allowed Glycine 0 N--CA 1.45 -0.375 0 N-CA-C 107.855 -2.098 . . . . 0.0 107.855 165.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.416 ' HG3' HD12 ' A' ' 60' ' ' LEU . 3.0 pt20 -140.0 176.11 9.03 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.485 0.714 . . . . 0.0 110.965 168.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -90.75 135.28 33.82 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.905 0.882 . . . . 0.0 111.205 176.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -158.48 175.71 13.34 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.193 1.397 . . . . 0.0 112.424 177.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -114.53 148.95 37.18 Favored 'General case' 0 CA--C 1.52 -0.188 0 C-N-CA 127.941 2.497 . . . . 0.0 109.141 178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.63 134.68 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 C-N-CA 125.199 1.399 . . . . 0.0 107.536 168.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -107.98 143.66 16.07 Favored Glycine 0 CA--C 1.52 0.352 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 158.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -177.95 167.9 38.97 Favored Glycine 0 CA--C 1.52 0.398 0 CA-C-N 118.457 1.129 . . . . 0.0 111.579 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 31.7 ttm -93.73 121.91 35.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 125.605 1.562 . . . . 0.0 109.708 -174.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.613 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.1 OUTLIER -66.2 137.98 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 109.222 -176.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 45.5 mtt -62.31 144.02 95.25 Favored Pre-proline 0 C--O 1.235 0.342 0 C-N-CA 123.878 0.871 . . . . 0.0 111.894 174.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.67 61.57 8.23 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 124.592 3.528 . . . . 0.0 110.804 173.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 145.15 63.06 0.02 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.0 m -152.72 -23.74 0.16 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 174.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.252 0.6 OUTLIER -68.56 100.23 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-N 120.261 1.391 . . . . 0.0 111.334 -176.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -82.91 81.46 8.59 Favored 'General case' 0 C--O 1.237 0.446 1 C-N-CA 132.667 4.387 . . . . 0.0 109.455 171.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 10.1 mtt180 -77.12 140.09 40.14 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 171.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -71.15 137.76 84.5 Favored Pre-proline 0 C--O 1.24 0.605 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -171.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -69.49 -20.74 35.69 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 121.159 1.239 . . . . 0.0 112.571 171.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -129.35 14.12 6.09 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 124.16 0.984 . . . . 0.0 110.653 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.8 t -153.14 -176.14 5.64 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 123.281 0.632 . . . . 0.0 109.902 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.54 8.78 29.48 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 126.162 1.785 . . . . 0.0 109.729 161.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tmtm? -50.0 145.24 5.86 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 160.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.88 166.77 27.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-O 122.244 1.021 . . . . 0.0 109.114 169.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.67 116.16 7.1 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 104.373 -2.454 . . . . 0.0 104.373 163.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.502 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.1 p90 -125.07 175.85 7.08 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 121.503 1.956 . . . . 0.0 111.483 171.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.9 m -124.76 145.56 49.66 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 172.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -130.5 138.45 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 126.256 1.822 . . . . 0.0 107.465 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -130.04 174.65 9.58 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.612 1.565 . . . . 0.0 108.89 -178.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -157.1 -163.84 1.48 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 169.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.46 -3.41 0.98 Allowed 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.365 1.866 . . . . 0.0 115.269 -172.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -118.84 -79.79 0.6 Allowed 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -169.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -135.14 -159.24 8.59 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.927 1.251 . . . . 0.0 111.796 -169.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 93.6 p -146.96 162.09 39.43 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.497 HG12 ' HB3' ' A' ' 119' ' ' ASN . 14.2 m -142.99 145.28 23.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 125.776 1.63 . . . . 0.0 109.255 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.49 159.74 24.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.517 HG11 HD11 ' A' ' 84' ' ' ILE . 3.9 m -136.27 138.5 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 C-N-CA 124.301 1.04 . . . . 0.0 109.134 168.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -108.1 106.72 17.06 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 127.054 2.142 . . . . 0.0 105.308 167.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -104.37 165.96 10.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.144 1.378 . . . . 0.0 107.487 171.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -157.12 117.33 3.51 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 170.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.92 -92.77 0.11 Allowed Glycine 0 N--CA 1.47 0.925 0 C-N-CA 115.246 -3.359 . . . . 0.0 118.234 165.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 10.1 tp -147.15 69.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.864 0 CA-C-O 123.881 1.801 . . . . 0.0 107.253 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.415 ' CD1' HG11 ' A' ' 126' ' ' VAL . 21.4 tp -49.85 135.09 20.63 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.371 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -63.3 138.82 68.38 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 N-CA-C 108.169 -1.512 . . . . 0.0 108.169 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -64.31 -14.82 58.33 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.462 170.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 10.3 mp -78.15 -23.78 47.59 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.655 1.582 . . . . 0.0 111.916 176.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -58.7 122.73 14.22 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 174.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -120.62 153.37 36.91 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 125.263 1.425 . . . . 0.0 107.232 171.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -76.13 117.49 17.88 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 173.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.613 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 122.21 8.93 6.91 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 116.376 -2.347 . . . . 0.0 115.864 -176.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.598 ' H ' HG13 ' A' ' 66' ' ' VAL . 0.0 OUTLIER -133.57 167.68 20.04 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 121.774 2.787 . . . . 0.0 112.305 -165.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -82.67 81.92 1.68 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.523 1.535 . . . . 0.0 112.348 -167.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -79.16 168.93 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.786 0.834 . . . . 0.0 109.916 -177.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.61 115.53 37.79 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 171.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 126' ' ' VAL . 2.1 t -105.31 156.75 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 127.086 2.155 . . . . 0.0 108.557 172.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -154.57 138.94 16.71 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 127.593 2.357 . . . . 0.0 106.154 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 163.96 -112.69 0.52 Allowed Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 105.936 -2.866 . . . . 0.0 105.936 169.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -140.9 157.68 45.03 Favored 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 119.432 1.616 . . . . 0.0 109.507 -167.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -91.48 154.71 18.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.953 1.301 . . . . 0.0 109.084 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -119.4 -79.09 0.59 Allowed 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.903 0.881 . . . . 0.0 110.675 -171.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.747 ' HE3' HG11 ' A' ' 56' ' ' VAL . 1.0 OUTLIER -178.29 169.04 1.88 Allowed 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 130.871 3.668 . . . . 0.0 106.325 177.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 59.39 20.92 52.76 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-N 119.455 1.025 . . . . 0.0 113.696 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.497 ' HB3' HG12 ' A' ' 91' ' ' VAL . 29.7 m120 54.64 68.07 0.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.121 1.368 . . . . 0.0 112.269 -164.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -131.18 132.56 44.81 Favored 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 124.55 1.14 . . . . 0.0 109.188 177.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 93' ' ' VAL . 20.9 mm -105.18 133.49 49.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 C-N-CA 126.164 1.786 . . . . 0.0 110.285 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.05 109.65 13.56 Favored 'General case' 0 CA--C 1.511 -0.555 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 160.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -82.48 139.19 34.08 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.83 -18.25 13.74 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.876 1.27 . . . . 0.0 111.513 178.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -139.31 -43.99 0.46 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -170.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.446 HG22 HG22 ' A' ' 111' ' ' VAL . 58.5 t 53.3 108.8 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 C-N-CA 126.767 2.027 . . . . 0.0 115.164 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.693 HD22 ' HG3' ' A' ' 132' ' ' GLU . 70.6 mt -124.1 152.38 42.8 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.74 1.616 . . . . 0.0 107.712 -177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.508 ' HB3' ' CD2' ' A' ' 130' ' ' HIS . . . -114.17 27.68 9.31 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 119.92 1.236 . . . . 0.0 110.806 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt 44.57 49.7 8.43 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.317 1.847 . . . . 0.0 113.183 -176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.508 ' CD2' ' HB3' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -90.02 -93.45 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 170.879 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -138.32 -59.91 0.62 Allowed 'General case' 0 CA--C 1.512 -0.518 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 -170.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.693 ' HG3' HD22 ' A' ' 127' ' ' LEU . 10.6 mm-40 50.21 75.03 0.19 Allowed 'General case' 0 C--O 1.234 0.258 0 C-N-CA 125.102 1.361 . . . . 0.0 110.137 -172.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -70.35 156.41 39.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 162.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -77.36 171.06 15.46 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.977 0.911 . . . . 0.0 109.271 164.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 88.0 m -133.53 130.85 21.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 166.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -66.34 174.79 5.68 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.441 2.761 . . . . 0.0 111.68 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -73.9 -32.43 7.23 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.515 1.477 . . . . 0.0 113.969 175.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.6 mp0 -68.34 46.03 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 127.826 2.451 . . . . 0.0 112.31 -174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.6 p -179.05 -50.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 C-N-CA 128.009 2.524 . . . . 0.0 106.84 -168.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -62.94 -20.33 65.11 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.39 0.676 . . . . 0.0 111.78 -175.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -129.74 133.86 47.27 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 155.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . 56.75 80.1 0.16 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 127.039 2.135 . . . . 0.0 112.299 -172.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 54.9 mtt . . . . . 0 C--O 1.248 1.006 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 148.781 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.471 0.595 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.3 ttm-85 162.98 116.57 0.0 OUTLIER 'General case' 0 C--O 1.235 0.3 0 C-N-CA 129.647 3.179 . . . . 0.0 103.606 -165.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.2 p -141.58 81.99 1.8 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.804 0.729 . . . . 0.0 109.495 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 60.14 -167.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.252 1.021 . . . . 0.0 111.189 -172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.7 mt -127.67 134.4 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -71.56 123.55 22.71 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 125.393 1.477 . . . . 0.0 109.655 173.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.6 mt -67.07 161.5 24.31 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 148.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 10.7 t80 100.27 140.85 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 1 C-N-CA 134.046 4.939 . . . . 0.0 106.28 -164.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.464 ' CE2' ' HD2' ' A' ' 47' ' ' LYS . 9.8 m-85 -141.88 175.08 10.0 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 127.363 2.265 . . . . 0.0 106.289 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 40' ' ' PRO . 6.8 p -140.86 170.97 8.34 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.249 175.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 39' ' ' THR . 9.2 Cg_endo -62.98 -5.97 8.63 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.723 2.949 . . . . 0.0 118.009 -166.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.27 -35.13 5.83 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-N 120.424 1.465 . . . . 0.0 110.404 165.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -84.55 -5.64 59.31 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.462 -1.611 . . . . 0.0 111.342 -158.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.2 mt -87.95 -18.1 8.31 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 124.507 1.123 . . . . 0.0 110.769 172.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.491 HD12 ' CE1' ' A' ' 45' ' ' TYR . 0.1 OUTLIER -111.06 -52.89 2.75 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -175.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' CE1' HD12 ' A' ' 44' ' ' LEU . 9.4 m-30 -80.28 -32.41 38.16 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.892 0.877 . . . . 0.0 111.3 -169.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 143.59 142.0 3.89 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 107.914 -2.075 . . . . 0.0 107.914 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.464 ' HD2' ' CE2' ' A' ' 38' ' ' TYR . 82.2 tttt -66.35 149.39 50.45 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-O 117.38 -1.295 . . . . 0.0 109.535 -175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.0 mtm180 -18.47 -71.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.225 1.41 . . . . 0.0 112.603 -142.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 19.0 mp0 -68.7 -85.73 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 14.6 t -158.49 6.67 0.12 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.86 0.864 . . . . 0.0 111.087 174.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -51.66 66.93 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 120.589 -1.319 . . . . 0.0 114.041 -150.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.11 161.69 17.28 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 171.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 13.7 mtp -87.38 163.96 37.27 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -69.02 155.41 68.48 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 121.276 1.317 . . . . 0.0 110.057 167.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -81.7 131.03 35.25 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 166.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 t -65.45 1.37 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.937 0 C-N-CA 126.102 1.761 . . . . 0.0 112.469 172.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -129.55 25.57 4.47 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-O 116.471 -2.294 . . . . 0.0 113.386 175.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -125.2 175.09 7.64 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 120.42 2.11 . . . . 0.0 112.861 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.407 ' HA ' ' HG2' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -85.7 140.01 30.88 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 125.464 1.505 . . . . 0.0 112.621 167.38 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.582 HD21 ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -160.77 171.5 18.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 126.269 1.828 . . . . 0.0 110.223 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 112' ' ' GLN . 0.0 OUTLIER -129.33 145.6 51.35 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 125.854 1.662 . . . . 0.0 108.282 179.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.5 t -123.68 132.66 71.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 105.656 -1.979 . . . . 0.0 105.656 176.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.55 153.15 20.11 Favored Glycine 0 CA--C 1.52 0.377 0 N-CA-C 106.981 -2.448 . . . . 0.0 106.981 157.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.48 -175.85 42.36 Favored Glycine 0 N--CA 1.461 0.364 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 22.0 ttm -118.87 125.26 49.11 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.27 1.828 . . . . 0.0 109.347 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.455 ' HB ' ' H ' ' A' ' 106' ' ' GLY . 58.0 t -65.57 124.25 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-N 119.242 0.928 . . . . 0.0 108.685 -169.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 5.6 ttm -59.66 124.23 75.03 Favored Pre-proline 0 CA--C 1.539 0.558 0 C-N-CA 124.293 1.037 . . . . 0.0 109.047 173.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.09 112.12 3.23 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 124.017 3.145 . . . . 0.0 110.404 -169.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.05 -15.06 51.86 Favored Glycine 0 CA--C 1.526 0.727 0 CA-C-O 118.74 -1.033 . . . . 0.0 112.051 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 82.7 p -67.13 -26.26 66.59 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.781 1.79 . . . . 0.0 112.877 -174.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.1 t -61.53 108.51 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 123.985 0.914 . . . . 0.0 110.148 -177.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -57.64 -70.39 0.13 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 126.105 1.762 . . . . 0.0 109.443 168.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 44.26 144.46 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 1 C-N-CA 131.736 4.014 . . . . 0.0 114.057 -164.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -88.3 131.58 42.02 Favored Pre-proline 0 C--O 1.235 0.316 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 171.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.78 -11.59 29.73 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 CA-C-N 120.858 1.342 . . . . 0.0 112.69 174.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -134.55 10.36 3.72 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.61 1.564 . . . . 0.0 110.639 -167.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -152.24 -172.65 4.29 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.765 1.226 . . . . 0.0 107.812 173.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.1 mp -107.19 -9.65 16.06 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 118.224 -0.893 . . . . 0.0 112.37 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.7 140.71 50.68 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 123.838 0.855 . . . . 0.0 109.269 172.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.91 145.0 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.7 m -147.1 135.87 22.14 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -175.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -147.13 174.58 11.45 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 124.491 1.116 . . . . 0.0 108.85 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -121.18 151.47 39.9 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 172.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 93' ' ' VAL . 0.0 OUTLIER -130.16 140.51 48.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -133.32 174.25 10.59 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.148 1.379 . . . . 0.0 109.388 -177.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -150.37 -165.67 2.33 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 127.593 2.357 . . . . 0.0 104.921 165.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.21 0.26 1.44 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.355 1.462 . . . . 0.0 114.263 177.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -110.37 -70.78 0.79 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 120.017 1.281 . . . . 0.0 108.718 -164.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -147.38 -166.51 12.54 Favored Glycine 0 N--CA 1.439 -1.114 0 C-N-CA 128.423 2.916 . . . . 0.0 108.188 -170.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.0 p -153.42 159.88 42.47 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 122.114 -0.639 . . . . 0.0 109.537 177.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.3 m -143.28 153.33 16.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 125.347 1.459 . . . . 0.0 110.122 -174.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -87.18 158.26 19.17 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 122.889 0.476 . . . . 0.0 109.978 177.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.414 ' CG2' HD11 ' A' ' 84' ' ' ILE . 44.7 t -141.35 120.62 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 C-N-CA 124.857 1.263 . . . . 0.0 108.388 173.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -96.83 131.55 43.46 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 162.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -131.85 167.66 19.18 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.353 1.861 . . . . 0.0 107.695 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -160.39 104.54 1.44 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 175.62 7.01 0.02 OUTLIER Glycine 0 C--O 1.225 -0.449 0 C-N-CA 116.272 -2.87 . . . . 0.0 117.026 175.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 99' ' ' LEU 0.281 0.4 OUTLIER 58.22 145.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-O 123.706 1.717 . . . . 0.0 109.66 -156.032 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.578 ' H ' HD13 ' A' ' 98' ' ' ILE . 14.1 mt -98.53 157.01 35.06 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 114.053 -1.43 . . . . 0.0 109.769 -173.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.02 150.9 84.64 Favored 'Trans proline' 0 N--CA 1.447 -1.231 0 N-CA-C 107.968 -1.589 . . . . 0.0 107.968 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -63.48 -23.03 67.22 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.994 0.902 . . . . 0.0 111.481 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -73.32 -20.88 60.69 Favored 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 125.725 1.61 . . . . 0.0 112.534 176.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.447 ' CE2' HG11 ' A' ' 109' ' ' VAL . 27.3 t80 -72.22 127.04 31.33 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 121.308 1.867 . . . . 0.0 108.216 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -135.74 166.42 23.32 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.489 1.115 . . . . 0.0 109.911 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -79.85 121.53 25.52 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.455 ' H ' ' HB ' ' A' ' 66' ' ' VAL . . . 101.64 17.67 20.76 Favored Glycine 0 CA--C 1.529 0.954 0 N-CA-C 115.609 1.003 . . . . 0.0 115.609 173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.78 174.61 7.02 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.199 1.499 . . . . 0.0 112.378 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.81 105.51 3.29 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 125.586 1.565 . . . . 0.0 111.288 -167.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.6 m -105.35 171.28 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.434 ' CG2' ' HE3' ' A' ' 129' ' ' LYS . 2.4 t -130.46 97.61 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 128.031 2.532 . . . . 0.0 104.193 176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 126' ' ' VAL . 2.0 t -79.6 154.77 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 124.579 1.152 . . . . 0.0 108.1 169.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 61' ' ' ARG . 9.1 tt0 -151.96 143.24 23.32 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 127.266 2.226 . . . . 0.0 106.115 168.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 174.33 -111.07 0.35 Allowed Glycine 0 N--CA 1.434 -1.447 1 N-CA-C 101.341 -4.704 . . . . 0.0 101.341 158.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.407 ' HG2' ' HA ' ' A' ' 59' ' ' ARG . 21.8 mt-10 -141.56 153.98 45.17 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 119.561 1.681 . . . . 0.0 109.34 -167.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 60' ' ' LEU . 19.5 tp -84.11 127.03 33.65 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 -175.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -79.27 -66.5 0.86 Allowed 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 123.51 0.724 . . . . 0.0 110.69 -168.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 2.3 ttmm -150.52 -66.54 0.2 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -92.45 -86.1 1.53 Allowed Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -139.34 51.68 1.76 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -176.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 13.2 t-160 -126.72 133.57 50.87 Favored 'General case' 0 C--O 1.225 -0.189 0 C-N-CA 125.313 1.445 . . . . 0.0 107.301 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.65 131.12 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.322 1.449 . . . . 0.0 108.92 177.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -78.99 100.84 7.48 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 158.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.5 144.61 46.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.791 0.805 . . . . 0.0 110.177 169.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 -22.78 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 127.171 2.189 . . . . 0.0 110.78 -178.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -154.19 -7.7 0.15 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.546 HG22 HG22 ' A' ' 111' ' ' VAL . 32.8 t 26.91 85.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.581 2.352 . . . . 0.0 114.49 173.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.9 mt -88.89 143.1 27.11 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.47 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -116.49 50.02 1.09 Allowed 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.361 1.064 . . . . 0.0 110.361 -178.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.434 ' HE3' ' CG2' ' A' ' 110' ' ' VAL . 16.9 mmtp 39.54 38.38 0.39 Allowed 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 127.074 2.15 . . . . 0.0 115.263 168.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.47 ' CE1' ' H ' ' A' ' 128' ' ' ALA . 0.0 OUTLIER -64.92 -49.52 70.06 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.603 1.161 . . . . 0.0 108.854 169.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -162.14 -26.93 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.18 0.808 . . . . 0.0 113.18 -178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -55.14 126.88 26.59 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.518 1.527 . . . . 0.0 113.064 -167.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -121.33 -175.01 2.98 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.762 1.225 . . . . 0.0 110.279 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -69.0 96.96 0.82 Allowed 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.908 1.283 . . . . 0.0 110.108 -172.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 136' ' ' PRO . 63.4 m -79.51 141.34 56.49 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.467 1.507 . . . . 0.0 109.735 177.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 135' ' ' THR . 21.1 Cg_exo -62.66 179.06 0.77 Allowed 'Trans proline' 0 CA--C 1.548 1.206 0 C-N-CA 124.339 3.359 . . . . 0.0 113.584 173.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -83.4 -172.89 1.47 Allowed 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 123.956 3.104 . . . . 0.0 111.194 162.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.17 36.43 24.89 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 126.719 2.008 . . . . 0.0 111.383 -170.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.0 -24.51 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 126.016 1.727 . . . . 0.0 109.45 175.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -59.79 146.7 40.74 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 15.9 tptm 40.81 64.97 0.86 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.015 1.326 . . . . 0.0 112.148 -174.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -156.02 -168.89 2.9 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.436 1.495 . . . . 0.0 107.138 167.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 15.2 mmt . . . . . 0 C--O 1.252 1.216 0 C-N-CA 127.402 2.281 . . . . 0.0 112.572 168.574 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 tp . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 119.494 -0.289 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.68 108.6 4.54 Favored 'General case' 0 C--N 1.345 0.39 0 O-C-N 120.931 -1.106 . . . . 0.0 110.055 176.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.5 p -68.39 149.38 49.42 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.37 0.605 . . . . 0.0 110.217 176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -147.94 171.43 15.8 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 163.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.456 HG22 ' N ' ' A' ' 35' ' ' ASP . 26.3 mt 61.96 -179.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.683 1.593 . . . . 0.0 109.07 -175.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.456 ' N ' HG22 ' A' ' 34' ' ' ILE . 0.4 OUTLIER -65.49 173.26 2.77 Favored 'General case' 0 C--O 1.239 0.521 0 O-C-N 120.297 -1.502 . . . . 0.0 110.135 161.18 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.558 ' H ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -73.99 -176.46 2.52 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.931 0.872 . . . . 0.0 111.431 170.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -170.72 152.2 3.7 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 130.549 3.54 . . . . 0.0 106.057 172.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -139.7 173.61 11.36 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.062 2.145 . . . . 0.0 108.711 175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.404 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 31.8 p -134.37 171.84 8.34 Favored Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 119.347 0.976 . . . . 0.0 112.054 169.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -56.35 1.59 0.13 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.989 3.126 . . . . 0.0 117.306 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.53 -24.98 5.66 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 121.296 1.862 . . . . 0.0 116.552 154.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HB2' ' H ' ' A' ' 39' ' ' THR . 11.0 mm-40 -67.84 -12.92 61.63 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 120.789 2.295 . . . . 0.0 112.284 -169.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.842 HG22 HD21 ' A' ' 119' ' ' ASN . 3.0 mt -105.8 -23.64 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.963 0 C-N-CA 126.929 2.092 . . . . 0.0 109.553 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.578 HD21 HG12 ' A' ' 91' ' ' VAL . 6.9 mt -87.4 -54.12 4.46 Favored 'General case' 0 N--CA 1.472 0.65 0 O-C-N 120.723 -1.235 . . . . 0.0 110.933 174.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -81.59 -76.51 0.25 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 126.389 1.876 . . . . 0.0 106.854 -171.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.6 161.42 23.75 Favored Glycine 0 CA--C 1.52 0.398 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -57.37 155.34 9.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 118.248 1.024 . . . . 0.0 108.514 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -19.53 -39.9 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.9 ' H ' HE22 ' A' ' 51' ' ' GLN . 12.7 mt-10 -121.55 -59.95 1.65 Allowed 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 120.019 1.281 . . . . 0.0 109.336 157.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 13.5 t -157.57 1.39 0.11 Allowed 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.9 HE22 ' H ' ' A' ' 49' ' ' GLU . 2.4 mp0 -58.34 -53.44 58.22 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 120.513 -1.367 . . . . 0.0 111.639 -147.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -170.72 142.23 1.95 Allowed 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.556 1.142 . . . . 0.0 108.111 167.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 15.3 mtp -73.46 161.69 77.84 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 162.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.25 162.44 33.92 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 121.127 1.218 . . . . 0.0 110.278 168.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -79.18 145.33 33.72 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 168.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.566 ' HA ' HD13 ' A' ' 115' ' ' LEU . 4.6 p -86.54 -2.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 125.056 1.343 . . . . 0.0 112.49 -173.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -127.9 71.85 0.48 Allowed Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 107.164 -2.375 . . . . 0.0 107.164 153.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.93 176.72 8.45 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.752 0.776 . . . . 0.0 109.62 157.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.8 ptt180 -79.56 138.88 37.62 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.399 165.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD21 HD12 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -148.31 166.21 28.71 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.293 0.637 . . . . 0.0 110.328 165.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 mtm180 -99.38 137.42 37.92 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.455 1.502 . . . . 0.0 108.504 166.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 54.6 t -111.37 158.38 11.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 125.443 1.497 . . . . 0.0 107.435 160.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.76 142.72 11.47 Favored Glycine 0 N--CA 1.453 -0.229 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 154.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.2 -177.25 40.89 Favored Glycine 0 CA--C 1.519 0.295 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 11.7 ttm -88.71 118.0 28.08 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 123.484 0.713 . . . . 0.0 110.257 -178.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 59.7 t -53.69 128.42 13.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 124.622 1.169 . . . . 0.0 109.085 176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 4.4 ttm -70.65 128.53 90.9 Favored Pre-proline 0 N--CA 1.449 -0.509 0 C-N-CA 124.058 0.943 . . . . 0.0 111.091 177.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -77.07 113.77 3.67 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 124.015 3.143 . . . . 0.0 110.701 177.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.409 ' H ' ' CD ' ' A' ' 105' ' ' GLU . . . 112.01 12.78 13.36 Favored Glycine 0 CA--C 1.524 0.647 0 C-N-CA 126.374 1.94 . . . . 0.0 111.898 -173.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.8 p -112.58 -34.98 5.67 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 120.135 1.967 . . . . 0.0 111.791 -175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.1 t -59.83 116.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 124.047 0.939 . . . . 0.0 110.187 -175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -120.46 63.82 0.84 Allowed 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 127.896 2.478 . . . . 0.0 107.919 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -66.75 143.78 56.72 Favored 'General case' 0 N--CA 1.472 0.631 0 O-C-N 121.021 -1.049 . . . . 0.0 109.509 169.299 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -71.86 129.81 87.67 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.37 -23.91 76.09 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 CA-C-N 122.281 1.85 . . . . 0.0 111.974 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -96.58 -3.97 42.03 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.298 -0.858 . . . . 0.0 112.848 -174.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.7 t -157.89 -169.74 2.93 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.904 1.335 . . . . 0.0 111.274 -163.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -113.91 -2.39 13.61 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 127.482 2.313 . . . . 0.0 110.293 178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.16 132.36 53.31 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 162.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 73' ' ' ARG . 2.9 p -152.1 141.4 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.236 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 177.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 36.6 m -133.95 148.77 51.21 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -148.94 -177.1 5.62 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 125.451 1.5 . . . . 0.0 109.725 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 85.1 m -127.98 152.93 47.31 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 105.272 -2.122 . . . . 0.0 105.272 172.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.55 HD11 HG21 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -126.66 152.49 34.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 106.567 -1.642 . . . . 0.0 106.567 176.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.58 174.95 10.06 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-O 121.798 0.808 . . . . 0.0 109.122 175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -151.3 -175.19 5.07 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 126.405 1.882 . . . . 0.0 107.553 -175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.73 -13.98 12.4 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.651 0.78 . . . . 0.0 113.037 171.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -109.84 -66.13 1.09 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.586 1.554 . . . . 0.0 107.276 -160.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.16 -162.67 11.58 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 126.096 1.808 . . . . 0.0 111.44 -176.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 85.8 p -141.65 159.16 42.8 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 118.26 1.03 . . . . 0.0 113.203 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.578 HG12 HD21 ' A' ' 44' ' ' LEU . 34.7 m -149.16 156.01 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 126.052 1.741 . . . . 0.0 111.537 -165.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.1 155.98 22.38 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 117.839 0.29 . . . . 0.0 111.235 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.55 HG21 HD11 ' A' ' 84' ' ' ILE . 57.6 t -139.94 124.51 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.362 1.065 . . . . 0.0 108.971 162.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 18.1 p -98.09 145.65 26.34 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 119.724 1.147 . . . . 0.0 108.386 159.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -139.88 167.72 21.47 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.734 1.614 . . . . 0.0 107.913 173.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -154.68 93.32 1.56 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 174.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.76 -175.4 44.54 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 118.538 -1.791 . . . . 0.0 114.096 -174.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.14 117.8 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 99' ' ' LEU . 14.2 tp -96.08 135.39 22.74 Favored Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 117.58 -1.2 . . . . 0.0 108.454 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -56.27 150.97 46.46 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.002 1.801 . . . . 0.0 111.686 -172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.96 -33.88 77.08 Favored 'General case' 0 C--N 1.332 -0.174 0 O-C-N 121.958 -0.464 . . . . 0.0 110.157 169.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.491 ' H ' HD12 ' A' ' 102' ' ' LEU . 6.1 mp -61.3 -40.26 93.52 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.877 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.693 ' CD2' HG21 ' A' ' 109' ' ' VAL . 22.2 t80 -54.47 125.34 19.17 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 124.93 1.292 . . . . 0.0 109.567 -166.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.02 157.09 45.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.409 ' CD ' ' H ' ' A' ' 69' ' ' GLY . 25.6 mt-10 -64.78 118.27 8.72 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.723 167.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 94.7 10.68 57.62 Favored Glycine 0 CA--C 1.526 0.774 0 CA-C-O 117.94 -1.478 . . . . 0.0 112.916 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.41 166.62 10.52 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 119.552 1.676 . . . . 0.0 109.765 162.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -79.3 138.46 20.53 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 124.57 1.081 . . . . 0.0 110.873 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.693 HG21 ' CD2' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -130.72 166.97 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 126.431 1.892 . . . . 0.0 108.463 173.542 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.16 131.4 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 127.167 2.187 . . . . 0.0 105.121 169.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.452 HG21 HG11 ' A' ' 93' ' ' VAL . 1.4 t -115.96 158.37 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 C-N-CA 125.481 1.512 . . . . 0.0 106.939 171.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -154.37 143.26 21.0 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 126.87 2.068 . . . . 0.0 105.616 176.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 171.79 -98.37 0.13 Allowed Glycine 0 CA--C 1.508 -0.362 0 CA-C-O 116.475 -2.291 . . . . 0.0 108.701 164.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.7 154.71 49.62 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 119.962 1.881 . . . . 0.0 108.946 169.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.566 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.4 OUTLIER -71.13 134.25 46.84 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 162.307 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -80.79 -70.98 0.49 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . 0.405 ' HA ' ' CG2' ' A' ' 56' ' ' VAL . 6.3 mtpp 172.86 -67.52 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 130.059 3.343 . . . . 0.0 108.612 -167.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . -83.81 57.66 5.04 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-O 118.85 -0.972 . . . . 0.0 112.887 -168.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.842 HD21 HG22 ' A' ' 43' ' ' ILE . 2.0 t-20 27.45 67.08 0.07 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 127.108 2.163 . . . . 0.0 113.269 -160.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -134.48 124.08 25.01 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 103.882 -2.636 . . . . 0.0 103.882 -172.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.444 HD12 HD21 ' A' ' 60' ' ' LEU . 13.6 mm -93.47 129.99 43.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 170.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -78.54 107.23 11.05 Favored 'General case' 0 CA--C 1.506 -0.75 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 160.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.36 141.93 41.35 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 122.134 0.968 . . . . 0.0 109.353 172.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.19 -15.68 14.44 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 126.867 2.067 . . . . 0.0 109.805 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -144.37 -49.44 0.27 Allowed 'General case' 0 C--N 1.349 0.552 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 -175.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 111' ' ' VAL . 93.8 t 62.88 135.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.548 0 C-N-CA 128.115 2.566 . . . . 0.0 112.091 -175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 17.7 mt -153.46 160.87 42.67 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -167.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.559 ' H ' ' CE1' ' A' ' 130' ' ' HIS . . . -119.16 54.7 0.97 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 121.505 1.957 . . . . 0.0 112.625 -163.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 22.8 mmmt 34.27 32.87 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 126.296 1.839 . . . . 0.0 115.792 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.633 ' H ' ' CD2' ' A' ' 130' ' ' HIS . 0.1 OUTLIER -89.16 56.95 3.86 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 128.19 2.596 . . . . 0.0 106.681 -169.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t0 47.94 41.0 14.09 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.414 1.486 . . . . 0.0 111.274 -171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -64.85 149.01 50.26 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 174.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -162.2 168.4 22.51 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.021 1.328 . . . . 0.0 108.039 171.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -39.75 117.32 0.73 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.136 1.374 . . . . 0.0 111.697 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 23.5 m -122.11 139.05 29.77 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 126.603 1.961 . . . . 0.0 106.214 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.66 -177.13 1.7 Allowed 'Trans proline' 0 CA--C 1.55 1.309 0 C-N-CA 124.168 3.245 . . . . 0.0 112.484 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.22 -44.14 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.794 2.33 . . . . 0.0 115.174 177.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -79.43 70.23 5.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 122.813 1.292 . . . . 0.0 108.743 -177.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 1.9 p -175.77 -37.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 128.725 2.81 . . . . 0.0 108.238 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -68.83 -78.77 0.06 Allowed 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.027 0.931 . . . . 0.0 108.874 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 75.55 1.16 Allowed 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 170.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -143.24 -26.5 0.58 Allowed 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 125.049 1.34 . . . . 0.0 110.248 166.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 C--O 1.255 1.374 0 N-CA-C 105.314 -2.106 . . . . 0.0 105.314 157.029 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 N--CA 1.471 0.617 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -148.24 158.24 43.97 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.951 1.7 . . . . 0.0 107.023 161.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 10.3 p -109.26 160.08 16.42 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 164.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -174.06 -69.18 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.185 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.4 mt -71.9 157.1 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 170.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.14 149.29 5.39 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 126.269 1.827 . . . . 0.0 112.875 176.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.51 HD13 ' HE1' ' A' ' 38' ' ' TYR . 2.1 pp -72.67 172.92 9.78 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 122.268 1.032 . . . . 0.0 109.381 159.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -169.76 149.66 3.83 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 128.822 2.849 . . . . 0.0 106.077 -170.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.616 ' CE2' ' HD3' ' A' ' 47' ' ' LYS . 86.4 m-85 -138.42 179.45 6.45 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.217 1.807 . . . . 0.0 109.587 -177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.54 ' H ' ' HB2' ' A' ' 42' ' ' GLU . 71.3 p -131.49 170.31 11.6 Favored Pre-proline 0 C--O 1.239 0.507 0 C-N-CA 124.241 1.017 . . . . 0.0 110.775 172.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -62.66 65.68 0.14 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.895 3.73 . . . . 0.0 110.815 161.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.466 ' HA3' ' HG3' ' A' ' 88' ' ' GLU . . . 167.52 -62.88 0.2 Allowed Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -158.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' H ' ' A' ' 39' ' ' THR . 28.4 mt-10 -65.66 -21.79 66.58 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.865 1.333 . . . . 0.0 111.9 177.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 3.4 mt -84.32 -13.97 11.45 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 124.146 0.978 . . . . 0.0 111.17 175.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 16.5 mt -115.41 -42.67 3.13 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 121.162 -0.961 . . . . 0.0 111.856 -164.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -107.71 -46.37 3.82 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 127.082 2.153 . . . . 0.0 109.504 -174.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.57 144.13 3.9 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 111.295 -0.722 . . . . 0.0 111.295 174.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.616 ' HD3' ' CE2' ' A' ' 38' ' ' TYR . 14.3 tptp -61.85 129.98 43.54 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 168.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 48.6 mtt180 -19.2 -64.3 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 127.312 2.245 . . . . 0.0 115.622 -138.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -80.08 -86.46 0.08 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 167.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.3 t -164.24 16.57 0.06 Allowed 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 118.881 0.764 . . . . 0.0 112.898 -170.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.07 -53.18 61.15 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 119.778 -1.826 . . . . 0.0 112.356 -168.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -168.18 135.73 2.17 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.681 0.792 . . . . 0.0 109.128 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 39.1 mtp -74.53 161.84 76.25 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 162.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -72.66 162.63 40.74 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 CA-C-N 120.307 1.145 . . . . 0.0 110.837 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -79.37 144.12 34.47 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.148 1.379 . . . . 0.0 108.197 166.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.67 0.85 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 122.879 1.323 . . . . 0.0 110.968 166.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -113.3 11.25 24.15 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 116.462 -2.299 . . . . 0.0 114.425 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -127.15 169.58 13.29 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.487 2.643 . . . . 0.0 111.715 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 35.1 ptt-85 -82.97 150.35 26.45 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.383 162.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.57 HD11 ' HB2' ' A' ' 115' ' ' LEU . 0.0 OUTLIER -156.12 -172.46 4.11 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 126.858 2.063 . . . . 0.0 108.749 171.614 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.17 150.05 48.87 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.517 1.127 . . . . 0.0 108.379 170.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 78.3 t -123.68 145.61 30.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 125.641 1.576 . . . . 0.0 107.439 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -122.18 124.23 5.67 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 165.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -159.7 164.09 33.94 Favored Glycine 0 CA--C 1.522 0.517 0 CA-C-N 117.693 0.746 . . . . 0.0 112.189 -176.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 12.6 ttm -95.67 122.46 38.46 Favored 'General case' 0 C--O 1.223 -0.305 0 C-N-CA 124.6 1.16 . . . . 0.0 110.286 -172.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.699 HG13 ' H ' ' A' ' 106' ' ' GLY . 0.2 OUTLIER -70.66 132.41 33.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.264 0 CA-C-N 119.676 1.125 . . . . 0.0 110.131 -172.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 51.8 mtt -60.93 151.89 72.23 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 123.902 0.881 . . . . 0.0 110.995 171.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.98 106.54 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 124.186 3.258 . . . . 0.0 109.409 176.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.55 36.49 91.51 Favored Glycine 0 CA--C 1.523 0.557 0 CA-C-O 118.396 -1.224 . . . . 0.0 113.241 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 59.8 p -80.72 -15.75 55.69 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 119.334 1.567 . . . . 0.0 111.887 162.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -82.16 96.16 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.571 1.148 . . . . 0.0 110.057 -168.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.01 78.6 7.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 125.681 1.592 . . . . 0.0 107.44 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -70.65 138.64 50.89 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 160.048 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 77' ' ' SER . 17.8 t0 -72.11 116.75 51.9 Favored Pre-proline 0 N--CA 1.45 -0.455 0 N-CA-C 103.964 -2.606 . . . . 0.0 103.964 169.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -70.83 -2.0 10.26 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.335 2.024 . . . . 0.0 113.574 -166.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -138.61 5.51 2.43 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.202 2.601 . . . . 0.0 112.021 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.473 ' HB3' ' HB3' ' A' ' 74' ' ' ASP . 4.3 t -120.57 -161.48 0.89 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.927 1.691 . . . . 0.0 108.901 165.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -124.74 -9.32 7.3 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 126.23 1.812 . . . . 0.0 110.537 177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.1 129.2 33.78 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 164.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.471 HG13 ' HB3' ' A' ' 95' ' ' TYR . 3.2 p -142.52 143.15 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.974 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 175.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . 0.301 35.8 m -140.99 133.57 28.61 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 104.634 -2.358 . . . . 0.0 104.634 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.512 ' CZ ' HG21 ' A' ' 93' ' ' VAL . 50.5 p90 -143.33 173.61 11.46 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 120.685 -1.259 . . . . 0.0 111.031 -175.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 47.5 m -128.37 136.89 51.55 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 177.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.477 HD11 HG11 ' A' ' 93' ' ' VAL . 0.4 OUTLIER -124.46 146.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 126.888 2.075 . . . . 0.0 106.035 -176.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -134.44 176.94 8.16 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 124.828 1.251 . . . . 0.0 109.505 -176.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -152.11 -168.71 3.15 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.967 1.307 . . . . 0.0 107.563 173.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.77 2.72 0.07 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.553 2.341 . . . . 0.0 113.722 173.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.466 ' HG3' ' HA3' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -126.7 -74.2 0.6 Allowed 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.133 1.373 . . . . 0.0 107.76 -164.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.88 -157.44 7.29 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.369 -0.693 . . . . 0.0 111.369 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.9 p -138.57 161.18 37.74 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 118.202 1.001 . . . . 0.0 111.9 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.13 149.55 16.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 125.745 1.618 . . . . 0.0 109.335 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -96.04 152.98 18.03 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 2.9 m -133.13 134.13 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.822 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.6 m -118.23 109.52 16.45 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 126.898 2.079 . . . . 0.0 107.355 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.471 ' HB3' HG13 ' A' ' 80' ' ' VAL . 8.9 t80 -115.49 171.2 7.87 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.997 1.719 . . . . 0.0 107.897 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -157.55 96.69 1.54 Allowed 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 176.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.81 178.8 42.38 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 tp -79.6 125.48 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.44 ' CD2' HG11 ' A' ' 126' ' ' VAL . 34.0 mt -75.85 149.79 83.29 Favored Pre-proline 0 C--O 1.236 0.394 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.252 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.49 146.32 89.18 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.593 2.195 . . . . 0.0 108.647 176.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -62.12 -24.23 67.02 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.104 -0.997 . . . . 0.0 111.597 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -19.52 60.87 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 127.759 2.423 . . . . 0.0 111.973 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -68.37 123.83 21.85 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 124.333 1.053 . . . . 0.0 110.599 177.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 8.0 mmt180 -136.5 140.73 43.23 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -66.76 113.85 5.18 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.699 ' H ' HG13 ' A' ' 66' ' ' VAL . . . 109.75 21.95 6.89 Favored Glycine 0 C--N 1.336 0.539 0 CA-C-O 116.741 -2.144 . . . . 0.0 113.436 -176.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.81 165.12 25.72 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.161 1.98 . . . . 0.0 111.308 179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -84.22 85.53 1.55 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 125.518 1.532 . . . . 0.0 110.739 -169.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 1.5 m -79.49 167.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 125.849 1.66 . . . . 0.0 108.877 -175.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.36 139.32 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 165.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.433 HG22 HG22 ' A' ' 126' ' ' VAL . 2.5 t -120.26 157.44 22.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.868 2.067 . . . . 0.0 107.505 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.98 146.51 25.65 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 127.893 2.477 . . . . 0.0 107.366 175.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 145.26 -131.44 4.23 Favored Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 104.447 -3.461 . . . . 0.0 104.447 -171.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -140.84 158.33 44.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 120.096 1.948 . . . . 0.0 110.841 -157.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.57 ' HB2' HD11 ' A' ' 60' ' ' LEU . 15.9 tp -90.75 128.78 36.8 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 123.771 0.828 . . . . 0.0 110.259 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.53 -66.75 0.9 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.674 0.79 . . . . 0.0 109.85 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.14 158.99 17.2 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 128.859 2.864 . . . . 0.0 106.42 171.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLY . . . . . . . . . . . . . . . 51.11 -99.21 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 124.34 0.971 . . . . 0.0 111.132 -175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -136.4 23.07 3.2 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.682 1.193 . . . . 0.0 110.815 -174.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 23.3 t-160 -92.03 128.03 37.72 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 29.2 mm -101.51 130.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 C-N-CA 125.343 1.457 . . . . 0.0 109.722 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.18 119.88 22.9 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 155.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -87.59 132.86 33.92 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.933 1.293 . . . . 0.0 108.789 171.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.27 -25.36 13.36 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.831 1.653 . . . . 0.0 111.693 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -142.67 -41.75 0.32 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 99' ' ' LEU . 20.0 t 62.98 139.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-O 124.654 2.168 . . . . 0.0 112.432 -172.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 40.2 mt -140.32 157.53 45.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 126.719 2.008 . . . . 0.0 106.181 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -121.33 42.06 3.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.383 1.073 . . . . 0.0 109.334 179.668 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? 51.34 33.65 10.33 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 127.75 2.42 . . . . 0.0 114.531 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . 0.453 ' CD2' ' H ' ' A' ' 130' ' ' HIS . 1.5 p80 -84.29 65.1 8.67 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 124.274 1.03 . . . . 0.0 108.676 177.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 41.6 t0 47.86 38.93 9.78 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 126.622 1.969 . . . . 0.0 113.221 161.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.36 130.29 42.44 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -131.18 136.71 48.52 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 106.287 -1.745 . . . . 0.0 106.287 151.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 4.3 t80 54.66 98.45 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.647 1.579 . . . . 0.0 114.796 179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 m -85.77 118.24 70.2 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 161.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -76.37 -176.56 3.16 Favored 'Trans proline' 0 CA--C 1.549 1.268 0 C-N-CA 123.1 2.533 . . . . 0.0 110.256 170.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -77.92 -179.57 5.57 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.106 1.871 . . . . 0.0 109.225 153.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 65.46 36.53 6.66 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 127.11 2.164 . . . . 0.0 111.16 -174.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.7 m -141.88 -40.74 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 123.892 0.877 . . . . 0.0 111.809 -178.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -61.26 -70.98 0.16 Allowed 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.392 1.477 . . . . 0.0 110.507 -166.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.49 ' HE2' ' O ' ' A' ' 141' ' ' LYS . 0.0 OUTLIER -140.35 6.9 2.14 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 125.986 1.714 . . . . 0.0 110.48 -176.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -119.75 85.36 2.36 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 105.523 -2.029 . . . . 0.0 105.523 167.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.257 1.452 0 C-N-CA 131.6 3.96 . . . . 0.0 106.795 174.613 . . . . . . . . 1 1 . 1 stop_ save_